data_2fho_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fho _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 18.1 tp . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.24 -0.652 . . . . 74.14 109.24 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.94 -41.88 90.76 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.833 0.853 . . . . 75.24 109.669 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.53 61.46 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.086 1.354 . . . . 51.53 111.48 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.0 mtp -88.95 -17.41 29.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.893 0.877 . . . . 64.55 112.64 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -83.11 145.51 49.38 Favored Pre-proline 0 N--CA 1.455 -0.212 0 CA-C-N 119.32 0.963 . . . . 72.25 110.212 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -67.28 157.49 61.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.423 2.082 . . . . 74.33 112.197 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.99 134.99 43.12 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.218 -1.356 . . . . 72.34 108.984 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.6 24.37 18.45 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-O 118.845 -0.975 . . . . 73.52 113.549 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.17 108.87 12.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.965 -1.495 . . . . 74.14 106.965 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.96 150.5 25.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 114.909 -1.041 . . . . 74.41 108.332 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.65 151.56 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.226 -0.657 . . . . 75.31 109.226 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 25.9 tp -120.76 78.88 30.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.999 0.92 . . . . 65.43 109.278 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.97 160.01 50.69 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 N-CA-C 108.346 -1.444 . . . . 61.14 108.346 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 157.5 61.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.141 1.894 . . . . 75.34 110.955 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.066 1.844 . . . . 72.41 109.755 -179.724 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 107.803 -1.184 . . . . 74.51 107.803 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.2 176.87 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.573 2.349 . . . . 72.21 108.022 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -77.54 -9.87 59.17 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.803 -0.56 . . . . 60.25 110.188 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -92.03 115.89 31.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.397 1.879 . . . . 64.12 107.641 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.51 127.02 55.59 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.473 1.509 . . . . 65.33 109.456 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -92.62 135.42 34.1 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.172 -1.418 . . . . 71.14 107.172 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mm -122.93 136.91 58.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.562 1.545 . . . . 74.22 107.968 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 mtp85 -123.42 162.06 23.55 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.786 1.234 . . . . 73.45 107.803 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.05 25.51 4.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.655 2.382 . . . . 63.14 113.776 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.27 150.81 97.17 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 108.215 -1.031 . . . . 60.33 108.215 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.66 151.6 85.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.728 1.619 . . . . 54.21 110.204 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -73.89 -25.46 60.04 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.704 -0.623 . . . . 75.43 110.364 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 109.56 17.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.259 -1.015 . . . . 74.13 108.259 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 tt -159.09 152.44 6.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.636 -1.246 . . . . 62.43 107.636 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 46.5 p -113.34 172.74 6.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.807 1.243 . . . . 72.45 110.33 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.9 -32.08 73.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.169 -1.048 . . . . 54.35 108.169 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.17 -49.61 63.44 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.722 2.009 . . . . 75.34 110.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -70.74 -49.93 41.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.26 1.024 . . . . 72.41 109.647 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 98.1 mmm -56.25 -43.35 78.62 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.694 -0.629 . . . . 64.35 112.186 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -67.82 -29.44 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.34 0.973 . . . . 75.54 110.789 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.56 -35.94 57.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.389 0.995 . . . . 71.44 110.585 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.26 -58.84 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 125.522 1.529 . . . . 60.21 110.84 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -74.09 -23.62 59.36 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.074 -1.016 . . . . 73.12 112.353 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -7.59 88.38 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.602 0.637 . . . . 61.14 112.638 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -63.06 -26.31 68.78 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.573 1.149 . . . . 75.32 111.745 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.58 -21.12 19.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.175 0.99 . . . . 75.42 112.802 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.71 -159.62 29.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.622 1.101 . . . . 74.14 110.387 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.92 151.25 56.38 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.381 2.054 . . . . 73.43 109.236 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mt -112.73 137.3 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.277 -1.749 . . . . 75.54 106.277 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -66.02 0.79 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.109 -1.071 . . . . 74.35 108.109 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -161.49 153.8 19.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.724 0.693 . . . . 75.24 111.41 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.0 150.75 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 123.223 1.487 . . . . 75.42 109.6 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -136.22 163.84 29.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 104.09 -2.559 . . . . 74.32 104.09 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -144.18 149.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 120.664 1.575 . . . . 74.22 108.4 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.2 139.1 48.38 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.85 -1.7 . . . . 72.14 108.85 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.67 -9.67 6.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.936 0.894 . . . . 75.52 112.332 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.94 159.73 32.53 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.52 1.928 . . . . 72.43 106.335 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.17 -29.57 89.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.95 1.767 . . . . 65.32 112.575 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -91.49 2.31 56.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.35 1.06 . . . . 74.12 112.786 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 49.5 p -116.42 -31.58 5.53 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.702 1.592 . . . . 75.24 112.452 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -54.52 136.04 45.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.264 1.026 . . . . 71.55 108.538 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.42 -5.57 44.79 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.078 0.847 . . . . 75.45 112.367 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 58.6 p -142.82 158.38 43.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 119.044 1.422 . . . . 64.32 108.849 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.21 160.59 21.4 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.446 0.698 . . . . 62.45 110.549 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.06 132.93 56.57 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 127.063 2.145 . . . . 74.22 106.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 89.3 t -111.82 150.5 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 125.302 1.441 . . . . 73.44 107.825 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -124.01 125.67 71.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.212 -1.403 . . . . 73.41 107.212 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -97.8 161.77 13.59 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.543 -1.28 . . . . 65.11 107.543 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -74.27 -31.24 62.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.167 -0.924 . . . . 74.53 111.765 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.63 172.45 8.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.763 1.225 . . . . 63.14 109.468 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -95.61 -29.16 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.986 -1.116 . . . . 62.14 107.986 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -62.44 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.713 1.605 . . . . 75.34 109.721 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.31 -35.05 74.7 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.402 1.081 . . . . 53.12 111.293 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -55.24 33.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.609 -0.886 . . . . 73.42 108.609 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -35.26 78.09 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.891 -1.052 . . . . 64.22 111.364 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -59.67 -53.46 57.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.984 0.811 . . . . 73.12 109.902 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.74 65.14 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 118.831 -0.604 . . . . 64.24 112.432 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.0 t -50.8 -48.77 59.52 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.314 1.046 . . . . 62.13 110.091 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -59.97 3.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.621 0.769 . . . . 63.15 109.373 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -15.54 9.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.922 1.823 . . . . 72.43 115.922 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 tp -99.67 -1.96 36.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.011 1.278 . . . . 74.33 111.153 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.1 p -75.47 132.59 40.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.257 -1.386 . . . . 71.35 107.257 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.29 10.28 81.7 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.048 -0.862 . . . . 63.12 113.114 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -66.45 133.91 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.961 1.381 . . . . 71.13 107.294 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.28 126.77 53.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.641 1.177 . . . . 74.24 109.119 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 5.4 m -136.83 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.115 1.766 . . . . 74.13 107.036 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 88.9 m 49.46 29.61 2.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.328 1.051 . . . . 63.13 111.887 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.7 m120 71.27 23.31 4.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.284 2.233 . . . . 72.31 113.279 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -132.14 141.74 49.23 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.223 1.409 . . . . 74.13 108.726 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -88.47 151.1 22.77 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.501 0.72 . . . . 73.12 109.164 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.44 167.67 9.68 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.878 -0.786 . . . . 73.43 108.878 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 79.4 t -132.73 137.75 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.538 -1.282 . . . . 71.33 107.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.9 139.89 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.328 1.451 . . . . 64.53 109.094 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 52.0 tp -146.42 165.43 29.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.154 1.782 . . . . 71.13 108.369 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.44 164.09 11.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.425 . . . . 74.44 112.486 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -83.32 115.14 21.86 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.772 1.229 . . . . 74.33 108.683 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 63.4 t30 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.201 -0.904 . . . . 75.53 110.852 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 60.8 tp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 108.176 -1.046 . . . . 73.53 108.176 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.93 -44.11 97.67 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.949 -0.76 . . . . 75.14 108.949 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.02 81.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.433 1.493 . . . . 63.2 111.6 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.47 -21.59 59.51 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.366 1.066 . . . . 75.22 112.527 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -76.71 152.65 83.1 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.076 1.307 . . . . 62.24 109.265 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.1 177.1 7.56 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.833 3.688 . . . . 74.52 112.521 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.01 143.58 26.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.111 0.964 . . . . 75.32 112.724 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.52 29.53 9.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.587 1.089 . . . . 73.51 113.658 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -125.98 157.12 38.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.049 1.34 . . . . 75.13 109.671 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.79 142.4 50.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.377 -1.342 . . . . 74.24 107.377 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.61 151.79 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.415 -0.957 . . . . 75.22 108.415 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.88 85.8 40.52 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.655 -0.653 . . . . 73.33 109.312 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.56 159.68 31.17 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.947 2.431 . . . . 62.44 111.051 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 166.47 26.76 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.385 3.39 . . . . 75.02 113.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 CA--C 1.541 0.838 0 C-N-CA 122.573 2.182 . . . . 75.42 109.238 178.537 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 t . . . . . 0 C--O 1.238 0.478 0 N-CA-C 106.982 -1.488 . . . . 75.05 106.982 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -131.82 159.15 39.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.532 1.533 . . . . 72.25 108.667 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -82.87 -25.24 32.73 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.706 0.802 . . . . 74.41 110.662 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -83.4 135.21 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 103.019 -2.956 . . . . 74.5 103.019 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.7 165.81 15.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.679 1.591 . . . . 73.25 108.518 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -129.04 130.25 46.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.951 2.1 . . . . 74.44 109.123 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -113.22 151.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.302 2.241 . . . . 75.13 107.849 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -146.57 159.93 42.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.661 -0.65 . . . . 62.43 110.945 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.97 19.03 11.75 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 127.204 2.202 . . . . 62.24 113.975 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 mt -58.92 152.77 47.69 Favored Pre-proline 0 C--O 1.236 0.372 0 C-N-CA 123.04 0.536 . . . . 75.04 112.239 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.92 144.53 96.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 73.01 110.34 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -77.78 -14.27 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.299 -0.876 . . . . 74.51 111.59 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -123.49 105.5 9.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.443 -1.688 . . . . 65.21 106.443 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 tt -156.59 164.35 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.915 1.686 . . . . 71.21 106.744 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.27 169.03 17.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.593 1.557 . . . . 73.41 109.336 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.22 -31.64 70.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.923 -0.561 . . . . 70.14 110.316 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.59 -39.79 71.18 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.388 1.475 . . . . 73.22 111.825 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -83.79 -47.79 10.76 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.646 1.178 . . . . 75.52 110.413 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.3 mmm -53.45 -47.98 69.22 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.609 0.364 . . . . 75.02 110.82 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -69.21 -34.96 75.68 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.281 -0.866 . . . . 72.53 111.672 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.28 -56.65 18.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.81 0.732 . . . . 74.04 109.328 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 48.8 mt -54.48 -63.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 126.751 2.02 . . . . 72.33 111.234 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -63.52 -24.34 67.77 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.204 0.911 . . . . 74.1 112.854 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.5 79.96 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.797 -1.001 . . . . 53.24 112.258 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -60.3 -19.34 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.53 1.665 . . . . 72.14 113.215 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.52 -31.25 8.2 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 117.404 -1.284 . . . . 74.1 113.861 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.0 -152.4 14.83 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 119.716 1.144 . . . . 73.31 112.774 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.18 162.48 28.56 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.163 3.242 . . . . 73.22 111.84 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.99 132.58 70.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.141 -1.429 . . . . 74.14 107.141 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -58.05 2.67 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.973 -1.121 . . . . 73.42 107.973 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -156.22 160.11 39.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.952 0.901 . . . . 64.35 109.368 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 48.7 mt -139.69 136.1 39.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.267 1.427 . . . . 64.53 108.0 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -137.77 143.57 41.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.247 -1.39 . . . . 73.34 107.247 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.84 165.37 27.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.287 1.035 . . . . 65.02 108.539 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.05 135.19 25.87 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 124.098 0.856 . . . . 74.52 113.054 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -104.88 -42.74 5.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.208 1.803 . . . . 71.22 109.211 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -66.32 158.78 76.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.906 -1.146 . . . . 73.33 107.906 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.55 -31.65 40.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.221 1.281 . . . . 65.23 110.947 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -70.99 -23.7 62.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.747 0.703 . . . . 72.33 112.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -89.94 -0.97 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.621 0.768 . . . . 64.11 111.79 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -67.84 120.48 14.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.291 -2.115 . . . . 74.5 105.291 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.11 2.34 36.04 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.116 0.865 . . . . 70.05 112.875 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 65.8 p -129.55 151.34 50.27 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.769 1.285 . . . . 74.14 108.058 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.55 171.13 16.26 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.001 -1.062 . . . . 74.3 110.74 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -138.38 151.87 47.9 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.947 0.899 . . . . 75.42 110.393 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.49 152.62 35.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.153 -2.166 . . . . 64.13 105.153 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 t -127.73 129.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.172 -1.788 . . . . 72.14 106.172 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.23 161.99 13.42 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.848 -1.538 . . . . 72.14 106.848 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.08 -43.85 41.64 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.722 -0.611 . . . . 72.42 111.083 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -123.02 164.13 19.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.78 1.232 . . . . 53.44 109.74 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.0 tt -83.33 -10.82 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 114.564 1.32 . . . . 74.55 114.564 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -83.55 -53.7 5.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.619 -1.252 . . . . 75.4 107.619 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.8 -40.56 88.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.746 0.654 . . . . 74.21 110.294 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.34 79.01 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.544 0.738 . . . . 73.13 111.082 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.57 -46.15 76.96 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 119.124 -0.465 . . . . 71.25 110.253 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -55.51 -44.57 76.75 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.731 0.645 . . . . 75.44 110.123 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.71 -50.01 54.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.481 0.712 . . . . 73.14 110.051 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.8 t -50.88 -54.16 26.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.624 1.17 . . . . 74.2 110.937 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -63.3 -33.8 76.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.268 0.84 . . . . 70.2 113.268 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -80.91 -23.29 39.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 118.607 0.639 . . . . 75.1 111.911 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.26 -23.6 22.28 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.167 0.508 . . . . 74.52 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -61.67 114.13 3.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.193 1.397 . . . . 70.25 108.677 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 10.63 75.01 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.394 -1.226 . . . . 74.52 114.578 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.6 119.11 9.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.573 1.187 . . . . 73.33 108.571 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.26 109.31 17.69 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.497 1.519 . . . . 75.43 110.431 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 10.6 m -141.23 151.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.702 1.201 . . . . 75.13 109.585 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 76.8 m 44.68 43.75 6.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.892 1.277 . . . . 73.03 110.661 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.53 35.49 11.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.138 2.575 . . . . 74.34 112.371 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -144.72 -179.99 6.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.311 2.245 . . . . 75.43 108.09 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -128.41 157.23 41.62 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.85 1.26 . . . . 71.54 108.909 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -120.15 119.3 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.195 -0.668 . . . . 74.14 109.195 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.14 122.73 38.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 126.847 2.059 . . . . 73.2 106.294 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.39 129.41 61.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.398 -1.704 . . . . 74.04 106.398 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.36 153.68 51.76 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.99 -1.115 . . . . 73.42 107.99 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -84.1 156.93 21.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 71.32 108.314 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.95 140.16 43.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 104.202 -2.518 . . . . 74.11 104.202 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.673 -1.232 . . . . 72.22 107.673 178.852 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . 0.444 ' CD2' HH22 ' B' ' 49' ' ' ARG . 29.4 tp . . . . . 0 C--O 1.224 -0.266 0 CA-C-O 118.779 -0.629 . . . . 73.53 109.712 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.18 -41.01 82.95 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.273 0.629 . . . . 72.35 110.291 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.87 -9.34 58.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.796 1.238 . . . . 74.2 112.871 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 79.9 mtp -76.21 -12.21 60.05 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.962 -1.086 . . . . 75.0 110.062 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -114.61 158.85 39.15 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.774 1.629 . . . . 75.41 112.601 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.37 170.93 17.19 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.978 1.785 . . . . 54.1 109.721 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -87.45 163.37 16.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.94 -1.027 . . . . 64.43 111.035 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.69 18.26 35.75 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.155 1.359 . . . . 65.03 112.415 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.26 157.05 39.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.15 1.38 . . . . 75.11 107.564 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -137.94 147.19 44.08 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.602 -0.518 . . . . 73.0 109.602 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.19 150.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.478 0.581 . . . . 74.11 109.664 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.08 86.21 57.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.23 -1.396 . . . . 74.0 107.23 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.49 159.55 27.23 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.951 2.434 . . . . 74.0 113.03 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.63 168.94 21.24 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.837 2.358 . . . . 75.54 110.803 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo . . . . . 0 C--N 1.348 0.517 0 C-N-CA 124.499 3.466 . . . . 74.41 115.348 -179.467 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 C--O 1.237 0.425 0 N-CA-C 106.645 -1.613 . . . . 75.44 106.645 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -121.96 -172.88 2.53 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.668 1.587 . . . . 73.45 109.449 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.37 -17.24 14.87 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.088 -1.008 . . . . 74.53 112.532 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.27 114.43 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.912 -1.514 . . . . 74.41 106.912 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 74.4 mt -102.97 170.83 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.251 1.02 . . . . 71.43 109.032 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -140.68 142.22 34.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.991 2.116 . . . . 74.03 106.509 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 mm -128.24 148.25 32.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 119.19 0.904 . . . . 74.42 108.711 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -133.42 162.31 32.2 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.264 1.825 . . . . 74.31 107.682 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.78 21.47 9.15 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.07 2.148 . . . . 74.31 112.292 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -61.03 155.25 55.9 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.396 1.078 . . . . 65.14 111.338 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.42 138.23 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.525 2.816 . . . . 71.11 111.05 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.47 -23.46 65.5 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.9 0.88 . . . . 72.51 112.635 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 113.58 14.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.024 -1.843 . . . . 74.32 106.024 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.5 129.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.195 -1.039 . . . . 73.3 108.195 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 12.5 p -83.23 169.15 16.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.385 -0.598 . . . . 73.01 109.385 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.78 84.47 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.663 -0.684 . . . . 62.14 109.47 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -47.98 -47.05 33.2 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.14 1.376 . . . . 74.34 112.571 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.87 -52.68 63.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.154 0.982 . . . . 75.15 109.701 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 75.4 mmm -59.38 -48.28 82.23 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.982 0.513 . . . . 63.11 110.812 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.22 -29.02 70.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.036 -0.983 . . . . 73.0 109.767 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.73 -62.28 1.45 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.726 1.148 . . . . 62.13 108.346 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 60.1 mt -45.44 -58.3 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.576 1.95 . . . . 70.3 111.339 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -78.04 -38.17 45.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.863 1.061 . . . . 65.32 113.863 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.04 -37.39 85.45 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.866 -0.894 . . . . 51.15 110.866 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -57.34 -31.48 65.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.463 0.631 . . . . 74.21 110.89 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -78.26 -55.35 5.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.599 -0.889 . . . . 73.3 108.599 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.81 -166.74 33.75 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.496 -0.752 . . . . 74.4 112.619 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.19 156.17 26.16 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.476 2.784 . . . . 72.31 114.453 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.83 102.84 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.175 -2.528 . . . . 73.52 104.175 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -75.77 -54.66 6.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.348 -0.982 . . . . 74.21 108.348 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -151.9 154.43 36.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.225 0.61 . . . . 70.41 109.613 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 80.1 mt -145.85 135.32 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.848 -1.538 . . . . 75.52 106.848 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . 0.444 HH22 ' CD2' ' A' ' 404' ' ' LEU . 13.6 mtm-85 -133.48 120.5 20.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.375 -2.084 . . . . 71.41 105.375 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.49 136.51 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 126.149 1.78 . . . . 71.31 110.404 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.35 134.67 45.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.114 -1.595 . . . . 61.42 109.114 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -118.79 -23.23 7.06 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.502 1.521 . . . . 71.12 112.824 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 64.1 p -70.84 158.61 87.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 75.44 106.904 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.09 -10.89 22.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.02 1.813 . . . . 75.22 112.618 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -97.07 -45.51 6.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.661 1.584 . . . . 64.42 109.51 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.4 p -76.51 -19.11 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.245 0.93 . . . . 73.23 113.022 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -52.89 139.27 27.73 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 107.428 -1.323 . . . . 73.55 107.428 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.85 -6.24 56.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.743 -1.032 . . . . 63.02 111.385 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -132.86 159.67 39.17 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 119.281 1.541 . . . . 71.31 111.115 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.36 164.8 32.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.726 1.611 . . . . 71.44 108.468 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.77 125.48 32.06 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.86 -1.534 . . . . 73.0 106.86 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.63 146.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.141 -1.8 . . . . 73.21 106.141 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.692 -2.336 . . . . 73.4 104.692 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -97.56 144.59 27.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.937 . . . . 75.53 108.471 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.15 -30.65 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 75.14 110.162 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -121.3 126.49 49.65 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.47 1.108 . . . . 74.41 109.487 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.73 -34.97 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.139 0.427 . . . . 73.03 111.621 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -61.45 -46.17 91.22 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.303 0.641 . . . . 74.23 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -67.6 -30.07 69.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.578 0.626 . . . . 73.12 110.139 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.3 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.807 -1.183 . . . . 71.02 107.807 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -60.29 -43.75 95.98 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 109.026 -0.731 . . . . 61.41 109.026 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.03 -58.03 9.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.008 0.923 . . . . 75.41 110.814 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.41 -33.49 71.3 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.264 1.026 . . . . 64.54 110.279 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.8 t -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.62 1.1 . . . . 63.11 109.289 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -48.32 45.84 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.947 -1.095 . . . . 70.3 111.711 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -65.13 -17.55 64.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.084 1.142 . . . . 75.4 114.084 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 tp -107.39 -17.54 14.1 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.988 1.267 . . . . 71.42 113.101 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -65.11 105.47 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.912 -0.493 . . . . 71.32 110.368 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.08 16.72 46.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.215 -1.325 . . . . 72.1 114.808 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.96 111.17 4.81 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.412 1.606 . . . . 74.52 109.028 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.88 120.08 19.94 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.004 0.921 . . . . 72.42 110.039 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -149.72 149.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.802 -1.555 . . . . 72.22 106.802 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 15.9 m 51.84 32.52 9.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.683 1.193 . . . . 74.53 112.711 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.54 30.63 17.57 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.761 1.624 . . . . 72.42 111.46 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -135.43 167.32 21.28 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 127.735 2.414 . . . . 74.12 108.076 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -115.27 124.17 50.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.148 0.979 . . . . 75.44 110.908 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -77.97 156.21 30.34 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.31 -1.367 . . . . 73.04 107.31 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.27 140.23 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.474 -1.676 . . . . 74.13 106.474 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.27 153.88 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.649 1.58 . . . . 75.12 107.308 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -157.06 165.88 34.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.466 1.506 . . . . 74.15 108.646 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -102.83 164.84 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.73 2.812 . . . . 75.33 110.76 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -114.79 160.76 19.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.206 -1.405 . . . . 75.04 107.206 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 115.985 -1.959 . . . . 74.02 111.38 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 111.742 0.275 . . . . 75.1 111.742 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.35 -44.37 62.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.869 1.268 . . . . 74.15 111.832 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.07 -22.55 62.1 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.623 0.369 . . . . 74.35 110.718 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.5 mtp -70.59 -38.59 74.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.629 -0.7 . . . . 65.14 109.517 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -72.18 155.54 91.52 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 119.352 0.978 . . . . 75.2 112.084 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.84 167.4 27.35 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.185 2.59 . . . . 73.34 111.372 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -79.45 153.32 29.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.309 1.444 . . . . 75.02 111.4 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.76 24.23 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.797 -1.001 . . . . 73.15 114.88 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -124.54 158.01 33.97 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.528 1.664 . . . . 74.4 111.901 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -127.28 133.95 50.1 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.457 1.503 . . . . 74.34 107.784 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.09 150.72 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.229 -1.397 . . . . 75.52 107.229 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.8 tp -125.07 78.02 66.71 Favored Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 108.667 -0.864 . . . . 63.53 108.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -56.76 162.79 8.11 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.076 2.517 . . . . 71.43 111.315 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 159.73 51.11 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.102 1.868 . . . . 73.24 110.914 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.452 -0.943 0 C-N-CA 122.671 2.247 . . . . 74.31 112.288 179.809 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.114 -1.439 . . . . 74.32 107.114 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.04 148.87 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.173 -1.788 . . . . 62.34 106.173 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.73 83.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 39.9 mt -68.56 116.08 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 125.934 1.694 . . . . 62.21 111.636 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 25.4 mt -104.2 149.15 25.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.111 -1.07 . . . . 75.41 108.111 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -123.7 137.56 54.68 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.511 -2.403 . . . . 74.21 104.511 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mm -125.41 151.2 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.583 -1.636 . . . . 74.43 106.583 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -136.27 164.28 28.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.549 1.94 . . . . 73.51 108.461 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.53 13.56 8.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.546 1.938 . . . . 71.21 111.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 67.6 mt -66.06 155.99 85.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.94 1.296 . . . . 73.51 112.715 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.59 153.3 72.58 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.11 2.54 . . . . 72.03 111.192 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -86.19 -19.81 29.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 74.34 110.496 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -130.39 115.59 17.09 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.797 1.639 . . . . 75.34 107.05 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 157.05 5.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.845 -1.168 . . . . 71.41 107.845 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 15.5 p -101.89 164.49 11.69 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.215 1.406 . . . . 74.33 110.363 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.4 84.27 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.504 -1.665 . . . . 73.42 106.504 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.46 -37.13 77.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.629 2.372 . . . . 63.24 111.16 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.61 -47.87 16.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.204 -0.935 . . . . 62.41 109.645 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.8 mmm -58.33 -42.86 87.75 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.336 0.516 . . . . 74.0 110.859 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -73.55 -34.95 65.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.932 -0.556 . . . . 64.54 111.444 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.25 -58.08 5.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.994 0.815 . . . . 75.45 111.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mt -52.16 -62.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.461 1.504 . . . . 71.24 110.734 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -64.96 -22.84 67.07 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 119.019 -0.515 . . . . 65.11 111.406 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -29.11 68.09 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 125.834 1.683 . . . . 62.41 111.171 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -61.44 -24.26 66.41 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.369 1.584 . . . . 75.51 110.185 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -88.94 -46.89 8.54 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.671 0.788 . . . . 73.54 110.386 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.17 -171.51 43.94 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 119.499 1.045 . . . . 72.22 114.835 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.47 116.57 3.71 Favored 'Trans proline' 0 C--N 1.347 0.477 1 C-N-CA 125.711 4.274 . . . . 72.15 113.985 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.1 mt -83.46 125.79 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.558 1.143 . . . . 73.12 109.731 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.36 -60.41 2.04 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.422 -1.325 . . . . 73.15 107.422 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -156.57 149.43 23.86 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.203 0.911 . . . . 74.1 109.497 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 29.5 mt -129.53 144.2 38.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.943 2.097 . . . . 74.13 108.48 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -141.96 154.79 45.31 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.335 -1.728 . . . . 74.34 106.335 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.01 165.7 19.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 72.1 109.354 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 145.78 49.39 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.532 -1.027 . . . . 74.4 110.532 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -105.18 -52.69 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.738 -1.208 . . . . 74.15 107.738 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 70.2 p -69.89 156.99 90.82 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 124.204 1.002 . . . . 74.42 109.825 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.81 -39.21 64.31 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.613 1.542 . . . . 74.02 109.796 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.64 -7.2 24.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.502 1.121 . . . . 75.33 113.398 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 8.3 p -102.25 -4.43 25.72 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.571 1.078 . . . . 74.4 109.651 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -69.86 150.04 47.23 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.156 -1.59 . . . . 73.01 108.32 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.18 -7.52 64.36 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.16 -1.356 . . . . 70.44 113.73 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.4 p -140.51 162.75 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.212 2.006 . . . . 74.45 107.346 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.66 173.63 10.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 71.42 109.98 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.63 144.72 50.82 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.801 0.841 . . . . 71.52 109.694 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 86.4 t -133.5 141.1 45.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.408 1.083 . . . . 74.14 108.626 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.92 130.64 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 106.454 -1.684 . . . . 73.53 106.454 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -104.09 166.35 10.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.869 2.068 . . . . 72.45 107.49 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.31 -69.54 0.3 Allowed 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.366 -0.834 . . . . 71.25 111.866 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.67 151.11 21.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.517 1.053 . . . . 73.25 110.642 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.5 tt -61.75 -33.86 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.483 0.713 . . . . 75.04 111.781 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -69.03 -47.67 64.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.103 -0.703 . . . . 73.52 109.103 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.04 -46.09 85.92 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.43 -54.85 42.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.161 1.385 . . . . 72.21 111.432 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -52.08 -36.83 51.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.706 1.202 . . . . 74.42 113.172 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -69.27 -36.3 76.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.896 0.771 . . . . 72.31 110.35 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.44 -32.06 71.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.108 0.867 . . . . 72.54 110.642 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 61.3 m -55.84 -41.57 74.49 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.075 0.55 . . . . 75.11 110.516 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -84.67 -35.98 22.23 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.547 0.739 . . . . 73.23 111.54 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -15.82 63.1 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.277 -0.889 . . . . 63.4 112.524 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.7 tp -104.84 -16.15 14.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.053 0.842 . . . . 75.42 112.206 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -72.2 134.67 45.79 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.446 -1.409 . . . . 72.22 110.085 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.32 10.1 84.38 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.777 1.18 . . . . 64.1 113.193 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -72.34 120.74 18.37 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.874 1.27 . . . . 71.43 110.078 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -87.79 120.07 28.75 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.19 1.796 . . . . 75.04 107.466 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.96 135.94 42.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.367 -0.975 . . . . 75.44 108.367 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.3 m 46.58 47.14 14.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.422 1.489 . . . . 72.51 112.194 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 18.0 m120 54.72 30.74 14.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.511 1.524 . . . . 72.05 112.786 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -136.2 -179.87 5.93 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.325 2.65 . . . . 75.34 106.48 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -139.59 133.84 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.326 -1.731 . . . . 62.31 106.326 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.89 172.79 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.352 -0.981 . . . . 73.22 108.352 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.59 140.13 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.28 -2.489 . . . . 72.23 104.28 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.81 142.72 41.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.807 1.243 . . . . 74.41 108.676 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -153.29 150.33 28.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.162 0.985 . . . . 74.14 109.665 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -85.55 163.49 18.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.098 1.359 . . . . 71.32 110.562 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -77.9 167.17 21.92 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.547 -0.538 . . . . 75.02 109.547 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.248 1.023 0 N-CA-C 105.422 -2.066 . . . . 63.14 105.422 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.2 tp . . . . . 0 C--O 1.223 -0.338 0 N-CA-C 106.971 -1.492 . . . . 74.32 106.971 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -65.45 -44.32 87.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.298 0.954 . . . . 71.41 110.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.84 60.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.502 1.121 . . . . 73.42 113.485 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.9 mtp -79.39 -6.6 57.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.062 1.345 . . . . 73.13 113.068 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -107.58 159.25 30.99 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 114.55 1.315 . . . . 73.44 114.55 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.66 158.94 54.87 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.215 3.276 . . . . 54.31 112.538 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -75.28 147.78 39.94 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.497 1.519 . . . . 75.11 109.165 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.35 17.41 62.52 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.529 -0.732 . . . . 64.45 114.656 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -124.35 102.97 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 105.325 -2.102 . . . . 73.11 105.325 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -83.78 155.39 23.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.508 1.123 . . . . 65.24 110.684 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.1 t -70.05 144.38 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.003 0.921 . . . . 75.25 110.193 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 50.7 tp -126.38 79.55 70.38 Favored Pre-proline 0 N--CA 1.452 -0.339 0 N-CA-C 107.346 -1.353 . . . . 71.44 107.346 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.18 163.81 37.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.124 1.883 . . . . 75.2 110.023 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.11 161.45 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.556 2.171 . . . . 73.01 109.774 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.451 -0.982 0 C-N-CA 121.43 1.42 . . . . 61.3 109.375 179.517 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.9 t . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 107.817 -1.179 . . . . 74.13 107.817 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -133.69 -176.97 4.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.4 1.88 . . . . 72.01 108.924 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.77 -43.86 5.45 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.649 -1.282 . . . . 75.44 111.607 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.5 mt -73.68 144.03 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.394 -1.335 . . . . 75.13 107.394 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 88.0 mt -124.18 157.2 35.28 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.737 1.615 . . . . 75.11 108.565 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -124.31 133.52 53.44 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.392 2.277 . . . . 74.23 106.837 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -120.29 146.95 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.601 1.16 . . . . 75.14 108.283 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -135.59 163.02 31.07 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.157 1.383 . . . . 74.0 109.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 65.08 14.69 9.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.952 2.101 . . . . 70.3 113.851 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.54 153.13 91.07 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 120.796 -1.19 . . . . 74.34 109.588 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.47 140.11 56.34 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.762 2.308 . . . . 74.53 110.532 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.58 -30.1 71.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.913 1.079 . . . . 75.03 113.913 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -130.26 117.91 20.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.888 -1.523 . . . . 74.41 106.888 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 tt -165.88 140.89 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.958 2.503 . . . . 72.23 104.366 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 18.0 p -75.12 174.4 9.47 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.027 0.831 . . . . 64.22 109.944 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.06 76.21 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 107.126 -1.435 . . . . 75.5 107.126 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -47.84 -54.3 12.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 128.326 2.65 . . . . 74.43 112.739 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -62.21 -49.51 75.48 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.36 0.527 . . . . 75.12 110.099 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 72.3 mmm -56.26 -49.44 74.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 119.213 -0.422 . . . . 75.2 111.088 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -61.51 -43.96 97.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.559 -1.21 . . . . 73.25 110.009 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -58.59 7.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.105 -1.072 . . . . 55.14 108.105 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 64.2 mt -47.61 -67.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.854 2.062 . . . . 72.35 112.345 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -68.34 -26.93 65.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.281 0.845 . . . . 74.21 113.281 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 -20.65 66.44 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 124.874 1.226 . . . . 64.34 112.983 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -26.75 68.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.387 1.593 . . . . 75.41 110.486 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -85.88 -10.16 55.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.784 0.661 . . . . 74.23 112.784 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.96 -171.59 22.37 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.355 0.98 . . . . 44.43 111.54 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.75 153.14 73.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.776 2.984 . . . . 74.04 111.36 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mt -118.21 138.25 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.286 -1.005 . . . . 75.34 108.286 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -51.9 9.78 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.17 1.388 . . . . 71.32 111.485 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -161.9 157.58 24.08 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.76 0.824 . . . . 74.34 109.473 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.4 mt -145.78 142.36 21.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.993 1.317 . . . . 73.33 108.268 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -145.45 150.76 37.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.763 -1.569 . . . . 72.42 106.763 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.16 147.27 30.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.468 0.707 . . . . 74.0 109.656 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.28 135.6 31.77 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.328 -1.909 . . . . 75.41 108.328 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.95 -21.36 5.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.876 1.065 . . . . 62.22 113.876 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.7 p -69.69 159.8 82.35 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 104.56 -2.385 . . . . 73.45 104.56 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.02 -45.36 36.56 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.505 1.47 . . . . 75.52 111.241 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.07 -5.8 29.3 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.826 1.417 . . . . 73.54 114.826 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -116.45 -18.07 10.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.293 1.406 . . . . 74.15 112.799 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -52.55 126.96 21.21 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.822 0.849 . . . . 75.44 109.686 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.05 48.33 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.459 -1.19 . . . . 70.13 112.653 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 61.6 p -127.56 146.81 50.4 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.03 1.915 . . . . 70.21 107.535 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -156.23 174.26 15.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.614 0.366 . . . . 73.13 111.229 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.14 155.46 48.13 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.396 1.078 . . . . 74.52 109.17 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -138.63 139.83 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 104.412 -2.44 . . . . 73.1 104.412 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.39 123.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.56 -2.015 . . . . 73.43 105.56 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -97.91 166.15 11.59 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.827 -1.546 . . . . 71.42 106.827 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -71.28 -47.6 55.9 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.754 -0.591 . . . . 72.44 109.774 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.86 154.6 38.06 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.911 0.778 . . . . 74.12 110.737 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.93 -37.5 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 113.736 1.013 . . . . 72.0 113.736 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -57.95 -48.23 80.58 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.161 -0.923 . . . . 75.03 111.528 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.14 -40.87 95.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 123.935 0.772 . . . . 72.24 109.349 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -54.71 42.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.156 -0.313 . . . . 73.45 110.156 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -69.76 -30.18 67.7 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.523 -0.751 . . . . 64.43 111.894 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.67 -53.97 51.79 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.109 -1.071 . . . . 72.33 108.109 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.03 93.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.417 1.087 . . . . 72.04 110.611 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 13.3 t -46.56 -69.16 0.14 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.823 1.249 . . . . 74.5 113.018 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.39 -27.77 67.37 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.074 1.138 . . . . 71.21 114.074 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -33.71 72.49 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.775 0.716 . . . . 73.13 109.607 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -90.01 -24.91 21.09 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.987 1.315 . . . . 71.33 112.992 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -57.34 111.26 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.481 1.512 . . . . 64.15 110.675 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.11 9.85 57.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.324 1.916 . . . . 74.02 114.43 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -61.74 130.03 43.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.543 1.671 . . . . 73.13 110.363 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -89.84 100.92 13.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.417 2.287 . . . . 64.13 110.653 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.84 133.51 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.402 1.081 . . . . 75.32 110.621 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m 42.79 49.41 5.03 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.827 1.651 . . . . 63.43 112.121 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 32.1 t30 58.94 33.25 22.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.603 2.361 . . . . 64.33 112.878 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -140.16 158.33 44.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.985 -1.072 . . . . 72.12 108.26 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -118.07 118.14 31.09 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.822 -1.547 . . . . 75.13 106.822 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.6 mt -73.63 174.05 8.87 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.692 -1.225 . . . . 73.25 107.692 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.02 137.4 52.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.094 -2.558 . . . . 71.33 104.094 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 t -126.83 121.67 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.743 -1.947 . . . . 74.41 105.743 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 34.6 tp -136.15 153.21 51.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.573 -0.899 . . . . 75.24 108.573 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -74.75 163.11 28.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.694 0.798 . . . . 73.12 108.949 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -104.49 154.58 19.72 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.957 -1.868 . . . . 75.53 105.957 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 C--O 1.246 0.871 0 C-N-CA 124.387 1.075 . . . . 74.1 110.652 -178.587 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 21.8 tp . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 110.302 -0.258 . . . . 73.23 110.302 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.93 -36.87 80.87 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.965 -0.459 . . . . 64.44 111.042 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.5 -37.62 36.27 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.378 1.071 . . . . 42.23 110.851 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.2 mtp -66.41 -12.51 57.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.519 1.128 . . . . 74.43 111.846 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -99.25 157.28 34.32 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 124.095 0.958 . . . . 74.35 110.107 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -89.41 172.5 4.09 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.199 2.599 . . . . 64.21 109.017 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.63 159.34 33.2 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.606 -0.684 . . . . 62.44 110.906 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.2 20.97 58.04 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 117.825 -1.541 . . . . 75.22 115.451 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -125.49 140.09 53.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.985 1.893 . . . . 74.03 110.631 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -122.26 151.28 41.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.572 1.949 . . . . 74.45 109.104 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.86 151.38 6.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 122.563 1.173 . . . . 64.43 110.604 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.0 tp -126.48 87.47 56.3 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 103.398 -2.815 . . . . 74.11 103.398 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -64.01 168.9 11.35 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.222 2.615 . . . . 72.43 111.226 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.74 163.3 35.83 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.37 1.38 . . . . 73.31 108.661 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo . . . . . 0 C--O 1.24 0.579 0 C-N-CA 123.604 2.869 . . . . 73.33 113.745 179.462 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.236 0.365 0 N-CA-C 107.511 -1.292 . . . . 75.14 107.511 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -61.92 152.52 31.79 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.743 1.217 . . . . 75.43 110.43 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 -59.11 -61.48 2.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.418 -0.801 . . . . 72.13 112.903 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.79 134.41 26.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.005 -0.739 . . . . 74.51 109.005 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.35 157.52 26.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.947 2.099 . . . . 73.41 109.175 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -124.93 135.7 53.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.493 1.917 . . . . 72.32 108.397 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mm -118.12 143.07 29.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 126.193 1.797 . . . . 74.21 108.767 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -133.6 162.59 31.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.324 . . . . 73.44 107.571 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 21.5 t30 65.58 30.23 10.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.422 2.689 . . . . 72.33 111.666 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 50.8 mt -70.06 147.67 95.78 Favored Pre-proline 0 C--O 1.236 0.348 0 O-C-N 121.736 -0.603 . . . . 74.22 111.196 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.99 152.49 68.16 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.826 2.351 . . . . 74.04 110.579 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -83.95 -11.03 57.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.496 0.718 . . . . 72.31 112.107 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.86 113.85 17.12 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.36 -2.089 . . . . 75.54 105.36 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -163.2 167.62 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.785 -1.561 . . . . 73.35 106.785 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -133.98 175.71 9.23 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.203 1.801 . . . . 74.11 111.607 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.02 -35.87 80.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.881 -0.785 . . . . 62.33 108.881 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.43 -50.63 71.1 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.771 -0.455 . . . . 74.23 109.771 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -63.72 -55.07 26.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.582 1.153 . . . . 71.04 111.374 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.8 mmm -57.28 -27.67 62.33 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 113.749 1.018 . . . . 74.44 113.749 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -93.85 -20.62 19.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.909 0.777 . . . . 65.0 111.208 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.9 -52.19 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.219 0.918 . . . . 54.12 110.957 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.99 -52.75 40.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.786 1.634 . . . . 75.22 110.858 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.93 -30.47 39.96 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 118.146 -0.93 . . . . 74.14 113.13 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -31.58 78.55 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.871 -0.892 . . . . 72.33 110.871 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -60.4 -15.35 25.38 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.203 1.401 . . . . 72.12 113.023 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.01 -16.76 14.21 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.315 1.046 . . . . 74.4 113.616 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.1 174.72 29.18 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.055 1.312 . . . . 74.53 110.902 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.48 145.4 64.64 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 124.297 3.331 . . . . 63.21 110.946 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 24.4 mt -99.78 124.68 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.547 1.139 . . . . 72.24 111.231 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -83.19 -56.34 3.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.56 -1.274 . . . . 74.03 107.56 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -157.72 152.85 25.72 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.426 1.012 . . . . 64.3 112.456 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mt -134.46 118.29 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.963 2.105 . . . . 74.41 107.627 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -127.21 120.34 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.119 -2.178 . . . . 73.33 105.119 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.41 159.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.235 2.214 . . . . 74.21 111.095 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.88 146.69 38.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.107 -1.597 . . . . 62.12 109.107 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -112.73 -45.61 3.2 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.471 1.108 . . . . 73.1 111.61 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 15.6 p -74.42 162.14 75.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.941 1.696 . . . . 73.35 111.858 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.88 9.29 2.03 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.626 2.884 . . . . 73.13 112.319 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.64 1.51 11.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.889 1.276 . . . . 71.13 111.521 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 35.6 p -116.75 -1.2 12.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.801 2.04 . . . . 74.02 109.461 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -63.77 145.9 54.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.806 2.042 . . . . 75.31 112.194 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.52 6.16 70.05 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.851 -0.971 . . . . 74.15 112.873 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 21.1 p -141.1 150.35 42.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.041 1.42 . . . . 75.41 110.613 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.92 171.32 14.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.444 1.498 . . . . 74.41 109.107 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -118.11 159.98 22.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.245 1.018 . . . . 71.13 109.428 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.36 139.11 47.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.278 -1.379 . . . . 74.22 107.278 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 t -127.71 123.74 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.757 -1.942 . . . . 74.52 105.757 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.3 165.78 11.52 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 105.13 -2.174 . . . . 73.14 105.13 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -73.32 -35.0 65.99 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.291 -0.881 . . . . 74.24 112.052 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.2 162.52 22.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.946 0.794 . . . . 75.55 112.54 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 tt -67.84 -43.49 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.051 0.94 . . . . 71.13 109.596 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.98 -41.81 99.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.754 1.222 . . . . 74.44 111.474 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.49 -44.92 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.511 -0.922 . . . . 54.22 108.511 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.42 85.79 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.129 0.572 . . . . 62.44 109.524 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -59.24 -48.87 79.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.375 1.07 . . . . 72.42 111.111 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.79 -40.01 94.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.326 0.967 . . . . 63.44 110.827 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.62 66.83 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.638 -0.696 . . . . 73.53 111.486 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.56 -64.37 0.97 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 117.85 -1.071 . . . . 73.34 109.319 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.34 -33.67 74.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.125 1.329 . . . . 70.33 112.969 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -64.47 -31.07 72.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.043 0.383 . . . . 74.33 110.262 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.4 tp -102.47 -26.23 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.882 1.438 . . . . 73.23 114.882 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -61.8 106.31 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.364 1.865 . . . . 75.52 110.34 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.54 10.74 63.19 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.55 -1.139 . . . . 64.3 113.19 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.22 121.26 10.93 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.934 1.367 . . . . 71.45 109.894 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.83 112.19 15.74 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.08 1.752 . . . . 64.31 107.815 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.97 148.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.348 0.659 . . . . 74.23 110.589 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 87.6 m 34.0 54.95 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.294 2.638 . . . . 75.12 114.588 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 52.33 31.26 9.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.859 2.064 . . . . 64.3 112.452 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -140.23 -170.71 3.03 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 128.781 2.833 . . . . 72.54 107.864 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -148.64 153.0 37.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.87 2.068 . . . . 64.34 105.741 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.1 172.84 6.6 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.421 -0.955 . . . . 74.12 108.421 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.21 150.66 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.068 -1.456 . . . . 75.12 107.068 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.1 136.17 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.476 1.91 . . . . 54.41 107.626 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.3 tp -146.61 151.61 37.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.209 1.803 . . . . 71.03 107.824 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.6 155.82 16.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.029 0.931 . . . . 73.42 111.288 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -80.5 175.55 10.56 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.212 0.605 . . . . 75.0 112.52 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 125.931 1.692 . . . . 75.51 109.985 -179.094 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 61.8 tp . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 118.543 -0.741 . . . . 74.14 110.273 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -66.52 -32.51 73.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.822 1.192 . . . . 73.14 110.018 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.84 56.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.331 1.052 . . . . 75.42 111.917 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 67.3 mtp -88.17 -12.26 44.45 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.293 1.437 . . . . 74.55 113.245 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -114.61 160.81 31.75 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 125.707 1.603 . . . . 74.1 111.59 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.25 167.42 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.232 1.954 . . . . 71.11 110.151 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.87 169.95 15.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.403 0.681 . . . . 71.41 110.306 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 80.51 22.42 62.37 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.034 -1.041 . . . . 72.21 113.277 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -124.58 156.86 36.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.851 -1.166 . . . . 74.43 107.851 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.0 149.47 47.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.032 0.933 . . . . 70.01 110.09 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.63 151.12 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.076 -0.712 . . . . 73.43 109.076 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.2 tp -131.09 82.98 61.93 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 107.978 -1.119 . . . . 74.1 107.978 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.45 164.18 7.49 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.872 3.048 . . . . 72.44 112.236 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.46 162.38 20.92 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.053 2.502 . . . . 74.02 112.648 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo . . . . . 0 N--CA 1.458 -0.606 0 C-N-CA 122.879 2.386 . . . . 73.31 110.485 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 t . . . . . 0 C--O 1.233 0.2 0 N-CA-C 106.307 -1.738 . . . . 74.32 106.307 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -134.46 158.84 42.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.494 -1.298 . . . . 72.15 107.494 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -65.42 -23.37 66.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 117.811 -1.09 . . . . 71.13 113.084 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 66.9 mt -89.53 126.11 42.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.441 -2.059 . . . . 75.43 105.441 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 95.0 mt -120.47 163.27 18.19 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.498 1.519 . . . . 72.42 109.229 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -129.29 136.49 50.12 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.211 1.804 . . . . 75.11 108.295 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mm -129.41 149.86 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.108 0.963 . . . . 73.35 108.5 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -139.49 163.87 31.39 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.813 1.645 . . . . 74.43 108.088 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 71.27 19.34 5.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.935 1.694 . . . . 72.05 111.222 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.86 155.4 89.86 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.119 0.968 . . . . 74.0 111.511 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.51 147.37 70.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.325 2.017 . . . . 71.43 107.31 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -82.8 -17.59 43.56 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.732 -0.605 . . . . 75.22 112.333 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -124.72 91.61 3.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.171 0.989 . . . . 75.34 110.572 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -146.69 139.15 19.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.191 -1.04 . . . . 73.21 108.191 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 1.2 p -89.26 164.7 14.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.368 1.067 . . . . 74.32 109.595 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.46 -23.43 65.86 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.594 -0.521 . . . . 74.35 109.594 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.5 -57.61 11.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.521 2.728 . . . . 63.44 110.215 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -72.26 -35.11 68.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.81 0.844 . . . . 75.51 109.933 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.6 mmm -63.43 -48.94 75.7 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.957 -0.757 . . . . 71.25 108.957 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.19 -29.83 70.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.385 -0.817 . . . . 75.44 110.387 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.75 -65.17 0.72 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.471 -0.937 . . . . 74.54 108.471 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.77 -60.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 126.128 1.771 . . . . 74.33 111.92 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -68.64 -17.16 64.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.106 -0.473 . . . . 72.54 112.047 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.96 -27.45 34.2 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.264 1.411 . . . . 45.52 113.068 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -52.59 -40.67 62.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.591 1.696 . . . . 70.04 109.507 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -77.0 -11.77 59.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 116.795 2.146 . . . . 75.15 116.795 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.97 20.53 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.362 1.437 . . . . 75.23 111.49 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.56 147.26 90.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.219 2.613 . . . . 63.23 111.666 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.9 131.7 50.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.55 1.54 . . . . 75.44 109.545 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.77 -58.08 3.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.375 -1.343 . . . . 74.14 107.375 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -162.85 160.86 25.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 0.667 . . . . 71.55 110.594 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mt -142.29 145.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.298 1.839 . . . . 75.44 108.548 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -140.59 144.44 35.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 104.377 -2.453 . . . . 70.23 104.377 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.35 162.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.315 1.046 . . . . 74.25 111.563 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.55 146.0 39.73 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.003 -0.839 . . . . 72.43 111.003 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -124.36 -0.63 8.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.652 1.581 . . . . 70.14 112.589 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -127.02 164.06 37.68 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.378 1.871 . . . . 75.42 109.814 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 -25.64 80.31 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.732 2.288 . . . . 75.24 113.956 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -93.39 1.58 56.84 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.73 1.15 . . . . 73.13 111.542 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.6 p -117.11 -28.78 6.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.283 1.033 . . . . 71.51 111.568 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 139.52 58.48 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.056 -1.028 . . . . 72.3 108.438 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.63 -23.51 35.86 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.302 1.43 . . . . 73.51 113.345 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.3 p -119.69 157.52 28.35 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 107.651 -1.24 . . . . 74.21 107.651 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.13 175.26 10.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.348 -0.845 . . . . 64.2 111.025 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -134.1 141.54 47.18 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.705 -1.22 . . . . 73.51 107.705 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 88.6 t -125.73 149.54 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.578 -1.638 . . . . 75.32 106.578 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t -127.73 132.6 68.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.48 -0.933 . . . . 74.1 108.48 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -101.09 164.02 12.01 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.667 -1.605 . . . . 74.5 106.667 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.7 -33.01 20.17 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.8 -1.187 . . . . 75.31 110.087 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -123.57 138.37 54.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.636 0.774 . . . . 74.23 109.868 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 tt -60.1 -30.55 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.594 -1.262 . . . . 75.01 107.594 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -60.46 -22.99 64.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.324 1.05 . . . . 74.23 111.647 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.23 -43.95 10.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.359 0.981 . . . . 72.05 108.441 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.21 74.67 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.226 -0.657 . . . . 75.24 109.226 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.35 -54.43 47.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.208 1.403 . . . . 72.23 109.817 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -64.88 -51.91 59.44 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.12 0.568 . . . . 73.33 110.955 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.39 -29.5 61.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.716 0.635 . . . . 73.43 112.716 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -64.37 0.98 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.061 -1.088 . . . . 75.22 108.061 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.55 -32.73 73.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.755 -0.64 . . . . 74.03 111.953 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -78.77 -16.4 57.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.612 0.967 . . . . 72.21 113.612 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 24.3 tp -110.68 -19.01 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.282 1.401 . . . . 75.43 112.331 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 83.9 p -58.26 118.05 5.08 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.061 1.345 . . . . 71.44 112.479 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.76 82.62 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.885 -1.508 . . . . 72.03 113.616 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.3 122.93 13.69 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.632 1.716 . . . . 72.14 108.728 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -96.72 115.73 27.93 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 126.079 1.752 . . . . 72.41 110.134 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 m -144.5 159.01 14.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.199 1.4 . . . . 74.21 107.535 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 69.1 m 43.85 41.56 3.89 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.206 1.402 . . . . 74.45 112.472 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 63.1 t30 56.75 21.77 6.27 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.632 2.373 . . . . 71.31 113.659 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -132.59 -179.3 5.37 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.874 2.07 . . . . 75.14 108.385 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -122.61 147.61 46.22 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.647 -1.612 . . . . 75.0 106.647 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 33.7 mt -96.31 156.39 16.36 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.343 -0.984 . . . . 73.02 108.343 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.41 128.55 66.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.955 -2.609 . . . . 63.02 103.955 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 94.4 t -124.7 111.89 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.05 -1.833 . . . . 75.32 106.05 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -136.5 164.35 28.37 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.292 1.037 . . . . 73.44 110.963 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -89.27 163.11 15.51 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.17 1.388 . . . . 72.03 111.364 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -101.24 169.1 9.13 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.567 -2.012 . . . . 74.44 105.567 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.46 -0.941 . . . . 55.1 108.46 -179.734 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 34.0 tp . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 119.444 -0.313 . . . . 75.12 111.135 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.5 -9.47 58.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.814 0.733 . . . . 75.32 112.239 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -123.22 -6.94 8.26 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.11 1.764 . . . . 74.33 112.504 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 57.7 mtp -73.73 -24.72 59.94 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.338 -1.476 . . . . 74.04 114.682 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -83.37 153.37 65.57 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 118.814 0.734 . . . . 74.22 111.546 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.74 172.14 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.477 3.451 . . . . 63.31 112.505 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -81.99 157.6 24.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.662 1.985 . . . . 75.03 110.388 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.38 19.08 53.89 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.052 0.834 . . . . 61.25 112.577 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -124.06 158.18 32.79 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.513 1.125 . . . . 74.35 111.338 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -129.21 145.64 51.29 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.909 1.684 . . . . 73.23 107.015 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.1 t -74.25 151.07 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.605 -0.887 . . . . 75.0 108.605 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.5 tp -124.19 85.51 54.98 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 105.062 -2.199 . . . . 75.24 105.062 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.23 167.9 10.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.432 2.755 . . . . 73.31 112.252 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.19 164.28 36.29 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.353 2.035 . . . . 73.43 110.107 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 123.925 3.083 . . . . 71.02 112.801 179.214 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 107.404 -1.332 . . . . 64.44 107.404 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -140.45 168.02 20.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.875 1.27 . . . . 75.25 110.273 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -82.57 -9.0 59.59 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.476 -1.39 . . . . 73.43 111.617 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 30.6 mt -106.18 141.26 21.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.321 -1.363 . . . . 71.33 107.321 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -116.24 151.59 35.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.603 1.561 . . . . 62.25 108.039 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -121.32 122.27 39.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.01 1.724 . . . . 74.43 106.696 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -114.07 147.95 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.12 1.768 . . . . 71.22 109.426 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -142.69 163.79 31.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.004 1.722 . . . . 64.44 111.362 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t30 74.56 18.19 2.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.18 2.592 . . . . 72.43 111.691 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 mt -70.03 153.37 95.42 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 124.452 1.101 . . . . 73.21 110.737 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.08 159.57 47.38 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.319 2.679 . . . . 75.05 110.757 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.27 -11.01 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.108 -0.37 . . . . 72.44 111.183 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -127.39 104.47 7.94 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.326 -2.102 . . . . 74.44 105.326 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 tt -158.58 155.08 4.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.193 1.397 . . . . 74.21 108.596 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -105.28 169.81 8.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.304 1.442 . . . . 73.53 111.106 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.11 84.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.05 -1.093 . . . . 73.55 108.05 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.1 -45.8 91.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.45 1.5 . . . . 75.2 111.675 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.74 -37.8 85.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.262 0.625 . . . . 54.11 110.628 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.9 mmm -73.81 -53.31 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.809 1.243 . . . . 73.12 111.736 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -59.79 -30.07 68.65 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 118.386 -0.816 . . . . 73.42 111.323 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.52 -61.32 2.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.991 0.814 . . . . 74.42 109.417 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 -65.4 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 125.781 1.633 . . . . 73.52 112.625 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -63.32 -34.45 77.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.596 0.961 . . . . 75.42 113.596 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.53 -24.22 77.08 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.088 0.858 . . . . 61.43 112.028 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -64.01 -14.67 55.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.022 0.911 . . . . 74.0 113.077 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -105.08 -4.48 21.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.566 1.546 . . . . 75.54 111.771 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.71 173.38 13.16 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.426 1.012 . . . . 71.21 111.637 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.53 128.85 21.03 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.544 2.829 . . . . 62.03 112.04 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.76 135.7 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.57 1.548 . . . . 74.33 108.179 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -81.25 -62.69 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 106.559 -1.645 . . . . 75.22 106.559 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -151.87 160.98 43.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.557 0.617 . . . . 74.24 111.886 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.96 134.55 48.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 126.923 2.089 . . . . 64.21 107.019 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -130.2 128.11 41.04 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.585 -2.006 . . . . 73.01 105.585 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 m -108.76 147.33 13.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.791 1.236 . . . . 73.34 109.009 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.35 135.24 14.97 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.471 -1.052 . . . . 72.02 110.471 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.96 -15.05 9.35 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.232 1.197 . . . . 72.43 114.232 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 21.6 p -77.71 160.21 75.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.411 -1.7 . . . . 74.45 106.411 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.54 -20.43 49.54 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.282 1.988 . . . . 73.21 114.021 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.74 -21.24 20.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.982 0.913 . . . . 64.4 113.064 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 80.4 p -101.58 -12.33 18.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.891 0.768 . . . . 72.02 112.374 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 -64.02 116.5 5.94 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.066 -1.457 . . . . 73.13 107.066 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.93 16.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.7 -1.056 . . . . 61.22 112.753 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -128.5 159.34 35.78 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 118.518 1.159 . . . . 73.45 108.26 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.98 170.38 20.69 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.291 -0.881 . . . . 71.32 110.503 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -122.31 142.57 50.35 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.716 -1.216 . . . . 73.12 107.716 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.06 137.63 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 126.174 1.79 . . . . 74.41 106.775 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -129.03 128.35 67.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 118.422 -0.799 . . . . 74.01 109.893 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -97.45 166.15 11.66 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.609 1.164 . . . . 73.33 107.878 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -74.92 -55.3 5.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.923 0.889 . . . . 75.34 108.72 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.98 121.44 32.08 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 114.274 1.213 . . . . 72.03 114.274 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.4 tt -66.08 -19.41 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.681 -0.489 . . . . 74.41 109.681 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.9 -60.83 2.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.322 1.049 . . . . 73.34 108.387 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.08 -36.69 70.88 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.785 0.834 . . . . 74.2 111.738 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -29.69 62.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.247 0.476 . . . . 74.22 112.014 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -80.05 -46.11 17.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.946 -1.096 . . . . 72.04 108.404 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -57.22 -32.2 66.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.268 0.556 . . . . 72.2 110.592 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.25 -43.95 18.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.269 1.428 . . . . 64.14 111.769 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 11.5 p -55.83 -42.36 75.6 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.198 0.908 . . . . 71.4 110.906 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.64 -18.17 62.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.401 0.519 . . . . 63.41 112.401 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -95.53 -17.88 21.07 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.678 0.791 . . . . 71.15 112.037 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 12.0 tp -101.52 -3.5 28.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.701 0.682 . . . . 74.25 112.534 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.7 p -68.08 134.9 51.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.652 1.215 . . . . 73.02 111.505 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.38 62.44 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.219 -0.926 . . . . 60.13 113.013 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -68.49 141.33 55.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.109 1.455 . . . . 74.21 110.876 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -90.45 127.66 36.28 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.821 1.248 . . . . 75.4 109.286 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.01 125.39 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 127.779 2.432 . . . . 61.12 109.034 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 72.5 m 50.78 41.98 27.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.779 1.232 . . . . 75.13 110.738 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 20.2 m120 61.19 14.64 5.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.476 1.91 . . . . 62.42 113.469 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -122.06 169.77 10.51 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.626 1.971 . . . . 74.02 107.461 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -107.22 -177.0 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.085 -1.079 . . . . 73.24 108.085 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.62 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.555 2.342 . . . . 54.43 106.072 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -133.25 110.52 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.627 -1.619 . . . . 73.24 106.627 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.88 144.59 9.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.007 -1.479 . . . . 75.43 107.007 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 tp -154.27 154.7 33.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.089 1.356 . . . . 73.11 107.342 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -81.24 164.28 22.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.841 1.656 . . . . 72.43 110.482 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -101.06 157.79 16.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.874 0.47 . . . . 73.25 110.229 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 36.0 m120 . . . . . 0 C--O 1.256 1.41 0 CA-C-O 115.945 -1.978 . . . . 64.15 110.229 -179.39 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 110.489 -0.189 . . . . 72.01 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -79.69 -51.51 9.14 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.907 -0.775 . . . . 74.02 108.907 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.19 89.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.511 1.924 . . . . 72.21 113.291 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.0 mtp -57.94 -36.87 73.12 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.307 1.043 . . . . 73.05 113.377 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -68.47 149.92 97.86 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.374 0.988 . . . . 74.11 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.44 160.47 47.68 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.162 1.908 . . . . 72.32 111.064 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -71.06 160.87 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.72 -1.127 . . . . 73.11 109.525 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.72 17.46 63.65 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 121.651 -0.655 . . . . 62.01 113.296 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -124.47 156.96 36.36 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.487 1.515 . . . . 75.11 108.009 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -136.68 144.58 44.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.733 1.213 . . . . 74.3 109.549 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.8 t -70.91 151.18 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.566 -0.901 . . . . 75.41 108.566 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 17.8 tp -120.72 83.44 35.75 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.699 1.6 . . . . 74.11 108.378 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.28 162.26 17.68 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.2 2.6 . . . . 53.44 112.909 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.65 168.39 22.84 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.109 3.206 . . . . 75.42 111.094 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 CA--C 1.539 0.76 0 C-N-CA 122.434 2.089 . . . . 75.45 109.855 177.662 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.2 t . . . . . 0 C--O 1.236 0.367 0 N-CA-C 108.501 -0.926 . . . . 71.44 108.501 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -128.65 171.37 12.24 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.183 1.393 . . . . 74.42 109.663 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -30.04 70.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.951 0.723 . . . . 73.1 112.951 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.93 135.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.625 1.57 . . . . 74.23 109.519 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 98.4 mt -126.47 158.71 35.34 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.005 1.722 . . . . 74.43 110.973 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -128.26 108.49 10.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.59 1.556 . . . . 75.44 110.635 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.84 144.71 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 127.19 2.196 . . . . 74.34 107.73 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -144.56 164.19 31.65 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.97 2.508 . . . . 74.41 110.98 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 52.1 t30 72.43 11.26 5.74 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.139 1.376 . . . . 62.11 111.544 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.55 154.58 79.19 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 124.851 1.261 . . . . 73.12 111.231 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.63 150.75 74.96 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.245 1.963 . . . . 73.14 112.652 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -83.37 -15.39 50.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.504 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -130.06 109.34 10.77 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.524 1.53 . . . . 70.24 107.506 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 15.9 tt -162.57 171.18 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 128.386 2.675 . . . . 72.32 105.466 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -126.18 165.87 18.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.585 1.154 . . . . 73.32 109.976 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.35 74.91 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.543 -0.91 . . . . 62.2 108.543 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.43 -54.61 45.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.831 1.652 . . . . 71.43 109.513 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.5 -36.46 84.27 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.187 1.395 . . . . 53.2 111.363 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 66.2 mmm -64.69 -58.2 6.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.473 -0.936 . . . . 74.31 108.473 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -58.8 -35.76 73.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.635 0.774 . . . . 75.01 110.915 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -59.81 -26.3 65.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 75.13 111.744 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.06 -69.74 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.01 0.924 . . . . 74.55 108.986 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -55.31 -38.09 68.22 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.921 1.452 . . . . 75.3 114.921 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -33.66 85.93 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.302 0.953 . . . . 73.14 112.942 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -65.87 -29.14 69.55 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.109 -1.23 . . . . 73.22 110.221 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -79.89 -22.27 43.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.762 0.825 . . . . 73.23 110.263 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.68 168.93 19.44 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.875 1.702 . . . . 62.44 109.48 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -63.22 159.92 37.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.108 2.539 . . . . 75.31 113.505 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -113.29 143.9 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.686 1.995 . . . . 73.15 110.536 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.34 -56.18 2.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 125.216 1.406 . . . . 71.53 108.043 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -153.72 155.09 35.29 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.359 -1.348 . . . . 75.22 107.359 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -136.82 135.38 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 104.491 -2.411 . . . . 73.11 104.491 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -133.2 123.98 26.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.314 -2.106 . . . . 73.44 105.314 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.8 m -110.04 151.26 12.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.593 -1.262 . . . . 73.23 107.593 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.69 30.79 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.446 -1.062 . . . . 72.14 110.446 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.78 -38.86 3.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.463 -0.78 . . . . 61.34 111.22 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 30.0 p -69.38 161.6 72.43 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.388 -0.597 . . . . 73.11 109.388 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.2 -2.58 8.33 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.141 1.894 . . . . 70.01 112.255 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -105.84 -9.72 17.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.487 1.915 . . . . 70.11 111.868 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -116.62 -12.05 10.97 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.87 1.268 . . . . 71.44 110.723 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -57.58 142.09 45.8 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.55 -1.344 . . . . 71.31 108.341 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.16 -5.68 83.56 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 118.676 -1.069 . . . . 52.14 114.633 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 36.1 p -124.52 153.85 41.45 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.399 1.6 . . . . 71.12 109.144 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.69 166.2 33.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.876 0.846 . . . . 73.03 109.525 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.94 141.98 51.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.532 -2.025 . . . . 72.35 105.532 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.84 142.56 42.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.591 -2.003 . . . . 75.32 105.591 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.78 134.33 65.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.222 -1.77 . . . . 75.03 106.222 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -98.03 166.84 11.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.881 1.672 . . . . 74.21 111.472 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.8 -73.64 0.46 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.94 -1.504 . . . . 75.31 106.94 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -81.77 134.96 35.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.116 0.96 . . . . 71.41 109.332 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -34.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 125.318 1.447 . . . . 72.32 108.443 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.33 -30.01 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.152 0.581 . . . . 74.3 110.874 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -71.43 -47.39 56.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.526 -0.916 . . . . 73.21 108.526 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.45 -42.94 74.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.768 0.827 . . . . 75.32 111.94 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -57.28 -61.9 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.38 1.072 . . . . 73.12 109.487 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -52.95 -53.09 54.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.769 0.827 . . . . 71.41 111.812 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.78 -38.67 86.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 114.428 1.27 . . . . 71.43 114.428 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 37.3 t -58.26 -49.81 75.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 118.437 0.562 . . . . 74.43 110.693 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -62.9 -52.77 61.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.795 -0.446 . . . . 74.23 109.795 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -58.36 -26.22 62.9 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.891 0.7 . . . . 74.34 112.891 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.9 tp -96.77 -6.75 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.432 0.901 . . . . 75.3 113.432 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -62.19 121.86 14.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.299 -1.501 . . . . 73.31 109.999 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.71 18.52 70.32 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.35 -1.25 . . . . 62.34 112.777 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -55.06 120.11 6.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.08 1.44 . . . . 71.45 110.32 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -72.88 115.99 12.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.69 2.396 . . . . 74.04 110.749 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.12 144.47 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.156 1.382 . . . . 74.23 108.83 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.0 m 39.73 52.18 2.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 73.31 112.992 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.36 23.54 9.03 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.089 1.356 . . . . 72.33 113.69 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -136.85 -176.6 4.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.591 2.356 . . . . 73.54 107.517 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.47 137.4 38.67 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.956 1.703 . . . . 74.32 107.071 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.39 148.94 24.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.335 0.588 . . . . 75.32 110.446 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.87 156.72 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.117 1.767 . . . . 73.14 107.186 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 93.2 t -142.33 123.12 11.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.714 -2.328 . . . . 73.33 104.714 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 42.4 tp -151.48 146.09 25.66 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.776 0.83 . . . . 74.01 109.754 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -80.37 156.63 26.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.158 -0.682 . . . . 75.0 109.158 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -75.71 175.39 8.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.373 -0.973 . . . . 73.4 108.373 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 124.302 1.041 . . . . 73.24 112.329 -178.472 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.3 tp . . . . . 0 C--O 1.225 -0.192 0 N-CA-C 107.244 -1.391 . . . . 65.22 107.244 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.58 -49.11 73.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.765 0.257 . . . . 71.05 110.816 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.51 -24.89 61.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.53 1.532 . . . . 61.45 113.777 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 62.4 mtp -86.59 -17.59 33.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.335 -0.853 . . . . 63.34 111.416 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -90.42 146.79 35.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 119.017 0.826 . . . . 72.23 111.844 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.84 163.85 23.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.292 2.661 . . . . 75.0 111.045 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -76.86 173.47 11.67 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.465 -0.939 . . . . 63.13 108.465 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 78.62 18.89 74.72 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 121.372 -0.83 . . . . 75.51 111.731 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.8 117.17 19.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.523 1.529 . . . . 74.32 108.901 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.42 148.0 22.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.45 1.1 . . . . 74.24 108.119 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.71 151.96 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.819 -1.175 . . . . 75.43 110.948 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 22.9 tp -120.67 77.9 29.18 Favored Pre-proline 0 C--O 1.237 0.401 0 N-CA-C 107.17 -1.419 . . . . 62.34 107.17 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.78 166.54 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.729 2.286 . . . . 73.41 111.467 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.17 174.92 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.882 1 C-N-CA 125.698 4.265 . . . . 62.15 115.063 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.457 -0.666 0 C-N-CA 122.732 2.288 . . . . 65.43 110.993 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.238 0.463 0 N-CA-C 107.87 -1.159 . . . . 74.03 107.87 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -98.03 175.25 6.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.635 1.174 . . . . 71.33 109.71 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.69 -34.31 72.72 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.686 -1.259 . . . . 72.52 114.215 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.12 138.05 21.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.512 1.125 . . . . 72.42 109.793 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.36 146.81 49.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.787 -1.19 . . . . 74.34 107.787 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -99.55 138.79 36.15 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.894 -1.891 . . . . 74.22 105.894 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.8 mm -117.03 134.86 59.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 126.155 1.782 . . . . 64.03 106.365 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -127.83 162.5 26.51 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.909 0.884 . . . . 64.35 110.485 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.57 38.35 12.45 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.656 1.983 . . . . 53.41 111.557 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 67.3 mt -76.56 153.76 83.62 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 108.488 -0.93 . . . . 63.42 108.488 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.96 163.94 35.71 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.632 2.221 . . . . 74.42 109.844 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -94.06 -13.03 27.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.994 0.518 . . . . 73.2 112.017 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -126.23 99.7 5.99 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.215 1.406 . . . . 74.43 107.943 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.1 143.43 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.565 -1.272 . . . . 55.23 107.565 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -98.45 178.13 5.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.98 0.912 . . . . 72.1 110.441 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.42 80.95 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.194 -0.457 . . . . 71.11 110.15 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -52.83 -60.54 3.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 127.73 2.412 . . . . 74.3 110.027 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.53 -47.55 81.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.426 1.49 . . . . 75.21 110.88 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.7 mmm -59.25 -39.09 81.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.088 -0.383 . . . . 75.21 110.865 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -76.37 -30.36 57.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.722 -0.656 . . . . 72.33 110.319 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.23 -27.13 65.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.67 1.188 . . . . 74.13 110.16 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 58.7 mt -76.26 -68.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.38 1.072 . . . . 74.2 109.16 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.32 -23.86 65.68 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.892 1.442 . . . . 73.14 114.892 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.92 -13.85 69.89 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 115.584 0.994 . . . . 64.43 115.584 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.51 -28.78 63.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.096 1.448 . . . . 72.51 110.592 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.82 -34.27 22.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.505 -0.76 . . . . 75.23 112.351 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.2 -166.55 39.67 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 120.204 1.365 . . . . 50.51 111.915 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.28 162.57 41.85 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.084 3.189 . . . . 62.45 112.858 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 59.5 mt -118.38 130.47 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.965 0.906 . . . . 73.22 109.247 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -88.44 -59.7 2.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.131 -1.063 . . . . 75.41 108.131 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -155.61 155.12 32.71 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.66 0.267 . . . . 74.31 110.851 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.05 127.79 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 104.984 -2.228 . . . . 73.14 104.984 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -128.31 120.82 27.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 102.842 -3.021 . . . . 74.21 102.842 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.65 144.65 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.736 0.814 . . . . 54.15 111.359 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.64 115.58 6.0 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 106.076 -2.81 . . . . 71.25 106.076 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -103.55 -10.89 18.12 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.194 0.998 . . . . 52.3 113.46 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.9 p -95.16 158.36 34.93 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.375 0.989 . . . . 73.21 108.461 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.59 -15.73 38.53 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.77 2.313 . . . . 73.11 113.045 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -97.29 -10.7 25.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.514 1.125 . . . . 75.15 112.286 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 39.9 p -116.96 -19.23 9.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.731 1.212 . . . . 71.04 112.21 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -53.26 150.32 6.32 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.434 1.494 . . . . 74.44 110.317 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.51 3.51 88.84 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.069 -1.406 . . . . 73.13 112.703 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 59.1 p -143.77 153.36 42.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.753 1.776 . . . . 74.11 109.979 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.35 172.82 12.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.751 2.021 . . . . 75.14 108.359 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -127.78 156.02 43.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.889 -1.522 . . . . 64.35 106.889 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.22 142.97 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.872 -1.159 . . . . 74.3 107.872 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.04 133.33 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.621 1.169 . . . . 73.54 108.369 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.99 154.12 17.91 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.374 -1.713 . . . . 72.31 106.374 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -72.69 -20.09 61.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 119.546 -0.862 . . . . 74.24 110.931 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.83 117.87 30.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.579 1.552 . . . . 72.23 109.681 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.76 -27.48 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 125.175 1.39 . . . . 71.34 111.966 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -73.36 -41.61 63.21 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.344 -1.472 . . . . 74.11 107.569 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -37.31 87.09 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.569 -0.901 . . . . 71.21 108.569 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.4 78.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.63 -0.7 . . . . 74.42 109.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -29.54 70.44 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.288 -0.863 . . . . 75.2 110.612 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.87 -53.31 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.129 1.331 . . . . 75.53 108.568 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.41 -14.15 17.36 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.086 1.143 . . . . 75.43 114.086 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 91.6 m -64.23 -66.62 0.52 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.448 1.022 . . . . 75.41 109.735 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.3 -34.56 76.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 119.13 -0.462 . . . . 74.22 110.168 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -64.83 -21.61 66.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.161 -0.923 . . . . 75.13 112.858 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 tp -106.54 -23.71 12.4 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.083 1.311 . . . . 75.32 111.324 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 12.5 m -69.79 110.1 4.76 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.005 -1.06 . . . . 72.01 108.352 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.44 10.54 53.58 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.649 1.595 . . . . 74.04 112.277 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -72.72 106.38 4.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.457 1.628 . . . . 71.23 107.627 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.93 124.93 27.11 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.349 -0.982 . . . . 63.4 108.349 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 m -141.31 144.37 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 118.983 0.811 . . . . 72.25 110.302 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 m 45.78 38.97 4.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.155 1.382 . . . . 54.04 113.384 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 64.79 20.91 12.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.558 1.143 . . . . 75.21 111.871 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.3 mmm-85 -135.6 -178.17 5.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.145 2.178 . . . . 73.34 108.257 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -133.07 155.31 49.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.867 1.267 . . . . 74.25 109.571 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -109.63 150.16 28.65 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.033 1.333 . . . . 74.51 107.514 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.18 112.76 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.335 -1.728 . . . . 74.31 106.335 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.56 141.73 14.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.072 -2.196 . . . . 74.35 105.072 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.57 142.51 45.33 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.269 -1.382 . . . . 74.03 107.269 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.11 114.0 21.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.457 -0.942 . . . . 74.21 108.457 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -74.05 148.22 42.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.192 -2.522 . . . . 75.11 104.192 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.06 1.744 . . . . 73.54 109.088 -178.868 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 52.0 tp . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 118.427 -0.796 . . . . 75.22 111.29 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.26 -38.24 88.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.069 0.849 . . . . 64.14 110.202 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.46 68.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.631 0.773 . . . . 54.2 110.964 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.4 mtp -65.42 -41.56 93.45 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 118.908 -0.568 . . . . 72.52 110.261 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -65.1 155.71 83.23 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 112.983 0.734 . . . . 73.1 112.983 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.73 159.86 34.79 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.077 1.851 . . . . 75.33 109.33 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.48 161.97 25.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.363 -1.289 . . . . 73.21 110.631 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.79 17.89 60.84 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.76 -0.587 . . . . 44.25 113.693 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -125.16 157.68 35.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.298 1.439 . . . . 73.13 108.896 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -127.07 143.82 51.18 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.445 1.498 . . . . 75.42 109.305 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 63.1 t -71.08 141.06 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.675 -0.861 . . . . 71.32 108.675 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 28.7 tp -117.17 84.05 16.49 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.096 1.358 . . . . 72.31 107.547 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.12 166.04 24.47 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.185 1.924 . . . . 74.42 110.041 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.21 171.84 2.12 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.615 2.877 . . . . 73.4 113.413 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 CA--C 1.536 0.622 0 C-N-CA 123.621 2.881 . . . . 75.54 110.369 178.252 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.447 -0.575 . . . . 71.14 109.447 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -140.58 159.21 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.263 -1.754 . . . . 73.4 106.263 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -56.24 -32.11 64.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.597 1.959 . . . . 73.34 111.917 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 53.4 mt -75.13 123.67 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 72.0 107.306 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 mt -120.15 126.53 50.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.733 2.013 . . . . 74.15 108.204 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.11 134.36 39.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.225 1.41 . . . . 74.42 108.917 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.2 mm -124.16 154.86 31.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.871 0.868 . . . . 75.31 109.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -135.01 163.52 29.69 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.833 2.053 . . . . 75.25 108.992 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 66.7 15.32 10.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.766 1.626 . . . . 64.34 113.545 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.01 152.17 92.82 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 107.571 -1.27 . . . . 74.02 107.571 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.23 160.06 46.83 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.588 1.525 . . . . 51.12 110.807 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -78.32 -20.95 50.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.893 0.877 . . . . 71.23 112.499 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.76 120.89 24.45 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.075 1.35 . . . . 73.32 107.553 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 tt -158.48 163.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.872 1.269 . . . . 75.13 108.201 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -117.43 168.23 10.55 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.916 1.286 . . . . 73.23 111.046 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.92 76.76 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.621 -0.704 . . . . 64.24 109.762 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -53.62 -51.33 63.42 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.531 1.133 . . . . 73.34 109.273 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.52 -39.62 94.12 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.335 0.654 . . . . 72.53 111.608 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.1 -45.04 82.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.859 -0.591 . . . . 74.11 110.101 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -71.52 -27.41 63.18 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.844 0.747 . . . . 75.53 109.585 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.59 -35.33 77.21 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.626 -1.296 . . . . 74.25 109.291 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.37 -72.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.76 1.224 . . . . 72.44 111.822 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.11 -34.51 73.6 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.14 0.976 . . . . 75.05 110.701 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.43 -6.69 88.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.972 -0.349 . . . . 72.44 112.269 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -64.21 -48.18 76.88 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.235 1.517 . . . . 54.15 108.531 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -62.32 -40.07 95.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.769 1.628 . . . . 72.43 112.342 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.58 37.73 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.07 0.843 . . . . 74.21 111.525 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.46 165.15 25.94 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.1 2.534 . . . . 74.45 111.434 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 mt -126.47 137.26 58.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.582 -1.266 . . . . 74.41 107.582 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -76.89 -56.18 4.82 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.409 -0.807 . . . . 71.41 110.273 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -163.28 153.39 15.72 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.189 -1.041 . . . . 73.51 108.189 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 49.7 mt -131.59 147.63 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.628 1.171 . . . . 74.11 108.537 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -142.91 141.83 31.58 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.772 -1.566 . . . . 73.51 106.772 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.14 155.88 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.848 0.859 . . . . 74.43 109.735 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.47 145.81 49.66 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.796 -1.321 . . . . 70.32 109.796 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.33 1.32 8.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.758 1.223 . . . . 74.25 112.535 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 60.6 p -124.71 162.35 43.41 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.433 1.493 . . . . 75.41 109.33 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -64.02 2.63 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.483 3.455 . . . . 74.12 114.258 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -116.74 -19.4 9.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.05 1.34 . . . . 72.53 111.883 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 42.5 p -104.96 -19.69 13.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.015 0.926 . . . . 71.31 109.384 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -64.15 138.19 58.33 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.038 -1.664 . . . . 75.04 107.02 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -20.22 44.35 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.32 0.962 . . . . 74.41 111.207 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 37.4 p -120.07 158.95 25.77 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 106.964 -1.495 . . . . 74.31 106.964 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.8 175.09 11.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.784 -1.198 . . . . 71.33 109.413 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -135.04 141.44 46.14 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.293 -1.003 . . . . 73.11 108.293 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.8 147.56 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.55 -2.018 . . . . 70.45 105.55 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 t -127.06 140.09 50.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.838 -1.541 . . . . 75.23 106.838 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -109.77 166.38 10.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.595 1.558 . . . . 70.34 110.469 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.97 -55.11 7.01 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.151 0.98 . . . . 70.35 110.551 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -112.32 177.56 4.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.361 1.065 . . . . 73.05 108.644 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -94.74 -24.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.067 -1.021 . . . . 73.54 110.178 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.57 -54.83 22.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.317 -0.864 . . . . 62.45 111.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -67.05 -35.69 80.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.149 0.979 . . . . 65.25 110.218 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.57 -49.33 77.08 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.956 -0.757 . . . . 74.51 108.956 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -61.45 -45.09 95.75 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.526 0.73 . . . . 72.33 109.676 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -55.93 -52.27 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.608 -0.516 . . . . 72.44 109.608 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.81 73.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.491 -0.766 . . . . 72.15 112.599 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.42 -49.58 77.02 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.57 1.077 . . . . 72.31 109.785 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -71.73 -44.62 63.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.18 -0.914 . . . . 61.23 111.297 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -60.33 -30.16 69.34 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.784 0.72 . . . . 73.44 112.854 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 23.0 tp -90.85 -29.12 17.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.262 0.483 . . . . 72.2 112.18 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 90.2 p -64.58 118.65 9.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.584 -0.895 . . . . 64.13 108.584 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.84 63.73 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.739 -1.034 . . . . 63.52 113.094 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -77.32 110.23 11.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.713 1.756 . . . . 75.31 106.359 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.94 121.92 15.77 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.098 1.359 . . . . 70.32 111.025 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.0 137.74 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.339 -0.985 . . . . 73.23 108.339 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 35.1 m 38.77 38.84 0.3 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.375 1.87 . . . . 73.44 113.596 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.13 42.54 25.54 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.322 1.449 . . . . 73.23 111.137 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -143.35 171.22 14.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.164 2.586 . . . . 74.54 107.633 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -133.19 137.08 46.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.975 1.31 . . . . 75.45 109.187 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -98.08 115.59 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.634 2.374 . . . . 70.51 110.151 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 97.8 t -84.34 129.61 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.148 -1.797 . . . . 73.02 106.148 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 84.3 t -111.26 137.06 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.738 2.015 . . . . 74.13 106.376 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -154.48 143.81 21.3 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.819 1.247 . . . . 75.53 109.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -74.36 155.75 37.81 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.527 -0.733 . . . . 74.45 110.941 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -78.23 170.2 17.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 106.905 -1.517 . . . . 75.53 106.905 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 123.985 0.914 . . . . 73.54 109.364 179.365 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 51.9 tp . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.237 -1.023 . . . . 75.01 108.237 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.47 -33.47 75.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.446 0.698 . . . . 74.03 110.79 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.98 -2.99 33.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.333 1.053 . . . . 74.21 112.288 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.6 mtp -100.07 7.21 44.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.723 1.209 . . . . 74.24 111.906 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -110.82 148.77 39.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 75.34 110.107 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.04 166.46 29.56 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.152 3.235 . . . . 65.31 113.581 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.16 159.38 22.05 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.49 1.516 . . . . 72.12 110.512 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.35 17.4 39.8 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.243 1.878 . . . . 63.15 113.729 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.75 157.81 43.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.354 2.262 . . . . 74.0 106.267 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.8 144.61 49.61 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.785 0.834 . . . . 74.44 109.122 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.03 143.99 14.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.997 -1.112 . . . . 75.51 107.997 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 47.1 tp -135.53 80.79 43.96 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.101 -1.444 . . . . 73.2 107.101 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.08 171.08 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.376 3.384 . . . . 72.04 112.814 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.17 162.21 3.06 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.105 3.203 . . . . 64.14 112.847 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo . . . . . 0 C--N 1.348 0.533 0 C-N-CA 123.575 2.85 . . . . 74.43 112.984 179.721 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 t . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 108.454 -0.943 . . . . 70.4 108.454 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -137.53 155.03 49.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.733 1.613 . . . . 74.51 106.95 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -26.19 68.56 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.745 -0.597 . . . . 73.15 112.093 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.92 115.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.597 -1.26 . . . . 73.44 107.597 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 59.6 mt -109.03 159.31 16.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.53 1.132 . . . . 72.3 109.291 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -127.88 135.39 49.95 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.59 2.356 . . . . 62.1 106.635 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mm -120.95 153.19 24.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.27 1.828 . . . . 71.14 110.191 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -142.71 163.96 31.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.639 1.976 . . . . 65.44 111.549 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 63.58 24.87 14.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.954 2.502 . . . . 75.42 114.708 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 71.9 mt -75.44 156.77 85.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.305 -0.872 . . . . 72.22 111.685 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.56 138.81 46.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 N-CA-C 106.521 -2.146 . . . . 74.23 106.521 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -71.13 -10.89 60.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.308 1.043 . . . . 73.42 112.269 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -126.47 108.8 11.52 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.195 1.798 . . . . 72.22 107.289 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -156.98 137.43 4.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.758 -0.83 . . . . 75.24 108.758 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -86.45 163.73 17.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.573 1.149 . . . . 64.1 110.481 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.16 -32.55 73.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 45.51 110.021 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.48 -32.58 74.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.622 1.169 . . . . 62.31 110.915 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.53 -45.76 43.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.552 -1.277 . . . . 73.22 107.552 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.4 mmm -55.44 -53.38 56.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.521 0.728 . . . . 64.52 110.168 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -71.66 -10.36 59.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.372 0.879 . . . . 74.51 113.372 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.43 -60.27 1.99 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.018 -1.104 . . . . 72.22 108.018 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.99 -54.81 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.324 1.85 . . . . 74.14 109.874 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -78.56 -16.47 57.4 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.601 0.593 . . . . 72.11 112.601 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.01 -27.2 74.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.266 0.936 . . . . 75.23 112.735 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -14.17 11.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.707 1.253 . . . . 75.54 113.157 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -107.72 -5.13 17.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.705 1.202 . . . . 75.22 113.831 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.93 -174.1 21.27 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.864 1.211 . . . . 74.15 112.874 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.2 138.99 40.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.986 3.124 . . . . 42.4 111.525 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 39.0 mt -101.4 122.3 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.756 1.622 . . . . 75.41 109.725 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -69.61 -47.99 61.58 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.529 -0.732 . . . . 73.32 112.404 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -165.48 159.87 17.28 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.457 1.026 . . . . 64.42 110.635 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 mt -144.32 135.83 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.78 2.032 . . . . 74.23 109.654 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.16 126.24 26.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 102.847 -3.019 . . . . 75.5 102.847 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 m -112.64 142.28 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.115 0.566 . . . . 74.34 110.581 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.1 46.89 Favored Glycine 0 C--O 1.241 0.591 0 C-N-CA 124.339 0.971 . . . . 72.11 111.282 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -118.39 -30.46 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.765 0.783 . . . . 65.3 111.806 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -74.14 158.08 86.02 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.695 -1.224 . . . . 74.01 107.695 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.31 -27.44 63.6 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.814 1.676 . . . . 73.41 110.099 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -17.61 63.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.824 1.25 . . . . 64.1 111.667 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 69.3 p -107.47 0.38 22.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.518 1.127 . . . . 74.43 111.928 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -56.14 127.95 33.14 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 120.148 -1.595 . . . . 72.13 108.793 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.17 89.31 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.847 -1.53 . . . . 71.03 114.348 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -121.18 152.44 38.79 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 120.343 2.071 . . . . 50.33 109.336 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.28 174.99 12.08 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.401 1.08 . . . . 64.03 109.274 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -132.25 134.63 45.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.004 -1.48 . . . . 71.31 107.004 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.2 142.62 43.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.634 -1.247 . . . . 74.33 107.634 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 t -122.53 147.25 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.42 -1.326 . . . . 72.4 107.42 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -120.91 166.38 13.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.763 1.625 . . . . 71.22 107.828 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.76 -68.6 0.36 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 113.039 0.755 . . . . 73.31 113.039 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -106.25 148.19 28.24 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.247 1.023 . . . . 65.21 110.862 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.67 -31.85 45.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.275 -0.875 . . . . 74.24 109.301 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -64.48 -30.7 71.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.924 1.29 . . . . 62.52 112.37 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.14 -60.46 2.27 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.235 -1.394 . . . . 75.25 107.235 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.34 67.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 64.12 113.898 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -60.25 3.78 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.256 0.934 . . . . 73.33 110.039 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -73.41 -39.61 64.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.999 -0.68 . . . . 64.24 110.314 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.76 -33.73 64.58 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.441 -0.79 . . . . 71.43 112.692 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.26 -52.99 62.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.27 -1.011 . . . . 73.42 108.27 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.83 -38.99 93.14 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.0 0.52 . . . . 73.12 110.81 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -18.5 60.57 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 117.492 -1.242 . . . . 74.32 112.22 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.82 -32.86 11.49 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.368 1.44 . . . . 63.04 111.716 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -63.26 152.27 38.16 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.916 -1.513 . . . . 50.33 106.916 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.49 9.57 44.5 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 119.166 -0.797 . . . . 71.45 113.624 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -74.06 125.23 27.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.132 -1.803 . . . . 74.13 106.132 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -80.86 116.67 20.96 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.738 1.615 . . . . 72.24 110.49 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.45 141.9 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 123.473 0.709 . . . . 71.31 109.829 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 62.9 m 24.47 58.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.115 2.566 . . . . 63.14 115.666 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 m120 56.18 27.51 11.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.369 1.468 . . . . 73.14 113.963 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -131.87 167.91 18.76 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.203 2.601 . . . . 72.31 109.353 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -138.74 104.26 5.05 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.749 -1.575 . . . . 74.53 106.749 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -69.31 161.06 30.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.066 1.347 . . . . 75.55 110.023 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -133.17 122.65 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.354 1.061 . . . . 71.42 108.618 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 t -98.35 136.22 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.434 1.093 . . . . 75.24 109.268 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -148.86 153.72 38.46 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.435 1.094 . . . . 73.21 109.343 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.93 147.1 23.92 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.27 1.028 . . . . 74.52 110.407 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -76.59 121.47 23.24 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 105.819 -1.919 . . . . 70.1 105.819 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.2 -0.905 . . . . 72.24 109.112 179.639 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 119.185 -0.436 . . . . 62.0 110.184 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.15 -45.58 92.58 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 123.343 0.657 . . . . 74.25 109.75 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.23 79.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.424 0.69 . . . . 74.44 111.904 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 85.2 mtp -71.73 -7.48 48.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.169 0.988 . . . . 72.34 111.1 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -107.46 143.26 26.85 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.219 0.918 . . . . 74.13 109.069 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.93 164.35 35.94 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.323 2.682 . . . . 74.03 114.035 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -70.02 161.14 30.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.836 2.054 . . . . 73.32 110.278 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 75.62 17.69 80.03 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.132 -0.98 . . . . 74.04 115.273 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -125.1 156.96 37.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 105.639 -1.985 . . . . 74.21 105.639 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -137.44 154.42 49.94 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.128 -0.693 . . . . 74.25 109.128 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.03 142.15 16.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.405 1.082 . . . . 73.45 110.625 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.45 83.42 66.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 106.171 -1.789 . . . . 72.22 106.171 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -67.96 171.97 11.55 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.34 2.026 . . . . 72.34 110.643 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.03 163.66 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.424 2.083 . . . . 63.5 110.834 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 C-N-CA 122.399 2.066 . . . . 61.44 108.9 177.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--O 1.238 0.488 0 N-CA-C 109.368 -0.604 . . . . 74.22 109.368 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.413 HD21 ' C ' ' B' ' 93' ' ' ASN . 27.7 t-20 -126.17 143.33 51.17 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.002 2.121 . . . . 62.41 108.693 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -60.34 -28.5 68.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.564 1.546 . . . . 74.53 111.149 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.4 mt -88.86 147.73 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.161 2.184 . . . . 75.32 108.513 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.51 155.34 39.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.445 1.498 . . . . 75.14 109.612 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -130.63 105.06 7.57 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.324 2.249 . . . . 73.44 107.215 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -83.88 149.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 126.527 1.931 . . . . 73.42 110.645 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -140.49 162.65 34.83 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.63 1.172 . . . . 65.51 109.379 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 68.32 24.97 7.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.248 2.219 . . . . 74.25 113.173 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -67.38 153.47 94.76 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 121.221 -0.924 . . . . 74.22 110.033 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.68 158.21 50.95 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.456 2.771 . . . . 72.32 109.965 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -73.1 -14.07 61.32 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.522 -0.736 . . . . 73.24 112.128 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -130.2 129.18 43.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.562 -1.273 . . . . 75.43 107.562 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -166.79 160.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.383 2.273 . . . . 74.5 106.048 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -122.13 177.21 5.43 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.651 1.18 . . . . 62.05 110.129 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.69 88.63 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.179 -0.674 . . . . 45.21 109.179 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.3 -46.39 86.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.409 1.483 . . . . 75.33 110.482 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.23 -41.33 99.09 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.896 0.771 . . . . 73.34 110.646 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.4 mmm -63.77 -55.95 19.25 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.711 -0.478 . . . . 75.14 109.711 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.52 -25.06 68.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.288 -0.863 . . . . 72.32 111.038 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.36 -57.82 4.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.406 1.003 . . . . 75.13 109.857 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.4 mt -60.27 -58.33 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 125.55 1.54 . . . . 74.31 110.434 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -65.16 -22.64 66.94 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.793 0.664 . . . . 73.44 112.793 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.68 79.87 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 118.481 0.582 . . . . 71.54 113.927 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -69.24 -9.09 51.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.06 0.93 . . . . 74.21 111.306 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -104.72 -7.31 19.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.374 1.07 . . . . 73.32 111.14 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.12 -174.29 21.23 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.137 1.827 . . . . 70.01 111.396 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.99 169.25 9.29 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.091 2.528 . . . . 64.41 109.764 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.58 145.06 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 O-C-N 120.887 -1.133 . . . . 74.41 109.286 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -78.71 -63.44 1.41 Allowed 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.392 -1.336 . . . . 72.01 107.392 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -160.14 165.93 30.73 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.129 0.972 . . . . 74.21 109.257 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.38 146.44 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.479 1.512 . . . . 74.24 107.484 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -137.22 126.98 25.48 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 104.319 -2.474 . . . . 73.23 104.319 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.04 164.53 17.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 123.377 0.671 . . . . 75.21 109.471 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.45 146.19 44.08 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.174 -1.171 . . . . 71.15 110.174 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -124.46 -58.99 1.49 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.951 -1.129 . . . . 71.15 107.951 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.37 161.05 61.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.305 0.642 . . . . 74.13 109.285 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.58 -9.34 23.94 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.786 2.324 . . . . 75.01 115.121 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.21 -11.51 16.51 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.347 0.976 . . . . 74.11 112.584 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -99.39 -11.42 21.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.596 0.635 . . . . 73.51 111.318 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -69.06 152.84 44.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.457 -0.942 . . . . 74.44 108.457 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.22 -20.23 50.84 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.684 1.135 . . . . 73.4 112.241 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 50.4 p -133.32 165.45 24.8 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.852 -1.536 . . . . 63.45 106.852 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.07 175.57 10.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.741 -1.225 . . . . 73.51 111.545 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.17 146.44 50.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.855 0.752 . . . . 73.11 111.575 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -131.94 145.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.2 1.4 . . . . 62.54 107.803 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.39 136.57 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.436 -1.691 . . . . 73.51 106.436 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.98 166.32 13.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.634 -1.617 . . . . 73.54 106.634 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -78.34 -68.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.478 0.711 . . . . 72.34 110.059 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.84 144.16 30.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 74.12 112.969 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.42 -33.83 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.918 0.887 . . . . 74.3 109.933 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -67.17 -45.97 75.37 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.064 0.946 . . . . 75.24 110.621 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -57.74 -46.6 84.25 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.754 0.822 . . . . 73.41 109.71 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.36 83.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.392 -0.337 . . . . 64.34 111.054 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -67.37 -53.63 27.67 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.206 0.602 . . . . 62.14 110.929 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -59.77 -42.64 93.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.905 -0.569 . . . . 73.13 109.789 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.86 92.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.373 -0.602 . . . . 72.34 109.373 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 t -51.98 -53.34 42.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.771 0.828 . . . . 74.15 110.683 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -73.77 -14.53 61.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.849 1.055 . . . . 64.23 113.849 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -95.19 -21.36 18.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.626 1.103 . . . . 74.35 110.002 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 35.8 tp -99.78 -7.46 25.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.308 1.843 . . . . 71.4 111.468 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 32.4 p -57.96 117.01 3.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.978 1.311 . . . . 73.24 111.442 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.64 10.6 71.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.231 -1.316 . . . . 73.45 114.654 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -51.55 121.94 7.22 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.72 1.208 . . . . 75.43 112.875 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -83.57 118.1 23.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.8 2.04 . . . . 72.12 110.655 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.9 155.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.216 2.606 . . . . 75.42 105.642 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 m 49.67 21.74 0.69 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.388 1.475 . . . . 62.12 112.992 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 38.7 t30 59.24 55.55 4.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.166 2.186 . . . . 74.13 108.572 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -142.81 -167.75 2.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 128.152 2.581 . . . . 75.4 107.572 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -145.11 111.99 5.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.496 -2.409 . . . . 75.42 104.496 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.0 mt -77.32 172.77 12.78 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.919 -1.113 . . . . 64.32 108.96 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.81 146.94 31.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.427 -1.323 . . . . 74.22 107.427 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.92 115.61 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.217 1.407 . . . . 74.24 107.383 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.29 120.59 25.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.063 1.345 . . . . 74.21 107.715 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -55.68 145.27 24.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.645 0.657 . . . . 74.14 111.408 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.95 175.53 10.46 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.407 -0.59 . . . . 72.44 109.407 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . 0.413 ' C ' HD21 ' B' ' 18' ' ' ASN . 4.2 t-20 . . . . . 0 C--O 1.245 0.848 0 C-N-CA 125.643 1.577 . . . . 70.31 107.073 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 118.536 -0.745 . . . . 74.51 110.744 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -67.17 -46.86 72.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.022 0.828 . . . . 64.13 109.189 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.52 -6.89 5.71 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.106 1.15 . . . . 72.21 114.106 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 95.8 mtp -100.51 -0.03 38.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.889 1.276 . . . . 72.22 110.123 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.25 155.94 43.79 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.327 1.451 . . . . 71.41 111.542 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.29 163.27 36.79 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.235 2.623 . . . . 50.41 111.243 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.13 164.87 19.37 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.735 0.814 . . . . 74.44 110.291 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 76.58 21.66 74.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.506 -1.163 . . . . 71.1 114.587 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -124.21 158.35 32.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.641 1.721 . . . . 74.53 108.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -135.46 153.28 51.81 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.659 1.184 . . . . 73.14 109.074 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.38 146.7 11.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 123.521 0.728 . . . . 75.34 109.416 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 37.8 tp -132.92 82.55 54.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.21 -1.404 . . . . 71.02 107.21 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.72 165.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.06 2.507 . . . . 73.23 111.656 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -69.45 160.23 50.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.045 1.83 . . . . 71.23 111.229 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo . . . . . 0 N--CA 1.459 -0.539 0 C-N-CA 125.226 3.951 . . . . 73.42 114.488 -179.072 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 C--O 1.244 0.78 0 N-CA-C 105.859 -1.904 . . . . 74.44 105.859 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' B' ' 92' ' ' TYR . 0.0 OUTLIER -145.07 161.21 40.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.375 1.47 . . . . 74.13 108.16 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -80.79 -7.55 59.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.331 2.252 . . . . 74.41 116.032 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -103.29 121.59 54.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 120.488 1.494 . . . . 72.42 107.549 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 71.2 mt -110.19 142.39 41.8 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.282 1.033 . . . . 75.44 108.781 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.46 125.01 53.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.77 -2.307 . . . . 73.45 104.77 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.41 153.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.256 1.422 . . . . 73.43 108.408 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -145.92 163.44 35.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.363 1.865 . . . . 74.15 108.744 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 70.17 21.28 6.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.088 1.755 . . . . 71.05 112.752 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.0 mt -78.17 156.05 79.35 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 121.022 -1.049 . . . . 72.32 110.883 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.03 164.25 36.41 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.971 1.781 . . . . 72.14 111.354 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -93.66 -16.85 23.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 74.32 111.646 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -120.57 99.03 6.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 74.25 106.066 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.5 tt -163.32 174.11 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.988 2.115 . . . . 75.55 106.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -136.47 -170.05 2.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.03 1.332 . . . . 61.45 110.438 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.75 -40.75 65.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.678 -0.49 . . . . 72.43 109.678 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -49.04 -58.36 5.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.095 2.158 . . . . 63.02 110.926 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.42 -42.74 99.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.859 0.299 . . . . 72.35 110.913 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 92.7 mmm -67.57 -23.05 65.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 117.86 -1.067 . . . . 53.32 113.047 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -90.88 -38.17 13.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.744 1.156 . . . . 74.44 108.562 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.44 -52.09 36.51 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.96 1.304 . . . . 73.33 111.601 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.68 -61.47 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.626 0.771 . . . . 72.32 109.41 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -64.17 -19.97 65.68 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.778 0.288 . . . . 74.21 111.778 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.34 -16.62 75.54 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 125.025 1.298 . . . . 70.43 112.143 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -57.25 -32.98 67.11 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.329 1.064 . . . . 75.14 109.759 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -74.71 -60.44 2.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.194 0.998 . . . . 74.33 109.345 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.27 37.41 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.926 -1.27 . . . . 73.54 109.926 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.35 162.72 22.73 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.544 2.163 . . . . 73.34 109.978 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mt -126.51 138.52 54.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.537 -0.912 . . . . 72.14 108.537 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -68.53 -64.21 0.91 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.893 -0.78 . . . . 73.03 108.893 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -159.01 164.21 35.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.234 1.014 . . . . 74.12 108.94 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 95.3 mt -137.66 150.94 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.471 1.908 . . . . 65.21 107.796 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -146.17 148.28 32.38 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.657 1.983 . . . . 75.01 106.318 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.11 166.88 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.374 1.07 . . . . 74.2 110.707 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.37 146.22 40.4 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.168 -1.173 . . . . 71.45 110.168 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -122.92 -16.68 7.0 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.741 1.216 . . . . 71.31 112.157 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 18.8 p -95.0 159.02 33.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.443 -1.688 . . . . 73.32 106.443 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.32 -34.35 93.67 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.758 1.639 . . . . 64.21 111.696 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -72.42 -21.14 61.3 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.314 1.227 . . . . 73.31 114.314 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 34.6 p -92.62 -0.13 57.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.895 0.878 . . . . 74.32 111.25 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.77 140.74 57.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.357 -1.349 . . . . 72.01 107.357 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.83 -10.82 61.39 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.503 -1.72 . . . . 72.31 114.129 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.3 p -113.32 149.41 34.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.275 2.037 . . . . 73.55 109.329 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.8 175.67 12.84 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.902 -1.124 . . . . 75.35 109.569 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -136.27 150.04 48.75 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 122.86 0.464 . . . . 74.13 110.1 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -133.23 146.99 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.722 1.609 . . . . 75.34 106.96 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.9 t -127.43 140.66 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.544 -2.021 . . . . 72.25 105.544 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.95 163.63 24.08 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.873 1.269 . . . . 73.03 109.052 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -97.68 -53.5 3.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.952 1.301 . . . . 73.35 109.722 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.74 115.09 15.07 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.893 -1.151 . . . . 70.24 107.893 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 tt -71.52 -21.45 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.938 -1.134 . . . . 72.14 107.938 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.34 -50.31 47.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.826 1.65 . . . . 75.04 109.421 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.54 -42.37 91.99 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.479 -0.934 . . . . 73.22 108.479 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.66 -45.88 92.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.319 0.648 . . . . 74.34 110.671 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -57.5 -47.09 82.85 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.915 0.78 . . . . 74.52 111.267 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -66.19 -55.09 18.02 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.915 -0.772 . . . . 75.31 108.915 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -38.63 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.688 1.595 . . . . 74.13 113.933 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.08 -41.33 78.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.463 1.105 . . . . 72.31 110.234 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.51 -35.93 17.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.178 -0.305 . . . . 73.53 110.178 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.24 -31.71 69.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 74.25 111.213 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.57 -9.63 21.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.313 1.445 . . . . 74.24 112.785 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 31.3 t -73.92 108.47 6.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.889 -1.152 . . . . 63.03 107.889 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.12 12.41 60.16 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.589 -1.117 . . . . 72.43 112.815 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -68.01 121.66 16.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.618 1.209 . . . . 74.54 108.111 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -76.12 115.46 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.259 1.024 . . . . 61.34 110.391 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 m -140.38 137.78 36.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.766 1.226 . . . . 71.12 109.414 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.6 m 42.39 46.86 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.407 1.883 . . . . 71.51 113.426 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 66.56 10.06 7.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.139 2.176 . . . . 52.14 113.361 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -117.36 -179.37 3.7 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.621 2.368 . . . . 73.2 108.248 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -140.43 117.79 11.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.228 -1.027 . . . . 75.22 108.228 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.34 162.21 29.11 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.482 0.658 . . . . 70.22 110.52 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 94.4 t -128.97 159.41 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.475 1.91 . . . . 74.11 107.015 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 t -143.41 128.0 14.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.241 -1.392 . . . . 71.23 107.241 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.83 144.56 37.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.378 1.071 . . . . 75.21 109.782 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -68.87 163.43 24.34 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 75.12 109.588 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . 0.531 ' H ' ' ND2' ' B' ' 18' ' ' ASN . 23.3 t80 -87.81 147.15 25.28 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.312 -1.366 . . . . 74.44 107.312 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.254 1.321 0 N-CA-C 106.272 -1.751 . . . . 75.21 106.272 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 40.0 tp . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 110.292 -0.262 . . . . 75.35 110.292 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.82 -30.13 67.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.777 1.631 . . . . 64.22 111.872 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.8 34.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.584 1.154 . . . . 64.24 111.693 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 94.4 mtp -85.5 -20.18 30.08 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.146 -0.972 . . . . 73.01 110.098 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.1 158.55 39.2 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 124.167 0.987 . . . . 74.31 111.388 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.98 160.31 30.39 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.14 1.894 . . . . 72.2 110.192 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.38 158.95 24.47 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.072 0.939 . . . . 72.24 109.811 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.16 51.63 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.77 0.7 . . . . 64.4 112.36 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.05 156.27 38.46 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.518 1.527 . . . . 73.24 107.008 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -132.07 147.71 52.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.833 0.453 . . . . 74.43 111.007 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.531 1.132 . . . . 72.02 108.331 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.24 85.94 42.5 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 106.743 -1.577 . . . . 75.44 106.743 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.28 168.39 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.056 3.171 . . . . 74.22 112.33 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . 0.404 ' HA ' ' CE1' ' B' ' 36' ' ' TYR . 73.0 Cg_endo -67.91 168.25 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.355 2.703 . . . . 64.22 111.944 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 N--CA 1.453 -0.911 0 C-N-CA 123.076 2.517 . . . . 61.54 110.817 179.11 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 94.6 t . . . . . 0 C--O 1.239 0.516 0 N-CA-C 105.031 -2.211 . . . . 73.24 105.031 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.19 160.05 32.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.256 1.023 . . . . 71.45 108.79 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -63.67 -24.3 67.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.859 1.663 . . . . 63.42 112.958 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.3 137.66 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.04 -1.467 . . . . 75.53 107.04 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 69.2 mt -127.79 157.23 40.97 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.838 2.055 . . . . 72.34 109.593 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -126.02 149.29 48.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.465 1.506 . . . . 65.2 107.12 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mm -136.68 154.72 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.825 -1.546 . . . . 75.21 106.825 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -135.13 163.77 29.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.479 1.512 . . . . 74.45 108.465 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 70.81 15.19 6.92 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.13 1.772 . . . . 73.21 111.068 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.0 mt -69.14 151.2 97.2 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 121.058 -1.026 . . . . 72.41 110.938 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.69 140.68 92.18 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.546 2.83 . . . . 72.21 112.412 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -75.63 -27.01 58.25 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.619 -0.675 . . . . 75.11 111.232 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.03 88.72 2.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.203 1.401 . . . . 72.12 107.877 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -134.7 154.58 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.773 -0.825 . . . . 73.11 108.773 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 43.6 p -114.88 176.17 5.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.833 2.053 . . . . 75.42 108.314 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.81 -38.36 90.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.706 -0.621 . . . . 73.41 111.315 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -49.38 -58.07 5.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.886 1.274 . . . . 73.01 113.582 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.95 -35.2 79.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.595 0.634 . . . . 64.23 111.511 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.9 mmm -68.17 -52.91 29.23 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.369 -0.832 . . . . 64.3 110.132 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 417' ' ' PRO . 39.3 m-85 -66.8 -25.92 66.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.953 -1.022 . . . . 75.03 111.824 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.63 -59.62 2.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.235 1.379 . . . . 74.35 109.938 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.67 -62.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.407 1.883 . . . . 74.54 111.486 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -63.36 -35.52 80.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.237 -0.585 . . . . 73.34 110.428 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.6 -29.7 67.37 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 123.726 0.679 . . . . 60.23 112.212 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -17.46 56.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.187 0.995 . . . . 73.34 111.566 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.66 -36.93 8.97 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.503 1.121 . . . . 74.41 111.768 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.54 -174.01 45.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 65.42 110.68 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.56 171.41 13.15 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.718 2.278 . . . . 71.32 112.052 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.0 mt -127.81 131.49 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.781 1.232 . . . . 75.12 108.288 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.38 -57.51 3.22 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.154 -1.054 . . . . 75.31 108.154 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -157.12 153.29 27.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.646 0.778 . . . . 72.11 109.944 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 42.1 mt -134.64 137.81 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.874 1.67 . . . . 74.42 107.185 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -137.8 129.19 27.91 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.951 -2.24 . . . . 75.15 104.951 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 18.7 m -110.9 154.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.217 1.407 . . . . 74.52 110.952 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.35 117.85 8.76 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.334 -1.506 . . . . 74.34 109.334 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -100.79 -38.14 8.4 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.135 0.974 . . . . 75.01 112.086 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -64.22 157.67 69.14 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.51 -0.922 . . . . 65.05 108.51 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.02 -14.67 46.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.486 1.457 . . . . 75.33 112.783 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -98.66 -11.09 22.38 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.389 -0.815 . . . . 72.12 112.355 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.1 p -103.02 -23.65 13.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.891 1.223 . . . . 72.12 112.187 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -51.11 131.07 27.23 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.051 -1.463 . . . . 75.04 107.051 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.45 -13.04 15.87 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.381 1.467 . . . . 70.14 110.902 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.1 p -134.01 166.68 22.17 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 118.595 1.197 . . . . 75.5 110.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.25 169.29 17.78 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.306 1.443 . . . . 74.52 107.807 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -119.84 147.72 44.34 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 74.34 108.489 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.55 140.35 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.515 -2.032 . . . . 70.33 105.515 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.1 130.79 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 102.481 -3.155 . . . . 75.24 102.481 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -99.49 161.28 13.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.051 -0.722 . . . . 74.11 109.051 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -76.37 -31.85 58.26 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.052 -0.659 . . . . 74.23 110.472 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -123.55 165.92 16.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.204 1.402 . . . . 71.43 110.682 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -76.37 -46.81 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 121.435 -0.79 . . . . 75.21 110.806 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -59.64 -38.31 81.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.986 0.914 . . . . 75.5 110.84 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -62.06 -42.13 98.87 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.946 -0.761 . . . . 74.01 108.946 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.33 -51.43 68.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.576 0.751 . . . . 75.41 109.753 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -55.82 -52.33 64.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.932 0.893 . . . . 75.24 110.825 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.84 -49.45 76.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.129 -0.693 . . . . 62.34 109.129 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.05 89.14 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 118.104 -0.95 . . . . 74.13 111.906 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 67.7 m -60.51 -53.82 52.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.575 1.08 . . . . 71.5 109.588 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.21 -42.99 99.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.167 -0.444 . . . . 70.5 112.026 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -69.26 -24.22 63.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.417 -0.802 . . . . 72.53 111.231 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.1 tp -98.27 -13.11 20.95 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.406 1.457 . . . . 72.02 113.262 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 127.2 31.87 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.718 -1.216 . . . . 71.01 107.718 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.49 75.74 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.274 -1.292 . . . . 72.34 113.031 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -68.54 111.99 5.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.382 1.591 . . . . 74.21 108.187 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -85.33 115.14 22.91 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.376 2.27 . . . . 75.2 110.445 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.9 144.55 20.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.074 -1.084 . . . . 63.01 108.074 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.7 m 40.48 49.81 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.026 1.73 . . . . 72.45 112.745 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 m120 63.0 18.54 10.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.48 2.312 . . . . 75.05 115.626 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -137.75 167.24 22.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 120.028 1.285 . . . . 73.4 109.988 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -112.28 127.15 55.9 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.288 1.035 . . . . 75.4 109.925 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.82 106.18 6.23 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.039 -1.097 . . . . 70.43 108.039 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.72 136.69 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.552 -0.907 . . . . 74.51 108.552 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.63 132.63 56.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.746 2.018 . . . . 72.5 108.866 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -154.65 130.25 9.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.494 1.043 . . . . 75.52 110.034 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -69.34 158.74 34.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.759 -0.588 . . . . 75.41 110.224 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -79.08 160.95 26.86 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 107.661 -1.237 . . . . 73.32 107.661 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 116.823 -1.561 . . . . 74.31 107.265 179.069 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 110.415 -0.217 . . . . 74.43 110.415 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.23 -62.52 1.44 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.355 -1.35 . . . . 72.42 107.355 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -64.21 -1.68 1.73 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.083 2.153 . . . . 64.42 115.722 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 70.4 mtp -95.51 -10.08 30.69 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.849 -1.157 . . . . 75.35 111.501 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -106.01 148.3 36.31 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 118.808 0.731 . . . . 75.33 111.251 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.67 158.98 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.149 1.899 . . . . 75.3 107.719 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -73.86 165.45 25.1 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.708 0.766 . . . . 74.22 111.609 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.83 17.92 36.52 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.653 1.597 . . . . 74.42 111.228 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.58 139.52 53.52 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.758 1.223 . . . . 75.34 109.72 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.202 1.401 . . . . 74.21 109.424 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.62 151.09 9.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.518 1.151 . . . . 73.41 109.095 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 33.5 tp -116.51 76.02 7.03 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.358 1.463 . . . . 74.13 111.44 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.66 163.92 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.011 1.807 . . . . 71.22 108.773 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.8 166.37 30.16 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.226 1.95 . . . . 55.41 110.988 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.617 2.211 . . . . 54.14 111.116 178.508 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 75.1 t . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 105.889 -1.893 . . . . 72.42 105.889 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -67.18 141.93 57.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.971 -1.122 . . . . 75.11 107.971 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . 0.283 0.0 OUTLIER -57.8 -7.33 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 118.151 2.648 . . . . 75.11 118.151 -178.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 65.5 mt -101.87 128.11 54.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 105.602 -1.999 . . . . 63.15 105.602 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 mt -100.76 142.19 32.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.466 -1.309 . . . . 72.43 107.466 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.44 128.56 55.24 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.605 -2.368 . . . . 54.41 104.605 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 mm -118.74 136.53 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.968 -1.494 . . . . 75.44 106.968 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -125.93 163.68 22.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.597 1.559 . . . . 74.34 107.735 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 71.24 20.18 5.15 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.634 1.574 . . . . 54.24 112.078 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.13 153.82 93.85 Favored Pre-proline 0 C--O 1.237 0.445 0 O-C-N 121.4 -0.813 . . . . 74.24 110.593 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.89 159.23 52.64 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.74 2.96 . . . . 74.33 110.077 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -89.74 -19.11 25.16 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.112 0.565 . . . . 73.23 111.351 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -130.08 101.04 5.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.9 1.68 . . . . 64.02 108.348 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.51 155.67 6.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 127.431 2.293 . . . . 64.21 105.472 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -105.1 174.17 5.99 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.273 -0.892 . . . . 73.21 109.671 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.28 72.78 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.352 -0.981 . . . . 70.04 108.352 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -54.67 -35.46 63.57 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.404 1.482 . . . . 64.04 112.474 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -70.34 -42.75 71.45 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.911 1.232 . . . . 64.41 108.229 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.6 mmm -64.75 -45.07 87.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.605 -0.887 . . . . 74.43 108.605 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.83 -27.48 69.2 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 117.98 -1.01 . . . . 72.43 111.644 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.18 -65.26 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.233 0.924 . . . . 71.45 110.148 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mt -57.55 -53.37 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.673 1.189 . . . . 74.21 111.818 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -74.72 -17.01 60.72 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.697 -0.627 . . . . 73.43 111.647 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.4 -12.91 66.53 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 124.0 0.81 . . . . 44.32 113.096 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -58.09 -29.91 65.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.16 1.48 . . . . 65.52 110.495 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.63 -5.42 59.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.034 2.134 . . . . 70.14 114.525 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.65 -171.87 23.58 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 119.808 1.186 . . . . 72.45 111.702 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.29 163.77 28.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.38 2.054 . . . . 60.1 109.247 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mt -129.43 123.22 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.981 -1.075 . . . . 72.2 108.532 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -65.11 -67.07 0.47 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.454 -0.943 . . . . 74.04 108.454 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -156.89 160.64 39.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.932 0.787 . . . . 75.12 112.062 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -140.11 140.95 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.062 2.145 . . . . 73.31 106.258 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -132.59 120.06 21.31 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 103.272 -2.862 . . . . 63.01 103.272 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.98 146.12 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 119.26 0.936 . . . . 75.24 111.435 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.09 141.31 41.22 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.768 -2.133 . . . . 63.05 107.768 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 -9.94 4.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.195 0.998 . . . . 72.33 113.017 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 44.9 p -97.51 161.57 25.46 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.762 1.225 . . . . 75.22 108.478 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.33 5.76 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.85 3.033 . . . . 74.3 113.635 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -120.58 -9.74 9.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.148 1.379 . . . . 74.15 111.408 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -117.36 -25.58 6.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.569 1.148 . . . . 74.31 113.147 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -50.6 143.47 9.34 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.917 0.887 . . . . 73.44 112.134 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.0 85.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.096 -0.836 . . . . 61.24 111.273 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -138.05 150.27 46.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.941 1.37 . . . . 72.1 108.71 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.12 168.35 19.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.177 1.391 . . . . 75.24 107.82 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -120.85 155.53 33.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.367 -1.716 . . . . 71.14 106.367 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 t -125.52 124.47 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.31 -2.107 . . . . 73.42 105.31 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -110.55 123.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.026 -2.212 . . . . 75.11 105.026 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -98.09 166.46 11.41 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.377 -1.712 . . . . 72.13 106.377 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.78 -42.59 94.95 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.491 -1.381 . . . . 74.41 110.366 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.78 175.32 5.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.605 1.562 . . . . 74.44 111.146 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.2 tt -81.69 -38.19 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.333 1.453 . . . . 75.23 108.621 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -60.44 -37.16 80.07 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.197 0.453 . . . . 72.41 111.661 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.14 -42.79 96.64 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 119.377 -0.344 . . . . 75.43 111.003 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.79 -50.19 63.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.445 -0.946 . . . . 63.45 108.445 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -48.87 -54.88 13.48 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.614 1.566 . . . . 73.24 110.23 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -59.63 -60.18 4.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.043 0.937 . . . . 73.52 110.273 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.65 -29.1 51.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.052 1.131 . . . . 73.41 114.052 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.6 t -60.46 -38.25 83.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.447 0.699 . . . . 55.41 111.917 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -88.51 -28.6 20.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.596 0.635 . . . . 72.21 110.954 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -67.58 -31.13 70.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.226 0.466 . . . . 75.11 111.449 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.67 -3.43 20.61 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.256 1.576 . . . . 74.32 115.256 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 25.7 p -60.08 124.56 20.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.343 1.429 . . . . 75.53 109.677 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.05 13.99 73.22 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.231 -1.316 . . . . 75.31 114.334 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.48 119.53 5.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.884 1.842 . . . . 73.02 110.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -78.08 129.76 35.6 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.911 -1.144 . . . . 73.44 107.911 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -144.08 140.18 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 125.835 1.654 . . . . 75.13 106.789 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m 37.43 49.28 0.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 73.43 112.749 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 35.57 15.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.242 1.417 . . . . 71.23 113.947 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.61 -177.22 4.63 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.847 3.259 . . . . 72.35 104.657 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -139.23 137.14 35.7 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.865 -1.147 . . . . 64.12 109.456 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.75 158.22 21.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.414 -1.328 . . . . 73.02 107.414 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.79 131.77 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.683 -2.71 . . . . 75.13 103.683 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 t -115.33 135.35 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.035 1.334 . . . . 61.13 107.859 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.46 150.67 36.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.745 0.818 . . . . 53.15 110.608 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -78.52 160.97 27.38 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.392 -0.818 . . . . 75.31 111.546 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.28 176.58 6.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.152 0.981 . . . . 75.11 110.156 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 112.624 0.601 . . . . 74.22 112.624 -179.772 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 108.533 -0.914 . . . . 74.31 108.533 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.93 -10.46 57.34 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.295 1.038 . . . . 73.43 112.289 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -97.55 -36.15 10.4 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.028 1.331 . . . . 64.44 109.481 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.28 -13.58 61.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 73.42 112.608 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.67 157.78 42.04 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.911 1.232 . . . . 73.52 112.003 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.09 166.29 28.14 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.803 2.336 . . . . 74.12 111.241 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -84.69 174.99 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.557 1.143 . . . . 72.43 108.889 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 82.32 19.02 65.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.762 -1.021 . . . . 63.24 112.826 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -125.49 155.71 40.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.382 1.591 . . . . 74.32 106.908 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -130.35 133.69 46.61 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.117 -0.99 . . . . 74.32 108.656 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.08 151.31 10.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.617 -1.253 . . . . 71.04 107.617 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.6 tp -125.73 85.72 58.61 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 125.637 1.575 . . . . 71.23 108.662 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -66.21 178.78 2.28 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.913 2.409 . . . . 72.43 109.566 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.44 170.99 1.04 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.704 2.936 . . . . 71.33 113.386 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo . . . . . 0 C--N 1.349 0.558 0 C-N-CA 125.06 3.84 . . . . 73.42 114.899 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.423 HG12 ' CE1' ' B' ' 91' ' ' TYR . 88.1 t . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 108.763 -0.829 . . . . 71.21 108.763 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -138.48 159.85 41.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.993 1.717 . . . . 65.21 108.73 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -72.63 -24.42 61.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.057 1.343 . . . . 72.41 109.505 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -89.54 129.65 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.296 1.438 . . . . 75.1 107.475 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.54 153.53 36.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.876 1.27 . . . . 75.01 107.882 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -119.31 111.6 18.39 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.963 -2.606 . . . . 74.31 103.963 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -96.59 145.67 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.661 -1.977 . . . . 65.42 105.661 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -136.88 163.2 31.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.038 1.335 . . . . 75.12 109.19 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.8 t30 63.12 33.68 14.3 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.062 2.145 . . . . 64.21 111.066 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 55.0 mt -73.79 158.72 85.71 Favored Pre-proline 0 C--O 1.237 0.417 0 O-C-N 121.497 -0.752 . . . . 74.32 109.013 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.16 156.38 65.99 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.886 1.724 . . . . 72.15 109.498 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.23 -25.69 58.33 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.536 -0.727 . . . . 70.44 112.002 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -129.75 128.09 41.73 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.261 -1.385 . . . . 74.43 107.261 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tt -157.51 169.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.553 -1.277 . . . . 71.13 107.553 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 16.9 p -126.49 169.1 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.532 1.933 . . . . 62.14 108.982 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.82 90.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.393 -0.966 . . . . 74.42 108.393 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.45 -55.31 30.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.018 1.327 . . . . 70.45 111.852 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.24 -40.41 85.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.069 0.395 . . . . 73.32 111.438 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.35 -44.01 72.48 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 74.04 111.587 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.14 -23.18 60.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.972 0.909 . . . . 73.33 111.026 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.63 -59.32 2.77 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.273 1.029 . . . . 73.55 108.51 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.17 -67.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.811 1.645 . . . . 74.25 111.027 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -66.99 -32.41 73.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.643 0.608 . . . . 73.35 112.643 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.84 -32.34 81.48 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 120.468 1.485 . . . . 74.05 112.567 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -75.58 -21.34 57.92 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.335 -1.097 . . . . 74.14 110.236 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.36 -30.97 30.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.347 1.059 . . . . 75.33 110.734 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.97 -175.29 44.71 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.116 0.871 . . . . 75.2 111.668 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.06 165.72 25.42 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.911 2.407 . . . . 73.44 110.673 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -132.52 113.68 21.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 123.662 0.785 . . . . 74.25 109.637 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -81.52 -49.09 11.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.526 -1.287 . . . . 74.32 107.526 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -168.9 162.24 11.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.442 1.497 . . . . 74.54 108.496 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.2 mt -144.78 140.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.43 2.292 . . . . 74.44 106.016 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.53 121.88 9.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.055 -1.831 . . . . 75.12 106.055 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.12 167.07 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.63 0.772 . . . . 74.03 109.629 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.38 137.14 42.6 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.669 -0.973 . . . . 54.41 110.669 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -107.34 -49.66 3.22 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.606 1.962 . . . . 74.4 110.661 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -70.57 158.21 88.35 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.109 -0.7 . . . . 73.32 109.109 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.51 14.83 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.549 3.499 . . . . 74.21 115.36 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.01 -47.13 2.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.817 2.047 . . . . 73.14 109.419 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 51.2 p -72.84 -29.45 63.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.972 0.909 . . . . 75.5 109.856 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -50.37 124.77 11.17 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.162 0.985 . . . . 74.42 110.249 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.81 -13.07 17.59 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.746 1.165 . . . . 72.35 110.56 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -128.02 166.07 19.09 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.897 1.348 . . . . 73.42 108.761 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.26 168.14 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.154 -0.966 . . . . 74.25 111.066 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -120.54 124.04 44.37 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.977 -1.12 . . . . 75.44 107.977 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.78 142.25 24.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.507 -2.405 . . . . 74.05 104.507 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.74 122.9 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.718 -1.586 . . . . 73.11 106.718 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.56 165.97 11.73 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.47 1.108 . . . . 74.34 108.467 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.14 -59.36 2.12 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.347 0.659 . . . . 75.23 109.744 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.06 117.6 29.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 126.087 1.755 . . . . 73.44 107.303 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.54 -35.62 60.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 119.39 -0.338 . . . . 71.11 110.815 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -60.37 -50.4 73.76 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.916 0.886 . . . . 73.43 110.073 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.33 -32.17 73.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.551 -0.537 . . . . 74.5 109.551 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.23 92.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.835 -0.802 . . . . 72.22 108.835 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -60.1 -46.56 89.2 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.17 -1.048 . . . . 74.12 108.17 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.99 -52.85 63.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.831 0.707 . . . . 74.04 110.031 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.02 79.74 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.655 -0.688 . . . . 64.52 111.705 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.13 -51.32 68.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.989 0.813 . . . . 75.05 108.995 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -65.71 -37.91 87.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.439 0.563 . . . . 74.41 111.814 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.18 -31.53 72.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.251 0.221 . . . . 75.32 110.424 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.6 tp -91.1 -24.23 20.07 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.844 0.683 . . . . 74.3 112.844 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 3.0 m -68.25 106.4 2.44 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.955 0.902 . . . . 72.25 109.931 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.51 9.45 56.6 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.751 1.643 . . . . 73.02 113.042 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -72.18 141.36 49.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.171 -1.418 . . . . 72.45 107.171 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -110.9 135.02 52.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.758 1.623 . . . . 61.34 110.848 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -157.16 150.16 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 127.499 2.32 . . . . 75.32 107.351 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 53.0 m 44.61 50.25 8.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.614 1.166 . . . . 75.54 113.7 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 44.5 t30 55.5 18.83 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.759 1.624 . . . . 74.34 113.235 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 61.2 mtt85 -134.97 173.82 11.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.739 2.016 . . . . 75.04 110.585 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -130.57 133.34 46.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 105.751 -1.944 . . . . 75.12 105.751 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.21 172.09 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.07 -1.085 . . . . 64.01 108.07 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 5.2 t -134.11 126.7 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 103.757 -2.683 . . . . 74.35 103.757 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.3 t -114.55 137.81 46.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.488 -1.671 . . . . 73.44 106.488 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 46.4 tp -146.81 155.94 42.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.619 1.567 . . . . 74.41 107.159 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . 0.423 ' CE1' HG12 ' B' ' 17' ' ' VAL . 52.8 m-85 -87.74 163.22 16.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.246 -0.65 . . . . 72.3 109.246 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.86 170.01 15.45 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.577 -0.897 . . . . 63.11 108.577 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 . . . . . 0 C--O 1.246 0.909 0 O-C-N 120.909 -1.119 . . . . 75.4 109.342 179.817 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 119.191 -0.433 . . . . 73.1 109.896 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.02 -37.76 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.3 0.64 . . . . 75.52 109.393 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.68 -29.22 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.177 0.991 . . . . 54.13 110.924 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 35.0 mtm -88.95 -1.63 58.2 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.198 0.999 . . . . 74.53 111.672 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -108.47 148.48 37.75 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 119.151 0.887 . . . . 73.31 112.978 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.95 149.74 59.83 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.634 2.223 . . . . 75.33 109.931 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.65 166.22 23.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.158 0.983 . . . . 75.32 111.661 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.48 17.61 56.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.753 1.168 . . . . 72.23 113.024 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -124.42 158.11 33.56 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.254 1.822 . . . . 75.23 108.462 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -127.88 151.65 48.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.553 -0.906 . . . . 73.31 108.553 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 13.9 t -69.98 150.96 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.212 -1.403 . . . . 73.41 107.212 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.0 tp -128.95 75.73 79.95 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.579 -0.897 . . . . 73.34 108.579 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.08 161.32 44.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.942 2.428 . . . . 73.44 110.736 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.69 159.13 54.96 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.974 2.449 . . . . 74.33 112.563 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 C-N-CA 123.661 2.908 . . . . 72.31 111.312 179.879 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 105.346 -2.094 . . . . 75.42 105.346 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -144.06 -179.02 6.23 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.11 -0.994 . . . . 72.13 110.005 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -88.24 -30.91 19.33 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.282 -0.886 . . . . 74.31 109.568 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 mt -82.45 132.93 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.389 -1.338 . . . . 75.23 107.389 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.33 151.84 42.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.121 2.168 . . . . 75.43 107.376 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -110.65 131.82 54.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.221 -1.77 . . . . 74.55 106.221 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.59 138.34 48.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.289 -1.375 . . . . 74.53 107.289 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -138.35 163.59 31.46 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.277 1.431 . . . . 75.35 109.572 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 67.31 31.21 6.65 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.329 1.852 . . . . 72.24 109.991 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 49.4 mt -70.34 156.41 91.92 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 124.468 1.107 . . . . 72.44 111.715 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.96 152.62 51.94 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.814 3.009 . . . . 70.2 109.961 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -80.28 -25.11 39.61 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.539 -0.726 . . . . 74.54 112.431 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -129.01 114.78 16.84 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.45 1.5 . . . . 75.33 106.956 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.28 168.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 127.068 2.147 . . . . 75.12 106.409 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -136.89 169.54 17.59 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.465 1.106 . . . . 65.15 108.605 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.78 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.041 0.536 . . . . 75.22 111.139 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.29 -25.41 64.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.62 1.568 . . . . 70.41 113.043 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -94.46 -35.88 12.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.213 1.005 . . . . 63.13 109.426 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.5 mmm -64.92 -53.2 50.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.501 1.12 . . . . 70.04 109.82 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -67.52 -16.89 64.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.606 -0.712 . . . . 73.22 111.938 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.26 -67.03 0.54 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.859 -1.163 . . . . 64.05 107.859 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.99 -62.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 C-N-CA 126.484 1.914 . . . . 74.05 111.353 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -62.34 -21.5 65.35 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.467 0.914 . . . . 73.12 113.467 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.46 66.24 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.122 0.868 . . . . 61.51 112.386 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.56 -31.46 72.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.218 -1.401 . . . . 64.45 107.218 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.95 -61.76 1.89 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.32 1.048 . . . . 75.15 109.708 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.84 178.11 45.86 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.719 1.145 . . . . 63.42 115.085 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 121.86 9.15 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.367 3.378 . . . . 75.34 109.927 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 mt -86.38 151.07 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.483 -0.932 . . . . 74.12 108.483 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -87.5 -62.86 1.4 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 107.168 -1.419 . . . . 72.23 107.168 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.53 161.27 41.73 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.122 0.969 . . . . 73.24 109.849 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -140.02 142.37 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.741 1.616 . . . . 74.43 107.482 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 -141.67 131.39 24.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.197 -2.89 . . . . 74.32 103.197 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.94 157.4 30.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.478 0.711 . . . . 70.22 111.3 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.05 146.99 44.88 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.821 1.201 . . . . 65.24 111.048 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.09 -49.53 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.46 1.104 . . . . 70.52 108.886 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -66.4 159.76 70.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.691 -0.855 . . . . 72.52 108.691 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.13 -12.21 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.719 1.612 . . . . 62.42 110.594 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.73 -9.88 45.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.015 2.526 . . . . 65.14 111.865 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 33.4 p -116.75 -33.42 4.82 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.039 0.936 . . . . 65.44 109.153 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -54.33 117.2 3.09 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.936 1.694 . . . . 74.01 108.049 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.31 -8.38 9.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.592 2.044 . . . . 73.41 109.75 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 71.8 p -139.77 158.89 43.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.567 1.147 . . . . 62.35 109.953 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.27 172.45 13.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 75.23 107.939 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -128.36 144.55 51.15 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.007 -1.849 . . . . 75.02 106.007 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.41 141.17 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.399 -2.075 . . . . 74.41 105.399 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -123.62 130.46 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.891 -1.892 . . . . 75.3 105.891 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -96.86 160.8 14.16 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 105.48 -2.044 . . . . 75.21 105.48 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.81 -46.27 89.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.1 0.407 . . . . 72.15 112.1 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -120.88 176.16 5.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.566 1.947 . . . . 75.43 110.526 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -90.59 -11.58 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.776 1.23 . . . . 75.13 113.653 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -83.24 -52.82 6.24 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.6 -1.313 . . . . 75.12 110.1 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -30.75 68.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.114 0.966 . . . . 73.4 110.846 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.68 88.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.014 0.526 . . . . 74.22 110.842 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -71.86 -39.12 69.9 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.535 -0.728 . . . . 75.22 109.809 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -54.77 -53.45 54.95 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 107.703 -1.221 . . . . 71.05 107.703 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.52 96.51 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.883 0.873 . . . . 71.24 111.937 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . 0.405 ' HG ' ' CG1' ' B' ' 89' ' ' VAL . 50.9 t -50.91 -58.6 5.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.852 0.861 . . . . 74.54 111.395 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.95 -37.16 83.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 119.3 -0.381 . . . . 73.12 111.528 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.47 -26.82 68.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.021 0.528 . . . . 71.24 112.114 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 30.3 tp -103.78 -14.38 16.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.693 1.197 . . . . 74.25 113.987 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 9.4 t -59.06 116.29 3.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.112 -0.992 . . . . 65.31 110.031 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.45 20.22 69.49 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.96 -1.467 . . . . 64.53 114.262 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -52.13 133.03 33.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.052 1.426 . . . . 75.51 109.988 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -84.98 97.14 9.63 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.643 1.577 . . . . 73.2 111.149 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.86 146.71 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.09 1.756 . . . . 74.41 107.369 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 32.6 m 46.36 31.68 1.34 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 71.13 113.297 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.07 23.71 11.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.52 1.528 . . . . 55.12 112.003 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -116.54 179.19 4.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.41 2.684 . . . . 74.53 108.03 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -137.82 121.69 17.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 74.03 106.707 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.73 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.537 -0.912 . . . . 73.42 108.537 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.96 107.07 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 105.167 -2.16 . . . . 74.51 105.167 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . 0.405 ' CG1' ' HG ' ' B' ' 74' ' ' CYS . 58.9 t -96.18 132.86 39.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.237 1.015 . . . . 73.43 109.197 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.6 tp -143.85 157.25 44.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.867 1.267 . . . . 72.43 109.182 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -86.28 157.73 19.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.064 0.946 . . . . 75.15 108.891 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -81.95 161.52 23.03 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.76 . . . . 75.12 109.756 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 38.4 t30 . . . . . 0 C--O 1.243 0.752 0 C-N-CA 126.265 1.826 . . . . 75.42 108.698 -179.245 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 119.36 -0.352 . . . . 62.32 110.936 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -61.95 -45.2 94.73 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.296 1.838 . . . . 74.13 108.743 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.754 1.222 . . . . 72.45 110.747 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 47.2 mtp -78.18 -20.71 51.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 75.21 111.55 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.2 155.34 42.85 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.08 0.952 . . . . 73.53 110.322 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.99 168.53 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.542 2.162 . . . . 54.31 110.523 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.33 169.68 5.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.955 2.102 . . . . 71.54 112.468 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 66.04 20.9 69.33 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.731 -1.038 . . . . 65.02 113.955 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -122.95 157.09 33.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.674 1.737 . . . . 73.15 109.533 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -135.99 146.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.759 -1.109 . . . . 72.23 108.657 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 98.0 t -70.28 151.06 9.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 105.779 -1.934 . . . . 54.53 105.779 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.59 90.62 31.58 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.231 -2.877 . . . . 72.21 103.231 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.9 163.4 7.52 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.681 2.254 . . . . 74.51 112.622 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.65 155.63 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.97 1.78 . . . . 74.23 109.284 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 C-N-CA 121.792 1.661 . . . . 73.24 112.581 -179.241 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 106.381 -1.711 . . . . 72.44 106.381 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -137.13 159.36 42.14 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.808 1.243 . . . . 75.11 109.24 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -55.92 -34.24 65.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.318 1.447 . . . . 72.33 113.514 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.5 136.13 24.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.155 -1.424 . . . . 64.22 107.155 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.5 mt -128.56 156.58 43.1 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.708 2.003 . . . . 75.22 107.912 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -124.94 126.13 45.01 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.297 1.839 . . . . 64.33 107.315 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -115.92 146.17 20.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.117 -1.438 . . . . 74.25 107.117 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -126.99 163.52 23.51 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.143 1.777 . . . . 75.24 107.529 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 66.11 28.96 10.12 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.313 1.445 . . . . 74.3 112.193 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.56 150.4 79.3 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 121.109 -0.994 . . . . 75.12 112.009 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.3 148.55 88.57 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.725 2.95 . . . . 71.5 109.647 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -84.97 -21.78 29.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 74.14 112.066 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -124.87 94.96 4.34 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.523 -1.288 . . . . 74.04 107.523 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 tt -147.53 170.42 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.525 2.33 . . . . 74.5 106.333 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 61.3 p -131.26 170.17 14.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.013 1.279 . . . . 75.13 110.761 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.55 74.45 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.614 -0.513 . . . . 71.22 109.614 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.74 -36.75 72.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.371 1.868 . . . . 74.21 110.323 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.86 -42.68 13.04 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.496 -0.752 . . . . 62.12 110.397 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 97.8 mmm -58.9 -35.27 72.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.667 -0.683 . . . . 73.05 111.362 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.59 -12.42 48.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.678 0.791 . . . . 62.42 111.535 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.69 -61.81 1.63 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.57 1.532 . . . . 72.52 108.606 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.0 mt -48.6 -57.82 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.514 1.126 . . . . 51.34 109.705 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -73.81 -23.91 59.73 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.443 0.535 . . . . 74.03 112.443 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.96 -23.41 74.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.165 0.888 . . . . 74.32 111.747 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -73.04 -2.77 22.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 1.227 . . . . 63.24 109.762 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -107.68 -11.58 15.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.78 -1.105 . . . . 75.21 111.863 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.32 26.6 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.512 1.051 . . . . 51.25 112.761 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.0 151.74 83.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.316 3.344 . . . . 75.44 110.818 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 54.0 mt -121.77 130.26 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 107.908 -1.145 . . . . 75.45 107.908 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -74.17 -63.42 1.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.478 -0.934 . . . . 75.42 108.478 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -158.16 165.62 34.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.476 0.71 . . . . 75.21 109.188 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 59.3 mt -140.84 145.98 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.912 1.685 . . . . 75.42 107.468 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -136.26 154.4 50.91 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.333 -2.099 . . . . 75.52 105.333 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.57 153.01 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 123.919 0.887 . . . . 72.24 109.009 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.73 136.27 19.61 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.174 -1.971 . . . . 73.15 108.174 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -115.69 -23.48 8.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.665 -0.494 . . . . 73.41 109.665 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.7 p -80.28 156.82 73.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.684 0.794 . . . . 73.24 110.276 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.2 -14.04 34.24 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.059 2.506 . . . . 64.21 114.065 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -97.52 -1.11 44.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.354 0.979 . . . . 75.11 112.999 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 81.4 p -116.86 -13.04 10.7 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.409 1.004 . . . . 75.12 113.159 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -50.84 116.47 1.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.08 1.352 . . . . 75.35 109.803 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 -20.79 9.03 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.674 1.131 . . . . 71.55 112.33 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -124.11 128.17 48.89 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.348 1.059 . . . . 73.33 109.797 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.34 175.76 9.33 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.512 1.125 . . . . 65.24 111.56 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -128.76 147.1 50.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.189 0.595 . . . . 75.24 110.269 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.59 148.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 126.667 1.987 . . . . 74.33 105.894 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 15.9 t -127.61 124.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.806 -1.924 . . . . 74.11 105.806 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -98.65 163.04 12.81 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.531 -1.285 . . . . 62.42 107.531 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -89.18 -61.71 1.64 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.759 -0.83 . . . . 72.21 108.759 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.18 138.82 32.78 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.033 -1.042 . . . . 73.13 110.986 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt -71.43 -43.47 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.203 -0.935 . . . . 75.4 110.7 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.159 0.89 . . . . 75.5 111.334 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.93 -48.05 22.77 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.316 1.446 . . . . 73.14 108.038 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.85 79.75 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.03 0.932 . . . . 64.3 108.832 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -65.03 -36.96 86.03 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.945 1.298 . . . . 70.44 111.321 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -63.59 -55.85 20.48 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 107.782 -1.192 . . . . 73.21 107.782 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.4 73.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.958 0.903 . . . . 74.51 111.09 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.96 -57.07 11.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.211 -1.403 . . . . 74.13 107.211 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.87 -42.12 98.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 119.253 -0.403 . . . . 73.11 111.11 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.263 -0.875 . . . . 72.41 112.592 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.46 -28.12 13.08 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.723 1.601 . . . . 73.31 111.293 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 20.6 t -66.23 107.92 2.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.517 1.527 . . . . 65.43 107.64 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.24 10.09 54.76 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.204 1.383 . . . . 75.45 113.57 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -74.7 122.12 22.76 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.362 1.581 . . . . 72.11 108.004 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -85.07 132.65 34.29 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.773 -1.195 . . . . 52.22 107.773 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -146.19 135.69 17.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.964 -1.495 . . . . 54.25 106.964 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.6 m 46.2 42.38 9.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.65 1.58 . . . . 74.43 113.268 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.64 3.93 4.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.804 2.842 . . . . 61.31 114.256 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.88 161.81 15.98 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.196 -1.565 . . . . 75.22 109.917 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -110.52 117.71 34.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.542 -0.911 . . . . 74.21 108.542 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.64 154.6 39.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.667 -0.864 . . . . 73.12 108.667 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.0 127.52 67.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.031 -1.47 . . . . 65.35 107.031 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -115.77 137.77 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 75.12 108.183 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -144.59 137.1 26.5 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.859 0.864 . . . . 64.4 110.272 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -66.87 153.66 42.91 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.043 0.937 . . . . 73.11 108.95 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -76.37 163.69 26.74 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.498 -0.752 . . . . 75.35 112.99 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 C--O 1.249 1.076 0 C-N-CA 127.284 2.234 . . . . 73.4 105.596 179.389 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 25.9 tp . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 107.033 -1.469 . . . . 75.31 107.033 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -60.73 -41.89 96.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.85 -0.796 . . . . 74.01 108.85 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.88 45.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.92 0.888 . . . . 61.32 112.493 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.1 mtp -84.94 -1.25 56.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.446 1.098 . . . . 73.23 111.486 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -112.4 158.16 38.02 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 119.817 1.19 . . . . 75.03 111.711 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.96 175.61 10.19 Favored 'Trans proline' 0 C--O 1.239 0.567 0 C-N-CA 123.619 2.879 . . . . 74.51 112.204 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.56 166.15 21.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.358 -0.837 . . . . 71.2 110.33 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.01 78.96 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 121.388 -0.82 . . . . 71.13 113.531 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -123.38 157.57 33.06 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.711 -1.464 . . . . 75.35 107.902 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.77 137.09 43.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.203 -1.777 . . . . 71.04 106.203 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.7 t -70.31 149.67 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.004 -0.739 . . . . 63.23 109.004 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 35.9 tp -125.52 77.63 68.86 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.777 -1.194 . . . . 72.0 107.777 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.4 169.27 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.838 2.358 . . . . 71.24 111.701 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.18 161.46 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.424 3.416 . . . . 73.4 114.387 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo . . . . . 0 N--CA 1.46 -0.465 0 C-N-CA 124.669 3.579 . . . . 63.01 115.837 179.809 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.235 0.315 0 N-CA-C 105.083 -2.191 . . . . 74.4 105.083 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -130.75 166.55 20.54 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.717 1.207 . . . . 72.42 109.738 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.21 -41.78 73.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.521 -0.752 . . . . 74.11 112.966 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.14 133.96 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.146 -1.057 . . . . 71.14 108.146 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 36.9 mt -123.47 156.58 35.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.175 1.39 . . . . 73.41 109.397 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -111.71 137.53 49.49 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.554 2.342 . . . . 73.54 107.554 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.8 mm -123.18 144.65 32.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.919 2.088 . . . . 62.31 107.189 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -144.83 163.03 35.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.426 1.09 . . . . 71.23 110.75 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 72.04 25.47 3.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.805 2.442 . . . . 74.55 111.278 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -73.91 157.22 87.44 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.998 1.319 . . . . 73.11 112.7 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.71 160.28 44.1 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.651 2.901 . . . . 64.45 112.263 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -93.73 -10.96 32.53 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.752 1.621 . . . . 75.31 110.936 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mmmp? -128.69 95.32 4.08 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 106.883 -1.525 . . . . 75.52 106.883 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -155.16 160.71 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 124.206 0.941 . . . . 74.12 108.526 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 8.4 p -138.08 175.73 9.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.171 1.388 . . . . 73.43 109.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.97 70.74 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.285 0.634 . . . . 75.22 111.981 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -56.93 -46.22 82.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.134 0.974 . . . . 73.33 111.96 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -78.29 -40.54 36.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.549 0.74 . . . . 72.34 109.721 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.2 mmm -61.05 -46.23 91.54 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 120.984 -1.072 . . . . 75.41 110.261 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -71.68 -23.27 61.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.374 -0.822 . . . . 71.11 109.938 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.64 -46.6 75.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.761 1.164 . . . . 65.21 108.063 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mt -67.79 -69.49 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.04 1.336 . . . . 73.21 110.902 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -60.32 -26.22 66.38 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.886 1.809 . . . . 71.25 115.886 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.54 -23.6 73.71 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.341 0.973 . . . . 64.51 111.946 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -65.83 -15.19 62.67 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.306 -1.114 . . . . 74.33 111.037 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -107.33 -4.48 18.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.936 1.458 . . . . 74.33 114.936 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.92 -173.7 21.45 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.753 1.16 . . . . 63.23 114.053 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.27 117.89 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 125.264 3.976 . . . . 65.22 113.791 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 71.5 mt -77.27 103.07 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 127.195 2.198 . . . . 74.21 108.682 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -66.46 -61.79 1.81 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.854 -1.154 . . . . 74.54 110.637 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -160.78 142.85 12.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.892 0.769 . . . . 73.14 111.603 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 16.7 mt -126.89 140.32 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.502 1.121 . . . . 74.24 109.539 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -137.37 122.47 19.13 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.767 -2.679 . . . . 73.3 103.767 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -111.17 145.99 16.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.501 1.12 . . . . 72.44 108.732 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.84 125.36 16.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.089 -2.405 . . . . 64.42 107.089 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -100.37 -20.57 15.76 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.521 1.16 . . . . 73.43 113.954 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -73.75 157.14 87.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.998 -1.853 . . . . 73.44 105.998 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.24 -20.29 70.39 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.106 1.871 . . . . 74.34 111.843 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.8 -44.43 16.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.282 1.433 . . . . 74.22 109.774 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 77.4 p -74.62 -0.94 19.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.254 -0.904 . . . . 61.2 112.176 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -64.61 163.44 13.71 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.887 -1.133 . . . . 73.44 109.363 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 -9.36 6.07 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.547 -1.141 . . . . 51.42 112.567 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 44.3 p -128.77 144.63 51.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.469 1.634 . . . . 74.42 110.312 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.72 175.37 12.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.224 1.01 . . . . 72.45 110.027 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -127.62 156.16 42.73 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.324 0.649 . . . . 60.24 110.531 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -142.55 144.95 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.537 -1.282 . . . . 70.1 107.537 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.48 149.16 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.077 -1.453 . . . . 75.43 107.077 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -116.24 160.2 20.78 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.403 -1.436 . . . . 75.32 108.78 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -65.7 -40.99 92.85 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.396 -0.594 . . . . 64.33 109.396 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -122.35 142.52 50.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.195 -1.039 . . . . 74.23 108.195 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.45 -24.51 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.681 -0.637 . . . . 74.42 110.845 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.66 -25.42 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.415 1.086 . . . . 74.53 110.581 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -74.9 -53.08 9.68 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 105.338 -2.097 . . . . 70.45 105.338 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.85 -35.71 33.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.241 1.016 . . . . 75.23 111.943 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -57.14 -69.14 0.17 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.07 1.348 . . . . 74.1 111.659 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -37.55 81.6 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.511 -0.743 . . . . 75.44 111.671 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.34 80.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.543 -0.741 . . . . 65.1 111.838 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.71 -61.67 2.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.053 -0.721 . . . . 73.31 109.053 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.51 -31.79 70.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.603 0.964 . . . . 74.31 113.603 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -73.88 -26.77 60.73 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.446 0.566 . . . . 72.32 111.1 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.21 -16.53 18.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.119 0.968 . . . . 74.45 112.669 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -63.11 108.06 1.16 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.141 1.777 . . . . 72.52 108.238 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.5 83.1 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.209 -1.329 . . . . 65.32 113.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.02 141.53 45.36 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 119.112 1.456 . . . . 73.32 111.006 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -94.96 113.61 25.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 115.231 1.567 . . . . 74.0 115.231 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 m -133.21 141.77 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 73.05 105.401 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 74.8 m 42.92 36.71 0.92 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.84 1.656 . . . . 74.13 113.607 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 65.26 21.56 12.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.299 1.84 . . . . 64.33 112.668 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.54 -179.54 3.74 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.779 2.432 . . . . 75.12 108.442 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -138.03 114.11 10.05 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.873 -1.899 . . . . 70.24 105.873 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -69.02 168.76 13.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.297 0.639 . . . . 72.33 110.97 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.02 107.85 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.855 1.262 . . . . 71.11 107.73 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.74 135.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.19 -1.411 . . . . 73.21 107.19 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -151.98 141.96 22.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.253 1.021 . . . . 75.33 108.803 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -73.17 154.75 40.17 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.943 0.792 . . . . 74.25 110.215 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.09 148.16 38.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.964 -1.495 . . . . 74.41 106.964 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 126.977 2.111 . . . . 74.31 106.417 178.771 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.87 0 N-CA-C 106.797 -2.521 . . . . 73.52 106.797 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.53 133.59 21.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 107.204 -1.406 . . . . 73.33 107.204 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.04 72.24 6.62 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.794 2.329 . . . . 73.24 108.356 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.64 134.5 51.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.125 -1.065 . . . . 75.22 108.125 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.26 -179.58 6.48 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.418 0.687 . . . . 74.43 111.614 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.74 -179.57 6.98 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.795 1.638 . . . . 72.51 109.468 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -136.52 168.54 19.28 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.756 1.622 . . . . 72.32 108.582 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -132.77 152.18 51.83 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.785 0.834 . . . . 71.22 109.836 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -125.24 -165.57 1.42 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.061 1.344 . . . . 74.43 109.286 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -139.5 179.05 6.78 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 126.09 1.756 . . . . 75.42 106.445 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -139.52 154.8 47.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.033 -1.84 . . . . 74.42 106.033 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -85.27 -166.12 1.41 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.221 1.809 . . . . 74.13 109.875 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -65.11 162.94 15.89 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.369 -0.832 . . . . 73.42 110.295 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.02 161.63 30.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.073 -0.967 . . . . 73.22 109.163 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 41.6 pt -71.18 173.81 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.721 1.208 . . . . 61.15 110.763 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 159.36 31.13 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.991 0.9 . . . . 74.52 111.127 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -155.8 176.12 13.04 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.911 1.685 . . . . 61.31 107.945 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 31.5 mtp85 -125.12 85.67 2.44 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.741 -0.599 . . . . 74.11 110.911 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -51.32 144.87 9.07 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.066 1.346 . . . . 73.22 109.411 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -56.54 160.45 5.39 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.918 1.287 . . . . 75.42 111.565 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.97 -174.58 1.79 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.123 1.882 . . . . 74.44 108.903 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 30.6 mt -73.34 70.62 1.21 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.144 -0.972 . . . . 74.52 109.69 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.5 m -81.87 175.48 10.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.048 1.339 . . . . 75.55 109.484 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.0 -40.7 73.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.489 1.116 . . . . 73.23 111.852 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -58.88 -26.03 63.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 113.491 0.922 . . . . 73.14 113.491 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -68.83 -20.86 64.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.741 1.155 . . . . 74.25 110.882 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.98 -34.08 77.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.24 -0.652 . . . . 74.14 109.24 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.94 -41.88 90.76 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.833 0.853 . . . . 75.24 109.669 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.53 61.46 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.086 1.354 . . . . 51.53 111.48 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.0 mtp -88.95 -17.41 29.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.893 0.877 . . . . 64.55 112.64 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -83.11 145.51 49.38 Favored Pre-proline 0 N--CA 1.455 -0.212 0 CA-C-N 119.32 0.963 . . . . 72.25 110.212 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -67.28 157.49 61.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.423 2.082 . . . . 74.33 112.197 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.99 134.99 43.12 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.218 -1.356 . . . . 72.34 108.984 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.6 24.37 18.45 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-O 118.845 -0.975 . . . . 73.52 113.549 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.17 108.87 12.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.965 -1.495 . . . . 74.14 106.965 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.96 150.5 25.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 114.909 -1.041 . . . . 74.41 108.332 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.65 151.56 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.226 -0.657 . . . . 75.31 109.226 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 25.9 tp -120.76 78.88 30.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.999 0.92 . . . . 65.43 109.278 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.97 160.01 50.69 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 N-CA-C 108.346 -1.444 . . . . 61.14 108.346 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 157.5 61.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.141 1.894 . . . . 75.34 110.955 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.23 149.78 81.58 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.066 1.844 . . . . 72.41 109.755 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -67.77 139.9 56.65 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 122.99 0.516 . . . . 74.32 109.731 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 73.57 14.04 79.86 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.911 -0.939 . . . . 74.24 113.396 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -69.39 122.89 19.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.395 1.597 . . . . 74.44 108.389 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 91.9 t -135.43 89.49 22.53 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 106.988 -1.486 . . . . 74.33 106.988 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.43 -168.53 0.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.065 2.51 . . . . 73.13 109.512 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--O 1.251 1.154 0 C-N-CA 126.522 1.929 . . . . 74.43 106.225 177.953 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.409 0 N-CA-C 109.386 -1.486 . . . . 73.43 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -146.26 91.87 2.11 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 105.404 -2.073 . . . . 74.24 105.404 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.06 -170.05 2.89 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.28 1.432 . . . . 54.12 110.055 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -129.11 108.28 10.24 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.52 1.128 . . . . 71.32 108.284 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 49.8 pt -132.84 144.94 35.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.667 -1.605 . . . . 73.24 106.667 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -69.31 171.93 7.82 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.342 -0.614 . . . . 75.35 109.342 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.7 tp 52.84 65.66 5.72 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 106.513 -1.662 . . . . 75.14 106.513 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -68.29 151.14 76.66 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.554 2.169 . . . . 74.41 113.78 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.46 -13.2 30.23 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.647 2.898 . . . . 75.14 112.853 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -77.82 -6.32 53.74 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.161 -0.962 . . . . 63.43 111.722 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 59.7 t -108.36 150.51 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.405 1.482 . . . . 74.51 107.803 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.2 176.87 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.573 2.349 . . . . 72.21 108.022 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -77.54 -9.87 59.17 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.803 -0.56 . . . . 60.25 110.188 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -92.03 115.89 31.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.397 1.879 . . . . 64.12 107.641 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.51 127.02 55.59 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.473 1.509 . . . . 65.33 109.456 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -92.62 135.42 34.1 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.172 -1.418 . . . . 71.14 107.172 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mm -122.93 136.91 58.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.562 1.545 . . . . 74.22 107.968 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 mtp85 -123.42 162.06 23.55 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.786 1.234 . . . . 73.45 107.803 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.05 25.51 4.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.655 2.382 . . . . 63.14 113.776 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.27 150.81 97.17 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 108.215 -1.031 . . . . 60.33 108.215 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.66 151.6 85.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.728 1.619 . . . . 54.21 110.204 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -73.89 -25.46 60.04 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.704 -0.623 . . . . 75.43 110.364 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 109.56 17.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.259 -1.015 . . . . 74.13 108.259 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 tt -159.09 152.44 6.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.636 -1.246 . . . . 62.43 107.636 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 46.5 p -113.34 172.74 6.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.807 1.243 . . . . 72.45 110.33 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.9 -32.08 73.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.169 -1.048 . . . . 54.35 108.169 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.17 -49.61 63.44 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.722 2.009 . . . . 75.34 110.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -70.74 -49.93 41.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.26 1.024 . . . . 72.41 109.647 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 98.1 mmm -56.25 -43.35 78.62 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.694 -0.629 . . . . 64.35 112.186 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -67.82 -29.44 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.34 0.973 . . . . 75.54 110.789 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.56 -35.94 57.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.389 0.995 . . . . 71.44 110.585 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.26 -58.84 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 125.522 1.529 . . . . 60.21 110.84 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -74.09 -23.62 59.36 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.074 -1.016 . . . . 73.12 112.353 -178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -7.59 88.38 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.602 0.637 . . . . 61.14 112.638 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -63.06 -26.31 68.78 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.573 1.149 . . . . 75.32 111.745 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.58 -21.12 19.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.175 0.99 . . . . 75.42 112.802 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.71 -159.62 29.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.622 1.101 . . . . 74.14 110.387 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.92 151.25 56.38 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.381 2.054 . . . . 73.43 109.236 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mt -112.73 137.3 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.277 -1.749 . . . . 75.54 106.277 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -66.02 0.79 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.109 -1.071 . . . . 74.35 108.109 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -161.49 153.8 19.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.724 0.693 . . . . 75.24 111.41 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.0 150.75 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 123.223 1.487 . . . . 75.42 109.6 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -136.22 163.84 29.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 104.09 -2.559 . . . . 74.32 104.09 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -144.18 149.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 120.664 1.575 . . . . 74.22 108.4 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.2 139.1 48.38 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.85 -1.7 . . . . 72.14 108.85 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.67 -9.67 6.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.936 0.894 . . . . 75.52 112.332 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.94 159.73 32.53 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.52 1.928 . . . . 72.43 106.335 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.17 -29.57 89.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.95 1.767 . . . . 65.32 112.575 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -91.49 2.31 56.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.35 1.06 . . . . 74.12 112.786 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 49.5 p -116.42 -31.58 5.53 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.702 1.592 . . . . 75.24 112.452 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -54.52 136.04 45.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.264 1.026 . . . . 71.55 108.538 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.42 -5.57 44.79 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.078 0.847 . . . . 75.45 112.367 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 58.6 p -142.82 158.38 43.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 119.044 1.422 . . . . 64.32 108.849 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.21 160.59 21.4 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.446 0.698 . . . . 62.45 110.549 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.06 132.93 56.57 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 127.063 2.145 . . . . 74.22 106.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 89.3 t -111.82 150.5 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 125.302 1.441 . . . . 73.44 107.825 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -124.01 125.67 71.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.212 -1.403 . . . . 73.41 107.212 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -97.8 161.77 13.59 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.543 -1.28 . . . . 65.11 107.543 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -74.27 -31.24 62.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.167 -0.924 . . . . 74.53 111.765 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.63 172.45 8.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.763 1.225 . . . . 63.14 109.468 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -95.61 -29.16 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.986 -1.116 . . . . 62.14 107.986 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -62.44 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.713 1.605 . . . . 75.34 109.721 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.31 -35.05 74.7 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.402 1.081 . . . . 53.12 111.293 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -55.24 33.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.609 -0.886 . . . . 73.42 108.609 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.06 -35.26 78.09 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.891 -1.052 . . . . 64.22 111.364 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -59.67 -53.46 57.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.984 0.811 . . . . 73.12 109.902 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.74 65.14 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 118.831 -0.604 . . . . 64.24 112.432 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.0 t -50.8 -48.77 59.52 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.314 1.046 . . . . 62.13 110.091 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -59.97 3.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.621 0.769 . . . . 63.15 109.373 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -15.54 9.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.922 1.823 . . . . 72.43 115.922 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 tp -99.67 -1.96 36.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.011 1.278 . . . . 74.33 111.153 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.1 p -75.47 132.59 40.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.257 -1.386 . . . . 71.35 107.257 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.29 10.28 81.7 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.048 -0.862 . . . . 63.12 113.114 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -66.45 133.91 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.961 1.381 . . . . 71.13 107.294 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.28 126.77 53.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.641 1.177 . . . . 74.24 109.119 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 5.4 m -136.83 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.115 1.766 . . . . 74.13 107.036 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 88.9 m 49.46 29.61 2.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.328 1.051 . . . . 63.13 111.887 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.7 m120 71.27 23.31 4.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.284 2.233 . . . . 72.31 113.279 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -132.14 141.74 49.23 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.223 1.409 . . . . 74.13 108.726 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -88.47 151.1 22.77 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.501 0.72 . . . . 73.12 109.164 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.44 167.67 9.68 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.878 -0.786 . . . . 73.43 108.878 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 79.4 t -132.73 137.75 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.538 -1.282 . . . . 71.33 107.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.9 139.89 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.328 1.451 . . . . 64.53 109.094 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 52.0 tp -146.42 165.43 29.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.154 1.782 . . . . 71.13 108.369 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.44 164.09 11.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.425 . . . . 74.44 112.486 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -83.32 115.14 21.86 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.772 1.229 . . . . 74.33 108.683 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 63.4 t30 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.201 -0.904 . . . . 75.53 110.852 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.314 0 N-CA-C 108.818 -1.713 . . . . 71.1 108.818 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 15.2 t -134.88 110.71 11.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 105.607 -1.997 . . . . 75.54 105.607 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.13 166.08 25.15 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.954 1.769 . . . . 74.12 109.381 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -155.37 146.52 22.64 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.036 -1.838 . . . . 74.24 106.036 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -145.85 47.19 1.26 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.089 2.556 . . . . 65.2 107.216 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -58.52 102.52 0.11 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.795 1.638 . . . . 74.21 109.719 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -112.34 100.11 8.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.898 1.279 . . . . 74.04 107.865 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -132.9 147.78 52.29 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 107.68 -1.23 . . . . 74.32 107.68 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -127.34 -178.24 4.38 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.324 1.45 . . . . 71.4 109.842 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -164.26 171.4 14.96 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.884 2.074 . . . . 72.14 106.846 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -170.7 120.09 0.55 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.386 -2.079 . . . . 73.24 105.386 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -109.65 154.13 23.26 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.965 -0.754 . . . . 73.44 108.965 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -149.65 138.88 21.33 Favored 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 120.918 -1.114 . . . . 74.4 109.467 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -116.24 148.07 40.83 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.108 -2.182 . . . . 70.52 105.108 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -162.04 120.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.742 -1.947 . . . . 73.4 105.742 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -147.16 93.41 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.603 -0.888 . . . . 72.2 108.603 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.17 163.77 26.96 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.066 -0.716 . . . . 75.41 109.066 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.79 120.58 42.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.62 -1.622 . . . . 75.22 106.62 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -116.78 72.01 0.81 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.254 -1.758 . . . . 73.25 106.254 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -142.08 157.06 64.59 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 124.482 1.113 . . . . 71.24 110.304 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.9 178.46 6.81 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.986 2.457 . . . . 72.31 108.591 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 69.2 mt -95.78 146.19 24.74 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.293 -0.879 . . . . 74.05 108.819 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 66.3 m -126.26 177.74 6.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.763 1.625 . . . . 74.41 108.38 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.26 -30.39 69.41 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.906 -1.122 . . . . 71.31 111.356 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.17 -30.96 71.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.256 0.48 . . . . 65.42 110.153 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -68.31 -30.62 69.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.936 -0.764 . . . . 73.34 108.936 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 60.8 tp -70.9 -42.17 70.32 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.176 -1.046 . . . . 73.53 108.176 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.93 -44.11 97.67 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.949 -0.76 . . . . 75.14 108.949 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.02 81.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.433 1.493 . . . . 63.2 111.6 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.47 -21.59 59.51 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.366 1.066 . . . . 75.22 112.527 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -76.71 152.65 83.1 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.076 1.307 . . . . 62.24 109.265 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.1 177.1 7.56 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.833 3.688 . . . . 74.52 112.521 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.01 143.58 26.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.111 0.964 . . . . 75.32 112.724 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.52 29.53 9.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.587 1.089 . . . . 73.51 113.658 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -125.98 157.12 38.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.049 1.34 . . . . 75.13 109.671 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.79 142.4 50.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.377 -1.342 . . . . 74.24 107.377 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.61 151.79 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.415 -0.957 . . . . 75.22 108.415 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.88 85.8 40.52 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.655 -0.653 . . . . 73.33 109.312 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.56 159.68 31.17 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.947 2.431 . . . . 62.44 111.051 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 166.47 26.76 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.385 3.39 . . . . 75.02 113.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.02 172.75 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.573 2.182 . . . . 75.42 109.238 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -104.21 100.07 9.8 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.549 1.139 . . . . 70.33 109.047 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 139.79 -12.83 3.15 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.883 1.23 . . . . 61.11 111.939 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -51.15 141.57 14.16 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.466 1.507 . . . . 73.43 111.842 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 73.4 t -116.75 96.49 48.68 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 127.125 2.17 . . . . 72.35 106.076 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -78.16 170.31 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.872 2.382 . . . . 64.24 111.497 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--O 1.255 1.382 0 N-CA-C 106.105 -1.813 . . . . 74.5 106.105 178.358 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.538 0 N-CA-C 111.118 -0.793 . . . . 55.32 111.118 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ttt-85 -124.47 110.02 13.99 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.53 -2.026 . . . . 73.31 105.53 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.86 172.11 14.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.924 0.89 . . . . 53.21 112.897 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.43 156.59 14.17 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 129.603 3.161 . . . . 73.4 105.518 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.65 107.96 19.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 104.419 -2.437 . . . . 74.41 104.419 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -142.69 163.47 32.73 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.801 -1.185 . . . . 75.44 107.801 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.77 157.41 88.74 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.991 0.917 . . . . 74.42 108.879 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.77 163.93 35.3 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.77 2.314 . . . . 74.33 110.264 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.04 -45.16 29.65 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.177 1.918 . . . . 61.53 110.149 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.34 170.08 19.33 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.84 0.856 . . . . 75.34 109.987 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 t -143.91 152.45 16.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.982 -1.488 . . . . 75.05 106.982 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -131.82 159.15 39.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.532 1.533 . . . . 72.25 108.667 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -82.87 -25.24 32.73 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.706 0.802 . . . . 74.41 110.662 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -83.4 135.21 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 103.019 -2.956 . . . . 74.5 103.019 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.7 165.81 15.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.679 1.591 . . . . 73.25 108.518 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -129.04 130.25 46.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.951 2.1 . . . . 74.44 109.123 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -113.22 151.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.302 2.241 . . . . 75.13 107.849 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -146.57 159.93 42.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.661 -0.65 . . . . 62.43 110.945 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.97 19.03 11.75 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 127.204 2.202 . . . . 62.24 113.975 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 mt -58.92 152.77 47.69 Favored Pre-proline 0 C--O 1.236 0.372 0 C-N-CA 123.04 0.536 . . . . 75.04 112.239 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.92 144.53 96.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 73.01 110.34 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -77.78 -14.27 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.299 -0.876 . . . . 74.51 111.59 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -123.49 105.5 9.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.443 -1.688 . . . . 65.21 106.443 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 tt -156.59 164.35 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.915 1.686 . . . . 71.21 106.744 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.27 169.03 17.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.593 1.557 . . . . 73.41 109.336 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.22 -31.64 70.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.923 -0.561 . . . . 70.14 110.316 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.59 -39.79 71.18 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.388 1.475 . . . . 73.22 111.825 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -83.79 -47.79 10.76 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.646 1.178 . . . . 75.52 110.413 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.3 mmm -53.45 -47.98 69.22 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.609 0.364 . . . . 75.02 110.82 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -69.21 -34.96 75.68 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.281 -0.866 . . . . 72.53 111.672 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.28 -56.65 18.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.81 0.732 . . . . 74.04 109.328 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 48.8 mt -54.48 -63.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 126.751 2.02 . . . . 72.33 111.234 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -63.52 -24.34 67.77 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.204 0.911 . . . . 74.1 112.854 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.5 79.96 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.797 -1.001 . . . . 53.24 112.258 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -60.3 -19.34 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.53 1.665 . . . . 72.14 113.215 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.52 -31.25 8.2 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 117.404 -1.284 . . . . 74.1 113.861 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.0 -152.4 14.83 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 119.716 1.144 . . . . 73.31 112.774 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.18 162.48 28.56 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.163 3.242 . . . . 73.22 111.84 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.99 132.58 70.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.141 -1.429 . . . . 74.14 107.141 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -58.05 2.67 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.973 -1.121 . . . . 73.42 107.973 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -156.22 160.11 39.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.952 0.901 . . . . 64.35 109.368 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 48.7 mt -139.69 136.1 39.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.267 1.427 . . . . 64.53 108.0 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -137.77 143.57 41.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.247 -1.39 . . . . 73.34 107.247 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.84 165.37 27.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.287 1.035 . . . . 65.02 108.539 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.05 135.19 25.87 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 124.098 0.856 . . . . 74.52 113.054 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -104.88 -42.74 5.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.208 1.803 . . . . 71.22 109.211 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -66.32 158.78 76.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.906 -1.146 . . . . 73.33 107.906 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.55 -31.65 40.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.221 1.281 . . . . 65.23 110.947 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -70.99 -23.7 62.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.747 0.703 . . . . 72.33 112.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -89.94 -0.97 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.621 0.768 . . . . 64.11 111.79 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -67.84 120.48 14.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.291 -2.115 . . . . 74.5 105.291 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.11 2.34 36.04 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.116 0.865 . . . . 70.05 112.875 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 65.8 p -129.55 151.34 50.27 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.769 1.285 . . . . 74.14 108.058 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.55 171.13 16.26 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.001 -1.062 . . . . 74.3 110.74 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -138.38 151.87 47.9 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.947 0.899 . . . . 75.42 110.393 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.49 152.62 35.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.153 -2.166 . . . . 64.13 105.153 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.5 t -127.73 129.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.172 -1.788 . . . . 72.14 106.172 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.23 161.99 13.42 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.848 -1.538 . . . . 72.14 106.848 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.08 -43.85 41.64 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.722 -0.611 . . . . 72.42 111.083 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -123.02 164.13 19.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.78 1.232 . . . . 53.44 109.74 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.0 tt -83.33 -10.82 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 114.564 1.32 . . . . 74.55 114.564 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -83.55 -53.7 5.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.619 -1.252 . . . . 75.4 107.619 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.8 -40.56 88.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.746 0.654 . . . . 74.21 110.294 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.34 79.01 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.544 0.738 . . . . 73.13 111.082 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.57 -46.15 76.96 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 119.124 -0.465 . . . . 71.25 110.253 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -55.51 -44.57 76.75 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.731 0.645 . . . . 75.44 110.123 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.71 -50.01 54.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.481 0.712 . . . . 73.14 110.051 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.8 t -50.88 -54.16 26.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.624 1.17 . . . . 74.2 110.937 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -63.3 -33.8 76.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.268 0.84 . . . . 70.2 113.268 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -80.91 -23.29 39.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 118.607 0.639 . . . . 75.1 111.911 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.26 -23.6 22.28 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.167 0.508 . . . . 74.52 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -61.67 114.13 3.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.193 1.397 . . . . 70.25 108.677 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 10.63 75.01 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.394 -1.226 . . . . 74.52 114.578 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.6 119.11 9.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.573 1.187 . . . . 73.33 108.571 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.26 109.31 17.69 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.497 1.519 . . . . 75.43 110.431 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 10.6 m -141.23 151.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.702 1.201 . . . . 75.13 109.585 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 76.8 m 44.68 43.75 6.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.892 1.277 . . . . 73.03 110.661 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.53 35.49 11.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.138 2.575 . . . . 74.34 112.371 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -144.72 -179.99 6.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.311 2.245 . . . . 75.43 108.09 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -128.41 157.23 41.62 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.85 1.26 . . . . 71.54 108.909 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -120.15 119.3 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.195 -0.668 . . . . 74.14 109.195 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.14 122.73 38.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 126.847 2.059 . . . . 73.2 106.294 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.39 129.41 61.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.398 -1.704 . . . . 74.04 106.398 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.36 153.68 51.76 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.99 -1.115 . . . . 73.42 107.99 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -84.1 156.93 21.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 71.32 108.314 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.95 140.16 43.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 104.202 -2.518 . . . . 74.11 104.202 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.673 -1.232 . . . . 72.22 107.673 178.852 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.823 0 N-CA-C 110.088 -1.205 . . . . 73.42 110.088 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . 0.252 10.0 t -131.81 69.58 81.08 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.858 0.863 . . . . 70.42 108.678 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.28 161.37 44.65 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.583 2.189 . . . . 72.51 109.771 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.21 -178.91 6.19 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 129.001 2.921 . . . . 74.12 107.968 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -116.49 77.45 1.11 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.894 -2.261 . . . . 64.52 104.894 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -59.84 145.82 44.18 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.521 0.329 . . . . 74.45 110.281 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -74.65 117.46 16.51 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.392 -2.077 . . . . 73.14 105.392 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -136.22 99.29 4.08 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.763 0.825 . . . . 71.35 112.332 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.47 177.37 1.96 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.013 1.325 . . . . 74.43 110.776 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 41.2 mtt-85 -140.86 158.47 43.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.575 1.15 . . . . 75.54 109.606 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -108.06 166.35 10.79 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.643 1.977 . . . . 63.41 108.955 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -77.43 168.02 20.7 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.005 0.922 . . . . 64.14 110.99 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -172.06 172.2 4.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.052 1.341 . . . . 73.21 108.135 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.11 104.88 15.41 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 101.94 -3.356 . . . . 63.32 101.94 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 6.3 tp 179.9 176.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 129.87 3.268 . . . . 73.43 105.241 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -139.97 128.05 22.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.77 -1.937 . . . . 54.32 105.77 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.17 159.74 11.5 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.954 0.724 . . . . 72.03 112.954 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.16 1.8 7.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.224 1.81 . . . . 75.14 111.475 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -64.06 -26.19 68.44 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.676 1.361 . . . . 62.33 114.676 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 118.87 154.7 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.909 1 C-N-CA 136.117 5.767 . . . . 74.43 106.322 -178.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -66.99 91.14 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.807 3.005 . . . . 73.1 108.574 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 86.2 mt -152.47 147.48 26.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.952 2.101 . . . . 75.42 107.917 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 24.8 t -153.67 164.55 38.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.877 0.871 . . . . 74.43 109.154 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.58 -22.22 66.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.957 0.903 . . . . 74.54 112.629 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -72.01 -22.4 61.42 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.296 -0.878 . . . . 63.4 110.167 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -85.24 -30.21 24.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.768 -0.826 . . . . 74.41 108.768 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . 0.444 ' CD2' HH22 ' B' ' 49' ' ' ARG . 29.4 tp -56.62 -39.64 73.96 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.677 0.791 . . . . 73.53 109.712 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.18 -41.01 82.95 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.273 0.629 . . . . 72.35 110.291 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.87 -9.34 58.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.796 1.238 . . . . 74.2 112.871 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 79.9 mtp -76.21 -12.21 60.05 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.962 -1.086 . . . . 75.0 110.062 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -114.61 158.85 39.15 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.774 1.629 . . . . 75.41 112.601 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.37 170.93 17.19 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.978 1.785 . . . . 54.1 109.721 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -87.45 163.37 16.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.94 -1.027 . . . . 64.43 111.035 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.69 18.26 35.75 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.155 1.359 . . . . 65.03 112.415 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.26 157.05 39.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.15 1.38 . . . . 75.11 107.564 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -137.94 147.19 44.08 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.602 -0.518 . . . . 73.0 109.602 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.19 150.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.478 0.581 . . . . 74.11 109.664 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.08 86.21 57.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.23 -1.396 . . . . 74.0 107.23 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.49 159.55 27.23 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.951 2.434 . . . . 74.0 113.03 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.63 168.94 21.24 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.837 2.358 . . . . 75.54 110.803 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.66 159.11 3.65 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 124.499 3.466 . . . . 74.41 115.348 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -93.24 82.36 4.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.055 1.342 . . . . 65.44 108.007 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 113.88 37.74 1.24 Allowed Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.269 -1.295 . . . . 65.23 114.103 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -65.27 1.32 1.1 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.703 1.752 . . . . 75.4 115.245 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 2.5 t 64.96 73.11 0.44 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 128.642 2.777 . . . . 73.5 111.938 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.18 0.05 10.34 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.909 3.073 . . . . 62.32 111.775 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 51.3 mt . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.453 1.901 . . . . 75.05 108.031 -178.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.938 0 N-CA-C 110.733 -0.947 . . . . 71.15 110.733 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -54.09 127.14 25.41 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.76 -1.2 . . . . 75.34 107.76 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.71 150.8 26.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.06 -0.719 . . . . 64.24 109.06 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -150.32 157.98 43.65 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.369 0.668 . . . . 63.13 110.459 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 tt -154.07 151.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 127.223 2.209 . . . . 74.04 105.186 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -156.89 176.04 13.28 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.303 -1.369 . . . . 74.13 107.303 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.46 150.15 36.7 Favored Pre-proline 0 C--O 1.239 0.51 0 N-CA-C 107.633 -1.247 . . . . 73.11 107.633 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.26 165.22 27.52 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.51 2.14 . . . . 61.31 109.681 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.31 -38.64 33.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.452 2.101 . . . . 75.03 112.552 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -154.39 164.14 39.09 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.846 1.658 . . . . 72.22 108.36 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 t -152.97 146.37 14.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.765 2.026 . . . . 75.44 106.645 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -121.96 -172.88 2.53 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.668 1.587 . . . . 73.45 109.449 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.37 -17.24 14.87 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.088 -1.008 . . . . 74.53 112.532 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.27 114.43 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.912 -1.514 . . . . 74.41 106.912 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 74.4 mt -102.97 170.83 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.251 1.02 . . . . 71.43 109.032 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -140.68 142.22 34.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.991 2.116 . . . . 74.03 106.509 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 mm -128.24 148.25 32.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 119.19 0.904 . . . . 74.42 108.711 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -133.42 162.31 32.2 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.264 1.825 . . . . 74.31 107.682 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.78 21.47 9.15 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.07 2.148 . . . . 74.31 112.292 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -61.03 155.25 55.9 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.396 1.078 . . . . 65.14 111.338 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.42 138.23 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.525 2.816 . . . . 71.11 111.05 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.47 -23.46 65.5 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.9 0.88 . . . . 72.51 112.635 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 113.58 14.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.024 -1.843 . . . . 74.32 106.024 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.5 129.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.195 -1.039 . . . . 73.3 108.195 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 12.5 p -83.23 169.15 16.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.385 -0.598 . . . . 73.01 109.385 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.78 84.47 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.663 -0.684 . . . . 62.14 109.47 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -47.98 -47.05 33.2 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.14 1.376 . . . . 74.34 112.571 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.87 -52.68 63.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.154 0.982 . . . . 75.15 109.701 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 75.4 mmm -59.38 -48.28 82.23 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.982 0.513 . . . . 63.11 110.812 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.22 -29.02 70.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.036 -0.983 . . . . 73.0 109.767 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.73 -62.28 1.45 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.726 1.148 . . . . 62.13 108.346 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 60.1 mt -45.44 -58.3 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.576 1.95 . . . . 70.3 111.339 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -78.04 -38.17 45.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.863 1.061 . . . . 65.32 113.863 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.04 -37.39 85.45 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.866 -0.894 . . . . 51.15 110.866 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -57.34 -31.48 65.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.463 0.631 . . . . 74.21 110.89 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -78.26 -55.35 5.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.599 -0.889 . . . . 73.3 108.599 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.81 -166.74 33.75 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.496 -0.752 . . . . 74.4 112.619 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.19 156.17 26.16 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.476 2.784 . . . . 72.31 114.453 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.83 102.84 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.175 -2.528 . . . . 73.52 104.175 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -75.77 -54.66 6.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.348 -0.982 . . . . 74.21 108.348 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -151.9 154.43 36.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.225 0.61 . . . . 70.41 109.613 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 80.1 mt -145.85 135.32 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.848 -1.538 . . . . 75.52 106.848 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . 0.444 HH22 ' CD2' ' A' ' 404' ' ' LEU . 13.6 mtm-85 -133.48 120.5 20.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.375 -2.084 . . . . 71.41 105.375 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.49 136.51 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 126.149 1.78 . . . . 71.31 110.404 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.35 134.67 45.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.114 -1.595 . . . . 61.42 109.114 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -118.79 -23.23 7.06 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.502 1.521 . . . . 71.12 112.824 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 64.1 p -70.84 158.61 87.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 75.44 106.904 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.09 -10.89 22.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.02 1.813 . . . . 75.22 112.618 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -97.07 -45.51 6.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.661 1.584 . . . . 64.42 109.51 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.4 p -76.51 -19.11 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.245 0.93 . . . . 73.23 113.022 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -52.89 139.27 27.73 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 107.428 -1.323 . . . . 73.55 107.428 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.85 -6.24 56.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.743 -1.032 . . . . 63.02 111.385 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -132.86 159.67 39.17 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 119.281 1.541 . . . . 71.31 111.115 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.36 164.8 32.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.726 1.611 . . . . 71.44 108.468 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.77 125.48 32.06 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.86 -1.534 . . . . 73.0 106.86 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.63 146.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.141 -1.8 . . . . 73.21 106.141 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.692 -2.336 . . . . 73.4 104.692 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -97.56 144.59 27.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.937 . . . . 75.53 108.471 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.15 -30.65 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 75.14 110.162 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -121.3 126.49 49.65 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.47 1.108 . . . . 74.41 109.487 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.73 -34.97 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.139 0.427 . . . . 73.03 111.621 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -61.45 -46.17 91.22 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.303 0.641 . . . . 74.23 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -67.6 -30.07 69.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.578 0.626 . . . . 73.12 110.139 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.3 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.807 -1.183 . . . . 71.02 107.807 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -60.29 -43.75 95.98 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 109.026 -0.731 . . . . 61.41 109.026 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.03 -58.03 9.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.008 0.923 . . . . 75.41 110.814 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.41 -33.49 71.3 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.264 1.026 . . . . 64.54 110.279 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.8 t -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.62 1.1 . . . . 63.11 109.289 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -48.32 45.84 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.947 -1.095 . . . . 70.3 111.711 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -65.13 -17.55 64.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.084 1.142 . . . . 75.4 114.084 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 tp -107.39 -17.54 14.1 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.988 1.267 . . . . 71.42 113.101 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -65.11 105.47 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.912 -0.493 . . . . 71.32 110.368 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.08 16.72 46.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.215 -1.325 . . . . 72.1 114.808 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.96 111.17 4.81 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.412 1.606 . . . . 74.52 109.028 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.88 120.08 19.94 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.004 0.921 . . . . 72.42 110.039 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -149.72 149.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.802 -1.555 . . . . 72.22 106.802 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 15.9 m 51.84 32.52 9.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.683 1.193 . . . . 74.53 112.711 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.54 30.63 17.57 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.761 1.624 . . . . 72.42 111.46 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -135.43 167.32 21.28 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 127.735 2.414 . . . . 74.12 108.076 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -115.27 124.17 50.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.148 0.979 . . . . 75.44 110.908 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -77.97 156.21 30.34 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.31 -1.367 . . . . 73.04 107.31 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.27 140.23 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.474 -1.676 . . . . 74.13 106.474 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.27 153.88 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.649 1.58 . . . . 75.12 107.308 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -157.06 165.88 34.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.466 1.506 . . . . 74.15 108.646 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -102.83 164.84 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.73 2.812 . . . . 75.33 110.76 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -114.79 160.76 19.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.206 -1.405 . . . . 75.04 107.206 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 115.985 -1.959 . . . . 74.02 111.38 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 105.248 -3.141 . . . . 74.3 105.248 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 1.1 p -68.3 166.83 21.62 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 106.582 -1.636 . . . . 74.3 106.582 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -67.41 161.96 40.97 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 N-CA-C 108.146 -1.521 . . . . 71.44 108.146 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.77 139.58 48.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.282 -1.377 . . . . 64.23 107.282 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.1 134.26 8.33 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.172 -1.788 . . . . 72.13 106.172 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.0 pp -159.37 172.52 17.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.511 1.524 . . . . 74.52 108.802 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -151.35 173.39 14.57 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.771 2.029 . . . . 74.34 108.278 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -77.55 -177.76 4.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.328 1.051 . . . . 75.13 108.711 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -67.55 -39.3 84.96 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.417 -0.802 . . . . 73.01 110.777 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -153.97 149.32 27.13 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.389 1.476 . . . . 72.13 109.321 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -86.74 165.61 15.92 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.426 -1.324 . . . . 74.31 107.426 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -65.11 141.86 58.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.715 0.806 . . . . 74.14 109.319 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -166.92 108.87 0.68 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.407 -1.331 . . . . 75.12 107.407 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -91.88 167.3 12.23 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.304 1.042 . . . . 72.03 109.792 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 16.0 tt -60.97 156.47 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.32 1.048 . . . . 72.1 112.115 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -80.87 150.44 29.09 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.495 -0.928 . . . . 73.33 108.495 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -79.8 137.05 36.87 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 105.874 -1.898 . . . . 73.3 105.874 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -104.22 127.49 51.85 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 106.212 -1.774 . . . . 73.44 106.212 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -67.49 -45.65 75.25 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.825 0.45 . . . . 73.32 110.659 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.63 152.21 87.26 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 118.49 -0.767 . . . . 73.54 109.26 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.24 108.94 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.958 2.439 . . . . 71.51 107.829 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 67.0 mt -145.53 57.94 1.25 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.245 1.818 . . . . 74.53 107.714 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 14.5 m -67.43 168.2 11.25 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.162 -0.681 . . . . 54.44 109.162 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -57.27 -33.75 67.93 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.012 0.745 . . . . 62.32 113.012 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -74.89 -25.87 59.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.631 0.975 . . . . 72.01 113.631 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -60.68 -28.37 68.55 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.565 1.075 . . . . 72.33 111.293 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.99 -37.64 64.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.811 2.045 . . . . 75.1 111.742 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.35 -44.37 62.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.869 1.268 . . . . 74.15 111.832 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.07 -22.55 62.1 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.623 0.369 . . . . 74.35 110.718 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.5 mtp -70.59 -38.59 74.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.629 -0.7 . . . . 65.14 109.517 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -72.18 155.54 91.52 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 119.352 0.978 . . . . 75.2 112.084 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.84 167.4 27.35 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.185 2.59 . . . . 73.34 111.372 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -79.45 153.32 29.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.309 1.444 . . . . 75.02 111.4 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.76 24.23 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.797 -1.001 . . . . 73.15 114.88 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -124.54 158.01 33.97 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.528 1.664 . . . . 74.4 111.901 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -127.28 133.95 50.1 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.457 1.503 . . . . 74.34 107.784 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.09 150.72 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.229 -1.397 . . . . 75.52 107.229 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.8 tp -125.07 78.02 66.71 Favored Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 108.667 -0.864 . . . . 63.53 108.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -56.76 162.79 8.11 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.076 2.517 . . . . 71.43 111.315 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 159.73 51.11 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.102 1.868 . . . . 73.24 110.914 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.91 170.43 11.56 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.671 2.247 . . . . 74.31 112.288 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -66.34 92.98 0.2 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.535 1.534 . . . . 64.21 113.114 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 93.11 34.71 6.63 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.524 -1.153 . . . . 74.43 115.37 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -65.87 130.21 42.48 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 119.667 1.734 . . . . 74.31 113.283 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.03 93.32 9.33 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 104.612 -2.366 . . . . 71.14 104.612 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.13 -12.71 23.5 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.495 2.13 . . . . 63.44 114.355 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 15.1 mm . . . . . 0 C--O 1.252 1.191 0 N-CA-C 107.097 -1.446 . . . . 73.15 107.097 -179.45 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 N-CA-C 110.36 -1.096 . . . . 73.51 110.36 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -141.82 162.34 35.72 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.467 1.134 . . . . 73.44 109.052 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.36 165.26 20.09 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.281 1.033 . . . . 64.34 110.072 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -84.79 91.3 7.95 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.207 -1.034 . . . . 52.22 108.207 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 83.1 mt -75.65 116.29 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 104.331 -2.47 . . . . 74.14 104.331 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -69.08 -61.58 1.73 Allowed 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 118.638 -0.696 . . . . 74.11 110.886 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -120.81 154.37 57.45 Favored Pre-proline 0 C--O 1.233 0.206 0 C-N-CA 123.274 0.629 . . . . 72.42 109.695 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.65 162.15 25.8 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.221 2.614 . . . . 74.13 111.062 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.69 -43.12 13.64 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.191 2.594 . . . . 72.12 112.599 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -155.07 155.83 34.79 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.991 -1.485 . . . . 74.44 106.991 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 85.2 t -148.14 102.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.114 -1.439 . . . . 74.32 107.114 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.04 148.87 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.173 -1.788 . . . . 62.34 106.173 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.73 83.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 39.9 mt -68.56 116.08 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 125.934 1.694 . . . . 62.21 111.636 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 25.4 mt -104.2 149.15 25.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.111 -1.07 . . . . 75.41 108.111 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -123.7 137.56 54.68 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.511 -2.403 . . . . 74.21 104.511 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mm -125.41 151.2 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.583 -1.636 . . . . 74.43 106.583 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -136.27 164.28 28.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.549 1.94 . . . . 73.51 108.461 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.53 13.56 8.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.546 1.938 . . . . 71.21 111.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 67.6 mt -66.06 155.99 85.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.94 1.296 . . . . 73.51 112.715 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.59 153.3 72.58 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.11 2.54 . . . . 72.03 111.192 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -86.19 -19.81 29.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 74.34 110.496 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -130.39 115.59 17.09 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.797 1.639 . . . . 75.34 107.05 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 157.05 5.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.845 -1.168 . . . . 71.41 107.845 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 15.5 p -101.89 164.49 11.69 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.215 1.406 . . . . 74.33 110.363 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.4 84.27 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.504 -1.665 . . . . 73.42 106.504 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.46 -37.13 77.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.629 2.372 . . . . 63.24 111.16 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.61 -47.87 16.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.204 -0.935 . . . . 62.41 109.645 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.8 mmm -58.33 -42.86 87.75 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.336 0.516 . . . . 74.0 110.859 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -73.55 -34.95 65.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.932 -0.556 . . . . 64.54 111.444 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.25 -58.08 5.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.994 0.815 . . . . 75.45 111.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mt -52.16 -62.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.461 1.504 . . . . 71.24 110.734 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -64.96 -22.84 67.07 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 119.019 -0.515 . . . . 65.11 111.406 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -29.11 68.09 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 125.834 1.683 . . . . 62.41 111.171 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -61.44 -24.26 66.41 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.369 1.584 . . . . 75.51 110.185 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -88.94 -46.89 8.54 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.671 0.788 . . . . 73.54 110.386 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.17 -171.51 43.94 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 119.499 1.045 . . . . 72.22 114.835 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.47 116.57 3.71 Favored 'Trans proline' 0 C--N 1.347 0.477 1 C-N-CA 125.711 4.274 . . . . 72.15 113.985 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.1 mt -83.46 125.79 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.558 1.143 . . . . 73.12 109.731 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.36 -60.41 2.04 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.422 -1.325 . . . . 73.15 107.422 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -156.57 149.43 23.86 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.203 0.911 . . . . 74.1 109.497 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 29.5 mt -129.53 144.2 38.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.943 2.097 . . . . 74.13 108.48 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -141.96 154.79 45.31 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.335 -1.728 . . . . 74.34 106.335 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.01 165.7 19.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 72.1 109.354 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 145.78 49.39 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.532 -1.027 . . . . 74.4 110.532 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -105.18 -52.69 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.738 -1.208 . . . . 74.15 107.738 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 70.2 p -69.89 156.99 90.82 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 124.204 1.002 . . . . 74.42 109.825 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.81 -39.21 64.31 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.613 1.542 . . . . 74.02 109.796 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.64 -7.2 24.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.502 1.121 . . . . 75.33 113.398 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 8.3 p -102.25 -4.43 25.72 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.571 1.078 . . . . 74.4 109.651 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -69.86 150.04 47.23 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.156 -1.59 . . . . 73.01 108.32 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.18 -7.52 64.36 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.16 -1.356 . . . . 70.44 113.73 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.4 p -140.51 162.75 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.212 2.006 . . . . 74.45 107.346 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -165.66 173.63 10.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 71.42 109.98 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.63 144.72 50.82 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.801 0.841 . . . . 71.52 109.694 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 86.4 t -133.5 141.1 45.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.408 1.083 . . . . 74.14 108.626 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.92 130.64 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 106.454 -1.684 . . . . 73.53 106.454 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -104.09 166.35 10.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.869 2.068 . . . . 72.45 107.49 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.31 -69.54 0.3 Allowed 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.366 -0.834 . . . . 71.25 111.866 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.67 151.11 21.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.517 1.053 . . . . 73.25 110.642 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.5 tt -61.75 -33.86 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.483 0.713 . . . . 75.04 111.781 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -69.03 -47.67 64.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.103 -0.703 . . . . 73.52 109.103 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.04 -46.09 85.92 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.43 -54.85 42.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.161 1.385 . . . . 72.21 111.432 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -52.08 -36.83 51.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.706 1.202 . . . . 74.42 113.172 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -69.27 -36.3 76.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.896 0.771 . . . . 72.31 110.35 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.44 -32.06 71.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.108 0.867 . . . . 72.54 110.642 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 61.3 m -55.84 -41.57 74.49 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.075 0.55 . . . . 75.11 110.516 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -84.67 -35.98 22.23 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.547 0.739 . . . . 73.23 111.54 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -15.82 63.1 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.277 -0.889 . . . . 63.4 112.524 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.7 tp -104.84 -16.15 14.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.053 0.842 . . . . 75.42 112.206 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -72.2 134.67 45.79 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.446 -1.409 . . . . 72.22 110.085 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.32 10.1 84.38 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.777 1.18 . . . . 64.1 113.193 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -72.34 120.74 18.37 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.874 1.27 . . . . 71.43 110.078 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -87.79 120.07 28.75 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.19 1.796 . . . . 75.04 107.466 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.96 135.94 42.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.367 -0.975 . . . . 75.44 108.367 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.3 m 46.58 47.14 14.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.422 1.489 . . . . 72.51 112.194 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 18.0 m120 54.72 30.74 14.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.511 1.524 . . . . 72.05 112.786 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -136.2 -179.87 5.93 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.325 2.65 . . . . 75.34 106.48 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -139.59 133.84 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.326 -1.731 . . . . 62.31 106.326 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.89 172.79 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.352 -0.981 . . . . 73.22 108.352 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.59 140.13 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.28 -2.489 . . . . 72.23 104.28 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.81 142.72 41.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.807 1.243 . . . . 74.41 108.676 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -153.29 150.33 28.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.162 0.985 . . . . 74.14 109.665 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -85.55 163.49 18.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.098 1.359 . . . . 71.32 110.562 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -77.9 167.17 21.92 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.547 -0.538 . . . . 75.02 109.547 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.248 1.023 0 N-CA-C 105.422 -2.066 . . . . 63.14 105.422 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.989 0 N-CA-C 108.662 -1.775 . . . . 52.01 108.662 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 5.6 t -146.98 120.9 5.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 102.477 -3.157 . . . . 71.21 102.477 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -74.3 166.23 29.98 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.756 1.638 . . . . 72.54 110.843 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.45 170.9 14.82 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 128.031 2.532 . . . . 73.53 109.028 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -149.39 147.56 28.43 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.055 -1.461 . . . . 73.32 107.055 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 93.4 mt -139.33 107.41 5.73 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.021 -1.103 . . . . 74.44 108.021 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -76.89 148.1 36.64 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.565 -0.902 . . . . 74.1 108.565 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -147.99 113.17 5.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.62 -0.881 . . . . 73.41 108.62 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.93 122.88 19.56 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.33 -0.989 . . . . 71.35 108.33 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -62.35 -54.25 43.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 118.567 -0.73 . . . . 72.34 111.073 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 41.9 t-105 -156.05 162.12 40.34 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.355 -1.35 . . . . 75.2 107.355 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -126.69 -158.69 0.88 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.577 2.351 . . . . 72.0 107.263 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.39 121.38 11.38 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 101.806 -3.405 . . . . 65.23 101.806 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -126.1 168.28 14.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.883 1.219 . . . . 75.04 110.147 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.05 142.29 41.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.832 0.853 . . . . 73.33 109.224 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -146.07 82.97 1.62 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 104.328 -2.471 . . . . 72.3 104.328 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -128.46 69.95 1.37 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.514 1.526 . . . . 75.04 108.081 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.6 172.99 7.68 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.874 2.469 . . . . 74.4 108.849 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -64.57 109.28 1.93 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.439 0.637 . . . . 72.33 109.785 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -89.36 142.23 29.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 126.241 1.816 . . . . 74.23 107.927 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.98 142.1 38.0 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 107.868 -1.628 . . . . 74.34 107.868 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.57 135.33 55.88 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.08 0.552 . . . . 74.14 110.582 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.5 t -158.68 -170.99 3.25 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.537 1.935 . . . . 72.35 107.212 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.38 -18.02 63.04 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.202 -0.936 . . . . 73.12 112.0 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -62.65 -44.26 96.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.787 1.235 . . . . 72.04 108.545 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -63.41 -20.91 65.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.204 1.001 . . . . 72.22 111.157 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.2 tp -82.64 -38.51 23.42 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.971 -1.492 . . . . 74.32 106.971 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -65.45 -44.32 87.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.298 0.954 . . . . 71.41 110.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.84 60.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.502 1.121 . . . . 73.42 113.485 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.9 mtp -79.39 -6.6 57.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.062 1.345 . . . . 73.13 113.068 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -107.58 159.25 30.99 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 114.55 1.315 . . . . 73.44 114.55 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.66 158.94 54.87 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.215 3.276 . . . . 54.31 112.538 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -75.28 147.78 39.94 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.497 1.519 . . . . 75.11 109.165 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.35 17.41 62.52 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.529 -0.732 . . . . 64.45 114.656 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -124.35 102.97 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 105.325 -2.102 . . . . 73.11 105.325 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -83.78 155.39 23.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.508 1.123 . . . . 65.24 110.684 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.1 t -70.05 144.38 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.003 0.921 . . . . 75.25 110.193 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 50.7 tp -126.38 79.55 70.38 Favored Pre-proline 0 N--CA 1.452 -0.339 0 N-CA-C 107.346 -1.353 . . . . 71.44 107.346 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.18 163.81 37.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.124 1.883 . . . . 75.2 110.023 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.11 161.45 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.556 2.171 . . . . 73.01 109.774 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.48 145.64 77.43 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.43 1.42 . . . . 61.3 109.375 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.02 70.9 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.714 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -74.02 11.42 6.24 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 117.184 -1.898 . . . . 62.31 115.906 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -66.48 161.36 23.01 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 121.161 2.48 . . . . 75.13 109.582 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 22.7 t -131.18 79.1 71.41 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.118 -1.438 . . . . 72.23 107.118 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.05 114.29 3.86 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 N-CA-C 106.019 -2.339 . . . . 72.22 106.019 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 36.2 mm . . . . . 0 C--O 1.25 1.084 0 C-N-CA 127.847 2.459 . . . . 73.42 106.34 -178.301 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.938 0 N-CA-C 110.508 -1.037 . . . . 75.45 110.508 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -145.7 131.5 19.05 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 103.193 -2.892 . . . . 75.24 103.193 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.0 67.46 4.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.881 0.764 . . . . 72.43 109.501 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.64 165.62 13.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.935 1.294 . . . . 73.24 109.436 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.25 137.82 51.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 105.516 -2.031 . . . . 74.33 105.516 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.39 163.64 35.85 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.733 1.213 . . . . 73.34 108.69 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.46 159.59 84.38 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 109.006 -0.739 . . . . 65.44 109.006 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.83 171.42 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.961 3.107 . . . . 73.55 111.386 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.7 -31.94 86.42 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.643 2.228 . . . . 70.11 113.231 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.04 167.61 29.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.198 1.399 . . . . 71.1 108.608 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.9 t -141.39 165.8 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.662 1.585 . . . . 74.13 107.817 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -133.69 -176.97 4.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.4 1.88 . . . . 72.01 108.924 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.77 -43.86 5.45 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.649 -1.282 . . . . 75.44 111.607 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.5 mt -73.68 144.03 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.394 -1.335 . . . . 75.13 107.394 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 88.0 mt -124.18 157.2 35.28 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.737 1.615 . . . . 75.11 108.565 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -124.31 133.52 53.44 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.392 2.277 . . . . 74.23 106.837 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -120.29 146.95 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.601 1.16 . . . . 75.14 108.283 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -135.59 163.02 31.07 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.157 1.383 . . . . 74.0 109.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 65.08 14.69 9.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.952 2.101 . . . . 70.3 113.851 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.54 153.13 91.07 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 120.796 -1.19 . . . . 74.34 109.588 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.47 140.11 56.34 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.762 2.308 . . . . 74.53 110.532 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.58 -30.1 71.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.913 1.079 . . . . 75.03 113.913 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -130.26 117.91 20.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.888 -1.523 . . . . 74.41 106.888 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 tt -165.88 140.89 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.958 2.503 . . . . 72.23 104.366 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 18.0 p -75.12 174.4 9.47 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.027 0.831 . . . . 64.22 109.944 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.06 76.21 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 107.126 -1.435 . . . . 75.5 107.126 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -47.84 -54.3 12.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 128.326 2.65 . . . . 74.43 112.739 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -62.21 -49.51 75.48 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.36 0.527 . . . . 75.12 110.099 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 72.3 mmm -56.26 -49.44 74.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 119.213 -0.422 . . . . 75.2 111.088 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -61.51 -43.96 97.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.559 -1.21 . . . . 73.25 110.009 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -58.59 7.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.105 -1.072 . . . . 55.14 108.105 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 64.2 mt -47.61 -67.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.854 2.062 . . . . 72.35 112.345 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -68.34 -26.93 65.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.281 0.845 . . . . 74.21 113.281 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 -20.65 66.44 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 124.874 1.226 . . . . 64.34 112.983 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -26.75 68.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.387 1.593 . . . . 75.41 110.486 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -85.88 -10.16 55.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.784 0.661 . . . . 74.23 112.784 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.96 -171.59 22.37 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.355 0.98 . . . . 44.43 111.54 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.75 153.14 73.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.776 2.984 . . . . 74.04 111.36 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mt -118.21 138.25 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.286 -1.005 . . . . 75.34 108.286 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -51.9 9.78 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.17 1.388 . . . . 71.32 111.485 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -161.9 157.58 24.08 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.76 0.824 . . . . 74.34 109.473 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.4 mt -145.78 142.36 21.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.993 1.317 . . . . 73.33 108.268 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -145.45 150.76 37.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.763 -1.569 . . . . 72.42 106.763 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.16 147.27 30.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.468 0.707 . . . . 74.0 109.656 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.28 135.6 31.77 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.328 -1.909 . . . . 75.41 108.328 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.95 -21.36 5.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.876 1.065 . . . . 62.22 113.876 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.7 p -69.69 159.8 82.35 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 104.56 -2.385 . . . . 73.45 104.56 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.02 -45.36 36.56 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.505 1.47 . . . . 75.52 111.241 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.07 -5.8 29.3 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.826 1.417 . . . . 73.54 114.826 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -116.45 -18.07 10.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.293 1.406 . . . . 74.15 112.799 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -52.55 126.96 21.21 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.822 0.849 . . . . 75.44 109.686 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.05 48.33 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.459 -1.19 . . . . 70.13 112.653 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 61.6 p -127.56 146.81 50.4 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.03 1.915 . . . . 70.21 107.535 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -156.23 174.26 15.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.614 0.366 . . . . 73.13 111.229 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.14 155.46 48.13 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.396 1.078 . . . . 74.52 109.17 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -138.63 139.83 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 104.412 -2.44 . . . . 73.1 104.412 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.39 123.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.56 -2.015 . . . . 73.43 105.56 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -97.91 166.15 11.59 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.827 -1.546 . . . . 71.42 106.827 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -71.28 -47.6 55.9 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.754 -0.591 . . . . 72.44 109.774 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.86 154.6 38.06 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.911 0.778 . . . . 74.12 110.737 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.93 -37.5 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 113.736 1.013 . . . . 72.0 113.736 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -57.95 -48.23 80.58 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.161 -0.923 . . . . 75.03 111.528 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.14 -40.87 95.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 123.935 0.772 . . . . 72.24 109.349 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -54.71 42.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.156 -0.313 . . . . 73.45 110.156 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -69.76 -30.18 67.7 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.523 -0.751 . . . . 64.43 111.894 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.67 -53.97 51.79 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.109 -1.071 . . . . 72.33 108.109 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.03 93.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.417 1.087 . . . . 72.04 110.611 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 13.3 t -46.56 -69.16 0.14 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.823 1.249 . . . . 74.5 113.018 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.39 -27.77 67.37 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.074 1.138 . . . . 71.21 114.074 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -33.71 72.49 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.775 0.716 . . . . 73.13 109.607 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -90.01 -24.91 21.09 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.987 1.315 . . . . 71.33 112.992 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -57.34 111.26 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.481 1.512 . . . . 64.15 110.675 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.11 9.85 57.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.324 1.916 . . . . 74.02 114.43 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -61.74 130.03 43.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.543 1.671 . . . . 73.13 110.363 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -89.84 100.92 13.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.417 2.287 . . . . 64.13 110.653 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.84 133.51 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.402 1.081 . . . . 75.32 110.621 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m 42.79 49.41 5.03 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.827 1.651 . . . . 63.43 112.121 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 32.1 t30 58.94 33.25 22.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.603 2.361 . . . . 64.33 112.878 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -140.16 158.33 44.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.985 -1.072 . . . . 72.12 108.26 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -118.07 118.14 31.09 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.822 -1.547 . . . . 75.13 106.822 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.6 mt -73.63 174.05 8.87 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.692 -1.225 . . . . 73.25 107.692 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.02 137.4 52.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.094 -2.558 . . . . 71.33 104.094 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 t -126.83 121.67 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.743 -1.947 . . . . 74.41 105.743 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 34.6 tp -136.15 153.21 51.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.573 -0.899 . . . . 75.24 108.573 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -74.75 163.11 28.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.694 0.798 . . . . 73.12 108.949 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -104.49 154.58 19.72 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.957 -1.868 . . . . 75.53 105.957 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 C--O 1.246 0.871 0 C-N-CA 124.387 1.075 . . . . 74.1 110.652 -178.587 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 CA-C-O 116.217 -2.435 . . . . 64.23 107.07 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 20.7 p 23.97 80.11 0.2 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 126.979 2.112 . . . . 75.53 114.594 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.89 168.26 23.55 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.567 1.511 . . . . 74.31 109.792 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -130.67 157.44 42.77 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.908 1.683 . . . . 74.32 106.876 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -136.73 86.02 2.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.444 -1.317 . . . . 74.35 107.444 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.59 160.83 24.48 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.457 -0.942 . . . . 74.52 108.457 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.37 169.06 18.28 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.311 0.645 . . . . 74.35 110.051 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -154.97 171.83 19.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.571 1.549 . . . . 72.01 107.285 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -122.85 130.66 53.15 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.18 -1.415 . . . . 74.42 107.18 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -76.48 149.42 36.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.634 -0.876 . . . . 75.33 108.634 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -155.03 158.69 39.5 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.187 -1.412 . . . . 74.54 107.187 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.89 172.09 13.7 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.594 0.711 . . . . 74.02 112.028 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -153.89 171.81 18.38 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.736 2.014 . . . . 74.44 107.492 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.38 131.48 39.16 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.438 -2.43 . . . . 71.25 104.438 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 10.4 tp -148.82 159.98 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 108.65 -0.87 . . . . 70.35 108.65 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.16 47.79 2.21 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.264 1.426 . . . . 71.4 109.62 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -56.67 118.45 4.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.086 0.955 . . . . 74.34 109.914 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -75.77 104.3 6.25 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.639 1.175 . . . . 74.51 108.341 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -111.05 178.29 4.39 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.291 0.636 . . . . 64.53 111.891 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -68.03 154.28 94.05 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.965 0.906 . . . . 74.2 111.095 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.04 -12.93 12.99 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.817 2.344 . . . . 75.23 112.68 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 91.8 mt -127.8 115.74 19.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 101.417 -3.549 . . . . 75.31 101.417 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.5 p -136.05 -175.05 3.85 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.958 0.885 . . . . 73.2 110.071 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -40.46 97.2 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.871 2.069 . . . . 70.2 108.127 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -67.26 -29.67 69.35 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.848 0.459 . . . . 65.34 110.607 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -75.32 -37.44 60.76 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.471 -0.566 . . . . 61.34 109.471 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.01 -30.98 69.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.429 0.559 . . . . 73.23 110.302 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.93 -36.87 80.87 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.965 -0.459 . . . . 64.44 111.042 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.5 -37.62 36.27 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.378 1.071 . . . . 42.23 110.851 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.2 mtp -66.41 -12.51 57.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.519 1.128 . . . . 74.43 111.846 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -99.25 157.28 34.32 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 124.095 0.958 . . . . 74.35 110.107 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -89.41 172.5 4.09 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.199 2.599 . . . . 64.21 109.017 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.63 159.34 33.2 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.606 -0.684 . . . . 62.44 110.906 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.2 20.97 58.04 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 117.825 -1.541 . . . . 75.22 115.451 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -125.49 140.09 53.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.985 1.893 . . . . 74.03 110.631 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -122.26 151.28 41.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.572 1.949 . . . . 74.45 109.104 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.86 151.38 6.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 122.563 1.173 . . . . 64.43 110.604 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.0 tp -126.48 87.47 56.3 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 103.398 -2.815 . . . . 74.11 103.398 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -64.01 168.9 11.35 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.222 2.615 . . . . 72.43 111.226 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.74 163.3 35.83 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.37 1.38 . . . . 73.31 108.661 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -48.58 152.94 3.71 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.604 2.869 . . . . 73.33 113.745 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -57.9 133.11 55.17 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.397 0.679 . . . . 63.34 112.634 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 55.26 25.14 39.3 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.453 -1.193 . . . . 72.12 113.06 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -64.55 101.63 0.47 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.731 1.265 . . . . 74.33 108.104 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.92 82.79 36.27 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 105.139 -2.171 . . . . 74.43 105.139 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.93 -176.4 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.046 2.498 . . . . 73.34 110.031 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.4 tt . . . . . 0 C--O 1.253 1.237 0 N-CA-C 104.78 -2.304 . . . . 75.54 104.78 178.836 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 109.441 -1.464 . . . . 64.53 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -145.1 112.19 6.01 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 106.795 -1.557 . . . . 65.31 106.795 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -156.48 136.33 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.515 1.526 . . . . 61.31 107.4 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -154.71 130.71 10.2 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.45 1.1 . . . . 53.05 108.896 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . 0.524 HD11 ' H ' ' B' ' 11' ' ' ILE . 1.9 mp -68.61 -25.37 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.858 1.663 . . . . 73.53 113.096 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.99 158.49 18.62 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.348 -0.845 . . . . 71.43 110.622 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.84 155.55 38.09 Favored Pre-proline 0 C--O 1.241 0.643 0 C-N-CA 124.176 0.99 . . . . 73.31 108.595 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.49 165.43 29.16 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.725 1.616 . . . . 75.43 111.103 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.92 2.68 4.54 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.506 3.47 . . . . 74.31 114.313 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -148.87 120.08 7.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.961 1.704 . . . . 54.0 107.287 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 t -145.14 91.92 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.511 -1.292 . . . . 75.14 107.511 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -61.92 152.52 31.79 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.743 1.217 . . . . 75.43 110.43 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 -59.11 -61.48 2.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.418 -0.801 . . . . 72.13 112.903 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.79 134.41 26.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.005 -0.739 . . . . 74.51 109.005 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.35 157.52 26.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.947 2.099 . . . . 73.41 109.175 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -124.93 135.7 53.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.493 1.917 . . . . 72.32 108.397 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mm -118.12 143.07 29.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 126.193 1.797 . . . . 74.21 108.767 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -133.6 162.59 31.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.324 . . . . 73.44 107.571 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 21.5 t30 65.58 30.23 10.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.422 2.689 . . . . 72.33 111.666 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 50.8 mt -70.06 147.67 95.78 Favored Pre-proline 0 C--O 1.236 0.348 0 O-C-N 121.736 -0.603 . . . . 74.22 111.196 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.99 152.49 68.16 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.826 2.351 . . . . 74.04 110.579 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -83.95 -11.03 57.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.496 0.718 . . . . 72.31 112.107 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.86 113.85 17.12 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.36 -2.089 . . . . 75.54 105.36 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -163.2 167.62 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.785 -1.561 . . . . 73.35 106.785 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -133.98 175.71 9.23 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.203 1.801 . . . . 74.11 111.607 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.02 -35.87 80.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.881 -0.785 . . . . 62.33 108.881 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.43 -50.63 71.1 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.771 -0.455 . . . . 74.23 109.771 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -63.72 -55.07 26.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.582 1.153 . . . . 71.04 111.374 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.8 mmm -57.28 -27.67 62.33 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 113.749 1.018 . . . . 74.44 113.749 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -93.85 -20.62 19.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.909 0.777 . . . . 65.0 111.208 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.9 -52.19 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.219 0.918 . . . . 54.12 110.957 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.99 -52.75 40.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.786 1.634 . . . . 75.22 110.858 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.93 -30.47 39.96 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 118.146 -0.93 . . . . 74.14 113.13 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -31.58 78.55 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.871 -0.892 . . . . 72.33 110.871 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -60.4 -15.35 25.38 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.203 1.401 . . . . 72.12 113.023 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.01 -16.76 14.21 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.315 1.046 . . . . 74.4 113.616 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.1 174.72 29.18 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.055 1.312 . . . . 74.53 110.902 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.48 145.4 64.64 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 124.297 3.331 . . . . 63.21 110.946 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 24.4 mt -99.78 124.68 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.547 1.139 . . . . 72.24 111.231 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -83.19 -56.34 3.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.56 -1.274 . . . . 74.03 107.56 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -157.72 152.85 25.72 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.426 1.012 . . . . 64.3 112.456 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mt -134.46 118.29 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.963 2.105 . . . . 74.41 107.627 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -127.21 120.34 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.119 -2.178 . . . . 73.33 105.119 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.41 159.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.235 2.214 . . . . 74.21 111.095 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.88 146.69 38.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.107 -1.597 . . . . 62.12 109.107 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -112.73 -45.61 3.2 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.471 1.108 . . . . 73.1 111.61 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 15.6 p -74.42 162.14 75.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.941 1.696 . . . . 73.35 111.858 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.88 9.29 2.03 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.626 2.884 . . . . 73.13 112.319 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.64 1.51 11.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.889 1.276 . . . . 71.13 111.521 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 35.6 p -116.75 -1.2 12.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.801 2.04 . . . . 74.02 109.461 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -63.77 145.9 54.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.806 2.042 . . . . 75.31 112.194 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.52 6.16 70.05 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.851 -0.971 . . . . 74.15 112.873 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 21.1 p -141.1 150.35 42.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.041 1.42 . . . . 75.41 110.613 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.92 171.32 14.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.444 1.498 . . . . 74.41 109.107 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -118.11 159.98 22.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.245 1.018 . . . . 71.13 109.428 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.36 139.11 47.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.278 -1.379 . . . . 74.22 107.278 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 t -127.71 123.74 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.757 -1.942 . . . . 74.52 105.757 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.3 165.78 11.52 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 105.13 -2.174 . . . . 73.14 105.13 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -73.32 -35.0 65.99 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.291 -0.881 . . . . 74.24 112.052 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.2 162.52 22.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.946 0.794 . . . . 75.55 112.54 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 tt -67.84 -43.49 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.051 0.94 . . . . 71.13 109.596 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.98 -41.81 99.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.754 1.222 . . . . 74.44 111.474 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.49 -44.92 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.511 -0.922 . . . . 54.22 108.511 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.42 85.79 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.129 0.572 . . . . 62.44 109.524 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -59.24 -48.87 79.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.375 1.07 . . . . 72.42 111.111 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.79 -40.01 94.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.326 0.967 . . . . 63.44 110.827 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.62 66.83 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.638 -0.696 . . . . 73.53 111.486 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.56 -64.37 0.97 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 117.85 -1.071 . . . . 73.34 109.319 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.34 -33.67 74.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.125 1.329 . . . . 70.33 112.969 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -64.47 -31.07 72.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.043 0.383 . . . . 74.33 110.262 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.4 tp -102.47 -26.23 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.882 1.438 . . . . 73.23 114.882 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -61.8 106.31 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.364 1.865 . . . . 75.52 110.34 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.54 10.74 63.19 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.55 -1.139 . . . . 64.3 113.19 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.22 121.26 10.93 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.934 1.367 . . . . 71.45 109.894 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.83 112.19 15.74 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.08 1.752 . . . . 64.31 107.815 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.97 148.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.348 0.659 . . . . 74.23 110.589 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 87.6 m 34.0 54.95 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.294 2.638 . . . . 75.12 114.588 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 52.33 31.26 9.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.859 2.064 . . . . 64.3 112.452 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -140.23 -170.71 3.03 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 128.781 2.833 . . . . 72.54 107.864 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -148.64 153.0 37.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.87 2.068 . . . . 64.34 105.741 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.1 172.84 6.6 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.421 -0.955 . . . . 74.12 108.421 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.21 150.66 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.068 -1.456 . . . . 75.12 107.068 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.1 136.17 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.476 1.91 . . . . 54.41 107.626 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.3 tp -146.61 151.61 37.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.209 1.803 . . . . 71.03 107.824 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -94.6 155.82 16.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.029 0.931 . . . . 73.42 111.288 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -80.5 175.55 10.56 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.212 0.605 . . . . 75.0 112.52 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 125.931 1.692 . . . . 75.51 109.985 -179.094 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 110.133 -1.187 . . . . 73.33 110.133 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 8.8 t -154.16 47.29 0.34 Allowed Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.881 0.872 . . . . 75.31 111.435 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -66.32 166.88 19.97 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.61 2.207 . . . . 74.43 112.239 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -83.02 134.96 35.02 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.916 -1.142 . . . . 73.14 107.916 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -120.08 151.2 39.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.96 -1.496 . . . . 63.42 106.96 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.59 130.63 47.79 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.916 -1.513 . . . . 73.43 106.916 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -67.6 79.86 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.831 1.253 . . . . 63.04 109.599 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -157.92 88.21 0.96 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 126.589 1.955 . . . . 75.31 107.828 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -82.22 173.54 12.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.059 -0.719 . . . . 64.4 109.059 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -88.31 161.73 16.98 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.639 -0.663 . . . . 74.13 111.252 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 52.64 48.34 22.73 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.393 1.477 . . . . 72.13 110.427 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.52 153.92 40.08 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.778 0.831 . . . . 75.44 110.431 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -80.82 148.81 29.82 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 109.748 -0.464 . . . . 65.52 109.748 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.59 36.65 2.68 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.578 2.351 . . . . 75.14 113.028 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 5.1 tp -61.39 131.53 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.014 1.726 . . . . 72.32 108.611 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -78.34 169.93 17.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.544 1.538 . . . . 74.13 111.965 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.37 109.05 5.81 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.861 -1.149 . . . . 72.02 108.477 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -111.24 132.56 54.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.38 1.072 . . . . 74.23 109.701 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -55.7 124.86 18.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.01 -1.478 . . . . 74.32 107.01 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -129.31 151.57 78.05 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 123.997 0.919 . . . . 73.31 111.432 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -74.13 177.18 8.57 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.344 2.696 . . . . 73.41 110.546 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.51 145.76 32.21 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.323 0.649 . . . . 72.52 109.529 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.3 t -81.15 -176.67 6.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 123.096 1.426 . . . . 61.24 109.706 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -70.86 -19.72 62.61 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.955 2.102 . . . . 71.01 109.963 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -81.45 -56.2 4.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.618 1.967 . . . . 75.01 111.332 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.84 -24.93 59.75 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.915 0.779 . . . . 74.41 111.798 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 61.8 tp -67.51 -27.57 67.1 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.088 1.355 . . . . 74.14 110.273 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -66.52 -32.51 73.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.822 1.192 . . . . 73.14 110.018 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.84 56.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.331 1.052 . . . . 75.42 111.917 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 67.3 mtp -88.17 -12.26 44.45 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.293 1.437 . . . . 74.55 113.245 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -114.61 160.81 31.75 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 125.707 1.603 . . . . 74.1 111.59 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.25 167.42 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.232 1.954 . . . . 71.11 110.151 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.87 169.95 15.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.403 0.681 . . . . 71.41 110.306 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 80.51 22.42 62.37 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.034 -1.041 . . . . 72.21 113.277 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -124.58 156.86 36.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.851 -1.166 . . . . 74.43 107.851 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.0 149.47 47.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.032 0.933 . . . . 70.01 110.09 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.63 151.12 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.076 -0.712 . . . . 73.43 109.076 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.2 tp -131.09 82.98 61.93 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 107.978 -1.119 . . . . 74.1 107.978 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.45 164.18 7.49 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.872 3.048 . . . . 72.44 112.236 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.46 162.38 20.92 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.053 2.502 . . . . 74.02 112.648 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.06 170.56 17.83 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.879 2.386 . . . . 73.31 110.485 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -66.49 151.48 47.14 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.898 -0.501 . . . . 72.21 109.77 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 55.29 21.32 25.78 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 116.566 1.386 . . . . 54.04 116.566 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -72.43 102.43 3.19 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 118.463 1.132 . . . . 65.52 110.043 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 12.1 t -134.99 70.08 70.45 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 104.572 -2.381 . . . . 73.04 104.572 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.97 170.43 16.83 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.735 2.957 . . . . 70.41 112.898 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.412 1.485 . . . . 72.33 110.646 -179.122 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.748 0 N-CA-C 110.549 -1.02 . . . . 71.34 110.549 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -84.47 117.69 23.82 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.531 -1.285 . . . . 71.13 107.531 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.8 159.64 33.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.572 1.949 . . . . 70.05 107.505 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -145.31 85.53 1.73 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.378 -2.082 . . . . 74.4 105.378 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 tt -137.0 139.92 43.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.924 -1.139 . . . . 75.0 107.924 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -60.47 163.4 5.31 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.38 -0.97 . . . . 55.51 108.38 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 76.33 85.7 0.09 OUTLIER Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 127.256 2.222 . . . . 60.52 105.072 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.53 161.37 45.63 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.272 2.648 . . . . 74.23 111.113 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.94 -37.13 9.14 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.346 2.031 . . . . 62.34 111.72 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -166.1 155.16 11.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.482 1.913 . . . . 71.24 106.639 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 t -151.19 128.41 2.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.307 -1.738 . . . . 74.32 106.307 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -134.46 158.84 42.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.494 -1.298 . . . . 72.15 107.494 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -65.42 -23.37 66.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 117.811 -1.09 . . . . 71.13 113.084 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 66.9 mt -89.53 126.11 42.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.441 -2.059 . . . . 75.43 105.441 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 95.0 mt -120.47 163.27 18.19 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.498 1.519 . . . . 72.42 109.229 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -129.29 136.49 50.12 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.211 1.804 . . . . 75.11 108.295 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mm -129.41 149.86 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.108 0.963 . . . . 73.35 108.5 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -139.49 163.87 31.39 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.813 1.645 . . . . 74.43 108.088 178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 71.27 19.34 5.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.935 1.694 . . . . 72.05 111.222 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.86 155.4 89.86 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.119 0.968 . . . . 74.0 111.511 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.51 147.37 70.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.325 2.017 . . . . 71.43 107.31 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -82.8 -17.59 43.56 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.732 -0.605 . . . . 75.22 112.333 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -124.72 91.61 3.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.171 0.989 . . . . 75.34 110.572 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -146.69 139.15 19.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.191 -1.04 . . . . 73.21 108.191 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 1.2 p -89.26 164.7 14.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.368 1.067 . . . . 74.32 109.595 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.46 -23.43 65.86 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.594 -0.521 . . . . 74.35 109.594 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.5 -57.61 11.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.521 2.728 . . . . 63.44 110.215 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -72.26 -35.11 68.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.81 0.844 . . . . 75.51 109.933 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.6 mmm -63.43 -48.94 75.7 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.957 -0.757 . . . . 71.25 108.957 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.19 -29.83 70.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.385 -0.817 . . . . 75.44 110.387 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.75 -65.17 0.72 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.471 -0.937 . . . . 74.54 108.471 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.77 -60.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 126.128 1.771 . . . . 74.33 111.92 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -68.64 -17.16 64.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.106 -0.473 . . . . 72.54 112.047 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.96 -27.45 34.2 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.264 1.411 . . . . 45.52 113.068 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -52.59 -40.67 62.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.591 1.696 . . . . 70.04 109.507 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -77.0 -11.77 59.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 116.795 2.146 . . . . 75.15 116.795 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.97 20.53 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.362 1.437 . . . . 75.23 111.49 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.56 147.26 90.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.219 2.613 . . . . 63.23 111.666 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.9 131.7 50.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.55 1.54 . . . . 75.44 109.545 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.77 -58.08 3.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.375 -1.343 . . . . 74.14 107.375 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -162.85 160.86 25.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 0.667 . . . . 71.55 110.594 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mt -142.29 145.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.298 1.839 . . . . 75.44 108.548 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -140.59 144.44 35.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 104.377 -2.453 . . . . 70.23 104.377 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 17.3 m -129.35 162.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.315 1.046 . . . . 74.25 111.563 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.55 146.0 39.73 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.003 -0.839 . . . . 72.43 111.003 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -124.36 -0.63 8.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.652 1.581 . . . . 70.14 112.589 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -127.02 164.06 37.68 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.378 1.871 . . . . 75.42 109.814 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 -25.64 80.31 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.732 2.288 . . . . 75.24 113.956 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -93.39 1.58 56.84 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.73 1.15 . . . . 73.13 111.542 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.6 p -117.11 -28.78 6.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.283 1.033 . . . . 71.51 111.568 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 139.52 58.48 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.056 -1.028 . . . . 72.3 108.438 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.63 -23.51 35.86 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.302 1.43 . . . . 73.51 113.345 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.3 p -119.69 157.52 28.35 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 107.651 -1.24 . . . . 74.21 107.651 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.13 175.26 10.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.348 -0.845 . . . . 64.2 111.025 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -134.1 141.54 47.18 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.705 -1.22 . . . . 73.51 107.705 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 88.6 t -125.73 149.54 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.578 -1.638 . . . . 75.32 106.578 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t -127.73 132.6 68.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.48 -0.933 . . . . 74.1 108.48 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -101.09 164.02 12.01 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.667 -1.605 . . . . 74.5 106.667 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.7 -33.01 20.17 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.8 -1.187 . . . . 75.31 110.087 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -123.57 138.37 54.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.636 0.774 . . . . 74.23 109.868 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 tt -60.1 -30.55 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.594 -1.262 . . . . 75.01 107.594 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -60.46 -22.99 64.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.324 1.05 . . . . 74.23 111.647 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.23 -43.95 10.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.359 0.981 . . . . 72.05 108.441 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.21 74.67 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.226 -0.657 . . . . 75.24 109.226 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.35 -54.43 47.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.208 1.403 . . . . 72.23 109.817 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -64.88 -51.91 59.44 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.12 0.568 . . . . 73.33 110.955 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.39 -29.5 61.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.716 0.635 . . . . 73.43 112.716 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -64.37 0.98 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.061 -1.088 . . . . 75.22 108.061 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.55 -32.73 73.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.755 -0.64 . . . . 74.03 111.953 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -78.77 -16.4 57.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.612 0.967 . . . . 72.21 113.612 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 24.3 tp -110.68 -19.01 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.282 1.401 . . . . 75.43 112.331 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 83.9 p -58.26 118.05 5.08 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.061 1.345 . . . . 71.44 112.479 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.76 82.62 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.885 -1.508 . . . . 72.03 113.616 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.3 122.93 13.69 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.632 1.716 . . . . 72.14 108.728 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -96.72 115.73 27.93 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 126.079 1.752 . . . . 72.41 110.134 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 m -144.5 159.01 14.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.199 1.4 . . . . 74.21 107.535 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 69.1 m 43.85 41.56 3.89 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.206 1.402 . . . . 74.45 112.472 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 63.1 t30 56.75 21.77 6.27 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.632 2.373 . . . . 71.31 113.659 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -132.59 -179.3 5.37 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.874 2.07 . . . . 75.14 108.385 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -122.61 147.61 46.22 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.647 -1.612 . . . . 75.0 106.647 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 33.7 mt -96.31 156.39 16.36 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.343 -0.984 . . . . 73.02 108.343 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.41 128.55 66.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.955 -2.609 . . . . 63.02 103.955 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 94.4 t -124.7 111.89 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.05 -1.833 . . . . 75.32 106.05 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -136.5 164.35 28.37 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.292 1.037 . . . . 73.44 110.963 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -89.27 163.11 15.51 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.17 1.388 . . . . 72.03 111.364 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -101.24 169.1 9.13 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.567 -2.012 . . . . 74.44 105.567 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.46 -0.941 . . . . 55.1 108.46 -179.734 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.851 0 CA-C-O 118.976 -0.902 . . . . 64.12 111.267 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 91.0 m -138.7 96.91 9.3 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 107.261 -1.385 . . . . 62.21 107.261 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.79 163.34 35.85 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.15 1.9 . . . . 72.14 109.349 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -146.51 82.02 1.58 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.211 -2.144 . . . . 74.32 105.211 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -142.75 158.97 43.11 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.906 1.282 . . . . 73.24 108.952 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 29.4 mt -51.82 156.71 1.37 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.248 2.219 . . . . 72.14 112.527 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -131.55 162.74 29.6 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.574 0.953 . . . . 63.53 113.574 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -122.29 160.41 25.37 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.081 1.752 . . . . 72.42 112.104 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -140.48 161.44 37.71 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.147 1.779 . . . . 75.33 108.308 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.04 130.51 31.48 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 119.067 0.849 . . . . 74.14 109.744 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -161.42 176.13 11.46 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.92 2.488 . . . . 75.21 105.642 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.95 158.0 35.55 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.344 -0.847 . . . . 73.13 111.642 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -127.74 43.46 3.12 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.031 1.332 . . . . 73.25 108.625 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -58.43 155.47 11.94 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.255 0.622 . . . . 74.31 110.263 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 17.9 pt -55.69 145.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 122.058 0.932 . . . . 65.32 112.811 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -157.48 -175.02 5.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 128.171 2.588 . . . . 72.01 106.655 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -137.46 79.67 1.76 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 103.543 -2.762 . . . . 72.12 103.543 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -154.31 164.53 38.45 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.856 0.863 . . . . 74.11 108.863 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -70.13 123.44 21.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.049 -1.834 . . . . 72.14 106.049 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.5 mtt-85 -146.26 162.6 34.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 124.667 1.187 . . . . 64.42 110.259 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.06 147.51 54.69 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.35 1.367 . . . . 73.25 109.768 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 63.1 mt -69.62 134.29 48.58 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.337 -1.727 . . . . 72.54 106.337 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 16.7 m -92.35 -177.04 4.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.427 1.108 . . . . 71.24 111.888 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.31 -46.16 51.16 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.945 2.098 . . . . 64.11 110.21 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.65 -29.92 71.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.875 1.216 . . . . 70.42 111.834 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.46 -35.8 82.11 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.287 -0.634 . . . . 62.25 109.287 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 34.0 tp -59.82 -27.23 66.42 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.862 -0.524 . . . . 75.12 111.135 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.5 -9.47 58.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.814 0.733 . . . . 75.32 112.239 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -123.22 -6.94 8.26 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.11 1.764 . . . . 74.33 112.504 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 57.7 mtp -73.73 -24.72 59.94 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.338 -1.476 . . . . 74.04 114.682 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -83.37 153.37 65.57 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 118.814 0.734 . . . . 74.22 111.546 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.74 172.14 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.477 3.451 . . . . 63.31 112.505 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -81.99 157.6 24.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.662 1.985 . . . . 75.03 110.388 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.38 19.08 53.89 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.052 0.834 . . . . 61.25 112.577 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -124.06 158.18 32.79 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.513 1.125 . . . . 74.35 111.338 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -129.21 145.64 51.29 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.909 1.684 . . . . 73.23 107.015 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.1 t -74.25 151.07 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.605 -0.887 . . . . 75.0 108.605 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.5 tp -124.19 85.51 54.98 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 105.062 -2.199 . . . . 75.24 105.062 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.23 167.9 10.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.432 2.755 . . . . 73.31 112.252 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.19 164.28 36.29 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.353 2.035 . . . . 73.43 110.107 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.49 149.81 29.39 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.925 3.083 . . . . 71.02 112.801 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -67.99 143.3 55.65 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.041 0.448 . . . . 75.22 110.84 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 69.93 -3.63 9.45 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.067 1.318 . . . . 70.43 114.365 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -61.72 156.55 19.94 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.575 1.688 . . . . 75.31 110.649 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.49 79.37 67.21 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.694 0.798 . . . . 75.14 109.195 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.1 171.19 18.32 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.629 2.219 . . . . 64.44 110.08 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 C--O 1.242 0.677 0 C-N-CA 125.563 1.545 . . . . 74.2 108.312 179.62 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.725 0 N-CA-C 110.906 -0.878 . . . . 75.22 110.906 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -62.43 111.07 1.87 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.234 1.013 . . . . 74.42 108.712 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.01 163.28 33.23 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 127.197 2.199 . . . . 64.42 107.594 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -117.52 73.76 0.9 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.136 0.97 . . . . 73.41 110.694 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 pt -70.82 153.73 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.184 1.394 . . . . 75.11 108.722 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -86.23 -17.9 33.56 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.713 -1.242 . . . . 74.12 111.299 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.22 156.92 34.04 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 127.139 2.176 . . . . 64.14 107.816 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.77 169.14 6.03 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.766 2.977 . . . . 71.5 111.876 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.98 -41.76 16.33 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.86 2.373 . . . . 74.24 113.738 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -163.92 153.59 14.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.399 1.88 . . . . 61.12 107.607 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t -150.67 161.01 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.023 1.729 . . . . 64.44 107.404 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -140.45 168.02 20.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.875 1.27 . . . . 75.25 110.273 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -82.57 -9.0 59.59 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.476 -1.39 . . . . 73.43 111.617 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 30.6 mt -106.18 141.26 21.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.321 -1.363 . . . . 71.33 107.321 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -116.24 151.59 35.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.603 1.561 . . . . 62.25 108.039 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -121.32 122.27 39.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.01 1.724 . . . . 74.43 106.696 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -114.07 147.95 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.12 1.768 . . . . 71.22 109.426 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -142.69 163.79 31.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.004 1.722 . . . . 64.44 111.362 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t30 74.56 18.19 2.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.18 2.592 . . . . 72.43 111.691 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 mt -70.03 153.37 95.42 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 124.452 1.101 . . . . 73.21 110.737 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.08 159.57 47.38 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.319 2.679 . . . . 75.05 110.757 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.27 -11.01 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.108 -0.37 . . . . 72.44 111.183 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -127.39 104.47 7.94 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.326 -2.102 . . . . 74.44 105.326 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 tt -158.58 155.08 4.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.193 1.397 . . . . 74.21 108.596 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -105.28 169.81 8.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.304 1.442 . . . . 73.53 111.106 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.11 84.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.05 -1.093 . . . . 73.55 108.05 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.1 -45.8 91.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.45 1.5 . . . . 75.2 111.675 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.74 -37.8 85.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.262 0.625 . . . . 54.11 110.628 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.9 mmm -73.81 -53.31 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.809 1.243 . . . . 73.12 111.736 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -59.79 -30.07 68.65 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 118.386 -0.816 . . . . 73.42 111.323 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.52 -61.32 2.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.991 0.814 . . . . 74.42 109.417 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 -65.4 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 125.781 1.633 . . . . 73.52 112.625 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -63.32 -34.45 77.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.596 0.961 . . . . 75.42 113.596 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.53 -24.22 77.08 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.088 0.858 . . . . 61.43 112.028 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -64.01 -14.67 55.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.022 0.911 . . . . 74.0 113.077 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -105.08 -4.48 21.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.566 1.546 . . . . 75.54 111.771 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.71 173.38 13.16 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.426 1.012 . . . . 71.21 111.637 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.53 128.85 21.03 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.544 2.829 . . . . 62.03 112.04 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.76 135.7 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.57 1.548 . . . . 74.33 108.179 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -81.25 -62.69 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 106.559 -1.645 . . . . 75.22 106.559 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -151.87 160.98 43.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.557 0.617 . . . . 74.24 111.886 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.96 134.55 48.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 126.923 2.089 . . . . 64.21 107.019 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -130.2 128.11 41.04 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.585 -2.006 . . . . 73.01 105.585 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 m -108.76 147.33 13.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.791 1.236 . . . . 73.34 109.009 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.35 135.24 14.97 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.471 -1.052 . . . . 72.02 110.471 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.96 -15.05 9.35 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.232 1.197 . . . . 72.43 114.232 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 21.6 p -77.71 160.21 75.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.411 -1.7 . . . . 74.45 106.411 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.54 -20.43 49.54 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.282 1.988 . . . . 73.21 114.021 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.74 -21.24 20.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.982 0.913 . . . . 64.4 113.064 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 80.4 p -101.58 -12.33 18.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.891 0.768 . . . . 72.02 112.374 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 -64.02 116.5 5.94 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.066 -1.457 . . . . 73.13 107.066 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.93 16.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.7 -1.056 . . . . 61.22 112.753 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -128.5 159.34 35.78 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 118.518 1.159 . . . . 73.45 108.26 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.98 170.38 20.69 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.291 -0.881 . . . . 71.32 110.503 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -122.31 142.57 50.35 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.716 -1.216 . . . . 73.12 107.716 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.06 137.63 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 126.174 1.79 . . . . 74.41 106.775 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -129.03 128.35 67.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 118.422 -0.799 . . . . 74.01 109.893 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -97.45 166.15 11.66 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.609 1.164 . . . . 73.33 107.878 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -74.92 -55.3 5.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.923 0.889 . . . . 75.34 108.72 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.98 121.44 32.08 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 114.274 1.213 . . . . 72.03 114.274 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.4 tt -66.08 -19.41 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.681 -0.489 . . . . 74.41 109.681 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.9 -60.83 2.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.322 1.049 . . . . 73.34 108.387 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.08 -36.69 70.88 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.785 0.834 . . . . 74.2 111.738 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -29.69 62.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.247 0.476 . . . . 74.22 112.014 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -80.05 -46.11 17.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.946 -1.096 . . . . 72.04 108.404 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -57.22 -32.2 66.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.268 0.556 . . . . 72.2 110.592 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.25 -43.95 18.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.269 1.428 . . . . 64.14 111.769 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 11.5 p -55.83 -42.36 75.6 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.198 0.908 . . . . 71.4 110.906 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.64 -18.17 62.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.401 0.519 . . . . 63.41 112.401 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -95.53 -17.88 21.07 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.678 0.791 . . . . 71.15 112.037 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 12.0 tp -101.52 -3.5 28.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.701 0.682 . . . . 74.25 112.534 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.7 p -68.08 134.9 51.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.652 1.215 . . . . 73.02 111.505 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.38 62.44 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.219 -0.926 . . . . 60.13 113.013 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -68.49 141.33 55.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.109 1.455 . . . . 74.21 110.876 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -90.45 127.66 36.28 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.821 1.248 . . . . 75.4 109.286 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.01 125.39 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 127.779 2.432 . . . . 61.12 109.034 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 72.5 m 50.78 41.98 27.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.779 1.232 . . . . 75.13 110.738 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 20.2 m120 61.19 14.64 5.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.476 1.91 . . . . 62.42 113.469 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -122.06 169.77 10.51 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.626 1.971 . . . . 74.02 107.461 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -107.22 -177.0 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.085 -1.079 . . . . 73.24 108.085 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.62 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.555 2.342 . . . . 54.43 106.072 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -133.25 110.52 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.627 -1.619 . . . . 73.24 106.627 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.88 144.59 9.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.007 -1.479 . . . . 75.43 107.007 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 tp -154.27 154.7 33.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.089 1.356 . . . . 73.11 107.342 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -81.24 164.28 22.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.841 1.656 . . . . 72.43 110.482 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -101.06 157.79 16.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.874 0.47 . . . . 73.25 110.229 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 36.0 m120 . . . . . 0 C--O 1.256 1.41 0 CA-C-O 115.945 -1.978 . . . . 64.15 110.229 -179.39 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 108.783 -1.727 . . . . 70.22 108.783 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 7.3 p -107.38 93.95 10.67 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 105.648 -1.982 . . . . 71.13 105.648 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.54 172.51 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.115 1.877 . . . . 72.4 111.465 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -79.88 -168.3 1.56 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.252 2.221 . . . . 75.2 108.337 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -129.4 -82.46 0.56 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 107.747 -1.205 . . . . 63.51 107.747 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 29.8 tp -157.57 164.55 37.18 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.544 -1.28 . . . . 75.32 107.544 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.62 164.12 31.31 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.792 1.237 . . . . 74.35 108.913 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -153.6 146.95 24.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.933 1.293 . . . . 65.25 107.586 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 73.5 t90 -153.3 130.26 11.02 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.733 -1.951 . . . . 74.31 105.733 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -159.92 139.27 11.07 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.493 -1.299 . . . . 75.43 107.493 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -149.44 151.67 34.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.791 1.636 . . . . 72.11 106.833 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -145.97 -168.85 3.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.488 1.115 . . . . 75.3 108.516 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -160.96 -164.23 1.16 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.607 1.094 . . . . 75.22 110.093 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -133.01 -177.07 4.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.739 2.416 . . . . 75.24 104.981 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.3 tp -141.66 123.7 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 120.596 -1.315 . . . . 71.24 108.017 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -160.29 157.66 28.45 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.281 1.833 . . . . 73.42 107.246 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.22 169.81 2.71 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.735 2.014 . . . . 73.51 108.0 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -153.83 161.19 42.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.268 1.827 . . . . 74.35 107.249 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . 0.498 ' CG ' ' H ' ' A' ' 397' ' ' ARG . 7.7 p-10 -101.1 -73.57 0.64 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.034 -1.099 . . . . 73.22 108.034 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . 0.498 ' H ' ' CG ' ' A' ' 396' ' ' ASN . 24.2 mmt85 65.46 151.86 0.12 Allowed Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 130.181 3.392 . . . . 75.12 115.544 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.91 113.41 3.66 Favored 'Trans proline' 0 C--N 1.351 0.691 0 N-CA-C 105.018 -2.724 . . . . 73.22 105.018 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 31.7 mt -128.72 -169.43 2.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.761 0.824 . . . . 75.41 110.974 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 12.1 m -142.45 -78.71 0.24 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.568 1.547 . . . . 73.21 109.532 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -33.11 67.0 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.638 -0.664 . . . . 74.33 110.533 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -75.68 -39.0 58.25 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.599 0.36 . . . . 73.44 110.85 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -64.64 -30.07 71.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.057 0.844 . . . . 70.43 110.112 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 12.3 tp -62.58 -25.54 68.13 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.607 1.163 . . . . 72.01 110.489 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -79.69 -51.51 9.14 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.907 -0.775 . . . . 74.02 108.907 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.19 89.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.511 1.924 . . . . 72.21 113.291 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.0 mtp -57.94 -36.87 73.12 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.307 1.043 . . . . 73.05 113.377 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -68.47 149.92 97.86 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.374 0.988 . . . . 74.11 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.44 160.47 47.68 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.162 1.908 . . . . 72.32 111.064 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -71.06 160.87 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.72 -1.127 . . . . 73.11 109.525 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.72 17.46 63.65 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 121.651 -0.655 . . . . 62.01 113.296 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -124.47 156.96 36.36 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.487 1.515 . . . . 75.11 108.009 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -136.68 144.58 44.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.733 1.213 . . . . 74.3 109.549 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.8 t -70.91 151.18 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.566 -0.901 . . . . 75.41 108.566 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 17.8 tp -120.72 83.44 35.75 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.699 1.6 . . . . 74.11 108.378 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.28 162.26 17.68 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.2 2.6 . . . . 53.44 112.909 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.65 168.39 22.84 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.109 3.206 . . . . 75.42 111.094 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.18 164.1 35.26 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.434 2.089 . . . . 75.45 109.855 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -88.22 160.42 17.71 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.451 -0.78 . . . . 74.03 110.057 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 59.5 1.83 1.36 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.795 1.664 . . . . 62.4 116.169 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -59.39 149.16 30.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.823 2.049 . . . . 73.34 112.997 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 35.1 t -134.06 89.47 28.78 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.472 1.109 . . . . 74.43 108.961 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -83.97 178.92 5.03 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.924 3.083 . . . . 74.24 109.698 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 12.4 tt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.991 1.316 . . . . 73.32 108.63 179.14 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.527 0 N-CA-C 109.939 -1.264 . . . . 54.43 109.939 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -154.72 173.06 16.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.882 0.841 . . . . 73.23 110.148 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.51 151.72 39.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.202 1.801 . . . . 75.15 106.143 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -141.83 117.37 10.29 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 127.408 2.283 . . . . 74.51 105.16 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.44 164.35 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 123.972 0.909 . . . . 73.44 111.035 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -74.09 168.33 19.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.824 -1.08 . . . . 75.54 109.122 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 36.9 mt 53.61 48.87 5.37 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.622 1.169 . . . . 74.1 112.672 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.66 166.64 29.32 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.654 2.236 . . . . 71.43 110.442 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.95 -50.26 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.086 2.524 . . . . 61.44 111.895 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.01 84.6 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 128.39 2.676 . . . . 74.44 112.901 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.2 t -149.29 137.91 14.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.501 -0.926 . . . . 71.44 108.501 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -128.65 171.37 12.24 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.183 1.393 . . . . 74.42 109.663 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -30.04 70.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.951 0.723 . . . . 73.1 112.951 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.93 135.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.625 1.57 . . . . 74.23 109.519 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 98.4 mt -126.47 158.71 35.34 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.005 1.722 . . . . 74.43 110.973 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -128.26 108.49 10.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.59 1.556 . . . . 75.44 110.635 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.84 144.71 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 127.19 2.196 . . . . 74.34 107.73 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 mtm180 -144.56 164.19 31.65 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.97 2.508 . . . . 74.41 110.98 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 52.1 t30 72.43 11.26 5.74 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.139 1.376 . . . . 62.11 111.544 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.55 154.58 79.19 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 124.851 1.261 . . . . 73.12 111.231 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.63 150.75 74.96 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.245 1.963 . . . . 73.14 112.652 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -83.37 -15.39 50.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.504 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -130.06 109.34 10.77 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.524 1.53 . . . . 70.24 107.506 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 15.9 tt -162.57 171.18 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 128.386 2.675 . . . . 72.32 105.466 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -126.18 165.87 18.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.585 1.154 . . . . 73.32 109.976 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.35 74.91 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.543 -0.91 . . . . 62.2 108.543 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.43 -54.61 45.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.831 1.652 . . . . 71.43 109.513 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.5 -36.46 84.27 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.187 1.395 . . . . 53.2 111.363 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 66.2 mmm -64.69 -58.2 6.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.473 -0.936 . . . . 74.31 108.473 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -58.8 -35.76 73.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.635 0.774 . . . . 75.01 110.915 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -59.81 -26.3 65.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 75.13 111.744 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.06 -69.74 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.01 0.924 . . . . 74.55 108.986 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -55.31 -38.09 68.22 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.921 1.452 . . . . 75.3 114.921 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -33.66 85.93 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.302 0.953 . . . . 73.14 112.942 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -65.87 -29.14 69.55 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.109 -1.23 . . . . 73.22 110.221 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -79.89 -22.27 43.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.762 0.825 . . . . 73.23 110.263 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.68 168.93 19.44 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.875 1.702 . . . . 62.44 109.48 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -63.22 159.92 37.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.108 2.539 . . . . 75.31 113.505 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -113.29 143.9 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.686 1.995 . . . . 73.15 110.536 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.34 -56.18 2.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 125.216 1.406 . . . . 71.53 108.043 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -153.72 155.09 35.29 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.359 -1.348 . . . . 75.22 107.359 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -136.82 135.38 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 104.491 -2.411 . . . . 73.11 104.491 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -133.2 123.98 26.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.314 -2.106 . . . . 73.44 105.314 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.8 m -110.04 151.26 12.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.593 -1.262 . . . . 73.23 107.593 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.69 30.79 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.446 -1.062 . . . . 72.14 110.446 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.78 -38.86 3.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.463 -0.78 . . . . 61.34 111.22 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 30.0 p -69.38 161.6 72.43 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.388 -0.597 . . . . 73.11 109.388 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.2 -2.58 8.33 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.141 1.894 . . . . 70.01 112.255 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -105.84 -9.72 17.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.487 1.915 . . . . 70.11 111.868 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -116.62 -12.05 10.97 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.87 1.268 . . . . 71.44 110.723 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -57.58 142.09 45.8 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.55 -1.344 . . . . 71.31 108.341 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.16 -5.68 83.56 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 118.676 -1.069 . . . . 52.14 114.633 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 36.1 p -124.52 153.85 41.45 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.399 1.6 . . . . 71.12 109.144 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.69 166.2 33.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.876 0.846 . . . . 73.03 109.525 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.94 141.98 51.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.532 -2.025 . . . . 72.35 105.532 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.84 142.56 42.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.591 -2.003 . . . . 75.32 105.591 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.78 134.33 65.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.222 -1.77 . . . . 75.03 106.222 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -98.03 166.84 11.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.881 1.672 . . . . 74.21 111.472 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.8 -73.64 0.46 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.94 -1.504 . . . . 75.31 106.94 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -81.77 134.96 35.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.116 0.96 . . . . 71.41 109.332 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -34.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 125.318 1.447 . . . . 72.32 108.443 177.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.33 -30.01 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.152 0.581 . . . . 74.3 110.874 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -71.43 -47.39 56.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.526 -0.916 . . . . 73.21 108.526 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.45 -42.94 74.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.768 0.827 . . . . 75.32 111.94 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -57.28 -61.9 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.38 1.072 . . . . 73.12 109.487 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -52.95 -53.09 54.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.769 0.827 . . . . 71.41 111.812 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.78 -38.67 86.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 114.428 1.27 . . . . 71.43 114.428 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 37.3 t -58.26 -49.81 75.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 118.437 0.562 . . . . 74.43 110.693 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -62.9 -52.77 61.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.795 -0.446 . . . . 74.23 109.795 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -58.36 -26.22 62.9 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.891 0.7 . . . . 74.34 112.891 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.9 tp -96.77 -6.75 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.432 0.901 . . . . 75.3 113.432 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -62.19 121.86 14.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.299 -1.501 . . . . 73.31 109.999 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.71 18.52 70.32 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.35 -1.25 . . . . 62.34 112.777 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -55.06 120.11 6.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.08 1.44 . . . . 71.45 110.32 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -72.88 115.99 12.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.69 2.396 . . . . 74.04 110.749 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.12 144.47 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.156 1.382 . . . . 74.23 108.83 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.0 m 39.73 52.18 2.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 73.31 112.992 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.36 23.54 9.03 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.089 1.356 . . . . 72.33 113.69 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -136.85 -176.6 4.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.591 2.356 . . . . 73.54 107.517 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.47 137.4 38.67 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.956 1.703 . . . . 74.32 107.071 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.39 148.94 24.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.335 0.588 . . . . 75.32 110.446 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.87 156.72 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.117 1.767 . . . . 73.14 107.186 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 93.2 t -142.33 123.12 11.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.714 -2.328 . . . . 73.33 104.714 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 42.4 tp -151.48 146.09 25.66 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.776 0.83 . . . . 74.01 109.754 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -80.37 156.63 26.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.158 -0.682 . . . . 75.0 109.158 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -75.71 175.39 8.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.373 -0.973 . . . . 73.4 108.373 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 124.302 1.041 . . . . 73.24 112.329 -178.472 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.244 0 N-CA-C 108.846 -1.702 . . . . 64.24 108.846 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.0 t -141.99 129.52 11.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 106.05 -1.833 . . . . 74.25 106.05 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -83.54 -179.19 4.06 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.665 2.243 . . . . 73.45 108.941 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -138.89 161.36 37.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.264 1.826 . . . . 74.44 106.116 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -134.41 97.28 3.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.868 -1.16 . . . . 72.02 107.868 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.32 144.26 57.1 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.236 -0.653 . . . . 74.31 109.236 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -74.95 80.07 2.16 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.952 -0.758 . . . . 55.12 108.952 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -78.21 57.38 1.84 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.662 1.185 . . . . 70.43 110.121 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -123.02 167.89 13.05 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.295 1.838 . . . . 74.43 109.527 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.22 179.27 4.59 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 128.568 2.747 . . . . 74.33 106.597 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -134.64 -170.61 2.59 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.294 0.497 . . . . 73.42 110.04 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -117.2 -175.86 2.88 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.653 1.181 . . . . 64.52 111.041 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 18.2 mtm105 -140.34 76.9 1.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.59 1.156 . . . . 55.34 108.888 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 147.65 51.49 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.633 0.651 . . . . 70.43 110.246 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 29.0 pt -141.48 143.06 28.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 124.971 1.308 . . . . 74.21 109.78 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -158.87 179.14 9.35 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.395 1.078 . . . . 62.34 111.094 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.91 179.91 2.09 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.5 0.72 . . . . 71.42 110.307 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -135.71 137.15 41.44 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.21 -0.931 . . . . 72.25 110.697 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.71 0.43 13.87 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 126.277 1.831 . . . . 74.24 110.204 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -100.94 146.93 32.98 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.686 1.194 . . . . 71.42 111.107 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.1 159.91 51.49 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.692 2.928 . . . . 64.41 109.2 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 59.8 mt -62.53 116.73 5.38 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.756 -0.59 . . . . 71.03 110.173 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 16.0 m -111.04 -149.28 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.089 2.156 . . . . 71.41 107.565 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.04 -33.6 17.09 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.152 -0.968 . . . . 73.31 112.622 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.95 -40.07 83.58 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.82 0.848 . . . . 73.22 110.723 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -64.77 -30.91 71.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.209 0.603 . . . . 62.14 110.26 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.3 tp -72.88 -47.49 45.48 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 107.244 -1.391 . . . . 65.22 107.244 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.58 -49.11 73.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.765 0.257 . . . . 71.05 110.816 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.51 -24.89 61.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.53 1.532 . . . . 61.45 113.777 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 62.4 mtp -86.59 -17.59 33.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.335 -0.853 . . . . 63.34 111.416 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -90.42 146.79 35.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 119.017 0.826 . . . . 72.23 111.844 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.84 163.85 23.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.292 2.661 . . . . 75.0 111.045 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -76.86 173.47 11.67 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.465 -0.939 . . . . 63.13 108.465 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 78.62 18.89 74.72 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 121.372 -0.83 . . . . 75.51 111.731 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.8 117.17 19.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.523 1.529 . . . . 74.32 108.901 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.42 148.0 22.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.45 1.1 . . . . 74.24 108.119 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.71 151.96 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.819 -1.175 . . . . 75.43 110.948 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 22.9 tp -120.67 77.9 29.18 Favored Pre-proline 0 C--O 1.237 0.401 0 N-CA-C 107.17 -1.419 . . . . 62.34 107.17 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.78 166.54 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.729 2.286 . . . . 73.41 111.467 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.17 174.92 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.882 1 C-N-CA 125.698 4.265 . . . . 62.15 115.063 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.79 149.87 66.26 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.732 2.288 . . . . 65.43 110.993 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -82.86 70.3 9.83 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.409 -1.7 . . . . 73.43 106.409 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 136.44 60.57 0.06 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.519 1.533 . . . . 75.32 111.052 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -93.82 9.58 36.65 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.775 0.787 . . . . 72.34 113.007 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 2.5 t 60.53 63.88 2.67 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 126.415 1.886 . . . . 72.31 110.766 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.62 125.1 11.81 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.307 2.671 . . . . 71.54 111.592 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--O 1.25 1.116 0 N-CA-C 105.371 -2.085 . . . . 74.14 105.371 177.422 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 111.49 -0.644 . . . . 72.1 111.49 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -134.84 116.06 14.36 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.12 -1.437 . . . . 74.3 107.12 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.7 120.08 8.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.699 -1.593 . . . . 73.15 106.699 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -124.46 164.1 20.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.02 1.328 . . . . 75.22 108.022 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 pt -126.1 11.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 113.918 1.081 . . . . 70.45 113.918 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -135.0 121.34 20.32 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.396 -1.335 . . . . 74.2 107.396 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 mp -54.95 155.75 7.84 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 123.591 0.757 . . . . 71.52 110.915 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.25 162.33 20.39 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.045 2.497 . . . . 61.31 114.491 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.03 -27.52 57.72 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.172 2.581 . . . . 75.43 113.123 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -58.22 -20.6 42.95 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.94 2.096 . . . . 72.41 113.427 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 41.4 t -74.79 104.15 3.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.908 1.283 . . . . 74.03 107.87 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -98.03 175.25 6.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.635 1.174 . . . . 71.33 109.71 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.69 -34.31 72.72 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.686 -1.259 . . . . 72.52 114.215 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.12 138.05 21.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.512 1.125 . . . . 72.42 109.793 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.36 146.81 49.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.787 -1.19 . . . . 74.34 107.787 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -99.55 138.79 36.15 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.894 -1.891 . . . . 74.22 105.894 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.8 mm -117.03 134.86 59.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 126.155 1.782 . . . . 64.03 106.365 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -127.83 162.5 26.51 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.909 0.884 . . . . 64.35 110.485 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.57 38.35 12.45 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.656 1.983 . . . . 53.41 111.557 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 67.3 mt -76.56 153.76 83.62 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 108.488 -0.93 . . . . 63.42 108.488 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.96 163.94 35.71 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.632 2.221 . . . . 74.42 109.844 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -94.06 -13.03 27.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.994 0.518 . . . . 73.2 112.017 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -126.23 99.7 5.99 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.215 1.406 . . . . 74.43 107.943 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.1 143.43 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.565 -1.272 . . . . 55.23 107.565 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -98.45 178.13 5.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.98 0.912 . . . . 72.1 110.441 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.42 80.95 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.194 -0.457 . . . . 71.11 110.15 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -52.83 -60.54 3.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 127.73 2.412 . . . . 74.3 110.027 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.53 -47.55 81.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.426 1.49 . . . . 75.21 110.88 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.7 mmm -59.25 -39.09 81.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.088 -0.383 . . . . 75.21 110.865 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -76.37 -30.36 57.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.722 -0.656 . . . . 72.33 110.319 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.23 -27.13 65.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.67 1.188 . . . . 74.13 110.16 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 58.7 mt -76.26 -68.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.38 1.072 . . . . 74.2 109.16 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.32 -23.86 65.68 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.892 1.442 . . . . 73.14 114.892 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.92 -13.85 69.89 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 115.584 0.994 . . . . 64.43 115.584 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.51 -28.78 63.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.096 1.448 . . . . 72.51 110.592 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.82 -34.27 22.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.505 -0.76 . . . . 75.23 112.351 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.2 -166.55 39.67 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 120.204 1.365 . . . . 50.51 111.915 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.28 162.57 41.85 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.084 3.189 . . . . 62.45 112.858 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 59.5 mt -118.38 130.47 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.965 0.906 . . . . 73.22 109.247 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -88.44 -59.7 2.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.131 -1.063 . . . . 75.41 108.131 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -155.61 155.12 32.71 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.66 0.267 . . . . 74.31 110.851 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.05 127.79 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 104.984 -2.228 . . . . 73.14 104.984 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -128.31 120.82 27.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 102.842 -3.021 . . . . 74.21 102.842 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.65 144.65 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.736 0.814 . . . . 54.15 111.359 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.64 115.58 6.0 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 106.076 -2.81 . . . . 71.25 106.076 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -103.55 -10.89 18.12 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.194 0.998 . . . . 52.3 113.46 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.9 p -95.16 158.36 34.93 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.375 0.989 . . . . 73.21 108.461 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.59 -15.73 38.53 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.77 2.313 . . . . 73.11 113.045 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -97.29 -10.7 25.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.514 1.125 . . . . 75.15 112.286 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 39.9 p -116.96 -19.23 9.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.731 1.212 . . . . 71.04 112.21 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -53.26 150.32 6.32 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.434 1.494 . . . . 74.44 110.317 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.51 3.51 88.84 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.069 -1.406 . . . . 73.13 112.703 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 59.1 p -143.77 153.36 42.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.753 1.776 . . . . 74.11 109.979 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.35 172.82 12.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.751 2.021 . . . . 75.14 108.359 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -127.78 156.02 43.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.889 -1.522 . . . . 64.35 106.889 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.22 142.97 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.872 -1.159 . . . . 74.3 107.872 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.04 133.33 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.621 1.169 . . . . 73.54 108.369 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.99 154.12 17.91 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.374 -1.713 . . . . 72.31 106.374 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -72.69 -20.09 61.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 119.546 -0.862 . . . . 74.24 110.931 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.83 117.87 30.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.579 1.552 . . . . 72.23 109.681 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.76 -27.48 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 125.175 1.39 . . . . 71.34 111.966 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -73.36 -41.61 63.21 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.344 -1.472 . . . . 74.11 107.569 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -37.31 87.09 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.569 -0.901 . . . . 71.21 108.569 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.4 78.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.63 -0.7 . . . . 74.42 109.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -29.54 70.44 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.288 -0.863 . . . . 75.2 110.612 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.87 -53.31 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.129 1.331 . . . . 75.53 108.568 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.41 -14.15 17.36 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.086 1.143 . . . . 75.43 114.086 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 91.6 m -64.23 -66.62 0.52 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.448 1.022 . . . . 75.41 109.735 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.3 -34.56 76.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 119.13 -0.462 . . . . 74.22 110.168 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -64.83 -21.61 66.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.161 -0.923 . . . . 75.13 112.858 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 tp -106.54 -23.71 12.4 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.083 1.311 . . . . 75.32 111.324 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 12.5 m -69.79 110.1 4.76 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.005 -1.06 . . . . 72.01 108.352 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.44 10.54 53.58 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.649 1.595 . . . . 74.04 112.277 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -72.72 106.38 4.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.457 1.628 . . . . 71.23 107.627 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.93 124.93 27.11 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.349 -0.982 . . . . 63.4 108.349 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 m -141.31 144.37 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 118.983 0.811 . . . . 72.25 110.302 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 m 45.78 38.97 4.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.155 1.382 . . . . 54.04 113.384 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 64.79 20.91 12.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.558 1.143 . . . . 75.21 111.871 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.3 mmm-85 -135.6 -178.17 5.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.145 2.178 . . . . 73.34 108.257 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -133.07 155.31 49.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.867 1.267 . . . . 74.25 109.571 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -109.63 150.16 28.65 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.033 1.333 . . . . 74.51 107.514 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.18 112.76 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.335 -1.728 . . . . 74.31 106.335 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.56 141.73 14.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.072 -2.196 . . . . 74.35 105.072 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.57 142.51 45.33 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.269 -1.382 . . . . 74.03 107.269 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.11 114.0 21.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.457 -0.942 . . . . 74.21 108.457 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -74.05 148.22 42.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.192 -2.522 . . . . 75.11 104.192 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.06 1.744 . . . . 73.54 109.088 -178.868 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.171 0 N-CA-C 108.669 -1.772 . . . . 72.11 108.669 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.8 t -140.07 139.67 21.91 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 105.572 -2.01 . . . . 65.43 105.572 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -81.61 -179.26 4.76 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.51 2.14 . . . . 74.0 109.233 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.27 173.24 11.82 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.656 2.382 . . . . 54.32 106.699 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -145.39 161.0 40.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.196 0.998 . . . . 73.33 108.415 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.1 pp -134.31 167.39 20.8 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 124.636 1.175 . . . . 75.21 109.709 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -159.58 178.54 9.76 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.92 1.688 . . . . 73.14 108.179 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -149.27 166.65 28.28 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.238 1.415 . . . . 75.11 108.096 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -139.76 169.74 17.17 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.593 1.157 . . . . 74.22 109.476 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -154.39 144.25 21.73 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 124.788 1.235 . . . . 71.41 107.716 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -76.59 116.42 17.26 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.1 -1.815 . . . . 65.52 106.1 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.27 166.01 23.74 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.22 -0.659 . . . . 72.23 109.22 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.53 104.96 5.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.367 1.467 . . . . 74.12 107.182 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -113.66 171.27 7.68 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.16 1.384 . . . . 74.2 107.915 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 81.2 mt -131.99 136.09 57.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.558 -2.016 . . . . 73.21 105.558 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -157.27 120.48 4.06 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.289 -1.375 . . . . 74.34 107.289 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.57 171.34 2.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.591 1.156 . . . . 74.23 109.919 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -128.23 -38.22 1.8 Allowed 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 121.748 -0.595 . . . . 73.33 110.115 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 56.78 12.1 1.07 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.139 1.375 . . . . 71.21 111.826 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -66.0 158.8 74.41 Favored Pre-proline 0 N--CA 1.455 -0.197 0 C-N-CA 128.649 2.78 . . . . 74.24 113.026 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.4 148.98 34.49 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.239 1.96 . . . . 74.33 109.207 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.09 119.46 9.55 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.982 0.913 . . . . 72.31 108.94 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 t -100.34 164.33 11.98 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 123.367 1.556 . . . . 73.15 111.183 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -73.53 -30.33 63.02 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.755 2.422 . . . . 74.24 111.128 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.13 -29.74 67.85 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 118.825 -0.607 . . . . 75.32 111.601 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.14 -34.26 77.2 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.684 -0.858 . . . . 65.31 108.684 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.47 -40.17 96.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.437 1.095 . . . . 75.22 111.29 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.26 -38.24 88.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.069 0.849 . . . . 64.14 110.202 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.46 68.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.631 0.773 . . . . 54.2 110.964 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.4 mtp -65.42 -41.56 93.45 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 118.908 -0.568 . . . . 72.52 110.261 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -65.1 155.71 83.23 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 112.983 0.734 . . . . 73.1 112.983 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.73 159.86 34.79 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.077 1.851 . . . . 75.33 109.33 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.48 161.97 25.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.363 -1.289 . . . . 73.21 110.631 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.79 17.89 60.84 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.76 -0.587 . . . . 44.25 113.693 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -125.16 157.68 35.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.298 1.439 . . . . 73.13 108.896 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -127.07 143.82 51.18 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.445 1.498 . . . . 75.42 109.305 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 63.1 t -71.08 141.06 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.675 -0.861 . . . . 71.32 108.675 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 28.7 tp -117.17 84.05 16.49 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.096 1.358 . . . . 72.31 107.547 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.12 166.04 24.47 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.185 1.924 . . . . 74.42 110.041 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.21 171.84 2.12 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.615 2.877 . . . . 73.4 113.413 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.48 118.94 5.42 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.621 2.881 . . . . 75.54 110.369 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -64.05 150.71 44.79 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.816 -0.552 . . . . 61.1 110.499 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 71.54 0.56 39.95 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 117.615 -1.659 . . . . 61.42 115.366 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -61.05 143.26 55.72 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.513 1.656 . . . . 75.15 110.277 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 95.6 t -137.24 80.14 35.1 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 107.727 -1.212 . . . . 71.41 107.727 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.05 137.86 29.88 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.528 2.152 . . . . 74.31 110.199 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 25.5 mt . . . . . 0 C--O 1.249 1.062 0 N-CA-C 106.785 -1.561 . . . . 74.21 106.785 179.139 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.978 0 N-CA-C 109.917 -1.273 . . . . 41.11 109.917 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -65.14 102.14 0.61 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.638 -1.616 . . . . 71.2 106.638 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.21 175.1 13.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.898 1.279 . . . . 71.03 109.658 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -65.21 127.81 33.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.771 0.828 . . . . 72.31 110.122 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 8.1 tt -136.79 116.85 16.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.835 0.854 . . . . 74.21 110.125 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -121.16 172.0 8.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.595 1.958 . . . . 65.23 106.973 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 19.6 tp 48.22 65.64 6.77 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.684 1.194 . . . . 65.1 110.155 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.07 158.44 55.13 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.751 1.634 . . . . 75.51 112.061 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.68 -15.69 41.32 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.487 2.792 . . . . 75.2 113.415 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.71 -16.52 64.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.03 0.932 . . . . 74.23 111.914 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.38 133.91 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.432 0.693 . . . . 71.14 109.447 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -140.58 159.21 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.263 -1.754 . . . . 73.4 106.263 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -56.24 -32.11 64.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.597 1.959 . . . . 73.34 111.917 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 53.4 mt -75.13 123.67 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 72.0 107.306 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 mt -120.15 126.53 50.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.733 2.013 . . . . 74.15 108.204 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.11 134.36 39.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.225 1.41 . . . . 74.42 108.917 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.2 mm -124.16 154.86 31.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.871 0.868 . . . . 75.31 109.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -135.01 163.52 29.69 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.833 2.053 . . . . 75.25 108.992 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 66.7 15.32 10.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.766 1.626 . . . . 64.34 113.545 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.01 152.17 92.82 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 107.571 -1.27 . . . . 74.02 107.571 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.23 160.06 46.83 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.588 1.525 . . . . 51.12 110.807 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -78.32 -20.95 50.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.893 0.877 . . . . 71.23 112.499 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.76 120.89 24.45 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.075 1.35 . . . . 73.32 107.553 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 tt -158.48 163.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.872 1.269 . . . . 75.13 108.201 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -117.43 168.23 10.55 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.916 1.286 . . . . 73.23 111.046 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.92 76.76 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.621 -0.704 . . . . 64.24 109.762 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -53.62 -51.33 63.42 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.531 1.133 . . . . 73.34 109.273 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.52 -39.62 94.12 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.335 0.654 . . . . 72.53 111.608 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.1 -45.04 82.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.859 -0.591 . . . . 74.11 110.101 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -71.52 -27.41 63.18 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.844 0.747 . . . . 75.53 109.585 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.59 -35.33 77.21 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.626 -1.296 . . . . 74.25 109.291 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.37 -72.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.76 1.224 . . . . 72.44 111.822 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.11 -34.51 73.6 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.14 0.976 . . . . 75.05 110.701 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.43 -6.69 88.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.972 -0.349 . . . . 72.44 112.269 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -64.21 -48.18 76.88 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.235 1.517 . . . . 54.15 108.531 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -62.32 -40.07 95.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.769 1.628 . . . . 72.43 112.342 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.58 37.73 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.07 0.843 . . . . 74.21 111.525 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.46 165.15 25.94 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.1 2.534 . . . . 74.45 111.434 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 mt -126.47 137.26 58.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.582 -1.266 . . . . 74.41 107.582 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -76.89 -56.18 4.82 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.409 -0.807 . . . . 71.41 110.273 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -163.28 153.39 15.72 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.189 -1.041 . . . . 73.51 108.189 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 49.7 mt -131.59 147.63 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.628 1.171 . . . . 74.11 108.537 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -142.91 141.83 31.58 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.772 -1.566 . . . . 73.51 106.772 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.14 155.88 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.848 0.859 . . . . 74.43 109.735 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.47 145.81 49.66 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.796 -1.321 . . . . 70.32 109.796 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.33 1.32 8.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.758 1.223 . . . . 74.25 112.535 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 60.6 p -124.71 162.35 43.41 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.433 1.493 . . . . 75.41 109.33 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -64.02 2.63 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.483 3.455 . . . . 74.12 114.258 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -116.74 -19.4 9.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.05 1.34 . . . . 72.53 111.883 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 42.5 p -104.96 -19.69 13.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.015 0.926 . . . . 71.31 109.384 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -64.15 138.19 58.33 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.038 -1.664 . . . . 75.04 107.02 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -20.22 44.35 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.32 0.962 . . . . 74.41 111.207 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 37.4 p -120.07 158.95 25.77 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 106.964 -1.495 . . . . 74.31 106.964 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.8 175.09 11.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.784 -1.198 . . . . 71.33 109.413 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -135.04 141.44 46.14 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.293 -1.003 . . . . 73.11 108.293 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.8 147.56 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.55 -2.018 . . . . 70.45 105.55 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 t -127.06 140.09 50.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.838 -1.541 . . . . 75.23 106.838 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -109.77 166.38 10.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.595 1.558 . . . . 70.34 110.469 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.97 -55.11 7.01 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.151 0.98 . . . . 70.35 110.551 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -112.32 177.56 4.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.361 1.065 . . . . 73.05 108.644 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -94.74 -24.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.067 -1.021 . . . . 73.54 110.178 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.57 -54.83 22.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.317 -0.864 . . . . 62.45 111.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -67.05 -35.69 80.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.149 0.979 . . . . 65.25 110.218 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.57 -49.33 77.08 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.956 -0.757 . . . . 74.51 108.956 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -61.45 -45.09 95.75 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.526 0.73 . . . . 72.33 109.676 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -55.93 -52.27 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.608 -0.516 . . . . 72.44 109.608 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.81 73.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.491 -0.766 . . . . 72.15 112.599 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.42 -49.58 77.02 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.57 1.077 . . . . 72.31 109.785 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -71.73 -44.62 63.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.18 -0.914 . . . . 61.23 111.297 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -60.33 -30.16 69.34 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.784 0.72 . . . . 73.44 112.854 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 23.0 tp -90.85 -29.12 17.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.262 0.483 . . . . 72.2 112.18 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 90.2 p -64.58 118.65 9.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.584 -0.895 . . . . 64.13 108.584 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.84 63.73 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.739 -1.034 . . . . 63.52 113.094 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -77.32 110.23 11.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.713 1.756 . . . . 75.31 106.359 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.94 121.92 15.77 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.098 1.359 . . . . 70.32 111.025 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.0 137.74 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.339 -0.985 . . . . 73.23 108.339 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 35.1 m 38.77 38.84 0.3 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.375 1.87 . . . . 73.44 113.596 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.13 42.54 25.54 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.322 1.449 . . . . 73.23 111.137 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -143.35 171.22 14.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.164 2.586 . . . . 74.54 107.633 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -133.19 137.08 46.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.975 1.31 . . . . 75.45 109.187 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -98.08 115.59 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.634 2.374 . . . . 70.51 110.151 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 97.8 t -84.34 129.61 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.148 -1.797 . . . . 73.02 106.148 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 84.3 t -111.26 137.06 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.738 2.015 . . . . 74.13 106.376 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -154.48 143.81 21.3 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.819 1.247 . . . . 75.53 109.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -74.36 155.75 37.81 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.527 -0.733 . . . . 74.45 110.941 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -78.23 170.2 17.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 106.905 -1.517 . . . . 75.53 106.905 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 123.985 0.914 . . . . 73.54 109.364 179.365 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.912 0 N-CA-C 107.188 -2.365 . . . . 73.53 107.188 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.3 m -135.74 109.76 10.15 Favored Pre-proline 0 N--CA 1.451 -0.415 0 N-CA-C 104.558 -2.386 . . . . 73.13 104.558 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.1 168.34 24.99 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.851 1.701 . . . . 75.14 110.145 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.39 -164.33 1.37 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.481 2.313 . . . . 72.44 108.828 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -133.8 113.24 12.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 103.857 -2.646 . . . . 75.21 103.857 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.6 157.8 25.91 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.744 0.818 . . . . 74.43 109.736 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.09 153.89 41.21 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.298 1.039 . . . . 70.31 109.549 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -86.21 148.6 25.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.468 0.707 . . . . 74.43 109.703 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -129.02 -14.08 4.46 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.948 0.899 . . . . 74.42 112.681 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -83.17 67.96 9.39 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.578 -1.267 . . . . 74.22 107.578 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -79.88 -61.52 1.97 Allowed 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.096 -1.076 . . . . 75.32 108.096 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -65.82 134.44 53.09 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.315 -0.624 . . . . 74.32 109.315 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -171.24 77.85 0.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.032 2.133 . . . . 70.54 107.658 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.65 128.21 35.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 104.838 -2.282 . . . . 74.14 104.838 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 42.8 pt -138.6 165.53 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 118.982 0.81 . . . . 74.4 110.658 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -134.36 164.6 27.06 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.327 1.851 . . . . 74.55 107.512 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.2 -73.81 0.17 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.601 -1.259 . . . . 70.44 107.601 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -171.08 91.97 0.15 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.961 0.904 . . . . 73.54 108.897 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -128.11 125.69 39.68 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.924 1.238 . . . . 74.34 110.203 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -169.4 159.2 7.35 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 126.562 1.945 . . . . 74.34 108.506 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.48 -177.33 2.06 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.545 2.163 . . . . 64.04 109.233 177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 76.0 mt -144.67 144.43 31.24 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.99 0.916 . . . . 74.11 108.573 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 18.7 t -111.91 169.51 8.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.76 1.224 . . . . 63.53 109.006 178.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.54 -30.05 68.75 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.306 -0.627 . . . . 64.11 109.306 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -79.58 -35.16 40.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.135 1.374 . . . . 73.51 110.249 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -63.7 -24.07 67.63 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.068 0.547 . . . . 70.2 111.414 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 51.9 tp -58.84 -43.14 90.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.237 -1.023 . . . . 75.01 108.237 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.47 -33.47 75.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.446 0.698 . . . . 74.03 110.79 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.98 -2.99 33.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.333 1.053 . . . . 74.21 112.288 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.6 mtp -100.07 7.21 44.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.723 1.209 . . . . 74.24 111.906 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -110.82 148.77 39.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 75.34 110.107 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.04 166.46 29.56 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.152 3.235 . . . . 65.31 113.581 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.16 159.38 22.05 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.49 1.516 . . . . 72.12 110.512 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.35 17.4 39.8 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.243 1.878 . . . . 63.15 113.729 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.75 157.81 43.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.354 2.262 . . . . 74.0 106.267 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.8 144.61 49.61 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.785 0.834 . . . . 74.44 109.122 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.9 t -70.03 143.99 14.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.997 -1.112 . . . . 75.51 107.997 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 47.1 tp -135.53 80.79 43.96 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.101 -1.444 . . . . 73.2 107.101 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.08 171.08 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.376 3.384 . . . . 72.04 112.814 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.17 162.21 3.06 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.105 3.203 . . . . 64.14 112.847 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -46.3 133.95 15.66 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.575 2.85 . . . . 74.43 112.984 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -64.59 -36.84 85.53 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.32 -0.993 . . . . 72.41 108.32 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -87.01 24.38 9.15 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.382 1.944 . . . . 65.41 112.958 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -69.33 134.56 49.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.558 1.179 . . . . 72.55 108.932 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.76 95.74 22.2 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 106.735 -1.58 . . . . 72.15 106.735 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.53 81.6 2.47 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.654 2.903 . . . . 75.51 111.556 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.247 0.962 0 N-CA-C 104.754 -2.313 . . . . 65.35 104.754 178.248 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 110.047 -1.221 . . . . 74.42 110.047 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -109.77 -51.95 2.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.934 1.293 . . . . 74.15 107.736 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.57 123.29 16.94 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.097 -1.446 . . . . 74.32 107.097 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -149.68 136.35 19.34 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.908 0.777 . . . . 74.01 109.713 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.17 139.14 52.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 124.55 1.14 . . . . 75.23 108.244 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 26.99 2.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.201 2.2 . . . . 75.3 108.835 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.75 64.78 15.73 Favored Pre-proline 0 C--O 1.239 0.544 0 O-C-N 121.009 -1.057 . . . . 73.52 109.72 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.07 167.46 24.79 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.304 2.669 . . . . 74.03 112.363 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.4 -18.99 25.76 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.639 2.226 . . . . 74.43 112.918 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -66.94 -15.23 63.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.302 1.041 . . . . 74.54 112.476 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.99 122.74 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.673 1.124 . . . . 70.4 108.454 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -137.53 155.03 49.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.733 1.613 . . . . 74.51 106.95 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -26.19 68.56 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.745 -0.597 . . . . 73.15 112.093 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.92 115.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.597 -1.26 . . . . 73.44 107.597 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 59.6 mt -109.03 159.31 16.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.53 1.132 . . . . 72.3 109.291 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -127.88 135.39 49.95 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.59 2.356 . . . . 62.1 106.635 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mm -120.95 153.19 24.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.27 1.828 . . . . 71.14 110.191 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -142.71 163.96 31.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.639 1.976 . . . . 65.44 111.549 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 63.58 24.87 14.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.954 2.502 . . . . 75.42 114.708 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 71.9 mt -75.44 156.77 85.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.305 -0.872 . . . . 72.22 111.685 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.56 138.81 46.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 N-CA-C 106.521 -2.146 . . . . 74.23 106.521 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -71.13 -10.89 60.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.308 1.043 . . . . 73.42 112.269 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -126.47 108.8 11.52 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.195 1.798 . . . . 72.22 107.289 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -156.98 137.43 4.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.758 -0.83 . . . . 75.24 108.758 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -86.45 163.73 17.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.573 1.149 . . . . 64.1 110.481 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.16 -32.55 73.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 45.51 110.021 179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.48 -32.58 74.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.622 1.169 . . . . 62.31 110.915 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.53 -45.76 43.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.552 -1.277 . . . . 73.22 107.552 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.4 mmm -55.44 -53.38 56.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.521 0.728 . . . . 64.52 110.168 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -71.66 -10.36 59.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.372 0.879 . . . . 74.51 113.372 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.43 -60.27 1.99 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.018 -1.104 . . . . 72.22 108.018 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.99 -54.81 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.324 1.85 . . . . 74.14 109.874 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -78.56 -16.47 57.4 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.601 0.593 . . . . 72.11 112.601 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.01 -27.2 74.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.266 0.936 . . . . 75.23 112.735 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -14.17 11.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.707 1.253 . . . . 75.54 113.157 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -107.72 -5.13 17.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.705 1.202 . . . . 75.22 113.831 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.93 -174.1 21.27 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.864 1.211 . . . . 74.15 112.874 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.2 138.99 40.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.986 3.124 . . . . 42.4 111.525 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 39.0 mt -101.4 122.3 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.756 1.622 . . . . 75.41 109.725 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -69.61 -47.99 61.58 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.529 -0.732 . . . . 73.32 112.404 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -165.48 159.87 17.28 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.457 1.026 . . . . 64.42 110.635 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 mt -144.32 135.83 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.78 2.032 . . . . 74.23 109.654 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.16 126.24 26.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 102.847 -3.019 . . . . 75.5 102.847 178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 m -112.64 142.28 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.115 0.566 . . . . 74.34 110.581 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.1 46.89 Favored Glycine 0 C--O 1.241 0.591 0 C-N-CA 124.339 0.971 . . . . 72.11 111.282 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -118.39 -30.46 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.765 0.783 . . . . 65.3 111.806 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -74.14 158.08 86.02 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.695 -1.224 . . . . 74.01 107.695 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.31 -27.44 63.6 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.814 1.676 . . . . 73.41 110.099 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -17.61 63.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.824 1.25 . . . . 64.1 111.667 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 69.3 p -107.47 0.38 22.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.518 1.127 . . . . 74.43 111.928 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -56.14 127.95 33.14 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 120.148 -1.595 . . . . 72.13 108.793 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.17 89.31 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.847 -1.53 . . . . 71.03 114.348 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -121.18 152.44 38.79 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 120.343 2.071 . . . . 50.33 109.336 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.28 174.99 12.08 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.401 1.08 . . . . 64.03 109.274 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -132.25 134.63 45.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.004 -1.48 . . . . 71.31 107.004 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.2 142.62 43.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.634 -1.247 . . . . 74.33 107.634 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 t -122.53 147.25 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.42 -1.326 . . . . 72.4 107.42 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -120.91 166.38 13.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.763 1.625 . . . . 71.22 107.828 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.76 -68.6 0.36 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 113.039 0.755 . . . . 73.31 113.039 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -106.25 148.19 28.24 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.247 1.023 . . . . 65.21 110.862 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.67 -31.85 45.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.275 -0.875 . . . . 74.24 109.301 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -64.48 -30.7 71.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.924 1.29 . . . . 62.52 112.37 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.14 -60.46 2.27 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.235 -1.394 . . . . 75.25 107.235 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.34 67.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 64.12 113.898 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -60.25 3.78 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.256 0.934 . . . . 73.33 110.039 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -73.41 -39.61 64.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.999 -0.68 . . . . 64.24 110.314 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.76 -33.73 64.58 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.441 -0.79 . . . . 71.43 112.692 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.26 -52.99 62.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.27 -1.011 . . . . 73.42 108.27 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.83 -38.99 93.14 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.0 0.52 . . . . 73.12 110.81 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -18.5 60.57 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 117.492 -1.242 . . . . 74.32 112.22 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.82 -32.86 11.49 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.368 1.44 . . . . 63.04 111.716 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -63.26 152.27 38.16 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.916 -1.513 . . . . 50.33 106.916 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.49 9.57 44.5 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 119.166 -0.797 . . . . 71.45 113.624 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -74.06 125.23 27.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.132 -1.803 . . . . 74.13 106.132 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -80.86 116.67 20.96 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.738 1.615 . . . . 72.24 110.49 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.45 141.9 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 123.473 0.709 . . . . 71.31 109.829 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 62.9 m 24.47 58.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.115 2.566 . . . . 63.14 115.666 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 m120 56.18 27.51 11.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.369 1.468 . . . . 73.14 113.963 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -131.87 167.91 18.76 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.203 2.601 . . . . 72.31 109.353 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -138.74 104.26 5.05 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.749 -1.575 . . . . 74.53 106.749 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -69.31 161.06 30.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.066 1.347 . . . . 75.55 110.023 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -133.17 122.65 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.354 1.061 . . . . 71.42 108.618 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 t -98.35 136.22 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.434 1.093 . . . . 75.24 109.268 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -148.86 153.72 38.46 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.435 1.094 . . . . 73.21 109.343 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.93 147.1 23.92 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.27 1.028 . . . . 74.52 110.407 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -76.59 121.47 23.24 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 105.819 -1.919 . . . . 70.1 105.819 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.2 -0.905 . . . . 72.24 109.112 179.639 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.999 0 N-CA-C 108.324 -1.91 . . . . 73.04 108.324 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 5.9 m -88.95 114.38 59.86 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 117.574 -1.203 . . . . 75.22 108.096 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -80.32 -178.44 4.48 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.529 2.152 . . . . 72.41 109.308 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.92 135.34 31.16 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 103.133 -2.914 . . . . 73.02 103.133 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -147.62 61.08 1.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.443 1.497 . . . . 74.43 109.424 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 65.8 tp -43.58 116.5 0.96 Allowed 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.826 2.05 . . . . 75.33 111.994 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -151.32 162.98 39.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.332 1.453 . . . . 74.22 108.362 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -156.34 171.34 20.4 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.997 0.919 . . . . 75.22 109.641 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -127.79 163.39 24.47 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.524 1.53 . . . . 74.53 107.972 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.42 114.87 26.96 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 117.535 -1.221 . . . . 75.34 110.097 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -75.74 116.28 16.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 100.721 -3.807 . . . . 74.1 100.721 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.47 -154.97 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.362 1.465 . . . . 70.32 112.183 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -137.9 148.05 44.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.758 1.623 . . . . 74.13 107.288 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -74.15 144.09 45.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.89 -1.152 . . . . 73.3 107.89 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 11.3 mt -131.67 134.64 60.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.612 -1.625 . . . . 71.22 106.612 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.52 172.44 12.97 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.026 1.73 . . . . 63.34 111.717 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.94 163.95 29.08 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.2 -1.407 . . . . 73.33 107.2 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -123.22 85.66 2.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.514 -1.662 . . . . 72.02 106.514 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -131.76 131.52 43.05 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.658 0.783 . . . . 75.14 109.831 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -99.61 162.19 22.0 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 123.873 0.869 . . . . 75.03 109.91 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.75 155.73 67.7 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 N-CA-C 106.342 -2.215 . . . . 54.32 106.342 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 15.8 mt -109.92 -70.95 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.654 -1.98 . . . . 73.24 105.654 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 29.4 t -105.97 -168.7 1.47 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 103.91 -2.626 . . . . 73.44 103.91 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.95 -11.71 59.77 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.53 -1.356 . . . . 71.43 109.539 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -66.71 -59.34 3.66 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 126.925 2.09 . . . . 75.1 109.817 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -64.7 -39.04 92.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.763 -1.199 . . . . 73.2 107.763 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.06 -45.81 91.61 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 119.185 -0.436 . . . . 62.0 110.184 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.15 -45.58 92.58 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 123.343 0.657 . . . . 74.25 109.75 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.23 79.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.424 0.69 . . . . 74.44 111.904 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 85.2 mtp -71.73 -7.48 48.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.169 0.988 . . . . 72.34 111.1 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -107.46 143.26 26.85 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.219 0.918 . . . . 74.13 109.069 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.93 164.35 35.94 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.323 2.682 . . . . 74.03 114.035 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -70.02 161.14 30.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.836 2.054 . . . . 73.32 110.278 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 75.62 17.69 80.03 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.132 -0.98 . . . . 74.04 115.273 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -125.1 156.96 37.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 105.639 -1.985 . . . . 74.21 105.639 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -137.44 154.42 49.94 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.128 -0.693 . . . . 74.25 109.128 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.03 142.15 16.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.405 1.082 . . . . 73.45 110.625 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.45 83.42 66.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 106.171 -1.789 . . . . 72.22 106.171 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -67.96 171.97 11.55 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.34 2.026 . . . . 72.34 110.643 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.03 163.66 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.424 2.083 . . . . 63.5 110.834 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.75 176.02 9.96 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.399 2.066 . . . . 61.44 108.9 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -93.47 174.66 7.08 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.271 -1.381 . . . . 74.45 107.271 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 59.77 29.9 68.24 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.3 -0.722 . . . . 62.25 112.449 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -101.93 158.27 16.26 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.048 -1.464 . . . . 75.53 107.048 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.1 t -116.45 80.57 10.23 Favored Pre-proline 0 C--O 1.233 0.218 0 O-C-N 121.712 -0.618 . . . . 73.2 110.002 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.09 173.78 8.91 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 N-CA-C 107.7 -1.692 . . . . 54.41 107.7 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--O 1.253 1.239 0 N-CA-C 102.894 -3.002 . . . . 74.32 102.894 179.39 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.512 0 N-CA-C 110.28 -1.128 . . . . 75.44 110.28 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -137.97 172.32 13.1 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.098 1.759 . . . . 72.14 109.241 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.97 -175.04 3.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.729 1.212 . . . . 61.13 109.162 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -132.62 151.53 51.92 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.964 1.706 . . . . 70.23 107.391 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -137.87 158.22 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.535 1.934 . . . . 75.44 106.706 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -92.87 -65.59 0.99 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 121.16 -0.963 . . . . 72.12 108.587 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.09 152.75 79.66 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 124.446 1.098 . . . . 75.11 109.705 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.37 161.46 43.09 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.122 3.215 . . . . 72.53 110.569 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.82 -48.3 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.75 2.3 . . . . 75.32 112.301 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -141.81 147.32 37.07 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.28 1.832 . . . . 72.12 108.436 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -148.31 151.18 13.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.541 1.137 . . . . 74.22 109.368 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.413 HD21 ' C ' ' B' ' 93' ' ' ASN . 27.7 t-20 -126.17 143.33 51.17 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.002 2.121 . . . . 62.41 108.693 179.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -60.34 -28.5 68.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.564 1.546 . . . . 74.53 111.149 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.4 mt -88.86 147.73 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.161 2.184 . . . . 75.32 108.513 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.51 155.34 39.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.445 1.498 . . . . 75.14 109.612 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -130.63 105.06 7.57 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.324 2.249 . . . . 73.44 107.215 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -83.88 149.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 126.527 1.931 . . . . 73.42 110.645 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -140.49 162.65 34.83 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.63 1.172 . . . . 65.51 109.379 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 68.32 24.97 7.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.248 2.219 . . . . 74.25 113.173 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -67.38 153.47 94.76 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 121.221 -0.924 . . . . 74.22 110.033 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.68 158.21 50.95 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.456 2.771 . . . . 72.32 109.965 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -73.1 -14.07 61.32 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.522 -0.736 . . . . 73.24 112.128 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -130.2 129.18 43.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.562 -1.273 . . . . 75.43 107.562 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -166.79 160.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.383 2.273 . . . . 74.5 106.048 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -122.13 177.21 5.43 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.651 1.18 . . . . 62.05 110.129 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.69 88.63 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.179 -0.674 . . . . 45.21 109.179 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.3 -46.39 86.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.409 1.483 . . . . 75.33 110.482 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.23 -41.33 99.09 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.896 0.771 . . . . 73.34 110.646 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.4 mmm -63.77 -55.95 19.25 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.711 -0.478 . . . . 75.14 109.711 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.52 -25.06 68.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.288 -0.863 . . . . 72.32 111.038 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.36 -57.82 4.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.406 1.003 . . . . 75.13 109.857 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.4 mt -60.27 -58.33 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 125.55 1.54 . . . . 74.31 110.434 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -65.16 -22.64 66.94 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.793 0.664 . . . . 73.44 112.793 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.68 79.87 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 118.481 0.582 . . . . 71.54 113.927 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -69.24 -9.09 51.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.06 0.93 . . . . 74.21 111.306 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -104.72 -7.31 19.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.374 1.07 . . . . 73.32 111.14 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.12 -174.29 21.23 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.137 1.827 . . . . 70.01 111.396 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.99 169.25 9.29 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.091 2.528 . . . . 64.41 109.764 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.58 145.06 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 O-C-N 120.887 -1.133 . . . . 74.41 109.286 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -78.71 -63.44 1.41 Allowed 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.392 -1.336 . . . . 72.01 107.392 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -160.14 165.93 30.73 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.129 0.972 . . . . 74.21 109.257 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.38 146.44 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.479 1.512 . . . . 74.24 107.484 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -137.22 126.98 25.48 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 104.319 -2.474 . . . . 73.23 104.319 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.04 164.53 17.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 123.377 0.671 . . . . 75.21 109.471 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.45 146.19 44.08 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.174 -1.171 . . . . 71.15 110.174 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -124.46 -58.99 1.49 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.951 -1.129 . . . . 71.15 107.951 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.37 161.05 61.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.305 0.642 . . . . 74.13 109.285 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.58 -9.34 23.94 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.786 2.324 . . . . 75.01 115.121 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.21 -11.51 16.51 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.347 0.976 . . . . 74.11 112.584 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -99.39 -11.42 21.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.596 0.635 . . . . 73.51 111.318 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -69.06 152.84 44.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.457 -0.942 . . . . 74.44 108.457 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.22 -20.23 50.84 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.684 1.135 . . . . 73.4 112.241 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 50.4 p -133.32 165.45 24.8 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.852 -1.536 . . . . 63.45 106.852 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.07 175.57 10.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.741 -1.225 . . . . 73.51 111.545 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.17 146.44 50.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.855 0.752 . . . . 73.11 111.575 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -131.94 145.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.2 1.4 . . . . 62.54 107.803 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.39 136.57 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.436 -1.691 . . . . 73.51 106.436 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.98 166.32 13.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.634 -1.617 . . . . 73.54 106.634 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -78.34 -68.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.478 0.711 . . . . 72.34 110.059 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.84 144.16 30.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 74.12 112.969 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.42 -33.83 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.918 0.887 . . . . 74.3 109.933 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -67.17 -45.97 75.37 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.064 0.946 . . . . 75.24 110.621 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -57.74 -46.6 84.25 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.754 0.822 . . . . 73.41 109.71 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.36 83.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.392 -0.337 . . . . 64.34 111.054 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -67.37 -53.63 27.67 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.206 0.602 . . . . 62.14 110.929 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -59.77 -42.64 93.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.905 -0.569 . . . . 73.13 109.789 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.86 92.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.373 -0.602 . . . . 72.34 109.373 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 t -51.98 -53.34 42.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.771 0.828 . . . . 74.15 110.683 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -73.77 -14.53 61.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.849 1.055 . . . . 64.23 113.849 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -95.19 -21.36 18.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.626 1.103 . . . . 74.35 110.002 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 35.8 tp -99.78 -7.46 25.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.308 1.843 . . . . 71.4 111.468 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 32.4 p -57.96 117.01 3.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.978 1.311 . . . . 73.24 111.442 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.64 10.6 71.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.231 -1.316 . . . . 73.45 114.654 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -51.55 121.94 7.22 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.72 1.208 . . . . 75.43 112.875 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -83.57 118.1 23.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.8 2.04 . . . . 72.12 110.655 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.9 155.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.216 2.606 . . . . 75.42 105.642 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 m 49.67 21.74 0.69 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.388 1.475 . . . . 62.12 112.992 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 38.7 t30 59.24 55.55 4.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.166 2.186 . . . . 74.13 108.572 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -142.81 -167.75 2.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 128.152 2.581 . . . . 75.4 107.572 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -145.11 111.99 5.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.496 -2.409 . . . . 75.42 104.496 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.0 mt -77.32 172.77 12.78 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.919 -1.113 . . . . 64.32 108.96 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.81 146.94 31.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.427 -1.323 . . . . 74.22 107.427 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.92 115.61 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.217 1.407 . . . . 74.24 107.383 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.29 120.59 25.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.063 1.345 . . . . 74.21 107.715 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -55.68 145.27 24.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.645 0.657 . . . . 74.14 111.408 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.95 175.53 10.46 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.407 -0.59 . . . . 72.44 109.407 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . 0.413 ' C ' HD21 ' B' ' 18' ' ' ASN . 4.2 t-20 . . . . . 0 C--O 1.245 0.848 0 C-N-CA 125.643 1.577 . . . . 70.31 107.073 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.548 0 N-CA-C 109.596 -1.402 . . . . 64.24 109.596 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 29.7 m 62.71 81.53 0.23 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.146 1.378 . . . . 75.4 111.788 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.81 113.34 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.962 2.441 . . . . 75.42 106.785 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.17 125.65 24.5 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 119.682 1.128 . . . . 63.14 110.771 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -114.33 121.15 42.77 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 106.98 -1.489 . . . . 75.34 106.98 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 6.2 mp -123.26 76.88 1.43 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.789 1.235 . . . . 72.34 108.904 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -72.87 -55.81 6.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.485 0.714 . . . . 72.43 109.765 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -162.17 170.9 18.29 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.944 1.297 . . . . 63.12 109.483 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -143.38 166.61 24.28 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.074 1.75 . . . . 75.4 109.152 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -140.27 158.33 44.2 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.535 0.734 . . . . 70.32 110.417 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -155.98 153.49 29.62 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.51 1.124 . . . . 72.13 110.471 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -169.57 171.59 7.48 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.694 2.397 . . . . 74.43 107.644 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -142.53 166.59 24.25 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.209 1.404 . . . . 75.22 109.622 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -124.6 -160.74 0.96 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.677 1.591 . . . . 75.12 108.713 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 60.6 mt -107.13 151.11 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 127.079 2.152 . . . . 73.53 106.17 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -112.88 87.8 2.67 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.22 0.608 . . . . 72.43 110.44 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -154.15 161.56 41.78 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.929 0.891 . . . . 61.35 109.006 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -117.42 99.56 7.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.829 -1.545 . . . . 71.33 106.829 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -157.85 131.48 7.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 118.163 0.438 . . . . 65.5 110.168 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 59.47 167.13 0.08 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.139 1.775 . . . . 72.4 113.031 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.83 121.96 6.12 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 N-CA-C 106.269 -2.243 . . . . 61.5 106.269 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 18.5 mt -119.48 -179.18 3.79 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.564 -1.272 . . . . 75.25 107.564 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 16.5 m -127.85 -92.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.423 -0.584 . . . . 72.42 109.423 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -65.53 -24.56 67.14 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 126.104 1.761 . . . . 74.41 112.046 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -79.1 -39.88 32.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.807 -0.812 . . . . 74.33 108.807 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.37 -27.36 68.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.641 0.776 . . . . 74.21 109.783 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.21 -37.89 89.02 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.048 0.939 . . . . 74.51 110.744 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -67.17 -46.86 72.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.022 0.828 . . . . 64.13 109.189 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.52 -6.89 5.71 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.106 1.15 . . . . 72.21 114.106 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 95.8 mtp -100.51 -0.03 38.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.889 1.276 . . . . 72.22 110.123 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.25 155.94 43.79 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.327 1.451 . . . . 71.41 111.542 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.29 163.27 36.79 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.235 2.623 . . . . 50.41 111.243 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.13 164.87 19.37 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.735 0.814 . . . . 74.44 110.291 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 76.58 21.66 74.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.506 -1.163 . . . . 71.1 114.587 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -124.21 158.35 32.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.641 1.721 . . . . 74.53 108.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -135.46 153.28 51.81 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.659 1.184 . . . . 73.14 109.074 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.38 146.7 11.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 123.521 0.728 . . . . 75.34 109.416 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 37.8 tp -132.92 82.55 54.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.21 -1.404 . . . . 71.02 107.21 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.72 165.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.06 2.507 . . . . 73.23 111.656 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -69.45 160.23 50.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.045 1.83 . . . . 71.23 111.229 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.44 177.46 8.78 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 125.226 3.951 . . . . 73.42 114.488 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -87.31 164.41 16.29 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.915 -1.142 . . . . 72.45 107.915 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 39.29 64.57 0.95 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.236 1.874 . . . . 73.21 113.89 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -133.25 164.8 26.28 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.852 1.261 . . . . 72.31 108.822 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 70.8 t -134.04 102.63 12.06 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 106.597 -1.631 . . . . 73.2 106.597 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.17 -18.16 18.58 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.24 2.627 . . . . 63.25 114.009 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.3 tp . . . . . 0 C--O 1.25 1.094 0 N-CA-C 106.352 -1.721 . . . . 75.13 106.352 179.46 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.559 0 N-CA-C 108.71 -1.756 . . . . 63.51 108.71 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 29.1 ptt-85 -144.39 176.93 9.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.659 1.73 . . . . 73.34 111.171 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.07 154.82 42.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.443 1.097 . . . . 61.44 109.839 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -83.07 128.76 34.77 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.143 1.777 . . . . 65.13 108.604 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 36.1 pt -105.93 172.32 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.796 -0.816 . . . . 74.31 108.796 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -155.18 159.55 40.21 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.687 -0.857 . . . . 72.51 108.687 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 24.17 72.72 0.32 Allowed Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 128.794 2.838 . . . . 74.25 114.528 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.05 162.82 40.8 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 121.943 1.762 . . . . 64.34 108.718 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.53 -34.57 7.21 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.816 1.678 . . . . 64.32 112.431 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -141.37 162.7 34.85 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.662 1.185 . . . . 73.42 109.727 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t -155.96 158.09 3.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 127.096 2.158 . . . . 74.44 105.859 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . 0.531 ' ND2' ' H ' ' B' ' 92' ' ' TYR . 0.0 OUTLIER -145.07 161.21 40.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.375 1.47 . . . . 74.13 108.16 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -80.79 -7.55 59.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.331 2.252 . . . . 74.41 116.032 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -103.29 121.59 54.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 120.488 1.494 . . . . 72.42 107.549 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 71.2 mt -110.19 142.39 41.8 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.282 1.033 . . . . 75.44 108.781 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.46 125.01 53.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.77 -2.307 . . . . 73.45 104.77 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.41 153.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.256 1.422 . . . . 73.43 108.408 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 65.1 mtt180 -145.92 163.44 35.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.363 1.865 . . . . 74.15 108.744 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 70.17 21.28 6.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.088 1.755 . . . . 71.05 112.752 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.0 mt -78.17 156.05 79.35 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 121.022 -1.049 . . . . 72.32 110.883 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.03 164.25 36.41 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.971 1.781 . . . . 72.14 111.354 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -93.66 -16.85 23.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 74.32 111.646 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -120.57 99.03 6.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 74.25 106.066 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.5 tt -163.32 174.11 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.988 2.115 . . . . 75.55 106.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -136.47 -170.05 2.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.03 1.332 . . . . 61.45 110.438 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.75 -40.75 65.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.678 -0.49 . . . . 72.43 109.678 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -49.04 -58.36 5.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.095 2.158 . . . . 63.02 110.926 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.42 -42.74 99.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.859 0.299 . . . . 72.35 110.913 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 92.7 mmm -67.57 -23.05 65.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 117.86 -1.067 . . . . 53.32 113.047 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -90.88 -38.17 13.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.744 1.156 . . . . 74.44 108.562 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.44 -52.09 36.51 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.96 1.304 . . . . 73.33 111.601 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.68 -61.47 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.626 0.771 . . . . 72.32 109.41 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -64.17 -19.97 65.68 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.778 0.288 . . . . 74.21 111.778 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.34 -16.62 75.54 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 125.025 1.298 . . . . 70.43 112.143 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -57.25 -32.98 67.11 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.329 1.064 . . . . 75.14 109.759 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -74.71 -60.44 2.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.194 0.998 . . . . 74.33 109.345 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.27 37.41 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.926 -1.27 . . . . 73.54 109.926 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.35 162.72 22.73 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.544 2.163 . . . . 73.34 109.978 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mt -126.51 138.52 54.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.537 -0.912 . . . . 72.14 108.537 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -68.53 -64.21 0.91 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.893 -0.78 . . . . 73.03 108.893 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -159.01 164.21 35.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.234 1.014 . . . . 74.12 108.94 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 95.3 mt -137.66 150.94 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.471 1.908 . . . . 65.21 107.796 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -146.17 148.28 32.38 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.657 1.983 . . . . 75.01 106.318 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.11 166.88 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.374 1.07 . . . . 74.2 110.707 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.37 146.22 40.4 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.168 -1.173 . . . . 71.45 110.168 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -122.92 -16.68 7.0 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.741 1.216 . . . . 71.31 112.157 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 18.8 p -95.0 159.02 33.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.443 -1.688 . . . . 73.32 106.443 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.32 -34.35 93.67 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.758 1.639 . . . . 64.21 111.696 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -72.42 -21.14 61.3 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.314 1.227 . . . . 73.31 114.314 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 34.6 p -92.62 -0.13 57.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.895 0.878 . . . . 74.32 111.25 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.77 140.74 57.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.357 -1.349 . . . . 72.01 107.357 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.83 -10.82 61.39 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.503 -1.72 . . . . 72.31 114.129 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 73.3 p -113.32 149.41 34.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.275 2.037 . . . . 73.55 109.329 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.8 175.67 12.84 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.902 -1.124 . . . . 75.35 109.569 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -136.27 150.04 48.75 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 122.86 0.464 . . . . 74.13 110.1 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -133.23 146.99 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.722 1.609 . . . . 75.34 106.96 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.9 t -127.43 140.66 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.544 -2.021 . . . . 72.25 105.544 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.95 163.63 24.08 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.873 1.269 . . . . 73.03 109.052 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -97.68 -53.5 3.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.952 1.301 . . . . 73.35 109.722 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.74 115.09 15.07 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.893 -1.151 . . . . 70.24 107.893 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 tt -71.52 -21.45 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.938 -1.134 . . . . 72.14 107.938 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.34 -50.31 47.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.826 1.65 . . . . 75.04 109.421 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.54 -42.37 91.99 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.479 -0.934 . . . . 73.22 108.479 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.66 -45.88 92.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.319 0.648 . . . . 74.34 110.671 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -57.5 -47.09 82.85 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.915 0.78 . . . . 74.52 111.267 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -66.19 -55.09 18.02 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.915 -0.772 . . . . 75.31 108.915 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -38.63 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.688 1.595 . . . . 74.13 113.933 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.08 -41.33 78.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.463 1.105 . . . . 72.31 110.234 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.51 -35.93 17.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.178 -0.305 . . . . 73.53 110.178 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.24 -31.71 69.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 74.25 111.213 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.57 -9.63 21.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.313 1.445 . . . . 74.24 112.785 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 31.3 t -73.92 108.47 6.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.889 -1.152 . . . . 63.03 107.889 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.12 12.41 60.16 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.589 -1.117 . . . . 72.43 112.815 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -68.01 121.66 16.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.618 1.209 . . . . 74.54 108.111 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -76.12 115.46 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.259 1.024 . . . . 61.34 110.391 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 m -140.38 137.78 36.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.766 1.226 . . . . 71.12 109.414 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.6 m 42.39 46.86 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.407 1.883 . . . . 71.51 113.426 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 66.56 10.06 7.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.139 2.176 . . . . 52.14 113.361 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -117.36 -179.37 3.7 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.621 2.368 . . . . 73.2 108.248 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -140.43 117.79 11.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.228 -1.027 . . . . 75.22 108.228 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.34 162.21 29.11 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.482 0.658 . . . . 70.22 110.52 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 94.4 t -128.97 159.41 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.475 1.91 . . . . 74.11 107.015 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 t -143.41 128.0 14.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.241 -1.392 . . . . 71.23 107.241 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.83 144.56 37.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.378 1.071 . . . . 75.21 109.782 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -68.87 163.43 24.34 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 75.12 109.588 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . 0.531 ' H ' ' ND2' ' B' ' 18' ' ' ASN . 23.3 t80 -87.81 147.15 25.28 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.312 -1.366 . . . . 74.44 107.312 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.254 1.321 0 N-CA-C 106.272 -1.751 . . . . 75.21 106.272 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.912 0 N-CA-C 106.036 -2.826 . . . . 63.33 106.036 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.69 163.99 43.59 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 107.682 -1.229 . . . . 73.44 107.682 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.56 -21.69 25.46 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.665 1.577 . . . . 70.43 110.485 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -123.75 172.59 8.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.859 2.064 . . . . 72.01 108.647 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -103.71 -4.79 23.26 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.622 1.169 . . . . 71.32 110.206 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.33 132.09 51.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.504 1.522 . . . . 72.33 108.246 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -156.18 161.88 40.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.986 0.914 . . . . 74.23 109.167 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -123.55 -4.24 8.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.386 1.074 . . . . 74.41 112.43 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -93.66 -177.27 4.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.308 1.043 . . . . 72.11 108.591 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -149.78 -166.93 2.68 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.973 1.309 . . . . 75.22 107.725 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -135.77 174.45 10.59 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 106.854 -1.536 . . . . 75.52 106.854 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -176.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 129.041 2.937 . . . . 64.03 112.791 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -140.24 172.17 13.12 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 120.978 -1.077 . . . . 73.21 113.581 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.64 178.82 4.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.621 -1.627 . . . . 74.11 107.856 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 61.0 mt -105.3 142.74 17.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 122.477 1.132 . . . . 73.33 110.658 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.24 127.81 33.93 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 128.381 2.672 . . . . 75.42 110.442 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -117.17 151.23 37.31 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 122.087 0.946 . . . . 75.3 109.703 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -64.55 108.47 1.68 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.523 1.529 . . . . 75.54 109.834 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -80.42 65.13 5.46 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.333 -1.729 . . . . 71.24 106.333 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -140.23 151.99 65.96 Favored Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 125.471 1.508 . . . . 75.44 110.464 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.68 119.05 6.04 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.191 1.928 . . . . 74.42 109.307 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.48 -73.66 0.17 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.217 -1.401 . . . . 75.22 107.217 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 6.2 t -157.09 -177.85 6.93 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.465 1.506 . . . . 70.03 107.513 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.14 -29.93 68.96 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.588 0.755 . . . . 74.15 111.789 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -62.55 -23.7 67.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.519 1.128 . . . . 73.2 112.469 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -92.19 -46.67 7.62 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.898 -1.519 . . . . 72.11 106.898 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 40.0 tp -57.45 -39.73 76.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.741 0.816 . . . . 75.35 110.292 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.82 -30.13 67.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.777 1.631 . . . . 64.22 111.872 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.8 34.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.584 1.154 . . . . 64.24 111.693 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 94.4 mtp -85.5 -20.18 30.08 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.146 -0.972 . . . . 73.01 110.098 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.1 158.55 39.2 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 124.167 0.987 . . . . 74.31 111.388 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.98 160.31 30.39 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.14 1.894 . . . . 72.2 110.192 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.38 158.95 24.47 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.072 0.939 . . . . 72.24 109.811 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.16 51.63 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.77 0.7 . . . . 64.4 112.36 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.05 156.27 38.46 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.518 1.527 . . . . 73.24 107.008 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -132.07 147.71 52.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.833 0.453 . . . . 74.43 111.007 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.531 1.132 . . . . 72.02 108.331 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.24 85.94 42.5 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 106.743 -1.577 . . . . 75.44 106.743 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.28 168.39 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.056 3.171 . . . . 74.22 112.33 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . 0.404 ' HA ' ' CE1' ' B' ' 36' ' ' TYR . 73.0 Cg_endo -67.91 168.25 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.355 2.703 . . . . 64.22 111.944 179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.2 146.91 37.26 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.076 2.517 . . . . 61.54 110.817 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -56.66 -3.32 0.1 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.472 2.309 . . . . 75.14 116.249 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -165.83 67.53 0.2 Allowed Glycine 0 CA--C 1.517 0.193 0 N-CA-C 106.839 -2.504 . . . . 51.23 106.839 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -84.42 113.83 21.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.338 0.655 . . . . 74.11 110.27 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.96 76.8 63.92 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 105.467 -2.049 . . . . 71.31 105.467 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.46 157.21 40.96 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.172 1.915 . . . . 55.44 109.842 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.262 0 N-CA-C 103.899 -2.63 . . . . 74.52 103.899 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 111.312 -0.715 . . . . 73.33 111.312 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -130.43 166.15 21.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.744 1.618 . . . . 74.2 107.755 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 42.05 75.91 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.742 1.617 . . . . 74.32 111.309 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -129.03 114.6 16.6 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.294 1.038 . . . . 73.41 109.177 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 22.5 pt -124.25 16.36 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.195 0.998 . . . . 74.51 112.286 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -46.33 148.41 0.93 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.116 0.966 . . . . 75.21 111.319 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 47.02 69.16 2.86 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 125.448 1.499 . . . . 72.45 109.571 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.15 165.28 22.37 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.505 2.137 . . . . 74.53 109.983 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.07 -27.25 65.52 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.133 1.889 . . . . 73.01 112.633 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -158.61 169.48 24.31 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.513 1.125 . . . . 75.51 108.859 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 94.6 t -152.47 140.32 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.031 -2.211 . . . . 73.24 105.031 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.19 160.05 32.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.256 1.023 . . . . 71.45 108.79 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -63.67 -24.3 67.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.859 1.663 . . . . 63.42 112.958 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.3 137.66 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.04 -1.467 . . . . 75.53 107.04 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 69.2 mt -127.79 157.23 40.97 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.838 2.055 . . . . 72.34 109.593 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -126.02 149.29 48.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.465 1.506 . . . . 65.2 107.12 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mm -136.68 154.72 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.825 -1.546 . . . . 75.21 106.825 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -135.13 163.77 29.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.479 1.512 . . . . 74.45 108.465 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 70.81 15.19 6.92 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.13 1.772 . . . . 73.21 111.068 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 45.0 mt -69.14 151.2 97.2 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 121.058 -1.026 . . . . 72.41 110.938 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.69 140.68 92.18 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.546 2.83 . . . . 72.21 112.412 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -75.63 -27.01 58.25 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.619 -0.675 . . . . 75.11 111.232 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.03 88.72 2.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.203 1.401 . . . . 72.12 107.877 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -134.7 154.58 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.773 -0.825 . . . . 73.11 108.773 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 43.6 p -114.88 176.17 5.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.833 2.053 . . . . 75.42 108.314 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.81 -38.36 90.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.706 -0.621 . . . . 73.41 111.315 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -49.38 -58.07 5.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.886 1.274 . . . . 73.01 113.582 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.95 -35.2 79.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.595 0.634 . . . . 64.23 111.511 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.9 mmm -68.17 -52.91 29.23 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.369 -0.832 . . . . 64.3 110.132 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . 0.404 ' CE1' ' HA ' ' A' ' 417' ' ' PRO . 39.3 m-85 -66.8 -25.92 66.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.953 -1.022 . . . . 75.03 111.824 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.63 -59.62 2.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.235 1.379 . . . . 74.35 109.938 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.67 -62.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.407 1.883 . . . . 74.54 111.486 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -63.36 -35.52 80.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.237 -0.585 . . . . 73.34 110.428 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.6 -29.7 67.37 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 123.726 0.679 . . . . 60.23 112.212 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -17.46 56.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.187 0.995 . . . . 73.34 111.566 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.66 -36.93 8.97 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.503 1.121 . . . . 74.41 111.768 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.54 -174.01 45.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 65.42 110.68 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.56 171.41 13.15 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.718 2.278 . . . . 71.32 112.052 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.0 mt -127.81 131.49 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.781 1.232 . . . . 75.12 108.288 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.38 -57.51 3.22 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.154 -1.054 . . . . 75.31 108.154 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -157.12 153.29 27.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.646 0.778 . . . . 72.11 109.944 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 42.1 mt -134.64 137.81 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.874 1.67 . . . . 74.42 107.185 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -137.8 129.19 27.91 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.951 -2.24 . . . . 75.15 104.951 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 18.7 m -110.9 154.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.217 1.407 . . . . 74.52 110.952 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.35 117.85 8.76 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.334 -1.506 . . . . 74.34 109.334 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -100.79 -38.14 8.4 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.135 0.974 . . . . 75.01 112.086 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -64.22 157.67 69.14 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.51 -0.922 . . . . 65.05 108.51 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.02 -14.67 46.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.486 1.457 . . . . 75.33 112.783 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -98.66 -11.09 22.38 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.389 -0.815 . . . . 72.12 112.355 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.1 p -103.02 -23.65 13.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.891 1.223 . . . . 72.12 112.187 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -51.11 131.07 27.23 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.051 -1.463 . . . . 75.04 107.051 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.45 -13.04 15.87 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.381 1.467 . . . . 70.14 110.902 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.1 p -134.01 166.68 22.17 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 118.595 1.197 . . . . 75.5 110.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.25 169.29 17.78 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.306 1.443 . . . . 74.52 107.807 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -119.84 147.72 44.34 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 74.34 108.489 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.55 140.35 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.515 -2.032 . . . . 70.33 105.515 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.1 130.79 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 102.481 -3.155 . . . . 75.24 102.481 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -99.49 161.28 13.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.051 -0.722 . . . . 74.11 109.051 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -76.37 -31.85 58.26 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.052 -0.659 . . . . 74.23 110.472 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -123.55 165.92 16.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.204 1.402 . . . . 71.43 110.682 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -76.37 -46.81 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 121.435 -0.79 . . . . 75.21 110.806 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -59.64 -38.31 81.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.986 0.914 . . . . 75.5 110.84 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -62.06 -42.13 98.87 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.946 -0.761 . . . . 74.01 108.946 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.33 -51.43 68.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.576 0.751 . . . . 75.41 109.753 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -55.82 -52.33 64.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.932 0.893 . . . . 75.24 110.825 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.84 -49.45 76.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.129 -0.693 . . . . 62.34 109.129 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.05 89.14 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 118.104 -0.95 . . . . 74.13 111.906 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 67.7 m -60.51 -53.82 52.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.575 1.08 . . . . 71.5 109.588 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.21 -42.99 99.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.167 -0.444 . . . . 70.5 112.026 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -69.26 -24.22 63.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.417 -0.802 . . . . 72.53 111.231 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.1 tp -98.27 -13.11 20.95 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.406 1.457 . . . . 72.02 113.262 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 127.2 31.87 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.718 -1.216 . . . . 71.01 107.718 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.49 75.74 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.274 -1.292 . . . . 72.34 113.031 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -68.54 111.99 5.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.382 1.591 . . . . 74.21 108.187 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -85.33 115.14 22.91 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.376 2.27 . . . . 75.2 110.445 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.9 144.55 20.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.074 -1.084 . . . . 63.01 108.074 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.7 m 40.48 49.81 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.026 1.73 . . . . 72.45 112.745 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 m120 63.0 18.54 10.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.48 2.312 . . . . 75.05 115.626 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -137.75 167.24 22.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 120.028 1.285 . . . . 73.4 109.988 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -112.28 127.15 55.9 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.288 1.035 . . . . 75.4 109.925 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.82 106.18 6.23 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.039 -1.097 . . . . 70.43 108.039 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.72 136.69 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.552 -0.907 . . . . 74.51 108.552 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.63 132.63 56.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.746 2.018 . . . . 72.5 108.866 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -154.65 130.25 9.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.494 1.043 . . . . 75.52 110.034 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -69.34 158.74 34.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.759 -0.588 . . . . 75.41 110.224 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -79.08 160.95 26.86 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 107.661 -1.237 . . . . 73.32 107.661 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 116.823 -1.561 . . . . 74.31 107.265 179.069 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.22 0 N-CA-C 108.358 -1.897 . . . . 73.22 108.358 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.5 t -128.5 128.19 23.59 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 105.684 -1.969 . . . . 73.24 105.684 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -83.32 -170.25 0.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.863 2.375 . . . . 55.21 108.492 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -125.12 174.69 7.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.512 1.925 . . . . 74.21 106.504 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -156.69 54.36 0.53 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.592 -0.521 . . . . 75.35 109.592 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.42 165.6 20.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.478 0.656 . . . . 75.31 109.354 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -152.93 169.08 23.73 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.162 0.985 . . . . 74.51 109.014 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -152.18 161.38 42.71 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.093 1.357 . . . . 73.24 107.695 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -125.44 172.88 9.29 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.845 0.858 . . . . 73.32 109.887 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -122.52 179.96 4.41 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.074 1.749 . . . . 74.21 108.728 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 60.4 t90 -147.84 160.49 42.7 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.927 1.691 . . . . 74.32 107.305 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.89 169.59 21.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.091 2.156 . . . . 74.44 107.167 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -143.18 158.14 43.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.968 0.907 . . . . 73.04 108.747 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -75.46 148.35 39.14 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 123.368 0.418 . . . . 75.23 111.559 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.76 123.44 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.553 -1.647 . . . . 72.11 106.553 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -77.16 175.99 9.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.493 1.117 . . . . 74.22 109.411 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.21 165.98 15.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.384 1.088 . . . . 72.23 112.746 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -156.12 165.07 37.49 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 128.844 2.857 . . . . 71.43 106.896 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -71.44 138.28 48.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.027 -1.101 . . . . 74.35 108.027 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -151.42 158.6 34.31 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 127.405 2.282 . . . . 63.52 107.657 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.91 167.0 28.47 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.897 1.732 . . . . 73.2 109.758 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.78 134.64 43.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.005 -1.109 . . . . 75.31 108.005 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.8 m -133.2 -174.24 3.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 129.3 3.04 . . . . 73.31 107.509 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.25 -15.93 63.48 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.289 -0.882 . . . . 74.14 109.69 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.86 -44.07 74.1 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 126.716 2.006 . . . . 73.42 110.071 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -71.6 -41.4 69.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.118 -1.068 . . . . 73.43 108.118 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 15.5 tp -61.1 -24.59 66.35 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.204 0.94 . . . . 74.43 110.415 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.23 -62.52 1.44 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.355 -1.35 . . . . 72.42 107.355 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -64.21 -1.68 1.73 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.083 2.153 . . . . 64.42 115.722 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 70.4 mtp -95.51 -10.08 30.69 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.849 -1.157 . . . . 75.35 111.501 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -106.01 148.3 36.31 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 118.808 0.731 . . . . 75.33 111.251 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.67 158.98 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.149 1.899 . . . . 75.3 107.719 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -73.86 165.45 25.1 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.708 0.766 . . . . 74.22 111.609 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.83 17.92 36.52 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.653 1.597 . . . . 74.42 111.228 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.58 139.52 53.52 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.758 1.223 . . . . 75.34 109.72 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.202 1.401 . . . . 74.21 109.424 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.62 151.09 9.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.518 1.151 . . . . 73.41 109.095 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 33.5 tp -116.51 76.02 7.03 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.358 1.463 . . . . 74.13 111.44 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.66 163.92 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.011 1.807 . . . . 71.22 108.773 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.8 166.37 30.16 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.226 1.95 . . . . 55.41 110.988 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.59 144.59 24.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.617 2.211 . . . . 54.14 111.116 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -52.2 -33.07 39.34 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.052 0.76 . . . . 75.02 113.052 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -116.76 35.94 3.97 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.343 -1.254 . . . . 63.41 112.269 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -63.98 154.33 34.44 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.087 1.943 . . . . 72.44 110.836 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 11.2 t -138.63 93.7 10.82 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.386 1.074 . . . . 73.1 110.245 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.01 -166.66 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.284 2.656 . . . . 73.21 110.129 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 C--O 1.245 0.822 0 N-CA-C 106.096 -1.816 . . . . 74.31 106.096 177.93 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.7 0 N-CA-C 108.198 -1.961 . . . . 65.42 108.198 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.52 84.05 2.08 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.281 -1.377 . . . . 70.22 107.281 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.22 58.9 3.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.01 0.924 . . . . 73.23 108.794 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -67.07 169.07 9.0 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.651 -0.655 . . . . 73.04 109.698 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 13.5 pt -123.12 32.76 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.187 0.995 . . . . 72.41 113.542 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -77.97 68.9 4.11 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.238 -1.539 . . . . 61.41 109.925 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 56.8 83.66 0.22 Allowed Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 127.596 2.358 . . . . 75.21 110.198 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.38 170.33 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.043 2.495 . . . . 63.31 112.88 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.8 -33.59 52.94 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.0 1.8 . . . . 74.21 111.127 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -67.8 8.92 0.32 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.98 2.512 . . . . 72.12 115.85 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 75.1 t -72.21 83.74 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 105.889 -1.893 . . . . 72.42 105.889 178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -67.18 141.93 57.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.971 -1.122 . . . . 75.11 107.971 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . 0.283 0.0 OUTLIER -57.8 -7.33 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 118.151 2.648 . . . . 75.11 118.151 -178.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 65.5 mt -101.87 128.11 54.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 105.602 -1.999 . . . . 63.15 105.602 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 mt -100.76 142.19 32.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.466 -1.309 . . . . 72.43 107.466 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.44 128.56 55.24 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.605 -2.368 . . . . 54.41 104.605 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 mm -118.74 136.53 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.968 -1.494 . . . . 75.44 106.968 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -125.93 163.68 22.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.597 1.559 . . . . 74.34 107.735 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 71.24 20.18 5.15 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.634 1.574 . . . . 54.24 112.078 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.13 153.82 93.85 Favored Pre-proline 0 C--O 1.237 0.445 0 O-C-N 121.4 -0.813 . . . . 74.24 110.593 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.89 159.23 52.64 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.74 2.96 . . . . 74.33 110.077 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -89.74 -19.11 25.16 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.112 0.565 . . . . 73.23 111.351 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -130.08 101.04 5.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.9 1.68 . . . . 64.02 108.348 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.51 155.67 6.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 127.431 2.293 . . . . 64.21 105.472 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -105.1 174.17 5.99 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.273 -0.892 . . . . 73.21 109.671 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.28 72.78 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.352 -0.981 . . . . 70.04 108.352 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -54.67 -35.46 63.57 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.404 1.482 . . . . 64.04 112.474 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -70.34 -42.75 71.45 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.911 1.232 . . . . 64.41 108.229 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.6 mmm -64.75 -45.07 87.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.605 -0.887 . . . . 74.43 108.605 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.83 -27.48 69.2 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 117.98 -1.01 . . . . 72.43 111.644 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.18 -65.26 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.233 0.924 . . . . 71.45 110.148 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mt -57.55 -53.37 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.673 1.189 . . . . 74.21 111.818 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -74.72 -17.01 60.72 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.697 -0.627 . . . . 73.43 111.647 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.4 -12.91 66.53 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 124.0 0.81 . . . . 44.32 113.096 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -58.09 -29.91 65.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.16 1.48 . . . . 65.52 110.495 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.63 -5.42 59.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.034 2.134 . . . . 70.14 114.525 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.65 -171.87 23.58 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 119.808 1.186 . . . . 72.45 111.702 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.29 163.77 28.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.38 2.054 . . . . 60.1 109.247 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mt -129.43 123.22 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.981 -1.075 . . . . 72.2 108.532 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -65.11 -67.07 0.47 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.454 -0.943 . . . . 74.04 108.454 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -156.89 160.64 39.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.932 0.787 . . . . 75.12 112.062 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -140.11 140.95 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.062 2.145 . . . . 73.31 106.258 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -132.59 120.06 21.31 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 103.272 -2.862 . . . . 63.01 103.272 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.98 146.12 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 119.26 0.936 . . . . 75.24 111.435 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.09 141.31 41.22 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.768 -2.133 . . . . 63.05 107.768 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 -9.94 4.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.195 0.998 . . . . 72.33 113.017 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 44.9 p -97.51 161.57 25.46 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.762 1.225 . . . . 75.22 108.478 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.33 5.76 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.85 3.033 . . . . 74.3 113.635 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -120.58 -9.74 9.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.148 1.379 . . . . 74.15 111.408 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -117.36 -25.58 6.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.569 1.148 . . . . 74.31 113.147 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -50.6 143.47 9.34 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.917 0.887 . . . . 73.44 112.134 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.0 85.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.096 -0.836 . . . . 61.24 111.273 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -138.05 150.27 46.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.941 1.37 . . . . 72.1 108.71 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.12 168.35 19.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.177 1.391 . . . . 75.24 107.82 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -120.85 155.53 33.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.367 -1.716 . . . . 71.14 106.367 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 t -125.52 124.47 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.31 -2.107 . . . . 73.42 105.31 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -110.55 123.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.026 -2.212 . . . . 75.11 105.026 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -98.09 166.46 11.41 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.377 -1.712 . . . . 72.13 106.377 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.78 -42.59 94.95 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.491 -1.381 . . . . 74.41 110.366 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.78 175.32 5.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.605 1.562 . . . . 74.44 111.146 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.2 tt -81.69 -38.19 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.333 1.453 . . . . 75.23 108.621 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -60.44 -37.16 80.07 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.197 0.453 . . . . 72.41 111.661 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.14 -42.79 96.64 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 119.377 -0.344 . . . . 75.43 111.003 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.79 -50.19 63.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.445 -0.946 . . . . 63.45 108.445 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.2 mmtp -48.87 -54.88 13.48 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.614 1.566 . . . . 73.24 110.23 179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -59.63 -60.18 4.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.043 0.937 . . . . 73.52 110.273 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.65 -29.1 51.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.052 1.131 . . . . 73.41 114.052 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.6 t -60.46 -38.25 83.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.447 0.699 . . . . 55.41 111.917 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -88.51 -28.6 20.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.596 0.635 . . . . 72.21 110.954 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -67.58 -31.13 70.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.226 0.466 . . . . 75.11 111.449 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.67 -3.43 20.61 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.256 1.576 . . . . 74.32 115.256 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 25.7 p -60.08 124.56 20.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.343 1.429 . . . . 75.53 109.677 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.05 13.99 73.22 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.231 -1.316 . . . . 75.31 114.334 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.48 119.53 5.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.884 1.842 . . . . 73.02 110.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -78.08 129.76 35.6 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.911 -1.144 . . . . 73.44 107.911 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -144.08 140.18 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 125.835 1.654 . . . . 75.13 106.789 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m 37.43 49.28 0.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 73.43 112.749 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 35.57 15.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.242 1.417 . . . . 71.23 113.947 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.61 -177.22 4.63 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.847 3.259 . . . . 72.35 104.657 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -139.23 137.14 35.7 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.865 -1.147 . . . . 64.12 109.456 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.75 158.22 21.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.414 -1.328 . . . . 73.02 107.414 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.79 131.77 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.683 -2.71 . . . . 75.13 103.683 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 t -115.33 135.35 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.035 1.334 . . . . 61.13 107.859 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.46 150.67 36.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.745 0.818 . . . . 53.15 110.608 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -78.52 160.97 27.38 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.392 -0.818 . . . . 75.31 111.546 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.28 176.58 6.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.152 0.981 . . . . 75.11 110.156 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 112.624 0.601 . . . . 74.22 112.624 -179.772 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.252 0 CA-C-O 116.585 -2.231 . . . . 51.21 107.845 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 21.9 p 32.95 69.95 0.82 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.784 1.634 . . . . 73.4 113.84 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.97 160.85 42.32 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.92 1.747 . . . . 72.22 111.143 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.27 62.83 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.563 1.945 . . . . 63.42 112.462 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -80.66 64.88 5.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.682 -1.229 . . . . 75.34 107.682 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.8 pp -132.16 -177.74 4.59 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.386 2.274 . . . . 65.43 108.563 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -153.38 178.53 9.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.299 1.039 . . . . 62.41 109.161 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -147.56 167.13 25.31 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.309 0.644 . . . . 71.44 111.657 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -135.52 163.59 29.74 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 127.813 2.445 . . . . 74.33 109.115 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -78.61 170.61 16.37 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.202 -1.407 . . . . 75.11 107.202 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -128.0 153.18 47.04 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.295 -0.878 . . . . 73.41 108.78 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -137.84 101.14 4.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.023 -1.473 . . . . 73.11 107.023 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -105.41 122.65 46.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.803 1.641 . . . . 74.24 106.863 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -73.22 126.82 30.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.593 -2.002 . . . . 70.51 105.593 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 48.6 mm -108.21 104.65 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 123.048 1.404 . . . . 74.03 108.67 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -82.7 -7.88 59.63 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.506 1.922 . . . . 61.23 110.369 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.18 167.17 21.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.737 1.215 . . . . 73.44 113.946 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -123.06 93.59 4.0 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 126.279 1.832 . . . . 74.11 108.131 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -108.11 13.95 25.53 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.075 0.95 . . . . 75.5 112.894 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -142.77 158.87 58.76 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 125.743 1.617 . . . . 72.2 109.39 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.62 9.9 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.657 2.904 . . . . 72.3 114.993 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 36.7 mt -141.67 146.37 36.04 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.756 1.222 . . . . 75.02 108.115 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.5 m -129.21 173.62 10.32 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.804 2.442 . . . . 75.42 109.651 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -61.56 -26.65 68.09 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.762 1.625 . . . . 64.2 115.121 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.04 -45.15 59.17 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.595 -1.316 . . . . 74.22 110.029 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.58 -21.35 66.68 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.527 -0.733 . . . . 73.14 109.821 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.8 tp -60.34 -40.05 89.31 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 108.533 -0.914 . . . . 74.31 108.533 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.93 -10.46 57.34 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.295 1.038 . . . . 73.43 112.289 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -97.55 -36.15 10.4 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.028 1.331 . . . . 64.44 109.481 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.28 -13.58 61.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 73.42 112.608 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.67 157.78 42.04 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.911 1.232 . . . . 73.52 112.003 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.09 166.29 28.14 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.803 2.336 . . . . 74.12 111.241 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -84.69 174.99 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.557 1.143 . . . . 72.43 108.889 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 82.32 19.02 65.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.762 -1.021 . . . . 63.24 112.826 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -125.49 155.71 40.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.382 1.591 . . . . 74.32 106.908 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -130.35 133.69 46.61 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.117 -0.99 . . . . 74.32 108.656 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 48.3 t -69.08 151.31 10.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.617 -1.253 . . . . 71.04 107.617 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.6 tp -125.73 85.72 58.61 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 125.637 1.575 . . . . 71.23 108.662 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -66.21 178.78 2.28 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.913 2.409 . . . . 72.43 109.566 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.44 170.99 1.04 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.704 2.936 . . . . 71.33 113.386 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.17 163.21 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 125.06 3.84 . . . . 73.42 114.899 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -73.95 -0.17 15.36 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 115.258 1.577 . . . . 75.51 115.258 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 162.9 60.12 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.441 -1.864 . . . . 64.44 108.441 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.64 159.21 2.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.752 0.821 . . . . 72.54 111.923 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.87 78.02 57.66 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.054 -1.462 . . . . 72.33 107.054 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -70.57 162.22 43.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.097 1.865 . . . . 74.54 109.357 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.2 tt . . . . . 0 C--O 1.251 1.144 0 N-CA-C 103.645 -2.724 . . . . 75.3 103.645 178.291 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 110.481 -1.048 . . . . 64.44 110.481 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -74.73 66.79 1.51 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.701 1.201 . . . . 71.13 109.255 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.52 98.88 4.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.082 0.953 . . . . 71.14 109.236 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -67.42 157.07 35.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.188 -1.042 . . . . 74.33 108.188 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -126.88 174.55 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.49 0.716 . . . . 71.41 110.921 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.15 17.77 2.61 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.4 1.88 . . . . 74.42 109.936 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 38.0 mt -128.53 62.44 59.91 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 124.613 1.165 . . . . 73.11 108.418 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.15 168.93 17.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.774 2.316 . . . . 61.45 108.478 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.48 -43.51 17.37 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.298 1.332 . . . . 73.44 111.508 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.13 163.46 40.07 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.26 1.424 . . . . 74.01 109.28 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.423 HG12 ' CE1' ' B' ' 91' ' ' TYR . 88.1 t -146.1 157.63 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.8 1.24 . . . . 71.21 108.763 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -138.48 159.85 41.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.993 1.717 . . . . 65.21 108.73 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -72.63 -24.42 61.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.057 1.343 . . . . 72.41 109.505 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -89.54 129.65 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.296 1.438 . . . . 75.1 107.475 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.54 153.53 36.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.876 1.27 . . . . 75.01 107.882 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -119.31 111.6 18.39 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.963 -2.606 . . . . 74.31 103.963 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -96.59 145.67 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.661 -1.977 . . . . 65.42 105.661 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -136.88 163.2 31.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.038 1.335 . . . . 75.12 109.19 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.8 t30 63.12 33.68 14.3 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.062 2.145 . . . . 64.21 111.066 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 55.0 mt -73.79 158.72 85.71 Favored Pre-proline 0 C--O 1.237 0.417 0 O-C-N 121.497 -0.752 . . . . 74.32 109.013 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.16 156.38 65.99 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.886 1.724 . . . . 72.15 109.498 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.23 -25.69 58.33 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.536 -0.727 . . . . 70.44 112.002 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -129.75 128.09 41.73 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.261 -1.385 . . . . 74.43 107.261 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tt -157.51 169.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.553 -1.277 . . . . 71.13 107.553 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 16.9 p -126.49 169.1 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.532 1.933 . . . . 62.14 108.982 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.82 90.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.393 -0.966 . . . . 74.42 108.393 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.45 -55.31 30.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.018 1.327 . . . . 70.45 111.852 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.24 -40.41 85.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.069 0.395 . . . . 73.32 111.438 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.35 -44.01 72.48 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 74.04 111.587 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.14 -23.18 60.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.972 0.909 . . . . 73.33 111.026 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.63 -59.32 2.77 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.273 1.029 . . . . 73.55 108.51 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.17 -67.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.811 1.645 . . . . 74.25 111.027 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -66.99 -32.41 73.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.643 0.608 . . . . 73.35 112.643 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.84 -32.34 81.48 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 120.468 1.485 . . . . 74.05 112.567 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -75.58 -21.34 57.92 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.335 -1.097 . . . . 74.14 110.236 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.36 -30.97 30.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.347 1.059 . . . . 75.33 110.734 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.97 -175.29 44.71 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.116 0.871 . . . . 75.2 111.668 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.06 165.72 25.42 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.911 2.407 . . . . 73.44 110.673 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -132.52 113.68 21.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 123.662 0.785 . . . . 74.25 109.637 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -81.52 -49.09 11.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.526 -1.287 . . . . 74.32 107.526 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -168.9 162.24 11.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.442 1.497 . . . . 74.54 108.496 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.2 mt -144.78 140.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.43 2.292 . . . . 74.44 106.016 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.53 121.88 9.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.055 -1.831 . . . . 75.12 106.055 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.12 167.07 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.63 0.772 . . . . 74.03 109.629 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.38 137.14 42.6 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.669 -0.973 . . . . 54.41 110.669 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -107.34 -49.66 3.22 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.606 1.962 . . . . 74.4 110.661 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -70.57 158.21 88.35 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.109 -0.7 . . . . 73.32 109.109 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.51 14.83 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.549 3.499 . . . . 74.21 115.36 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.01 -47.13 2.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.817 2.047 . . . . 73.14 109.419 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 51.2 p -72.84 -29.45 63.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.972 0.909 . . . . 75.5 109.856 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -50.37 124.77 11.17 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.162 0.985 . . . . 74.42 110.249 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.81 -13.07 17.59 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.746 1.165 . . . . 72.35 110.56 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -128.02 166.07 19.09 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.897 1.348 . . . . 73.42 108.761 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.26 168.14 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.154 -0.966 . . . . 74.25 111.066 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -120.54 124.04 44.37 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.977 -1.12 . . . . 75.44 107.977 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.78 142.25 24.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.507 -2.405 . . . . 74.05 104.507 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.74 122.9 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.718 -1.586 . . . . 73.11 106.718 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.56 165.97 11.73 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.47 1.108 . . . . 74.34 108.467 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.14 -59.36 2.12 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.347 0.659 . . . . 75.23 109.744 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.06 117.6 29.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 126.087 1.755 . . . . 73.44 107.303 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.54 -35.62 60.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 119.39 -0.338 . . . . 71.11 110.815 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -60.37 -50.4 73.76 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.916 0.886 . . . . 73.43 110.073 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.33 -32.17 73.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.551 -0.537 . . . . 74.5 109.551 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.23 92.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.835 -0.802 . . . . 72.22 108.835 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -60.1 -46.56 89.2 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.17 -1.048 . . . . 74.12 108.17 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.99 -52.85 63.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.831 0.707 . . . . 74.04 110.031 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.02 79.74 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.655 -0.688 . . . . 64.52 111.705 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.13 -51.32 68.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.989 0.813 . . . . 75.05 108.995 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -65.71 -37.91 87.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.439 0.563 . . . . 74.41 111.814 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.18 -31.53 72.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.251 0.221 . . . . 75.32 110.424 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.6 tp -91.1 -24.23 20.07 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.844 0.683 . . . . 74.3 112.844 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 3.0 m -68.25 106.4 2.44 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.955 0.902 . . . . 72.25 109.931 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.51 9.45 56.6 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.751 1.643 . . . . 73.02 113.042 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -72.18 141.36 49.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.171 -1.418 . . . . 72.45 107.171 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -110.9 135.02 52.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.758 1.623 . . . . 61.34 110.848 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -157.16 150.16 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 127.499 2.32 . . . . 75.32 107.351 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 53.0 m 44.61 50.25 8.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.614 1.166 . . . . 75.54 113.7 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 44.5 t30 55.5 18.83 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.759 1.624 . . . . 74.34 113.235 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 61.2 mtt85 -134.97 173.82 11.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.739 2.016 . . . . 75.04 110.585 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -130.57 133.34 46.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 105.751 -1.944 . . . . 75.12 105.751 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.21 172.09 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.07 -1.085 . . . . 64.01 108.07 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 5.2 t -134.11 126.7 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 103.757 -2.683 . . . . 74.35 103.757 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.3 t -114.55 137.81 46.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.488 -1.671 . . . . 73.44 106.488 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 46.4 tp -146.81 155.94 42.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.619 1.567 . . . . 74.41 107.159 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . 0.423 ' CE1' HG12 ' B' ' 17' ' ' VAL . 52.8 m-85 -87.74 163.22 16.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.246 -0.65 . . . . 72.3 109.246 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.86 170.01 15.45 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.577 -0.897 . . . . 63.11 108.577 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 . . . . . 0 C--O 1.246 0.909 0 O-C-N 120.909 -1.119 . . . . 75.4 109.342 179.817 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.282 0 N-CA-C 111.368 -0.693 . . . . 73.5 111.368 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . 0.272 3.5 t -148.64 -161.27 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.27 1 C-N-CA 132.564 4.346 . . . . 73.14 102.458 179.14 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.92 86.86 0.88 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 CA-C-N 124.963 2.808 . . . . 74.14 108.057 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.89 -5.88 3.28 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.426 1.89 . . . . 65.31 112.179 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -150.08 158.21 43.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.151 2.58 . . . . 73.32 106.412 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 97.4 mt -123.13 128.42 50.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.528 -0.916 . . . . 74.23 108.528 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -109.21 41.54 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.175 1.39 . . . . 74.11 109.125 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.3 161.82 29.51 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.353 -0.842 . . . . 63.52 109.571 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -124.8 169.85 11.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.927 0.891 . . . . 73.23 110.443 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -142.71 157.92 44.17 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.017 1.727 . . . . 72.4 107.739 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -148.29 60.91 1.1 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.534 0.734 . . . . 74.33 112.006 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -69.61 170.95 9.75 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.154 -0.966 . . . . 74.12 108.959 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -154.22 123.0 6.27 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.119 1.368 . . . . 74.3 107.515 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.74 126.09 2.12 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.267 1.427 . . . . 71.34 107.255 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 8.2 tp -156.69 141.59 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.345 -1.724 . . . . 74.11 106.345 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -155.96 141.39 17.67 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.985 -1.117 . . . . 72.32 107.985 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.92 167.3 23.63 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.991 0.916 . . . . 71.42 109.89 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -105.89 166.9 10.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.399 0.68 . . . . 71.5 109.634 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -67.23 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.956 2.502 . . . . 73.55 114.103 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -64.46 154.07 85.0 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 125.251 1.42 . . . . 73.23 109.374 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -67.96 162.53 39.43 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 107.052 -1.941 . . . . 65.24 107.052 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 53.1 mt -61.06 108.71 0.92 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.438 0.695 . . . . 71.1 111.081 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 1.2 m -63.81 160.93 16.3 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.453 1.101 . . . . 75.31 108.646 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -73.28 -12.01 60.7 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.755 -1.215 . . . . 75.24 110.993 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -79.97 -46.47 16.62 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.527 1.531 . . . . 73.34 107.07 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -62.83 -19.22 63.86 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.498 1.519 . . . . 74.01 111.028 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.3 tp -72.95 -35.46 66.98 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.057 0.943 . . . . 73.1 109.896 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.02 -37.76 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.3 0.64 . . . . 75.52 109.393 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.68 -29.22 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.177 0.991 . . . . 54.13 110.924 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 35.0 mtm -88.95 -1.63 58.2 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.198 0.999 . . . . 74.53 111.672 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -108.47 148.48 37.75 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 119.151 0.887 . . . . 73.31 112.978 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.95 149.74 59.83 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.634 2.223 . . . . 75.33 109.931 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.65 166.22 23.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.158 0.983 . . . . 75.32 111.661 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.48 17.61 56.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.753 1.168 . . . . 72.23 113.024 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -124.42 158.11 33.56 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.254 1.822 . . . . 75.23 108.462 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -127.88 151.65 48.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.553 -0.906 . . . . 73.31 108.553 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 13.9 t -69.98 150.96 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.212 -1.403 . . . . 73.41 107.212 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.0 tp -128.95 75.73 79.95 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.579 -0.897 . . . . 73.34 108.579 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.08 161.32 44.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.942 2.428 . . . . 73.44 110.736 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.69 159.13 54.96 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.974 2.449 . . . . 74.33 112.563 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.31 125.6 17.31 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.661 2.908 . . . . 72.31 111.312 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -65.97 147.87 52.68 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.779 -0.823 . . . . 75.32 108.779 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 67.36 1.02 12.67 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.569 1.081 . . . . 63.21 114.051 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -63.19 142.02 58.54 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.45 2.125 . . . . 75.24 109.25 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 89.7 t -135.3 89.29 23.48 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 124.019 0.928 . . . . 71.42 109.56 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -72.1 147.23 48.16 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 N-CA-C 107.844 -1.637 . . . . 72.35 107.844 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--O 1.251 1.17 0 C-N-CA 127.745 2.418 . . . . 74.23 104.509 179.528 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.546 -0.622 . . . . 74.0 111.546 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.71 36.79 1.63 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.811 2.045 . . . . 74.24 111.126 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.68 158.39 43.37 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.613 -1.304 . . . . 73.31 109.702 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -138.86 168.32 20.09 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.291 1.836 . . . . 74.43 108.527 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 5.7 tp -145.71 153.74 13.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.241 -2.133 . . . . 72.34 105.241 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -143.4 162.66 35.17 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.55 1.14 . . . . 74.52 108.363 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 39.93 71.2 1.25 Allowed Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 126.623 1.969 . . . . 73.31 110.125 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.05 161.26 40.65 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 N-CA-C 108.299 -1.462 . . . . 72.51 108.299 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.47 -22.22 65.64 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.945 1.763 . . . . 64.44 112.205 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -163.74 164.87 23.63 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.123 1.369 . . . . 71.1 109.702 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 t -151.6 158.5 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 105.346 -2.094 . . . . 75.42 105.346 177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -144.06 -179.02 6.23 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.11 -0.994 . . . . 72.13 110.005 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -88.24 -30.91 19.33 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.282 -0.886 . . . . 74.31 109.568 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 mt -82.45 132.93 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.389 -1.338 . . . . 75.23 107.389 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.33 151.84 42.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.121 2.168 . . . . 75.43 107.376 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -110.65 131.82 54.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.221 -1.77 . . . . 74.55 106.221 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.59 138.34 48.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.289 -1.375 . . . . 74.53 107.289 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -138.35 163.59 31.46 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.277 1.431 . . . . 75.35 109.572 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 67.31 31.21 6.65 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.329 1.852 . . . . 72.24 109.991 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 49.4 mt -70.34 156.41 91.92 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 124.468 1.107 . . . . 72.44 111.715 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.96 152.62 51.94 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.814 3.009 . . . . 70.2 109.961 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -80.28 -25.11 39.61 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.539 -0.726 . . . . 74.54 112.431 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -129.01 114.78 16.84 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.45 1.5 . . . . 75.33 106.956 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.28 168.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 127.068 2.147 . . . . 75.12 106.409 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -136.89 169.54 17.59 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.465 1.106 . . . . 65.15 108.605 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.78 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.041 0.536 . . . . 75.22 111.139 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.29 -25.41 64.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.62 1.568 . . . . 70.41 113.043 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -94.46 -35.88 12.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.213 1.005 . . . . 63.13 109.426 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.5 mmm -64.92 -53.2 50.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.501 1.12 . . . . 70.04 109.82 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -67.52 -16.89 64.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.606 -0.712 . . . . 73.22 111.938 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.26 -67.03 0.54 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.859 -1.163 . . . . 64.05 107.859 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.99 -62.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 C-N-CA 126.484 1.914 . . . . 74.05 111.353 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -62.34 -21.5 65.35 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.467 0.914 . . . . 73.12 113.467 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.46 66.24 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.122 0.868 . . . . 61.51 112.386 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.56 -31.46 72.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.218 -1.401 . . . . 64.45 107.218 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.95 -61.76 1.89 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.32 1.048 . . . . 75.15 109.708 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.84 178.11 45.86 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.719 1.145 . . . . 63.42 115.085 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 121.86 9.15 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.367 3.378 . . . . 75.34 109.927 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 mt -86.38 151.07 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.483 -0.932 . . . . 74.12 108.483 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -87.5 -62.86 1.4 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 107.168 -1.419 . . . . 72.23 107.168 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.53 161.27 41.73 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.122 0.969 . . . . 73.24 109.849 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -140.02 142.37 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.741 1.616 . . . . 74.43 107.482 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 -141.67 131.39 24.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.197 -2.89 . . . . 74.32 103.197 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.94 157.4 30.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.478 0.711 . . . . 70.22 111.3 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.05 146.99 44.88 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.821 1.201 . . . . 65.24 111.048 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.09 -49.53 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.46 1.104 . . . . 70.52 108.886 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -66.4 159.76 70.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.691 -0.855 . . . . 72.52 108.691 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.13 -12.21 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.719 1.612 . . . . 62.42 110.594 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.73 -9.88 45.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.015 2.526 . . . . 65.14 111.865 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 33.4 p -116.75 -33.42 4.82 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.039 0.936 . . . . 65.44 109.153 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -54.33 117.2 3.09 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.936 1.694 . . . . 74.01 108.049 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.31 -8.38 9.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.592 2.044 . . . . 73.41 109.75 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 71.8 p -139.77 158.89 43.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.567 1.147 . . . . 62.35 109.953 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.27 172.45 13.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 75.23 107.939 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -128.36 144.55 51.15 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.007 -1.849 . . . . 75.02 106.007 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.41 141.17 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.399 -2.075 . . . . 74.41 105.399 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -123.62 130.46 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.891 -1.892 . . . . 75.3 105.891 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -96.86 160.8 14.16 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 105.48 -2.044 . . . . 75.21 105.48 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.81 -46.27 89.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.1 0.407 . . . . 72.15 112.1 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -120.88 176.16 5.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.566 1.947 . . . . 75.43 110.526 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -90.59 -11.58 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.776 1.23 . . . . 75.13 113.653 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -83.24 -52.82 6.24 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.6 -1.313 . . . . 75.12 110.1 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -30.75 68.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.114 0.966 . . . . 73.4 110.846 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.68 88.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.014 0.526 . . . . 74.22 110.842 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -71.86 -39.12 69.9 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.535 -0.728 . . . . 75.22 109.809 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -54.77 -53.45 54.95 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 107.703 -1.221 . . . . 71.05 107.703 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.52 96.51 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.883 0.873 . . . . 71.24 111.937 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . 0.405 ' HG ' ' CG1' ' B' ' 89' ' ' VAL . 50.9 t -50.91 -58.6 5.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.852 0.861 . . . . 74.54 111.395 -179.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.95 -37.16 83.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 119.3 -0.381 . . . . 73.12 111.528 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.47 -26.82 68.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.021 0.528 . . . . 71.24 112.114 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 30.3 tp -103.78 -14.38 16.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.693 1.197 . . . . 74.25 113.987 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 9.4 t -59.06 116.29 3.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.112 -0.992 . . . . 65.31 110.031 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.45 20.22 69.49 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.96 -1.467 . . . . 64.53 114.262 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -52.13 133.03 33.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.052 1.426 . . . . 75.51 109.988 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -84.98 97.14 9.63 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.643 1.577 . . . . 73.2 111.149 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.86 146.71 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.09 1.756 . . . . 74.41 107.369 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 32.6 m 46.36 31.68 1.34 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 71.13 113.297 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.07 23.71 11.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.52 1.528 . . . . 55.12 112.003 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -116.54 179.19 4.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.41 2.684 . . . . 74.53 108.03 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -137.82 121.69 17.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 74.03 106.707 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.73 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.537 -0.912 . . . . 73.42 108.537 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.96 107.07 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 105.167 -2.16 . . . . 74.51 105.167 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . 0.405 ' CG1' ' HG ' ' B' ' 74' ' ' CYS . 58.9 t -96.18 132.86 39.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.237 1.015 . . . . 73.43 109.197 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.6 tp -143.85 157.25 44.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.867 1.267 . . . . 72.43 109.182 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -86.28 157.73 19.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.064 0.946 . . . . 75.15 108.891 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -81.95 161.52 23.03 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.76 . . . . 75.12 109.756 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 38.4 t30 . . . . . 0 C--O 1.243 0.752 0 C-N-CA 126.265 1.826 . . . . 75.42 108.698 -179.245 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 109.135 -1.586 . . . . 74.34 109.135 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 5.2 t -147.9 150.51 36.04 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 105.59 -2.004 . . . . 75.42 105.59 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.21 107.97 1.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.772 2.315 . . . . 74.34 109.434 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -85.84 89.29 7.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.401 -1.333 . . . . 71.33 107.401 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -80.68 107.46 13.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.717 -1.586 . . . . 72.13 106.717 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.04 95.25 0.54 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.956 1.302 . . . . 75.41 109.918 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -128.95 134.26 48.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.152 -2.166 . . . . 75.34 105.152 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . 53.65 28.09 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.099 0.56 . . . . 54.33 111.49 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -71.99 -23.92 61.49 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.962 1.305 . . . . 75.3 110.592 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -66.1 156.62 33.37 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.809 -1.182 . . . . 72.44 107.809 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -130.24 -89.11 0.48 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.709 -1.589 . . . . 74.12 106.709 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -75.92 -165.97 0.52 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.61 1.964 . . . . 74.51 110.484 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.64 156.63 41.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.243 1.017 . . . . 74.51 108.378 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.24 54.85 1.74 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.241 1.417 . . . . 60.44 108.502 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 2.4 pp -114.17 148.69 16.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 C-N-CA 124.724 1.21 . . . . 64.24 109.081 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 53.31 21.63 2.4 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.373 1.869 . . . . 73.52 113.544 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -75.71 47.46 0.41 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.641 2.377 . . . . 72.43 111.004 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -74.04 1.97 9.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.507 1.523 . . . . 74.44 110.961 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -65.17 -34.89 79.45 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.907 1.283 . . . . 73.2 111.177 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -68.56 151.13 97.41 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 107.201 -1.407 . . . . 74.43 107.201 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.8 -11.36 31.67 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.585 2.19 . . . . 73.44 112.013 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 50.3 mt -55.8 136.86 50.9 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.713 2.005 . . . . 75.02 107.097 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 70.0 p -151.23 -172.31 4.18 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 124.008 0.923 . . . . 73.55 108.52 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -67.33 -30.61 70.48 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.248 -1.39 . . . . 74.21 107.248 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.92 -48.9 42.19 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 125.09 1.356 . . . . 74.31 108.852 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -60.27 -33.11 71.86 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 119.254 -0.978 . . . . 73.35 109.091 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 13.5 tp -73.91 -40.29 63.25 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.728 0.811 . . . . 62.32 110.936 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -61.95 -45.2 94.73 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.296 1.838 . . . . 74.13 108.743 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.754 1.222 . . . . 72.45 110.747 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 47.2 mtp -78.18 -20.71 51.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 75.21 111.55 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.2 155.34 42.85 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.08 0.952 . . . . 73.53 110.322 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.99 168.53 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.542 2.162 . . . . 54.31 110.523 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.33 169.68 5.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.955 2.102 . . . . 71.54 112.468 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 66.04 20.9 69.33 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.731 -1.038 . . . . 65.02 113.955 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -122.95 157.09 33.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.674 1.737 . . . . 73.15 109.533 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -135.99 146.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.759 -1.109 . . . . 72.23 108.657 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 98.0 t -70.28 151.06 9.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 105.779 -1.934 . . . . 54.53 105.779 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.59 90.62 31.58 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.231 -2.877 . . . . 72.21 103.231 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.9 163.4 7.52 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.681 2.254 . . . . 74.51 112.622 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.65 155.63 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.97 1.78 . . . . 74.23 109.284 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.65 151.45 76.0 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.792 1.661 . . . . 73.24 112.581 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -69.65 150.35 47.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.898 -1.149 . . . . 62.33 107.898 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 63.31 23.44 66.44 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.244 -1.309 . . . . 74.41 114.036 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -75.17 120.81 21.17 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 119.587 1.693 . . . . 74.42 111.297 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.49 83.49 62.17 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.971 1.708 . . . . 75.42 107.06 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.89 173.38 4.84 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.22 2.613 . . . . 75.43 113.639 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 13.5 tt . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.816 1.647 . . . . 72.54 109.199 -179.281 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.686 0 N-CA-C 111.27 -0.732 . . . . 70.24 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -83.65 89.58 7.15 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.564 -2.013 . . . . 73.42 105.564 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -176.4 167.8 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.963 2.105 . . . . 71.44 107.71 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -109.15 169.61 8.58 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.663 -0.866 . . . . 74.34 108.663 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 47.4 pt -138.87 143.14 32.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.143 -1.429 . . . . 74.32 107.143 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -69.95 170.65 10.82 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.873 0.469 . . . . 74.2 109.982 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.4 tp 50.37 70.35 2.08 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.271 1.428 . . . . 75.43 109.093 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.84 166.31 14.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.148 1.899 . . . . 60.45 111.487 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.96 -47.58 12.46 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.978 1.786 . . . . 73.5 109.352 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.9 170.0 23.5 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.359 1.864 . . . . 75.13 108.889 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 65.5 t -152.9 137.97 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 106.381 -1.711 . . . . 72.44 106.381 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -137.13 159.36 42.14 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.808 1.243 . . . . 75.11 109.24 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -55.92 -34.24 65.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.318 1.447 . . . . 72.33 113.514 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.5 136.13 24.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.155 -1.424 . . . . 64.22 107.155 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.5 mt -128.56 156.58 43.1 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.708 2.003 . . . . 75.22 107.912 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -124.94 126.13 45.01 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.297 1.839 . . . . 64.33 107.315 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -115.92 146.17 20.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.117 -1.438 . . . . 74.25 107.117 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -126.99 163.52 23.51 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.143 1.777 . . . . 75.24 107.529 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 66.11 28.96 10.12 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.313 1.445 . . . . 74.3 112.193 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 78.2 mt -77.56 150.4 79.3 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 121.109 -0.994 . . . . 75.12 112.009 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.3 148.55 88.57 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.725 2.95 . . . . 71.5 109.647 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -84.97 -21.78 29.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 74.14 112.066 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -124.87 94.96 4.34 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.523 -1.288 . . . . 74.04 107.523 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 tt -147.53 170.42 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.525 2.33 . . . . 74.5 106.333 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 61.3 p -131.26 170.17 14.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.013 1.279 . . . . 75.13 110.761 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.55 74.45 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.614 -0.513 . . . . 71.22 109.614 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.74 -36.75 72.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.371 1.868 . . . . 74.21 110.323 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.86 -42.68 13.04 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.496 -0.752 . . . . 62.12 110.397 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 97.8 mmm -58.9 -35.27 72.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.667 -0.683 . . . . 73.05 111.362 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.59 -12.42 48.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.678 0.791 . . . . 62.42 111.535 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.69 -61.81 1.63 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.57 1.532 . . . . 72.52 108.606 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.0 mt -48.6 -57.82 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.514 1.126 . . . . 51.34 109.705 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -73.81 -23.91 59.73 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.443 0.535 . . . . 74.03 112.443 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.96 -23.41 74.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.165 0.888 . . . . 74.32 111.747 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -73.04 -2.77 22.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 1.227 . . . . 63.24 109.762 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -107.68 -11.58 15.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.78 -1.105 . . . . 75.21 111.863 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.32 26.6 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.512 1.051 . . . . 51.25 112.761 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.0 151.74 83.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.316 3.344 . . . . 75.44 110.818 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 54.0 mt -121.77 130.26 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 107.908 -1.145 . . . . 75.45 107.908 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -74.17 -63.42 1.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.478 -0.934 . . . . 75.42 108.478 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -158.16 165.62 34.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.476 0.71 . . . . 75.21 109.188 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 59.3 mt -140.84 145.98 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.912 1.685 . . . . 75.42 107.468 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -136.26 154.4 50.91 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.333 -2.099 . . . . 75.52 105.333 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.57 153.01 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 123.919 0.887 . . . . 72.24 109.009 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.73 136.27 19.61 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.174 -1.971 . . . . 73.15 108.174 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -115.69 -23.48 8.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.665 -0.494 . . . . 73.41 109.665 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.7 p -80.28 156.82 73.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.684 0.794 . . . . 73.24 110.276 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.2 -14.04 34.24 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.059 2.506 . . . . 64.21 114.065 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -97.52 -1.11 44.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.354 0.979 . . . . 75.11 112.999 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 81.4 p -116.86 -13.04 10.7 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.409 1.004 . . . . 75.12 113.159 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -50.84 116.47 1.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.08 1.352 . . . . 75.35 109.803 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 -20.79 9.03 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.674 1.131 . . . . 71.55 112.33 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -124.11 128.17 48.89 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.348 1.059 . . . . 73.33 109.797 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.34 175.76 9.33 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.512 1.125 . . . . 65.24 111.56 -178.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -128.76 147.1 50.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.189 0.595 . . . . 75.24 110.269 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.59 148.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 126.667 1.987 . . . . 74.33 105.894 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 15.9 t -127.61 124.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.806 -1.924 . . . . 74.11 105.806 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -98.65 163.04 12.81 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.531 -1.285 . . . . 62.42 107.531 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -89.18 -61.71 1.64 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.759 -0.83 . . . . 72.21 108.759 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.18 138.82 32.78 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.033 -1.042 . . . . 73.13 110.986 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt -71.43 -43.47 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.203 -0.935 . . . . 75.4 110.7 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.159 0.89 . . . . 75.5 111.334 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.93 -48.05 22.77 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.316 1.446 . . . . 73.14 108.038 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.85 79.75 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.03 0.932 . . . . 64.3 108.832 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -65.03 -36.96 86.03 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.945 1.298 . . . . 70.44 111.321 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -63.59 -55.85 20.48 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 107.782 -1.192 . . . . 73.21 107.782 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.4 73.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.958 0.903 . . . . 74.51 111.09 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.96 -57.07 11.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.211 -1.403 . . . . 74.13 107.211 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.87 -42.12 98.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 119.253 -0.403 . . . . 73.11 111.11 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.263 -0.875 . . . . 72.41 112.592 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.46 -28.12 13.08 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.723 1.601 . . . . 73.31 111.293 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 20.6 t -66.23 107.92 2.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.517 1.527 . . . . 65.43 107.64 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.24 10.09 54.76 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.204 1.383 . . . . 75.45 113.57 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -74.7 122.12 22.76 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.362 1.581 . . . . 72.11 108.004 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -85.07 132.65 34.29 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.773 -1.195 . . . . 52.22 107.773 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -146.19 135.69 17.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.964 -1.495 . . . . 54.25 106.964 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.6 m 46.2 42.38 9.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.65 1.58 . . . . 74.43 113.268 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.64 3.93 4.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.804 2.842 . . . . 61.31 114.256 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.88 161.81 15.98 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.196 -1.565 . . . . 75.22 109.917 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -110.52 117.71 34.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.542 -0.911 . . . . 74.21 108.542 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.64 154.6 39.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.667 -0.864 . . . . 73.12 108.667 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.0 127.52 67.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.031 -1.47 . . . . 65.35 107.031 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -115.77 137.77 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 75.12 108.183 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -144.59 137.1 26.5 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.859 0.864 . . . . 64.4 110.272 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -66.87 153.66 42.91 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.043 0.937 . . . . 73.11 108.95 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -76.37 163.69 26.74 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.498 -0.752 . . . . 75.35 112.99 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 C--O 1.249 1.076 0 C-N-CA 127.284 2.234 . . . . 73.4 105.596 179.389 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.745 0 N-CA-C 111.034 -0.826 . . . . 64.3 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 6.0 t -131.96 154.27 81.66 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.943 2.097 . . . . 74.24 106.075 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.25 123.99 11.94 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 CA-C-N 121.447 1.553 . . . . 65.05 108.646 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -153.0 159.7 42.93 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.384 1.074 . . . . 74.44 108.217 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -139.39 162.03 36.02 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.176 1.79 . . . . 72.3 106.905 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -103.06 156.31 17.77 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.598 -0.519 . . . . 71.13 109.598 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -156.5 176.28 12.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.565 2.746 . . . . 71.52 106.46 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -147.11 118.96 8.09 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.936 1.695 . . . . 73.45 107.658 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -70.27 167.69 17.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.122 0.569 . . . . 73.21 110.791 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -120.6 145.69 47.12 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.714 1.205 . . . . 73.12 109.033 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -138.61 139.76 38.69 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.931 -1.137 . . . . 73.03 107.931 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -153.84 125.75 7.77 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 103.848 -2.649 . . . . 74.4 103.848 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -147.36 88.43 1.71 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.173 0.897 . . . . 72.24 109.678 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.89 179.51 5.32 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.294 -0.632 . . . . 74.43 109.294 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 64.8 mt -115.01 107.79 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.434 -1.691 . . . . 71.11 106.434 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -145.32 179.24 7.52 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.524 1.93 . . . . 71.53 106.32 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -149.61 125.04 10.25 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.466 -2.05 . . . . 74.53 105.466 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -140.31 168.9 18.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.951 1.301 . . . . 71.1 109.888 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -85.84 25.96 1.04 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.136 1.775 . . . . 71.51 110.382 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -65.58 149.06 97.73 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.043 0.937 . . . . 73.0 109.733 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.78 167.49 26.19 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.831 2.354 . . . . 73.44 112.4 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 58.5 mt -37.61 118.1 0.62 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 127.59 2.356 . . . . 71.24 112.041 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 25.1 m -138.11 -166.61 2.0 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.799 2.04 . . . . 75.51 108.426 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.96 -23.68 65.98 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.446 -0.784 . . . . 71.41 111.179 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -61.82 -48.1 82.14 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.613 -1.254 . . . . 73.23 107.613 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -68.38 -17.03 64.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.458 1.103 . . . . 74.3 110.624 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 25.9 tp -86.64 -38.91 16.6 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.033 -1.469 . . . . 75.31 107.033 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -60.73 -41.89 96.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.85 -0.796 . . . . 74.01 108.85 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.88 45.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.92 0.888 . . . . 61.32 112.493 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.1 mtp -84.94 -1.25 56.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.446 1.098 . . . . 73.23 111.486 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -112.4 158.16 38.02 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 119.817 1.19 . . . . 75.03 111.711 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.96 175.61 10.19 Favored 'Trans proline' 0 C--O 1.239 0.567 0 C-N-CA 123.619 2.879 . . . . 74.51 112.204 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.56 166.15 21.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.358 -0.837 . . . . 71.2 110.33 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.01 78.96 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 121.388 -0.82 . . . . 71.13 113.531 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -123.38 157.57 33.06 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.711 -1.464 . . . . 75.35 107.902 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.77 137.09 43.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.203 -1.777 . . . . 71.04 106.203 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.7 t -70.31 149.67 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.004 -0.739 . . . . 63.23 109.004 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 35.9 tp -125.52 77.63 68.86 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.777 -1.194 . . . . 72.0 107.777 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.4 169.27 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.838 2.358 . . . . 71.24 111.701 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.18 161.46 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.424 3.416 . . . . 73.4 114.387 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.4 155.63 9.44 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.669 3.579 . . . . 63.01 115.837 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -80.81 155.93 26.4 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.736 -1.579 . . . . 63.51 106.736 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 67.33 13.34 62.47 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.979 -0.901 . . . . 75.41 114.477 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -78.94 156.21 28.64 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 119.326 1.563 . . . . 73.34 109.485 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 4.3 t -125.63 67.32 58.37 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.971 0.908 . . . . 73.14 109.759 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.99 -1.56 11.57 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.393 2.728 . . . . 65.41 114.571 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 29.3 mm . . . . . 0 C--O 1.253 1.272 0 CA-C-N 120.316 1.416 . . . . 74.01 107.979 -179.433 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.688 0 N-CA-C 109.936 -1.265 . . . . 62.42 109.936 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.68 124.22 23.04 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.343 -1.725 . . . . 74.22 106.343 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.76 126.63 28.34 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.316 0.507 . . . . 74.22 110.142 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -107.56 -3.52 19.26 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.3 1.84 . . . . 75.21 113.201 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 pt -95.84 171.65 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 126.586 1.954 . . . . 73.31 110.92 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -92.89 -36.38 12.84 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.484 -0.76 . . . . 75.01 112.226 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.7 mp -100.14 172.91 4.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.047 1.339 . . . . 72.54 113.952 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.25 172.41 16.07 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.87 3.047 . . . . 73.12 109.41 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.78 -63.77 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.86 2.374 . . . . 63.43 111.657 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -149.61 142.97 25.24 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 127.811 2.444 . . . . 74.22 106.109 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t -142.4 135.92 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.083 -2.191 . . . . 74.4 105.083 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -130.75 166.55 20.54 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.717 1.207 . . . . 72.42 109.738 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.21 -41.78 73.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.521 -0.752 . . . . 74.11 112.966 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.14 133.96 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.146 -1.057 . . . . 71.14 108.146 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 36.9 mt -123.47 156.58 35.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.175 1.39 . . . . 73.41 109.397 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -111.71 137.53 49.49 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.554 2.342 . . . . 73.54 107.554 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.8 mm -123.18 144.65 32.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.919 2.088 . . . . 62.31 107.189 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -144.83 163.03 35.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.426 1.09 . . . . 71.23 110.75 -179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 72.04 25.47 3.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.805 2.442 . . . . 74.55 111.278 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -73.91 157.22 87.44 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.998 1.319 . . . . 73.11 112.7 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.71 160.28 44.1 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.651 2.901 . . . . 64.45 112.263 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -93.73 -10.96 32.53 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.752 1.621 . . . . 75.31 110.936 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mmmp? -128.69 95.32 4.08 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 106.883 -1.525 . . . . 75.52 106.883 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -155.16 160.71 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 124.206 0.941 . . . . 74.12 108.526 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 8.4 p -138.08 175.73 9.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.171 1.388 . . . . 73.43 109.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.97 70.74 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.285 0.634 . . . . 75.22 111.981 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -56.93 -46.22 82.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.134 0.974 . . . . 73.33 111.96 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -78.29 -40.54 36.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.549 0.74 . . . . 72.34 109.721 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.2 mmm -61.05 -46.23 91.54 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 120.984 -1.072 . . . . 75.41 110.261 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -71.68 -23.27 61.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.374 -0.822 . . . . 71.11 109.938 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.64 -46.6 75.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.761 1.164 . . . . 65.21 108.063 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mt -67.79 -69.49 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.04 1.336 . . . . 73.21 110.902 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -60.32 -26.22 66.38 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.886 1.809 . . . . 71.25 115.886 -177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.54 -23.6 73.71 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.341 0.973 . . . . 64.51 111.946 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -65.83 -15.19 62.67 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.306 -1.114 . . . . 74.33 111.037 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -107.33 -4.48 18.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.936 1.458 . . . . 74.33 114.936 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.92 -173.7 21.45 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.753 1.16 . . . . 63.23 114.053 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.27 117.89 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 125.264 3.976 . . . . 65.22 113.791 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 71.5 mt -77.27 103.07 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 127.195 2.198 . . . . 74.21 108.682 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -66.46 -61.79 1.81 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.854 -1.154 . . . . 74.54 110.637 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -160.78 142.85 12.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.892 0.769 . . . . 73.14 111.603 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 16.7 mt -126.89 140.32 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.502 1.121 . . . . 74.24 109.539 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -137.37 122.47 19.13 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.767 -2.679 . . . . 73.3 103.767 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -111.17 145.99 16.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.501 1.12 . . . . 72.44 108.732 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.84 125.36 16.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.089 -2.405 . . . . 64.42 107.089 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -100.37 -20.57 15.76 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.521 1.16 . . . . 73.43 113.954 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -73.75 157.14 87.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.998 -1.853 . . . . 73.44 105.998 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.24 -20.29 70.39 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.106 1.871 . . . . 74.34 111.843 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.8 -44.43 16.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.282 1.433 . . . . 74.22 109.774 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 77.4 p -74.62 -0.94 19.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.254 -0.904 . . . . 61.2 112.176 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -64.61 163.44 13.71 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.887 -1.133 . . . . 73.44 109.363 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 -9.36 6.07 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.547 -1.141 . . . . 51.42 112.567 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 44.3 p -128.77 144.63 51.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.469 1.634 . . . . 74.42 110.312 -178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.72 175.37 12.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.224 1.01 . . . . 72.45 110.027 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -127.62 156.16 42.73 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.324 0.649 . . . . 60.24 110.531 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -142.55 144.95 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.537 -1.282 . . . . 70.1 107.537 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.48 149.16 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.077 -1.453 . . . . 75.43 107.077 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -116.24 160.2 20.78 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.403 -1.436 . . . . 75.32 108.78 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -65.7 -40.99 92.85 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.396 -0.594 . . . . 64.33 109.396 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -122.35 142.52 50.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.195 -1.039 . . . . 74.23 108.195 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.45 -24.51 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.681 -0.637 . . . . 74.42 110.845 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.66 -25.42 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.415 1.086 . . . . 74.53 110.581 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -74.9 -53.08 9.68 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 105.338 -2.097 . . . . 70.45 105.338 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.85 -35.71 33.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.241 1.016 . . . . 75.23 111.943 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -57.14 -69.14 0.17 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.07 1.348 . . . . 74.1 111.659 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -37.55 81.6 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.511 -0.743 . . . . 75.44 111.671 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.34 80.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.543 -0.741 . . . . 65.1 111.838 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.71 -61.67 2.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.053 -0.721 . . . . 73.31 109.053 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.51 -31.79 70.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.603 0.964 . . . . 74.31 113.603 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -73.88 -26.77 60.73 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.446 0.566 . . . . 72.32 111.1 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.21 -16.53 18.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.119 0.968 . . . . 74.45 112.669 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -63.11 108.06 1.16 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.141 1.777 . . . . 72.52 108.238 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.5 83.1 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.209 -1.329 . . . . 65.32 113.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.02 141.53 45.36 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 119.112 1.456 . . . . 73.32 111.006 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -94.96 113.61 25.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 115.231 1.567 . . . . 74.0 115.231 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 m -133.21 141.77 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 73.05 105.401 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 74.8 m 42.92 36.71 0.92 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.84 1.656 . . . . 74.13 113.607 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 65.26 21.56 12.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.299 1.84 . . . . 64.33 112.668 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.54 -179.54 3.74 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.779 2.432 . . . . 75.12 108.442 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -138.03 114.11 10.05 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.873 -1.899 . . . . 70.24 105.873 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -69.02 168.76 13.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.297 0.639 . . . . 72.33 110.97 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.02 107.85 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.855 1.262 . . . . 71.11 107.73 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.74 135.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.19 -1.411 . . . . 73.21 107.19 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -151.98 141.96 22.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.253 1.021 . . . . 75.33 108.803 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -73.17 154.75 40.17 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.943 0.792 . . . . 74.25 110.215 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.09 148.16 38.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.964 -1.495 . . . . 74.41 106.964 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 126.977 2.111 . . . . 74.31 106.417 178.771 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 18.1 tp . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.24 -0.652 . . . . 63.21 109.24 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.94 -41.88 90.76 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.833 0.853 . . . . 75.24 109.669 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.53 61.46 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.086 1.354 . . . . 42.34 111.48 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.0 mtp -88.95 -17.41 29.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.893 0.877 . . . . 64.11 112.64 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -83.11 145.51 49.38 Favored Pre-proline 0 N--CA 1.455 -0.212 0 CA-C-N 119.32 0.963 . . . . 71.34 110.212 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -67.28 157.49 61.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.423 2.082 . . . . 74.33 112.197 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.99 134.99 43.12 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.218 -1.356 . . . . 72.34 108.984 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.6 24.37 18.45 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-O 118.845 -0.975 . . . . 63.33 113.549 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.17 108.87 12.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.965 -1.495 . . . . 74.14 106.965 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.96 150.5 25.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 114.909 -1.041 . . . . 74.41 108.332 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.65 151.56 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.226 -0.657 . . . . 74.31 109.226 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 25.9 tp -120.76 78.88 30.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.999 0.92 . . . . 65.43 109.278 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.97 160.01 50.69 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 N-CA-C 108.346 -1.444 . . . . 61.14 108.346 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 157.5 61.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.141 1.894 . . . . 75.34 110.955 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.066 1.844 . . . . 72.41 109.755 -179.724 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.446 HG11 ' HG2' ' B' ' 71' ' ' LYS . 59.7 t . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 107.803 -1.184 . . . . 74.51 107.803 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.2 176.87 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.573 2.349 . . . . 54.13 108.022 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -77.54 -9.87 59.17 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.803 -0.56 . . . . 60.25 110.188 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -92.03 115.89 31.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.397 1.879 . . . . 64.12 107.641 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.51 127.02 55.59 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.473 1.509 . . . . 64.33 109.456 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -92.62 135.42 34.1 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.172 -1.418 . . . . 71.14 107.172 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mm -122.93 136.91 58.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.562 1.545 . . . . 73.44 107.968 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 mtp85 -123.42 162.06 23.55 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.786 1.234 . . . . 73.33 107.803 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.05 25.51 4.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.655 2.382 . . . . 63.14 113.776 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.27 150.81 97.17 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 108.215 -1.031 . . . . 60.33 108.215 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.66 151.6 85.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.728 1.619 . . . . 54.21 110.204 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -73.89 -25.46 60.04 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.704 -0.623 . . . . 62.41 110.364 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 109.56 17.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.259 -1.015 . . . . 74.13 108.259 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 tt -159.09 152.44 6.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.636 -1.246 . . . . 55.23 107.636 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 46.5 p -113.34 172.74 6.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.807 1.243 . . . . 72.45 110.33 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.9 -32.08 73.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.169 -1.048 . . . . 52.12 108.169 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.17 -49.61 63.44 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.722 2.009 . . . . 74.12 110.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -70.74 -49.93 41.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.26 1.024 . . . . 62.33 109.647 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 98.1 mmm -56.25 -43.35 78.62 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.694 -0.629 . . . . 64.35 112.186 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -67.82 -29.44 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.34 0.973 . . . . 75.54 110.789 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.56 -35.94 57.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.389 0.995 . . . . 71.44 110.585 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.26 -58.84 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 125.522 1.529 . . . . 60.21 110.84 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.462 ' CE2' HG21 ' B' ' 62' ' ' VAL . 78.9 m-85 -74.09 -23.62 59.36 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.074 -1.016 . . . . 71.42 112.353 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -7.59 88.38 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.602 0.637 . . . . 52.11 112.638 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -63.06 -26.31 68.78 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.573 1.149 . . . . 63.42 111.745 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.58 -21.12 19.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.175 0.99 . . . . 75.42 112.802 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.71 -159.62 29.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.622 1.101 . . . . 51.14 110.387 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.92 151.25 56.38 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.381 2.054 . . . . 73.43 109.236 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mt -112.73 137.3 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.277 -1.749 . . . . 75.54 106.277 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -66.02 0.79 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.109 -1.071 . . . . 74.35 108.109 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -161.49 153.8 19.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.724 0.693 . . . . 71.13 111.41 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.0 150.75 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 123.223 1.487 . . . . 74.34 109.6 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -136.22 163.84 29.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 104.09 -2.559 . . . . 74.32 104.09 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -144.18 149.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 120.664 1.575 . . . . 74.22 108.4 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.2 139.1 48.38 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.85 -1.7 . . . . 72.14 108.85 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.67 -9.67 6.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.936 0.894 . . . . 75.52 112.332 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.94 159.73 32.53 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.52 1.928 . . . . 64.24 106.335 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.17 -29.57 89.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.95 1.767 . . . . 65.32 112.575 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -91.49 2.31 56.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.35 1.06 . . . . 74.12 112.786 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 49.5 p -116.42 -31.58 5.53 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.702 1.592 . . . . 75.24 112.452 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -54.52 136.04 45.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.264 1.026 . . . . 62.22 108.538 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.42 -5.57 44.79 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.078 0.847 . . . . 54.13 112.367 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 58.6 p -142.82 158.38 43.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 119.044 1.422 . . . . 64.32 108.849 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.21 160.59 21.4 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.446 0.698 . . . . 51.22 110.549 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.06 132.93 56.57 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 127.063 2.145 . . . . 63.14 106.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.462 HG21 ' CE2' ' B' ' 39' ' ' PHE . 89.3 t -111.82 150.5 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 125.302 1.441 . . . . 51.14 107.825 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -124.01 125.67 71.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.212 -1.403 . . . . 72.43 107.212 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -97.8 161.77 13.59 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.543 -1.28 . . . . 63.21 107.543 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -74.27 -31.24 62.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.167 -0.924 . . . . 73.15 111.765 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.63 172.45 8.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.763 1.225 . . . . 63.14 109.468 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -95.61 -29.16 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.986 -1.116 . . . . 61.21 107.986 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -62.44 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.713 1.605 . . . . 75.34 109.721 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.31 -35.05 74.7 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.402 1.081 . . . . 51.45 111.293 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -55.24 33.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.609 -0.886 . . . . 72.42 108.609 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.446 ' HG2' HG11 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -62.06 -35.26 78.09 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.891 -1.052 . . . . 60.41 111.364 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -59.67 -53.46 57.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.984 0.811 . . . . 60.24 109.902 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.74 65.14 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 118.831 -0.604 . . . . 64.24 112.432 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.0 t -50.8 -48.77 59.52 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.314 1.046 . . . . 62.13 110.091 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -59.97 3.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.621 0.769 . . . . 62.33 109.373 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -15.54 9.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.922 1.823 . . . . 72.33 115.922 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 tp -99.67 -1.96 36.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.011 1.278 . . . . 52.41 111.153 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.1 p -75.47 132.59 40.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.257 -1.386 . . . . 71.33 107.257 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.29 10.28 81.7 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.048 -0.862 . . . . 63.12 113.114 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -66.45 133.91 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.961 1.381 . . . . 61.33 107.294 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -109.28 126.77 53.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.641 1.177 . . . . 64.33 109.119 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 5.4 m -136.83 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.115 1.766 . . . . 74.13 107.036 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 88.9 m 49.46 29.61 2.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.328 1.051 . . . . 60.14 111.887 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.7 m120 71.27 23.31 4.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.284 2.233 . . . . 72.31 113.279 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -132.14 141.74 49.23 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.223 1.409 . . . . 74.13 108.726 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -88.47 151.1 22.77 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.501 0.72 . . . . 73.12 109.164 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.44 167.67 9.68 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.878 -0.786 . . . . 73.43 108.878 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 79.4 t -132.73 137.75 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.538 -1.282 . . . . 64.53 107.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.9 139.89 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.328 1.451 . . . . 64.53 109.094 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 52.0 tp -146.42 165.43 29.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.154 1.782 . . . . 71.13 108.369 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.44 164.09 11.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.425 . . . . 74.44 112.486 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -83.32 115.14 21.86 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.772 1.229 . . . . 74.33 108.683 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 63.4 t30 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.201 -0.904 . . . . 75.53 110.852 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 404' ' ' LEU . . . . . 0.401 HD21 HG21 ' B' ' 63' ' ' VAL . 60.8 tp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.93 -44.11 97.67 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.949 -0.76 . . . . 75.14 108.949 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.02 81.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.433 1.493 . . . . 63.2 111.6 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.47 -21.59 59.51 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.366 1.066 . . . . 74.13 112.527 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -76.71 152.65 83.1 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.076 1.307 . . . . 62.24 109.265 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.499 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 86.8 Cg_endo -72.1 177.1 7.56 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.833 3.688 . . . . 65.14 112.521 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.01 143.58 26.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.111 0.964 . . . . 75.32 112.724 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.52 29.53 9.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.587 1.089 . . . . 73.51 113.658 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.499 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 49.6 m-85 -125.98 157.12 38.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.049 1.34 . . . . 75.13 109.671 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.79 142.4 50.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.377 -1.342 . . . . 74.24 107.377 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.61 151.79 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.415 -0.957 . . . . 52.11 108.415 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.88 85.8 40.52 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.655 -0.653 . . . . 71.03 109.312 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.56 159.68 31.17 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.947 2.431 . . . . 62.44 111.051 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 166.47 26.76 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.385 3.39 . . . . 75.02 113.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 CA--C 1.541 0.838 0 C-N-CA 122.573 2.182 . . . . 75.42 109.238 178.537 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 t . . . . . 0 C--O 1.238 0.478 0 N-CA-C 106.982 -1.488 . . . . 63.25 106.982 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -131.82 159.15 39.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.532 1.533 . . . . 64.25 108.667 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -82.87 -25.24 32.73 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.706 0.802 . . . . 74.41 110.662 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -83.4 135.21 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 103.019 -2.956 . . . . 74.5 103.019 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.7 165.81 15.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.679 1.591 . . . . 73.25 108.518 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -129.04 130.25 46.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.951 2.1 . . . . 63.24 109.123 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -113.22 151.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.302 2.241 . . . . 71.32 107.849 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -146.57 159.93 42.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.661 -0.65 . . . . 62.21 110.945 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.97 19.03 11.75 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 127.204 2.202 . . . . 54.1 113.975 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 mt -58.92 152.77 47.69 Favored Pre-proline 0 C--O 1.236 0.372 0 C-N-CA 123.04 0.536 . . . . 75.04 112.239 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.92 144.53 96.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 73.01 110.34 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -77.78 -14.27 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.299 -0.876 . . . . 74.51 111.59 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -123.49 105.5 9.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.443 -1.688 . . . . 62.32 106.443 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 tt -156.59 164.35 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.915 1.686 . . . . 71.21 106.744 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.27 169.03 17.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.593 1.557 . . . . 55.53 109.336 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.22 -31.64 70.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.923 -0.561 . . . . 52.11 110.316 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.59 -39.79 71.18 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.388 1.475 . . . . 73.22 111.825 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -83.79 -47.79 10.76 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.646 1.178 . . . . 75.52 110.413 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.3 mmm -53.45 -47.98 69.22 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.609 0.364 . . . . 75.02 110.82 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -69.21 -34.96 75.68 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.281 -0.866 . . . . 64.14 111.672 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.28 -56.65 18.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.81 0.732 . . . . 74.04 109.328 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 48.8 mt -54.48 -63.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 126.751 2.02 . . . . 72.33 111.234 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -63.52 -24.34 67.77 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.204 0.911 . . . . 74.1 112.854 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.5 79.96 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.797 -1.001 . . . . 53.24 112.258 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.409 ' HA ' ' HE2' ' B' ' 41' ' ' LYS . 7.3 mmpt? -60.3 -19.34 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.53 1.665 . . . . 52.53 113.215 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.52 -31.25 8.2 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 117.404 -1.284 . . . . 72.44 113.861 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.0 -152.4 14.83 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 119.716 1.144 . . . . 73.31 112.774 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.18 162.48 28.56 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.163 3.242 . . . . 73.22 111.84 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.99 132.58 70.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.141 -1.429 . . . . 33.44 107.141 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -58.05 2.67 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.973 -1.121 . . . . 72.3 107.973 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -156.22 160.11 39.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.952 0.901 . . . . 61.34 109.368 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 48.7 mt -139.69 136.1 39.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.267 1.427 . . . . 64.53 108.0 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -137.77 143.57 41.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.247 -1.39 . . . . 64.3 107.247 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.84 165.37 27.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.287 1.035 . . . . 52.21 108.539 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.05 135.19 25.87 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 124.098 0.856 . . . . 74.52 113.054 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -104.88 -42.74 5.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.208 1.803 . . . . 70.04 109.211 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -66.32 158.78 76.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.906 -1.146 . . . . 73.33 107.906 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.55 -31.65 40.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.221 1.281 . . . . 64.33 110.947 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -70.99 -23.7 62.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.747 0.703 . . . . 61.23 112.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -89.94 -0.97 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.621 0.768 . . . . 32.14 111.79 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -67.84 120.48 14.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.291 -2.115 . . . . 74.5 105.291 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.11 2.34 36.04 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.116 0.865 . . . . 42.44 112.875 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 65.8 p -129.55 151.34 50.27 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.769 1.285 . . . . 70.34 108.058 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.55 171.13 16.26 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.001 -1.062 . . . . 74.3 110.74 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -138.38 151.87 47.9 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.947 0.899 . . . . 71.13 110.393 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.49 152.62 35.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.153 -2.166 . . . . 63.22 105.153 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 404' ' ' LEU . 23.5 t -127.73 129.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.172 -1.788 . . . . 72.14 106.172 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.23 161.99 13.42 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.848 -1.538 . . . . 72.14 106.848 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.08 -43.85 41.64 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.722 -0.611 . . . . 72.42 111.083 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -123.02 164.13 19.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.78 1.232 . . . . 53.44 109.74 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.0 tt -83.33 -10.82 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 114.564 1.32 . . . . 74.55 114.564 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -83.55 -53.7 5.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.619 -1.252 . . . . 75.4 107.619 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.8 -40.56 88.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.746 0.654 . . . . 74.21 110.294 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.34 79.01 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.544 0.738 . . . . 61.11 111.082 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.57 -46.15 76.96 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 119.124 -0.465 . . . . 64.23 110.253 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -55.51 -44.57 76.75 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.731 0.645 . . . . 75.44 110.123 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.71 -50.01 54.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.481 0.712 . . . . 71.2 110.051 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.8 t -50.88 -54.16 26.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.624 1.17 . . . . 74.2 110.937 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -63.3 -33.8 76.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.268 0.84 . . . . 63.21 113.268 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -80.91 -23.29 39.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 118.607 0.639 . . . . 75.1 111.911 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.26 -23.6 22.28 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.167 0.508 . . . . 63.32 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -61.67 114.13 3.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.193 1.397 . . . . 42.0 108.677 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 10.63 75.01 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.394 -1.226 . . . . 74.52 114.578 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.6 119.11 9.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.573 1.187 . . . . 73.33 108.571 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.26 109.31 17.69 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.497 1.519 . . . . 75.43 110.431 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 10.6 m -141.23 151.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.702 1.201 . . . . 75.13 109.585 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 76.8 m 44.68 43.75 6.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.892 1.277 . . . . 73.03 110.661 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.53 35.49 11.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.138 2.575 . . . . 74.34 112.371 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -144.72 -179.99 6.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.311 2.245 . . . . 75.43 108.09 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -128.41 157.23 41.62 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.85 1.26 . . . . 64.41 108.909 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -120.15 119.3 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.195 -0.668 . . . . 73.21 109.195 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.14 122.73 38.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 126.847 2.059 . . . . 73.2 106.294 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.39 129.41 61.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.398 -1.704 . . . . 71.42 106.398 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.36 153.68 51.76 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.99 -1.115 . . . . 72.42 107.99 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -84.1 156.93 21.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 71.32 108.314 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.95 140.16 43.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 104.202 -2.518 . . . . 74.11 104.202 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.673 -1.232 . . . . 72.22 107.673 178.852 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 404' ' ' LEU . . . . . 0.435 ' CD2' HH22 ' B' ' 49' ' ' ARG . 29.4 tp . . . . . 0 C--O 1.224 -0.266 0 CA-C-O 118.779 -0.629 . . . . 63.34 109.712 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.18 -41.01 82.95 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.273 0.629 . . . . 72.35 110.291 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.87 -9.34 58.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.796 1.238 . . . . 64.24 112.871 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 79.9 mtp -76.21 -12.21 60.05 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.962 -1.086 . . . . 64.44 110.062 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -114.61 158.85 39.15 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.774 1.629 . . . . 75.41 112.601 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.37 170.93 17.19 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.978 1.785 . . . . 42.31 109.721 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -87.45 163.37 16.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.94 -1.027 . . . . 63.32 111.035 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.69 18.26 35.75 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.155 1.359 . . . . 65.03 112.415 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.26 157.05 39.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.15 1.38 . . . . 70.3 107.564 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -137.94 147.19 44.08 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.602 -0.518 . . . . 61.54 109.602 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.19 150.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.478 0.581 . . . . 54.22 109.664 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.08 86.21 57.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.23 -1.396 . . . . 70.32 107.23 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.49 159.55 27.23 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.951 2.434 . . . . 74.0 113.03 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.63 168.94 21.24 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.837 2.358 . . . . 65.14 110.803 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo . . . . . 0 C--N 1.348 0.517 0 C-N-CA 124.499 3.466 . . . . 74.41 115.348 -179.467 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 C--O 1.237 0.425 0 N-CA-C 106.645 -1.613 . . . . 75.13 106.645 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -121.96 -172.88 2.53 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.668 1.587 . . . . 52.11 109.449 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.37 -17.24 14.87 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.088 -1.008 . . . . 61.01 112.532 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.27 114.43 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.912 -1.514 . . . . 74.41 106.912 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 74.4 mt -102.97 170.83 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.251 1.02 . . . . 71.43 109.032 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -140.68 142.22 34.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.991 2.116 . . . . 74.03 106.509 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 mm -128.24 148.25 32.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 119.19 0.904 . . . . 74.42 108.711 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -133.42 162.31 32.2 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.264 1.825 . . . . 74.31 107.682 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.78 21.47 9.15 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.07 2.148 . . . . 71.15 112.292 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -61.03 155.25 55.9 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.396 1.078 . . . . 54.11 111.338 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.42 138.23 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.525 2.816 . . . . 71.11 111.05 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.47 -23.46 65.5 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.9 0.88 . . . . 72.51 112.635 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 113.58 14.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.024 -1.843 . . . . 62.25 106.024 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.5 129.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.195 -1.039 . . . . 73.3 108.195 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 12.5 p -83.23 169.15 16.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.385 -0.598 . . . . 64.5 109.385 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.78 84.47 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.663 -0.684 . . . . 44.32 109.47 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -47.98 -47.05 33.2 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.14 1.376 . . . . 73.21 112.571 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.87 -52.68 63.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.154 0.982 . . . . 74.34 109.701 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 75.4 mmm -59.38 -48.28 82.23 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.982 0.513 . . . . 44.13 110.812 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.22 -29.02 70.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.036 -0.983 . . . . 73.0 109.767 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.73 -62.28 1.45 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.726 1.148 . . . . 62.13 108.346 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 60.1 mt -45.44 -58.3 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.576 1.95 . . . . 70.3 111.339 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -78.04 -38.17 45.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.863 1.061 . . . . 63.54 113.863 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.04 -37.39 85.45 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.866 -0.894 . . . . 42.32 110.866 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -57.34 -31.48 65.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.463 0.631 . . . . 74.21 110.89 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -78.26 -55.35 5.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.599 -0.889 . . . . 73.3 108.599 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.81 -166.74 33.75 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.496 -0.752 . . . . 51.41 112.619 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.19 156.17 26.16 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.476 2.784 . . . . 72.31 114.453 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.83 102.84 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.175 -2.528 . . . . 73.52 104.175 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -75.77 -54.66 6.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.348 -0.982 . . . . 74.21 108.348 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -151.9 154.43 36.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.225 0.61 . . . . 70.41 109.613 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 80.1 mt -145.85 135.32 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.848 -1.538 . . . . 72.01 106.848 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.435 HH22 ' CD2' ' A' ' 404' ' ' LEU . 13.6 mtm-85 -133.48 120.5 20.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.375 -2.084 . . . . 71.41 105.375 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.49 136.51 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 126.149 1.78 . . . . 61.32 110.404 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.35 134.67 45.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.114 -1.595 . . . . 51.03 109.114 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -118.79 -23.23 7.06 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.502 1.521 . . . . 71.12 112.824 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 64.1 p -70.84 158.61 87.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 71.53 106.904 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.09 -10.89 22.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.02 1.813 . . . . 63.05 112.618 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -97.07 -45.51 6.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.661 1.584 . . . . 64.22 109.51 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.4 p -76.51 -19.11 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.245 0.93 . . . . 73.23 113.022 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -52.89 139.27 27.73 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 107.428 -1.323 . . . . 65.31 107.428 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.85 -6.24 56.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.743 -1.032 . . . . 62.24 111.385 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -132.86 159.67 39.17 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 119.281 1.541 . . . . 63.23 111.115 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.36 164.8 32.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.726 1.611 . . . . 64.54 108.468 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.77 125.48 32.06 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.86 -1.534 . . . . 64.12 106.86 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.63 146.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.141 -1.8 . . . . 73.21 106.141 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.692 -2.336 . . . . 73.4 104.692 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 22.0 m-85 -97.56 144.59 27.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.937 . . . . 74.45 108.471 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.15 -30.65 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 75.14 110.162 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -121.3 126.49 49.65 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.47 1.108 . . . . 74.41 109.487 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.73 -34.97 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.139 0.427 . . . . 73.03 111.621 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -61.45 -46.17 91.22 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.303 0.641 . . . . 73.11 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -67.6 -30.07 69.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.578 0.626 . . . . 73.12 110.139 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -62.44 -49.3 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.807 -1.183 . . . . 63.0 107.807 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -60.29 -43.75 95.98 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 109.026 -0.731 . . . . 61.41 109.026 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.03 -58.03 9.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.008 0.923 . . . . 75.41 110.814 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.41 -33.49 71.3 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.264 1.026 . . . . 64.54 110.279 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.8 t -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.62 1.1 . . . . 63.11 109.289 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -48.32 45.84 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.947 -1.095 . . . . 70.3 111.711 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -65.13 -17.55 64.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.084 1.142 . . . . 75.4 114.084 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 tp -107.39 -17.54 14.1 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.988 1.267 . . . . 65.01 113.101 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -65.11 105.47 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.912 -0.493 . . . . 65.31 110.368 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.08 16.72 46.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.215 -1.325 . . . . 54.4 114.808 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.96 111.17 4.81 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.412 1.606 . . . . 74.52 109.028 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.88 120.08 19.94 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.004 0.921 . . . . 72.42 110.039 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -149.72 149.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.802 -1.555 . . . . 65.34 106.802 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 15.9 m 51.84 32.52 9.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.683 1.193 . . . . 74.53 112.711 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.54 30.63 17.57 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.761 1.624 . . . . 72.42 111.46 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -135.43 167.32 21.28 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 127.735 2.414 . . . . 62.41 108.076 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -115.27 124.17 50.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.148 0.979 . . . . 74.31 110.908 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -77.97 156.21 30.34 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.31 -1.367 . . . . 72.44 107.31 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.27 140.23 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.474 -1.676 . . . . 71.53 106.474 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.27 153.88 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.649 1.58 . . . . 64.12 107.308 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -157.06 165.88 34.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.466 1.506 . . . . 63.23 108.646 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -102.83 164.84 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.73 2.812 . . . . 75.33 110.76 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -114.79 160.76 19.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.206 -1.405 . . . . 75.04 107.206 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 115.985 -1.959 . . . . 74.02 111.38 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 111.742 0.275 . . . . 75.1 111.742 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.35 -44.37 62.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.869 1.268 . . . . 74.15 111.832 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.07 -22.55 62.1 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.623 0.369 . . . . 61.24 110.718 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.5 mtp -70.59 -38.59 74.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.629 -0.7 . . . . 65.14 109.517 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -72.18 155.54 91.52 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 119.352 0.978 . . . . 71.11 112.084 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.471 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 71.8 Cg_endo -72.84 167.4 27.35 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.185 2.59 . . . . 61.11 111.372 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -79.45 153.32 29.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.309 1.444 . . . . 75.02 111.4 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.76 24.23 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.797 -1.001 . . . . 73.15 114.88 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.471 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 13.1 m-85 -124.54 158.01 33.97 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.528 1.664 . . . . 74.4 111.901 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -127.28 133.95 50.1 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.457 1.503 . . . . 70.02 107.784 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.09 150.72 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.229 -1.397 . . . . 72.25 107.229 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.8 tp -125.07 78.02 66.71 Favored Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 108.667 -0.864 . . . . 63.13 108.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -56.76 162.79 8.11 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.076 2.517 . . . . 71.43 111.315 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 159.73 51.11 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.102 1.868 . . . . 73.24 110.914 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.452 -0.943 0 C-N-CA 122.671 2.247 . . . . 74.31 112.288 179.809 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.114 -1.439 . . . . 72.02 107.114 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.04 148.87 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.173 -1.788 . . . . 62.34 106.173 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.73 83.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 39.9 mt -68.56 116.08 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 125.934 1.694 . . . . 61.31 111.636 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 25.4 mt -104.2 149.15 25.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.111 -1.07 . . . . 75.41 108.111 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -123.7 137.56 54.68 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.511 -2.403 . . . . 63.14 104.511 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.427 ' HB ' HD11 ' B' ' 26' ' ' LEU . 6.3 mm -125.41 151.2 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.583 -1.636 . . . . 74.43 106.583 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -136.27 164.28 28.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.549 1.94 . . . . 73.51 108.461 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.53 13.56 8.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.546 1.938 . . . . 71.15 111.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' B' ' 23' ' ' ILE . 67.6 mt -66.06 155.99 85.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.94 1.296 . . . . 70.43 112.715 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.59 153.3 72.58 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.11 2.54 . . . . 72.03 111.192 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -86.19 -19.81 29.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 74.34 110.496 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -130.39 115.59 17.09 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.797 1.639 . . . . 73.22 107.05 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 157.05 5.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.845 -1.168 . . . . 71.41 107.845 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 15.5 p -101.89 164.49 11.69 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.215 1.406 . . . . 44.02 110.363 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.4 84.27 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.504 -1.665 . . . . 65.0 106.504 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.46 -37.13 77.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.629 2.372 . . . . 63.24 111.16 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.61 -47.87 16.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.204 -0.935 . . . . 62.41 109.645 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.8 mmm -58.33 -42.86 87.75 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.336 0.516 . . . . 74.0 110.859 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -73.55 -34.95 65.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.932 -0.556 . . . . 64.54 111.444 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.25 -58.08 5.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.994 0.815 . . . . 75.45 111.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mt -52.16 -62.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.461 1.504 . . . . 62.41 110.734 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -64.96 -22.84 67.07 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 119.019 -0.515 . . . . 65.11 111.406 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -29.11 68.09 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 125.834 1.683 . . . . 62.41 111.171 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -61.44 -24.26 66.41 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.369 1.584 . . . . 75.51 110.185 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -88.94 -46.89 8.54 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.671 0.788 . . . . 73.54 110.386 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.17 -171.51 43.94 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 119.499 1.045 . . . . 72.22 114.835 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.47 116.57 3.71 Favored 'Trans proline' 0 C--N 1.347 0.477 1 C-N-CA 125.711 4.274 . . . . 72.15 113.985 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.1 mt -83.46 125.79 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.558 1.143 . . . . 73.12 109.731 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.36 -60.41 2.04 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.422 -1.325 . . . . 73.15 107.422 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -156.57 149.43 23.86 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.203 0.911 . . . . 74.1 109.497 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 29.5 mt -129.53 144.2 38.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.943 2.097 . . . . 74.13 108.48 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -141.96 154.79 45.31 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.335 -1.728 . . . . 71.54 106.335 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.01 165.7 19.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 71.43 109.354 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 145.78 49.39 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.532 -1.027 . . . . 43.4 110.532 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -105.18 -52.69 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.738 -1.208 . . . . 74.15 107.738 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 70.2 p -69.89 156.99 90.82 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 124.204 1.002 . . . . 74.42 109.825 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.81 -39.21 64.31 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.613 1.542 . . . . 62.02 109.796 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.64 -7.2 24.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.502 1.121 . . . . 75.33 113.398 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 8.3 p -102.25 -4.43 25.72 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.571 1.078 . . . . 64.13 109.651 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -69.86 150.04 47.23 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.156 -1.59 . . . . 71.24 108.32 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.18 -7.52 64.36 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.16 -1.356 . . . . 65.13 113.73 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.4 p -140.51 162.75 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.212 2.006 . . . . 44.21 107.346 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.424 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -165.66 173.63 10.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 61.3 109.98 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.63 144.72 50.82 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.801 0.841 . . . . 71.52 109.694 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 86.4 t -133.5 141.1 45.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.408 1.083 . . . . 74.14 108.626 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.92 130.64 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 106.454 -1.684 . . . . 65.25 106.454 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 45.0 m-85 -104.09 166.35 10.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.869 2.068 . . . . 72.45 107.49 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.31 -69.54 0.3 Allowed 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.366 -0.834 . . . . 71.25 111.866 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.67 151.11 21.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.517 1.053 . . . . 73.25 110.642 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.5 tt -61.75 -33.86 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.483 0.713 . . . . 73.21 111.781 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -69.03 -47.67 64.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.103 -0.703 . . . . 71.44 109.103 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.04 -46.09 85.92 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -57.43 -54.85 42.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.161 1.385 . . . . 72.21 111.432 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -52.08 -36.83 51.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.706 1.202 . . . . 71.51 113.172 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -69.27 -36.3 76.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.896 0.771 . . . . 71.55 110.35 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.44 -32.06 71.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.108 0.867 . . . . 72.54 110.642 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 61.3 m -55.84 -41.57 74.49 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.075 0.55 . . . . 75.11 110.516 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -84.67 -35.98 22.23 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.547 0.739 . . . . 73.23 111.54 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -15.82 63.1 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.277 -0.889 . . . . 63.4 112.524 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.7 tp -104.84 -16.15 14.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.053 0.842 . . . . 41.22 112.206 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -72.2 134.67 45.79 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.446 -1.409 . . . . 72.22 110.085 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.32 10.1 84.38 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.777 1.18 . . . . 64.1 113.193 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -72.34 120.74 18.37 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.874 1.27 . . . . 71.43 110.078 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -87.79 120.07 28.75 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.19 1.796 . . . . 75.04 107.466 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.96 135.94 42.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.367 -0.975 . . . . 75.44 108.367 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.3 m 46.58 47.14 14.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.422 1.489 . . . . 71.51 112.194 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 18.0 m120 54.72 30.74 14.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.511 1.524 . . . . 63.02 112.786 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -136.2 -179.87 5.93 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.325 2.65 . . . . 74.53 106.48 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -139.59 133.84 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.326 -1.731 . . . . 60.05 106.326 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.89 172.79 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.352 -0.981 . . . . 71.53 108.352 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.59 140.13 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.28 -2.489 . . . . 65.43 104.28 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.81 142.72 41.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.807 1.243 . . . . 72.5 108.676 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -153.29 150.33 28.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.162 0.985 . . . . 71.32 109.665 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -85.55 163.49 18.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.098 1.359 . . . . 71.32 110.562 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -77.9 167.17 21.92 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.547 -0.538 . . . . 71.42 109.547 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.248 1.023 0 N-CA-C 105.422 -2.066 . . . . 61.35 105.422 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.2 tp . . . . . 0 C--O 1.223 -0.338 0 N-CA-C 106.971 -1.492 . . . . 72.35 106.971 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -65.45 -44.32 87.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.298 0.954 . . . . 71.41 110.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.84 60.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.502 1.121 . . . . 42.13 113.485 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.9 mtp -79.39 -6.6 57.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.062 1.345 . . . . 73.13 113.068 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -107.58 159.25 30.99 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 114.55 1.315 . . . . 72.02 114.55 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.66 158.94 54.87 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.215 3.276 . . . . 54.31 112.538 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -75.28 147.78 39.94 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.497 1.519 . . . . 75.11 109.165 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.35 17.41 62.52 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.529 -0.732 . . . . 51.44 114.656 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -124.35 102.97 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 105.325 -2.102 . . . . 73.02 105.325 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -83.78 155.39 23.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.508 1.123 . . . . 65.24 110.684 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.1 t -70.05 144.38 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.003 0.921 . . . . 62.23 110.193 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 50.7 tp -126.38 79.55 70.38 Favored Pre-proline 0 N--CA 1.452 -0.339 0 N-CA-C 107.346 -1.353 . . . . 71.44 107.346 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.18 163.81 37.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.124 1.883 . . . . 75.2 110.023 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.11 161.45 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.556 2.171 . . . . 73.01 109.774 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.451 -0.982 0 C-N-CA 121.43 1.42 . . . . 54.35 109.375 179.517 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.9 t . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 107.817 -1.179 . . . . 74.13 107.817 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -133.69 -176.97 4.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.4 1.88 . . . . 72.01 108.924 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.77 -43.86 5.45 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.649 -1.282 . . . . 75.23 111.607 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.5 mt -73.68 144.03 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.394 -1.335 . . . . 75.13 107.394 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 88.0 mt -124.18 157.2 35.28 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.737 1.615 . . . . 54.41 108.565 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -124.31 133.52 53.44 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.392 2.277 . . . . 71.32 106.837 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -120.29 146.95 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.601 1.16 . . . . 75.14 108.283 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -135.59 163.02 31.07 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.157 1.383 . . . . 74.0 109.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 65.08 14.69 9.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.952 2.101 . . . . 70.3 113.851 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.54 153.13 91.07 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 120.796 -1.19 . . . . 73.15 109.588 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.47 140.11 56.34 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.762 2.308 . . . . 74.53 110.532 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.58 -30.1 71.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.913 1.079 . . . . 75.03 113.913 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -130.26 117.91 20.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.888 -1.523 . . . . 72.25 106.888 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 tt -165.88 140.89 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.958 2.503 . . . . 72.23 104.366 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 18.0 p -75.12 174.4 9.47 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.027 0.831 . . . . 64.22 109.944 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.06 76.21 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 107.126 -1.435 . . . . 52.05 107.126 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -47.84 -54.3 12.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 128.326 2.65 . . . . 71.22 112.739 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -62.21 -49.51 75.48 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.36 0.527 . . . . 75.12 110.099 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 72.3 mmm -56.26 -49.44 74.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 119.213 -0.422 . . . . 75.2 111.088 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' TYR . . . . . 0.407 ' CZ ' HD12 ' B' ' 48' ' ' ILE . 14.8 m-85 -61.51 -43.96 97.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.559 -1.21 . . . . 73.25 110.009 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -58.59 7.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.105 -1.072 . . . . 43.25 108.105 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 64.2 mt -47.61 -67.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.854 2.062 . . . . 64.45 112.345 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -68.34 -26.93 65.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.281 0.845 . . . . 74.21 113.281 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 -20.65 66.44 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 124.874 1.226 . . . . 64.34 112.983 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -26.75 68.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.387 1.593 . . . . 75.41 110.486 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -85.88 -10.16 55.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.784 0.661 . . . . 74.04 112.784 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.96 -171.59 22.37 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.355 0.98 . . . . 40.33 111.54 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.75 153.14 73.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.776 2.984 . . . . 70.3 111.36 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mt -118.21 138.25 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.286 -1.005 . . . . 71.21 108.286 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -51.9 9.78 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.17 1.388 . . . . 70.12 111.485 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -161.9 157.58 24.08 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.76 0.824 . . . . 74.34 109.473 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ILE . . . . . 0.407 HD12 ' CZ ' ' B' ' 36' ' ' TYR . 21.4 mt -145.78 142.36 21.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.993 1.317 . . . . 73.33 108.268 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -145.45 150.76 37.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.763 -1.569 . . . . 72.42 106.763 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.16 147.27 30.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.468 0.707 . . . . 65.44 109.656 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.28 135.6 31.77 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.328 -1.909 . . . . 75.41 108.328 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.95 -21.36 5.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.876 1.065 . . . . 62.22 113.876 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.7 p -69.69 159.8 82.35 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 104.56 -2.385 . . . . 72.14 104.56 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.02 -45.36 36.56 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.505 1.47 . . . . 75.52 111.241 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.07 -5.8 29.3 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.826 1.417 . . . . 73.54 114.826 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -116.45 -18.07 10.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.293 1.406 . . . . 64.22 112.799 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -52.55 126.96 21.21 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.822 0.849 . . . . 75.44 109.686 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.05 48.33 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.459 -1.19 . . . . 70.13 112.653 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 61.6 p -127.56 146.81 50.4 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.03 1.915 . . . . 70.21 107.535 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -156.23 174.26 15.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.614 0.366 . . . . 41.21 111.229 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.14 155.46 48.13 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.396 1.078 . . . . 74.52 109.17 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -138.63 139.83 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 104.412 -2.44 . . . . 73.1 104.412 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.39 123.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.56 -2.015 . . . . 53.35 105.56 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -97.91 166.15 11.59 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.827 -1.546 . . . . 71.42 106.827 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -71.28 -47.6 55.9 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.754 -0.591 . . . . 72.44 109.774 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.86 154.6 38.06 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.911 0.778 . . . . 73.15 110.737 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.93 -37.5 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 113.736 1.013 . . . . 72.0 113.736 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -57.95 -48.23 80.58 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.161 -0.923 . . . . 75.03 111.528 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.14 -40.87 95.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 123.935 0.772 . . . . 72.24 109.349 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -54.71 42.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.156 -0.313 . . . . 54.21 110.156 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -69.76 -30.18 67.7 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.523 -0.751 . . . . 64.34 111.894 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.67 -53.97 51.79 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.109 -1.071 . . . . 72.33 108.109 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.03 93.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.417 1.087 . . . . 63.5 110.611 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 13.3 t -46.56 -69.16 0.14 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.823 1.249 . . . . 73.44 113.018 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.39 -27.77 67.37 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.074 1.138 . . . . 71.21 114.074 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -33.71 72.49 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.775 0.716 . . . . 73.13 109.607 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -90.01 -24.91 21.09 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.987 1.315 . . . . 71.33 112.992 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -57.34 111.26 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.481 1.512 . . . . 42.53 110.675 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.11 9.85 57.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.324 1.916 . . . . 74.02 114.43 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -61.74 130.03 43.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.543 1.671 . . . . 73.13 110.363 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -89.84 100.92 13.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.417 2.287 . . . . 64.13 110.653 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.84 133.51 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.402 1.081 . . . . 72.22 110.621 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m 42.79 49.41 5.03 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.827 1.651 . . . . 50.43 112.121 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 32.1 t30 58.94 33.25 22.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.603 2.361 . . . . 64.33 112.878 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -140.16 158.33 44.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.985 -1.072 . . . . 72.12 108.26 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -118.07 118.14 31.09 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.822 -1.547 . . . . 75.13 106.822 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.6 mt -73.63 174.05 8.87 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.692 -1.225 . . . . 65.15 107.692 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.02 137.4 52.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.094 -2.558 . . . . 71.33 104.094 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 t -126.83 121.67 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.743 -1.947 . . . . 74.41 105.743 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 34.6 tp -136.15 153.21 51.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.573 -0.899 . . . . 63.44 108.573 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -74.75 163.11 28.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.694 0.798 . . . . 73.12 108.949 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -104.49 154.58 19.72 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.957 -1.868 . . . . 60.53 105.957 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 C--O 1.246 0.871 0 C-N-CA 124.387 1.075 . . . . 74.1 110.652 -178.587 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 21.8 tp . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 110.302 -0.258 . . . . 53.01 110.302 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.93 -36.87 80.87 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.965 -0.459 . . . . 64.44 111.042 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.5 -37.62 36.27 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.378 1.071 . . . . 33.22 110.851 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.2 mtp -66.41 -12.51 57.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.519 1.128 . . . . 74.43 111.846 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -99.25 157.28 34.32 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 124.095 0.958 . . . . 63.1 110.107 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -89.41 172.5 4.09 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.199 2.599 . . . . 64.21 109.017 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.63 159.34 33.2 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.606 -0.684 . . . . 54.24 110.906 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.2 20.97 58.04 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 117.825 -1.541 . . . . 75.22 115.451 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -125.49 140.09 53.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.985 1.893 . . . . 74.03 110.631 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -122.26 151.28 41.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.572 1.949 . . . . 62.24 109.104 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.86 151.38 6.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 122.563 1.173 . . . . 64.43 110.604 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.0 tp -126.48 87.47 56.3 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 103.398 -2.815 . . . . 74.11 103.398 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -64.01 168.9 11.35 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.222 2.615 . . . . 71.32 111.226 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.74 163.3 35.83 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.37 1.38 . . . . 64.12 108.661 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo . . . . . 0 C--O 1.24 0.579 0 C-N-CA 123.604 2.869 . . . . 73.33 113.745 179.462 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.568 HG11 ' HG2' ' B' ' 71' ' ' LYS . 35.2 t . . . . . 0 C--O 1.236 0.365 0 N-CA-C 107.511 -1.292 . . . . 75.14 107.511 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -61.92 152.52 31.79 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.743 1.217 . . . . 73.24 110.43 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 -59.11 -61.48 2.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.418 -0.801 . . . . 72.13 112.903 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.79 134.41 26.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.005 -0.739 . . . . 74.51 109.005 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.35 157.52 26.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.947 2.099 . . . . 63.25 109.175 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -124.93 135.7 53.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.493 1.917 . . . . 72.32 108.397 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mm -118.12 143.07 29.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 126.193 1.797 . . . . 74.12 108.767 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -133.6 162.59 31.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.324 . . . . 73.44 107.571 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 21.5 t30 65.58 30.23 10.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.422 2.689 . . . . 72.33 111.666 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 50.8 mt -70.06 147.67 95.78 Favored Pre-proline 0 C--O 1.236 0.348 0 O-C-N 121.736 -0.603 . . . . 72.14 111.196 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.99 152.49 68.16 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.826 2.351 . . . . 74.04 110.579 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -83.95 -11.03 57.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.496 0.718 . . . . 72.31 112.107 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.86 113.85 17.12 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.36 -2.089 . . . . 75.54 105.36 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -163.2 167.62 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.785 -1.561 . . . . 73.35 106.785 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -133.98 175.71 9.23 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.203 1.801 . . . . 74.11 111.607 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.02 -35.87 80.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.881 -0.785 . . . . 61.24 108.881 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.43 -50.63 71.1 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.771 -0.455 . . . . 74.23 109.771 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -63.72 -55.07 26.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.582 1.153 . . . . 71.04 111.374 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.8 mmm -57.28 -27.67 62.33 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 113.749 1.018 . . . . 70.53 113.749 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -93.85 -20.62 19.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.909 0.777 . . . . 65.0 111.208 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.9 -52.19 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.219 0.918 . . . . 54.12 110.957 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.99 -52.75 40.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.786 1.634 . . . . 61.22 110.858 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.93 -30.47 39.96 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 118.146 -0.93 . . . . 61.11 113.13 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -31.58 78.55 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.871 -0.892 . . . . 64.2 110.871 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -60.4 -15.35 25.38 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.203 1.401 . . . . 71.45 113.023 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.01 -16.76 14.21 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.315 1.046 . . . . 74.32 113.616 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.1 174.72 29.18 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.055 1.312 . . . . 74.53 110.902 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.48 145.4 64.64 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 124.297 3.331 . . . . 63.21 110.946 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 24.4 mt -99.78 124.68 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.547 1.139 . . . . 55.11 111.231 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -83.19 -56.34 3.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.56 -1.274 . . . . 74.02 107.56 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -157.72 152.85 25.72 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.426 1.012 . . . . 64.3 112.456 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mt -134.46 118.29 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.963 2.105 . . . . 70.02 107.627 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -127.21 120.34 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.119 -2.178 . . . . 73.23 105.119 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.41 159.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.235 2.214 . . . . 73.22 111.095 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.88 146.69 38.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.107 -1.597 . . . . 40.24 109.107 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -112.73 -45.61 3.2 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.471 1.108 . . . . 73.1 111.61 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 15.6 p -74.42 162.14 75.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.941 1.696 . . . . 63.33 111.858 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.88 9.29 2.03 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.626 2.884 . . . . 60.44 112.319 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.64 1.51 11.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.889 1.276 . . . . 71.13 111.521 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 35.6 p -116.75 -1.2 12.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.801 2.04 . . . . 74.02 109.461 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -63.77 145.9 54.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.806 2.042 . . . . 71.13 112.194 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.52 6.16 70.05 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.851 -0.971 . . . . 74.15 112.873 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 21.1 p -141.1 150.35 42.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.041 1.42 . . . . 64.22 110.613 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.92 171.32 14.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.444 1.498 . . . . 74.41 109.107 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -118.11 159.98 22.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.245 1.018 . . . . 71.13 109.428 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.36 139.11 47.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.278 -1.379 . . . . 74.22 107.278 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 t -127.71 123.74 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.757 -1.942 . . . . 73.24 105.757 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.3 165.78 11.52 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 105.13 -2.174 . . . . 63.44 105.13 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -73.32 -35.0 65.99 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.291 -0.881 . . . . 74.24 112.052 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.2 162.52 22.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.946 0.794 . . . . 75.55 112.54 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 tt -67.84 -43.49 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.051 0.94 . . . . 65.21 109.596 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.98 -41.81 99.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.754 1.222 . . . . 74.44 111.474 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.49 -44.92 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.511 -0.922 . . . . 54.22 108.511 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.42 85.79 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.129 0.572 . . . . 62.44 109.524 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.568 ' HG2' HG11 ' B' ' 17' ' ' VAL . 41.2 mtpt -59.24 -48.87 79.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.375 1.07 . . . . 72.42 111.111 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.79 -40.01 94.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.326 0.967 . . . . 52.32 110.827 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.62 66.83 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.638 -0.696 . . . . 65.1 111.486 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.56 -64.37 0.97 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 117.85 -1.071 . . . . 73.34 109.319 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.34 -33.67 74.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.125 1.329 . . . . 70.33 112.969 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -64.47 -31.07 72.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.043 0.383 . . . . 74.33 110.262 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.4 tp -102.47 -26.23 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.882 1.438 . . . . 73.23 114.882 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -61.8 106.31 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.364 1.865 . . . . 75.52 110.34 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.54 10.74 63.19 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.55 -1.139 . . . . 51.44 113.19 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.22 121.26 10.93 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.934 1.367 . . . . 71.45 109.894 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.83 112.19 15.74 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.08 1.752 . . . . 64.31 107.815 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.97 148.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.348 0.659 . . . . 74.23 110.589 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 87.6 m 34.0 54.95 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.294 2.638 . . . . 65.25 114.588 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 52.33 31.26 9.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.859 2.064 . . . . 43.42 112.452 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -140.23 -170.71 3.03 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 128.781 2.833 . . . . 43.44 107.864 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -148.64 153.0 37.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.87 2.068 . . . . 64.34 105.741 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.1 172.84 6.6 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.421 -0.955 . . . . 73.44 108.421 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.21 150.66 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.068 -1.456 . . . . 75.12 107.068 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.1 136.17 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.476 1.91 . . . . 54.41 107.626 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.3 tp -146.61 151.61 37.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.209 1.803 . . . . 71.03 107.824 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' TYR . . . . . 0.46 ' CZ ' HG13 ' B' ' 17' ' ' VAL . 7.0 m-85 -94.6 155.82 16.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.029 0.931 . . . . 73.32 111.288 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -80.5 175.55 10.56 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.212 0.605 . . . . 75.0 112.52 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 125.931 1.692 . . . . 75.51 109.985 -179.094 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 61.8 tp . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 118.543 -0.741 . . . . 53.32 110.273 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -66.52 -32.51 73.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.822 1.192 . . . . 53.35 110.018 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.84 56.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.331 1.052 . . . . 75.42 111.917 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 67.3 mtp -88.17 -12.26 44.45 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.293 1.437 . . . . 74.55 113.245 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -114.61 160.81 31.75 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 125.707 1.603 . . . . 54.54 111.59 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.25 167.42 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.232 1.954 . . . . 71.11 110.151 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.87 169.95 15.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.403 0.681 . . . . 71.41 110.306 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 80.51 22.42 62.37 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.034 -1.041 . . . . 72.21 113.277 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -124.58 156.86 36.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.851 -1.166 . . . . 74.43 107.851 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.0 149.47 47.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.032 0.933 . . . . 42.45 110.09 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.63 151.12 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.076 -0.712 . . . . 73.43 109.076 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.419 HD22 HG11 ' B' ' 50' ' ' VAL . 34.2 tp -131.09 82.98 61.93 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 107.978 -1.119 . . . . 70.32 107.978 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.45 164.18 7.49 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.872 3.048 . . . . 71.11 112.236 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.46 162.38 20.92 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.053 2.502 . . . . 72.53 112.648 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo . . . . . 0 N--CA 1.458 -0.606 0 C-N-CA 122.879 2.386 . . . . 73.31 110.485 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 t . . . . . 0 C--O 1.233 0.2 0 N-CA-C 106.307 -1.738 . . . . 65.53 106.307 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -134.46 158.84 42.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.494 -1.298 . . . . 64.13 107.494 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -65.42 -23.37 66.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 117.811 -1.09 . . . . 61.13 113.084 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 66.9 mt -89.53 126.11 42.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.441 -2.059 . . . . 75.43 105.441 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 95.0 mt -120.47 163.27 18.19 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.498 1.519 . . . . 64.42 109.229 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -129.29 136.49 50.12 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.211 1.804 . . . . 75.11 108.295 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mm -129.41 149.86 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.108 0.963 . . . . 73.35 108.5 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.469 ' HE ' HG11 ' B' ' 88' ' ' VAL . 56.1 mtm180 -139.49 163.87 31.39 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.813 1.645 . . . . 74.43 108.088 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 71.27 19.34 5.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.935 1.694 . . . . 72.05 111.222 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.86 155.4 89.86 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.119 0.968 . . . . 73.01 111.511 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.51 147.37 70.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.325 2.017 . . . . 71.43 107.31 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -82.8 -17.59 43.56 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.732 -0.605 . . . . 75.22 112.333 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -124.72 91.61 3.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.171 0.989 . . . . 75.34 110.572 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -146.69 139.15 19.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.191 -1.04 . . . . 70.1 108.191 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 1.2 p -89.26 164.7 14.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.368 1.067 . . . . 71.35 109.595 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.46 -23.43 65.86 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.594 -0.521 . . . . 74.35 109.594 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.5 -57.61 11.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.521 2.728 . . . . 63.44 110.215 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -72.26 -35.11 68.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.81 0.844 . . . . 73.1 109.933 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.6 mmm -63.43 -48.94 75.7 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.957 -0.757 . . . . 71.25 108.957 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.19 -29.83 70.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.385 -0.817 . . . . 75.44 110.387 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.75 -65.17 0.72 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.471 -0.937 . . . . 74.54 108.471 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.77 -60.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 126.128 1.771 . . . . 74.33 111.92 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -68.64 -17.16 64.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.106 -0.473 . . . . 72.54 112.047 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.96 -27.45 34.2 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.264 1.411 . . . . 41.21 113.068 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -52.59 -40.67 62.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.591 1.696 . . . . 64.11 109.507 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -77.0 -11.77 59.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 116.795 2.146 . . . . 75.15 116.795 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.97 20.53 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.362 1.437 . . . . 75.23 111.49 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.56 147.26 90.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.219 2.613 . . . . 63.23 111.666 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.9 131.7 50.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.55 1.54 . . . . 63.32 109.545 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.77 -58.08 3.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.375 -1.343 . . . . 54.41 107.375 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -162.85 160.86 25.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 0.667 . . . . 64.23 110.594 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mt -142.29 145.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.298 1.839 . . . . 75.44 108.548 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -140.59 144.44 35.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 104.377 -2.453 . . . . 64.02 104.377 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' VAL . . . . . 0.419 HG11 HD22 ' A' ' 415' ' ' LEU . 17.3 m -129.35 162.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.315 1.046 . . . . 62.41 111.563 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.55 146.0 39.73 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.003 -0.839 . . . . 43.34 111.003 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -124.36 -0.63 8.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.652 1.581 . . . . 70.14 112.589 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -127.02 164.06 37.68 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.378 1.871 . . . . 73.05 109.814 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 -25.64 80.31 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.732 2.288 . . . . 60.1 113.956 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -93.39 1.58 56.84 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.73 1.15 . . . . 73.13 111.542 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.6 p -117.11 -28.78 6.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.283 1.033 . . . . 71.51 111.568 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 139.52 58.48 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.056 -1.028 . . . . 72.3 108.438 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.63 -23.51 35.86 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.302 1.43 . . . . 54.31 113.345 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.3 p -119.69 157.52 28.35 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 107.651 -1.24 . . . . 74.0 107.651 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.13 175.26 10.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.348 -0.845 . . . . 64.2 111.025 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -134.1 141.54 47.18 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.705 -1.22 . . . . 73.51 107.705 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 88.6 t -125.73 149.54 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.578 -1.638 . . . . 70.34 106.578 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t -127.73 132.6 68.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.48 -0.933 . . . . 74.1 108.48 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -101.09 164.02 12.01 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.667 -1.605 . . . . 74.5 106.667 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.7 -33.01 20.17 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.8 -1.187 . . . . 75.31 110.087 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -123.57 138.37 54.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.636 0.774 . . . . 74.23 109.868 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 tt -60.1 -30.55 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.594 -1.262 . . . . 73.13 107.594 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -60.46 -22.99 64.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.324 1.05 . . . . 74.23 111.647 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.23 -43.95 10.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.359 0.981 . . . . 70.31 108.441 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.21 74.67 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.226 -0.657 . . . . 70.23 109.226 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.35 -54.43 47.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.208 1.403 . . . . 72.23 109.817 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -64.88 -51.91 59.44 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.12 0.568 . . . . 73.33 110.955 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.39 -29.5 61.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.716 0.635 . . . . 54.31 112.716 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -64.37 0.98 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.061 -1.088 . . . . 75.22 108.061 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.55 -32.73 73.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.755 -0.64 . . . . 74.03 111.953 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -78.77 -16.4 57.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.612 0.967 . . . . 62.53 113.612 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 24.3 tp -110.68 -19.01 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.282 1.401 . . . . 73.2 112.331 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 83.9 p -58.26 118.05 5.08 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.061 1.345 . . . . 71.44 112.479 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.76 82.62 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.885 -1.508 . . . . 72.03 113.616 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.3 122.93 13.69 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.632 1.716 . . . . 72.14 108.728 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -96.72 115.73 27.93 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 126.079 1.752 . . . . 71.25 110.134 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 m -144.5 159.01 14.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.199 1.4 . . . . 74.21 107.535 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 69.1 m 43.85 41.56 3.89 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.206 1.402 . . . . 55.21 112.472 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 63.1 t30 56.75 21.77 6.27 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.632 2.373 . . . . 71.31 113.659 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -132.59 -179.3 5.37 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.874 2.07 . . . . 75.14 108.385 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -122.61 147.61 46.22 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.647 -1.612 . . . . 71.52 106.647 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 33.7 mt -96.31 156.39 16.36 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.343 -0.984 . . . . 71.35 108.343 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' VAL . . . . . 0.469 HG11 ' HE ' ' B' ' 24' ' ' ARG . 70.9 t -110.41 128.55 66.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.955 -2.609 . . . . 63.01 103.955 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 94.4 t -124.7 111.89 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.05 -1.833 . . . . 63.45 106.05 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -136.5 164.35 28.37 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.292 1.037 . . . . 44.31 110.963 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -89.27 163.11 15.51 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.17 1.388 . . . . 72.03 111.364 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -101.24 169.1 9.13 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.567 -2.012 . . . . 74.05 105.567 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.46 -0.941 . . . . 55.1 108.46 -179.734 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 34.0 tp . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 119.444 -0.313 . . . . 53.44 111.135 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.5 -9.47 58.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.814 0.733 . . . . 75.32 112.239 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -123.22 -6.94 8.26 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.11 1.764 . . . . 74.33 112.504 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 57.7 mtp -73.73 -24.72 59.94 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.338 -1.476 . . . . 61.44 114.682 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -83.37 153.37 65.57 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 118.814 0.734 . . . . 74.22 111.546 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.74 172.14 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.477 3.451 . . . . 63.31 112.505 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -81.99 157.6 24.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.662 1.985 . . . . 73.41 110.388 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.38 19.08 53.89 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.052 0.834 . . . . 61.25 112.577 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -124.06 158.18 32.79 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.513 1.125 . . . . 74.35 111.338 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -129.21 145.64 51.29 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.909 1.684 . . . . 73.23 107.015 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.1 t -74.25 151.07 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.605 -0.887 . . . . 75.0 108.605 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.5 tp -124.19 85.51 54.98 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 105.062 -2.199 . . . . 73.31 105.062 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.23 167.9 10.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.432 2.755 . . . . 73.31 112.252 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.19 164.28 36.29 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.353 2.035 . . . . 54.11 110.107 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 123.925 3.083 . . . . 71.02 112.801 179.214 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 107.404 -1.332 . . . . 64.44 107.404 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -140.45 168.02 20.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.875 1.27 . . . . 55.15 110.273 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -82.57 -9.0 59.59 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.476 -1.39 . . . . 60.34 111.617 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 30.6 mt -106.18 141.26 21.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.321 -1.363 . . . . 65.01 107.321 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -116.24 151.59 35.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.603 1.561 . . . . 51.02 108.039 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -121.32 122.27 39.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.01 1.724 . . . . 53.13 106.696 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -114.07 147.95 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.12 1.768 . . . . 71.14 109.426 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -142.69 163.79 31.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.004 1.722 . . . . 64.44 111.362 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t30 74.56 18.19 2.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.18 2.592 . . . . 70.31 111.691 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 mt -70.03 153.37 95.42 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 124.452 1.101 . . . . 73.21 110.737 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.08 159.57 47.38 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.319 2.679 . . . . 73.11 110.757 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.27 -11.01 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.108 -0.37 . . . . 72.44 111.183 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -127.39 104.47 7.94 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.326 -2.102 . . . . 70.44 105.326 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 tt -158.58 155.08 4.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.193 1.397 . . . . 61.11 108.596 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -105.28 169.81 8.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.304 1.442 . . . . 73.53 111.106 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.11 84.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.05 -1.093 . . . . 73.55 108.05 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.1 -45.8 91.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.45 1.5 . . . . 61.54 111.675 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.74 -37.8 85.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.262 0.625 . . . . 54.11 110.628 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.9 mmm -73.81 -53.31 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.809 1.243 . . . . 65.42 111.736 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -59.79 -30.07 68.65 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 118.386 -0.816 . . . . 73.42 111.323 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.52 -61.32 2.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.991 0.814 . . . . 73.04 109.417 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 -65.4 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 125.781 1.633 . . . . 73.52 112.625 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -63.32 -34.45 77.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.596 0.961 . . . . 74.24 113.596 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.53 -24.22 77.08 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.088 0.858 . . . . 61.43 112.028 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -64.01 -14.67 55.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.022 0.911 . . . . 64.52 113.077 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -105.08 -4.48 21.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.566 1.546 . . . . 75.54 111.771 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.71 173.38 13.16 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.426 1.012 . . . . 71.21 111.637 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.53 128.85 21.03 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.544 2.829 . . . . 62.03 112.04 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.76 135.7 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.57 1.548 . . . . 62.42 108.179 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -81.25 -62.69 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 106.559 -1.645 . . . . 75.22 106.559 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -151.87 160.98 43.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.557 0.617 . . . . 73.21 111.886 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.96 134.55 48.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 126.923 2.089 . . . . 63.13 107.019 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -130.2 128.11 41.04 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.585 -2.006 . . . . 72.42 105.585 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 m -108.76 147.33 13.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.791 1.236 . . . . 52.15 109.009 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.35 135.24 14.97 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.471 -1.052 . . . . 72.02 110.471 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.96 -15.05 9.35 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.232 1.197 . . . . 63.32 114.232 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 21.6 p -77.71 160.21 75.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.411 -1.7 . . . . 74.45 106.411 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.54 -20.43 49.54 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.282 1.988 . . . . 73.21 114.021 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.74 -21.24 20.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.982 0.913 . . . . 64.4 113.064 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 80.4 p -101.58 -12.33 18.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.891 0.768 . . . . 72.02 112.374 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 -64.02 116.5 5.94 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.066 -1.457 . . . . 73.13 107.066 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.93 16.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.7 -1.056 . . . . 51.42 112.753 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -128.5 159.34 35.78 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 118.518 1.159 . . . . 65.41 108.26 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.98 170.38 20.69 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.291 -0.881 . . . . 71.32 110.503 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -122.31 142.57 50.35 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.716 -1.216 . . . . 73.12 107.716 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.06 137.63 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 126.174 1.79 . . . . 74.41 106.775 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -129.03 128.35 67.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 118.422 -0.799 . . . . 63.15 109.893 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -97.45 166.15 11.66 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.609 1.164 . . . . 73.33 107.878 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -74.92 -55.3 5.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.923 0.889 . . . . 75.34 108.72 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.98 121.44 32.08 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 114.274 1.213 . . . . 62.04 114.274 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.4 tt -66.08 -19.41 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.681 -0.489 . . . . 74.41 109.681 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.9 -60.83 2.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.322 1.049 . . . . 73.34 108.387 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.08 -36.69 70.88 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.785 0.834 . . . . 71.03 111.738 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -29.69 62.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.247 0.476 . . . . 74.22 112.014 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -80.05 -46.11 17.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.946 -1.096 . . . . 72.04 108.404 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -57.22 -32.2 66.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.268 0.556 . . . . 72.2 110.592 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.25 -43.95 18.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.269 1.428 . . . . 64.14 111.769 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 11.5 p -55.83 -42.36 75.6 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.198 0.908 . . . . 71.4 110.906 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.64 -18.17 62.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.401 0.519 . . . . 63.41 112.401 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -95.53 -17.88 21.07 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.678 0.791 . . . . 71.15 112.037 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 12.0 tp -101.52 -3.5 28.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.701 0.682 . . . . 74.23 112.534 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.7 p -68.08 134.9 51.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.652 1.215 . . . . 73.02 111.505 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.38 62.44 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.219 -0.926 . . . . 60.13 113.013 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -68.49 141.33 55.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.109 1.455 . . . . 73.31 110.876 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -90.45 127.66 36.28 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.821 1.248 . . . . 74.22 109.286 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.01 125.39 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 127.779 2.432 . . . . 54.14 109.034 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 72.5 m 50.78 41.98 27.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.779 1.232 . . . . 73.42 110.738 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 20.2 m120 61.19 14.64 5.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.476 1.91 . . . . 62.42 113.469 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -122.06 169.77 10.51 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.626 1.971 . . . . 74.02 107.461 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -107.22 -177.0 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.085 -1.079 . . . . 72.44 108.085 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.62 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.555 2.342 . . . . 54.43 106.072 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -133.25 110.52 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.627 -1.619 . . . . 44.33 106.627 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.88 144.59 9.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.007 -1.479 . . . . 75.43 107.007 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 tp -154.27 154.7 33.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.089 1.356 . . . . 43.31 107.342 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -81.24 164.28 22.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.841 1.656 . . . . 64.02 110.482 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -101.06 157.79 16.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.874 0.47 . . . . 73.25 110.229 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 36.0 m120 . . . . . 0 C--O 1.256 1.41 0 CA-C-O 115.945 -1.978 . . . . 62.3 110.229 -179.39 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 110.489 -0.189 . . . . 72.01 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -79.69 -51.51 9.14 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.907 -0.775 . . . . 74.02 108.907 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.19 89.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.511 1.924 . . . . 61.41 113.291 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.0 mtp -57.94 -36.87 73.12 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.307 1.043 . . . . 73.05 113.377 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -68.47 149.92 97.86 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.374 0.988 . . . . 74.11 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.44 160.47 47.68 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.162 1.908 . . . . 64.4 111.064 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -71.06 160.87 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.72 -1.127 . . . . 71.21 109.525 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.72 17.46 63.65 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 121.651 -0.655 . . . . 62.01 113.296 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -124.47 156.96 36.36 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.487 1.515 . . . . 75.11 108.009 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -136.68 144.58 44.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.733 1.213 . . . . 63.14 109.549 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.8 t -70.91 151.18 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.566 -0.901 . . . . 53.1 108.566 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 17.8 tp -120.72 83.44 35.75 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.699 1.6 . . . . 64.23 108.378 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.28 162.26 17.68 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.2 2.6 . . . . 53.44 112.909 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.65 168.39 22.84 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.109 3.206 . . . . 75.42 111.094 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 CA--C 1.539 0.76 0 C-N-CA 122.434 2.089 . . . . 75.45 109.855 177.662 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.2 t . . . . . 0 C--O 1.236 0.367 0 N-CA-C 108.501 -0.926 . . . . 31.35 108.501 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -128.65 171.37 12.24 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.183 1.393 . . . . 74.42 109.663 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -30.04 70.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.951 0.723 . . . . 71.12 112.951 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.93 135.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.625 1.57 . . . . 74.23 109.519 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 98.4 mt -126.47 158.71 35.34 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.005 1.722 . . . . 52.23 110.973 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -128.26 108.49 10.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.59 1.556 . . . . 63.23 110.635 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.84 144.71 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 127.19 2.196 . . . . 74.3 107.73 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' B' ' 59' ' ' THR . 58.0 mtm180 -144.56 164.19 31.65 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.97 2.508 . . . . 73.22 110.98 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 52.1 t30 72.43 11.26 5.74 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.139 1.376 . . . . 62.11 111.544 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.55 154.58 79.19 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 124.851 1.261 . . . . 73.12 111.231 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.63 150.75 74.96 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.245 1.963 . . . . 73.14 112.652 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -83.37 -15.39 50.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.504 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -130.06 109.34 10.77 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.524 1.53 . . . . 70.24 107.506 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 15.9 tt -162.57 171.18 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 128.386 2.675 . . . . 64.15 105.466 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -126.18 165.87 18.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.585 1.154 . . . . 72.14 109.976 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.35 74.91 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.543 -0.91 . . . . 23.2 108.543 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.43 -54.61 45.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.831 1.652 . . . . 71.43 109.513 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.5 -36.46 84.27 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.187 1.395 . . . . 51.12 111.363 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 66.2 mmm -64.69 -58.2 6.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.473 -0.936 . . . . 70.42 108.473 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -58.8 -35.76 73.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.635 0.774 . . . . 75.01 110.915 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -59.81 -26.3 65.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 75.13 111.744 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.06 -69.74 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.01 0.924 . . . . 73.05 108.986 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -55.31 -38.09 68.22 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.921 1.452 . . . . 75.3 114.921 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -33.66 85.93 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.302 0.953 . . . . 73.14 112.942 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -65.87 -29.14 69.55 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.109 -1.23 . . . . 64.41 110.221 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -79.89 -22.27 43.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.762 0.825 . . . . 73.23 110.263 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.68 168.93 19.44 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.875 1.702 . . . . 62.44 109.48 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -63.22 159.92 37.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.108 2.539 . . . . 60.22 113.505 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -113.29 143.9 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.686 1.995 . . . . 71.43 110.536 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.34 -56.18 2.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 125.216 1.406 . . . . 71.53 108.043 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -153.72 155.09 35.29 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.359 -1.348 . . . . 75.22 107.359 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -136.82 135.38 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 104.491 -2.411 . . . . 65.43 104.491 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -133.2 123.98 26.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.314 -2.106 . . . . 73.44 105.314 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.8 m -110.04 151.26 12.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.593 -1.262 . . . . 73.23 107.593 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.69 30.79 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.446 -1.062 . . . . 72.14 110.446 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.78 -38.86 3.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.463 -0.78 . . . . 61.34 111.22 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 30.0 p -69.38 161.6 72.43 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.388 -0.597 . . . . 65.42 109.388 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.2 -2.58 8.33 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.141 1.894 . . . . 70.01 112.255 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -105.84 -9.72 17.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.487 1.915 . . . . 70.11 111.868 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -116.62 -12.05 10.97 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.87 1.268 . . . . 71.44 110.723 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -57.58 142.09 45.8 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.55 -1.344 . . . . 64.53 108.341 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.16 -5.68 83.56 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 118.676 -1.069 . . . . 52.14 114.633 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' THR . . . . . 0.422 HG22 ' HG2' ' B' ' 24' ' ' ARG . 36.1 p -124.52 153.85 41.45 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.399 1.6 . . . . 71.04 109.144 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.69 166.2 33.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.876 0.846 . . . . 72.54 109.525 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.94 141.98 51.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.532 -2.025 . . . . 72.35 105.532 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.84 142.56 42.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.591 -2.003 . . . . 74.44 105.591 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.78 134.33 65.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.222 -1.77 . . . . 74.42 106.222 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 9.8 m-85 -98.03 166.84 11.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.881 1.672 . . . . 64.42 111.472 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.8 -73.64 0.46 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.94 -1.504 . . . . 75.31 106.94 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -81.77 134.96 35.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.116 0.96 . . . . 71.41 109.332 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.46 HG22 ' H ' ' B' ' 67' ' ' ILE . 1.0 OUTLIER -58.65 -34.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 125.318 1.447 . . . . 62.21 108.443 177.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.33 -30.01 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.152 0.581 . . . . 72.41 110.874 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -71.43 -47.39 56.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.526 -0.916 . . . . 73.21 108.526 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -55.45 -42.94 74.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.768 0.827 . . . . 75.32 111.94 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -57.28 -61.9 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.38 1.072 . . . . 70.33 109.487 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -52.95 -53.09 54.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.769 0.827 . . . . 62.12 111.812 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.78 -38.67 86.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 114.428 1.27 . . . . 71.33 114.428 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 37.3 t -58.26 -49.81 75.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 118.437 0.562 . . . . 62.12 110.693 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -62.9 -52.77 61.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.795 -0.446 . . . . 73.24 109.795 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -58.36 -26.22 62.9 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.891 0.7 . . . . 74.34 112.891 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.9 tp -96.77 -6.75 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.432 0.901 . . . . 74.04 113.432 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -62.19 121.86 14.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.299 -1.501 . . . . 73.31 109.999 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.71 18.52 70.32 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.35 -1.25 . . . . 52.31 112.777 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -55.06 120.11 6.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.08 1.44 . . . . 71.45 110.32 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -72.88 115.99 12.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.69 2.396 . . . . 73.03 110.749 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.12 144.47 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.156 1.382 . . . . 73.2 108.83 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.0 m 39.73 52.18 2.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 73.31 112.992 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.36 23.54 9.03 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.089 1.356 . . . . 72.33 113.69 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -136.85 -176.6 4.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.591 2.356 . . . . 73.54 107.517 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.47 137.4 38.67 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.956 1.703 . . . . 74.32 107.071 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.39 148.94 24.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.335 0.588 . . . . 74.11 110.446 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.87 156.72 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.117 1.767 . . . . 62.33 107.186 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 93.2 t -142.33 123.12 11.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.714 -2.328 . . . . 64.44 104.714 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 42.4 tp -151.48 146.09 25.66 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.776 0.83 . . . . 74.01 109.754 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -80.37 156.63 26.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.158 -0.682 . . . . 75.0 109.158 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -75.71 175.39 8.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.373 -0.973 . . . . 73.2 108.373 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 124.302 1.041 . . . . 73.24 112.329 -178.472 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.3 tp . . . . . 0 C--O 1.225 -0.192 0 N-CA-C 107.244 -1.391 . . . . 64.04 107.244 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.58 -49.11 73.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.765 0.257 . . . . 65.34 110.816 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.51 -24.89 61.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.53 1.532 . . . . 30.04 113.777 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 62.4 mtp -86.59 -17.59 33.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.335 -0.853 . . . . 63.34 111.416 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -90.42 146.79 35.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 119.017 0.826 . . . . 53.02 111.844 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.84 163.85 23.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.292 2.661 . . . . 61.24 111.045 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -76.86 173.47 11.67 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.465 -0.939 . . . . 63.13 108.465 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 78.62 18.89 74.72 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 121.372 -0.83 . . . . 51.52 111.731 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.8 117.17 19.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.523 1.529 . . . . 74.32 108.901 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.42 148.0 22.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.45 1.1 . . . . 72.11 108.119 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.71 151.96 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.819 -1.175 . . . . 63.12 110.948 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 22.9 tp -120.67 77.9 29.18 Favored Pre-proline 0 C--O 1.237 0.401 0 N-CA-C 107.17 -1.419 . . . . 54.52 107.17 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.78 166.54 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.729 2.286 . . . . 73.41 111.467 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.17 174.92 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.882 1 C-N-CA 125.698 4.265 . . . . 53.42 115.063 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.457 -0.666 0 C-N-CA 122.732 2.288 . . . . 65.43 110.993 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.238 0.463 0 N-CA-C 107.87 -1.159 . . . . 73.33 107.87 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -98.03 175.25 6.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.635 1.174 . . . . 71.33 109.71 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.69 -34.31 72.72 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.686 -1.259 . . . . 72.52 114.215 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.12 138.05 21.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.512 1.125 . . . . 72.41 109.793 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.36 146.81 49.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.787 -1.19 . . . . 72.41 107.787 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -99.55 138.79 36.15 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.894 -1.891 . . . . 74.22 105.894 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.8 mm -117.03 134.86 59.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 126.155 1.782 . . . . 60.44 106.365 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -127.83 162.5 26.51 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.909 0.884 . . . . 61.3 110.485 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.57 38.35 12.45 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.656 1.983 . . . . 53.15 111.557 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 67.3 mt -76.56 153.76 83.62 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 108.488 -0.93 . . . . 62.33 108.488 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.96 163.94 35.71 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.632 2.221 . . . . 74.42 109.844 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -94.06 -13.03 27.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.994 0.518 . . . . 73.2 112.017 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -126.23 99.7 5.99 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.215 1.406 . . . . 74.43 107.943 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.1 143.43 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.565 -1.272 . . . . 51.44 107.565 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -98.45 178.13 5.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.98 0.912 . . . . 64.3 110.441 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.42 80.95 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.194 -0.457 . . . . 70.12 110.15 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -52.83 -60.54 3.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 127.73 2.412 . . . . 64.24 110.027 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.53 -47.55 81.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.426 1.49 . . . . 71.53 110.88 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.7 mmm -59.25 -39.09 81.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.088 -0.383 . . . . 75.21 110.865 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -76.37 -30.36 57.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.722 -0.656 . . . . 72.01 110.319 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.23 -27.13 65.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.67 1.188 . . . . 74.13 110.16 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 58.7 mt -76.26 -68.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.38 1.072 . . . . 74.2 109.16 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.32 -23.86 65.68 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.892 1.442 . . . . 73.14 114.892 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.92 -13.85 69.89 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 115.584 0.994 . . . . 64.12 115.584 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.51 -28.78 63.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.096 1.448 . . . . 72.51 110.592 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.82 -34.27 22.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.505 -0.76 . . . . 73.1 112.351 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.2 -166.55 39.67 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 120.204 1.365 . . . . 50.51 111.915 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.28 162.57 41.85 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.084 3.189 . . . . 62.45 112.858 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 59.5 mt -118.38 130.47 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.965 0.906 . . . . 61.31 109.247 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -88.44 -59.7 2.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.131 -1.063 . . . . 75.41 108.131 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -155.61 155.12 32.71 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.66 0.267 . . . . 74.31 110.851 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.05 127.79 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 104.984 -2.228 . . . . 73.12 104.984 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -128.31 120.82 27.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 102.842 -3.021 . . . . 74.21 102.842 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.65 144.65 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.736 0.814 . . . . 54.15 111.359 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.64 115.58 6.0 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 106.076 -2.81 . . . . 70.5 106.076 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -103.55 -10.89 18.12 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.194 0.998 . . . . 52.3 113.46 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.9 p -95.16 158.36 34.93 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.375 0.989 . . . . 71.13 108.461 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.59 -15.73 38.53 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.77 2.313 . . . . 73.11 113.045 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -97.29 -10.7 25.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.514 1.125 . . . . 74.24 112.286 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 39.9 p -116.96 -19.23 9.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.731 1.212 . . . . 61.33 112.21 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -53.26 150.32 6.32 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.434 1.494 . . . . 74.41 110.317 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.51 3.51 88.84 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.069 -1.406 . . . . 73.13 112.703 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 59.1 p -143.77 153.36 42.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.753 1.776 . . . . 64.33 109.979 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.35 172.82 12.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.751 2.021 . . . . 75.14 108.359 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -127.78 156.02 43.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.889 -1.522 . . . . 64.35 106.889 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.22 142.97 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.872 -1.159 . . . . 74.3 107.872 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.04 133.33 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.621 1.169 . . . . 73.03 108.369 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.99 154.12 17.91 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.374 -1.713 . . . . 71.23 106.374 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -72.69 -20.09 61.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 119.546 -0.862 . . . . 74.24 110.931 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.83 117.87 30.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.579 1.552 . . . . 52.43 109.681 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.76 -27.48 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 125.175 1.39 . . . . 62.4 111.966 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -73.36 -41.61 63.21 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.344 -1.472 . . . . 74.11 107.569 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -37.31 87.09 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.569 -0.901 . . . . 71.21 108.569 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.4 78.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.63 -0.7 . . . . 63.0 109.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -29.54 70.44 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.288 -0.863 . . . . 75.2 110.612 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.87 -53.31 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.129 1.331 . . . . 75.53 108.568 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.41 -14.15 17.36 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.086 1.143 . . . . 74.12 114.086 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 91.6 m -64.23 -66.62 0.52 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.448 1.022 . . . . 71.42 109.735 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.3 -34.56 76.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 119.13 -0.462 . . . . 74.22 110.168 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -64.83 -21.61 66.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.161 -0.923 . . . . 75.13 112.858 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 tp -106.54 -23.71 12.4 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.083 1.311 . . . . 74.35 111.324 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 12.5 m -69.79 110.1 4.76 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.005 -1.06 . . . . 72.01 108.352 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.44 10.54 53.58 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.649 1.595 . . . . 74.04 112.277 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -72.72 106.38 4.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.457 1.628 . . . . 71.23 107.627 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.93 124.93 27.11 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.349 -0.982 . . . . 63.4 108.349 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 m -141.31 144.37 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 118.983 0.811 . . . . 72.25 110.302 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 m 45.78 38.97 4.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.155 1.382 . . . . 53.04 113.384 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 64.79 20.91 12.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.558 1.143 . . . . 75.21 111.871 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.3 mmm-85 -135.6 -178.17 5.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.145 2.178 . . . . 73.34 108.257 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -133.07 155.31 49.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.867 1.267 . . . . 74.25 109.571 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -109.63 150.16 28.65 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.033 1.333 . . . . 74.44 107.514 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.18 112.76 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.335 -1.728 . . . . 74.31 106.335 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.56 141.73 14.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.072 -2.196 . . . . 74.35 105.072 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.57 142.51 45.33 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.269 -1.382 . . . . 63.43 107.269 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.11 114.0 21.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.457 -0.942 . . . . 74.21 108.457 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -74.05 148.22 42.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.192 -2.522 . . . . 73.03 104.192 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.06 1.744 . . . . 72.24 109.088 -178.868 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 52.0 tp . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 118.427 -0.796 . . . . 74.1 111.29 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.26 -38.24 88.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.069 0.849 . . . . 64.14 110.202 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.46 68.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.631 0.773 . . . . 52.03 110.964 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.4 mtp -65.42 -41.56 93.45 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 118.908 -0.568 . . . . 72.52 110.261 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -65.1 155.71 83.23 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 112.983 0.734 . . . . 73.1 112.983 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.73 159.86 34.79 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.077 1.851 . . . . 52.44 109.33 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.48 161.97 25.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.363 -1.289 . . . . 73.21 110.631 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.79 17.89 60.84 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.76 -0.587 . . . . 44.25 113.693 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -125.16 157.68 35.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.298 1.439 . . . . 64.41 108.896 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -127.07 143.82 51.18 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.445 1.498 . . . . 63.11 109.305 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 63.1 t -71.08 141.06 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.675 -0.861 . . . . 61.13 108.675 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 28.7 tp -117.17 84.05 16.49 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.096 1.358 . . . . 71.01 107.547 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.12 166.04 24.47 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.185 1.924 . . . . 74.42 110.041 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.21 171.84 2.12 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.615 2.877 . . . . 64.34 113.413 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 CA--C 1.536 0.622 0 C-N-CA 123.621 2.881 . . . . 63.42 110.369 178.252 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.447 -0.575 . . . . 71.14 109.447 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -140.58 159.21 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.263 -1.754 . . . . 72.44 106.263 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -56.24 -32.11 64.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.597 1.959 . . . . 73.34 111.917 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 53.4 mt -75.13 123.67 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 71.22 107.306 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 mt -120.15 126.53 50.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.733 2.013 . . . . 74.15 108.204 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.11 134.36 39.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.225 1.41 . . . . 74.42 108.917 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.2 mm -124.16 154.86 31.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.871 0.868 . . . . 75.31 109.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -135.01 163.52 29.69 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.833 2.053 . . . . 75.1 108.992 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 66.7 15.32 10.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.766 1.626 . . . . 53.12 113.545 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.01 152.17 92.82 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 107.571 -1.27 . . . . 74.02 107.571 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.23 160.06 46.83 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.588 1.525 . . . . 51.12 110.807 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -78.32 -20.95 50.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.893 0.877 . . . . 71.23 112.499 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.76 120.89 24.45 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.075 1.35 . . . . 73.32 107.553 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 tt -158.48 163.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.872 1.269 . . . . 75.13 108.201 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -117.43 168.23 10.55 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.916 1.286 . . . . 63.23 111.046 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.92 76.76 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.621 -0.704 . . . . 64.24 109.762 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -53.62 -51.33 63.42 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.531 1.133 . . . . 61.32 109.273 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.52 -39.62 94.12 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.335 0.654 . . . . 72.53 111.608 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.1 -45.04 82.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.859 -0.591 . . . . 53.52 110.101 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -71.52 -27.41 63.18 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.844 0.747 . . . . 74.21 109.585 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.59 -35.33 77.21 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.626 -1.296 . . . . 74.25 109.291 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.37 -72.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.76 1.224 . . . . 65.13 111.822 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.11 -34.51 73.6 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.14 0.976 . . . . 64.12 110.701 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.43 -6.69 88.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.972 -0.349 . . . . 63.03 112.269 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -64.21 -48.18 76.88 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.235 1.517 . . . . 54.15 108.531 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -62.32 -40.07 95.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.769 1.628 . . . . 65.05 112.342 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.58 37.73 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.07 0.843 . . . . 74.21 111.525 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.46 165.15 25.94 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.1 2.534 . . . . 74.45 111.434 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 mt -126.47 137.26 58.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.582 -1.266 . . . . 74.41 107.582 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -76.89 -56.18 4.82 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.409 -0.807 . . . . 71.41 110.273 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -163.28 153.39 15.72 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.189 -1.041 . . . . 65.24 108.189 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 49.7 mt -131.59 147.63 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.628 1.171 . . . . 74.11 108.537 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -142.91 141.83 31.58 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.772 -1.566 . . . . 73.51 106.772 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.14 155.88 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.848 0.859 . . . . 71.5 109.735 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.47 145.81 49.66 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.796 -1.321 . . . . 51.45 109.796 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.33 1.32 8.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.758 1.223 . . . . 74.25 112.535 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' B' ' 54' ' ' PRO . 60.6 p -124.71 162.35 43.41 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.433 1.493 . . . . 75.41 109.33 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' B' ' 53' ' ' THR . 50.7 Cg_endo -64.02 2.63 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.483 3.455 . . . . 74.12 114.258 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -116.74 -19.4 9.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.05 1.34 . . . . 53.13 111.883 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 42.5 p -104.96 -19.69 13.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.015 0.926 . . . . 71.31 109.384 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -64.15 138.19 58.33 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.038 -1.664 . . . . 75.04 107.02 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -20.22 44.35 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.32 0.962 . . . . 74.41 111.207 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 37.4 p -120.07 158.95 25.77 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 106.964 -1.495 . . . . 60.24 106.964 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.8 175.09 11.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.784 -1.198 . . . . 62.21 109.413 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -135.04 141.44 46.14 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.293 -1.003 . . . . 73.11 108.293 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.8 147.56 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.55 -2.018 . . . . 70.45 105.55 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 t -127.06 140.09 50.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.838 -1.541 . . . . 74.25 106.838 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -109.77 166.38 10.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.595 1.558 . . . . 70.34 110.469 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.97 -55.11 7.01 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.151 0.98 . . . . 70.35 110.551 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -112.32 177.56 4.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.361 1.065 . . . . 73.05 108.644 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -94.74 -24.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.067 -1.021 . . . . 52.2 110.178 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.57 -54.83 22.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.317 -0.864 . . . . 62.45 111.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -67.05 -35.69 80.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.149 0.979 . . . . 53.15 110.218 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.57 -49.33 77.08 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.956 -0.757 . . . . 74.51 108.956 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -61.45 -45.09 95.75 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.526 0.73 . . . . 62.43 109.676 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -55.93 -52.27 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.608 -0.516 . . . . 72.44 109.608 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.81 73.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.491 -0.766 . . . . 61.13 112.599 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.42 -49.58 77.02 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.57 1.077 . . . . 65.52 109.785 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -71.73 -44.62 63.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.18 -0.914 . . . . 61.22 111.297 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -60.33 -30.16 69.34 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.784 0.72 . . . . 72.51 112.854 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 23.0 tp -90.85 -29.12 17.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.262 0.483 . . . . 72.2 112.18 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 90.2 p -64.58 118.65 9.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.584 -0.895 . . . . 64.13 108.584 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.84 63.73 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.739 -1.034 . . . . 63.52 113.094 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -77.32 110.23 11.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.713 1.756 . . . . 72.02 106.359 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.94 121.92 15.77 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.098 1.359 . . . . 70.32 111.025 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.0 137.74 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.339 -0.985 . . . . 73.23 108.339 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 35.1 m 38.77 38.84 0.3 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.375 1.87 . . . . 73.44 113.596 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.13 42.54 25.54 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.322 1.449 . . . . 73.23 111.137 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -143.35 171.22 14.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.164 2.586 . . . . 74.54 107.633 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -133.19 137.08 46.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.975 1.31 . . . . 70.14 109.187 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -98.08 115.59 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.634 2.374 . . . . 70.51 110.151 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 97.8 t -84.34 129.61 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.148 -1.797 . . . . 65.14 106.148 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 84.3 t -111.26 137.06 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.738 2.015 . . . . 74.13 106.376 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -154.48 143.81 21.3 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.819 1.247 . . . . 75.45 109.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -74.36 155.75 37.81 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.527 -0.733 . . . . 74.35 110.941 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -78.23 170.2 17.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 106.905 -1.517 . . . . 64.13 106.905 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 123.985 0.914 . . . . 73.54 109.364 179.365 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 51.9 tp . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.237 -1.023 . . . . 73.24 108.237 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.47 -33.47 75.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.446 0.698 . . . . 70.44 110.79 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.98 -2.99 33.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.333 1.053 . . . . 73.42 112.288 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.6 mtp -100.07 7.21 44.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.723 1.209 . . . . 64.12 111.906 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -110.82 148.77 39.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 73.5 110.107 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.04 166.46 29.56 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.152 3.235 . . . . 65.31 113.581 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.16 159.38 22.05 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.49 1.516 . . . . 72.12 110.512 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.35 17.4 39.8 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.243 1.878 . . . . 40.3 113.729 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.75 157.81 43.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.354 2.262 . . . . 74.0 106.267 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.8 144.61 49.61 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.785 0.834 . . . . 72.11 109.122 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.427 HG22 ' HD2' ' B' ' 49' ' ' ARG . 34.9 t -70.03 143.99 14.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.997 -1.112 . . . . 70.02 107.997 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' B' ' 32' ' ' ALA . 47.1 tp -135.53 80.79 43.96 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.101 -1.444 . . . . 73.2 107.101 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.08 171.08 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.376 3.384 . . . . 72.04 112.814 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.17 162.21 3.06 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.105 3.203 . . . . 64.14 112.847 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo . . . . . 0 C--N 1.348 0.533 0 C-N-CA 123.575 2.85 . . . . 74.43 112.984 179.721 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.413 HG11 ' HD3' ' B' ' 71' ' ' LYS . 20.4 t . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 108.454 -0.943 . . . . 70.4 108.454 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -137.53 155.03 49.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.733 1.613 . . . . 74.51 106.95 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -26.19 68.56 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.745 -0.597 . . . . 73.15 112.093 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.92 115.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.597 -1.26 . . . . 63.41 107.597 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 59.6 mt -109.03 159.31 16.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.53 1.132 . . . . 72.3 109.291 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -127.88 135.39 49.95 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.59 2.356 . . . . 62.1 106.635 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mm -120.95 153.19 24.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.27 1.828 . . . . 71.14 110.191 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -142.71 163.96 31.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.639 1.976 . . . . 64.03 111.549 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 63.58 24.87 14.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.954 2.502 . . . . 75.42 114.708 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 71.9 mt -75.44 156.77 85.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.305 -0.872 . . . . 72.22 111.685 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.56 138.81 46.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 N-CA-C 106.521 -2.146 . . . . 74.23 106.521 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -71.13 -10.89 60.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.308 1.043 . . . . 73.42 112.269 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -126.47 108.8 11.52 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.195 1.798 . . . . 72.22 107.289 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -156.98 137.43 4.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.758 -0.83 . . . . 74.4 108.758 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -86.45 163.73 17.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.573 1.149 . . . . 63.02 110.481 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ALA . . . . . 0.574 ' HB2' HD11 ' A' ' 415' ' ' LEU . . . -62.16 -32.55 73.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 43.42 110.021 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.48 -32.58 74.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.622 1.169 . . . . 62.31 110.915 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.53 -45.76 43.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.552 -1.277 . . . . 73.22 107.552 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.4 mmm -55.44 -53.38 56.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.521 0.728 . . . . 64.52 110.168 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -71.66 -10.36 59.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.372 0.879 . . . . 74.51 113.372 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.43 -60.27 1.99 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.018 -1.104 . . . . 72.22 108.018 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.99 -54.81 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.324 1.85 . . . . 61.21 109.874 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -78.56 -16.47 57.4 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.601 0.593 . . . . 71.52 112.601 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.01 -27.2 74.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.266 0.936 . . . . 73.33 112.735 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -14.17 11.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.707 1.253 . . . . 70.04 113.157 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -107.72 -5.13 17.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.705 1.202 . . . . 64.41 113.831 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.93 -174.1 21.27 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.864 1.211 . . . . 74.15 112.874 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.2 138.99 40.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.986 3.124 . . . . 42.4 111.525 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 39.0 mt -101.4 122.3 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.756 1.622 . . . . 75.41 109.725 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -69.61 -47.99 61.58 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.529 -0.732 . . . . 71.14 112.404 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -165.48 159.87 17.28 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.457 1.026 . . . . 64.42 110.635 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 mt -144.32 135.83 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.78 2.032 . . . . 64.33 109.654 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.427 ' HD2' HG22 ' A' ' 414' ' ' VAL . 0.5 OUTLIER -136.16 126.24 26.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 102.847 -3.019 . . . . 75.5 102.847 178.125 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 m -112.64 142.28 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.115 0.566 . . . . 74.34 110.581 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.1 46.89 Favored Glycine 0 C--O 1.241 0.591 0 C-N-CA 124.339 0.971 . . . . 72.11 111.282 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -118.39 -30.46 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.765 0.783 . . . . 43.22 111.806 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -74.14 158.08 86.02 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.695 -1.224 . . . . 73.51 107.695 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.31 -27.44 63.6 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.814 1.676 . . . . 64.51 110.099 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -17.61 63.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.824 1.25 . . . . 64.1 111.667 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 69.3 p -107.47 0.38 22.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.518 1.127 . . . . 72.44 111.928 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -56.14 127.95 33.14 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 120.148 -1.595 . . . . 71.45 108.793 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.17 89.31 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.847 -1.53 . . . . 71.03 114.348 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -121.18 152.44 38.79 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 120.343 2.071 . . . . 50.33 109.336 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.28 174.99 12.08 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.401 1.08 . . . . 62.22 109.274 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -132.25 134.63 45.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.004 -1.48 . . . . 71.31 107.004 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.2 142.62 43.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.634 -1.247 . . . . 74.33 107.634 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 t -122.53 147.25 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.42 -1.326 . . . . 71.34 107.42 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -120.91 166.38 13.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.763 1.625 . . . . 71.22 107.828 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.76 -68.6 0.36 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 113.039 0.755 . . . . 73.31 113.039 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -106.25 148.19 28.24 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.247 1.023 . . . . 65.21 110.862 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.67 -31.85 45.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.275 -0.875 . . . . 74.24 109.301 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -64.48 -30.7 71.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.924 1.29 . . . . 60.35 112.37 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.14 -60.46 2.27 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.235 -1.394 . . . . 61.43 107.235 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.34 67.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 62.3 113.898 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.413 ' HD3' HG11 ' B' ' 17' ' ' VAL . 0.3 OUTLIER -56.25 -60.25 3.78 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.256 0.934 . . . . 73.33 110.039 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -73.41 -39.61 64.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.999 -0.68 . . . . 62.11 110.314 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.76 -33.73 64.58 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.441 -0.79 . . . . 71.43 112.692 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.26 -52.99 62.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.27 -1.011 . . . . 61.22 108.27 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.83 -38.99 93.14 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.0 0.52 . . . . 73.12 110.81 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -18.5 60.57 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 117.492 -1.242 . . . . 73.54 112.22 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.82 -32.86 11.49 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.368 1.44 . . . . 63.04 111.716 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -63.26 152.27 38.16 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.916 -1.513 . . . . 41.14 106.916 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.49 9.57 44.5 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 119.166 -0.797 . . . . 65.41 113.624 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -74.06 125.23 27.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.132 -1.803 . . . . 65.15 106.132 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -80.86 116.67 20.96 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.738 1.615 . . . . 72.24 110.49 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.45 141.9 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 123.473 0.709 . . . . 71.31 109.829 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 62.9 m 24.47 58.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.115 2.566 . . . . 63.14 115.666 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 m120 56.18 27.51 11.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.369 1.468 . . . . 73.14 113.963 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -131.87 167.91 18.76 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.203 2.601 . . . . 72.31 109.353 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -138.74 104.26 5.05 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.749 -1.575 . . . . 74.53 106.749 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -69.31 161.06 30.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.066 1.347 . . . . 61.25 110.023 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -133.17 122.65 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.354 1.061 . . . . 64.14 108.618 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 t -98.35 136.22 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.434 1.093 . . . . 73.33 109.268 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -148.86 153.72 38.46 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.435 1.094 . . . . 73.21 109.343 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.93 147.1 23.92 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.27 1.028 . . . . 74.52 110.407 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -76.59 121.47 23.24 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 105.819 -1.919 . . . . 70.1 105.819 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.2 -0.905 . . . . 72.24 109.112 179.639 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 119.185 -0.436 . . . . 62.0 110.184 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.15 -45.58 92.58 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 123.343 0.657 . . . . 74.25 109.75 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.23 79.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.424 0.69 . . . . 71.34 111.904 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 85.2 mtp -71.73 -7.48 48.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.169 0.988 . . . . 71.12 111.1 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -107.46 143.26 26.85 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.219 0.918 . . . . 74.13 109.069 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 36.3 Cg_endo -71.93 164.35 35.94 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.323 2.682 . . . . 74.03 114.035 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -70.02 161.14 30.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.836 2.054 . . . . 70.22 110.278 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 75.62 17.69 80.03 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.132 -0.98 . . . . 74.04 115.273 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' TYR . . . . . 0.479 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 67.1 m-85 -125.1 156.96 37.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 105.639 -1.985 . . . . 70.13 105.639 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -137.44 154.42 49.94 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.128 -0.693 . . . . 74.25 109.128 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.03 142.15 16.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.405 1.082 . . . . 73.45 110.625 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.45 83.42 66.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 106.171 -1.789 . . . . 71.23 106.171 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -67.96 171.97 11.55 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.34 2.026 . . . . 51.32 110.643 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.03 163.66 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.424 2.083 . . . . 33.04 110.834 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 C-N-CA 122.399 2.066 . . . . 61.44 108.9 177.964 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--O 1.238 0.488 0 N-CA-C 109.368 -0.604 . . . . 72.43 109.368 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -126.17 143.33 51.17 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.002 2.121 . . . . 43.53 108.693 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -60.34 -28.5 68.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.564 1.546 . . . . 64.31 111.149 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.4 mt -88.86 147.73 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.161 2.184 . . . . 75.32 108.513 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.51 155.34 39.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.445 1.498 . . . . 73.34 109.612 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -130.63 105.06 7.57 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.324 2.249 . . . . 73.44 107.215 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -83.88 149.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 126.527 1.931 . . . . 73.42 110.645 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -140.49 162.65 34.83 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.63 1.172 . . . . 53.23 109.379 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 68.32 24.97 7.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.248 2.219 . . . . 62.42 113.173 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -67.38 153.47 94.76 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 121.221 -0.924 . . . . 74.01 110.033 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.68 158.21 50.95 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.456 2.771 . . . . 72.32 109.965 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -73.1 -14.07 61.32 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.522 -0.736 . . . . 64.41 112.128 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -130.2 129.18 43.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.562 -1.273 . . . . 75.43 107.562 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -166.79 160.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.383 2.273 . . . . 74.33 106.048 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -122.13 177.21 5.43 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.651 1.18 . . . . 60.24 110.129 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.69 88.63 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.179 -0.674 . . . . 45.21 109.179 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.3 -46.39 86.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.409 1.483 . . . . 72.23 110.482 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.23 -41.33 99.09 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.896 0.771 . . . . 72.45 110.646 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.4 mmm -63.77 -55.95 19.25 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.711 -0.478 . . . . 75.14 109.711 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.52 -25.06 68.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.288 -0.863 . . . . 72.22 111.038 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.36 -57.82 4.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.406 1.003 . . . . 75.13 109.857 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.4 mt -60.27 -58.33 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 125.55 1.54 . . . . 74.31 110.434 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -65.16 -22.64 66.94 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.793 0.664 . . . . 73.44 112.793 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.68 79.87 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 118.481 0.582 . . . . 64.11 113.927 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -69.24 -9.09 51.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.06 0.93 . . . . 52.14 111.306 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -104.72 -7.31 19.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.374 1.07 . . . . 73.32 111.14 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.12 -174.29 21.23 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.137 1.827 . . . . 70.01 111.396 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.99 169.25 9.29 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.091 2.528 . . . . 64.24 109.764 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.58 145.06 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 O-C-N 120.887 -1.133 . . . . 53.32 109.286 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -78.71 -63.44 1.41 Allowed 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.392 -1.336 . . . . 70.34 107.392 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -160.14 165.93 30.73 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.129 0.972 . . . . 74.21 109.257 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.38 146.44 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.479 1.512 . . . . 74.24 107.484 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -137.22 126.98 25.48 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 104.319 -2.474 . . . . 44.42 104.319 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.04 164.53 17.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 123.377 0.671 . . . . 75.21 109.471 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.45 146.19 44.08 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.174 -1.171 . . . . 71.15 110.174 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -124.46 -58.99 1.49 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.951 -1.129 . . . . 54.12 107.951 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.37 161.05 61.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.305 0.642 . . . . 74.13 109.285 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.58 -9.34 23.94 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.786 2.324 . . . . 75.01 115.121 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.21 -11.51 16.51 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.347 0.976 . . . . 64.53 112.584 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -99.39 -11.42 21.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.596 0.635 . . . . 73.51 111.318 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -69.06 152.84 44.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.457 -0.942 . . . . 74.44 108.457 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.22 -20.23 50.84 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.684 1.135 . . . . 73.4 112.241 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 50.4 p -133.32 165.45 24.8 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.852 -1.536 . . . . 63.45 106.852 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.07 175.57 10.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.741 -1.225 . . . . 73.51 111.545 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.17 146.44 50.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.855 0.752 . . . . 73.11 111.575 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -131.94 145.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.2 1.4 . . . . 62.54 107.803 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.39 136.57 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.436 -1.691 . . . . 73.51 106.436 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.98 166.32 13.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.634 -1.617 . . . . 71.22 106.634 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -78.34 -68.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.478 0.711 . . . . 64.43 110.059 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.84 144.16 30.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 74.12 112.969 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.42 -33.83 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.918 0.887 . . . . 74.3 109.933 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -67.17 -45.97 75.37 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.064 0.946 . . . . 75.24 110.621 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -57.74 -46.6 84.25 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.754 0.822 . . . . 71.21 109.71 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.36 83.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.392 -0.337 . . . . 64.34 111.054 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -67.37 -53.63 27.67 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.206 0.602 . . . . 62.14 110.929 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -59.77 -42.64 93.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.905 -0.569 . . . . 60.52 109.789 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.86 92.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.373 -0.602 . . . . 71.23 109.373 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 t -51.98 -53.34 42.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.771 0.828 . . . . 74.15 110.683 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -73.77 -14.53 61.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.849 1.055 . . . . 64.23 113.849 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -95.19 -21.36 18.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.626 1.103 . . . . 74.35 110.002 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 35.8 tp -99.78 -7.46 25.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.308 1.843 . . . . 65.05 111.468 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 32.4 p -57.96 117.01 3.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.978 1.311 . . . . 62.2 111.442 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.64 10.6 71.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.231 -1.316 . . . . 73.45 114.654 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -51.55 121.94 7.22 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.72 1.208 . . . . 75.43 112.875 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -83.57 118.1 23.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.8 2.04 . . . . 72.12 110.655 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.9 155.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.216 2.606 . . . . 72.42 105.642 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 m 49.67 21.74 0.69 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.388 1.475 . . . . 62.12 112.992 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 38.7 t30 59.24 55.55 4.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.166 2.186 . . . . 74.13 108.572 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -142.81 -167.75 2.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 128.152 2.581 . . . . 72.14 107.572 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -145.11 111.99 5.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.496 -2.409 . . . . 73.52 104.496 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.0 mt -77.32 172.77 12.78 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.919 -1.113 . . . . 54.42 108.96 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.81 146.94 31.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.427 -1.323 . . . . 74.22 107.427 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.92 115.61 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.217 1.407 . . . . 74.24 107.383 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.29 120.59 25.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.063 1.345 . . . . 74.21 107.715 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -55.68 145.27 24.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.645 0.657 . . . . 74.14 111.408 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.95 175.53 10.46 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.407 -0.59 . . . . 72.44 109.407 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--O 1.245 0.848 0 C-N-CA 125.643 1.577 . . . . 52.14 107.073 178.661 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 118.536 -0.745 . . . . 74.51 110.744 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -67.17 -46.86 72.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.022 0.828 . . . . 64.13 109.189 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.52 -6.89 5.71 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.106 1.15 . . . . 72.21 114.106 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 95.8 mtp -100.51 -0.03 38.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.889 1.276 . . . . 72.22 110.123 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.25 155.94 43.79 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.327 1.451 . . . . 65.13 111.542 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.29 163.27 36.79 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.235 2.623 . . . . 41.53 111.243 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.13 164.87 19.37 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.735 0.814 . . . . 74.44 110.291 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 76.58 21.66 74.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.506 -1.163 . . . . 64.43 114.587 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -124.21 158.35 32.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.641 1.721 . . . . 74.53 108.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -135.46 153.28 51.81 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.659 1.184 . . . . 73.14 109.074 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.38 146.7 11.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 123.521 0.728 . . . . 63.43 109.416 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 37.8 tp -132.92 82.55 54.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.21 -1.404 . . . . 63.14 107.21 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.72 165.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.06 2.507 . . . . 73.23 111.656 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -69.45 160.23 50.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.045 1.83 . . . . 71.23 111.229 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo . . . . . 0 N--CA 1.459 -0.539 0 C-N-CA 125.226 3.951 . . . . 73.42 114.488 -179.072 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 C--O 1.244 0.78 0 N-CA-C 105.859 -1.904 . . . . 74.44 105.859 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' B' ' 92' ' ' TYR . 0.0 OUTLIER -145.07 161.21 40.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.375 1.47 . . . . 74.13 108.16 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -80.79 -7.55 59.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.331 2.252 . . . . 74.41 116.032 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -103.29 121.59 54.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 120.488 1.494 . . . . 64.45 107.549 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 71.2 mt -110.19 142.39 41.8 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.282 1.033 . . . . 72.42 108.781 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.46 125.01 53.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.77 -2.307 . . . . 73.45 104.77 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.41 153.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.256 1.422 . . . . 73.25 108.408 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.437 ' HG2' HG22 ' B' ' 59' ' ' THR . 65.1 mtt180 -145.92 163.44 35.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.363 1.865 . . . . 74.15 108.744 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 70.17 21.28 6.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.088 1.755 . . . . 64.11 112.752 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.0 mt -78.17 156.05 79.35 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 121.022 -1.049 . . . . 63.11 110.883 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.03 164.25 36.41 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.971 1.781 . . . . 72.14 111.354 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -93.66 -16.85 23.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 74.32 111.646 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -120.57 99.03 6.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 74.24 106.066 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.5 tt -163.32 174.11 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.988 2.115 . . . . 74.1 106.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -136.47 -170.05 2.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.03 1.332 . . . . 61.11 110.438 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.75 -40.75 65.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.678 -0.49 . . . . 64.22 109.678 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -49.04 -58.36 5.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.095 2.158 . . . . 63.0 110.926 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.42 -42.74 99.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.859 0.299 . . . . 62.34 110.913 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 92.7 mmm -67.57 -23.05 65.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 117.86 -1.067 . . . . 53.32 113.047 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -90.88 -38.17 13.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.744 1.156 . . . . 74.44 108.562 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.44 -52.09 36.51 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.96 1.304 . . . . 73.33 111.601 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.68 -61.47 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.626 0.771 . . . . 72.12 109.41 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -64.17 -19.97 65.68 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.778 0.288 . . . . 74.21 111.778 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.34 -16.62 75.54 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 125.025 1.298 . . . . 54.11 112.143 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -57.25 -32.98 67.11 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.329 1.064 . . . . 64.21 109.759 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -74.71 -60.44 2.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.194 0.998 . . . . 74.33 109.345 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.27 37.41 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.926 -1.27 . . . . 73.54 109.926 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.35 162.72 22.73 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.544 2.163 . . . . 73.34 109.978 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mt -126.51 138.52 54.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.537 -0.912 . . . . 72.14 108.537 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -68.53 -64.21 0.91 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.893 -0.78 . . . . 73.03 108.893 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -159.01 164.21 35.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.234 1.014 . . . . 74.12 108.94 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 95.3 mt -137.66 150.94 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.471 1.908 . . . . 65.21 107.796 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -146.17 148.28 32.38 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.657 1.983 . . . . 74.04 106.318 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.11 166.88 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.374 1.07 . . . . 74.2 110.707 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.37 146.22 40.4 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.168 -1.173 . . . . 71.45 110.168 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -122.92 -16.68 7.0 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.741 1.216 . . . . 71.31 112.157 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 18.8 p -95.0 159.02 33.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.443 -1.688 . . . . 33.24 106.443 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.32 -34.35 93.67 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.758 1.639 . . . . 64.21 111.696 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -72.42 -21.14 61.3 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.314 1.227 . . . . 73.31 114.314 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 34.6 p -92.62 -0.13 57.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.895 0.878 . . . . 74.32 111.25 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.77 140.74 57.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.357 -1.349 . . . . 64.15 107.357 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.83 -10.82 61.39 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.503 -1.72 . . . . 64.32 114.129 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' THR . . . . . 0.437 HG22 ' HG2' ' B' ' 24' ' ' ARG . 73.3 p -113.32 149.41 34.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.275 2.037 . . . . 64.43 109.329 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.8 175.67 12.84 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.902 -1.124 . . . . 75.35 109.569 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -136.27 150.04 48.75 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 122.86 0.464 . . . . 74.13 110.1 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -133.23 146.99 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.722 1.609 . . . . 62.11 106.96 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.9 t -127.43 140.66 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.544 -2.021 . . . . 71.03 105.544 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.95 163.63 24.08 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.873 1.269 . . . . 73.03 109.052 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -97.68 -53.5 3.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.952 1.301 . . . . 73.35 109.722 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.74 115.09 15.07 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.893 -1.151 . . . . 70.24 107.893 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 tt -71.52 -21.45 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.938 -1.134 . . . . 72.14 107.938 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.34 -50.31 47.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.826 1.65 . . . . 74.43 109.421 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.54 -42.37 91.99 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.479 -0.934 . . . . 70.43 108.479 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.66 -45.88 92.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.319 0.648 . . . . 74.34 110.671 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -57.5 -47.09 82.85 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.915 0.78 . . . . 74.52 111.267 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -66.19 -55.09 18.02 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.915 -0.772 . . . . 75.31 108.915 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -38.63 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.688 1.595 . . . . 74.13 113.933 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.08 -41.33 78.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.463 1.105 . . . . 30.55 110.234 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.51 -35.93 17.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.178 -0.305 . . . . 73.21 110.178 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.24 -31.71 69.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 74.25 111.213 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.57 -9.63 21.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.313 1.445 . . . . 74.24 112.785 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 31.3 t -73.92 108.47 6.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.889 -1.152 . . . . 63.03 107.889 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.12 12.41 60.16 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.589 -1.117 . . . . 22.43 112.815 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -68.01 121.66 16.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.618 1.209 . . . . 55.02 108.111 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -76.12 115.46 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.259 1.024 . . . . 61.34 110.391 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 m -140.38 137.78 36.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.766 1.226 . . . . 63.31 109.414 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.6 m 42.39 46.86 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.407 1.883 . . . . 71.51 113.426 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 66.56 10.06 7.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.139 2.176 . . . . 31.2 113.361 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -117.36 -179.37 3.7 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.621 2.368 . . . . 72.35 108.248 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -140.43 117.79 11.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.228 -1.027 . . . . 75.22 108.228 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.34 162.21 29.11 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.482 0.658 . . . . 53.23 110.52 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 94.4 t -128.97 159.41 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.475 1.91 . . . . 74.04 107.015 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 t -143.41 128.0 14.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.241 -1.392 . . . . 65.32 107.241 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.83 144.56 37.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.378 1.071 . . . . 75.21 109.782 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -68.87 163.43 24.34 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 75.12 109.588 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' TYR . . . . . 0.524 ' H ' ' ND2' ' B' ' 18' ' ' ASN . 23.3 t80 -87.81 147.15 25.28 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.312 -1.366 . . . . 74.44 107.312 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.254 1.321 0 N-CA-C 106.272 -1.751 . . . . 75.21 106.272 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 40.0 tp . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 110.292 -0.262 . . . . 75.35 110.292 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.82 -30.13 67.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.777 1.631 . . . . 64.22 111.872 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.8 34.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.584 1.154 . . . . 64.24 111.693 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 94.4 mtp -85.5 -20.18 30.08 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.146 -0.972 . . . . 73.01 110.098 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.1 158.55 39.2 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 124.167 0.987 . . . . 74.31 111.388 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.98 160.31 30.39 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.14 1.894 . . . . 41.4 110.192 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.38 158.95 24.47 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.072 0.939 . . . . 72.24 109.811 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.16 51.63 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.77 0.7 . . . . 55.03 112.36 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.05 156.27 38.46 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.518 1.527 . . . . 73.24 107.008 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -132.07 147.71 52.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.833 0.453 . . . . 74.43 111.007 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.531 1.132 . . . . 62.54 108.331 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.24 85.94 42.5 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 106.743 -1.577 . . . . 72.12 106.743 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.28 168.39 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.056 3.171 . . . . 65.53 112.33 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.91 168.25 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.355 2.703 . . . . 54.24 111.944 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 N--CA 1.453 -0.911 0 C-N-CA 123.076 2.517 . . . . 61.54 110.817 179.11 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.429 HG13 ' CE1' ' B' ' 91' ' ' TYR . 94.6 t . . . . . 0 C--O 1.239 0.516 0 N-CA-C 105.031 -2.211 . . . . 73.24 105.031 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.19 160.05 32.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.256 1.023 . . . . 71.45 108.79 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -63.67 -24.3 67.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.859 1.663 . . . . 63.42 112.958 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.3 137.66 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.04 -1.467 . . . . 75.53 107.04 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 69.2 mt -127.79 157.23 40.97 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.838 2.055 . . . . 64.41 109.593 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -126.02 149.29 48.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.465 1.506 . . . . 65.2 107.12 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mm -136.68 154.72 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.825 -1.546 . . . . 73.51 106.825 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -135.13 163.77 29.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.479 1.512 . . . . 74.45 108.465 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 70.81 15.19 6.92 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.13 1.772 . . . . 73.21 111.068 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' B' ' 60' ' ' ALA . 45.0 mt -69.14 151.2 97.2 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 121.058 -1.026 . . . . 70.4 110.938 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.69 140.68 92.18 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.546 2.83 . . . . 72.21 112.412 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -75.63 -27.01 58.25 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.619 -0.675 . . . . 73.35 111.232 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.03 88.72 2.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.203 1.401 . . . . 72.12 107.877 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -134.7 154.58 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.773 -0.825 . . . . 54.24 108.773 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 43.6 p -114.88 176.17 5.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.833 2.053 . . . . 71.03 108.314 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.81 -38.36 90.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.706 -0.621 . . . . 73.41 111.315 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -49.38 -58.07 5.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.886 1.274 . . . . 73.01 113.582 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.95 -35.2 79.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.595 0.634 . . . . 64.23 111.511 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.9 mmm -68.17 -52.91 29.23 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.369 -0.832 . . . . 55.04 110.132 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -66.8 -25.92 66.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.953 -1.022 . . . . 72.32 111.824 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.63 -59.62 2.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.235 1.379 . . . . 73.14 109.938 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.67 -62.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.407 1.883 . . . . 72.2 111.486 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -63.36 -35.52 80.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.237 -0.585 . . . . 55.14 110.428 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.6 -29.7 67.37 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 123.726 0.679 . . . . 60.23 112.212 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -17.46 56.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.187 0.995 . . . . 73.34 111.566 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.66 -36.93 8.97 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.503 1.121 . . . . 44.02 111.768 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.54 -174.01 45.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 65.42 110.68 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.56 171.41 13.15 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.718 2.278 . . . . 71.32 112.052 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.0 mt -127.81 131.49 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.781 1.232 . . . . 75.12 108.288 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.38 -57.51 3.22 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.154 -1.054 . . . . 63.34 108.154 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -157.12 153.29 27.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.646 0.778 . . . . 71.43 109.944 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 42.1 mt -134.64 137.81 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.874 1.67 . . . . 74.42 107.185 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -137.8 129.19 27.91 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.951 -2.24 . . . . 75.15 104.951 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 18.7 m -110.9 154.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.217 1.407 . . . . 72.32 110.952 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.35 117.85 8.76 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.334 -1.506 . . . . 65.03 109.334 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -100.79 -38.14 8.4 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.135 0.974 . . . . 75.01 112.086 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -64.22 157.67 69.14 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.51 -0.922 . . . . 52.31 108.51 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.02 -14.67 46.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.486 1.457 . . . . 74.23 112.783 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -98.66 -11.09 22.38 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.389 -0.815 . . . . 63.34 112.355 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.1 p -103.02 -23.65 13.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.891 1.223 . . . . 72.12 112.187 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -51.11 131.07 27.23 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.051 -1.463 . . . . 75.04 107.051 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.45 -13.04 15.87 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.381 1.467 . . . . 70.14 110.902 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.1 p -134.01 166.68 22.17 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 118.595 1.197 . . . . 75.5 110.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -164.25 169.29 17.78 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.306 1.443 . . . . 65.41 107.807 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -119.84 147.72 44.34 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 74.34 108.489 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.55 140.35 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.515 -2.032 . . . . 70.33 105.515 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.1 130.79 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 102.481 -3.155 . . . . 63.04 102.481 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -99.49 161.28 13.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.051 -0.722 . . . . 74.11 109.051 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -76.37 -31.85 58.26 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.052 -0.659 . . . . 74.23 110.472 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -123.55 165.92 16.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.204 1.402 . . . . 63.0 110.682 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -76.37 -46.81 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 121.435 -0.79 . . . . 73.21 110.806 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -59.64 -38.31 81.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.986 0.914 . . . . 75.5 110.84 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -62.06 -42.13 98.87 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.946 -0.761 . . . . 74.01 108.946 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.33 -51.43 68.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.576 0.751 . . . . 75.41 109.753 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -55.82 -52.33 64.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.932 0.893 . . . . 75.24 110.825 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.84 -49.45 76.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.129 -0.693 . . . . 62.34 109.129 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.05 89.14 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 118.104 -0.95 . . . . 74.13 111.906 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 67.7 m -60.51 -53.82 52.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.575 1.08 . . . . 45.25 109.588 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.21 -42.99 99.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.167 -0.444 . . . . 70.5 112.026 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -69.26 -24.22 63.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.417 -0.802 . . . . 72.53 111.231 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.1 tp -98.27 -13.11 20.95 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.406 1.457 . . . . 65.41 113.262 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 127.2 31.87 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.718 -1.216 . . . . 51.52 107.718 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.49 75.74 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.274 -1.292 . . . . 54.42 113.031 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -68.54 111.99 5.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.382 1.591 . . . . 74.21 108.187 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -85.33 115.14 22.91 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.376 2.27 . . . . 75.2 110.445 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.9 144.55 20.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.074 -1.084 . . . . 53.23 108.074 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.7 m 40.48 49.81 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.026 1.73 . . . . 72.45 112.745 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 m120 63.0 18.54 10.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.48 2.312 . . . . 75.05 115.626 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -137.75 167.24 22.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 120.028 1.285 . . . . 72.21 109.988 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -112.28 127.15 55.9 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.288 1.035 . . . . 75.4 109.925 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.82 106.18 6.23 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.039 -1.097 . . . . 65.03 108.039 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.72 136.69 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.552 -0.907 . . . . 74.51 108.552 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.63 132.63 56.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.746 2.018 . . . . 72.5 108.866 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -154.65 130.25 9.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.494 1.043 . . . . 71.41 110.034 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' TYR . . . . . 0.429 ' CE1' HG13 ' B' ' 17' ' ' VAL . 70.0 m-85 -69.34 158.74 34.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.759 -0.588 . . . . 75.41 110.224 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -79.08 160.95 26.86 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 107.661 -1.237 . . . . 73.32 107.661 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 116.823 -1.561 . . . . 74.31 107.265 179.069 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 110.415 -0.217 . . . . 74.43 110.415 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.23 -62.52 1.44 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.355 -1.35 . . . . 72.42 107.355 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -64.21 -1.68 1.73 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.083 2.153 . . . . 61.44 115.722 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 70.4 mtp -95.51 -10.08 30.69 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.849 -1.157 . . . . 75.35 111.501 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -106.01 148.3 36.31 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 118.808 0.731 . . . . 73.53 111.251 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.67 158.98 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.149 1.899 . . . . 61.53 107.719 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -73.86 165.45 25.1 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.708 0.766 . . . . 74.22 111.609 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.83 17.92 36.52 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.653 1.597 . . . . 54.12 111.228 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.58 139.52 53.52 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.758 1.223 . . . . 75.34 109.72 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.202 1.401 . . . . 74.21 109.424 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.62 151.09 9.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.518 1.151 . . . . 72.43 109.095 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 33.5 tp -116.51 76.02 7.03 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.358 1.463 . . . . 71.42 111.44 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.66 163.92 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.011 1.807 . . . . 71.22 108.773 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.8 166.37 30.16 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.226 1.95 . . . . 55.41 110.988 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.617 2.211 . . . . 54.14 111.116 178.508 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.542 HG11 ' HD3' ' B' ' 71' ' ' LYS . 75.1 t . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 105.889 -1.893 . . . . 72.42 105.889 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -67.18 141.93 57.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.971 -1.122 . . . . 75.11 107.971 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ARG . . . . . 0.46 ' H ' ' HD3' ' B' ' 19' ' ' ARG 0.283 0.0 OUTLIER -57.8 -7.33 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 118.151 2.648 . . . . 52.32 118.151 -178.714 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.453 HG13 ' HE ' ' B' ' 19' ' ' ARG . 65.5 mt -101.87 128.11 54.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 105.602 -1.999 . . . . 61.25 105.602 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 mt -100.76 142.19 32.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.466 -1.309 . . . . 72.14 107.466 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.44 128.56 55.24 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.605 -2.368 . . . . 54.41 104.605 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 mm -118.74 136.53 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.968 -1.494 . . . . 75.44 106.968 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -125.93 163.68 22.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.597 1.559 . . . . 74.34 107.735 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 71.24 20.18 5.15 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.634 1.574 . . . . 54.24 112.078 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.13 153.82 93.85 Favored Pre-proline 0 C--O 1.237 0.445 0 O-C-N 121.4 -0.813 . . . . 62.41 110.593 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.89 159.23 52.64 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.74 2.96 . . . . 74.33 110.077 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -89.74 -19.11 25.16 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.112 0.565 . . . . 73.23 111.351 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' B' ' 29' ' ' LYS . 7.8 mmpt? -130.08 101.04 5.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.9 1.68 . . . . 62.32 108.348 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.51 155.67 6.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 127.431 2.293 . . . . 63.44 105.472 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -105.1 174.17 5.99 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.273 -0.892 . . . . 72.21 109.671 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.28 72.78 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.352 -0.981 . . . . 64.32 108.352 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -54.67 -35.46 63.57 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.404 1.482 . . . . 54.24 112.474 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -70.34 -42.75 71.45 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.911 1.232 . . . . 63.45 108.229 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.6 mmm -64.75 -45.07 87.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.605 -0.887 . . . . 72.13 108.605 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.83 -27.48 69.2 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 117.98 -1.01 . . . . 72.43 111.644 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.18 -65.26 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.233 0.924 . . . . 71.45 110.148 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mt -57.55 -53.37 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.673 1.189 . . . . 74.21 111.818 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -74.72 -17.01 60.72 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.697 -0.627 . . . . 64.22 111.647 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.4 -12.91 66.53 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 124.0 0.81 . . . . 44.32 113.096 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -58.09 -29.91 65.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.16 1.48 . . . . 65.52 110.495 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.63 -5.42 59.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.034 2.134 . . . . 50.12 114.525 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.65 -171.87 23.58 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 119.808 1.186 . . . . 22.12 111.702 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.29 163.77 28.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.38 2.054 . . . . 60.1 109.247 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mt -129.43 123.22 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.981 -1.075 . . . . 70.52 108.532 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -65.11 -67.07 0.47 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.454 -0.943 . . . . 64.41 108.454 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -156.89 160.64 39.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.932 0.787 . . . . 71.32 112.062 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -140.11 140.95 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.062 2.145 . . . . 73.31 106.258 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -132.59 120.06 21.31 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 103.272 -2.862 . . . . 63.01 103.272 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.98 146.12 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 119.26 0.936 . . . . 75.22 111.435 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.09 141.31 41.22 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.768 -2.133 . . . . 63.05 107.768 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 -9.94 4.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.195 0.998 . . . . 72.33 113.017 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 44.9 p -97.51 161.57 25.46 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.762 1.225 . . . . 75.22 108.478 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.33 5.76 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.85 3.033 . . . . 74.3 113.635 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -120.58 -9.74 9.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.148 1.379 . . . . 74.15 111.408 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -117.36 -25.58 6.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.569 1.148 . . . . 74.31 113.147 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -50.6 143.47 9.34 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.917 0.887 . . . . 73.44 112.134 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.0 85.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.096 -0.836 . . . . 61.24 111.273 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -138.05 150.27 46.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.941 1.37 . . . . 70.13 108.71 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.12 168.35 19.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.177 1.391 . . . . 75.24 107.82 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -120.85 155.53 33.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.367 -1.716 . . . . 63.43 106.367 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 t -125.52 124.47 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.31 -2.107 . . . . 61.43 105.31 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -110.55 123.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.026 -2.212 . . . . 64.51 105.026 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -98.09 166.46 11.41 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.377 -1.712 . . . . 72.13 106.377 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.78 -42.59 94.95 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.491 -1.381 . . . . 74.41 110.366 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.78 175.32 5.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.605 1.562 . . . . 74.44 111.146 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.2 tt -81.69 -38.19 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.333 1.453 . . . . 60.31 108.621 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -60.44 -37.16 80.07 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.197 0.453 . . . . 72.41 111.661 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.14 -42.79 96.64 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 119.377 -0.344 . . . . 75.43 111.003 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.79 -50.19 63.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.445 -0.946 . . . . 63.45 108.445 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.542 ' HD3' HG11 ' B' ' 17' ' ' VAL . 7.2 mmtp -48.87 -54.88 13.48 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.614 1.566 . . . . 73.24 110.23 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -59.63 -60.18 4.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.043 0.937 . . . . 71.32 110.273 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.65 -29.1 51.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.052 1.131 . . . . 73.41 114.052 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.6 t -60.46 -38.25 83.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.447 0.699 . . . . 55.41 111.917 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -88.51 -28.6 20.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.596 0.635 . . . . 72.21 110.954 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -67.58 -31.13 70.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.226 0.466 . . . . 75.11 111.449 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.67 -3.43 20.61 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.256 1.576 . . . . 64.34 115.256 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 25.7 p -60.08 124.56 20.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.343 1.429 . . . . 75.53 109.677 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.05 13.99 73.22 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.231 -1.316 . . . . 75.31 114.334 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.48 119.53 5.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.884 1.842 . . . . 73.02 110.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -78.08 129.76 35.6 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.911 -1.144 . . . . 73.44 107.911 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -144.08 140.18 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 125.835 1.654 . . . . 75.13 106.789 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m 37.43 49.28 0.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 73.43 112.749 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 35.57 15.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.242 1.417 . . . . 41.22 113.947 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.61 -177.22 4.63 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.847 3.259 . . . . 72.35 104.657 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -139.23 137.14 35.7 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.865 -1.147 . . . . 61.32 109.456 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.75 158.22 21.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.414 -1.328 . . . . 73.02 107.414 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.79 131.77 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.683 -2.71 . . . . 75.13 103.683 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 t -115.33 135.35 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.035 1.334 . . . . 61.13 107.859 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.46 150.67 36.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.745 0.818 . . . . 51.32 110.608 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' TYR . . . . . 0.482 ' CD1' HG13 ' B' ' 17' ' ' VAL . 6.7 m-85 -78.52 160.97 27.38 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.392 -0.818 . . . . 75.31 111.546 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.28 176.58 6.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.152 0.981 . . . . 75.11 110.156 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 112.624 0.601 . . . . 52.4 112.624 -179.772 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 108.533 -0.914 . . . . 74.31 108.533 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.93 -10.46 57.34 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.295 1.038 . . . . 70.02 112.289 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -97.55 -36.15 10.4 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.028 1.331 . . . . 55.54 109.481 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.28 -13.58 61.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 73.42 112.608 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.67 157.78 42.04 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.911 1.232 . . . . 73.52 112.003 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.09 166.29 28.14 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.803 2.336 . . . . 74.12 111.241 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -84.69 174.99 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.557 1.143 . . . . 72.43 108.889 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 82.32 19.02 65.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.762 -1.021 . . . . 51.12 112.826 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -125.49 155.71 40.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.382 1.591 . . . . 74.32 106.908 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -130.35 133.69 46.61 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.117 -0.99 . . . . 74.32 108.656 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' B' ' 49' ' ' ARG . 48.3 t -69.08 151.31 10.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.617 -1.253 . . . . 71.04 107.617 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.6 tp -125.73 85.72 58.61 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 125.637 1.575 . . . . 71.23 108.662 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -66.21 178.78 2.28 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.913 2.409 . . . . 72.43 109.566 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.44 170.99 1.04 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.704 2.936 . . . . 71.33 113.386 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo . . . . . 0 C--N 1.349 0.558 0 C-N-CA 125.06 3.84 . . . . 73.42 114.899 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.601 HG13 ' CE1' ' B' ' 91' ' ' TYR . 88.1 t . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 108.763 -0.829 . . . . 52.41 108.763 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -138.48 159.85 41.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.993 1.717 . . . . 65.21 108.73 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -72.63 -24.42 61.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.057 1.343 . . . . 72.41 109.505 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -89.54 129.65 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.296 1.438 . . . . 53.04 107.475 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.54 153.53 36.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.876 1.27 . . . . 75.01 107.882 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -119.31 111.6 18.39 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.963 -2.606 . . . . 72.44 103.963 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -96.59 145.67 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.661 -1.977 . . . . 65.42 105.661 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -136.88 163.2 31.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.038 1.335 . . . . 75.12 109.19 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.8 t30 63.12 33.68 14.3 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.062 2.145 . . . . 64.21 111.066 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 55.0 mt -73.79 158.72 85.71 Favored Pre-proline 0 C--O 1.237 0.417 0 O-C-N 121.497 -0.752 . . . . 74.14 109.013 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.16 156.38 65.99 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.886 1.724 . . . . 72.15 109.498 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.23 -25.69 58.33 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.536 -0.727 . . . . 70.44 112.002 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -129.75 128.09 41.73 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.261 -1.385 . . . . 74.43 107.261 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tt -157.51 169.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.553 -1.277 . . . . 63.32 107.553 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 16.9 p -126.49 169.1 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.532 1.933 . . . . 62.14 108.982 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.82 90.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.393 -0.966 . . . . 72.42 108.393 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.45 -55.31 30.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.018 1.327 . . . . 45.21 111.852 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.24 -40.41 85.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.069 0.395 . . . . 73.32 111.438 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.35 -44.01 72.48 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 73.53 111.587 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.14 -23.18 60.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.972 0.909 . . . . 73.33 111.026 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.63 -59.32 2.77 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.273 1.029 . . . . 73.55 108.51 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.17 -67.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.811 1.645 . . . . 74.25 111.027 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -66.99 -32.41 73.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.643 0.608 . . . . 73.35 112.643 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.84 -32.34 81.48 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 120.468 1.485 . . . . 64.41 112.567 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -75.58 -21.34 57.92 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.335 -1.097 . . . . 70.41 110.236 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.36 -30.97 30.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.347 1.059 . . . . 74.21 110.734 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.97 -175.29 44.71 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.116 0.871 . . . . 75.2 111.668 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.06 165.72 25.42 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.911 2.407 . . . . 73.44 110.673 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -132.52 113.68 21.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 123.662 0.785 . . . . 74.25 109.637 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -81.52 -49.09 11.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.526 -1.287 . . . . 74.32 107.526 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -168.9 162.24 11.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.442 1.497 . . . . 74.54 108.496 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.2 mt -144.78 140.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.43 2.292 . . . . 64.43 106.016 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 414' ' ' VAL . 0.1 OUTLIER -148.53 121.88 9.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.055 -1.831 . . . . 75.12 106.055 176.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.12 167.07 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.63 0.772 . . . . 60.25 109.629 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.38 137.14 42.6 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.669 -0.973 . . . . 54.41 110.669 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -107.34 -49.66 3.22 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.606 1.962 . . . . 62.3 110.661 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -70.57 158.21 88.35 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.109 -0.7 . . . . 61.24 109.109 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.51 14.83 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.549 3.499 . . . . 70.55 115.36 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.01 -47.13 2.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.817 2.047 . . . . 73.14 109.419 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 51.2 p -72.84 -29.45 63.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.972 0.909 . . . . 43.25 109.856 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -50.37 124.77 11.17 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.162 0.985 . . . . 74.42 110.249 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.81 -13.07 17.59 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.746 1.165 . . . . 72.35 110.56 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -128.02 166.07 19.09 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.897 1.348 . . . . 64.25 108.761 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.26 168.14 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.154 -0.966 . . . . 74.25 111.066 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -120.54 124.04 44.37 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.977 -1.12 . . . . 75.44 107.977 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.78 142.25 24.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.507 -2.405 . . . . 64.04 104.507 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.74 122.9 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.718 -1.586 . . . . 73.11 106.718 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.56 165.97 11.73 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.47 1.108 . . . . 74.34 108.467 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.14 -59.36 2.12 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.347 0.659 . . . . 75.23 109.744 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.06 117.6 29.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 126.087 1.755 . . . . 73.44 107.303 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.54 -35.62 60.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 119.39 -0.338 . . . . 70.11 110.815 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -60.37 -50.4 73.76 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.916 0.886 . . . . 73.43 110.073 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.33 -32.17 73.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.551 -0.537 . . . . 74.5 109.551 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.23 92.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.835 -0.802 . . . . 72.22 108.835 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.49 ' HG2' HG11 ' B' ' 17' ' ' VAL . 13.7 mtmt -60.1 -46.56 89.2 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.17 -1.048 . . . . 55.13 108.17 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.99 -52.85 63.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.831 0.707 . . . . 74.04 110.031 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.02 79.74 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.655 -0.688 . . . . 63.01 111.705 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.13 -51.32 68.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.989 0.813 . . . . 75.05 108.995 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -65.71 -37.91 87.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.439 0.563 . . . . 74.41 111.814 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.18 -31.53 72.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.251 0.221 . . . . 75.32 110.424 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.6 tp -91.1 -24.23 20.07 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.844 0.683 . . . . 74.3 112.844 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 3.0 m -68.25 106.4 2.44 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.955 0.902 . . . . 72.25 109.931 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.51 9.45 56.6 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.751 1.643 . . . . 71.14 113.042 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -72.18 141.36 49.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.171 -1.418 . . . . 72.45 107.171 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -110.9 135.02 52.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.758 1.623 . . . . 60.25 110.848 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -157.16 150.16 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 127.499 2.32 . . . . 75.32 107.351 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 53.0 m 44.61 50.25 8.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.614 1.166 . . . . 75.54 113.7 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 44.5 t30 55.5 18.83 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.759 1.624 . . . . 74.34 113.235 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 61.2 mtt85 -134.97 173.82 11.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.739 2.016 . . . . 73.34 110.585 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -130.57 133.34 46.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 105.751 -1.944 . . . . 74.35 105.751 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.21 172.09 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.07 -1.085 . . . . 44.31 108.07 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 5.2 t -134.11 126.7 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 103.757 -2.683 . . . . 72.03 103.757 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.3 t -114.55 137.81 46.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.488 -1.671 . . . . 73.3 106.488 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 46.4 tp -146.81 155.94 42.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.619 1.567 . . . . 74.41 107.159 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' TYR . . . . . 0.601 ' CE1' HG13 ' B' ' 17' ' ' VAL . 52.8 m-85 -87.74 163.22 16.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.246 -0.65 . . . . 61.25 109.246 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.86 170.01 15.45 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.577 -0.897 . . . . 62.44 108.577 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 . . . . . 0 C--O 1.246 0.909 0 O-C-N 120.909 -1.119 . . . . 75.4 109.342 179.817 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 119.191 -0.433 . . . . 63.12 109.896 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.02 -37.76 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.3 0.64 . . . . 75.52 109.393 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.68 -29.22 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.177 0.991 . . . . 54.13 110.924 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 35.0 mtm -88.95 -1.63 58.2 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.198 0.999 . . . . 73.51 111.672 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -108.47 148.48 37.75 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 119.151 0.887 . . . . 73.31 112.978 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.95 149.74 59.83 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.634 2.223 . . . . 74.13 109.931 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.65 166.22 23.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.158 0.983 . . . . 75.32 111.661 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.48 17.61 56.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.753 1.168 . . . . 72.23 113.024 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -124.42 158.11 33.56 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.254 1.822 . . . . 72.44 108.462 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -127.88 151.65 48.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.553 -0.906 . . . . 73.31 108.553 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 13.9 t -69.98 150.96 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.212 -1.403 . . . . 62.4 107.212 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.0 tp -128.95 75.73 79.95 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.579 -0.897 . . . . 73.34 108.579 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.08 161.32 44.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.942 2.428 . . . . 73.44 110.736 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.69 159.13 54.96 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.974 2.449 . . . . 51.43 112.563 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 C-N-CA 123.661 2.908 . . . . 72.31 111.312 179.879 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.412 HG11 ' HG2' ' B' ' 71' ' ' LYS . 3.9 t . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 105.346 -2.094 . . . . 75.42 105.346 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -144.06 -179.02 6.23 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.11 -0.994 . . . . 72.13 110.005 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -88.24 -30.91 19.33 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.282 -0.886 . . . . 74.31 109.568 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 mt -82.45 132.93 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.389 -1.338 . . . . 74.33 107.389 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.33 151.84 42.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.121 2.168 . . . . 64.54 107.376 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -110.65 131.82 54.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.221 -1.77 . . . . 74.55 106.221 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.59 138.34 48.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.289 -1.375 . . . . 74.23 107.289 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -138.35 163.59 31.46 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.277 1.431 . . . . 73.11 109.572 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 67.31 31.21 6.65 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.329 1.852 . . . . 43.34 109.991 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 49.4 mt -70.34 156.41 91.92 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 124.468 1.107 . . . . 63.12 111.715 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.96 152.62 51.94 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.814 3.009 . . . . 70.2 109.961 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -80.28 -25.11 39.61 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.539 -0.726 . . . . 74.54 112.431 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -129.01 114.78 16.84 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.45 1.5 . . . . 62.03 106.956 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.28 168.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 127.068 2.147 . . . . 61.44 106.409 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -136.89 169.54 17.59 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.465 1.106 . . . . 52.13 108.605 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.78 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.041 0.536 . . . . 72.23 111.139 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.29 -25.41 64.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.62 1.568 . . . . 62.12 113.043 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -94.46 -35.88 12.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.213 1.005 . . . . 63.13 109.426 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.5 mmm -64.92 -53.2 50.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.501 1.12 . . . . 54.12 109.82 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -67.52 -16.89 64.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.606 -0.712 . . . . 65.41 111.938 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.26 -67.03 0.54 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.859 -1.163 . . . . 64.04 107.859 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.99 -62.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 C-N-CA 126.484 1.914 . . . . 72.32 111.353 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -62.34 -21.5 65.35 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.467 0.914 . . . . 73.12 113.467 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.46 66.24 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.122 0.868 . . . . 51.41 112.386 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.56 -31.46 72.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.218 -1.401 . . . . 64.45 107.218 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.95 -61.76 1.89 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.32 1.048 . . . . 75.15 109.708 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.84 178.11 45.86 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.719 1.145 . . . . 63.42 115.085 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 121.86 9.15 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.367 3.378 . . . . 75.34 109.927 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 mt -86.38 151.07 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.483 -0.932 . . . . 74.12 108.483 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -87.5 -62.86 1.4 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 107.168 -1.419 . . . . 72.03 107.168 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.53 161.27 41.73 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.122 0.969 . . . . 73.21 109.849 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -140.02 142.37 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.741 1.616 . . . . 74.43 107.482 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 -141.67 131.39 24.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.197 -2.89 . . . . 60.31 103.197 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.94 157.4 30.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.478 0.711 . . . . 62.43 111.3 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.05 146.99 44.88 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.821 1.201 . . . . 65.24 111.048 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.09 -49.53 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.46 1.104 . . . . 70.52 108.886 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -66.4 159.76 70.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.691 -0.855 . . . . 72.52 108.691 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.13 -12.21 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.719 1.612 . . . . 62.42 110.594 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.73 -9.88 45.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.015 2.526 . . . . 65.14 111.865 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 33.4 p -116.75 -33.42 4.82 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.039 0.936 . . . . 62.15 109.153 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -54.33 117.2 3.09 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.936 1.694 . . . . 74.01 108.049 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.31 -8.38 9.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.592 2.044 . . . . 73.41 109.75 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 71.8 p -139.77 158.89 43.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.567 1.147 . . . . 61.1 109.953 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.27 172.45 13.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 75.23 107.939 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -128.36 144.55 51.15 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.007 -1.849 . . . . 75.02 106.007 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.41 141.17 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.399 -2.075 . . . . 44.01 105.399 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -123.62 130.46 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.891 -1.892 . . . . 54.22 105.891 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -96.86 160.8 14.16 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 105.48 -2.044 . . . . 63.42 105.48 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.81 -46.27 89.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.1 0.407 . . . . 72.15 112.1 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -120.88 176.16 5.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.566 1.947 . . . . 75.43 110.526 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -90.59 -11.58 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.776 1.23 . . . . 72.23 113.653 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -83.24 -52.82 6.24 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.6 -1.313 . . . . 72.22 110.1 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -30.75 68.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.114 0.966 . . . . 73.4 110.846 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.68 88.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.014 0.526 . . . . 71.44 110.842 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' LYS . . . . . 0.412 ' HG2' HG11 ' B' ' 17' ' ' VAL . 22.7 mttp -71.86 -39.12 69.9 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.535 -0.728 . . . . 70.05 109.809 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -54.77 -53.45 54.95 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 107.703 -1.221 . . . . 71.05 107.703 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.52 96.51 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.883 0.873 . . . . 71.13 111.937 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 50.9 t -50.91 -58.6 5.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.852 0.861 . . . . 74.54 111.395 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.95 -37.16 83.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 119.3 -0.381 . . . . 71.31 111.528 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.47 -26.82 68.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.021 0.528 . . . . 71.24 112.114 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 30.3 tp -103.78 -14.38 16.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.693 1.197 . . . . 73.43 113.987 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 9.4 t -59.06 116.29 3.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.112 -0.992 . . . . 55.13 110.031 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.45 20.22 69.49 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.96 -1.467 . . . . 62.0 114.262 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -52.13 133.03 33.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.052 1.426 . . . . 75.51 109.988 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -84.98 97.14 9.63 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.643 1.577 . . . . 73.2 111.149 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.86 146.71 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.09 1.756 . . . . 62.53 107.369 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 32.6 m 46.36 31.68 1.34 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 54.14 113.297 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.07 23.71 11.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.52 1.528 . . . . 55.12 112.003 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -116.54 179.19 4.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.41 2.684 . . . . 74.53 108.03 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -137.82 121.69 17.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 71.11 106.707 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.73 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.537 -0.912 . . . . 73.42 108.537 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.96 107.07 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 105.167 -2.16 . . . . 44.43 105.167 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.18 132.86 39.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.237 1.015 . . . . 72.33 109.197 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.6 tp -143.85 157.25 44.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.867 1.267 . . . . 72.43 109.182 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -86.28 157.73 19.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.064 0.946 . . . . 53.04 108.891 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -81.95 161.52 23.03 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.76 . . . . 75.12 109.756 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 38.4 t30 . . . . . 0 C--O 1.243 0.752 0 C-N-CA 126.265 1.826 . . . . 72.21 108.698 -179.245 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 119.36 -0.352 . . . . 62.32 110.936 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -61.95 -45.2 94.73 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.296 1.838 . . . . 74.13 108.743 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.754 1.222 . . . . 71.22 110.747 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 47.2 mtp -78.18 -20.71 51.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 75.21 111.55 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.2 155.34 42.85 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.08 0.952 . . . . 64.33 110.322 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.99 168.53 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.542 2.162 . . . . 54.31 110.523 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.33 169.68 5.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.955 2.102 . . . . 71.54 112.468 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 66.04 20.9 69.33 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.731 -1.038 . . . . 65.02 113.955 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -122.95 157.09 33.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.674 1.737 . . . . 73.15 109.533 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -135.99 146.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.759 -1.109 . . . . 72.23 108.657 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 98.0 t -70.28 151.06 9.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 105.779 -1.934 . . . . 54.53 105.779 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.59 90.62 31.58 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.231 -2.877 . . . . 65.22 103.231 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.9 163.4 7.52 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.681 2.254 . . . . 74.51 112.622 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.65 155.63 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.97 1.78 . . . . 74.23 109.284 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 C-N-CA 121.792 1.661 . . . . 54.3 112.581 -179.241 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 106.381 -1.711 . . . . 72.44 106.381 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -137.13 159.36 42.14 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.808 1.243 . . . . 63.31 109.24 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -55.92 -34.24 65.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.318 1.447 . . . . 62.22 113.514 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.5 136.13 24.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.155 -1.424 . . . . 64.22 107.155 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.5 mt -128.56 156.58 43.1 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.708 2.003 . . . . 75.13 107.912 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -124.94 126.13 45.01 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.297 1.839 . . . . 64.33 107.315 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -115.92 146.17 20.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.117 -1.438 . . . . 74.25 107.117 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -126.99 163.52 23.51 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.143 1.777 . . . . 75.24 107.529 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 66.11 28.96 10.12 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.313 1.445 . . . . 74.3 112.193 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' B' ' 60' ' ' ALA . 78.2 mt -77.56 150.4 79.3 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 121.109 -0.994 . . . . 75.12 112.009 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.3 148.55 88.57 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.725 2.95 . . . . 71.5 109.647 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -84.97 -21.78 29.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 74.14 112.066 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -124.87 94.96 4.34 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.523 -1.288 . . . . 74.02 107.523 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 tt -147.53 170.42 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.525 2.33 . . . . 74.5 106.333 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 61.3 p -131.26 170.17 14.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.013 1.279 . . . . 75.13 110.761 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.55 74.45 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.614 -0.513 . . . . 71.22 109.614 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.74 -36.75 72.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.371 1.868 . . . . 64.52 110.323 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.86 -42.68 13.04 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.496 -0.752 . . . . 62.12 110.397 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 97.8 mmm -58.9 -35.27 72.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.667 -0.683 . . . . 73.05 111.362 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.59 -12.42 48.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.678 0.791 . . . . 62.42 111.535 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.69 -61.81 1.63 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.57 1.532 . . . . 72.51 108.606 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.0 mt -48.6 -57.82 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.514 1.126 . . . . 42.1 109.705 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -73.81 -23.91 59.73 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.443 0.535 . . . . 71.11 112.443 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.96 -23.41 74.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.165 0.888 . . . . 44.24 111.747 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -73.04 -2.77 22.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 1.227 . . . . 43.3 109.762 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -107.68 -11.58 15.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.78 -1.105 . . . . 75.21 111.863 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.32 26.6 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.512 1.051 . . . . 51.25 112.761 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.0 151.74 83.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.316 3.344 . . . . 75.44 110.818 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 54.0 mt -121.77 130.26 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 107.908 -1.145 . . . . 75.45 107.908 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -74.17 -63.42 1.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.478 -0.934 . . . . 75.42 108.478 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -158.16 165.62 34.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.476 0.71 . . . . 71.43 109.188 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 59.3 mt -140.84 145.98 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.912 1.685 . . . . 75.42 107.468 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -136.26 154.4 50.91 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.333 -2.099 . . . . 75.52 105.333 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.57 153.01 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 123.919 0.887 . . . . 35.02 109.009 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.73 136.27 19.61 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.174 -1.971 . . . . 71.52 108.174 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -115.69 -23.48 8.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.665 -0.494 . . . . 73.41 109.665 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.7 p -80.28 156.82 73.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.684 0.794 . . . . 64.22 110.276 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.2 -14.04 34.24 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.059 2.506 . . . . 64.21 114.065 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -97.52 -1.11 44.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.354 0.979 . . . . 72.45 112.999 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 81.4 p -116.86 -13.04 10.7 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.409 1.004 . . . . 52.34 113.159 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -50.84 116.47 1.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.08 1.352 . . . . 73.34 109.803 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 -20.79 9.03 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.674 1.131 . . . . 54.54 112.33 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -124.11 128.17 48.89 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.348 1.059 . . . . 73.33 109.797 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.427 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -140.34 175.76 9.33 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.512 1.125 . . . . 65.24 111.56 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -128.76 147.1 50.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.189 0.595 . . . . 75.24 110.269 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.59 148.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 126.667 1.987 . . . . 63.1 105.894 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 15.9 t -127.61 124.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.806 -1.924 . . . . 73.21 105.806 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -98.65 163.04 12.81 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.531 -1.285 . . . . 62.42 107.531 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -89.18 -61.71 1.64 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.759 -0.83 . . . . 72.21 108.759 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.18 138.82 32.78 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.033 -1.042 . . . . 73.13 110.986 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt -71.43 -43.47 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.203 -0.935 . . . . 74.04 110.7 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.159 0.89 . . . . 75.5 111.334 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.93 -48.05 22.77 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.316 1.446 . . . . 51.13 108.038 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.85 79.75 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.03 0.932 . . . . 51.31 108.832 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -65.03 -36.96 86.03 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.945 1.298 . . . . 64.05 111.321 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -63.59 -55.85 20.48 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 107.782 -1.192 . . . . 60.13 107.782 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.4 73.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.958 0.903 . . . . 25.51 111.09 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.96 -57.07 11.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.211 -1.403 . . . . 74.13 107.211 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.87 -42.12 98.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 119.253 -0.403 . . . . 71.41 111.11 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.263 -0.875 . . . . 72.41 112.592 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.46 -28.12 13.08 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.723 1.601 . . . . 73.31 111.293 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 20.6 t -66.23 107.92 2.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.517 1.527 . . . . 65.43 107.64 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.24 10.09 54.76 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.204 1.383 . . . . 75.45 113.57 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -74.7 122.12 22.76 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.362 1.581 . . . . 71.41 108.004 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -85.07 132.65 34.29 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.773 -1.195 . . . . 34.3 107.773 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -146.19 135.69 17.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.964 -1.495 . . . . 51.43 106.964 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.6 m 46.2 42.38 9.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.65 1.58 . . . . 73.24 113.268 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.64 3.93 4.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.804 2.842 . . . . 54.45 114.256 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.88 161.81 15.98 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.196 -1.565 . . . . 75.22 109.917 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -110.52 117.71 34.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.542 -0.911 . . . . 74.21 108.542 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.64 154.6 39.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.667 -0.864 . . . . 73.11 108.667 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.0 127.52 67.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.031 -1.47 . . . . 65.35 107.031 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -115.77 137.77 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 71.35 108.183 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -144.59 137.1 26.5 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.859 0.864 . . . . 54.34 110.272 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -66.87 153.66 42.91 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.043 0.937 . . . . 73.11 108.95 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -76.37 163.69 26.74 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.498 -0.752 . . . . 75.35 112.99 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 C--O 1.249 1.076 0 C-N-CA 127.284 2.234 . . . . 73.4 105.596 179.389 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 25.9 tp . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 107.033 -1.469 . . . . 75.31 107.033 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -60.73 -41.89 96.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.85 -0.796 . . . . 74.01 108.85 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.88 45.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.92 0.888 . . . . 51.32 112.493 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.1 mtp -84.94 -1.25 56.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.446 1.098 . . . . 72.22 111.486 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -112.4 158.16 38.02 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 119.817 1.19 . . . . 75.03 111.711 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.96 175.61 10.19 Favored 'Trans proline' 0 C--O 1.239 0.567 0 C-N-CA 123.619 2.879 . . . . 74.34 112.204 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.56 166.15 21.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.358 -0.837 . . . . 71.2 110.33 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.01 78.96 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 121.388 -0.82 . . . . 71.13 113.531 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -123.38 157.57 33.06 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.711 -1.464 . . . . 75.35 107.902 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.77 137.09 43.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.203 -1.777 . . . . 71.04 106.203 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.7 t -70.31 149.67 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.004 -0.739 . . . . 63.23 109.004 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 35.9 tp -125.52 77.63 68.86 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.777 -1.194 . . . . 64.32 107.777 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.4 169.27 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.838 2.358 . . . . 71.24 111.701 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.18 161.46 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.424 3.416 . . . . 52.35 114.387 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo . . . . . 0 N--CA 1.46 -0.465 0 C-N-CA 124.669 3.579 . . . . 55.33 115.837 179.809 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.235 0.315 0 N-CA-C 105.083 -2.191 . . . . 72.32 105.083 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -130.75 166.55 20.54 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.717 1.207 . . . . 72.42 109.738 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.21 -41.78 73.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.521 -0.752 . . . . 74.11 112.966 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.14 133.96 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.146 -1.057 . . . . 63.23 108.146 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 36.9 mt -123.47 156.58 35.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.175 1.39 . . . . 73.41 109.397 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -111.71 137.53 49.49 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.554 2.342 . . . . 73.54 107.554 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.8 mm -123.18 144.65 32.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.919 2.088 . . . . 53.33 107.189 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.4 ' HG2' HG22 ' B' ' 59' ' ' THR . 74.8 mtp85 -144.83 163.03 35.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.426 1.09 . . . . 53.43 110.75 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 72.04 25.47 3.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.805 2.442 . . . . 74.55 111.278 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -73.91 157.22 87.44 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.998 1.319 . . . . 65.0 112.7 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.71 160.28 44.1 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.651 2.901 . . . . 63.31 112.263 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -93.73 -10.96 32.53 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.752 1.621 . . . . 75.31 110.936 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mmmp? -128.69 95.32 4.08 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 106.883 -1.525 . . . . 73.14 106.883 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -155.16 160.71 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 124.206 0.941 . . . . 61.4 108.526 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 8.4 p -138.08 175.73 9.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.171 1.388 . . . . 73.43 109.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.97 70.74 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.285 0.634 . . . . 35.23 111.981 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -56.93 -46.22 82.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.134 0.974 . . . . 73.33 111.96 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -78.29 -40.54 36.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.549 0.74 . . . . 72.34 109.721 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.2 mmm -61.05 -46.23 91.54 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 120.984 -1.072 . . . . 70.42 110.261 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -71.68 -23.27 61.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.374 -0.822 . . . . 71.11 109.938 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.64 -46.6 75.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.761 1.164 . . . . 54.34 108.063 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mt -67.79 -69.49 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.04 1.336 . . . . 73.21 110.902 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' PHE . . . . . 0.429 ' CE1' HG21 ' B' ' 62' ' ' VAL . 86.7 m-85 -60.32 -26.22 66.38 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.886 1.809 . . . . 71.25 115.886 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.54 -23.6 73.71 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.341 0.973 . . . . 54.33 111.946 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -65.83 -15.19 62.67 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.306 -1.114 . . . . 74.33 111.037 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -107.33 -4.48 18.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.936 1.458 . . . . 73.02 114.936 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.92 -173.7 21.45 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.753 1.16 . . . . 63.23 114.053 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.27 117.89 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 125.264 3.976 . . . . 53.25 113.791 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 71.5 mt -77.27 103.07 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 127.195 2.198 . . . . 74.21 108.682 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -66.46 -61.79 1.81 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.854 -1.154 . . . . 74.54 110.637 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -160.78 142.85 12.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.892 0.769 . . . . 73.03 111.603 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 16.7 mt -126.89 140.32 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.502 1.121 . . . . 74.24 109.539 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -137.37 122.47 19.13 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.767 -2.679 . . . . 65.32 103.767 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -111.17 145.99 16.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.501 1.12 . . . . 72.44 108.732 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.84 125.36 16.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.089 -2.405 . . . . 64.42 107.089 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.37 -20.57 15.76 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.521 1.16 . . . . 65.0 113.954 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -73.75 157.14 87.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.998 -1.853 . . . . 73.44 105.998 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.24 -20.29 70.39 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.106 1.871 . . . . 53.11 111.843 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.8 -44.43 16.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.282 1.433 . . . . 74.22 109.774 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 77.4 p -74.62 -0.94 19.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.254 -0.904 . . . . 61.12 112.176 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -64.61 163.44 13.71 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.887 -1.133 . . . . 73.44 109.363 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 -9.36 6.07 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.547 -1.141 . . . . 32.44 112.567 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' THR . . . . . 0.4 HG22 ' HG2' ' B' ' 24' ' ' ARG . 44.3 p -128.77 144.63 51.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.469 1.634 . . . . 65.22 110.312 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.72 175.37 12.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.224 1.01 . . . . 64.21 110.027 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -127.62 156.16 42.73 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.324 0.649 . . . . 51.31 110.531 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' B' ' 39' ' ' PHE . 62.1 t -142.55 144.95 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.537 -1.282 . . . . 70.1 107.537 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.48 149.16 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.077 -1.453 . . . . 75.42 107.077 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -116.24 160.2 20.78 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.403 -1.436 . . . . 75.32 108.78 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -65.7 -40.99 92.85 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.396 -0.594 . . . . 52.45 109.396 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -122.35 142.52 50.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.195 -1.039 . . . . 73.11 108.195 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.45 -24.51 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.681 -0.637 . . . . 73.43 110.845 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.66 -25.42 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.415 1.086 . . . . 73.55 110.581 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -74.9 -53.08 9.68 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 105.338 -2.097 . . . . 70.45 105.338 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.85 -35.71 33.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.241 1.016 . . . . 72.21 111.943 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -57.14 -69.14 0.17 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.07 1.348 . . . . 74.1 111.659 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -37.55 81.6 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.511 -0.743 . . . . 64.22 111.671 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.34 80.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.543 -0.741 . . . . 65.1 111.838 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.71 -61.67 2.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.053 -0.721 . . . . 73.31 109.053 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.51 -31.79 70.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.603 0.964 . . . . 74.31 113.603 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -73.88 -26.77 60.73 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.446 0.566 . . . . 72.32 111.1 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.21 -16.53 18.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.119 0.968 . . . . 74.45 112.669 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -63.11 108.06 1.16 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.141 1.777 . . . . 72.52 108.238 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.5 83.1 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.209 -1.329 . . . . 65.32 113.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.02 141.53 45.36 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 119.112 1.456 . . . . 73.15 111.006 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -94.96 113.61 25.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 115.231 1.567 . . . . 74.0 115.231 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 m -133.21 141.77 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 71.13 105.401 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 74.8 m 42.92 36.71 0.92 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.84 1.656 . . . . 54.32 113.607 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 65.26 21.56 12.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.299 1.84 . . . . 60.04 112.668 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.54 -179.54 3.74 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.779 2.432 . . . . 75.12 108.442 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -138.03 114.11 10.05 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.873 -1.899 . . . . 70.24 105.873 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -69.02 168.76 13.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.297 0.639 . . . . 71.44 110.97 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.02 107.85 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.855 1.262 . . . . 71.11 107.73 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.74 135.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.19 -1.411 . . . . 71.32 107.19 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -151.98 141.96 22.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.253 1.021 . . . . 74.03 108.803 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -73.17 154.75 40.17 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.943 0.792 . . . . 74.25 110.215 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.09 148.16 38.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.964 -1.495 . . . . 74.41 106.964 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 126.977 2.111 . . . . 74.31 106.417 178.771 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.87 0 N-CA-C 106.797 -2.521 . . . . 73.52 106.797 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.53 133.59 21.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 107.204 -1.406 . . . . 73.33 107.204 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.04 72.24 6.62 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.794 2.329 . . . . 52.55 108.356 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.64 134.5 51.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.125 -1.065 . . . . 75.22 108.125 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.26 -179.58 6.48 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.418 0.687 . . . . 74.13 111.614 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.74 -179.57 6.98 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.795 1.638 . . . . 72.51 109.468 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -136.52 168.54 19.28 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.756 1.622 . . . . 72.32 108.582 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -132.77 152.18 51.83 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.785 0.834 . . . . 41.44 109.836 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -125.24 -165.57 1.42 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.061 1.344 . . . . 74.43 109.286 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -139.5 179.05 6.78 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 126.09 1.756 . . . . 75.42 106.445 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -139.52 154.8 47.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.033 -1.84 . . . . 74.42 106.033 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -85.27 -166.12 1.41 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.221 1.809 . . . . 74.13 109.875 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -65.11 162.94 15.89 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.369 -0.832 . . . . 73.42 110.295 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.02 161.63 30.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.073 -0.967 . . . . 71.11 109.163 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 41.6 pt -71.18 173.81 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.721 1.208 . . . . 55.01 110.763 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 159.36 31.13 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.991 0.9 . . . . 64.41 111.127 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -155.8 176.12 13.04 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.911 1.685 . . . . 54.05 107.945 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 31.5 mtp85 -125.12 85.67 2.44 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.741 -0.599 . . . . 74.11 110.911 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -51.32 144.87 9.07 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.066 1.346 . . . . 73.22 109.411 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -56.54 160.45 5.39 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.918 1.287 . . . . 75.13 111.565 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.97 -174.58 1.79 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.123 1.882 . . . . 74.44 108.903 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 30.6 mt -73.34 70.62 1.21 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.144 -0.972 . . . . 74.52 109.69 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.5 m -81.87 175.48 10.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.048 1.339 . . . . 75.55 109.484 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.0 -40.7 73.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.489 1.116 . . . . 73.23 111.852 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -58.88 -26.03 63.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 113.491 0.922 . . . . 73.14 113.491 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -68.83 -20.86 64.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.741 1.155 . . . . 54.31 110.882 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.98 -34.08 77.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.24 -0.652 . . . . 63.21 109.24 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.94 -41.88 90.76 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.833 0.853 . . . . 75.24 109.669 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.53 61.46 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.086 1.354 . . . . 42.34 111.48 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.0 mtp -88.95 -17.41 29.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.893 0.877 . . . . 64.11 112.64 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -83.11 145.51 49.38 Favored Pre-proline 0 N--CA 1.455 -0.212 0 CA-C-N 119.32 0.963 . . . . 71.34 110.212 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -67.28 157.49 61.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.423 2.082 . . . . 74.33 112.197 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.99 134.99 43.12 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.218 -1.356 . . . . 72.34 108.984 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.6 24.37 18.45 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-O 118.845 -0.975 . . . . 63.33 113.549 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.17 108.87 12.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.965 -1.495 . . . . 74.14 106.965 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.96 150.5 25.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 114.909 -1.041 . . . . 74.41 108.332 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.65 151.56 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.226 -0.657 . . . . 74.31 109.226 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 25.9 tp -120.76 78.88 30.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.999 0.92 . . . . 65.43 109.278 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.97 160.01 50.69 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 N-CA-C 108.346 -1.444 . . . . 61.14 108.346 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 157.5 61.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.141 1.894 . . . . 75.34 110.955 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.23 149.78 81.58 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.066 1.844 . . . . 72.41 109.755 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -67.77 139.9 56.65 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 122.99 0.516 . . . . 64.54 109.731 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 73.57 14.04 79.86 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.911 -0.939 . . . . 74.13 113.396 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -69.39 122.89 19.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.395 1.597 . . . . 74.44 108.389 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 91.9 t -135.43 89.49 22.53 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 106.988 -1.486 . . . . 74.33 106.988 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.43 -168.53 0.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.065 2.51 . . . . 64.12 109.512 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--O 1.251 1.154 0 C-N-CA 126.522 1.929 . . . . 64.51 106.225 177.953 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.409 0 N-CA-C 109.386 -1.486 . . . . 73.43 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -146.26 91.87 2.11 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 105.404 -2.073 . . . . 73.34 105.404 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.06 -170.05 2.89 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.28 1.432 . . . . 52.35 110.055 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -129.11 108.28 10.24 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.52 1.128 . . . . 71.32 108.284 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 49.8 pt -132.84 144.94 35.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.667 -1.605 . . . . 73.24 106.667 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -69.31 171.93 7.82 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.342 -0.614 . . . . 75.35 109.342 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.7 tp 52.84 65.66 5.72 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 106.513 -1.662 . . . . 71.11 106.513 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -68.29 151.14 76.66 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.554 2.169 . . . . 74.41 113.78 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.46 -13.2 30.23 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.647 2.898 . . . . 75.14 112.853 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -77.82 -6.32 53.74 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.161 -0.962 . . . . 53.14 111.722 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.446 HG11 ' HG2' ' B' ' 71' ' ' LYS . 59.7 t -108.36 150.51 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.405 1.482 . . . . 74.51 107.803 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.2 176.87 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.573 2.349 . . . . 54.13 108.022 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -77.54 -9.87 59.17 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.803 -0.56 . . . . 60.25 110.188 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -92.03 115.89 31.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.397 1.879 . . . . 64.12 107.641 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.51 127.02 55.59 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.473 1.509 . . . . 64.33 109.456 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -92.62 135.42 34.1 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.172 -1.418 . . . . 71.14 107.172 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mm -122.93 136.91 58.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.562 1.545 . . . . 73.44 107.968 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 mtp85 -123.42 162.06 23.55 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.786 1.234 . . . . 73.33 107.803 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.05 25.51 4.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.655 2.382 . . . . 63.14 113.776 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.27 150.81 97.17 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 108.215 -1.031 . . . . 60.33 108.215 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.66 151.6 85.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.728 1.619 . . . . 54.21 110.204 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -73.89 -25.46 60.04 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.704 -0.623 . . . . 62.41 110.364 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 109.56 17.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.259 -1.015 . . . . 74.13 108.259 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 tt -159.09 152.44 6.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.636 -1.246 . . . . 55.23 107.636 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 46.5 p -113.34 172.74 6.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.807 1.243 . . . . 72.45 110.33 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.9 -32.08 73.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.169 -1.048 . . . . 52.12 108.169 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.17 -49.61 63.44 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.722 2.009 . . . . 74.12 110.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -70.74 -49.93 41.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.26 1.024 . . . . 62.33 109.647 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 98.1 mmm -56.25 -43.35 78.62 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.694 -0.629 . . . . 64.35 112.186 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -67.82 -29.44 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.34 0.973 . . . . 75.54 110.789 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.56 -35.94 57.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.389 0.995 . . . . 71.44 110.585 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.26 -58.84 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 125.522 1.529 . . . . 60.21 110.84 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.462 ' CE2' HG21 ' B' ' 62' ' ' VAL . 78.9 m-85 -74.09 -23.62 59.36 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.074 -1.016 . . . . 71.42 112.353 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -7.59 88.38 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.602 0.637 . . . . 52.11 112.638 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -63.06 -26.31 68.78 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.573 1.149 . . . . 63.42 111.745 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.58 -21.12 19.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.175 0.99 . . . . 75.42 112.802 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.71 -159.62 29.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.622 1.101 . . . . 51.14 110.387 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.92 151.25 56.38 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.381 2.054 . . . . 73.43 109.236 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mt -112.73 137.3 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.277 -1.749 . . . . 75.54 106.277 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -66.02 0.79 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.109 -1.071 . . . . 74.35 108.109 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -161.49 153.8 19.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.724 0.693 . . . . 71.13 111.41 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.0 150.75 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 123.223 1.487 . . . . 74.34 109.6 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -136.22 163.84 29.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 104.09 -2.559 . . . . 74.32 104.09 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -144.18 149.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 120.664 1.575 . . . . 74.22 108.4 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.2 139.1 48.38 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.85 -1.7 . . . . 72.14 108.85 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.67 -9.67 6.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.936 0.894 . . . . 75.52 112.332 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.94 159.73 32.53 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.52 1.928 . . . . 64.24 106.335 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.17 -29.57 89.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.95 1.767 . . . . 65.32 112.575 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -91.49 2.31 56.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.35 1.06 . . . . 74.12 112.786 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 49.5 p -116.42 -31.58 5.53 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.702 1.592 . . . . 75.24 112.452 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -54.52 136.04 45.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.264 1.026 . . . . 62.22 108.538 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.42 -5.57 44.79 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.078 0.847 . . . . 54.13 112.367 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 58.6 p -142.82 158.38 43.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 119.044 1.422 . . . . 64.32 108.849 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.21 160.59 21.4 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.446 0.698 . . . . 51.22 110.549 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.06 132.93 56.57 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 127.063 2.145 . . . . 63.14 106.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.462 HG21 ' CE2' ' B' ' 39' ' ' PHE . 89.3 t -111.82 150.5 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 125.302 1.441 . . . . 51.14 107.825 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -124.01 125.67 71.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.212 -1.403 . . . . 72.43 107.212 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -97.8 161.77 13.59 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.543 -1.28 . . . . 63.21 107.543 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -74.27 -31.24 62.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.167 -0.924 . . . . 73.15 111.765 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.63 172.45 8.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.763 1.225 . . . . 63.14 109.468 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -95.61 -29.16 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.986 -1.116 . . . . 61.21 107.986 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -62.44 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.713 1.605 . . . . 75.34 109.721 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.31 -35.05 74.7 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.402 1.081 . . . . 51.45 111.293 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -55.24 33.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.609 -0.886 . . . . 72.42 108.609 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.446 ' HG2' HG11 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -62.06 -35.26 78.09 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.891 -1.052 . . . . 60.41 111.364 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -59.67 -53.46 57.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.984 0.811 . . . . 60.24 109.902 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.74 65.14 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 118.831 -0.604 . . . . 64.24 112.432 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.0 t -50.8 -48.77 59.52 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.314 1.046 . . . . 62.13 110.091 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -59.97 3.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.621 0.769 . . . . 62.33 109.373 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -15.54 9.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.922 1.823 . . . . 72.33 115.922 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 tp -99.67 -1.96 36.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.011 1.278 . . . . 52.41 111.153 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.1 p -75.47 132.59 40.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.257 -1.386 . . . . 71.33 107.257 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.29 10.28 81.7 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.048 -0.862 . . . . 63.12 113.114 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -66.45 133.91 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.961 1.381 . . . . 61.33 107.294 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -109.28 126.77 53.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.641 1.177 . . . . 64.33 109.119 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 5.4 m -136.83 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.115 1.766 . . . . 74.13 107.036 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 88.9 m 49.46 29.61 2.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.328 1.051 . . . . 60.14 111.887 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.7 m120 71.27 23.31 4.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.284 2.233 . . . . 72.31 113.279 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -132.14 141.74 49.23 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.223 1.409 . . . . 74.13 108.726 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -88.47 151.1 22.77 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.501 0.72 . . . . 73.12 109.164 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.44 167.67 9.68 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.878 -0.786 . . . . 73.43 108.878 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 79.4 t -132.73 137.75 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.538 -1.282 . . . . 64.53 107.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.9 139.89 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.328 1.451 . . . . 64.53 109.094 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 52.0 tp -146.42 165.43 29.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.154 1.782 . . . . 71.13 108.369 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.44 164.09 11.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.425 . . . . 74.44 112.486 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -83.32 115.14 21.86 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.772 1.229 . . . . 74.33 108.683 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 63.4 t30 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.201 -0.904 . . . . 75.53 110.852 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.314 0 N-CA-C 108.818 -1.713 . . . . 71.1 108.818 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 15.2 t -134.88 110.71 11.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 105.607 -1.997 . . . . 71.35 105.607 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.13 166.08 25.15 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.954 1.769 . . . . 74.12 109.381 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -155.37 146.52 22.64 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.036 -1.838 . . . . 74.24 106.036 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -145.85 47.19 1.26 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.089 2.556 . . . . 65.2 107.216 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -58.52 102.52 0.11 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.795 1.638 . . . . 71.25 109.719 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -112.34 100.11 8.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.898 1.279 . . . . 72.14 107.865 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -132.9 147.78 52.29 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 107.68 -1.23 . . . . 74.32 107.68 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -127.34 -178.24 4.38 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.324 1.45 . . . . 71.4 109.842 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -164.26 171.4 14.96 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.884 2.074 . . . . 71.13 106.846 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -170.7 120.09 0.55 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.386 -2.079 . . . . 73.24 105.386 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -109.65 154.13 23.26 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.965 -0.754 . . . . 73.44 108.965 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -149.65 138.88 21.33 Favored 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 120.918 -1.114 . . . . 65.2 109.467 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -116.24 148.07 40.83 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.108 -2.182 . . . . 70.52 105.108 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -162.04 120.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.742 -1.947 . . . . 73.02 105.742 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -147.16 93.41 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.603 -0.888 . . . . 43.52 108.603 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.17 163.77 26.96 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.066 -0.716 . . . . 75.41 109.066 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.79 120.58 42.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.62 -1.622 . . . . 73.23 106.62 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -116.78 72.01 0.81 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.254 -1.758 . . . . 73.25 106.254 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -142.08 157.06 64.59 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 124.482 1.113 . . . . 71.24 110.304 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.9 178.46 6.81 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.986 2.457 . . . . 55.11 108.591 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 69.2 mt -95.78 146.19 24.74 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.293 -0.879 . . . . 71.4 108.819 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 66.3 m -126.26 177.74 6.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.763 1.625 . . . . 74.41 108.38 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.26 -30.39 69.41 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.906 -1.122 . . . . 71.31 111.356 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.17 -30.96 71.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.256 0.48 . . . . 65.42 110.153 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -68.31 -30.62 69.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.936 -0.764 . . . . 73.34 108.936 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 404' ' ' LEU . . . . . 0.401 HD21 HG21 ' B' ' 63' ' ' VAL . 60.8 tp -70.9 -42.17 70.32 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.93 -44.11 97.67 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.949 -0.76 . . . . 75.14 108.949 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.02 81.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.433 1.493 . . . . 63.2 111.6 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.47 -21.59 59.51 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.366 1.066 . . . . 74.13 112.527 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -76.71 152.65 83.1 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.076 1.307 . . . . 62.24 109.265 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.499 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 86.8 Cg_endo -72.1 177.1 7.56 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.833 3.688 . . . . 65.14 112.521 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.01 143.58 26.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.111 0.964 . . . . 75.32 112.724 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.52 29.53 9.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.587 1.089 . . . . 73.51 113.658 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.499 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 49.6 m-85 -125.98 157.12 38.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.049 1.34 . . . . 75.13 109.671 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.79 142.4 50.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.377 -1.342 . . . . 74.24 107.377 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.61 151.79 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.415 -0.957 . . . . 52.11 108.415 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.88 85.8 40.52 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.655 -0.653 . . . . 71.03 109.312 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.56 159.68 31.17 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.947 2.431 . . . . 62.44 111.051 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 166.47 26.76 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.385 3.39 . . . . 75.02 113.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.02 172.75 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.573 2.182 . . . . 75.42 109.238 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -104.21 100.07 9.8 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.549 1.139 . . . . 70.33 109.047 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 139.79 -12.83 3.15 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.883 1.23 . . . . 32.21 111.939 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -51.15 141.57 14.16 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.466 1.507 . . . . 73.43 111.842 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 73.4 t -116.75 96.49 48.68 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 127.125 2.17 . . . . 53.21 106.076 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -78.16 170.31 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.872 2.382 . . . . 64.24 111.497 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--O 1.255 1.382 0 N-CA-C 106.105 -1.813 . . . . 64.14 106.105 178.358 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.538 0 N-CA-C 111.118 -0.793 . . . . 32.13 111.118 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ttt-85 -124.47 110.02 13.99 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.53 -2.026 . . . . 71.14 105.53 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.86 172.11 14.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.924 0.89 . . . . 40.33 112.897 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.43 156.59 14.17 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 129.603 3.161 . . . . 73.4 105.518 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.65 107.96 19.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 104.419 -2.437 . . . . 74.41 104.419 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -142.69 163.47 32.73 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.801 -1.185 . . . . 54.55 107.801 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.77 157.41 88.74 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.991 0.917 . . . . 74.42 108.879 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.77 163.93 35.3 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.77 2.314 . . . . 74.33 110.264 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.04 -45.16 29.65 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.177 1.918 . . . . 61.53 110.149 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.34 170.08 19.33 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.84 0.856 . . . . 70.45 109.987 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 t -143.91 152.45 16.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.982 -1.488 . . . . 63.25 106.982 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -131.82 159.15 39.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.532 1.533 . . . . 64.25 108.667 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -82.87 -25.24 32.73 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.706 0.802 . . . . 74.41 110.662 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -83.4 135.21 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 103.019 -2.956 . . . . 74.5 103.019 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.7 165.81 15.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.679 1.591 . . . . 73.25 108.518 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -129.04 130.25 46.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.951 2.1 . . . . 63.24 109.123 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -113.22 151.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.302 2.241 . . . . 71.32 107.849 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -146.57 159.93 42.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.661 -0.65 . . . . 62.21 110.945 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.97 19.03 11.75 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 127.204 2.202 . . . . 54.1 113.975 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 mt -58.92 152.77 47.69 Favored Pre-proline 0 C--O 1.236 0.372 0 C-N-CA 123.04 0.536 . . . . 75.04 112.239 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.92 144.53 96.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 73.01 110.34 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -77.78 -14.27 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.299 -0.876 . . . . 74.51 111.59 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -123.49 105.5 9.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.443 -1.688 . . . . 62.32 106.443 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 tt -156.59 164.35 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.915 1.686 . . . . 71.21 106.744 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.27 169.03 17.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.593 1.557 . . . . 55.53 109.336 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.22 -31.64 70.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.923 -0.561 . . . . 52.11 110.316 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.59 -39.79 71.18 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.388 1.475 . . . . 73.22 111.825 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -83.79 -47.79 10.76 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.646 1.178 . . . . 75.52 110.413 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.3 mmm -53.45 -47.98 69.22 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.609 0.364 . . . . 75.02 110.82 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -69.21 -34.96 75.68 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.281 -0.866 . . . . 64.14 111.672 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.28 -56.65 18.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.81 0.732 . . . . 74.04 109.328 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 48.8 mt -54.48 -63.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 126.751 2.02 . . . . 72.33 111.234 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -63.52 -24.34 67.77 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.204 0.911 . . . . 74.1 112.854 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.5 79.96 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.797 -1.001 . . . . 53.24 112.258 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.409 ' HA ' ' HE2' ' B' ' 41' ' ' LYS . 7.3 mmpt? -60.3 -19.34 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.53 1.665 . . . . 52.53 113.215 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.52 -31.25 8.2 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 117.404 -1.284 . . . . 72.44 113.861 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.0 -152.4 14.83 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 119.716 1.144 . . . . 73.31 112.774 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.18 162.48 28.56 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.163 3.242 . . . . 73.22 111.84 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.99 132.58 70.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.141 -1.429 . . . . 33.44 107.141 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -58.05 2.67 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.973 -1.121 . . . . 72.3 107.973 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -156.22 160.11 39.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.952 0.901 . . . . 61.34 109.368 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 48.7 mt -139.69 136.1 39.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.267 1.427 . . . . 64.53 108.0 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -137.77 143.57 41.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.247 -1.39 . . . . 64.3 107.247 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.84 165.37 27.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.287 1.035 . . . . 52.21 108.539 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.05 135.19 25.87 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 124.098 0.856 . . . . 74.52 113.054 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -104.88 -42.74 5.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.208 1.803 . . . . 70.04 109.211 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -66.32 158.78 76.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.906 -1.146 . . . . 73.33 107.906 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.55 -31.65 40.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.221 1.281 . . . . 64.33 110.947 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -70.99 -23.7 62.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.747 0.703 . . . . 61.23 112.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -89.94 -0.97 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.621 0.768 . . . . 32.14 111.79 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -67.84 120.48 14.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.291 -2.115 . . . . 74.5 105.291 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.11 2.34 36.04 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.116 0.865 . . . . 42.44 112.875 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 65.8 p -129.55 151.34 50.27 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.769 1.285 . . . . 70.34 108.058 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.55 171.13 16.26 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.001 -1.062 . . . . 74.3 110.74 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -138.38 151.87 47.9 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.947 0.899 . . . . 71.13 110.393 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.49 152.62 35.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.153 -2.166 . . . . 63.22 105.153 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 404' ' ' LEU . 23.5 t -127.73 129.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.172 -1.788 . . . . 72.14 106.172 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.23 161.99 13.42 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.848 -1.538 . . . . 72.14 106.848 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.08 -43.85 41.64 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.722 -0.611 . . . . 72.42 111.083 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -123.02 164.13 19.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.78 1.232 . . . . 53.44 109.74 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.0 tt -83.33 -10.82 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 114.564 1.32 . . . . 74.55 114.564 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -83.55 -53.7 5.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.619 -1.252 . . . . 75.4 107.619 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.8 -40.56 88.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.746 0.654 . . . . 74.21 110.294 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.34 79.01 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.544 0.738 . . . . 61.11 111.082 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.57 -46.15 76.96 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 119.124 -0.465 . . . . 64.23 110.253 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -55.51 -44.57 76.75 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.731 0.645 . . . . 75.44 110.123 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.71 -50.01 54.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.481 0.712 . . . . 71.2 110.051 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.8 t -50.88 -54.16 26.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.624 1.17 . . . . 74.2 110.937 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -63.3 -33.8 76.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.268 0.84 . . . . 63.21 113.268 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -80.91 -23.29 39.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 118.607 0.639 . . . . 75.1 111.911 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.26 -23.6 22.28 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.167 0.508 . . . . 63.32 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -61.67 114.13 3.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.193 1.397 . . . . 42.0 108.677 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 10.63 75.01 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.394 -1.226 . . . . 74.52 114.578 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.6 119.11 9.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.573 1.187 . . . . 73.33 108.571 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.26 109.31 17.69 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.497 1.519 . . . . 75.43 110.431 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 10.6 m -141.23 151.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.702 1.201 . . . . 75.13 109.585 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 76.8 m 44.68 43.75 6.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.892 1.277 . . . . 73.03 110.661 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.53 35.49 11.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.138 2.575 . . . . 74.34 112.371 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -144.72 -179.99 6.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.311 2.245 . . . . 75.43 108.09 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -128.41 157.23 41.62 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.85 1.26 . . . . 64.41 108.909 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -120.15 119.3 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.195 -0.668 . . . . 73.21 109.195 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.14 122.73 38.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 126.847 2.059 . . . . 73.2 106.294 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.39 129.41 61.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.398 -1.704 . . . . 71.42 106.398 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.36 153.68 51.76 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.99 -1.115 . . . . 72.42 107.99 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -84.1 156.93 21.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 71.32 108.314 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.95 140.16 43.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 104.202 -2.518 . . . . 74.11 104.202 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.673 -1.232 . . . . 72.22 107.673 178.852 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.823 0 N-CA-C 110.088 -1.205 . . . . 40.42 110.088 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . 0.252 10.0 t -131.81 69.58 81.08 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.858 0.863 . . . . 61.32 108.678 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.28 161.37 44.65 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.583 2.189 . . . . 62.33 109.771 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.21 -178.91 6.19 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 129.001 2.921 . . . . 73.15 107.968 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -116.49 77.45 1.11 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.894 -2.261 . . . . 64.52 104.894 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -59.84 145.82 44.18 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.521 0.329 . . . . 61.44 110.281 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -74.65 117.46 16.51 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.392 -2.077 . . . . 71.34 105.392 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -136.22 99.29 4.08 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.763 0.825 . . . . 71.35 112.332 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.47 177.37 1.96 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.013 1.325 . . . . 74.43 110.776 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 41.2 mtt-85 -140.86 158.47 43.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.575 1.15 . . . . 75.54 109.606 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -108.06 166.35 10.79 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.643 1.977 . . . . 63.41 108.955 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -77.43 168.02 20.7 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.005 0.922 . . . . 64.14 110.99 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -172.06 172.2 4.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.052 1.341 . . . . 64.32 108.135 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.11 104.88 15.41 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 101.94 -3.356 . . . . 60.31 101.94 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 6.3 tp 179.9 176.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 129.87 3.268 . . . . 73.43 105.241 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -139.97 128.05 22.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.77 -1.937 . . . . 54.32 105.77 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.17 159.74 11.5 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.954 0.724 . . . . 72.03 112.954 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.16 1.8 7.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.224 1.81 . . . . 75.14 111.475 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -64.06 -26.19 68.44 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.676 1.361 . . . . 62.33 114.676 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 118.87 154.7 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.909 1 C-N-CA 136.117 5.767 . . . . 74.43 106.322 -178.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -66.99 91.14 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.807 3.005 . . . . 73.1 108.574 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 86.2 mt -152.47 147.48 26.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.952 2.101 . . . . 75.42 107.917 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 24.8 t -153.67 164.55 38.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.877 0.871 . . . . 74.43 109.154 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.58 -22.22 66.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.957 0.903 . . . . 74.54 112.629 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -72.01 -22.4 61.42 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.296 -0.878 . . . . 62.23 110.167 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -85.24 -30.21 24.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.768 -0.826 . . . . 74.21 108.768 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 404' ' ' LEU . . . . . 0.435 ' CD2' HH22 ' B' ' 49' ' ' ARG . 29.4 tp -56.62 -39.64 73.96 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.677 0.791 . . . . 63.34 109.712 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.18 -41.01 82.95 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.273 0.629 . . . . 72.35 110.291 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.87 -9.34 58.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.796 1.238 . . . . 64.24 112.871 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 79.9 mtp -76.21 -12.21 60.05 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.962 -1.086 . . . . 64.44 110.062 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -114.61 158.85 39.15 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.774 1.629 . . . . 75.41 112.601 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.37 170.93 17.19 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.978 1.785 . . . . 42.31 109.721 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -87.45 163.37 16.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.94 -1.027 . . . . 63.32 111.035 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.69 18.26 35.75 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.155 1.359 . . . . 65.03 112.415 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.26 157.05 39.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.15 1.38 . . . . 70.3 107.564 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -137.94 147.19 44.08 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.602 -0.518 . . . . 61.54 109.602 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.19 150.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.478 0.581 . . . . 54.22 109.664 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.08 86.21 57.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.23 -1.396 . . . . 70.32 107.23 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.49 159.55 27.23 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.951 2.434 . . . . 74.0 113.03 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.63 168.94 21.24 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.837 2.358 . . . . 65.14 110.803 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.66 159.11 3.65 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 124.499 3.466 . . . . 74.41 115.348 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -93.24 82.36 4.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.055 1.342 . . . . 42.41 108.007 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 113.88 37.74 1.24 Allowed Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.269 -1.295 . . . . 65.23 114.103 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -65.27 1.32 1.1 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.703 1.752 . . . . 70.42 115.245 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 2.5 t 64.96 73.11 0.44 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 128.642 2.777 . . . . 73.5 111.938 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.18 0.05 10.34 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.909 3.073 . . . . 62.32 111.775 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 51.3 mt . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.453 1.901 . . . . 75.05 108.031 -178.976 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.938 0 N-CA-C 110.733 -0.947 . . . . 71.15 110.733 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -54.09 127.14 25.41 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.76 -1.2 . . . . 75.34 107.76 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.71 150.8 26.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.06 -0.719 . . . . 64.24 109.06 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -150.32 157.98 43.65 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.369 0.668 . . . . 63.13 110.459 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 tt -154.07 151.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 127.223 2.209 . . . . 62.52 105.186 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -156.89 176.04 13.28 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.303 -1.369 . . . . 71.02 107.303 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.46 150.15 36.7 Favored Pre-proline 0 C--O 1.239 0.51 0 N-CA-C 107.633 -1.247 . . . . 53.31 107.633 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.26 165.22 27.52 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.51 2.14 . . . . 54.54 109.681 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.31 -38.64 33.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.452 2.101 . . . . 75.03 112.552 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -154.39 164.14 39.09 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.846 1.658 . . . . 72.22 108.36 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 t -152.97 146.37 14.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.765 2.026 . . . . 75.13 106.645 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -121.96 -172.88 2.53 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.668 1.587 . . . . 52.11 109.449 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.37 -17.24 14.87 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.088 -1.008 . . . . 61.01 112.532 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.27 114.43 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.912 -1.514 . . . . 74.41 106.912 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 74.4 mt -102.97 170.83 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.251 1.02 . . . . 71.43 109.032 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -140.68 142.22 34.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.991 2.116 . . . . 74.03 106.509 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 mm -128.24 148.25 32.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 119.19 0.904 . . . . 74.42 108.711 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -133.42 162.31 32.2 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.264 1.825 . . . . 74.31 107.682 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.78 21.47 9.15 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.07 2.148 . . . . 71.15 112.292 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -61.03 155.25 55.9 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.396 1.078 . . . . 54.11 111.338 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.42 138.23 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.525 2.816 . . . . 71.11 111.05 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.47 -23.46 65.5 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.9 0.88 . . . . 72.51 112.635 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 113.58 14.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.024 -1.843 . . . . 62.25 106.024 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.5 129.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.195 -1.039 . . . . 73.3 108.195 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 12.5 p -83.23 169.15 16.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.385 -0.598 . . . . 64.5 109.385 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.78 84.47 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.663 -0.684 . . . . 44.32 109.47 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -47.98 -47.05 33.2 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.14 1.376 . . . . 73.21 112.571 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.87 -52.68 63.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.154 0.982 . . . . 74.34 109.701 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 75.4 mmm -59.38 -48.28 82.23 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.982 0.513 . . . . 44.13 110.812 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.22 -29.02 70.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.036 -0.983 . . . . 73.0 109.767 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.73 -62.28 1.45 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.726 1.148 . . . . 62.13 108.346 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 60.1 mt -45.44 -58.3 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.576 1.95 . . . . 70.3 111.339 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -78.04 -38.17 45.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.863 1.061 . . . . 63.54 113.863 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.04 -37.39 85.45 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.866 -0.894 . . . . 42.32 110.866 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -57.34 -31.48 65.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.463 0.631 . . . . 74.21 110.89 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -78.26 -55.35 5.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.599 -0.889 . . . . 73.3 108.599 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.81 -166.74 33.75 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.496 -0.752 . . . . 51.41 112.619 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.19 156.17 26.16 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.476 2.784 . . . . 72.31 114.453 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.83 102.84 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.175 -2.528 . . . . 73.52 104.175 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -75.77 -54.66 6.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.348 -0.982 . . . . 74.21 108.348 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -151.9 154.43 36.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.225 0.61 . . . . 70.41 109.613 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 80.1 mt -145.85 135.32 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.848 -1.538 . . . . 72.01 106.848 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.435 HH22 ' CD2' ' A' ' 404' ' ' LEU . 13.6 mtm-85 -133.48 120.5 20.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.375 -2.084 . . . . 71.41 105.375 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.49 136.51 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 126.149 1.78 . . . . 61.32 110.404 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.35 134.67 45.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.114 -1.595 . . . . 51.03 109.114 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -118.79 -23.23 7.06 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.502 1.521 . . . . 71.12 112.824 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 64.1 p -70.84 158.61 87.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 71.53 106.904 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.09 -10.89 22.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.02 1.813 . . . . 63.05 112.618 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -97.07 -45.51 6.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.661 1.584 . . . . 64.22 109.51 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.4 p -76.51 -19.11 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.245 0.93 . . . . 73.23 113.022 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -52.89 139.27 27.73 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 107.428 -1.323 . . . . 65.31 107.428 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.85 -6.24 56.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.743 -1.032 . . . . 62.24 111.385 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -132.86 159.67 39.17 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 119.281 1.541 . . . . 63.23 111.115 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.36 164.8 32.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.726 1.611 . . . . 64.54 108.468 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.77 125.48 32.06 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.86 -1.534 . . . . 64.12 106.86 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.63 146.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.141 -1.8 . . . . 73.21 106.141 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.692 -2.336 . . . . 73.4 104.692 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 22.0 m-85 -97.56 144.59 27.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.937 . . . . 74.45 108.471 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.15 -30.65 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 75.14 110.162 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -121.3 126.49 49.65 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.47 1.108 . . . . 74.41 109.487 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.73 -34.97 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.139 0.427 . . . . 73.03 111.621 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -61.45 -46.17 91.22 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.303 0.641 . . . . 73.11 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -67.6 -30.07 69.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.578 0.626 . . . . 73.12 110.139 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -62.44 -49.3 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.807 -1.183 . . . . 63.0 107.807 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -60.29 -43.75 95.98 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 109.026 -0.731 . . . . 61.41 109.026 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.03 -58.03 9.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.008 0.923 . . . . 75.41 110.814 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.41 -33.49 71.3 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.264 1.026 . . . . 64.54 110.279 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.8 t -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.62 1.1 . . . . 63.11 109.289 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -48.32 45.84 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.947 -1.095 . . . . 70.3 111.711 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -65.13 -17.55 64.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.084 1.142 . . . . 75.4 114.084 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 tp -107.39 -17.54 14.1 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.988 1.267 . . . . 65.01 113.101 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -65.11 105.47 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.912 -0.493 . . . . 65.31 110.368 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.08 16.72 46.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.215 -1.325 . . . . 54.4 114.808 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.96 111.17 4.81 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.412 1.606 . . . . 74.52 109.028 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.88 120.08 19.94 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.004 0.921 . . . . 72.42 110.039 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -149.72 149.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.802 -1.555 . . . . 65.34 106.802 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 15.9 m 51.84 32.52 9.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.683 1.193 . . . . 74.53 112.711 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.54 30.63 17.57 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.761 1.624 . . . . 72.42 111.46 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -135.43 167.32 21.28 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 127.735 2.414 . . . . 62.41 108.076 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -115.27 124.17 50.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.148 0.979 . . . . 74.31 110.908 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -77.97 156.21 30.34 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.31 -1.367 . . . . 72.44 107.31 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.27 140.23 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.474 -1.676 . . . . 71.53 106.474 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.27 153.88 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.649 1.58 . . . . 64.12 107.308 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -157.06 165.88 34.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.466 1.506 . . . . 63.23 108.646 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -102.83 164.84 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.73 2.812 . . . . 75.33 110.76 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -114.79 160.76 19.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.206 -1.405 . . . . 75.04 107.206 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 115.985 -1.959 . . . . 74.02 111.38 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 105.248 -3.141 . . . . 74.3 105.248 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 1.1 p -68.3 166.83 21.62 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 106.582 -1.636 . . . . 74.3 106.582 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -67.41 161.96 40.97 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 N-CA-C 108.146 -1.521 . . . . 71.44 108.146 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.77 139.58 48.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.282 -1.377 . . . . 43.02 107.282 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.1 134.26 8.33 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.172 -1.788 . . . . 72.13 106.172 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.0 pp -159.37 172.52 17.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.511 1.524 . . . . 74.52 108.802 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -151.35 173.39 14.57 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.771 2.029 . . . . 74.34 108.278 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -77.55 -177.76 4.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.328 1.051 . . . . 75.13 108.711 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -67.55 -39.3 84.96 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.417 -0.802 . . . . 72.12 110.777 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -153.97 149.32 27.13 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.389 1.476 . . . . 72.13 109.321 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -86.74 165.61 15.92 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.426 -1.324 . . . . 74.31 107.426 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -65.11 141.86 58.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.715 0.806 . . . . 65.21 109.319 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -166.92 108.87 0.68 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.407 -1.331 . . . . 75.12 107.407 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -91.88 167.3 12.23 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.304 1.042 . . . . 72.03 109.792 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 16.0 tt -60.97 156.47 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.32 1.048 . . . . 64.21 112.115 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -80.87 150.44 29.09 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.495 -0.928 . . . . 73.33 108.495 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -79.8 137.05 36.87 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 105.874 -1.898 . . . . 73.3 105.874 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -104.22 127.49 51.85 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 106.212 -1.774 . . . . 64.51 106.212 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -67.49 -45.65 75.25 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.825 0.45 . . . . 73.32 110.659 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.63 152.21 87.26 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 118.49 -0.767 . . . . 61.32 109.26 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.24 108.94 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.958 2.439 . . . . 55.13 107.829 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 67.0 mt -145.53 57.94 1.25 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.245 1.818 . . . . 74.53 107.714 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 14.5 m -67.43 168.2 11.25 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.162 -0.681 . . . . 42.42 109.162 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -57.27 -33.75 67.93 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.012 0.745 . . . . 53.32 113.012 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -74.89 -25.87 59.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.631 0.975 . . . . 72.01 113.631 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -60.68 -28.37 68.55 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.565 1.075 . . . . 72.33 111.293 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.99 -37.64 64.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.811 2.045 . . . . 75.1 111.742 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.35 -44.37 62.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.869 1.268 . . . . 74.15 111.832 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.07 -22.55 62.1 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.623 0.369 . . . . 61.24 110.718 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.5 mtp -70.59 -38.59 74.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.629 -0.7 . . . . 65.14 109.517 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -72.18 155.54 91.52 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 119.352 0.978 . . . . 71.11 112.084 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.471 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 71.8 Cg_endo -72.84 167.4 27.35 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.185 2.59 . . . . 61.11 111.372 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -79.45 153.32 29.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.309 1.444 . . . . 75.02 111.4 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.76 24.23 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.797 -1.001 . . . . 73.15 114.88 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.471 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 13.1 m-85 -124.54 158.01 33.97 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.528 1.664 . . . . 74.4 111.901 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -127.28 133.95 50.1 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.457 1.503 . . . . 70.02 107.784 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.09 150.72 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.229 -1.397 . . . . 72.25 107.229 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.8 tp -125.07 78.02 66.71 Favored Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 108.667 -0.864 . . . . 63.13 108.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -56.76 162.79 8.11 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.076 2.517 . . . . 71.43 111.315 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 159.73 51.11 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.102 1.868 . . . . 73.24 110.914 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.91 170.43 11.56 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.671 2.247 . . . . 74.31 112.288 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -66.34 92.98 0.2 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.535 1.534 . . . . 64.21 113.114 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 93.11 34.71 6.63 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.524 -1.153 . . . . 74.43 115.37 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -65.87 130.21 42.48 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 119.667 1.734 . . . . 74.31 113.283 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.03 93.32 9.33 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 104.612 -2.366 . . . . 71.14 104.612 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.13 -12.71 23.5 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.495 2.13 . . . . 63.44 114.355 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 15.1 mm . . . . . 0 C--O 1.252 1.191 0 N-CA-C 107.097 -1.446 . . . . 73.15 107.097 -179.45 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 N-CA-C 110.36 -1.096 . . . . 52.02 110.36 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -141.82 162.34 35.72 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.467 1.134 . . . . 65.43 109.052 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.36 165.26 20.09 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.281 1.033 . . . . 61.15 110.072 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -84.79 91.3 7.95 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.207 -1.034 . . . . 43.11 108.207 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 83.1 mt -75.65 116.29 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 104.331 -2.47 . . . . 65.25 104.331 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -69.08 -61.58 1.73 Allowed 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 118.638 -0.696 . . . . 74.11 110.886 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -120.81 154.37 57.45 Favored Pre-proline 0 C--O 1.233 0.206 0 C-N-CA 123.274 0.629 . . . . 60.54 109.695 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.65 162.15 25.8 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.221 2.614 . . . . 62.4 111.062 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.69 -43.12 13.64 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.191 2.594 . . . . 72.12 112.599 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -155.07 155.83 34.79 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.991 -1.485 . . . . 74.44 106.991 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 85.2 t -148.14 102.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.114 -1.439 . . . . 72.02 107.114 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.04 148.87 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.173 -1.788 . . . . 62.34 106.173 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.73 83.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 39.9 mt -68.56 116.08 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 125.934 1.694 . . . . 61.31 111.636 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 25.4 mt -104.2 149.15 25.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.111 -1.07 . . . . 75.41 108.111 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -123.7 137.56 54.68 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.511 -2.403 . . . . 63.14 104.511 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.427 ' HB ' HD11 ' B' ' 26' ' ' LEU . 6.3 mm -125.41 151.2 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.583 -1.636 . . . . 74.43 106.583 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -136.27 164.28 28.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.549 1.94 . . . . 73.51 108.461 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.53 13.56 8.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.546 1.938 . . . . 71.15 111.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' B' ' 23' ' ' ILE . 67.6 mt -66.06 155.99 85.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.94 1.296 . . . . 70.43 112.715 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.59 153.3 72.58 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.11 2.54 . . . . 72.03 111.192 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -86.19 -19.81 29.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 74.34 110.496 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -130.39 115.59 17.09 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.797 1.639 . . . . 73.22 107.05 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 157.05 5.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.845 -1.168 . . . . 71.41 107.845 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 15.5 p -101.89 164.49 11.69 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.215 1.406 . . . . 44.02 110.363 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.4 84.27 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.504 -1.665 . . . . 65.0 106.504 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.46 -37.13 77.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.629 2.372 . . . . 63.24 111.16 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.61 -47.87 16.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.204 -0.935 . . . . 62.41 109.645 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.8 mmm -58.33 -42.86 87.75 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.336 0.516 . . . . 74.0 110.859 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -73.55 -34.95 65.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.932 -0.556 . . . . 64.54 111.444 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.25 -58.08 5.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.994 0.815 . . . . 75.45 111.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mt -52.16 -62.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.461 1.504 . . . . 62.41 110.734 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -64.96 -22.84 67.07 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 119.019 -0.515 . . . . 65.11 111.406 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -29.11 68.09 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 125.834 1.683 . . . . 62.41 111.171 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -61.44 -24.26 66.41 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.369 1.584 . . . . 75.51 110.185 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -88.94 -46.89 8.54 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.671 0.788 . . . . 73.54 110.386 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.17 -171.51 43.94 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 119.499 1.045 . . . . 72.22 114.835 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.47 116.57 3.71 Favored 'Trans proline' 0 C--N 1.347 0.477 1 C-N-CA 125.711 4.274 . . . . 72.15 113.985 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.1 mt -83.46 125.79 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.558 1.143 . . . . 73.12 109.731 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.36 -60.41 2.04 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.422 -1.325 . . . . 73.15 107.422 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -156.57 149.43 23.86 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.203 0.911 . . . . 74.1 109.497 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 29.5 mt -129.53 144.2 38.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.943 2.097 . . . . 74.13 108.48 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -141.96 154.79 45.31 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.335 -1.728 . . . . 71.54 106.335 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.01 165.7 19.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 71.43 109.354 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 145.78 49.39 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.532 -1.027 . . . . 43.4 110.532 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -105.18 -52.69 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.738 -1.208 . . . . 74.15 107.738 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 70.2 p -69.89 156.99 90.82 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 124.204 1.002 . . . . 74.42 109.825 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.81 -39.21 64.31 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.613 1.542 . . . . 62.02 109.796 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.64 -7.2 24.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.502 1.121 . . . . 75.33 113.398 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 8.3 p -102.25 -4.43 25.72 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.571 1.078 . . . . 64.13 109.651 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -69.86 150.04 47.23 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.156 -1.59 . . . . 71.24 108.32 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.18 -7.52 64.36 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.16 -1.356 . . . . 65.13 113.73 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.4 p -140.51 162.75 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.212 2.006 . . . . 44.21 107.346 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.424 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -165.66 173.63 10.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 61.3 109.98 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.63 144.72 50.82 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.801 0.841 . . . . 71.52 109.694 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 86.4 t -133.5 141.1 45.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.408 1.083 . . . . 74.14 108.626 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.92 130.64 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 106.454 -1.684 . . . . 65.25 106.454 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 45.0 m-85 -104.09 166.35 10.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.869 2.068 . . . . 72.45 107.49 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.31 -69.54 0.3 Allowed 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.366 -0.834 . . . . 71.25 111.866 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.67 151.11 21.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.517 1.053 . . . . 73.25 110.642 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.5 tt -61.75 -33.86 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.483 0.713 . . . . 73.21 111.781 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -69.03 -47.67 64.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.103 -0.703 . . . . 71.44 109.103 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.04 -46.09 85.92 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -57.43 -54.85 42.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.161 1.385 . . . . 72.21 111.432 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -52.08 -36.83 51.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.706 1.202 . . . . 71.51 113.172 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -69.27 -36.3 76.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.896 0.771 . . . . 71.55 110.35 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.44 -32.06 71.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.108 0.867 . . . . 72.54 110.642 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 61.3 m -55.84 -41.57 74.49 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.075 0.55 . . . . 75.11 110.516 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -84.67 -35.98 22.23 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.547 0.739 . . . . 73.23 111.54 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -15.82 63.1 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.277 -0.889 . . . . 63.4 112.524 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.7 tp -104.84 -16.15 14.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.053 0.842 . . . . 41.22 112.206 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -72.2 134.67 45.79 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.446 -1.409 . . . . 72.22 110.085 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.32 10.1 84.38 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.777 1.18 . . . . 64.1 113.193 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -72.34 120.74 18.37 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.874 1.27 . . . . 71.43 110.078 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -87.79 120.07 28.75 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.19 1.796 . . . . 75.04 107.466 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.96 135.94 42.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.367 -0.975 . . . . 75.44 108.367 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.3 m 46.58 47.14 14.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.422 1.489 . . . . 71.51 112.194 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 18.0 m120 54.72 30.74 14.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.511 1.524 . . . . 63.02 112.786 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -136.2 -179.87 5.93 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.325 2.65 . . . . 74.53 106.48 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -139.59 133.84 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.326 -1.731 . . . . 60.05 106.326 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.89 172.79 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.352 -0.981 . . . . 71.53 108.352 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.59 140.13 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.28 -2.489 . . . . 65.43 104.28 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.81 142.72 41.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.807 1.243 . . . . 72.5 108.676 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -153.29 150.33 28.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.162 0.985 . . . . 71.32 109.665 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -85.55 163.49 18.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.098 1.359 . . . . 71.32 110.562 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -77.9 167.17 21.92 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.547 -0.538 . . . . 71.42 109.547 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.248 1.023 0 N-CA-C 105.422 -2.066 . . . . 61.35 105.422 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.989 0 N-CA-C 108.662 -1.775 . . . . 52.01 108.662 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 5.6 t -146.98 120.9 5.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 102.477 -3.157 . . . . 71.21 102.477 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -74.3 166.23 29.98 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.756 1.638 . . . . 72.54 110.843 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.45 170.9 14.82 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 128.031 2.532 . . . . 73.53 109.028 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -149.39 147.56 28.43 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.055 -1.461 . . . . 63.21 107.055 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 93.4 mt -139.33 107.41 5.73 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.021 -1.103 . . . . 73.34 108.021 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -76.89 148.1 36.64 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.565 -0.902 . . . . 74.1 108.565 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -147.99 113.17 5.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.62 -0.881 . . . . 73.41 108.62 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.93 122.88 19.56 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.33 -0.989 . . . . 71.35 108.33 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -62.35 -54.25 43.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 118.567 -0.73 . . . . 71.4 111.073 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 41.9 t-105 -156.05 162.12 40.34 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.355 -1.35 . . . . 75.2 107.355 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 390' ' ' ARG . 6.3 tt0 -126.69 -158.69 0.88 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.577 2.351 . . . . 72.0 107.263 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ARG . . . . . 0.4 ' H ' ' HG2' ' A' ' 389' ' ' GLU . 0.0 OUTLIER -144.39 121.38 11.38 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 101.806 -3.405 . . . . 65.23 101.806 178.205 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -126.1 168.28 14.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.883 1.219 . . . . 71.54 110.147 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.05 142.29 41.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.832 0.853 . . . . 43.34 109.224 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -146.07 82.97 1.62 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 104.328 -2.471 . . . . 60.15 104.328 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -128.46 69.95 1.37 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.514 1.526 . . . . 75.04 108.081 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.6 172.99 7.68 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.874 2.469 . . . . 74.4 108.849 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -64.57 109.28 1.93 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.439 0.637 . . . . 72.33 109.785 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -89.36 142.23 29.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 126.241 1.816 . . . . 63.04 107.927 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.98 142.1 38.0 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 107.868 -1.628 . . . . 74.34 107.868 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.57 135.33 55.88 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.08 0.552 . . . . 74.14 110.582 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.5 t -158.68 -170.99 3.25 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.537 1.935 . . . . 72.35 107.212 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.38 -18.02 63.04 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.202 -0.936 . . . . 53.43 112.0 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -62.65 -44.26 96.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.787 1.235 . . . . 72.04 108.545 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -63.41 -20.91 65.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.204 1.001 . . . . 72.22 111.157 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.2 tp -82.64 -38.51 23.42 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.971 -1.492 . . . . 72.35 106.971 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -65.45 -44.32 87.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.298 0.954 . . . . 71.41 110.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.84 60.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.502 1.121 . . . . 42.13 113.485 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.9 mtp -79.39 -6.6 57.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.062 1.345 . . . . 73.13 113.068 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -107.58 159.25 30.99 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 114.55 1.315 . . . . 72.02 114.55 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.66 158.94 54.87 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.215 3.276 . . . . 54.31 112.538 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -75.28 147.78 39.94 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.497 1.519 . . . . 75.11 109.165 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.35 17.41 62.52 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.529 -0.732 . . . . 51.44 114.656 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -124.35 102.97 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 105.325 -2.102 . . . . 73.02 105.325 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -83.78 155.39 23.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.508 1.123 . . . . 65.24 110.684 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.1 t -70.05 144.38 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.003 0.921 . . . . 62.23 110.193 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 50.7 tp -126.38 79.55 70.38 Favored Pre-proline 0 N--CA 1.452 -0.339 0 N-CA-C 107.346 -1.353 . . . . 71.44 107.346 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.18 163.81 37.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.124 1.883 . . . . 75.2 110.023 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.11 161.45 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.556 2.171 . . . . 73.01 109.774 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.48 145.64 77.43 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.43 1.42 . . . . 54.35 109.375 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.02 70.9 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.714 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -74.02 11.42 6.24 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 117.184 -1.898 . . . . 62.31 115.906 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -66.48 161.36 23.01 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 121.161 2.48 . . . . 74.42 109.582 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 22.7 t -131.18 79.1 71.41 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.118 -1.438 . . . . 72.23 107.118 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.05 114.29 3.86 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 N-CA-C 106.019 -2.339 . . . . 72.22 106.019 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 36.2 mm . . . . . 0 C--O 1.25 1.084 0 C-N-CA 127.847 2.459 . . . . 73.42 106.34 -178.301 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.938 0 N-CA-C 110.508 -1.037 . . . . 75.45 110.508 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -145.7 131.5 19.05 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 103.193 -2.892 . . . . 72.25 103.193 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.0 67.46 4.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.881 0.764 . . . . 72.43 109.501 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.64 165.62 13.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.935 1.294 . . . . 73.24 109.436 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.25 137.82 51.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 105.516 -2.031 . . . . 43.23 105.516 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.39 163.64 35.85 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.733 1.213 . . . . 73.34 108.69 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.46 159.59 84.38 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 109.006 -0.739 . . . . 61.24 109.006 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.83 171.42 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.961 3.107 . . . . 73.55 111.386 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.7 -31.94 86.42 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.643 2.228 . . . . 70.11 113.231 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.04 167.61 29.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.198 1.399 . . . . 71.1 108.608 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.9 t -141.39 165.8 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.662 1.585 . . . . 74.13 107.817 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -133.69 -176.97 4.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.4 1.88 . . . . 72.01 108.924 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.77 -43.86 5.45 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.649 -1.282 . . . . 75.23 111.607 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.5 mt -73.68 144.03 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.394 -1.335 . . . . 75.13 107.394 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 88.0 mt -124.18 157.2 35.28 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.737 1.615 . . . . 54.41 108.565 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -124.31 133.52 53.44 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.392 2.277 . . . . 71.32 106.837 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -120.29 146.95 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.601 1.16 . . . . 75.14 108.283 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -135.59 163.02 31.07 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.157 1.383 . . . . 74.0 109.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 65.08 14.69 9.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.952 2.101 . . . . 70.3 113.851 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.54 153.13 91.07 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 120.796 -1.19 . . . . 73.15 109.588 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.47 140.11 56.34 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.762 2.308 . . . . 74.53 110.532 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.58 -30.1 71.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.913 1.079 . . . . 75.03 113.913 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -130.26 117.91 20.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.888 -1.523 . . . . 72.25 106.888 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 tt -165.88 140.89 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.958 2.503 . . . . 72.23 104.366 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 18.0 p -75.12 174.4 9.47 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.027 0.831 . . . . 64.22 109.944 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.06 76.21 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 107.126 -1.435 . . . . 52.05 107.126 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -47.84 -54.3 12.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 128.326 2.65 . . . . 71.22 112.739 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -62.21 -49.51 75.48 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.36 0.527 . . . . 75.12 110.099 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 72.3 mmm -56.26 -49.44 74.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 119.213 -0.422 . . . . 75.2 111.088 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' TYR . . . . . 0.407 ' CZ ' HD12 ' B' ' 48' ' ' ILE . 14.8 m-85 -61.51 -43.96 97.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.559 -1.21 . . . . 73.25 110.009 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -58.59 7.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.105 -1.072 . . . . 43.25 108.105 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 64.2 mt -47.61 -67.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.854 2.062 . . . . 64.45 112.345 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -68.34 -26.93 65.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.281 0.845 . . . . 74.21 113.281 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 -20.65 66.44 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 124.874 1.226 . . . . 64.34 112.983 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -26.75 68.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.387 1.593 . . . . 75.41 110.486 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -85.88 -10.16 55.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.784 0.661 . . . . 74.04 112.784 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.96 -171.59 22.37 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.355 0.98 . . . . 40.33 111.54 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.75 153.14 73.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.776 2.984 . . . . 70.3 111.36 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mt -118.21 138.25 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.286 -1.005 . . . . 71.21 108.286 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -51.9 9.78 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.17 1.388 . . . . 70.12 111.485 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -161.9 157.58 24.08 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.76 0.824 . . . . 74.34 109.473 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ILE . . . . . 0.407 HD12 ' CZ ' ' B' ' 36' ' ' TYR . 21.4 mt -145.78 142.36 21.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.993 1.317 . . . . 73.33 108.268 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -145.45 150.76 37.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.763 -1.569 . . . . 72.42 106.763 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.16 147.27 30.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.468 0.707 . . . . 65.44 109.656 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.28 135.6 31.77 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.328 -1.909 . . . . 75.41 108.328 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.95 -21.36 5.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.876 1.065 . . . . 62.22 113.876 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.7 p -69.69 159.8 82.35 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 104.56 -2.385 . . . . 72.14 104.56 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.02 -45.36 36.56 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.505 1.47 . . . . 75.52 111.241 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.07 -5.8 29.3 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.826 1.417 . . . . 73.54 114.826 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -116.45 -18.07 10.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.293 1.406 . . . . 64.22 112.799 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -52.55 126.96 21.21 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.822 0.849 . . . . 75.44 109.686 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.05 48.33 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.459 -1.19 . . . . 70.13 112.653 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 61.6 p -127.56 146.81 50.4 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.03 1.915 . . . . 70.21 107.535 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -156.23 174.26 15.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.614 0.366 . . . . 41.21 111.229 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.14 155.46 48.13 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.396 1.078 . . . . 74.52 109.17 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -138.63 139.83 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 104.412 -2.44 . . . . 73.1 104.412 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.39 123.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.56 -2.015 . . . . 53.35 105.56 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -97.91 166.15 11.59 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.827 -1.546 . . . . 71.42 106.827 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -71.28 -47.6 55.9 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.754 -0.591 . . . . 72.44 109.774 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.86 154.6 38.06 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.911 0.778 . . . . 73.15 110.737 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.93 -37.5 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 113.736 1.013 . . . . 72.0 113.736 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -57.95 -48.23 80.58 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.161 -0.923 . . . . 75.03 111.528 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.14 -40.87 95.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 123.935 0.772 . . . . 72.24 109.349 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -54.71 42.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.156 -0.313 . . . . 54.21 110.156 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -69.76 -30.18 67.7 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.523 -0.751 . . . . 64.34 111.894 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.67 -53.97 51.79 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.109 -1.071 . . . . 72.33 108.109 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.03 93.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.417 1.087 . . . . 63.5 110.611 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 13.3 t -46.56 -69.16 0.14 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.823 1.249 . . . . 73.44 113.018 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.39 -27.77 67.37 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.074 1.138 . . . . 71.21 114.074 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -33.71 72.49 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.775 0.716 . . . . 73.13 109.607 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -90.01 -24.91 21.09 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.987 1.315 . . . . 71.33 112.992 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -57.34 111.26 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.481 1.512 . . . . 42.53 110.675 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.11 9.85 57.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.324 1.916 . . . . 74.02 114.43 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -61.74 130.03 43.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.543 1.671 . . . . 73.13 110.363 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -89.84 100.92 13.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.417 2.287 . . . . 64.13 110.653 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.84 133.51 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.402 1.081 . . . . 72.22 110.621 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m 42.79 49.41 5.03 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.827 1.651 . . . . 50.43 112.121 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 32.1 t30 58.94 33.25 22.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.603 2.361 . . . . 64.33 112.878 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -140.16 158.33 44.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.985 -1.072 . . . . 72.12 108.26 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -118.07 118.14 31.09 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.822 -1.547 . . . . 75.13 106.822 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.6 mt -73.63 174.05 8.87 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.692 -1.225 . . . . 65.15 107.692 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.02 137.4 52.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.094 -2.558 . . . . 71.33 104.094 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 t -126.83 121.67 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.743 -1.947 . . . . 74.41 105.743 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 34.6 tp -136.15 153.21 51.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.573 -0.899 . . . . 63.44 108.573 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -74.75 163.11 28.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.694 0.798 . . . . 73.12 108.949 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -104.49 154.58 19.72 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.957 -1.868 . . . . 60.53 105.957 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 C--O 1.246 0.871 0 C-N-CA 124.387 1.075 . . . . 74.1 110.652 -178.587 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 CA-C-O 116.217 -2.435 . . . . 63.41 107.07 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 20.7 p 23.97 80.11 0.2 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 126.979 2.112 . . . . 75.53 114.594 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.89 168.26 23.55 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.567 1.511 . . . . 74.25 109.792 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -130.67 157.44 42.77 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.908 1.683 . . . . 74.21 106.876 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -136.73 86.02 2.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.444 -1.317 . . . . 74.35 107.444 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.59 160.83 24.48 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.457 -0.942 . . . . 74.52 108.457 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -136.37 169.06 18.28 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.311 0.645 . . . . 53.33 110.051 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -154.97 171.83 19.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.571 1.549 . . . . 72.01 107.285 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -122.85 130.66 53.15 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.18 -1.415 . . . . 64.22 107.18 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -76.48 149.42 36.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.634 -0.876 . . . . 52.2 108.634 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -155.03 158.69 39.5 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.187 -1.412 . . . . 74.54 107.187 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.89 172.09 13.7 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.594 0.711 . . . . 74.02 112.028 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -153.89 171.81 18.38 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.736 2.014 . . . . 72.23 107.492 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.38 131.48 39.16 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.438 -2.43 . . . . 71.25 104.438 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 10.4 tp -148.82 159.98 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 108.65 -0.87 . . . . 64.53 108.65 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.16 47.79 2.21 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.264 1.426 . . . . 71.4 109.62 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -56.67 118.45 4.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.086 0.955 . . . . 74.34 109.914 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -75.77 104.3 6.25 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.639 1.175 . . . . 74.02 108.341 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -111.05 178.29 4.39 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.291 0.636 . . . . 64.53 111.891 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -68.03 154.28 94.05 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.965 0.906 . . . . 72.3 111.095 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.04 -12.93 12.99 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.817 2.344 . . . . 62.25 112.68 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 91.8 mt -127.8 115.74 19.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 101.417 -3.549 . . . . 32.13 101.417 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.5 p -136.05 -175.05 3.85 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.958 0.885 . . . . 73.2 110.071 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -40.46 97.2 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.871 2.069 . . . . 70.2 108.127 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -67.26 -29.67 69.35 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.848 0.459 . . . . 65.34 110.607 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -75.32 -37.44 60.76 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.471 -0.566 . . . . 54.42 109.471 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.01 -30.98 69.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.429 0.559 . . . . 53.01 110.302 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.93 -36.87 80.87 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.965 -0.459 . . . . 64.44 111.042 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.5 -37.62 36.27 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.378 1.071 . . . . 33.22 110.851 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.2 mtp -66.41 -12.51 57.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.519 1.128 . . . . 74.43 111.846 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -99.25 157.28 34.32 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 124.095 0.958 . . . . 63.1 110.107 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -89.41 172.5 4.09 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.199 2.599 . . . . 64.21 109.017 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.63 159.34 33.2 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.606 -0.684 . . . . 54.24 110.906 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.2 20.97 58.04 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 117.825 -1.541 . . . . 75.22 115.451 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -125.49 140.09 53.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.985 1.893 . . . . 74.03 110.631 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -122.26 151.28 41.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.572 1.949 . . . . 62.24 109.104 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.86 151.38 6.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 122.563 1.173 . . . . 64.43 110.604 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.0 tp -126.48 87.47 56.3 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 103.398 -2.815 . . . . 74.11 103.398 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -64.01 168.9 11.35 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.222 2.615 . . . . 71.32 111.226 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.74 163.3 35.83 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.37 1.38 . . . . 64.12 108.661 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -48.58 152.94 3.71 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.604 2.869 . . . . 73.33 113.745 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -57.9 133.11 55.17 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.397 0.679 . . . . 63.34 112.634 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 55.26 25.14 39.3 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.453 -1.193 . . . . 53.11 113.06 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -64.55 101.63 0.47 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.731 1.265 . . . . 74.33 108.104 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.92 82.79 36.27 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 105.139 -2.171 . . . . 74.43 105.139 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.93 -176.4 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.046 2.498 . . . . 72.44 110.031 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.4 tt . . . . . 0 C--O 1.253 1.237 0 N-CA-C 104.78 -2.304 . . . . 74.11 104.78 178.836 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 109.441 -1.464 . . . . 53.14 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -145.1 112.19 6.01 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 106.795 -1.557 . . . . 65.31 106.795 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -156.48 136.33 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.515 1.526 . . . . 61.31 107.4 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -154.71 130.71 10.2 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.45 1.1 . . . . 53.05 108.896 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ILE . . . . . 0.618 ' H ' HD12 ' B' ' 11' ' ' ILE . 1.9 mp -68.61 -25.37 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.858 1.663 . . . . 42.43 113.096 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.99 158.49 18.62 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.348 -0.845 . . . . 63.31 110.622 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.84 155.55 38.09 Favored Pre-proline 0 C--O 1.241 0.643 0 C-N-CA 124.176 0.99 . . . . 52.43 108.595 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.49 165.43 29.16 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.725 1.616 . . . . 73.13 111.103 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.92 2.68 4.54 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.506 3.47 . . . . 64.22 114.313 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -148.87 120.08 7.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.961 1.704 . . . . 54.0 107.287 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.568 HG11 ' HG2' ' B' ' 71' ' ' LYS . 35.2 t -145.14 91.92 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.511 -1.292 . . . . 75.14 107.511 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -61.92 152.52 31.79 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.743 1.217 . . . . 73.24 110.43 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 -59.11 -61.48 2.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.418 -0.801 . . . . 72.13 112.903 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.79 134.41 26.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.005 -0.739 . . . . 74.51 109.005 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.35 157.52 26.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.947 2.099 . . . . 63.25 109.175 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -124.93 135.7 53.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.493 1.917 . . . . 72.32 108.397 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mm -118.12 143.07 29.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 126.193 1.797 . . . . 74.12 108.767 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -133.6 162.59 31.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.324 . . . . 73.44 107.571 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 21.5 t30 65.58 30.23 10.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.422 2.689 . . . . 72.33 111.666 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 50.8 mt -70.06 147.67 95.78 Favored Pre-proline 0 C--O 1.236 0.348 0 O-C-N 121.736 -0.603 . . . . 72.14 111.196 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.99 152.49 68.16 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.826 2.351 . . . . 74.04 110.579 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -83.95 -11.03 57.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.496 0.718 . . . . 72.31 112.107 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.86 113.85 17.12 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.36 -2.089 . . . . 75.54 105.36 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -163.2 167.62 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.785 -1.561 . . . . 73.35 106.785 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -133.98 175.71 9.23 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.203 1.801 . . . . 74.11 111.607 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.02 -35.87 80.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.881 -0.785 . . . . 61.24 108.881 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.43 -50.63 71.1 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.771 -0.455 . . . . 74.23 109.771 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -63.72 -55.07 26.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.582 1.153 . . . . 71.04 111.374 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.8 mmm -57.28 -27.67 62.33 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 113.749 1.018 . . . . 70.53 113.749 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -93.85 -20.62 19.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.909 0.777 . . . . 65.0 111.208 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.9 -52.19 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.219 0.918 . . . . 54.12 110.957 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.99 -52.75 40.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.786 1.634 . . . . 61.22 110.858 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.93 -30.47 39.96 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 118.146 -0.93 . . . . 61.11 113.13 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -31.58 78.55 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.871 -0.892 . . . . 64.2 110.871 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -60.4 -15.35 25.38 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.203 1.401 . . . . 71.45 113.023 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.01 -16.76 14.21 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.315 1.046 . . . . 74.32 113.616 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.1 174.72 29.18 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.055 1.312 . . . . 74.53 110.902 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.48 145.4 64.64 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 124.297 3.331 . . . . 63.21 110.946 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 24.4 mt -99.78 124.68 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.547 1.139 . . . . 55.11 111.231 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -83.19 -56.34 3.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.56 -1.274 . . . . 74.02 107.56 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -157.72 152.85 25.72 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.426 1.012 . . . . 64.3 112.456 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mt -134.46 118.29 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.963 2.105 . . . . 70.02 107.627 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -127.21 120.34 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.119 -2.178 . . . . 73.23 105.119 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.41 159.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.235 2.214 . . . . 73.22 111.095 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.88 146.69 38.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.107 -1.597 . . . . 40.24 109.107 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -112.73 -45.61 3.2 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.471 1.108 . . . . 73.1 111.61 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 15.6 p -74.42 162.14 75.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.941 1.696 . . . . 63.33 111.858 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.88 9.29 2.03 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.626 2.884 . . . . 60.44 112.319 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.64 1.51 11.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.889 1.276 . . . . 71.13 111.521 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 35.6 p -116.75 -1.2 12.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.801 2.04 . . . . 74.02 109.461 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -63.77 145.9 54.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.806 2.042 . . . . 71.13 112.194 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.52 6.16 70.05 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.851 -0.971 . . . . 74.15 112.873 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 21.1 p -141.1 150.35 42.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.041 1.42 . . . . 64.22 110.613 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.92 171.32 14.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.444 1.498 . . . . 74.41 109.107 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -118.11 159.98 22.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.245 1.018 . . . . 71.13 109.428 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.36 139.11 47.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.278 -1.379 . . . . 74.22 107.278 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 t -127.71 123.74 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.757 -1.942 . . . . 73.24 105.757 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.3 165.78 11.52 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 105.13 -2.174 . . . . 63.44 105.13 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -73.32 -35.0 65.99 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.291 -0.881 . . . . 74.24 112.052 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.2 162.52 22.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.946 0.794 . . . . 75.55 112.54 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 tt -67.84 -43.49 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.051 0.94 . . . . 65.21 109.596 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.98 -41.81 99.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.754 1.222 . . . . 74.44 111.474 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.49 -44.92 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.511 -0.922 . . . . 54.22 108.511 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.42 85.79 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.129 0.572 . . . . 62.44 109.524 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.568 ' HG2' HG11 ' B' ' 17' ' ' VAL . 41.2 mtpt -59.24 -48.87 79.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.375 1.07 . . . . 72.42 111.111 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.79 -40.01 94.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.326 0.967 . . . . 52.32 110.827 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.62 66.83 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.638 -0.696 . . . . 65.1 111.486 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.56 -64.37 0.97 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 117.85 -1.071 . . . . 73.34 109.319 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.34 -33.67 74.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.125 1.329 . . . . 70.33 112.969 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -64.47 -31.07 72.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.043 0.383 . . . . 74.33 110.262 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.4 tp -102.47 -26.23 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.882 1.438 . . . . 73.23 114.882 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -61.8 106.31 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.364 1.865 . . . . 75.52 110.34 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.54 10.74 63.19 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.55 -1.139 . . . . 51.44 113.19 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.22 121.26 10.93 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.934 1.367 . . . . 71.45 109.894 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.83 112.19 15.74 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.08 1.752 . . . . 64.31 107.815 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.97 148.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.348 0.659 . . . . 74.23 110.589 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 87.6 m 34.0 54.95 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.294 2.638 . . . . 65.25 114.588 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 52.33 31.26 9.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.859 2.064 . . . . 43.42 112.452 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -140.23 -170.71 3.03 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 128.781 2.833 . . . . 43.44 107.864 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -148.64 153.0 37.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.87 2.068 . . . . 64.34 105.741 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.1 172.84 6.6 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.421 -0.955 . . . . 73.44 108.421 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.21 150.66 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.068 -1.456 . . . . 75.12 107.068 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.1 136.17 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.476 1.91 . . . . 54.41 107.626 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.3 tp -146.61 151.61 37.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.209 1.803 . . . . 71.03 107.824 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' TYR . . . . . 0.46 ' CZ ' HG13 ' B' ' 17' ' ' VAL . 7.0 m-85 -94.6 155.82 16.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.029 0.931 . . . . 73.32 111.288 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -80.5 175.55 10.56 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.212 0.605 . . . . 75.0 112.52 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 125.931 1.692 . . . . 75.51 109.985 -179.094 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 110.133 -1.187 . . . . 73.33 110.133 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 8.8 t -154.16 47.29 0.34 Allowed Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.881 0.872 . . . . 75.31 111.435 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -66.32 166.88 19.97 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.61 2.207 . . . . 54.2 112.239 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -83.02 134.96 35.02 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.916 -1.142 . . . . 73.14 107.916 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -120.08 151.2 39.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.96 -1.496 . . . . 63.42 106.96 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.59 130.63 47.79 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.916 -1.513 . . . . 73.32 106.916 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -67.6 79.86 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.831 1.253 . . . . 61.04 109.599 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -157.92 88.21 0.96 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 126.589 1.955 . . . . 75.31 107.828 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -82.22 173.54 12.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.059 -0.719 . . . . 53.41 109.059 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -88.31 161.73 16.98 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.639 -0.663 . . . . 63.24 111.252 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 52.64 48.34 22.73 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.393 1.477 . . . . 72.13 110.427 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.52 153.92 40.08 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.778 0.831 . . . . 75.44 110.431 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -80.82 148.81 29.82 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 109.748 -0.464 . . . . 65.52 109.748 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.59 36.65 2.68 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.578 2.351 . . . . 75.14 113.028 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 5.1 tp -61.39 131.53 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.014 1.726 . . . . 70.25 108.611 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -78.34 169.93 17.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.544 1.538 . . . . 72.3 111.965 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.37 109.05 5.81 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.861 -1.149 . . . . 72.02 108.477 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -111.24 132.56 54.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.38 1.072 . . . . 74.23 109.701 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -55.7 124.86 18.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.01 -1.478 . . . . 74.32 107.01 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -129.31 151.57 78.05 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 123.997 0.919 . . . . 73.31 111.432 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -74.13 177.18 8.57 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.344 2.696 . . . . 73.41 110.546 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.51 145.76 32.21 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.323 0.649 . . . . 52.43 109.529 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.3 t -81.15 -176.67 6.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 123.096 1.426 . . . . 61.24 109.706 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -70.86 -19.72 62.61 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.955 2.102 . . . . 71.01 109.963 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -81.45 -56.2 4.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.618 1.967 . . . . 73.11 111.332 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.84 -24.93 59.75 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.915 0.779 . . . . 74.41 111.798 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 61.8 tp -67.51 -27.57 67.1 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.088 1.355 . . . . 53.32 110.273 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -66.52 -32.51 73.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.822 1.192 . . . . 53.35 110.018 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.84 56.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.331 1.052 . . . . 75.42 111.917 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 67.3 mtp -88.17 -12.26 44.45 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.293 1.437 . . . . 74.55 113.245 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -114.61 160.81 31.75 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 125.707 1.603 . . . . 54.54 111.59 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.25 167.42 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.232 1.954 . . . . 71.11 110.151 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.87 169.95 15.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.403 0.681 . . . . 71.41 110.306 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 80.51 22.42 62.37 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.034 -1.041 . . . . 72.21 113.277 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -124.58 156.86 36.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.851 -1.166 . . . . 74.43 107.851 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.0 149.47 47.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.032 0.933 . . . . 42.45 110.09 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.63 151.12 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.076 -0.712 . . . . 73.43 109.076 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.419 HD22 HG11 ' B' ' 50' ' ' VAL . 34.2 tp -131.09 82.98 61.93 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 107.978 -1.119 . . . . 70.32 107.978 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.45 164.18 7.49 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.872 3.048 . . . . 71.11 112.236 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.46 162.38 20.92 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.053 2.502 . . . . 72.53 112.648 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.06 170.56 17.83 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.879 2.386 . . . . 73.31 110.485 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -66.49 151.48 47.14 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.898 -0.501 . . . . 60.12 109.77 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 55.29 21.32 25.78 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 116.566 1.386 . . . . 54.01 116.566 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -72.43 102.43 3.19 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 118.463 1.132 . . . . 65.52 110.043 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 12.1 t -134.99 70.08 70.45 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 104.572 -2.381 . . . . 70.2 104.572 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.97 170.43 16.83 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.735 2.957 . . . . 70.41 112.898 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.412 1.485 . . . . 72.05 110.646 -179.122 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.748 0 N-CA-C 110.549 -1.02 . . . . 43.1 110.549 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -84.47 117.69 23.82 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.531 -1.285 . . . . 71.13 107.531 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.8 159.64 33.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.572 1.949 . . . . 42.32 107.505 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -145.31 85.53 1.73 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.378 -2.082 . . . . 71.14 105.378 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 tt -137.0 139.92 43.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.924 -1.139 . . . . 52.32 107.924 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -60.47 163.4 5.31 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.38 -0.97 . . . . 55.51 108.38 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 76.33 85.7 0.09 OUTLIER Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 127.256 2.222 . . . . 34.33 105.072 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.53 161.37 45.63 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.272 2.648 . . . . 74.23 111.113 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.94 -37.13 9.14 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.346 2.031 . . . . 62.34 111.72 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -166.1 155.16 11.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.482 1.913 . . . . 71.24 106.639 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 t -151.19 128.41 2.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.307 -1.738 . . . . 65.53 106.307 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -134.46 158.84 42.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.494 -1.298 . . . . 64.13 107.494 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -65.42 -23.37 66.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 117.811 -1.09 . . . . 61.13 113.084 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 66.9 mt -89.53 126.11 42.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.441 -2.059 . . . . 75.43 105.441 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 95.0 mt -120.47 163.27 18.19 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.498 1.519 . . . . 64.42 109.229 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -129.29 136.49 50.12 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.211 1.804 . . . . 75.11 108.295 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mm -129.41 149.86 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.108 0.963 . . . . 73.35 108.5 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.469 ' HE ' HG11 ' B' ' 88' ' ' VAL . 56.1 mtm180 -139.49 163.87 31.39 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.813 1.645 . . . . 74.43 108.088 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 71.27 19.34 5.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.935 1.694 . . . . 72.05 111.222 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.86 155.4 89.86 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.119 0.968 . . . . 73.01 111.511 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.51 147.37 70.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.325 2.017 . . . . 71.43 107.31 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -82.8 -17.59 43.56 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.732 -0.605 . . . . 75.22 112.333 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -124.72 91.61 3.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.171 0.989 . . . . 75.34 110.572 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -146.69 139.15 19.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.191 -1.04 . . . . 70.1 108.191 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 1.2 p -89.26 164.7 14.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.368 1.067 . . . . 71.35 109.595 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.46 -23.43 65.86 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.594 -0.521 . . . . 74.35 109.594 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.5 -57.61 11.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.521 2.728 . . . . 63.44 110.215 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -72.26 -35.11 68.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.81 0.844 . . . . 73.1 109.933 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.6 mmm -63.43 -48.94 75.7 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.957 -0.757 . . . . 71.25 108.957 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.19 -29.83 70.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.385 -0.817 . . . . 75.44 110.387 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.75 -65.17 0.72 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.471 -0.937 . . . . 74.54 108.471 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.77 -60.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 126.128 1.771 . . . . 74.33 111.92 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -68.64 -17.16 64.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.106 -0.473 . . . . 72.54 112.047 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.96 -27.45 34.2 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.264 1.411 . . . . 41.21 113.068 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -52.59 -40.67 62.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.591 1.696 . . . . 64.11 109.507 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -77.0 -11.77 59.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 116.795 2.146 . . . . 75.15 116.795 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.97 20.53 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.362 1.437 . . . . 75.23 111.49 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.56 147.26 90.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.219 2.613 . . . . 63.23 111.666 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.9 131.7 50.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.55 1.54 . . . . 63.32 109.545 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.77 -58.08 3.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.375 -1.343 . . . . 54.41 107.375 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -162.85 160.86 25.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 0.667 . . . . 64.23 110.594 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mt -142.29 145.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.298 1.839 . . . . 75.44 108.548 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -140.59 144.44 35.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 104.377 -2.453 . . . . 64.02 104.377 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' VAL . . . . . 0.419 HG11 HD22 ' A' ' 415' ' ' LEU . 17.3 m -129.35 162.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.315 1.046 . . . . 62.41 111.563 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.55 146.0 39.73 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.003 -0.839 . . . . 43.34 111.003 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -124.36 -0.63 8.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.652 1.581 . . . . 70.14 112.589 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -127.02 164.06 37.68 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.378 1.871 . . . . 73.05 109.814 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 -25.64 80.31 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.732 2.288 . . . . 60.1 113.956 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -93.39 1.58 56.84 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.73 1.15 . . . . 73.13 111.542 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.6 p -117.11 -28.78 6.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.283 1.033 . . . . 71.51 111.568 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 139.52 58.48 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.056 -1.028 . . . . 72.3 108.438 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.63 -23.51 35.86 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.302 1.43 . . . . 54.31 113.345 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.3 p -119.69 157.52 28.35 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 107.651 -1.24 . . . . 74.0 107.651 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.13 175.26 10.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.348 -0.845 . . . . 64.2 111.025 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -134.1 141.54 47.18 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.705 -1.22 . . . . 73.51 107.705 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 88.6 t -125.73 149.54 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.578 -1.638 . . . . 70.34 106.578 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t -127.73 132.6 68.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.48 -0.933 . . . . 74.1 108.48 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -101.09 164.02 12.01 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.667 -1.605 . . . . 74.5 106.667 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.7 -33.01 20.17 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.8 -1.187 . . . . 75.31 110.087 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -123.57 138.37 54.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.636 0.774 . . . . 74.23 109.868 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 tt -60.1 -30.55 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.594 -1.262 . . . . 73.13 107.594 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -60.46 -22.99 64.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.324 1.05 . . . . 74.23 111.647 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.23 -43.95 10.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.359 0.981 . . . . 70.31 108.441 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.21 74.67 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.226 -0.657 . . . . 70.23 109.226 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.35 -54.43 47.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.208 1.403 . . . . 72.23 109.817 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -64.88 -51.91 59.44 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.12 0.568 . . . . 73.33 110.955 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.39 -29.5 61.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.716 0.635 . . . . 54.31 112.716 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -64.37 0.98 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.061 -1.088 . . . . 75.22 108.061 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.55 -32.73 73.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.755 -0.64 . . . . 74.03 111.953 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -78.77 -16.4 57.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.612 0.967 . . . . 62.53 113.612 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 24.3 tp -110.68 -19.01 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.282 1.401 . . . . 73.2 112.331 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 83.9 p -58.26 118.05 5.08 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.061 1.345 . . . . 71.44 112.479 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.76 82.62 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.885 -1.508 . . . . 72.03 113.616 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.3 122.93 13.69 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.632 1.716 . . . . 72.14 108.728 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -96.72 115.73 27.93 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 126.079 1.752 . . . . 71.25 110.134 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 m -144.5 159.01 14.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.199 1.4 . . . . 74.21 107.535 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 69.1 m 43.85 41.56 3.89 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.206 1.402 . . . . 55.21 112.472 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 63.1 t30 56.75 21.77 6.27 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.632 2.373 . . . . 71.31 113.659 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -132.59 -179.3 5.37 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.874 2.07 . . . . 75.14 108.385 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -122.61 147.61 46.22 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.647 -1.612 . . . . 71.52 106.647 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 33.7 mt -96.31 156.39 16.36 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.343 -0.984 . . . . 71.35 108.343 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' VAL . . . . . 0.469 HG11 ' HE ' ' B' ' 24' ' ' ARG . 70.9 t -110.41 128.55 66.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.955 -2.609 . . . . 63.01 103.955 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 94.4 t -124.7 111.89 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.05 -1.833 . . . . 63.45 106.05 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -136.5 164.35 28.37 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.292 1.037 . . . . 44.31 110.963 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -89.27 163.11 15.51 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.17 1.388 . . . . 72.03 111.364 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -101.24 169.1 9.13 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.567 -2.012 . . . . 74.05 105.567 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.46 -0.941 . . . . 55.1 108.46 -179.734 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.851 0 CA-C-O 118.976 -0.902 . . . . 51.12 111.267 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 91.0 m -138.7 96.91 9.3 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 107.261 -1.385 . . . . 62.21 107.261 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.79 163.34 35.85 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.15 1.9 . . . . 72.14 109.349 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -146.51 82.02 1.58 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.211 -2.144 . . . . 74.32 105.211 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -142.75 158.97 43.11 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.906 1.282 . . . . 73.24 108.952 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 29.4 mt -51.82 156.71 1.37 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.248 2.219 . . . . 54.43 112.527 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -131.55 162.74 29.6 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.574 0.953 . . . . 62.12 113.574 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -122.29 160.41 25.37 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.081 1.752 . . . . 72.42 112.104 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -140.48 161.44 37.71 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.147 1.779 . . . . 73.5 108.308 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.04 130.51 31.48 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 119.067 0.849 . . . . 71.13 109.744 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -161.42 176.13 11.46 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.92 2.488 . . . . 74.32 105.642 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.95 158.0 35.55 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.344 -0.847 . . . . 73.13 111.642 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -127.74 43.46 3.12 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.031 1.332 . . . . 73.25 108.625 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -58.43 155.47 11.94 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.255 0.622 . . . . 73.03 110.263 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 17.9 pt -55.69 145.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 122.058 0.932 . . . . 65.32 112.811 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -157.48 -175.02 5.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 128.171 2.588 . . . . 72.01 106.655 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -137.46 79.67 1.76 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 103.543 -2.762 . . . . 72.12 103.543 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -154.31 164.53 38.45 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.856 0.863 . . . . 74.11 108.863 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -70.13 123.44 21.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.049 -1.834 . . . . 72.14 106.049 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.5 mtt-85 -146.26 162.6 34.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 124.667 1.187 . . . . 64.42 110.259 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.06 147.51 54.69 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.35 1.367 . . . . 64.12 109.768 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 63.1 mt -69.62 134.29 48.58 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.337 -1.727 . . . . 65.32 106.337 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 16.7 m -92.35 -177.04 4.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.427 1.108 . . . . 35.23 111.888 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.31 -46.16 51.16 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.945 2.098 . . . . 62.55 110.21 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.65 -29.92 71.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.875 1.216 . . . . 63.13 111.834 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.46 -35.8 82.11 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.287 -0.634 . . . . 61.42 109.287 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 34.0 tp -59.82 -27.23 66.42 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.862 -0.524 . . . . 53.44 111.135 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.5 -9.47 58.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.814 0.733 . . . . 75.32 112.239 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -123.22 -6.94 8.26 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.11 1.764 . . . . 74.33 112.504 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 57.7 mtp -73.73 -24.72 59.94 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.338 -1.476 . . . . 61.44 114.682 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -83.37 153.37 65.57 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 118.814 0.734 . . . . 74.22 111.546 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.74 172.14 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.477 3.451 . . . . 63.31 112.505 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -81.99 157.6 24.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.662 1.985 . . . . 73.41 110.388 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.38 19.08 53.89 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.052 0.834 . . . . 61.25 112.577 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -124.06 158.18 32.79 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.513 1.125 . . . . 74.35 111.338 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -129.21 145.64 51.29 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.909 1.684 . . . . 73.23 107.015 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.1 t -74.25 151.07 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.605 -0.887 . . . . 75.0 108.605 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.5 tp -124.19 85.51 54.98 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 105.062 -2.199 . . . . 73.31 105.062 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.23 167.9 10.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.432 2.755 . . . . 73.31 112.252 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.19 164.28 36.29 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.353 2.035 . . . . 54.11 110.107 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.49 149.81 29.39 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.925 3.083 . . . . 71.02 112.801 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -67.99 143.3 55.65 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.041 0.448 . . . . 75.22 110.84 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 69.93 -3.63 9.45 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.067 1.318 . . . . 52.52 114.365 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -61.72 156.55 19.94 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.575 1.688 . . . . 75.31 110.649 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.49 79.37 67.21 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.694 0.798 . . . . 64.43 109.195 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.1 171.19 18.32 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.629 2.219 . . . . 64.44 110.08 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 C--O 1.242 0.677 0 C-N-CA 125.563 1.545 . . . . 51.1 108.312 179.62 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.725 0 N-CA-C 110.906 -0.878 . . . . 75.22 110.906 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -62.43 111.07 1.87 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.234 1.013 . . . . 71.13 108.712 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.01 163.28 33.23 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 127.197 2.199 . . . . 61.21 107.594 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -117.52 73.76 0.9 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.136 0.97 . . . . 62.23 110.694 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 pt -70.82 153.73 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.184 1.394 . . . . 75.11 108.722 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -86.23 -17.9 33.56 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.713 -1.242 . . . . 74.12 111.299 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.22 156.92 34.04 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 127.139 2.176 . . . . 64.14 107.816 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.77 169.14 6.03 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.766 2.977 . . . . 71.5 111.876 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.98 -41.76 16.33 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.86 2.373 . . . . 74.24 113.738 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -163.92 153.59 14.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.399 1.88 . . . . 61.12 107.607 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t -150.67 161.01 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.023 1.729 . . . . 64.44 107.404 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -140.45 168.02 20.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.875 1.27 . . . . 55.15 110.273 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -82.57 -9.0 59.59 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.476 -1.39 . . . . 60.34 111.617 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 30.6 mt -106.18 141.26 21.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.321 -1.363 . . . . 65.01 107.321 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -116.24 151.59 35.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.603 1.561 . . . . 51.02 108.039 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -121.32 122.27 39.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.01 1.724 . . . . 53.13 106.696 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -114.07 147.95 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.12 1.768 . . . . 71.14 109.426 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -142.69 163.79 31.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.004 1.722 . . . . 64.44 111.362 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t30 74.56 18.19 2.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.18 2.592 . . . . 70.31 111.691 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 mt -70.03 153.37 95.42 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 124.452 1.101 . . . . 73.21 110.737 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.08 159.57 47.38 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.319 2.679 . . . . 73.11 110.757 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.27 -11.01 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.108 -0.37 . . . . 72.44 111.183 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -127.39 104.47 7.94 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.326 -2.102 . . . . 70.44 105.326 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 tt -158.58 155.08 4.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.193 1.397 . . . . 61.11 108.596 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -105.28 169.81 8.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.304 1.442 . . . . 73.53 111.106 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.11 84.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.05 -1.093 . . . . 73.55 108.05 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.1 -45.8 91.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.45 1.5 . . . . 61.54 111.675 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.74 -37.8 85.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.262 0.625 . . . . 54.11 110.628 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.9 mmm -73.81 -53.31 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.809 1.243 . . . . 65.42 111.736 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -59.79 -30.07 68.65 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 118.386 -0.816 . . . . 73.42 111.323 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.52 -61.32 2.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.991 0.814 . . . . 73.04 109.417 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 -65.4 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 125.781 1.633 . . . . 73.52 112.625 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -63.32 -34.45 77.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.596 0.961 . . . . 74.24 113.596 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.53 -24.22 77.08 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.088 0.858 . . . . 61.43 112.028 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -64.01 -14.67 55.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.022 0.911 . . . . 64.52 113.077 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -105.08 -4.48 21.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.566 1.546 . . . . 75.54 111.771 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.71 173.38 13.16 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.426 1.012 . . . . 71.21 111.637 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.53 128.85 21.03 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.544 2.829 . . . . 62.03 112.04 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.76 135.7 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.57 1.548 . . . . 62.42 108.179 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -81.25 -62.69 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 106.559 -1.645 . . . . 75.22 106.559 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -151.87 160.98 43.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.557 0.617 . . . . 73.21 111.886 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.96 134.55 48.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 126.923 2.089 . . . . 63.13 107.019 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -130.2 128.11 41.04 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.585 -2.006 . . . . 72.42 105.585 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 m -108.76 147.33 13.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.791 1.236 . . . . 52.15 109.009 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.35 135.24 14.97 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.471 -1.052 . . . . 72.02 110.471 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.96 -15.05 9.35 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.232 1.197 . . . . 63.32 114.232 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 21.6 p -77.71 160.21 75.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.411 -1.7 . . . . 74.45 106.411 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.54 -20.43 49.54 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.282 1.988 . . . . 73.21 114.021 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.74 -21.24 20.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.982 0.913 . . . . 64.4 113.064 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 80.4 p -101.58 -12.33 18.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.891 0.768 . . . . 72.02 112.374 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 -64.02 116.5 5.94 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.066 -1.457 . . . . 73.13 107.066 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.93 16.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.7 -1.056 . . . . 51.42 112.753 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -128.5 159.34 35.78 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 118.518 1.159 . . . . 65.41 108.26 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.98 170.38 20.69 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.291 -0.881 . . . . 71.32 110.503 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -122.31 142.57 50.35 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.716 -1.216 . . . . 73.12 107.716 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.06 137.63 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 126.174 1.79 . . . . 74.41 106.775 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -129.03 128.35 67.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 118.422 -0.799 . . . . 63.15 109.893 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -97.45 166.15 11.66 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.609 1.164 . . . . 73.33 107.878 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -74.92 -55.3 5.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.923 0.889 . . . . 75.34 108.72 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.98 121.44 32.08 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 114.274 1.213 . . . . 62.04 114.274 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.4 tt -66.08 -19.41 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.681 -0.489 . . . . 74.41 109.681 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.9 -60.83 2.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.322 1.049 . . . . 73.34 108.387 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.08 -36.69 70.88 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.785 0.834 . . . . 71.03 111.738 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -29.69 62.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.247 0.476 . . . . 74.22 112.014 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -80.05 -46.11 17.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.946 -1.096 . . . . 72.04 108.404 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -57.22 -32.2 66.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.268 0.556 . . . . 72.2 110.592 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.25 -43.95 18.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.269 1.428 . . . . 64.14 111.769 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 11.5 p -55.83 -42.36 75.6 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.198 0.908 . . . . 71.4 110.906 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.64 -18.17 62.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.401 0.519 . . . . 63.41 112.401 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -95.53 -17.88 21.07 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.678 0.791 . . . . 71.15 112.037 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 12.0 tp -101.52 -3.5 28.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.701 0.682 . . . . 74.23 112.534 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.7 p -68.08 134.9 51.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.652 1.215 . . . . 73.02 111.505 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.38 62.44 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.219 -0.926 . . . . 60.13 113.013 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -68.49 141.33 55.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.109 1.455 . . . . 73.31 110.876 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -90.45 127.66 36.28 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.821 1.248 . . . . 74.22 109.286 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.01 125.39 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 127.779 2.432 . . . . 54.14 109.034 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 72.5 m 50.78 41.98 27.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.779 1.232 . . . . 73.42 110.738 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 20.2 m120 61.19 14.64 5.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.476 1.91 . . . . 62.42 113.469 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -122.06 169.77 10.51 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.626 1.971 . . . . 74.02 107.461 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -107.22 -177.0 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.085 -1.079 . . . . 72.44 108.085 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.62 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.555 2.342 . . . . 54.43 106.072 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -133.25 110.52 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.627 -1.619 . . . . 44.33 106.627 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.88 144.59 9.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.007 -1.479 . . . . 75.43 107.007 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 tp -154.27 154.7 33.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.089 1.356 . . . . 43.31 107.342 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -81.24 164.28 22.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.841 1.656 . . . . 64.02 110.482 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -101.06 157.79 16.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.874 0.47 . . . . 73.25 110.229 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 36.0 m120 . . . . . 0 C--O 1.256 1.41 0 CA-C-O 115.945 -1.978 . . . . 62.3 110.229 -179.39 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 108.783 -1.727 . . . . 70.22 108.783 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 7.3 p -107.38 93.95 10.67 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 105.648 -1.982 . . . . 51.2 105.648 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.54 172.51 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.115 1.877 . . . . 72.4 111.465 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -79.88 -168.3 1.56 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.252 2.221 . . . . 75.2 108.337 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -129.4 -82.46 0.56 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 107.747 -1.205 . . . . 63.51 107.747 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 29.8 tp -157.57 164.55 37.18 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.544 -1.28 . . . . 75.32 107.544 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.62 164.12 31.31 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.792 1.237 . . . . 74.35 108.913 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -153.6 146.95 24.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.933 1.293 . . . . 63.34 107.586 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 73.5 t90 -153.3 130.26 11.02 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.733 -1.951 . . . . 74.31 105.733 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -159.92 139.27 11.07 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.493 -1.299 . . . . 75.43 107.493 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -149.44 151.67 34.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.791 1.636 . . . . 72.11 106.833 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -145.97 -168.85 3.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.488 1.115 . . . . 74.43 108.516 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -160.96 -164.23 1.16 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.607 1.094 . . . . 73.52 110.093 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -133.01 -177.07 4.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.739 2.416 . . . . 75.24 104.981 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.3 tp -141.66 123.7 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 120.596 -1.315 . . . . 71.21 108.017 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -160.29 157.66 28.45 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.281 1.833 . . . . 73.42 107.246 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.22 169.81 2.71 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.735 2.014 . . . . 73.51 108.0 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -153.83 161.19 42.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.268 1.827 . . . . 61.43 107.249 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 397' ' ' ARG . 7.7 p-10 -101.1 -73.57 0.64 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.034 -1.099 . . . . 73.22 108.034 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 396' ' ' ASN . 24.2 mmt85 65.46 151.86 0.12 Allowed Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 130.181 3.392 . . . . 63.44 115.544 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.91 113.41 3.66 Favored 'Trans proline' 0 C--N 1.351 0.691 0 N-CA-C 105.018 -2.724 . . . . 70.5 105.018 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 31.7 mt -128.72 -169.43 2.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.761 0.824 . . . . 75.41 110.974 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 12.1 m -142.45 -78.71 0.24 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.568 1.547 . . . . 63.13 109.532 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -33.11 67.0 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.638 -0.664 . . . . 74.33 110.533 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -75.68 -39.0 58.25 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.599 0.36 . . . . 73.44 110.85 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -64.64 -30.07 71.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.057 0.844 . . . . 55.11 110.112 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 12.3 tp -62.58 -25.54 68.13 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.607 1.163 . . . . 72.01 110.489 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -79.69 -51.51 9.14 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.907 -0.775 . . . . 74.02 108.907 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.19 89.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.511 1.924 . . . . 61.41 113.291 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.0 mtp -57.94 -36.87 73.12 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.307 1.043 . . . . 73.05 113.377 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -68.47 149.92 97.86 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.374 0.988 . . . . 74.11 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.44 160.47 47.68 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.162 1.908 . . . . 64.4 111.064 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -71.06 160.87 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.72 -1.127 . . . . 71.21 109.525 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.72 17.46 63.65 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 121.651 -0.655 . . . . 62.01 113.296 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -124.47 156.96 36.36 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.487 1.515 . . . . 75.11 108.009 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -136.68 144.58 44.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.733 1.213 . . . . 63.14 109.549 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.8 t -70.91 151.18 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.566 -0.901 . . . . 53.1 108.566 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 17.8 tp -120.72 83.44 35.75 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.699 1.6 . . . . 64.23 108.378 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.28 162.26 17.68 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.2 2.6 . . . . 53.44 112.909 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.65 168.39 22.84 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.109 3.206 . . . . 75.42 111.094 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.18 164.1 35.26 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.434 2.089 . . . . 75.45 109.855 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -88.22 160.42 17.71 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.451 -0.78 . . . . 73.42 110.057 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 59.5 1.83 1.36 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.795 1.664 . . . . 62.4 116.169 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -59.39 149.16 30.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.823 2.049 . . . . 73.34 112.997 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 35.1 t -134.06 89.47 28.78 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.472 1.109 . . . . 73.41 108.961 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -83.97 178.92 5.03 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.924 3.083 . . . . 63.43 109.698 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 12.4 tt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.991 1.316 . . . . 73.32 108.63 179.14 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.527 0 N-CA-C 109.939 -1.264 . . . . 54.43 109.939 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -154.72 173.06 16.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.882 0.841 . . . . 71.03 110.148 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.51 151.72 39.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.202 1.801 . . . . 74.24 106.143 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -141.83 117.37 10.29 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 127.408 2.283 . . . . 74.33 105.16 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.44 164.35 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 123.972 0.909 . . . . 71.14 111.035 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -74.09 168.33 19.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.824 -1.08 . . . . 60.45 109.122 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 36.9 mt 53.61 48.87 5.37 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.622 1.169 . . . . 74.1 112.672 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.66 166.64 29.32 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.654 2.236 . . . . 70.54 110.442 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.95 -50.26 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.086 2.524 . . . . 54.23 111.895 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.01 84.6 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 128.39 2.676 . . . . 62.21 112.901 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.2 t -149.29 137.91 14.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.501 -0.926 . . . . 31.35 108.501 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -128.65 171.37 12.24 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.183 1.393 . . . . 74.42 109.663 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -30.04 70.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.951 0.723 . . . . 71.12 112.951 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.93 135.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.625 1.57 . . . . 74.23 109.519 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 98.4 mt -126.47 158.71 35.34 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.005 1.722 . . . . 52.23 110.973 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -128.26 108.49 10.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.59 1.556 . . . . 63.23 110.635 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.84 144.71 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 127.19 2.196 . . . . 74.3 107.73 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' B' ' 59' ' ' THR . 58.0 mtm180 -144.56 164.19 31.65 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.97 2.508 . . . . 73.22 110.98 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 52.1 t30 72.43 11.26 5.74 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.139 1.376 . . . . 62.11 111.544 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.55 154.58 79.19 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 124.851 1.261 . . . . 73.12 111.231 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.63 150.75 74.96 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.245 1.963 . . . . 73.14 112.652 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -83.37 -15.39 50.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.504 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -130.06 109.34 10.77 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.524 1.53 . . . . 70.24 107.506 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 15.9 tt -162.57 171.18 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 128.386 2.675 . . . . 64.15 105.466 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -126.18 165.87 18.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.585 1.154 . . . . 72.14 109.976 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.35 74.91 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.543 -0.91 . . . . 23.2 108.543 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.43 -54.61 45.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.831 1.652 . . . . 71.43 109.513 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.5 -36.46 84.27 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.187 1.395 . . . . 51.12 111.363 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 66.2 mmm -64.69 -58.2 6.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.473 -0.936 . . . . 70.42 108.473 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -58.8 -35.76 73.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.635 0.774 . . . . 75.01 110.915 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -59.81 -26.3 65.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 75.13 111.744 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.06 -69.74 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.01 0.924 . . . . 73.05 108.986 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -55.31 -38.09 68.22 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.921 1.452 . . . . 75.3 114.921 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -33.66 85.93 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.302 0.953 . . . . 73.14 112.942 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -65.87 -29.14 69.55 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.109 -1.23 . . . . 64.41 110.221 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -79.89 -22.27 43.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.762 0.825 . . . . 73.23 110.263 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.68 168.93 19.44 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.875 1.702 . . . . 62.44 109.48 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -63.22 159.92 37.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.108 2.539 . . . . 60.22 113.505 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -113.29 143.9 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.686 1.995 . . . . 71.43 110.536 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.34 -56.18 2.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 125.216 1.406 . . . . 71.53 108.043 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -153.72 155.09 35.29 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.359 -1.348 . . . . 75.22 107.359 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -136.82 135.38 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 104.491 -2.411 . . . . 65.43 104.491 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -133.2 123.98 26.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.314 -2.106 . . . . 73.44 105.314 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.8 m -110.04 151.26 12.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.593 -1.262 . . . . 73.23 107.593 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.69 30.79 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.446 -1.062 . . . . 72.14 110.446 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.78 -38.86 3.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.463 -0.78 . . . . 61.34 111.22 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 30.0 p -69.38 161.6 72.43 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.388 -0.597 . . . . 65.42 109.388 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.2 -2.58 8.33 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.141 1.894 . . . . 70.01 112.255 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -105.84 -9.72 17.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.487 1.915 . . . . 70.11 111.868 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -116.62 -12.05 10.97 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.87 1.268 . . . . 71.44 110.723 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -57.58 142.09 45.8 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.55 -1.344 . . . . 64.53 108.341 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.16 -5.68 83.56 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 118.676 -1.069 . . . . 52.14 114.633 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' THR . . . . . 0.422 HG22 ' HG2' ' B' ' 24' ' ' ARG . 36.1 p -124.52 153.85 41.45 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.399 1.6 . . . . 71.04 109.144 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.69 166.2 33.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.876 0.846 . . . . 72.54 109.525 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.94 141.98 51.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.532 -2.025 . . . . 72.35 105.532 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.84 142.56 42.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.591 -2.003 . . . . 74.44 105.591 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.78 134.33 65.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.222 -1.77 . . . . 74.42 106.222 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 9.8 m-85 -98.03 166.84 11.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.881 1.672 . . . . 64.42 111.472 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.8 -73.64 0.46 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.94 -1.504 . . . . 75.31 106.94 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -81.77 134.96 35.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.116 0.96 . . . . 71.41 109.332 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.46 HG22 ' H ' ' B' ' 67' ' ' ILE . 1.0 OUTLIER -58.65 -34.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 125.318 1.447 . . . . 62.21 108.443 177.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.33 -30.01 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.152 0.581 . . . . 72.41 110.874 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -71.43 -47.39 56.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.526 -0.916 . . . . 73.21 108.526 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -55.45 -42.94 74.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.768 0.827 . . . . 75.32 111.94 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -57.28 -61.9 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.38 1.072 . . . . 70.33 109.487 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -52.95 -53.09 54.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.769 0.827 . . . . 62.12 111.812 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.78 -38.67 86.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 114.428 1.27 . . . . 71.33 114.428 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 37.3 t -58.26 -49.81 75.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 118.437 0.562 . . . . 62.12 110.693 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -62.9 -52.77 61.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.795 -0.446 . . . . 73.24 109.795 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -58.36 -26.22 62.9 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.891 0.7 . . . . 74.34 112.891 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.9 tp -96.77 -6.75 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.432 0.901 . . . . 74.04 113.432 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -62.19 121.86 14.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.299 -1.501 . . . . 73.31 109.999 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.71 18.52 70.32 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.35 -1.25 . . . . 52.31 112.777 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -55.06 120.11 6.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.08 1.44 . . . . 71.45 110.32 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -72.88 115.99 12.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.69 2.396 . . . . 73.03 110.749 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.12 144.47 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.156 1.382 . . . . 73.2 108.83 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.0 m 39.73 52.18 2.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 73.31 112.992 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.36 23.54 9.03 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.089 1.356 . . . . 72.33 113.69 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -136.85 -176.6 4.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.591 2.356 . . . . 73.54 107.517 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.47 137.4 38.67 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.956 1.703 . . . . 74.32 107.071 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.39 148.94 24.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.335 0.588 . . . . 74.11 110.446 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.87 156.72 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.117 1.767 . . . . 62.33 107.186 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 93.2 t -142.33 123.12 11.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.714 -2.328 . . . . 64.44 104.714 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 42.4 tp -151.48 146.09 25.66 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.776 0.83 . . . . 74.01 109.754 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -80.37 156.63 26.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.158 -0.682 . . . . 75.0 109.158 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -75.71 175.39 8.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.373 -0.973 . . . . 73.2 108.373 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 124.302 1.041 . . . . 73.24 112.329 -178.472 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.244 0 N-CA-C 108.846 -1.702 . . . . 64.24 108.846 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.0 t -141.99 129.52 11.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 106.05 -1.833 . . . . 64.04 106.05 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -83.54 -179.19 4.06 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.665 2.243 . . . . 73.45 108.941 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -138.89 161.36 37.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.264 1.826 . . . . 74.44 106.116 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -134.41 97.28 3.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.868 -1.16 . . . . 54.53 107.868 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.32 144.26 57.1 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.236 -0.653 . . . . 74.31 109.236 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -74.95 80.07 2.16 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.952 -0.758 . . . . 55.12 108.952 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -78.21 57.38 1.84 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.662 1.185 . . . . 70.43 110.121 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -123.02 167.89 13.05 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.295 1.838 . . . . 73.52 109.527 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.22 179.27 4.59 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 128.568 2.747 . . . . 70.2 106.597 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -134.64 -170.61 2.59 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.294 0.497 . . . . 61.55 110.04 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -117.2 -175.86 2.88 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.653 1.181 . . . . 64.52 111.041 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 18.2 mtm105 -140.34 76.9 1.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.59 1.156 . . . . 53.34 108.888 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 147.65 51.49 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.633 0.651 . . . . 70.43 110.246 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 29.0 pt -141.48 143.06 28.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 124.971 1.308 . . . . 73.33 109.78 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -158.87 179.14 9.35 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.395 1.078 . . . . 45.55 111.094 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.91 179.91 2.09 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.5 0.72 . . . . 61.12 110.307 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -135.71 137.15 41.44 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.21 -0.931 . . . . 63.3 110.697 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -114.71 0.43 13.87 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 126.277 1.831 . . . . 72.34 110.204 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -100.94 146.93 32.98 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.686 1.194 . . . . 71.42 111.107 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.1 159.91 51.49 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.692 2.928 . . . . 64.41 109.2 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 59.8 mt -62.53 116.73 5.38 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.756 -0.59 . . . . 71.03 110.173 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 16.0 m -111.04 -149.28 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.089 2.156 . . . . 54.44 107.565 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.04 -33.6 17.09 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.152 -0.968 . . . . 73.31 112.622 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.95 -40.07 83.58 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.82 0.848 . . . . 73.22 110.723 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -64.77 -30.91 71.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.209 0.603 . . . . 62.14 110.26 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.3 tp -72.88 -47.49 45.48 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 107.244 -1.391 . . . . 64.04 107.244 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.58 -49.11 73.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.765 0.257 . . . . 65.34 110.816 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.51 -24.89 61.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.53 1.532 . . . . 30.04 113.777 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 62.4 mtp -86.59 -17.59 33.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.335 -0.853 . . . . 63.34 111.416 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -90.42 146.79 35.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 119.017 0.826 . . . . 53.02 111.844 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.84 163.85 23.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.292 2.661 . . . . 61.24 111.045 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -76.86 173.47 11.67 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.465 -0.939 . . . . 63.13 108.465 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 78.62 18.89 74.72 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 121.372 -0.83 . . . . 51.52 111.731 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.8 117.17 19.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.523 1.529 . . . . 74.32 108.901 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.42 148.0 22.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.45 1.1 . . . . 72.11 108.119 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.71 151.96 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.819 -1.175 . . . . 63.12 110.948 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 22.9 tp -120.67 77.9 29.18 Favored Pre-proline 0 C--O 1.237 0.401 0 N-CA-C 107.17 -1.419 . . . . 54.52 107.17 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.78 166.54 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.729 2.286 . . . . 73.41 111.467 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.17 174.92 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.882 1 C-N-CA 125.698 4.265 . . . . 53.42 115.063 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.79 149.87 66.26 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.732 2.288 . . . . 65.43 110.993 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -82.86 70.3 9.83 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.409 -1.7 . . . . 73.43 106.409 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 136.44 60.57 0.06 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.519 1.533 . . . . 34.12 111.052 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -93.82 9.58 36.65 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.775 0.787 . . . . 72.34 113.007 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 2.5 t 60.53 63.88 2.67 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 126.415 1.886 . . . . 72.31 110.766 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.62 125.1 11.81 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.307 2.671 . . . . 71.54 111.592 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--O 1.25 1.116 0 N-CA-C 105.371 -2.085 . . . . 72.22 105.371 177.422 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 111.49 -0.644 . . . . 72.1 111.49 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -134.84 116.06 14.36 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.12 -1.437 . . . . 74.23 107.12 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.7 120.08 8.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.699 -1.593 . . . . 34.32 106.699 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -124.46 164.1 20.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.02 1.328 . . . . 75.22 108.022 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 pt -126.1 11.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 113.918 1.081 . . . . 61.44 113.918 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -135.0 121.34 20.32 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.396 -1.335 . . . . 74.2 107.396 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 mp -54.95 155.75 7.84 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 123.591 0.757 . . . . 71.52 110.915 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.25 162.33 20.39 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.045 2.497 . . . . 61.31 114.491 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.03 -27.52 57.72 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.172 2.581 . . . . 75.43 113.123 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -58.22 -20.6 42.95 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.94 2.096 . . . . 53.2 113.427 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 41.4 t -74.79 104.15 3.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.908 1.283 . . . . 73.33 107.87 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -98.03 175.25 6.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.635 1.174 . . . . 71.33 109.71 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.69 -34.31 72.72 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.686 -1.259 . . . . 72.52 114.215 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.12 138.05 21.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.512 1.125 . . . . 72.41 109.793 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.36 146.81 49.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.787 -1.19 . . . . 72.41 107.787 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -99.55 138.79 36.15 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.894 -1.891 . . . . 74.22 105.894 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.8 mm -117.03 134.86 59.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 126.155 1.782 . . . . 60.44 106.365 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -127.83 162.5 26.51 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.909 0.884 . . . . 61.3 110.485 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.57 38.35 12.45 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.656 1.983 . . . . 53.15 111.557 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 67.3 mt -76.56 153.76 83.62 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 108.488 -0.93 . . . . 62.33 108.488 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.96 163.94 35.71 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.632 2.221 . . . . 74.42 109.844 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -94.06 -13.03 27.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.994 0.518 . . . . 73.2 112.017 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -126.23 99.7 5.99 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.215 1.406 . . . . 74.43 107.943 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.1 143.43 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.565 -1.272 . . . . 51.44 107.565 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -98.45 178.13 5.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.98 0.912 . . . . 64.3 110.441 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.42 80.95 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.194 -0.457 . . . . 70.12 110.15 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -52.83 -60.54 3.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 127.73 2.412 . . . . 64.24 110.027 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.53 -47.55 81.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.426 1.49 . . . . 71.53 110.88 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.7 mmm -59.25 -39.09 81.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.088 -0.383 . . . . 75.21 110.865 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -76.37 -30.36 57.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.722 -0.656 . . . . 72.01 110.319 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.23 -27.13 65.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.67 1.188 . . . . 74.13 110.16 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 58.7 mt -76.26 -68.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.38 1.072 . . . . 74.2 109.16 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.32 -23.86 65.68 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.892 1.442 . . . . 73.14 114.892 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.92 -13.85 69.89 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 115.584 0.994 . . . . 64.12 115.584 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.51 -28.78 63.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.096 1.448 . . . . 72.51 110.592 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.82 -34.27 22.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.505 -0.76 . . . . 73.1 112.351 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.2 -166.55 39.67 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 120.204 1.365 . . . . 50.51 111.915 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.28 162.57 41.85 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.084 3.189 . . . . 62.45 112.858 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 59.5 mt -118.38 130.47 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.965 0.906 . . . . 61.31 109.247 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -88.44 -59.7 2.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.131 -1.063 . . . . 75.41 108.131 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -155.61 155.12 32.71 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.66 0.267 . . . . 74.31 110.851 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.05 127.79 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 104.984 -2.228 . . . . 73.12 104.984 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -128.31 120.82 27.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 102.842 -3.021 . . . . 74.21 102.842 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.65 144.65 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.736 0.814 . . . . 54.15 111.359 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.64 115.58 6.0 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 106.076 -2.81 . . . . 70.5 106.076 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -103.55 -10.89 18.12 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.194 0.998 . . . . 52.3 113.46 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.9 p -95.16 158.36 34.93 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.375 0.989 . . . . 71.13 108.461 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.59 -15.73 38.53 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.77 2.313 . . . . 73.11 113.045 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -97.29 -10.7 25.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.514 1.125 . . . . 74.24 112.286 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 39.9 p -116.96 -19.23 9.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.731 1.212 . . . . 61.33 112.21 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -53.26 150.32 6.32 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.434 1.494 . . . . 74.41 110.317 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.51 3.51 88.84 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.069 -1.406 . . . . 73.13 112.703 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 59.1 p -143.77 153.36 42.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.753 1.776 . . . . 64.33 109.979 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.35 172.82 12.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.751 2.021 . . . . 75.14 108.359 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -127.78 156.02 43.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.889 -1.522 . . . . 64.35 106.889 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.22 142.97 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.872 -1.159 . . . . 74.3 107.872 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.04 133.33 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.621 1.169 . . . . 73.03 108.369 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.99 154.12 17.91 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.374 -1.713 . . . . 71.23 106.374 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -72.69 -20.09 61.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 119.546 -0.862 . . . . 74.24 110.931 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.83 117.87 30.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.579 1.552 . . . . 52.43 109.681 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.76 -27.48 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 125.175 1.39 . . . . 62.4 111.966 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -73.36 -41.61 63.21 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.344 -1.472 . . . . 74.11 107.569 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -37.31 87.09 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.569 -0.901 . . . . 71.21 108.569 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.4 78.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.63 -0.7 . . . . 63.0 109.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -29.54 70.44 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.288 -0.863 . . . . 75.2 110.612 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.87 -53.31 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.129 1.331 . . . . 75.53 108.568 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.41 -14.15 17.36 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.086 1.143 . . . . 74.12 114.086 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 91.6 m -64.23 -66.62 0.52 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.448 1.022 . . . . 71.42 109.735 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.3 -34.56 76.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 119.13 -0.462 . . . . 74.22 110.168 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -64.83 -21.61 66.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.161 -0.923 . . . . 75.13 112.858 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 tp -106.54 -23.71 12.4 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.083 1.311 . . . . 74.35 111.324 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 12.5 m -69.79 110.1 4.76 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.005 -1.06 . . . . 72.01 108.352 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.44 10.54 53.58 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.649 1.595 . . . . 74.04 112.277 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -72.72 106.38 4.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.457 1.628 . . . . 71.23 107.627 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.93 124.93 27.11 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.349 -0.982 . . . . 63.4 108.349 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 m -141.31 144.37 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 118.983 0.811 . . . . 72.25 110.302 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 m 45.78 38.97 4.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.155 1.382 . . . . 53.04 113.384 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 64.79 20.91 12.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.558 1.143 . . . . 75.21 111.871 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.3 mmm-85 -135.6 -178.17 5.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.145 2.178 . . . . 73.34 108.257 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -133.07 155.31 49.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.867 1.267 . . . . 74.25 109.571 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -109.63 150.16 28.65 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.033 1.333 . . . . 74.44 107.514 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.18 112.76 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.335 -1.728 . . . . 74.31 106.335 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.56 141.73 14.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.072 -2.196 . . . . 74.35 105.072 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.57 142.51 45.33 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.269 -1.382 . . . . 63.43 107.269 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.11 114.0 21.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.457 -0.942 . . . . 74.21 108.457 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -74.05 148.22 42.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.192 -2.522 . . . . 73.03 104.192 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.06 1.744 . . . . 72.24 109.088 -178.868 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.171 0 N-CA-C 108.669 -1.772 . . . . 72.11 108.669 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.8 t -140.07 139.67 21.91 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 105.572 -2.01 . . . . 65.34 105.572 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -81.61 -179.26 4.76 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.51 2.14 . . . . 72.24 109.233 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.27 173.24 11.82 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.656 2.382 . . . . 54.32 106.699 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -145.39 161.0 40.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.196 0.998 . . . . 72.22 108.415 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.1 pp -134.31 167.39 20.8 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 124.636 1.175 . . . . 75.21 109.709 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -159.58 178.54 9.76 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.92 1.688 . . . . 73.14 108.179 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -149.27 166.65 28.28 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.238 1.415 . . . . 74.22 108.096 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -139.76 169.74 17.17 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.593 1.157 . . . . 74.22 109.476 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -154.39 144.25 21.73 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 124.788 1.235 . . . . 71.41 107.716 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -76.59 116.42 17.26 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.1 -1.815 . . . . 65.52 106.1 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.27 166.01 23.74 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.22 -0.659 . . . . 72.23 109.22 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.53 104.96 5.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.367 1.467 . . . . 73.12 107.182 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -113.66 171.27 7.68 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.16 1.384 . . . . 74.2 107.915 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 81.2 mt -131.99 136.09 57.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.558 -2.016 . . . . 73.21 105.558 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -157.27 120.48 4.06 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.289 -1.375 . . . . 74.34 107.289 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.57 171.34 2.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.591 1.156 . . . . 74.23 109.919 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -128.23 -38.22 1.8 Allowed 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 121.748 -0.595 . . . . 73.33 110.115 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 56.78 12.1 1.07 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.139 1.375 . . . . 71.21 111.826 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -66.0 158.8 74.41 Favored Pre-proline 0 N--CA 1.455 -0.197 0 C-N-CA 128.649 2.78 . . . . 61.05 113.026 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.4 148.98 34.49 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.239 1.96 . . . . 74.33 109.207 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.09 119.46 9.55 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.982 0.913 . . . . 64.53 108.94 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 t -100.34 164.33 11.98 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 123.367 1.556 . . . . 63.33 111.183 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -73.53 -30.33 63.02 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.755 2.422 . . . . 74.24 111.128 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.13 -29.74 67.85 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 118.825 -0.607 . . . . 75.32 111.601 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.14 -34.26 77.2 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.684 -0.858 . . . . 65.31 108.684 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.47 -40.17 96.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.437 1.095 . . . . 74.1 111.29 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.26 -38.24 88.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.069 0.849 . . . . 64.14 110.202 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.46 68.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.631 0.773 . . . . 52.03 110.964 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.4 mtp -65.42 -41.56 93.45 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 118.908 -0.568 . . . . 72.52 110.261 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -65.1 155.71 83.23 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 112.983 0.734 . . . . 73.1 112.983 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.73 159.86 34.79 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.077 1.851 . . . . 52.44 109.33 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.48 161.97 25.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.363 -1.289 . . . . 73.21 110.631 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.79 17.89 60.84 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.76 -0.587 . . . . 44.25 113.693 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -125.16 157.68 35.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.298 1.439 . . . . 64.41 108.896 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -127.07 143.82 51.18 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.445 1.498 . . . . 63.11 109.305 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 63.1 t -71.08 141.06 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.675 -0.861 . . . . 61.13 108.675 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 28.7 tp -117.17 84.05 16.49 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.096 1.358 . . . . 71.01 107.547 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.12 166.04 24.47 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.185 1.924 . . . . 74.42 110.041 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.21 171.84 2.12 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.615 2.877 . . . . 64.34 113.413 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.48 118.94 5.42 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.621 2.881 . . . . 63.42 110.369 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -64.05 150.71 44.79 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.816 -0.552 . . . . 44.14 110.499 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 71.54 0.56 39.95 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 117.615 -1.659 . . . . 61.42 115.366 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -61.05 143.26 55.72 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.513 1.656 . . . . 75.15 110.277 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 95.6 t -137.24 80.14 35.1 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 107.727 -1.212 . . . . 71.41 107.727 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.05 137.86 29.88 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.528 2.152 . . . . 72.44 110.199 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 25.5 mt . . . . . 0 C--O 1.249 1.062 0 N-CA-C 106.785 -1.561 . . . . 74.21 106.785 179.139 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.978 0 N-CA-C 109.917 -1.273 . . . . 41.11 109.917 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -65.14 102.14 0.61 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.638 -1.616 . . . . 71.2 106.638 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.21 175.1 13.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.898 1.279 . . . . 71.03 109.658 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -65.21 127.81 33.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.771 0.828 . . . . 64.23 110.122 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 8.1 tt -136.79 116.85 16.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.835 0.854 . . . . 51.02 110.125 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -121.16 172.0 8.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.595 1.958 . . . . 40.22 106.973 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 19.6 tp 48.22 65.64 6.77 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.684 1.194 . . . . 65.1 110.155 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.07 158.44 55.13 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.751 1.634 . . . . 62.34 112.061 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.68 -15.69 41.32 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.487 2.792 . . . . 75.2 113.415 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.71 -16.52 64.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.03 0.932 . . . . 73.03 111.914 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.38 133.91 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.432 0.693 . . . . 71.14 109.447 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -140.58 159.21 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.263 -1.754 . . . . 72.44 106.263 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -56.24 -32.11 64.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.597 1.959 . . . . 73.34 111.917 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 53.4 mt -75.13 123.67 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 71.22 107.306 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 mt -120.15 126.53 50.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.733 2.013 . . . . 74.15 108.204 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.11 134.36 39.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.225 1.41 . . . . 74.42 108.917 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.2 mm -124.16 154.86 31.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.871 0.868 . . . . 75.31 109.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -135.01 163.52 29.69 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.833 2.053 . . . . 75.1 108.992 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 66.7 15.32 10.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.766 1.626 . . . . 53.12 113.545 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.01 152.17 92.82 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 107.571 -1.27 . . . . 74.02 107.571 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.23 160.06 46.83 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.588 1.525 . . . . 51.12 110.807 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -78.32 -20.95 50.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.893 0.877 . . . . 71.23 112.499 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.76 120.89 24.45 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.075 1.35 . . . . 73.32 107.553 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 tt -158.48 163.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.872 1.269 . . . . 75.13 108.201 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -117.43 168.23 10.55 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.916 1.286 . . . . 63.23 111.046 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.92 76.76 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.621 -0.704 . . . . 64.24 109.762 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -53.62 -51.33 63.42 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.531 1.133 . . . . 61.32 109.273 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.52 -39.62 94.12 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.335 0.654 . . . . 72.53 111.608 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.1 -45.04 82.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.859 -0.591 . . . . 53.52 110.101 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -71.52 -27.41 63.18 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.844 0.747 . . . . 74.21 109.585 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.59 -35.33 77.21 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.626 -1.296 . . . . 74.25 109.291 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.37 -72.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.76 1.224 . . . . 65.13 111.822 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.11 -34.51 73.6 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.14 0.976 . . . . 64.12 110.701 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.43 -6.69 88.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.972 -0.349 . . . . 63.03 112.269 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -64.21 -48.18 76.88 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.235 1.517 . . . . 54.15 108.531 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -62.32 -40.07 95.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.769 1.628 . . . . 65.05 112.342 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.58 37.73 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.07 0.843 . . . . 74.21 111.525 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.46 165.15 25.94 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.1 2.534 . . . . 74.45 111.434 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 mt -126.47 137.26 58.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.582 -1.266 . . . . 74.41 107.582 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -76.89 -56.18 4.82 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.409 -0.807 . . . . 71.41 110.273 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -163.28 153.39 15.72 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.189 -1.041 . . . . 65.24 108.189 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 49.7 mt -131.59 147.63 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.628 1.171 . . . . 74.11 108.537 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -142.91 141.83 31.58 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.772 -1.566 . . . . 73.51 106.772 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.14 155.88 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.848 0.859 . . . . 71.5 109.735 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.47 145.81 49.66 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.796 -1.321 . . . . 51.45 109.796 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.33 1.32 8.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.758 1.223 . . . . 74.25 112.535 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' B' ' 54' ' ' PRO . 60.6 p -124.71 162.35 43.41 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.433 1.493 . . . . 75.41 109.33 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' B' ' 53' ' ' THR . 50.7 Cg_endo -64.02 2.63 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.483 3.455 . . . . 74.12 114.258 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -116.74 -19.4 9.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.05 1.34 . . . . 53.13 111.883 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 42.5 p -104.96 -19.69 13.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.015 0.926 . . . . 71.31 109.384 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -64.15 138.19 58.33 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.038 -1.664 . . . . 75.04 107.02 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -20.22 44.35 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.32 0.962 . . . . 74.41 111.207 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 37.4 p -120.07 158.95 25.77 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 106.964 -1.495 . . . . 60.24 106.964 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.8 175.09 11.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.784 -1.198 . . . . 62.21 109.413 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -135.04 141.44 46.14 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.293 -1.003 . . . . 73.11 108.293 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.8 147.56 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.55 -2.018 . . . . 70.45 105.55 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 t -127.06 140.09 50.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.838 -1.541 . . . . 74.25 106.838 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -109.77 166.38 10.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.595 1.558 . . . . 70.34 110.469 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.97 -55.11 7.01 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.151 0.98 . . . . 70.35 110.551 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -112.32 177.56 4.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.361 1.065 . . . . 73.05 108.644 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -94.74 -24.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.067 -1.021 . . . . 52.2 110.178 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.57 -54.83 22.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.317 -0.864 . . . . 62.45 111.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -67.05 -35.69 80.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.149 0.979 . . . . 53.15 110.218 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.57 -49.33 77.08 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.956 -0.757 . . . . 74.51 108.956 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -61.45 -45.09 95.75 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.526 0.73 . . . . 62.43 109.676 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -55.93 -52.27 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.608 -0.516 . . . . 72.44 109.608 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.81 73.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.491 -0.766 . . . . 61.13 112.599 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.42 -49.58 77.02 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.57 1.077 . . . . 65.52 109.785 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -71.73 -44.62 63.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.18 -0.914 . . . . 61.22 111.297 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -60.33 -30.16 69.34 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.784 0.72 . . . . 72.51 112.854 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 23.0 tp -90.85 -29.12 17.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.262 0.483 . . . . 72.2 112.18 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 90.2 p -64.58 118.65 9.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.584 -0.895 . . . . 64.13 108.584 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.84 63.73 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.739 -1.034 . . . . 63.52 113.094 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -77.32 110.23 11.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.713 1.756 . . . . 72.02 106.359 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.94 121.92 15.77 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.098 1.359 . . . . 70.32 111.025 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.0 137.74 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.339 -0.985 . . . . 73.23 108.339 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 35.1 m 38.77 38.84 0.3 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.375 1.87 . . . . 73.44 113.596 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.13 42.54 25.54 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.322 1.449 . . . . 73.23 111.137 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -143.35 171.22 14.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.164 2.586 . . . . 74.54 107.633 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -133.19 137.08 46.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.975 1.31 . . . . 70.14 109.187 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -98.08 115.59 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.634 2.374 . . . . 70.51 110.151 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 97.8 t -84.34 129.61 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.148 -1.797 . . . . 65.14 106.148 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 84.3 t -111.26 137.06 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.738 2.015 . . . . 74.13 106.376 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -154.48 143.81 21.3 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.819 1.247 . . . . 75.45 109.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -74.36 155.75 37.81 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.527 -0.733 . . . . 74.35 110.941 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -78.23 170.2 17.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 106.905 -1.517 . . . . 64.13 106.905 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 123.985 0.914 . . . . 73.54 109.364 179.365 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.912 0 N-CA-C 107.188 -2.365 . . . . 63.13 107.188 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.3 m -135.74 109.76 10.15 Favored Pre-proline 0 N--CA 1.451 -0.415 0 N-CA-C 104.558 -2.386 . . . . 71.14 104.558 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.1 168.34 24.99 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.851 1.701 . . . . 75.14 110.145 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.39 -164.33 1.37 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.481 2.313 . . . . 65.34 108.828 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -133.8 113.24 12.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 103.857 -2.646 . . . . 75.21 103.857 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.6 157.8 25.91 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.744 0.818 . . . . 74.43 109.736 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.09 153.89 41.21 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.298 1.039 . . . . 70.31 109.549 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -86.21 148.6 25.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.468 0.707 . . . . 74.43 109.703 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -129.02 -14.08 4.46 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.948 0.899 . . . . 74.42 112.681 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -83.17 67.96 9.39 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.578 -1.267 . . . . 74.22 107.578 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -79.88 -61.52 1.97 Allowed 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.096 -1.076 . . . . 73.14 108.096 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -65.82 134.44 53.09 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.315 -0.624 . . . . 74.32 109.315 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -171.24 77.85 0.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.032 2.133 . . . . 54.34 107.658 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.65 128.21 35.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 104.838 -2.282 . . . . 74.14 104.838 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 42.8 pt -138.6 165.53 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 118.982 0.81 . . . . 74.4 110.658 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -134.36 164.6 27.06 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.327 1.851 . . . . 74.55 107.512 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.2 -73.81 0.17 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.601 -1.259 . . . . 54.22 107.601 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -171.08 91.97 0.15 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.961 0.904 . . . . 72.32 108.897 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -128.11 125.69 39.68 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.924 1.238 . . . . 74.34 110.203 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -169.4 159.2 7.35 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 126.562 1.945 . . . . 74.34 108.506 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.48 -177.33 2.06 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.545 2.163 . . . . 64.04 109.233 177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 76.0 mt -144.67 144.43 31.24 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.99 0.916 . . . . 74.11 108.573 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' A' ' 403' ' ' GLU . 18.7 t -111.91 169.51 8.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.76 1.224 . . . . 62.14 109.006 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.54 -30.05 68.75 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.306 -0.627 . . . . 64.11 109.306 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -79.58 -35.16 40.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.135 1.374 . . . . 73.51 110.249 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 400' ' ' SER . 29.7 mt-10 -63.7 -24.07 67.63 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.068 0.547 . . . . 61.03 111.414 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 51.9 tp -58.84 -43.14 90.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.237 -1.023 . . . . 73.24 108.237 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.47 -33.47 75.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.446 0.698 . . . . 70.44 110.79 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.98 -2.99 33.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.333 1.053 . . . . 73.42 112.288 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.6 mtp -100.07 7.21 44.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.723 1.209 . . . . 64.12 111.906 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -110.82 148.77 39.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 73.5 110.107 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.04 166.46 29.56 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.152 3.235 . . . . 65.31 113.581 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.16 159.38 22.05 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.49 1.516 . . . . 72.12 110.512 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.35 17.4 39.8 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.243 1.878 . . . . 40.3 113.729 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.75 157.81 43.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.354 2.262 . . . . 74.0 106.267 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.8 144.61 49.61 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.785 0.834 . . . . 72.11 109.122 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.427 HG22 ' HD2' ' B' ' 49' ' ' ARG . 34.9 t -70.03 143.99 14.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.997 -1.112 . . . . 70.02 107.997 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' B' ' 32' ' ' ALA . 47.1 tp -135.53 80.79 43.96 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.101 -1.444 . . . . 73.2 107.101 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.08 171.08 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.376 3.384 . . . . 72.04 112.814 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.17 162.21 3.06 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.105 3.203 . . . . 64.14 112.847 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -46.3 133.95 15.66 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.575 2.85 . . . . 74.43 112.984 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -64.59 -36.84 85.53 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.32 -0.993 . . . . 72.11 108.32 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -87.01 24.38 9.15 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.382 1.944 . . . . 64.03 112.958 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -69.33 134.56 49.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.558 1.179 . . . . 72.55 108.932 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.76 95.74 22.2 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 106.735 -1.58 . . . . 64.33 106.735 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.53 81.6 2.47 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.654 2.903 . . . . 55.25 111.556 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.247 0.962 0 N-CA-C 104.754 -2.313 . . . . 65.35 104.754 178.248 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 110.047 -1.221 . . . . 74.42 110.047 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -109.77 -51.95 2.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.934 1.293 . . . . 64.22 107.736 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.57 123.29 16.94 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.097 -1.446 . . . . 74.32 107.097 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -149.68 136.35 19.34 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.908 0.777 . . . . 74.01 109.713 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.17 139.14 52.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 124.55 1.14 . . . . 75.23 108.244 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 26.99 2.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.201 2.2 . . . . 73.32 108.835 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.75 64.78 15.73 Favored Pre-proline 0 C--O 1.239 0.544 0 O-C-N 121.009 -1.057 . . . . 52.13 109.72 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.07 167.46 24.79 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.304 2.669 . . . . 74.03 112.363 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.4 -18.99 25.76 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.639 2.226 . . . . 74.43 112.918 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -66.94 -15.23 63.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.302 1.041 . . . . 64.45 112.476 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.413 HG11 ' HD3' ' B' ' 71' ' ' LYS . 20.4 t -77.99 122.74 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.673 1.124 . . . . 70.4 108.454 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -137.53 155.03 49.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.733 1.613 . . . . 74.51 106.95 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -26.19 68.56 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.745 -0.597 . . . . 73.15 112.093 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.92 115.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.597 -1.26 . . . . 63.41 107.597 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 59.6 mt -109.03 159.31 16.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.53 1.132 . . . . 72.3 109.291 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -127.88 135.39 49.95 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.59 2.356 . . . . 62.1 106.635 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mm -120.95 153.19 24.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.27 1.828 . . . . 71.14 110.191 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -142.71 163.96 31.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.639 1.976 . . . . 64.03 111.549 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 63.58 24.87 14.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.954 2.502 . . . . 75.42 114.708 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 71.9 mt -75.44 156.77 85.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.305 -0.872 . . . . 72.22 111.685 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.56 138.81 46.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 N-CA-C 106.521 -2.146 . . . . 74.23 106.521 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -71.13 -10.89 60.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.308 1.043 . . . . 73.42 112.269 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -126.47 108.8 11.52 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.195 1.798 . . . . 72.22 107.289 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -156.98 137.43 4.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.758 -0.83 . . . . 74.4 108.758 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -86.45 163.73 17.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.573 1.149 . . . . 63.02 110.481 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.574 ' HB2' HD11 ' A' ' 415' ' ' LEU . . . -62.16 -32.55 73.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 43.42 110.021 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.48 -32.58 74.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.622 1.169 . . . . 62.31 110.915 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.53 -45.76 43.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.552 -1.277 . . . . 73.22 107.552 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.4 mmm -55.44 -53.38 56.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.521 0.728 . . . . 64.52 110.168 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -71.66 -10.36 59.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.372 0.879 . . . . 74.51 113.372 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.43 -60.27 1.99 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.018 -1.104 . . . . 72.22 108.018 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.99 -54.81 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.324 1.85 . . . . 61.21 109.874 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -78.56 -16.47 57.4 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.601 0.593 . . . . 71.52 112.601 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.01 -27.2 74.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.266 0.936 . . . . 73.33 112.735 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -14.17 11.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.707 1.253 . . . . 70.04 113.157 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -107.72 -5.13 17.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.705 1.202 . . . . 64.41 113.831 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.93 -174.1 21.27 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.864 1.211 . . . . 74.15 112.874 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.2 138.99 40.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.986 3.124 . . . . 42.4 111.525 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 39.0 mt -101.4 122.3 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.756 1.622 . . . . 75.41 109.725 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -69.61 -47.99 61.58 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.529 -0.732 . . . . 71.14 112.404 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -165.48 159.87 17.28 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.457 1.026 . . . . 64.42 110.635 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 mt -144.32 135.83 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.78 2.032 . . . . 64.33 109.654 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.427 ' HD2' HG22 ' A' ' 414' ' ' VAL . 0.5 OUTLIER -136.16 126.24 26.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 102.847 -3.019 . . . . 75.5 102.847 178.125 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 m -112.64 142.28 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.115 0.566 . . . . 74.34 110.581 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.1 46.89 Favored Glycine 0 C--O 1.241 0.591 0 C-N-CA 124.339 0.971 . . . . 72.11 111.282 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -118.39 -30.46 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.765 0.783 . . . . 43.22 111.806 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -74.14 158.08 86.02 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.695 -1.224 . . . . 73.51 107.695 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.31 -27.44 63.6 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.814 1.676 . . . . 64.51 110.099 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -17.61 63.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.824 1.25 . . . . 64.1 111.667 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 69.3 p -107.47 0.38 22.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.518 1.127 . . . . 72.44 111.928 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -56.14 127.95 33.14 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 120.148 -1.595 . . . . 71.45 108.793 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.17 89.31 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.847 -1.53 . . . . 71.03 114.348 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -121.18 152.44 38.79 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 120.343 2.071 . . . . 50.33 109.336 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.28 174.99 12.08 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.401 1.08 . . . . 62.22 109.274 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -132.25 134.63 45.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.004 -1.48 . . . . 71.31 107.004 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.2 142.62 43.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.634 -1.247 . . . . 74.33 107.634 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 t -122.53 147.25 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.42 -1.326 . . . . 71.34 107.42 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -120.91 166.38 13.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.763 1.625 . . . . 71.22 107.828 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.76 -68.6 0.36 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 113.039 0.755 . . . . 73.31 113.039 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -106.25 148.19 28.24 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.247 1.023 . . . . 65.21 110.862 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.67 -31.85 45.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.275 -0.875 . . . . 74.24 109.301 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -64.48 -30.7 71.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.924 1.29 . . . . 60.35 112.37 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.14 -60.46 2.27 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.235 -1.394 . . . . 61.43 107.235 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.34 67.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 62.3 113.898 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.413 ' HD3' HG11 ' B' ' 17' ' ' VAL . 0.3 OUTLIER -56.25 -60.25 3.78 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.256 0.934 . . . . 73.33 110.039 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -73.41 -39.61 64.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.999 -0.68 . . . . 62.11 110.314 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.76 -33.73 64.58 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.441 -0.79 . . . . 71.43 112.692 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.26 -52.99 62.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.27 -1.011 . . . . 61.22 108.27 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.83 -38.99 93.14 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.0 0.52 . . . . 73.12 110.81 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -18.5 60.57 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 117.492 -1.242 . . . . 73.54 112.22 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.82 -32.86 11.49 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.368 1.44 . . . . 63.04 111.716 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -63.26 152.27 38.16 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.916 -1.513 . . . . 41.14 106.916 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.49 9.57 44.5 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 119.166 -0.797 . . . . 65.41 113.624 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -74.06 125.23 27.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.132 -1.803 . . . . 65.15 106.132 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -80.86 116.67 20.96 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.738 1.615 . . . . 72.24 110.49 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.45 141.9 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 123.473 0.709 . . . . 71.31 109.829 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 62.9 m 24.47 58.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.115 2.566 . . . . 63.14 115.666 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 m120 56.18 27.51 11.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.369 1.468 . . . . 73.14 113.963 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -131.87 167.91 18.76 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.203 2.601 . . . . 72.31 109.353 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -138.74 104.26 5.05 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.749 -1.575 . . . . 74.53 106.749 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -69.31 161.06 30.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.066 1.347 . . . . 61.25 110.023 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -133.17 122.65 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.354 1.061 . . . . 64.14 108.618 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 t -98.35 136.22 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.434 1.093 . . . . 73.33 109.268 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -148.86 153.72 38.46 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.435 1.094 . . . . 73.21 109.343 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.93 147.1 23.92 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.27 1.028 . . . . 74.52 110.407 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -76.59 121.47 23.24 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 105.819 -1.919 . . . . 70.1 105.819 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.2 -0.905 . . . . 72.24 109.112 179.639 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.999 0 N-CA-C 108.324 -1.91 . . . . 53.34 108.324 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 5.9 m -88.95 114.38 59.86 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 117.574 -1.203 . . . . 75.22 108.096 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -80.32 -178.44 4.48 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.529 2.152 . . . . 72.41 109.308 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.92 135.34 31.16 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 103.133 -2.914 . . . . 73.02 103.133 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -147.62 61.08 1.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.443 1.497 . . . . 74.43 109.424 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 65.8 tp -43.58 116.5 0.96 Allowed 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.826 2.05 . . . . 75.23 111.994 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -151.32 162.98 39.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.332 1.453 . . . . 74.22 108.362 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -156.34 171.34 20.4 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.997 0.919 . . . . 75.22 109.641 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -127.79 163.39 24.47 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.524 1.53 . . . . 71.44 107.972 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.42 114.87 26.96 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 117.535 -1.221 . . . . 75.34 110.097 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -75.74 116.28 16.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 100.721 -3.807 . . . . 74.1 100.721 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.47 -154.97 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.362 1.465 . . . . 70.32 112.183 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -137.9 148.05 44.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.758 1.623 . . . . 72.11 107.288 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -74.15 144.09 45.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.89 -1.152 . . . . 73.3 107.89 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 11.3 mt -131.67 134.64 60.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.612 -1.625 . . . . 53.51 106.612 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.52 172.44 12.97 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.026 1.73 . . . . 63.34 111.717 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.94 163.95 29.08 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.2 -1.407 . . . . 73.33 107.2 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -123.22 85.66 2.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.514 -1.662 . . . . 64.04 106.514 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -131.76 131.52 43.05 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.658 0.783 . . . . 62.14 109.831 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -99.61 162.19 22.0 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 123.873 0.869 . . . . 75.03 109.91 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.75 155.73 67.7 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 N-CA-C 106.342 -2.215 . . . . 53.53 106.342 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 15.8 mt -109.92 -70.95 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.654 -1.98 . . . . 65.33 105.654 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 29.4 t -105.97 -168.7 1.47 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 103.91 -2.626 . . . . 51.25 103.91 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.95 -11.71 59.77 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.53 -1.356 . . . . 71.43 109.539 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -66.71 -59.34 3.66 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 126.925 2.09 . . . . 75.1 109.817 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -64.7 -39.04 92.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.763 -1.199 . . . . 44.02 107.763 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.06 -45.81 91.61 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 119.185 -0.436 . . . . 62.0 110.184 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.15 -45.58 92.58 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 123.343 0.657 . . . . 74.25 109.75 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.23 79.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.424 0.69 . . . . 71.34 111.904 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 85.2 mtp -71.73 -7.48 48.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.169 0.988 . . . . 71.12 111.1 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -107.46 143.26 26.85 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.219 0.918 . . . . 74.13 109.069 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 36.3 Cg_endo -71.93 164.35 35.94 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.323 2.682 . . . . 74.03 114.035 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -70.02 161.14 30.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.836 2.054 . . . . 70.22 110.278 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 75.62 17.69 80.03 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.132 -0.98 . . . . 74.04 115.273 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' TYR . . . . . 0.479 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 67.1 m-85 -125.1 156.96 37.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 105.639 -1.985 . . . . 70.13 105.639 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -137.44 154.42 49.94 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.128 -0.693 . . . . 74.25 109.128 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.03 142.15 16.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.405 1.082 . . . . 73.45 110.625 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.45 83.42 66.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 106.171 -1.789 . . . . 71.23 106.171 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -67.96 171.97 11.55 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.34 2.026 . . . . 51.32 110.643 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.03 163.66 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.424 2.083 . . . . 33.04 110.834 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.75 176.02 9.96 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.399 2.066 . . . . 61.44 108.9 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -93.47 174.66 7.08 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.271 -1.381 . . . . 73.3 107.271 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 59.77 29.9 68.24 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.3 -0.722 . . . . 62.25 112.449 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -101.93 158.27 16.26 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.048 -1.464 . . . . 70.21 107.048 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.1 t -116.45 80.57 10.23 Favored Pre-proline 0 C--O 1.233 0.218 0 O-C-N 121.712 -0.618 . . . . 73.12 110.002 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.09 173.78 8.91 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 N-CA-C 107.7 -1.692 . . . . 41.43 107.7 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--O 1.253 1.239 0 N-CA-C 102.894 -3.002 . . . . 74.32 102.894 179.39 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.512 0 N-CA-C 110.28 -1.128 . . . . 75.44 110.28 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -137.97 172.32 13.1 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.098 1.759 . . . . 72.14 109.241 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.97 -175.04 3.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.729 1.212 . . . . 54.15 109.162 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -132.62 151.53 51.92 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.964 1.706 . . . . 70.23 107.391 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -137.87 158.22 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.535 1.934 . . . . 75.31 106.706 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -92.87 -65.59 0.99 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 121.16 -0.963 . . . . 72.12 108.587 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.09 152.75 79.66 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 124.446 1.098 . . . . 73.23 109.705 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.37 161.46 43.09 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.122 3.215 . . . . 72.53 110.569 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.82 -48.3 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.75 2.3 . . . . 54.13 112.301 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -141.81 147.32 37.07 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.28 1.832 . . . . 63.31 108.436 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -148.31 151.18 13.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.541 1.137 . . . . 72.43 109.368 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -126.17 143.33 51.17 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.002 2.121 . . . . 43.53 108.693 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -60.34 -28.5 68.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.564 1.546 . . . . 64.31 111.149 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.4 mt -88.86 147.73 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.161 2.184 . . . . 75.32 108.513 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.51 155.34 39.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.445 1.498 . . . . 73.34 109.612 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -130.63 105.06 7.57 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.324 2.249 . . . . 73.44 107.215 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -83.88 149.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 126.527 1.931 . . . . 73.42 110.645 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -140.49 162.65 34.83 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.63 1.172 . . . . 53.23 109.379 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 68.32 24.97 7.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.248 2.219 . . . . 62.42 113.173 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -67.38 153.47 94.76 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 121.221 -0.924 . . . . 74.01 110.033 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.68 158.21 50.95 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.456 2.771 . . . . 72.32 109.965 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -73.1 -14.07 61.32 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.522 -0.736 . . . . 64.41 112.128 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -130.2 129.18 43.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.562 -1.273 . . . . 75.43 107.562 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -166.79 160.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.383 2.273 . . . . 74.33 106.048 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -122.13 177.21 5.43 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.651 1.18 . . . . 60.24 110.129 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.69 88.63 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.179 -0.674 . . . . 45.21 109.179 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.3 -46.39 86.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.409 1.483 . . . . 72.23 110.482 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.23 -41.33 99.09 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.896 0.771 . . . . 72.45 110.646 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.4 mmm -63.77 -55.95 19.25 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.711 -0.478 . . . . 75.14 109.711 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.52 -25.06 68.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.288 -0.863 . . . . 72.22 111.038 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.36 -57.82 4.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.406 1.003 . . . . 75.13 109.857 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.4 mt -60.27 -58.33 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 125.55 1.54 . . . . 74.31 110.434 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -65.16 -22.64 66.94 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.793 0.664 . . . . 73.44 112.793 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.68 79.87 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 118.481 0.582 . . . . 64.11 113.927 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -69.24 -9.09 51.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.06 0.93 . . . . 52.14 111.306 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -104.72 -7.31 19.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.374 1.07 . . . . 73.32 111.14 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.12 -174.29 21.23 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.137 1.827 . . . . 70.01 111.396 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.99 169.25 9.29 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.091 2.528 . . . . 64.24 109.764 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.58 145.06 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 O-C-N 120.887 -1.133 . . . . 53.32 109.286 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -78.71 -63.44 1.41 Allowed 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.392 -1.336 . . . . 70.34 107.392 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -160.14 165.93 30.73 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.129 0.972 . . . . 74.21 109.257 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.38 146.44 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.479 1.512 . . . . 74.24 107.484 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -137.22 126.98 25.48 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 104.319 -2.474 . . . . 44.42 104.319 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.04 164.53 17.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 123.377 0.671 . . . . 75.21 109.471 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.45 146.19 44.08 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.174 -1.171 . . . . 71.15 110.174 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -124.46 -58.99 1.49 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.951 -1.129 . . . . 54.12 107.951 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.37 161.05 61.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.305 0.642 . . . . 74.13 109.285 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.58 -9.34 23.94 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.786 2.324 . . . . 75.01 115.121 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.21 -11.51 16.51 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.347 0.976 . . . . 64.53 112.584 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -99.39 -11.42 21.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.596 0.635 . . . . 73.51 111.318 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -69.06 152.84 44.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.457 -0.942 . . . . 74.44 108.457 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.22 -20.23 50.84 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.684 1.135 . . . . 73.4 112.241 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 50.4 p -133.32 165.45 24.8 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.852 -1.536 . . . . 63.45 106.852 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.07 175.57 10.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.741 -1.225 . . . . 73.51 111.545 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.17 146.44 50.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.855 0.752 . . . . 73.11 111.575 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -131.94 145.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.2 1.4 . . . . 62.54 107.803 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.39 136.57 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.436 -1.691 . . . . 73.51 106.436 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.98 166.32 13.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.634 -1.617 . . . . 71.22 106.634 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -78.34 -68.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.478 0.711 . . . . 64.43 110.059 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.84 144.16 30.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 74.12 112.969 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.42 -33.83 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.918 0.887 . . . . 74.3 109.933 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -67.17 -45.97 75.37 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.064 0.946 . . . . 75.24 110.621 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -57.74 -46.6 84.25 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.754 0.822 . . . . 71.21 109.71 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.36 83.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.392 -0.337 . . . . 64.34 111.054 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -67.37 -53.63 27.67 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.206 0.602 . . . . 62.14 110.929 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -59.77 -42.64 93.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.905 -0.569 . . . . 60.52 109.789 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.86 92.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.373 -0.602 . . . . 71.23 109.373 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 t -51.98 -53.34 42.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.771 0.828 . . . . 74.15 110.683 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -73.77 -14.53 61.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.849 1.055 . . . . 64.23 113.849 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -95.19 -21.36 18.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.626 1.103 . . . . 74.35 110.002 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 35.8 tp -99.78 -7.46 25.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.308 1.843 . . . . 65.05 111.468 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 32.4 p -57.96 117.01 3.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.978 1.311 . . . . 62.2 111.442 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.64 10.6 71.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.231 -1.316 . . . . 73.45 114.654 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -51.55 121.94 7.22 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.72 1.208 . . . . 75.43 112.875 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -83.57 118.1 23.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.8 2.04 . . . . 72.12 110.655 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.9 155.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.216 2.606 . . . . 72.42 105.642 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 m 49.67 21.74 0.69 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.388 1.475 . . . . 62.12 112.992 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 38.7 t30 59.24 55.55 4.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.166 2.186 . . . . 74.13 108.572 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -142.81 -167.75 2.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 128.152 2.581 . . . . 72.14 107.572 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -145.11 111.99 5.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.496 -2.409 . . . . 73.52 104.496 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.0 mt -77.32 172.77 12.78 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.919 -1.113 . . . . 54.42 108.96 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.81 146.94 31.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.427 -1.323 . . . . 74.22 107.427 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.92 115.61 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.217 1.407 . . . . 74.24 107.383 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.29 120.59 25.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.063 1.345 . . . . 74.21 107.715 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -55.68 145.27 24.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.645 0.657 . . . . 74.14 111.408 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.95 175.53 10.46 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.407 -0.59 . . . . 72.44 109.407 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--O 1.245 0.848 0 C-N-CA 125.643 1.577 . . . . 52.14 107.073 178.661 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.548 0 N-CA-C 109.596 -1.402 . . . . 62.05 109.596 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 29.7 m 62.71 81.53 0.23 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.146 1.378 . . . . 75.4 111.788 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.81 113.34 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.962 2.441 . . . . 75.02 106.785 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.17 125.65 24.5 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 119.682 1.128 . . . . 62.11 110.771 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -114.33 121.15 42.77 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 106.98 -1.489 . . . . 75.34 106.98 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 6.2 mp -123.26 76.88 1.43 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.789 1.235 . . . . 72.34 108.904 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -72.87 -55.81 6.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.485 0.714 . . . . 72.43 109.765 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -162.17 170.9 18.29 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.944 1.297 . . . . 53.53 109.483 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -143.38 166.61 24.28 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.074 1.75 . . . . 70.14 109.152 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -140.27 158.33 44.2 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.535 0.734 . . . . 61.04 110.417 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -155.98 153.49 29.62 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.51 1.124 . . . . 72.13 110.471 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -169.57 171.59 7.48 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.694 2.397 . . . . 73.01 107.644 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -142.53 166.59 24.25 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.209 1.404 . . . . 75.22 109.622 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -124.6 -160.74 0.96 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.677 1.591 . . . . 75.12 108.713 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 60.6 mt -107.13 151.11 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 127.079 2.152 . . . . 40.14 106.17 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -112.88 87.8 2.67 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.22 0.608 . . . . 72.43 110.44 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -154.15 161.56 41.78 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.929 0.891 . . . . 61.35 109.006 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -117.42 99.56 7.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.829 -1.545 . . . . 63.02 106.829 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -157.85 131.48 7.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 118.163 0.438 . . . . 43.32 110.168 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 59.47 167.13 0.08 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.139 1.775 . . . . 72.02 113.031 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.83 121.96 6.12 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 N-CA-C 106.269 -2.243 . . . . 61.5 106.269 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 18.5 mt -119.48 -179.18 3.79 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.564 -1.272 . . . . 75.25 107.564 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 16.5 m -127.85 -92.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.423 -0.584 . . . . 72.42 109.423 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -65.53 -24.56 67.14 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 126.104 1.761 . . . . 74.41 112.046 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -79.1 -39.88 32.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.807 -0.812 . . . . 74.33 108.807 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.37 -27.36 68.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.641 0.776 . . . . 62.34 109.783 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.21 -37.89 89.02 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.048 0.939 . . . . 74.51 110.744 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -67.17 -46.86 72.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.022 0.828 . . . . 64.13 109.189 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.52 -6.89 5.71 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.106 1.15 . . . . 72.21 114.106 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 95.8 mtp -100.51 -0.03 38.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.889 1.276 . . . . 72.22 110.123 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.25 155.94 43.79 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.327 1.451 . . . . 65.13 111.542 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.29 163.27 36.79 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.235 2.623 . . . . 41.53 111.243 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.13 164.87 19.37 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.735 0.814 . . . . 74.44 110.291 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 76.58 21.66 74.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.506 -1.163 . . . . 64.43 114.587 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -124.21 158.35 32.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.641 1.721 . . . . 74.53 108.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -135.46 153.28 51.81 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.659 1.184 . . . . 73.14 109.074 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.38 146.7 11.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 123.521 0.728 . . . . 63.43 109.416 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 37.8 tp -132.92 82.55 54.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.21 -1.404 . . . . 63.14 107.21 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.72 165.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.06 2.507 . . . . 73.23 111.656 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -69.45 160.23 50.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.045 1.83 . . . . 71.23 111.229 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.44 177.46 8.78 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 125.226 3.951 . . . . 73.42 114.488 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -87.31 164.41 16.29 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.915 -1.142 . . . . 72.45 107.915 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 39.29 64.57 0.95 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.236 1.874 . . . . 73.21 113.89 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -133.25 164.8 26.28 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.852 1.261 . . . . 62.35 108.822 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 70.8 t -134.04 102.63 12.06 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 106.597 -1.631 . . . . 71.11 106.597 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.17 -18.16 18.58 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.24 2.627 . . . . 63.21 114.009 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.3 tp . . . . . 0 C--O 1.25 1.094 0 N-CA-C 106.352 -1.721 . . . . 75.13 106.352 179.46 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.559 0 N-CA-C 108.71 -1.756 . . . . 53.03 108.71 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 29.1 ptt-85 -144.39 176.93 9.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.659 1.73 . . . . 73.34 111.171 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.07 154.82 42.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.443 1.097 . . . . 61.44 109.839 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -83.07 128.76 34.77 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.143 1.777 . . . . 52.13 108.604 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 36.1 pt -105.93 172.32 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.796 -0.816 . . . . 74.31 108.796 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -155.18 159.55 40.21 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.687 -0.857 . . . . 64.01 108.687 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 24.17 72.72 0.32 Allowed Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 128.794 2.838 . . . . 74.04 114.528 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.05 162.82 40.8 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 121.943 1.762 . . . . 53.3 108.718 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.53 -34.57 7.21 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.816 1.678 . . . . 64.32 112.431 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -141.37 162.7 34.85 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.662 1.185 . . . . 73.42 109.727 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t -155.96 158.09 3.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 127.096 2.158 . . . . 74.44 105.859 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' B' ' 92' ' ' TYR . 0.0 OUTLIER -145.07 161.21 40.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.375 1.47 . . . . 74.13 108.16 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -80.79 -7.55 59.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.331 2.252 . . . . 74.41 116.032 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -103.29 121.59 54.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 120.488 1.494 . . . . 64.45 107.549 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 71.2 mt -110.19 142.39 41.8 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.282 1.033 . . . . 72.42 108.781 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.46 125.01 53.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.77 -2.307 . . . . 73.45 104.77 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.41 153.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.256 1.422 . . . . 73.25 108.408 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.437 ' HG2' HG22 ' B' ' 59' ' ' THR . 65.1 mtt180 -145.92 163.44 35.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.363 1.865 . . . . 74.15 108.744 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 70.17 21.28 6.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.088 1.755 . . . . 64.11 112.752 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.0 mt -78.17 156.05 79.35 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 121.022 -1.049 . . . . 63.11 110.883 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.03 164.25 36.41 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.971 1.781 . . . . 72.14 111.354 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -93.66 -16.85 23.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 74.32 111.646 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -120.57 99.03 6.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 74.24 106.066 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.5 tt -163.32 174.11 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.988 2.115 . . . . 74.1 106.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -136.47 -170.05 2.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.03 1.332 . . . . 61.11 110.438 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.75 -40.75 65.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.678 -0.49 . . . . 64.22 109.678 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -49.04 -58.36 5.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.095 2.158 . . . . 63.0 110.926 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.42 -42.74 99.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.859 0.299 . . . . 62.34 110.913 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 92.7 mmm -67.57 -23.05 65.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 117.86 -1.067 . . . . 53.32 113.047 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -90.88 -38.17 13.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.744 1.156 . . . . 74.44 108.562 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.44 -52.09 36.51 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.96 1.304 . . . . 73.33 111.601 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.68 -61.47 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.626 0.771 . . . . 72.12 109.41 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -64.17 -19.97 65.68 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.778 0.288 . . . . 74.21 111.778 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.34 -16.62 75.54 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 125.025 1.298 . . . . 54.11 112.143 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -57.25 -32.98 67.11 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.329 1.064 . . . . 64.21 109.759 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -74.71 -60.44 2.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.194 0.998 . . . . 74.33 109.345 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.27 37.41 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.926 -1.27 . . . . 73.54 109.926 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.35 162.72 22.73 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.544 2.163 . . . . 73.34 109.978 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mt -126.51 138.52 54.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.537 -0.912 . . . . 72.14 108.537 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -68.53 -64.21 0.91 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.893 -0.78 . . . . 73.03 108.893 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -159.01 164.21 35.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.234 1.014 . . . . 74.12 108.94 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 95.3 mt -137.66 150.94 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.471 1.908 . . . . 65.21 107.796 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -146.17 148.28 32.38 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.657 1.983 . . . . 74.04 106.318 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.11 166.88 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.374 1.07 . . . . 74.2 110.707 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.37 146.22 40.4 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.168 -1.173 . . . . 71.45 110.168 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -122.92 -16.68 7.0 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.741 1.216 . . . . 71.31 112.157 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 18.8 p -95.0 159.02 33.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.443 -1.688 . . . . 33.24 106.443 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.32 -34.35 93.67 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.758 1.639 . . . . 64.21 111.696 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -72.42 -21.14 61.3 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.314 1.227 . . . . 73.31 114.314 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 34.6 p -92.62 -0.13 57.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.895 0.878 . . . . 74.32 111.25 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.77 140.74 57.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.357 -1.349 . . . . 64.15 107.357 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.83 -10.82 61.39 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.503 -1.72 . . . . 64.32 114.129 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' THR . . . . . 0.437 HG22 ' HG2' ' B' ' 24' ' ' ARG . 73.3 p -113.32 149.41 34.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.275 2.037 . . . . 64.43 109.329 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.8 175.67 12.84 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.902 -1.124 . . . . 75.35 109.569 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -136.27 150.04 48.75 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 122.86 0.464 . . . . 74.13 110.1 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -133.23 146.99 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.722 1.609 . . . . 62.11 106.96 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.9 t -127.43 140.66 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.544 -2.021 . . . . 71.03 105.544 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.95 163.63 24.08 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.873 1.269 . . . . 73.03 109.052 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -97.68 -53.5 3.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.952 1.301 . . . . 73.35 109.722 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.74 115.09 15.07 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.893 -1.151 . . . . 70.24 107.893 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 tt -71.52 -21.45 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.938 -1.134 . . . . 72.14 107.938 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.34 -50.31 47.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.826 1.65 . . . . 74.43 109.421 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.54 -42.37 91.99 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.479 -0.934 . . . . 70.43 108.479 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.66 -45.88 92.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.319 0.648 . . . . 74.34 110.671 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -57.5 -47.09 82.85 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.915 0.78 . . . . 74.52 111.267 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -66.19 -55.09 18.02 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.915 -0.772 . . . . 75.31 108.915 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -38.63 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.688 1.595 . . . . 74.13 113.933 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.08 -41.33 78.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.463 1.105 . . . . 30.55 110.234 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.51 -35.93 17.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.178 -0.305 . . . . 73.21 110.178 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.24 -31.71 69.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 74.25 111.213 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.57 -9.63 21.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.313 1.445 . . . . 74.24 112.785 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 31.3 t -73.92 108.47 6.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.889 -1.152 . . . . 63.03 107.889 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.12 12.41 60.16 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.589 -1.117 . . . . 22.43 112.815 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -68.01 121.66 16.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.618 1.209 . . . . 55.02 108.111 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -76.12 115.46 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.259 1.024 . . . . 61.34 110.391 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 m -140.38 137.78 36.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.766 1.226 . . . . 63.31 109.414 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.6 m 42.39 46.86 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.407 1.883 . . . . 71.51 113.426 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 66.56 10.06 7.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.139 2.176 . . . . 31.2 113.361 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -117.36 -179.37 3.7 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.621 2.368 . . . . 72.35 108.248 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -140.43 117.79 11.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.228 -1.027 . . . . 75.22 108.228 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.34 162.21 29.11 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.482 0.658 . . . . 53.23 110.52 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 94.4 t -128.97 159.41 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.475 1.91 . . . . 74.04 107.015 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 t -143.41 128.0 14.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.241 -1.392 . . . . 65.32 107.241 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.83 144.56 37.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.378 1.071 . . . . 75.21 109.782 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -68.87 163.43 24.34 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 75.12 109.588 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' TYR . . . . . 0.524 ' H ' ' ND2' ' B' ' 18' ' ' ASN . 23.3 t80 -87.81 147.15 25.28 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.312 -1.366 . . . . 74.44 107.312 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.254 1.321 0 N-CA-C 106.272 -1.751 . . . . 75.21 106.272 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.912 0 N-CA-C 106.036 -2.826 . . . . 50.11 106.036 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.69 163.99 43.59 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 107.682 -1.229 . . . . 73.24 107.682 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.56 -21.69 25.46 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.665 1.577 . . . . 70.35 110.485 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -123.75 172.59 8.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.859 2.064 . . . . 71.3 108.647 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -103.71 -4.79 23.26 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.622 1.169 . . . . 71.32 110.206 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.33 132.09 51.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.504 1.522 . . . . 72.33 108.246 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -156.18 161.88 40.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.986 0.914 . . . . 54.32 109.167 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -123.55 -4.24 8.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.386 1.074 . . . . 52.21 112.43 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -93.66 -177.27 4.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.308 1.043 . . . . 72.11 108.591 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -149.78 -166.93 2.68 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.973 1.309 . . . . 71.45 107.725 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -135.77 174.45 10.59 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 106.854 -1.536 . . . . 75.52 106.854 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -176.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 129.041 2.937 . . . . 45.33 112.791 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -140.24 172.17 13.12 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 120.978 -1.077 . . . . 73.21 113.581 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.64 178.82 4.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.621 -1.627 . . . . 63.24 107.856 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 61.0 mt -105.3 142.74 17.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 122.477 1.132 . . . . 60.11 110.658 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.24 127.81 33.93 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 128.381 2.672 . . . . 75.42 110.442 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -117.17 151.23 37.31 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 122.087 0.946 . . . . 73.01 109.703 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -64.55 108.47 1.68 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.523 1.529 . . . . 75.54 109.834 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -80.42 65.13 5.46 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.333 -1.729 . . . . 71.24 106.333 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -140.23 151.99 65.96 Favored Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 125.471 1.508 . . . . 75.44 110.464 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.68 119.05 6.04 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.191 1.928 . . . . 74.42 109.307 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.48 -73.66 0.17 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.217 -1.401 . . . . 61.32 107.217 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 6.2 t -157.09 -177.85 6.93 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.465 1.506 . . . . 70.03 107.513 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.14 -29.93 68.96 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.588 0.755 . . . . 74.15 111.789 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -62.55 -23.7 67.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.519 1.128 . . . . 73.2 112.469 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -92.19 -46.67 7.62 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.898 -1.519 . . . . 71.44 106.898 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 40.0 tp -57.45 -39.73 76.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.741 0.816 . . . . 75.35 110.292 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.82 -30.13 67.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.777 1.631 . . . . 64.22 111.872 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.8 34.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.584 1.154 . . . . 64.24 111.693 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 94.4 mtp -85.5 -20.18 30.08 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.146 -0.972 . . . . 73.01 110.098 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.1 158.55 39.2 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 124.167 0.987 . . . . 74.31 111.388 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.98 160.31 30.39 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.14 1.894 . . . . 41.4 110.192 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.38 158.95 24.47 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.072 0.939 . . . . 72.24 109.811 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.16 51.63 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.77 0.7 . . . . 55.03 112.36 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.05 156.27 38.46 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.518 1.527 . . . . 73.24 107.008 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -132.07 147.71 52.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.833 0.453 . . . . 74.43 111.007 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.531 1.132 . . . . 62.54 108.331 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.24 85.94 42.5 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 106.743 -1.577 . . . . 72.12 106.743 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.28 168.39 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.056 3.171 . . . . 65.53 112.33 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.91 168.25 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.355 2.703 . . . . 54.24 111.944 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.2 146.91 37.26 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.076 2.517 . . . . 61.54 110.817 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -56.66 -3.32 0.1 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.472 2.309 . . . . 63.35 116.249 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -165.83 67.53 0.2 Allowed Glycine 0 CA--C 1.517 0.193 0 N-CA-C 106.839 -2.504 . . . . 51.23 106.839 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -84.42 113.83 21.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.338 0.655 . . . . 74.11 110.27 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.96 76.8 63.92 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 105.467 -2.049 . . . . 65.1 105.467 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.46 157.21 40.96 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.172 1.915 . . . . 52.41 109.842 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.262 0 N-CA-C 103.899 -2.63 . . . . 74.52 103.899 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 111.312 -0.715 . . . . 73.24 111.312 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -130.43 166.15 21.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.744 1.618 . . . . 74.2 107.755 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 42.05 75.91 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.742 1.617 . . . . 74.32 111.309 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -129.03 114.6 16.6 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.294 1.038 . . . . 73.41 109.177 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 22.5 pt -124.25 16.36 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.195 0.998 . . . . 71.25 112.286 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -46.33 148.41 0.93 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.116 0.966 . . . . 75.21 111.319 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 47.02 69.16 2.86 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 125.448 1.499 . . . . 72.41 109.571 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.15 165.28 22.37 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.505 2.137 . . . . 74.53 109.983 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.07 -27.25 65.52 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.133 1.889 . . . . 73.01 112.633 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -158.61 169.48 24.31 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.513 1.125 . . . . 75.51 108.859 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.429 HG13 ' CE1' ' B' ' 91' ' ' TYR . 94.6 t -152.47 140.32 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.031 -2.211 . . . . 73.24 105.031 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.19 160.05 32.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.256 1.023 . . . . 71.45 108.79 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -63.67 -24.3 67.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.859 1.663 . . . . 63.42 112.958 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.3 137.66 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.04 -1.467 . . . . 75.53 107.04 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 69.2 mt -127.79 157.23 40.97 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.838 2.055 . . . . 64.41 109.593 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -126.02 149.29 48.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.465 1.506 . . . . 65.2 107.12 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mm -136.68 154.72 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.825 -1.546 . . . . 73.51 106.825 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -135.13 163.77 29.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.479 1.512 . . . . 74.45 108.465 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 70.81 15.19 6.92 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.13 1.772 . . . . 73.21 111.068 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' B' ' 60' ' ' ALA . 45.0 mt -69.14 151.2 97.2 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 121.058 -1.026 . . . . 70.4 110.938 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.69 140.68 92.18 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.546 2.83 . . . . 72.21 112.412 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -75.63 -27.01 58.25 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.619 -0.675 . . . . 73.35 111.232 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.03 88.72 2.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.203 1.401 . . . . 72.12 107.877 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -134.7 154.58 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.773 -0.825 . . . . 54.24 108.773 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 43.6 p -114.88 176.17 5.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.833 2.053 . . . . 71.03 108.314 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.81 -38.36 90.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.706 -0.621 . . . . 73.41 111.315 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -49.38 -58.07 5.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.886 1.274 . . . . 73.01 113.582 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.95 -35.2 79.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.595 0.634 . . . . 64.23 111.511 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.9 mmm -68.17 -52.91 29.23 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.369 -0.832 . . . . 55.04 110.132 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -66.8 -25.92 66.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.953 -1.022 . . . . 72.32 111.824 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.63 -59.62 2.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.235 1.379 . . . . 73.14 109.938 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.67 -62.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.407 1.883 . . . . 72.2 111.486 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -63.36 -35.52 80.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.237 -0.585 . . . . 55.14 110.428 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.6 -29.7 67.37 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 123.726 0.679 . . . . 60.23 112.212 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -17.46 56.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.187 0.995 . . . . 73.34 111.566 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.66 -36.93 8.97 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.503 1.121 . . . . 44.02 111.768 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.54 -174.01 45.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 65.42 110.68 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.56 171.41 13.15 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.718 2.278 . . . . 71.32 112.052 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.0 mt -127.81 131.49 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.781 1.232 . . . . 75.12 108.288 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.38 -57.51 3.22 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.154 -1.054 . . . . 63.34 108.154 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -157.12 153.29 27.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.646 0.778 . . . . 71.43 109.944 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 42.1 mt -134.64 137.81 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.874 1.67 . . . . 74.42 107.185 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -137.8 129.19 27.91 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.951 -2.24 . . . . 75.15 104.951 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 18.7 m -110.9 154.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.217 1.407 . . . . 72.32 110.952 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.35 117.85 8.76 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.334 -1.506 . . . . 65.03 109.334 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -100.79 -38.14 8.4 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.135 0.974 . . . . 75.01 112.086 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -64.22 157.67 69.14 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.51 -0.922 . . . . 52.31 108.51 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.02 -14.67 46.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.486 1.457 . . . . 74.23 112.783 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -98.66 -11.09 22.38 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.389 -0.815 . . . . 63.34 112.355 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.1 p -103.02 -23.65 13.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.891 1.223 . . . . 72.12 112.187 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -51.11 131.07 27.23 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.051 -1.463 . . . . 75.04 107.051 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.45 -13.04 15.87 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.381 1.467 . . . . 70.14 110.902 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.1 p -134.01 166.68 22.17 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 118.595 1.197 . . . . 75.5 110.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -164.25 169.29 17.78 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.306 1.443 . . . . 65.41 107.807 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -119.84 147.72 44.34 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 74.34 108.489 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.55 140.35 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.515 -2.032 . . . . 70.33 105.515 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.1 130.79 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 102.481 -3.155 . . . . 63.04 102.481 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -99.49 161.28 13.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.051 -0.722 . . . . 74.11 109.051 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -76.37 -31.85 58.26 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.052 -0.659 . . . . 74.23 110.472 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -123.55 165.92 16.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.204 1.402 . . . . 63.0 110.682 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -76.37 -46.81 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 121.435 -0.79 . . . . 73.21 110.806 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -59.64 -38.31 81.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.986 0.914 . . . . 75.5 110.84 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -62.06 -42.13 98.87 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.946 -0.761 . . . . 74.01 108.946 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.33 -51.43 68.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.576 0.751 . . . . 75.41 109.753 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -55.82 -52.33 64.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.932 0.893 . . . . 75.24 110.825 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.84 -49.45 76.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.129 -0.693 . . . . 62.34 109.129 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.05 89.14 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 118.104 -0.95 . . . . 74.13 111.906 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 67.7 m -60.51 -53.82 52.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.575 1.08 . . . . 45.25 109.588 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.21 -42.99 99.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.167 -0.444 . . . . 70.5 112.026 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -69.26 -24.22 63.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.417 -0.802 . . . . 72.53 111.231 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.1 tp -98.27 -13.11 20.95 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.406 1.457 . . . . 65.41 113.262 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 127.2 31.87 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.718 -1.216 . . . . 51.52 107.718 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.49 75.74 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.274 -1.292 . . . . 54.42 113.031 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -68.54 111.99 5.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.382 1.591 . . . . 74.21 108.187 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -85.33 115.14 22.91 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.376 2.27 . . . . 75.2 110.445 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.9 144.55 20.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.074 -1.084 . . . . 53.23 108.074 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.7 m 40.48 49.81 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.026 1.73 . . . . 72.45 112.745 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 m120 63.0 18.54 10.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.48 2.312 . . . . 75.05 115.626 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -137.75 167.24 22.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 120.028 1.285 . . . . 72.21 109.988 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -112.28 127.15 55.9 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.288 1.035 . . . . 75.4 109.925 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.82 106.18 6.23 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.039 -1.097 . . . . 65.03 108.039 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.72 136.69 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.552 -0.907 . . . . 74.51 108.552 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.63 132.63 56.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.746 2.018 . . . . 72.5 108.866 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -154.65 130.25 9.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.494 1.043 . . . . 71.41 110.034 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' TYR . . . . . 0.429 ' CE1' HG13 ' B' ' 17' ' ' VAL . 70.0 m-85 -69.34 158.74 34.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.759 -0.588 . . . . 75.41 110.224 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -79.08 160.95 26.86 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 107.661 -1.237 . . . . 73.32 107.661 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 116.823 -1.561 . . . . 74.31 107.265 179.069 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.22 0 N-CA-C 108.358 -1.897 . . . . 73.22 108.358 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.5 t -128.5 128.19 23.59 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 105.684 -1.969 . . . . 70.55 105.684 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -83.32 -170.25 0.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.863 2.375 . . . . 55.21 108.492 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -125.12 174.69 7.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.512 1.925 . . . . 74.21 106.504 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -156.69 54.36 0.53 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.592 -0.521 . . . . 75.35 109.592 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.42 165.6 20.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.478 0.656 . . . . 75.31 109.354 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -152.93 169.08 23.73 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.162 0.985 . . . . 74.51 109.014 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -152.18 161.38 42.71 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.093 1.357 . . . . 53.33 107.695 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -125.44 172.88 9.29 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.845 0.858 . . . . 73.32 109.887 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -122.52 179.96 4.41 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.074 1.749 . . . . 74.21 108.728 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 60.4 t90 -147.84 160.49 42.7 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.927 1.691 . . . . 74.32 107.305 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.89 169.59 21.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.091 2.156 . . . . 71.14 107.167 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -143.18 158.14 43.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.968 0.907 . . . . 65.51 108.747 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -75.46 148.35 39.14 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 123.368 0.418 . . . . 75.23 111.559 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.76 123.44 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.553 -1.647 . . . . 72.11 106.553 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -77.16 175.99 9.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.493 1.117 . . . . 74.22 109.411 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.21 165.98 15.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.384 1.088 . . . . 72.23 112.746 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -156.12 165.07 37.49 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 128.844 2.857 . . . . 65.31 106.896 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -71.44 138.28 48.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.027 -1.101 . . . . 64.31 108.027 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -151.42 158.6 34.31 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 127.405 2.282 . . . . 63.33 107.657 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.91 167.0 28.47 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.897 1.732 . . . . 73.2 109.758 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.78 134.64 43.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.005 -1.109 . . . . 75.31 108.005 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.8 m -133.2 -174.24 3.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 129.3 3.04 . . . . 73.31 107.509 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.25 -15.93 63.48 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.289 -0.882 . . . . 74.14 109.69 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.86 -44.07 74.1 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 126.716 2.006 . . . . 73.42 110.071 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -71.6 -41.4 69.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.118 -1.068 . . . . 73.43 108.118 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 15.5 tp -61.1 -24.59 66.35 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.204 0.94 . . . . 74.43 110.415 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.23 -62.52 1.44 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.355 -1.35 . . . . 72.42 107.355 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -64.21 -1.68 1.73 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.083 2.153 . . . . 61.44 115.722 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 70.4 mtp -95.51 -10.08 30.69 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.849 -1.157 . . . . 75.35 111.501 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -106.01 148.3 36.31 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 118.808 0.731 . . . . 73.53 111.251 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.67 158.98 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.149 1.899 . . . . 61.53 107.719 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -73.86 165.45 25.1 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.708 0.766 . . . . 74.22 111.609 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.83 17.92 36.52 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.653 1.597 . . . . 54.12 111.228 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.58 139.52 53.52 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.758 1.223 . . . . 75.34 109.72 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.202 1.401 . . . . 74.21 109.424 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.62 151.09 9.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.518 1.151 . . . . 72.43 109.095 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 33.5 tp -116.51 76.02 7.03 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.358 1.463 . . . . 71.42 111.44 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.66 163.92 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.011 1.807 . . . . 71.22 108.773 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.8 166.37 30.16 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.226 1.95 . . . . 55.41 110.988 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.59 144.59 24.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.617 2.211 . . . . 54.14 111.116 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -52.2 -33.07 39.34 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.052 0.76 . . . . 75.01 113.052 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -116.76 35.94 3.97 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.343 -1.254 . . . . 41.43 112.269 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -63.98 154.33 34.44 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.087 1.943 . . . . 72.44 110.836 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 11.2 t -138.63 93.7 10.82 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.386 1.074 . . . . 64.43 110.245 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.01 -166.66 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.284 2.656 . . . . 73.21 110.129 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 C--O 1.245 0.822 0 N-CA-C 106.096 -1.816 . . . . 74.31 106.096 177.93 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.7 0 N-CA-C 108.198 -1.961 . . . . 33.41 108.198 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.52 84.05 2.08 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.281 -1.377 . . . . 70.22 107.281 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.22 58.9 3.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.01 0.924 . . . . 73.23 108.794 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -67.07 169.07 9.0 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.651 -0.655 . . . . 73.04 109.698 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 13.5 pt -123.12 32.76 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.187 0.995 . . . . 71.12 113.542 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -77.97 68.9 4.11 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.238 -1.539 . . . . 61.13 109.925 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 56.8 83.66 0.22 Allowed Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 127.596 2.358 . . . . 75.21 110.198 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.38 170.33 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.043 2.495 . . . . 61.33 112.88 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.8 -33.59 52.94 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.0 1.8 . . . . 44.52 111.127 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -67.8 8.92 0.32 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.98 2.512 . . . . 55.22 115.85 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.542 HG11 ' HD3' ' B' ' 71' ' ' LYS . 75.1 t -72.21 83.74 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 105.889 -1.893 . . . . 72.42 105.889 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -67.18 141.93 57.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.971 -1.122 . . . . 75.11 107.971 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ARG . . . . . 0.46 ' H ' ' HD3' ' B' ' 19' ' ' ARG 0.283 0.0 OUTLIER -57.8 -7.33 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 118.151 2.648 . . . . 52.32 118.151 -178.714 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.453 HG13 ' HE ' ' B' ' 19' ' ' ARG . 65.5 mt -101.87 128.11 54.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 105.602 -1.999 . . . . 61.25 105.602 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 mt -100.76 142.19 32.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.466 -1.309 . . . . 72.14 107.466 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.44 128.56 55.24 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.605 -2.368 . . . . 54.41 104.605 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 mm -118.74 136.53 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.968 -1.494 . . . . 75.44 106.968 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -125.93 163.68 22.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.597 1.559 . . . . 74.34 107.735 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 71.24 20.18 5.15 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.634 1.574 . . . . 54.24 112.078 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.13 153.82 93.85 Favored Pre-proline 0 C--O 1.237 0.445 0 O-C-N 121.4 -0.813 . . . . 62.41 110.593 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.89 159.23 52.64 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.74 2.96 . . . . 74.33 110.077 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -89.74 -19.11 25.16 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.112 0.565 . . . . 73.23 111.351 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' B' ' 29' ' ' LYS . 7.8 mmpt? -130.08 101.04 5.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.9 1.68 . . . . 62.32 108.348 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.51 155.67 6.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 127.431 2.293 . . . . 63.44 105.472 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -105.1 174.17 5.99 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.273 -0.892 . . . . 72.21 109.671 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.28 72.78 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.352 -0.981 . . . . 64.32 108.352 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -54.67 -35.46 63.57 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.404 1.482 . . . . 54.24 112.474 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -70.34 -42.75 71.45 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.911 1.232 . . . . 63.45 108.229 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.6 mmm -64.75 -45.07 87.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.605 -0.887 . . . . 72.13 108.605 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.83 -27.48 69.2 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 117.98 -1.01 . . . . 72.43 111.644 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.18 -65.26 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.233 0.924 . . . . 71.45 110.148 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mt -57.55 -53.37 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.673 1.189 . . . . 74.21 111.818 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -74.72 -17.01 60.72 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.697 -0.627 . . . . 64.22 111.647 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.4 -12.91 66.53 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 124.0 0.81 . . . . 44.32 113.096 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -58.09 -29.91 65.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.16 1.48 . . . . 65.52 110.495 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.63 -5.42 59.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.034 2.134 . . . . 50.12 114.525 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.65 -171.87 23.58 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 119.808 1.186 . . . . 22.12 111.702 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.29 163.77 28.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.38 2.054 . . . . 60.1 109.247 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mt -129.43 123.22 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.981 -1.075 . . . . 70.52 108.532 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -65.11 -67.07 0.47 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.454 -0.943 . . . . 64.41 108.454 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -156.89 160.64 39.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.932 0.787 . . . . 71.32 112.062 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -140.11 140.95 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.062 2.145 . . . . 73.31 106.258 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -132.59 120.06 21.31 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 103.272 -2.862 . . . . 63.01 103.272 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.98 146.12 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 119.26 0.936 . . . . 75.22 111.435 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.09 141.31 41.22 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.768 -2.133 . . . . 63.05 107.768 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 -9.94 4.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.195 0.998 . . . . 72.33 113.017 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 44.9 p -97.51 161.57 25.46 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.762 1.225 . . . . 75.22 108.478 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.33 5.76 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.85 3.033 . . . . 74.3 113.635 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -120.58 -9.74 9.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.148 1.379 . . . . 74.15 111.408 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -117.36 -25.58 6.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.569 1.148 . . . . 74.31 113.147 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -50.6 143.47 9.34 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.917 0.887 . . . . 73.44 112.134 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.0 85.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.096 -0.836 . . . . 61.24 111.273 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -138.05 150.27 46.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.941 1.37 . . . . 70.13 108.71 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.12 168.35 19.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.177 1.391 . . . . 75.24 107.82 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -120.85 155.53 33.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.367 -1.716 . . . . 63.43 106.367 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 t -125.52 124.47 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.31 -2.107 . . . . 61.43 105.31 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -110.55 123.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.026 -2.212 . . . . 64.51 105.026 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -98.09 166.46 11.41 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.377 -1.712 . . . . 72.13 106.377 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.78 -42.59 94.95 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.491 -1.381 . . . . 74.41 110.366 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.78 175.32 5.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.605 1.562 . . . . 74.44 111.146 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.2 tt -81.69 -38.19 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.333 1.453 . . . . 60.31 108.621 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -60.44 -37.16 80.07 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.197 0.453 . . . . 72.41 111.661 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.14 -42.79 96.64 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 119.377 -0.344 . . . . 75.43 111.003 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.79 -50.19 63.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.445 -0.946 . . . . 63.45 108.445 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.542 ' HD3' HG11 ' B' ' 17' ' ' VAL . 7.2 mmtp -48.87 -54.88 13.48 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.614 1.566 . . . . 73.24 110.23 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -59.63 -60.18 4.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.043 0.937 . . . . 71.32 110.273 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.65 -29.1 51.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.052 1.131 . . . . 73.41 114.052 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.6 t -60.46 -38.25 83.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.447 0.699 . . . . 55.41 111.917 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -88.51 -28.6 20.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.596 0.635 . . . . 72.21 110.954 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -67.58 -31.13 70.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.226 0.466 . . . . 75.11 111.449 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.67 -3.43 20.61 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.256 1.576 . . . . 64.34 115.256 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 25.7 p -60.08 124.56 20.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.343 1.429 . . . . 75.53 109.677 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.05 13.99 73.22 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.231 -1.316 . . . . 75.31 114.334 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.48 119.53 5.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.884 1.842 . . . . 73.02 110.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -78.08 129.76 35.6 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.911 -1.144 . . . . 73.44 107.911 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -144.08 140.18 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 125.835 1.654 . . . . 75.13 106.789 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m 37.43 49.28 0.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 73.43 112.749 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 35.57 15.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.242 1.417 . . . . 41.22 113.947 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.61 -177.22 4.63 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.847 3.259 . . . . 72.35 104.657 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -139.23 137.14 35.7 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.865 -1.147 . . . . 61.32 109.456 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.75 158.22 21.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.414 -1.328 . . . . 73.02 107.414 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.79 131.77 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.683 -2.71 . . . . 75.13 103.683 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 t -115.33 135.35 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.035 1.334 . . . . 61.13 107.859 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.46 150.67 36.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.745 0.818 . . . . 51.32 110.608 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' TYR . . . . . 0.482 ' CD1' HG13 ' B' ' 17' ' ' VAL . 6.7 m-85 -78.52 160.97 27.38 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.392 -0.818 . . . . 75.31 111.546 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.28 176.58 6.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.152 0.981 . . . . 75.11 110.156 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 112.624 0.601 . . . . 52.4 112.624 -179.772 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.252 0 CA-C-O 116.585 -2.231 . . . . 51.21 107.845 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 21.9 p 32.95 69.95 0.82 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.784 1.634 . . . . 73.4 113.84 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.97 160.85 42.32 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.92 1.747 . . . . 72.22 111.143 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.27 62.83 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.563 1.945 . . . . 53.1 112.462 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -80.66 64.88 5.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.682 -1.229 . . . . 73.43 107.682 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.8 pp -132.16 -177.74 4.59 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.386 2.274 . . . . 62.53 108.563 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -153.38 178.53 9.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.299 1.039 . . . . 44.34 109.161 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -147.56 167.13 25.31 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.309 0.644 . . . . 55.35 111.657 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -135.52 163.59 29.74 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 127.813 2.445 . . . . 74.33 109.115 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -78.61 170.61 16.37 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.202 -1.407 . . . . 75.11 107.202 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -128.0 153.18 47.04 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.295 -0.878 . . . . 73.41 108.78 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -137.84 101.14 4.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.023 -1.473 . . . . 73.11 107.023 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -105.41 122.65 46.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.803 1.641 . . . . 73.12 106.863 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -73.22 126.82 30.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.593 -2.002 . . . . 55.22 105.593 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 48.6 mm -108.21 104.65 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 123.048 1.404 . . . . 63.42 108.67 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -82.7 -7.88 59.63 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.506 1.922 . . . . 61.23 110.369 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.18 167.17 21.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.737 1.215 . . . . 73.44 113.946 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -123.06 93.59 4.0 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 126.279 1.832 . . . . 64.04 108.131 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -108.11 13.95 25.53 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.075 0.95 . . . . 60.32 112.894 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -142.77 158.87 58.76 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 125.743 1.617 . . . . 72.2 109.39 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.62 9.9 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.657 2.904 . . . . 72.3 114.993 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 36.7 mt -141.67 146.37 36.04 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.756 1.222 . . . . 62.32 108.115 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.5 m -129.21 173.62 10.32 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.804 2.442 . . . . 75.42 109.651 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -61.56 -26.65 68.09 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.762 1.625 . . . . 52.01 115.121 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.04 -45.15 59.17 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.595 -1.316 . . . . 53.42 110.029 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.58 -21.35 66.68 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.527 -0.733 . . . . 73.14 109.821 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.8 tp -60.34 -40.05 89.31 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 108.533 -0.914 . . . . 74.31 108.533 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.93 -10.46 57.34 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.295 1.038 . . . . 70.02 112.289 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -97.55 -36.15 10.4 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.028 1.331 . . . . 55.54 109.481 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.28 -13.58 61.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 73.42 112.608 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.67 157.78 42.04 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.911 1.232 . . . . 73.52 112.003 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.09 166.29 28.14 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.803 2.336 . . . . 74.12 111.241 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -84.69 174.99 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.557 1.143 . . . . 72.43 108.889 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 82.32 19.02 65.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.762 -1.021 . . . . 51.12 112.826 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -125.49 155.71 40.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.382 1.591 . . . . 74.32 106.908 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -130.35 133.69 46.61 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.117 -0.99 . . . . 74.32 108.656 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' B' ' 49' ' ' ARG . 48.3 t -69.08 151.31 10.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.617 -1.253 . . . . 71.04 107.617 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.6 tp -125.73 85.72 58.61 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 125.637 1.575 . . . . 71.23 108.662 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -66.21 178.78 2.28 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.913 2.409 . . . . 72.43 109.566 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.44 170.99 1.04 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.704 2.936 . . . . 71.33 113.386 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.17 163.21 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 125.06 3.84 . . . . 73.42 114.899 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -73.95 -0.17 15.36 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 115.258 1.577 . . . . 52.2 115.258 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 162.9 60.12 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.441 -1.864 . . . . 64.44 108.441 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.64 159.21 2.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.752 0.821 . . . . 70.02 111.923 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.87 78.02 57.66 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.054 -1.462 . . . . 63.3 107.054 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -70.57 162.22 43.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.097 1.865 . . . . 73.4 109.357 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.2 tt . . . . . 0 C--O 1.251 1.144 0 N-CA-C 103.645 -2.724 . . . . 75.3 103.645 178.291 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 110.481 -1.048 . . . . 64.44 110.481 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -74.73 66.79 1.51 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.701 1.201 . . . . 71.13 109.255 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.52 98.88 4.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.082 0.953 . . . . 71.14 109.236 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -67.42 157.07 35.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.188 -1.042 . . . . 60.3 108.188 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -126.88 174.55 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.49 0.716 . . . . 60.44 110.921 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.15 17.77 2.61 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.4 1.88 . . . . 73.32 109.936 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 38.0 mt -128.53 62.44 59.91 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 124.613 1.165 . . . . 63.23 108.418 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.15 168.93 17.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.774 2.316 . . . . 61.45 108.478 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.48 -43.51 17.37 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.298 1.332 . . . . 54.05 111.508 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.13 163.46 40.07 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.26 1.424 . . . . 74.01 109.28 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.601 HG13 ' CE1' ' B' ' 91' ' ' TYR . 88.1 t -146.1 157.63 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.8 1.24 . . . . 52.41 108.763 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -138.48 159.85 41.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.993 1.717 . . . . 65.21 108.73 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -72.63 -24.42 61.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.057 1.343 . . . . 72.41 109.505 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -89.54 129.65 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.296 1.438 . . . . 53.04 107.475 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.54 153.53 36.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.876 1.27 . . . . 75.01 107.882 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -119.31 111.6 18.39 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.963 -2.606 . . . . 72.44 103.963 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -96.59 145.67 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.661 -1.977 . . . . 65.42 105.661 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -136.88 163.2 31.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.038 1.335 . . . . 75.12 109.19 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.8 t30 63.12 33.68 14.3 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.062 2.145 . . . . 64.21 111.066 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 55.0 mt -73.79 158.72 85.71 Favored Pre-proline 0 C--O 1.237 0.417 0 O-C-N 121.497 -0.752 . . . . 74.14 109.013 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.16 156.38 65.99 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.886 1.724 . . . . 72.15 109.498 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.23 -25.69 58.33 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.536 -0.727 . . . . 70.44 112.002 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -129.75 128.09 41.73 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.261 -1.385 . . . . 74.43 107.261 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tt -157.51 169.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.553 -1.277 . . . . 63.32 107.553 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 16.9 p -126.49 169.1 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.532 1.933 . . . . 62.14 108.982 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.82 90.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.393 -0.966 . . . . 72.42 108.393 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.45 -55.31 30.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.018 1.327 . . . . 45.21 111.852 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.24 -40.41 85.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.069 0.395 . . . . 73.32 111.438 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.35 -44.01 72.48 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 73.53 111.587 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.14 -23.18 60.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.972 0.909 . . . . 73.33 111.026 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.63 -59.32 2.77 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.273 1.029 . . . . 73.55 108.51 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.17 -67.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.811 1.645 . . . . 74.25 111.027 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -66.99 -32.41 73.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.643 0.608 . . . . 73.35 112.643 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.84 -32.34 81.48 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 120.468 1.485 . . . . 64.41 112.567 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -75.58 -21.34 57.92 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.335 -1.097 . . . . 70.41 110.236 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.36 -30.97 30.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.347 1.059 . . . . 74.21 110.734 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.97 -175.29 44.71 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.116 0.871 . . . . 75.2 111.668 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.06 165.72 25.42 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.911 2.407 . . . . 73.44 110.673 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -132.52 113.68 21.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 123.662 0.785 . . . . 74.25 109.637 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -81.52 -49.09 11.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.526 -1.287 . . . . 74.32 107.526 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -168.9 162.24 11.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.442 1.497 . . . . 74.54 108.496 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.2 mt -144.78 140.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.43 2.292 . . . . 64.43 106.016 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 414' ' ' VAL . 0.1 OUTLIER -148.53 121.88 9.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.055 -1.831 . . . . 75.12 106.055 176.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.12 167.07 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.63 0.772 . . . . 60.25 109.629 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.38 137.14 42.6 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.669 -0.973 . . . . 54.41 110.669 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -107.34 -49.66 3.22 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.606 1.962 . . . . 62.3 110.661 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -70.57 158.21 88.35 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.109 -0.7 . . . . 61.24 109.109 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.51 14.83 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.549 3.499 . . . . 70.55 115.36 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.01 -47.13 2.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.817 2.047 . . . . 73.14 109.419 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 51.2 p -72.84 -29.45 63.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.972 0.909 . . . . 43.25 109.856 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -50.37 124.77 11.17 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.162 0.985 . . . . 74.42 110.249 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.81 -13.07 17.59 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.746 1.165 . . . . 72.35 110.56 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -128.02 166.07 19.09 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.897 1.348 . . . . 64.25 108.761 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.26 168.14 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.154 -0.966 . . . . 74.25 111.066 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -120.54 124.04 44.37 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.977 -1.12 . . . . 75.44 107.977 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.78 142.25 24.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.507 -2.405 . . . . 64.04 104.507 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.74 122.9 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.718 -1.586 . . . . 73.11 106.718 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.56 165.97 11.73 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.47 1.108 . . . . 74.34 108.467 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.14 -59.36 2.12 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.347 0.659 . . . . 75.23 109.744 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.06 117.6 29.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 126.087 1.755 . . . . 73.44 107.303 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.54 -35.62 60.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 119.39 -0.338 . . . . 70.11 110.815 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -60.37 -50.4 73.76 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.916 0.886 . . . . 73.43 110.073 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.33 -32.17 73.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.551 -0.537 . . . . 74.5 109.551 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.23 92.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.835 -0.802 . . . . 72.22 108.835 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.49 ' HG2' HG11 ' B' ' 17' ' ' VAL . 13.7 mtmt -60.1 -46.56 89.2 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.17 -1.048 . . . . 55.13 108.17 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.99 -52.85 63.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.831 0.707 . . . . 74.04 110.031 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.02 79.74 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.655 -0.688 . . . . 63.01 111.705 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.13 -51.32 68.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.989 0.813 . . . . 75.05 108.995 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -65.71 -37.91 87.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.439 0.563 . . . . 74.41 111.814 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.18 -31.53 72.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.251 0.221 . . . . 75.32 110.424 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.6 tp -91.1 -24.23 20.07 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.844 0.683 . . . . 74.3 112.844 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 3.0 m -68.25 106.4 2.44 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.955 0.902 . . . . 72.25 109.931 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.51 9.45 56.6 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.751 1.643 . . . . 71.14 113.042 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -72.18 141.36 49.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.171 -1.418 . . . . 72.45 107.171 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -110.9 135.02 52.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.758 1.623 . . . . 60.25 110.848 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -157.16 150.16 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 127.499 2.32 . . . . 75.32 107.351 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 53.0 m 44.61 50.25 8.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.614 1.166 . . . . 75.54 113.7 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 44.5 t30 55.5 18.83 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.759 1.624 . . . . 74.34 113.235 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 61.2 mtt85 -134.97 173.82 11.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.739 2.016 . . . . 73.34 110.585 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -130.57 133.34 46.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 105.751 -1.944 . . . . 74.35 105.751 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.21 172.09 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.07 -1.085 . . . . 44.31 108.07 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 5.2 t -134.11 126.7 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 103.757 -2.683 . . . . 72.03 103.757 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.3 t -114.55 137.81 46.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.488 -1.671 . . . . 73.3 106.488 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 46.4 tp -146.81 155.94 42.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.619 1.567 . . . . 74.41 107.159 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' TYR . . . . . 0.601 ' CE1' HG13 ' B' ' 17' ' ' VAL . 52.8 m-85 -87.74 163.22 16.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.246 -0.65 . . . . 61.25 109.246 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.86 170.01 15.45 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.577 -0.897 . . . . 62.44 108.577 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 . . . . . 0 C--O 1.246 0.909 0 O-C-N 120.909 -1.119 . . . . 75.4 109.342 179.817 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.282 0 N-CA-C 111.368 -0.693 . . . . 70.11 111.368 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . 0.272 3.5 t -148.64 -161.27 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.27 1 C-N-CA 132.564 4.346 . . . . 73.14 102.458 179.14 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.92 86.86 0.88 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 CA-C-N 124.963 2.808 . . . . 74.14 108.057 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.89 -5.88 3.28 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.426 1.89 . . . . 64.35 112.179 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -150.08 158.21 43.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.151 2.58 . . . . 73.32 106.412 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 97.4 mt -123.13 128.42 50.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.528 -0.916 . . . . 74.23 108.528 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -109.21 41.54 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.175 1.39 . . . . 72.11 109.125 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.3 161.82 29.51 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.353 -0.842 . . . . 63.52 109.571 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -124.8 169.85 11.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.927 0.891 . . . . 72.24 110.443 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -142.71 157.92 44.17 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.017 1.727 . . . . 72.4 107.739 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -148.29 60.91 1.1 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.534 0.734 . . . . 74.33 112.006 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -69.61 170.95 9.75 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.154 -0.966 . . . . 72.23 108.959 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -154.22 123.0 6.27 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.119 1.368 . . . . 74.3 107.515 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.74 126.09 2.12 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.267 1.427 . . . . 71.34 107.255 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 8.2 tp -156.69 141.59 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.345 -1.724 . . . . 73.13 106.345 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -155.96 141.39 17.67 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.985 -1.117 . . . . 64.2 107.985 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.92 167.3 23.63 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.991 0.916 . . . . 54.41 109.89 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -105.89 166.9 10.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.399 0.68 . . . . 71.5 109.634 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -67.23 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.956 2.502 . . . . 73.55 114.103 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -64.46 154.07 85.0 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 125.251 1.42 . . . . 73.23 109.374 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -67.96 162.53 39.43 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 107.052 -1.941 . . . . 61.04 107.052 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 53.1 mt -61.06 108.71 0.92 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.438 0.695 . . . . 65.25 111.081 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 1.2 m -63.81 160.93 16.3 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.453 1.101 . . . . 73.31 108.646 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -73.28 -12.01 60.7 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.755 -1.215 . . . . 75.24 110.993 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -79.97 -46.47 16.62 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.527 1.531 . . . . 73.34 107.07 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -62.83 -19.22 63.86 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.498 1.519 . . . . 74.01 111.028 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.3 tp -72.95 -35.46 66.98 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.057 0.943 . . . . 63.12 109.896 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.02 -37.76 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.3 0.64 . . . . 75.52 109.393 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.68 -29.22 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.177 0.991 . . . . 54.13 110.924 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 35.0 mtm -88.95 -1.63 58.2 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.198 0.999 . . . . 73.51 111.672 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -108.47 148.48 37.75 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 119.151 0.887 . . . . 73.31 112.978 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.95 149.74 59.83 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.634 2.223 . . . . 74.13 109.931 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.65 166.22 23.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.158 0.983 . . . . 75.32 111.661 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.48 17.61 56.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.753 1.168 . . . . 72.23 113.024 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -124.42 158.11 33.56 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.254 1.822 . . . . 72.44 108.462 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -127.88 151.65 48.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.553 -0.906 . . . . 73.31 108.553 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 13.9 t -69.98 150.96 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.212 -1.403 . . . . 62.4 107.212 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.0 tp -128.95 75.73 79.95 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.579 -0.897 . . . . 73.34 108.579 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.08 161.32 44.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.942 2.428 . . . . 73.44 110.736 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.69 159.13 54.96 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.974 2.449 . . . . 51.43 112.563 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.31 125.6 17.31 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.661 2.908 . . . . 72.31 111.312 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -65.97 147.87 52.68 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.779 -0.823 . . . . 75.32 108.779 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 67.36 1.02 12.67 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.569 1.081 . . . . 61.34 114.051 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -63.19 142.02 58.54 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.45 2.125 . . . . 65.44 109.25 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 89.7 t -135.3 89.29 23.48 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 124.019 0.928 . . . . 54.12 109.56 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -72.1 147.23 48.16 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 N-CA-C 107.844 -1.637 . . . . 72.35 107.844 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--O 1.251 1.17 0 C-N-CA 127.745 2.418 . . . . 74.23 104.509 179.528 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.546 -0.622 . . . . 74.0 111.546 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.71 36.79 1.63 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.811 2.045 . . . . 74.24 111.126 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.68 158.39 43.37 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.613 -1.304 . . . . 73.31 109.702 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -138.86 168.32 20.09 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.291 1.836 . . . . 71.42 108.527 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 5.7 tp -145.71 153.74 13.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.241 -2.133 . . . . 72.34 105.241 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -143.4 162.66 35.17 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.55 1.14 . . . . 74.52 108.363 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 39.93 71.2 1.25 Allowed Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 126.623 1.969 . . . . 73.31 110.125 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.05 161.26 40.65 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 N-CA-C 108.299 -1.462 . . . . 62.44 108.299 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.47 -22.22 65.64 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.945 1.763 . . . . 61.43 112.205 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -163.74 164.87 23.63 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.123 1.369 . . . . 71.1 109.702 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.412 HG11 ' HG2' ' B' ' 71' ' ' LYS . 3.9 t -151.6 158.5 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 105.346 -2.094 . . . . 75.42 105.346 177.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -144.06 -179.02 6.23 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.11 -0.994 . . . . 72.13 110.005 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -88.24 -30.91 19.33 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.282 -0.886 . . . . 74.31 109.568 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 mt -82.45 132.93 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.389 -1.338 . . . . 74.33 107.389 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.33 151.84 42.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.121 2.168 . . . . 64.54 107.376 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -110.65 131.82 54.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.221 -1.77 . . . . 74.55 106.221 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.59 138.34 48.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.289 -1.375 . . . . 74.23 107.289 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -138.35 163.59 31.46 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.277 1.431 . . . . 73.11 109.572 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 67.31 31.21 6.65 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.329 1.852 . . . . 43.34 109.991 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 49.4 mt -70.34 156.41 91.92 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 124.468 1.107 . . . . 63.12 111.715 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.96 152.62 51.94 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.814 3.009 . . . . 70.2 109.961 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -80.28 -25.11 39.61 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.539 -0.726 . . . . 74.54 112.431 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -129.01 114.78 16.84 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.45 1.5 . . . . 62.03 106.956 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.28 168.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 127.068 2.147 . . . . 61.44 106.409 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -136.89 169.54 17.59 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.465 1.106 . . . . 52.13 108.605 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.78 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.041 0.536 . . . . 72.23 111.139 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.29 -25.41 64.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.62 1.568 . . . . 62.12 113.043 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -94.46 -35.88 12.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.213 1.005 . . . . 63.13 109.426 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.5 mmm -64.92 -53.2 50.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.501 1.12 . . . . 54.12 109.82 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -67.52 -16.89 64.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.606 -0.712 . . . . 65.41 111.938 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.26 -67.03 0.54 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.859 -1.163 . . . . 64.04 107.859 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.99 -62.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 C-N-CA 126.484 1.914 . . . . 72.32 111.353 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -62.34 -21.5 65.35 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.467 0.914 . . . . 73.12 113.467 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.46 66.24 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.122 0.868 . . . . 51.41 112.386 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.56 -31.46 72.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.218 -1.401 . . . . 64.45 107.218 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.95 -61.76 1.89 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.32 1.048 . . . . 75.15 109.708 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.84 178.11 45.86 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.719 1.145 . . . . 63.42 115.085 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 121.86 9.15 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.367 3.378 . . . . 75.34 109.927 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 mt -86.38 151.07 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.483 -0.932 . . . . 74.12 108.483 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -87.5 -62.86 1.4 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 107.168 -1.419 . . . . 72.03 107.168 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.53 161.27 41.73 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.122 0.969 . . . . 73.21 109.849 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -140.02 142.37 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.741 1.616 . . . . 74.43 107.482 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 -141.67 131.39 24.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.197 -2.89 . . . . 60.31 103.197 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.94 157.4 30.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.478 0.711 . . . . 62.43 111.3 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.05 146.99 44.88 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.821 1.201 . . . . 65.24 111.048 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.09 -49.53 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.46 1.104 . . . . 70.52 108.886 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -66.4 159.76 70.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.691 -0.855 . . . . 72.52 108.691 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.13 -12.21 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.719 1.612 . . . . 62.42 110.594 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.73 -9.88 45.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.015 2.526 . . . . 65.14 111.865 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 33.4 p -116.75 -33.42 4.82 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.039 0.936 . . . . 62.15 109.153 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -54.33 117.2 3.09 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.936 1.694 . . . . 74.01 108.049 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.31 -8.38 9.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.592 2.044 . . . . 73.41 109.75 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 71.8 p -139.77 158.89 43.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.567 1.147 . . . . 61.1 109.953 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.27 172.45 13.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 75.23 107.939 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -128.36 144.55 51.15 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.007 -1.849 . . . . 75.02 106.007 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.41 141.17 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.399 -2.075 . . . . 44.01 105.399 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -123.62 130.46 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.891 -1.892 . . . . 54.22 105.891 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -96.86 160.8 14.16 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 105.48 -2.044 . . . . 63.42 105.48 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.81 -46.27 89.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.1 0.407 . . . . 72.15 112.1 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -120.88 176.16 5.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.566 1.947 . . . . 75.43 110.526 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -90.59 -11.58 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.776 1.23 . . . . 72.23 113.653 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -83.24 -52.82 6.24 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.6 -1.313 . . . . 72.22 110.1 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -30.75 68.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.114 0.966 . . . . 73.4 110.846 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.68 88.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.014 0.526 . . . . 71.44 110.842 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.412 ' HG2' HG11 ' B' ' 17' ' ' VAL . 22.7 mttp -71.86 -39.12 69.9 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.535 -0.728 . . . . 70.05 109.809 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -54.77 -53.45 54.95 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 107.703 -1.221 . . . . 71.05 107.703 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.52 96.51 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.883 0.873 . . . . 71.13 111.937 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 50.9 t -50.91 -58.6 5.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.852 0.861 . . . . 74.54 111.395 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.95 -37.16 83.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 119.3 -0.381 . . . . 71.31 111.528 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.47 -26.82 68.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.021 0.528 . . . . 71.24 112.114 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 30.3 tp -103.78 -14.38 16.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.693 1.197 . . . . 73.43 113.987 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 9.4 t -59.06 116.29 3.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.112 -0.992 . . . . 55.13 110.031 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.45 20.22 69.49 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.96 -1.467 . . . . 62.0 114.262 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -52.13 133.03 33.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.052 1.426 . . . . 75.51 109.988 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -84.98 97.14 9.63 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.643 1.577 . . . . 73.2 111.149 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.86 146.71 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.09 1.756 . . . . 62.53 107.369 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 32.6 m 46.36 31.68 1.34 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 54.14 113.297 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.07 23.71 11.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.52 1.528 . . . . 55.12 112.003 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -116.54 179.19 4.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.41 2.684 . . . . 74.53 108.03 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -137.82 121.69 17.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 71.11 106.707 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.73 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.537 -0.912 . . . . 73.42 108.537 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.96 107.07 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 105.167 -2.16 . . . . 44.43 105.167 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.18 132.86 39.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.237 1.015 . . . . 72.33 109.197 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.6 tp -143.85 157.25 44.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.867 1.267 . . . . 72.43 109.182 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -86.28 157.73 19.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.064 0.946 . . . . 53.04 108.891 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -81.95 161.52 23.03 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.76 . . . . 75.12 109.756 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 38.4 t30 . . . . . 0 C--O 1.243 0.752 0 C-N-CA 126.265 1.826 . . . . 72.21 108.698 -179.245 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 109.135 -1.586 . . . . 74.34 109.135 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 5.2 t -147.9 150.51 36.04 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 105.59 -2.004 . . . . 75.42 105.59 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.21 107.97 1.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.772 2.315 . . . . 74.03 109.434 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -85.84 89.29 7.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.401 -1.333 . . . . 71.33 107.401 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -80.68 107.46 13.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.717 -1.586 . . . . 71.13 106.717 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.04 95.25 0.54 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.956 1.302 . . . . 75.41 109.918 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -128.95 134.26 48.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.152 -2.166 . . . . 53.3 105.152 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . 53.65 28.09 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.099 0.56 . . . . 35.35 111.49 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -71.99 -23.92 61.49 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.962 1.305 . . . . 74.45 110.592 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -66.1 156.62 33.37 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.809 -1.182 . . . . 72.44 107.809 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -130.24 -89.11 0.48 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.709 -1.589 . . . . 73.24 106.709 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -75.92 -165.97 0.52 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.61 1.964 . . . . 74.51 110.484 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.64 156.63 41.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.243 1.017 . . . . 74.51 108.378 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.24 54.85 1.74 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.241 1.417 . . . . 60.44 108.502 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 2.4 pp -114.17 148.69 16.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 C-N-CA 124.724 1.21 . . . . 64.24 109.081 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 53.31 21.63 2.4 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.373 1.869 . . . . 73.52 113.544 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -75.71 47.46 0.41 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.641 2.377 . . . . 70.13 111.004 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -74.04 1.97 9.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.507 1.523 . . . . 74.44 110.961 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -65.17 -34.89 79.45 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.907 1.283 . . . . 72.02 111.177 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -68.56 151.13 97.41 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 107.201 -1.407 . . . . 74.43 107.201 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.8 -11.36 31.67 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.585 2.19 . . . . 73.44 112.013 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 50.3 mt -55.8 136.86 50.9 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.713 2.005 . . . . 75.02 107.097 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 70.0 p -151.23 -172.31 4.18 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 124.008 0.923 . . . . 64.53 108.52 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -67.33 -30.61 70.48 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.248 -1.39 . . . . 74.21 107.248 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.92 -48.9 42.19 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 125.09 1.356 . . . . 74.31 108.852 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -60.27 -33.11 71.86 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 119.254 -0.978 . . . . 73.35 109.091 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 13.5 tp -73.91 -40.29 63.25 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.728 0.811 . . . . 62.32 110.936 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -61.95 -45.2 94.73 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.296 1.838 . . . . 74.13 108.743 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.754 1.222 . . . . 71.22 110.747 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 47.2 mtp -78.18 -20.71 51.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 75.21 111.55 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.2 155.34 42.85 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.08 0.952 . . . . 64.33 110.322 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.99 168.53 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.542 2.162 . . . . 54.31 110.523 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.33 169.68 5.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.955 2.102 . . . . 71.54 112.468 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 66.04 20.9 69.33 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.731 -1.038 . . . . 65.02 113.955 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -122.95 157.09 33.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.674 1.737 . . . . 73.15 109.533 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -135.99 146.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.759 -1.109 . . . . 72.23 108.657 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' VAL . . . . . 0.409 HG13 HE21 ' B' ' 47' ' ' GLN . 98.0 t -70.28 151.06 9.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 105.779 -1.934 . . . . 54.53 105.779 178.269 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.59 90.62 31.58 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.231 -2.877 . . . . 65.22 103.231 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.9 163.4 7.52 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.681 2.254 . . . . 74.51 112.622 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.65 155.63 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.97 1.78 . . . . 74.23 109.284 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.65 151.45 76.0 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.792 1.661 . . . . 54.3 112.581 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -69.65 150.35 47.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.898 -1.149 . . . . 33.03 107.898 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 63.31 23.44 66.44 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.244 -1.309 . . . . 74.41 114.036 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -75.17 120.81 21.17 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 119.587 1.693 . . . . 61.34 111.297 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.49 83.49 62.17 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.971 1.708 . . . . 70.34 107.06 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.89 173.38 4.84 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.22 2.613 . . . . 75.43 113.639 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 13.5 tt . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.816 1.647 . . . . 54.33 109.199 -179.281 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.686 0 N-CA-C 111.27 -0.732 . . . . 23.33 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -83.65 89.58 7.15 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.564 -2.013 . . . . 64.13 105.564 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -176.4 167.8 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.963 2.105 . . . . 71.44 107.71 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -109.15 169.61 8.58 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.663 -0.866 . . . . 74.34 108.663 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 47.4 pt -138.87 143.14 32.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.143 -1.429 . . . . 65.01 107.143 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -69.95 170.65 10.82 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.873 0.469 . . . . 74.2 109.982 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.4 tp 50.37 70.35 2.08 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.271 1.428 . . . . 64.23 109.093 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.84 166.31 14.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.148 1.899 . . . . 60.14 111.487 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.96 -47.58 12.46 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.978 1.786 . . . . 73.5 109.352 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.9 170.0 23.5 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.359 1.864 . . . . 75.13 108.889 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 65.5 t -152.9 137.97 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 106.381 -1.711 . . . . 72.44 106.381 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -137.13 159.36 42.14 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.808 1.243 . . . . 63.31 109.24 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -55.92 -34.24 65.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.318 1.447 . . . . 62.22 113.514 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.5 136.13 24.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.155 -1.424 . . . . 64.22 107.155 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.5 mt -128.56 156.58 43.1 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.708 2.003 . . . . 75.13 107.912 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -124.94 126.13 45.01 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.297 1.839 . . . . 64.33 107.315 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -115.92 146.17 20.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.117 -1.438 . . . . 74.25 107.117 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -126.99 163.52 23.51 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.143 1.777 . . . . 75.24 107.529 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 66.11 28.96 10.12 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.313 1.445 . . . . 74.3 112.193 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' B' ' 60' ' ' ALA . 78.2 mt -77.56 150.4 79.3 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 121.109 -0.994 . . . . 75.12 112.009 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.3 148.55 88.57 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.725 2.95 . . . . 71.5 109.647 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -84.97 -21.78 29.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 74.14 112.066 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -124.87 94.96 4.34 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.523 -1.288 . . . . 74.02 107.523 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 tt -147.53 170.42 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.525 2.33 . . . . 74.5 106.333 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 61.3 p -131.26 170.17 14.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.013 1.279 . . . . 75.13 110.761 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.55 74.45 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.614 -0.513 . . . . 71.22 109.614 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.74 -36.75 72.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.371 1.868 . . . . 64.52 110.323 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.86 -42.68 13.04 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.496 -0.752 . . . . 62.12 110.397 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 97.8 mmm -58.9 -35.27 72.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.667 -0.683 . . . . 73.05 111.362 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.59 -12.42 48.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.678 0.791 . . . . 62.42 111.535 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.69 -61.81 1.63 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.57 1.532 . . . . 72.51 108.606 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.0 mt -48.6 -57.82 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.514 1.126 . . . . 42.1 109.705 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -73.81 -23.91 59.73 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.443 0.535 . . . . 71.11 112.443 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.96 -23.41 74.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.165 0.888 . . . . 44.24 111.747 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -73.04 -2.77 22.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 1.227 . . . . 43.3 109.762 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -107.68 -11.58 15.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.78 -1.105 . . . . 75.21 111.863 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.32 26.6 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.512 1.051 . . . . 51.25 112.761 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.0 151.74 83.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.316 3.344 . . . . 75.44 110.818 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 54.0 mt -121.77 130.26 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 107.908 -1.145 . . . . 75.45 107.908 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -74.17 -63.42 1.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.478 -0.934 . . . . 75.42 108.478 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLN . . . . . 0.409 HE21 HG13 ' A' ' 414' ' ' VAL . 10.9 tt0 -158.16 165.62 34.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.476 0.71 . . . . 71.43 109.188 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 59.3 mt -140.84 145.98 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.912 1.685 . . . . 75.42 107.468 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -136.26 154.4 50.91 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.333 -2.099 . . . . 75.52 105.333 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.57 153.01 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 123.919 0.887 . . . . 35.02 109.009 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.73 136.27 19.61 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.174 -1.971 . . . . 71.52 108.174 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -115.69 -23.48 8.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.665 -0.494 . . . . 73.41 109.665 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.7 p -80.28 156.82 73.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.684 0.794 . . . . 64.22 110.276 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.2 -14.04 34.24 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.059 2.506 . . . . 64.21 114.065 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -97.52 -1.11 44.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.354 0.979 . . . . 72.45 112.999 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 81.4 p -116.86 -13.04 10.7 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.409 1.004 . . . . 52.34 113.159 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -50.84 116.47 1.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.08 1.352 . . . . 73.34 109.803 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 -20.79 9.03 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.674 1.131 . . . . 54.54 112.33 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -124.11 128.17 48.89 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.348 1.059 . . . . 73.33 109.797 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.427 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -140.34 175.76 9.33 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.512 1.125 . . . . 65.24 111.56 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -128.76 147.1 50.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.189 0.595 . . . . 75.24 110.269 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.59 148.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 126.667 1.987 . . . . 63.1 105.894 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 15.9 t -127.61 124.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.806 -1.924 . . . . 73.21 105.806 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -98.65 163.04 12.81 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.531 -1.285 . . . . 62.42 107.531 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -89.18 -61.71 1.64 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.759 -0.83 . . . . 72.21 108.759 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.18 138.82 32.78 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.033 -1.042 . . . . 73.13 110.986 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt -71.43 -43.47 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.203 -0.935 . . . . 74.04 110.7 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.159 0.89 . . . . 75.5 111.334 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.93 -48.05 22.77 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.316 1.446 . . . . 51.13 108.038 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.85 79.75 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.03 0.932 . . . . 51.31 108.832 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -65.03 -36.96 86.03 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.945 1.298 . . . . 64.05 111.321 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -63.59 -55.85 20.48 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 107.782 -1.192 . . . . 60.13 107.782 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.4 73.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.958 0.903 . . . . 25.51 111.09 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.96 -57.07 11.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.211 -1.403 . . . . 74.13 107.211 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.87 -42.12 98.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 119.253 -0.403 . . . . 71.41 111.11 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.263 -0.875 . . . . 72.41 112.592 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.46 -28.12 13.08 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.723 1.601 . . . . 73.31 111.293 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 20.6 t -66.23 107.92 2.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.517 1.527 . . . . 65.43 107.64 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.24 10.09 54.76 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.204 1.383 . . . . 75.45 113.57 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -74.7 122.12 22.76 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.362 1.581 . . . . 71.41 108.004 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -85.07 132.65 34.29 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.773 -1.195 . . . . 34.3 107.773 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -146.19 135.69 17.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.964 -1.495 . . . . 51.43 106.964 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.6 m 46.2 42.38 9.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.65 1.58 . . . . 73.24 113.268 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.64 3.93 4.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.804 2.842 . . . . 54.45 114.256 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.88 161.81 15.98 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.196 -1.565 . . . . 75.22 109.917 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -110.52 117.71 34.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.542 -0.911 . . . . 74.21 108.542 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.64 154.6 39.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.667 -0.864 . . . . 73.11 108.667 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.0 127.52 67.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.031 -1.47 . . . . 65.35 107.031 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -115.77 137.77 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 71.35 108.183 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -144.59 137.1 26.5 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.859 0.864 . . . . 54.34 110.272 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -66.87 153.66 42.91 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.043 0.937 . . . . 73.11 108.95 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -76.37 163.69 26.74 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.498 -0.752 . . . . 75.35 112.99 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 . . . . . 0 C--O 1.249 1.076 0 C-N-CA 127.284 2.234 . . . . 73.4 105.596 179.389 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.745 0 N-CA-C 111.034 -0.826 . . . . 64.3 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 6.0 t -131.96 154.27 81.66 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.943 2.097 . . . . 74.24 106.075 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.25 123.99 11.94 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 CA-C-N 121.447 1.553 . . . . 53.11 108.646 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -153.0 159.7 42.93 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.384 1.074 . . . . 74.44 108.217 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -139.39 162.03 36.02 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.176 1.79 . . . . 72.3 106.905 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -103.06 156.31 17.77 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.598 -0.519 . . . . 65.43 109.598 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -156.5 176.28 12.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.565 2.746 . . . . 71.52 106.46 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -147.11 118.96 8.09 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.936 1.695 . . . . 73.45 107.658 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -70.27 167.69 17.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.122 0.569 . . . . 73.21 110.791 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -120.6 145.69 47.12 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.714 1.205 . . . . 72.53 109.033 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -138.61 139.76 38.69 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.931 -1.137 . . . . 73.03 107.931 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -153.84 125.75 7.77 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 103.848 -2.649 . . . . 74.4 103.848 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -147.36 88.43 1.71 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.173 0.897 . . . . 70.21 109.678 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.89 179.51 5.32 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.294 -0.632 . . . . 64.22 109.294 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 64.8 mt -115.01 107.79 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.434 -1.691 . . . . 71.11 106.434 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -145.32 179.24 7.52 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.524 1.93 . . . . 71.53 106.32 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -149.61 125.04 10.25 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.466 -2.05 . . . . 73.44 105.466 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -140.31 168.9 18.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.951 1.301 . . . . 71.1 109.888 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -85.84 25.96 1.04 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.136 1.775 . . . . 63.45 110.382 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -65.58 149.06 97.73 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.043 0.937 . . . . 61.2 109.733 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.78 167.49 26.19 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.831 2.354 . . . . 64.34 112.4 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 58.5 mt -37.61 118.1 0.62 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 127.59 2.356 . . . . 63.21 112.041 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 25.1 m -138.11 -166.61 2.0 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.799 2.04 . . . . 53.55 108.426 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.96 -23.68 65.98 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.446 -0.784 . . . . 71.41 111.179 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -61.82 -48.1 82.14 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.613 -1.254 . . . . 73.23 107.613 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -68.38 -17.03 64.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.458 1.103 . . . . 74.3 110.624 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 25.9 tp -86.64 -38.91 16.6 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.033 -1.469 . . . . 75.31 107.033 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -60.73 -41.89 96.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.85 -0.796 . . . . 74.01 108.85 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.88 45.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.92 0.888 . . . . 51.32 112.493 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.1 mtp -84.94 -1.25 56.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.446 1.098 . . . . 72.22 111.486 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -112.4 158.16 38.02 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 119.817 1.19 . . . . 75.03 111.711 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.96 175.61 10.19 Favored 'Trans proline' 0 C--O 1.239 0.567 0 C-N-CA 123.619 2.879 . . . . 74.34 112.204 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.56 166.15 21.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.358 -0.837 . . . . 71.2 110.33 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.01 78.96 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 121.388 -0.82 . . . . 71.13 113.531 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -123.38 157.57 33.06 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.711 -1.464 . . . . 75.35 107.902 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.77 137.09 43.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.203 -1.777 . . . . 71.04 106.203 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.7 t -70.31 149.67 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.004 -0.739 . . . . 63.23 109.004 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 35.9 tp -125.52 77.63 68.86 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.777 -1.194 . . . . 64.32 107.777 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.4 169.27 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.838 2.358 . . . . 71.24 111.701 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.18 161.46 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.424 3.416 . . . . 52.35 114.387 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.4 155.63 9.44 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.669 3.579 . . . . 55.33 115.837 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -80.81 155.93 26.4 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.736 -1.579 . . . . 63.51 106.736 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 67.33 13.34 62.47 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.979 -0.901 . . . . 63.13 114.477 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -78.94 156.21 28.64 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 119.326 1.563 . . . . 73.34 109.485 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 4.3 t -125.63 67.32 58.37 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.971 0.908 . . . . 71.41 109.759 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.99 -1.56 11.57 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.393 2.728 . . . . 65.41 114.571 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 29.3 mm . . . . . 0 C--O 1.253 1.272 0 CA-C-N 120.316 1.416 . . . . 74.01 107.979 -179.433 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.688 0 N-CA-C 109.936 -1.265 . . . . 54.12 109.936 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.68 124.22 23.04 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.343 -1.725 . . . . 74.21 106.343 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.76 126.63 28.34 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.316 0.507 . . . . 74.22 110.142 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -107.56 -3.52 19.26 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.3 1.84 . . . . 75.21 113.201 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 pt -95.84 171.65 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 126.586 1.954 . . . . 60.11 110.92 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -92.89 -36.38 12.84 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.484 -0.76 . . . . 74.3 112.226 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.7 mp -100.14 172.91 4.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.047 1.339 . . . . 55.34 113.952 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.25 172.41 16.07 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.87 3.047 . . . . 73.03 109.41 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.78 -63.77 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.86 2.374 . . . . 63.43 111.657 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -149.61 142.97 25.24 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 127.811 2.444 . . . . 74.22 106.109 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t -142.4 135.92 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.083 -2.191 . . . . 72.32 105.083 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -130.75 166.55 20.54 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.717 1.207 . . . . 72.42 109.738 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.21 -41.78 73.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.521 -0.752 . . . . 74.11 112.966 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.14 133.96 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.146 -1.057 . . . . 63.23 108.146 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 36.9 mt -123.47 156.58 35.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.175 1.39 . . . . 73.41 109.397 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -111.71 137.53 49.49 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.554 2.342 . . . . 73.54 107.554 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.8 mm -123.18 144.65 32.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.919 2.088 . . . . 53.33 107.189 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.4 ' HG2' HG22 ' B' ' 59' ' ' THR . 74.8 mtp85 -144.83 163.03 35.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.426 1.09 . . . . 53.43 110.75 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 72.04 25.47 3.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.805 2.442 . . . . 74.55 111.278 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -73.91 157.22 87.44 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.998 1.319 . . . . 65.0 112.7 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.71 160.28 44.1 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.651 2.901 . . . . 63.31 112.263 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -93.73 -10.96 32.53 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.752 1.621 . . . . 75.31 110.936 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mmmp? -128.69 95.32 4.08 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 106.883 -1.525 . . . . 73.14 106.883 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -155.16 160.71 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 124.206 0.941 . . . . 61.4 108.526 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 8.4 p -138.08 175.73 9.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.171 1.388 . . . . 73.43 109.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.97 70.74 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.285 0.634 . . . . 35.23 111.981 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -56.93 -46.22 82.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.134 0.974 . . . . 73.33 111.96 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -78.29 -40.54 36.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.549 0.74 . . . . 72.34 109.721 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.2 mmm -61.05 -46.23 91.54 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 120.984 -1.072 . . . . 70.42 110.261 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -71.68 -23.27 61.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.374 -0.822 . . . . 71.11 109.938 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.64 -46.6 75.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.761 1.164 . . . . 54.34 108.063 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mt -67.79 -69.49 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.04 1.336 . . . . 73.21 110.902 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' PHE . . . . . 0.429 ' CE1' HG21 ' B' ' 62' ' ' VAL . 86.7 m-85 -60.32 -26.22 66.38 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.886 1.809 . . . . 71.25 115.886 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.54 -23.6 73.71 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.341 0.973 . . . . 54.33 111.946 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -65.83 -15.19 62.67 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.306 -1.114 . . . . 74.33 111.037 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -107.33 -4.48 18.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.936 1.458 . . . . 73.02 114.936 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.92 -173.7 21.45 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.753 1.16 . . . . 63.23 114.053 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.27 117.89 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 125.264 3.976 . . . . 53.25 113.791 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 71.5 mt -77.27 103.07 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 127.195 2.198 . . . . 74.21 108.682 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -66.46 -61.79 1.81 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.854 -1.154 . . . . 74.54 110.637 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -160.78 142.85 12.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.892 0.769 . . . . 73.03 111.603 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 16.7 mt -126.89 140.32 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.502 1.121 . . . . 74.24 109.539 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -137.37 122.47 19.13 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.767 -2.679 . . . . 65.32 103.767 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -111.17 145.99 16.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.501 1.12 . . . . 72.44 108.732 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.84 125.36 16.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.089 -2.405 . . . . 64.42 107.089 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -100.37 -20.57 15.76 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.521 1.16 . . . . 65.0 113.954 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -73.75 157.14 87.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.998 -1.853 . . . . 73.44 105.998 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.24 -20.29 70.39 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.106 1.871 . . . . 53.11 111.843 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.8 -44.43 16.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.282 1.433 . . . . 74.22 109.774 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 77.4 p -74.62 -0.94 19.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.254 -0.904 . . . . 61.12 112.176 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -64.61 163.44 13.71 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.887 -1.133 . . . . 73.44 109.363 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 -9.36 6.07 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.547 -1.141 . . . . 32.44 112.567 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' THR . . . . . 0.4 HG22 ' HG2' ' B' ' 24' ' ' ARG . 44.3 p -128.77 144.63 51.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.469 1.634 . . . . 65.22 110.312 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.72 175.37 12.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.224 1.01 . . . . 64.21 110.027 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -127.62 156.16 42.73 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.324 0.649 . . . . 51.31 110.531 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' B' ' 39' ' ' PHE . 62.1 t -142.55 144.95 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.537 -1.282 . . . . 70.1 107.537 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.48 149.16 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.077 -1.453 . . . . 75.42 107.077 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -116.24 160.2 20.78 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.403 -1.436 . . . . 75.32 108.78 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -65.7 -40.99 92.85 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.396 -0.594 . . . . 52.45 109.396 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -122.35 142.52 50.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.195 -1.039 . . . . 73.11 108.195 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.45 -24.51 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.681 -0.637 . . . . 73.43 110.845 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.66 -25.42 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.415 1.086 . . . . 73.55 110.581 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -74.9 -53.08 9.68 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 105.338 -2.097 . . . . 70.45 105.338 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.85 -35.71 33.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.241 1.016 . . . . 72.21 111.943 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -57.14 -69.14 0.17 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.07 1.348 . . . . 74.1 111.659 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -37.55 81.6 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.511 -0.743 . . . . 64.22 111.671 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.34 80.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.543 -0.741 . . . . 65.1 111.838 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.71 -61.67 2.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.053 -0.721 . . . . 73.31 109.053 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.51 -31.79 70.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.603 0.964 . . . . 74.31 113.603 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -73.88 -26.77 60.73 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.446 0.566 . . . . 72.32 111.1 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.21 -16.53 18.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.119 0.968 . . . . 74.45 112.669 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -63.11 108.06 1.16 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.141 1.777 . . . . 72.52 108.238 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.5 83.1 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.209 -1.329 . . . . 65.32 113.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.02 141.53 45.36 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 119.112 1.456 . . . . 73.15 111.006 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 25.3 t30 -94.96 113.61 25.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 115.231 1.567 . . . . 74.0 115.231 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 m -133.21 141.77 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 71.13 105.401 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 74.8 m 42.92 36.71 0.92 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.84 1.656 . . . . 54.32 113.607 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 65.26 21.56 12.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.299 1.84 . . . . 60.04 112.668 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.54 -179.54 3.74 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.779 2.432 . . . . 75.12 108.442 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -138.03 114.11 10.05 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.873 -1.899 . . . . 70.24 105.873 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -69.02 168.76 13.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.297 0.639 . . . . 71.44 110.97 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.02 107.85 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.855 1.262 . . . . 71.11 107.73 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.74 135.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.19 -1.411 . . . . 71.32 107.19 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -151.98 141.96 22.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.253 1.021 . . . . 74.03 108.803 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -73.17 154.75 40.17 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.943 0.792 . . . . 74.25 110.215 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.09 148.16 38.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.964 -1.495 . . . . 74.41 106.964 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 126.977 2.111 . . . . 74.31 106.417 178.771 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 18.1 tp . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.24 -0.652 . . . . 63.21 109.24 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.94 -41.88 90.76 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.833 0.853 . . . . 75.24 109.669 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.53 61.46 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.086 1.354 . . . . 42.34 111.48 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.0 mtp -88.95 -17.41 29.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.893 0.877 . . . . 64.11 112.64 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -83.11 145.51 49.38 Favored Pre-proline 0 N--CA 1.455 -0.212 0 CA-C-N 119.32 0.963 . . . . 71.34 110.212 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -67.28 157.49 61.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.423 2.082 . . . . 74.33 112.197 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.99 134.99 43.12 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.218 -1.356 . . . . 72.34 108.984 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.6 24.37 18.45 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-O 118.845 -0.975 . . . . 63.33 113.549 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.17 108.87 12.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.965 -1.495 . . . . 74.14 106.965 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.96 150.5 25.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 114.909 -1.041 . . . . 74.41 108.332 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.65 151.56 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.226 -0.657 . . . . 74.31 109.226 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 25.9 tp -120.76 78.88 30.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.999 0.92 . . . . 65.43 109.278 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.97 160.01 50.69 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 N-CA-C 108.346 -1.444 . . . . 61.14 108.346 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 157.5 61.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.141 1.894 . . . . 75.34 110.955 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.066 1.844 . . . . 72.41 109.755 -179.724 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.446 HG11 ' HG2' ' B' ' 71' ' ' LYS . 59.7 t . . . . . 0 CA--C 1.534 0.351 0 N-CA-C 107.803 -1.184 . . . . 74.51 107.803 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.2 176.87 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.573 2.349 . . . . 54.13 108.022 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -77.54 -9.87 59.17 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.803 -0.56 . . . . 60.25 110.188 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -92.03 115.89 31.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.397 1.879 . . . . 64.12 107.641 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.51 127.02 55.59 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.473 1.509 . . . . 64.33 109.456 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -92.62 135.42 34.1 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.172 -1.418 . . . . 71.14 107.172 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mm -122.93 136.91 58.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.562 1.545 . . . . 73.44 107.968 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 mtp85 -123.42 162.06 23.55 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.786 1.234 . . . . 73.33 107.803 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.05 25.51 4.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.655 2.382 . . . . 63.14 113.776 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.27 150.81 97.17 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 108.215 -1.031 . . . . 60.33 108.215 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.66 151.6 85.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.728 1.619 . . . . 54.21 110.204 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -73.89 -25.46 60.04 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.704 -0.623 . . . . 62.41 110.364 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 109.56 17.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.259 -1.015 . . . . 74.13 108.259 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 tt -159.09 152.44 6.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.636 -1.246 . . . . 55.23 107.636 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 46.5 p -113.34 172.74 6.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.807 1.243 . . . . 72.45 110.33 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.9 -32.08 73.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.169 -1.048 . . . . 52.12 108.169 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.17 -49.61 63.44 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.722 2.009 . . . . 74.12 110.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -70.74 -49.93 41.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.26 1.024 . . . . 62.33 109.647 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 98.1 mmm -56.25 -43.35 78.62 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.694 -0.629 . . . . 64.35 112.186 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -67.82 -29.44 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.34 0.973 . . . . 75.54 110.789 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.56 -35.94 57.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.389 0.995 . . . . 71.44 110.585 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.26 -58.84 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 125.522 1.529 . . . . 60.21 110.84 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.462 ' CE2' HG21 ' B' ' 62' ' ' VAL . 78.9 m-85 -74.09 -23.62 59.36 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.074 -1.016 . . . . 71.42 112.353 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -7.59 88.38 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.602 0.637 . . . . 52.11 112.638 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -63.06 -26.31 68.78 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.573 1.149 . . . . 63.42 111.745 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.58 -21.12 19.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.175 0.99 . . . . 75.42 112.802 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.71 -159.62 29.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.622 1.101 . . . . 51.14 110.387 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.92 151.25 56.38 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.381 2.054 . . . . 73.43 109.236 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mt -112.73 137.3 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.277 -1.749 . . . . 75.54 106.277 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -66.02 0.79 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.109 -1.071 . . . . 74.35 108.109 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -161.49 153.8 19.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.724 0.693 . . . . 71.13 111.41 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.0 150.75 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 123.223 1.487 . . . . 74.34 109.6 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -136.22 163.84 29.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 104.09 -2.559 . . . . 74.32 104.09 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -144.18 149.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 120.664 1.575 . . . . 74.22 108.4 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.2 139.1 48.38 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.85 -1.7 . . . . 72.14 108.85 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.67 -9.67 6.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.936 0.894 . . . . 75.52 112.332 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.94 159.73 32.53 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.52 1.928 . . . . 64.24 106.335 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.17 -29.57 89.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.95 1.767 . . . . 65.32 112.575 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -91.49 2.31 56.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.35 1.06 . . . . 74.12 112.786 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 49.5 p -116.42 -31.58 5.53 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.702 1.592 . . . . 75.24 112.452 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -54.52 136.04 45.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.264 1.026 . . . . 62.22 108.538 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.42 -5.57 44.79 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.078 0.847 . . . . 54.13 112.367 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 58.6 p -142.82 158.38 43.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 119.044 1.422 . . . . 64.32 108.849 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.21 160.59 21.4 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.446 0.698 . . . . 51.22 110.549 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.06 132.93 56.57 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 127.063 2.145 . . . . 63.14 106.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.462 HG21 ' CE2' ' B' ' 39' ' ' PHE . 89.3 t -111.82 150.5 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 125.302 1.441 . . . . 51.14 107.825 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -124.01 125.67 71.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.212 -1.403 . . . . 72.43 107.212 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -97.8 161.77 13.59 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.543 -1.28 . . . . 63.21 107.543 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -74.27 -31.24 62.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.167 -0.924 . . . . 73.15 111.765 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.63 172.45 8.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.763 1.225 . . . . 63.14 109.468 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -95.61 -29.16 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.986 -1.116 . . . . 61.21 107.986 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -62.44 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.713 1.605 . . . . 75.34 109.721 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.31 -35.05 74.7 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.402 1.081 . . . . 51.45 111.293 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -55.24 33.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.609 -0.886 . . . . 72.42 108.609 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.446 ' HG2' HG11 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -62.06 -35.26 78.09 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.891 -1.052 . . . . 60.41 111.364 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -59.67 -53.46 57.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.984 0.811 . . . . 60.24 109.902 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.74 65.14 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 118.831 -0.604 . . . . 64.24 112.432 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.0 t -50.8 -48.77 59.52 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.314 1.046 . . . . 62.13 110.091 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -59.97 3.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.621 0.769 . . . . 62.33 109.373 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -15.54 9.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.922 1.823 . . . . 72.33 115.922 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 tp -99.67 -1.96 36.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.011 1.278 . . . . 52.41 111.153 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.1 p -75.47 132.59 40.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.257 -1.386 . . . . 71.33 107.257 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.29 10.28 81.7 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.048 -0.862 . . . . 63.12 113.114 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -66.45 133.91 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.961 1.381 . . . . 61.33 107.294 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.28 126.77 53.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.641 1.177 . . . . 64.33 109.119 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 5.4 m -136.83 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.115 1.766 . . . . 74.13 107.036 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 88.9 m 49.46 29.61 2.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.328 1.051 . . . . 60.14 111.887 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.7 m120 71.27 23.31 4.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.284 2.233 . . . . 72.31 113.279 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -132.14 141.74 49.23 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.223 1.409 . . . . 74.13 108.726 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -88.47 151.1 22.77 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.501 0.72 . . . . 73.12 109.164 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.44 167.67 9.68 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.878 -0.786 . . . . 73.43 108.878 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 79.4 t -132.73 137.75 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.538 -1.282 . . . . 64.53 107.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.9 139.89 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.328 1.451 . . . . 64.53 109.094 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 52.0 tp -146.42 165.43 29.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.154 1.782 . . . . 71.13 108.369 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.44 164.09 11.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.425 . . . . 74.44 112.486 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -83.32 115.14 21.86 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.772 1.229 . . . . 74.33 108.683 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 63.4 t30 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.201 -0.904 . . . . 75.53 110.852 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . 0.401 HD21 HG21 ' B' ' 63' ' ' VAL . 60.8 tp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.93 -44.11 97.67 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.949 -0.76 . . . . 75.14 108.949 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.02 81.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.433 1.493 . . . . 63.2 111.6 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.47 -21.59 59.51 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.366 1.066 . . . . 74.13 112.527 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -76.71 152.65 83.1 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.076 1.307 . . . . 62.24 109.265 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.499 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 86.8 Cg_endo -72.1 177.1 7.56 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.833 3.688 . . . . 65.14 112.521 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.01 143.58 26.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.111 0.964 . . . . 75.32 112.724 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.52 29.53 9.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.587 1.089 . . . . 73.51 113.658 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.499 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 49.6 m-85 -125.98 157.12 38.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.049 1.34 . . . . 75.13 109.671 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.79 142.4 50.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.377 -1.342 . . . . 74.24 107.377 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.61 151.79 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.415 -0.957 . . . . 52.11 108.415 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.88 85.8 40.52 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.655 -0.653 . . . . 71.03 109.312 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.56 159.68 31.17 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.947 2.431 . . . . 62.44 111.051 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 166.47 26.76 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.385 3.39 . . . . 75.02 113.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 CA--C 1.541 0.838 0 C-N-CA 122.573 2.182 . . . . 75.42 109.238 178.537 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 t . . . . . 0 C--O 1.238 0.478 0 N-CA-C 106.982 -1.488 . . . . 63.25 106.982 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -131.82 159.15 39.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.532 1.533 . . . . 64.25 108.667 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -82.87 -25.24 32.73 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.706 0.802 . . . . 74.41 110.662 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -83.4 135.21 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 103.019 -2.956 . . . . 74.5 103.019 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.7 165.81 15.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.679 1.591 . . . . 73.25 108.518 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -129.04 130.25 46.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.951 2.1 . . . . 63.24 109.123 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -113.22 151.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.302 2.241 . . . . 71.32 107.849 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -146.57 159.93 42.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.661 -0.65 . . . . 62.21 110.945 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.97 19.03 11.75 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 127.204 2.202 . . . . 54.1 113.975 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 mt -58.92 152.77 47.69 Favored Pre-proline 0 C--O 1.236 0.372 0 C-N-CA 123.04 0.536 . . . . 75.04 112.239 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.92 144.53 96.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 73.01 110.34 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -77.78 -14.27 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.299 -0.876 . . . . 74.51 111.59 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -123.49 105.5 9.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.443 -1.688 . . . . 62.32 106.443 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 tt -156.59 164.35 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.915 1.686 . . . . 71.21 106.744 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.27 169.03 17.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.593 1.557 . . . . 55.53 109.336 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.22 -31.64 70.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.923 -0.561 . . . . 52.11 110.316 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.59 -39.79 71.18 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.388 1.475 . . . . 73.22 111.825 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -83.79 -47.79 10.76 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.646 1.178 . . . . 75.52 110.413 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.3 mmm -53.45 -47.98 69.22 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.609 0.364 . . . . 75.02 110.82 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -69.21 -34.96 75.68 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.281 -0.866 . . . . 64.14 111.672 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.28 -56.65 18.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.81 0.732 . . . . 74.04 109.328 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 48.8 mt -54.48 -63.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 126.751 2.02 . . . . 72.33 111.234 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -63.52 -24.34 67.77 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.204 0.911 . . . . 74.1 112.854 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.5 79.96 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.797 -1.001 . . . . 53.24 112.258 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.409 ' HA ' ' HE2' ' B' ' 41' ' ' LYS . 7.3 mmpt? -60.3 -19.34 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.53 1.665 . . . . 52.53 113.215 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.52 -31.25 8.2 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 117.404 -1.284 . . . . 72.44 113.861 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.0 -152.4 14.83 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 119.716 1.144 . . . . 73.31 112.774 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.18 162.48 28.56 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.163 3.242 . . . . 73.22 111.84 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.99 132.58 70.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.141 -1.429 . . . . 33.44 107.141 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -58.05 2.67 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.973 -1.121 . . . . 72.3 107.973 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -156.22 160.11 39.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.952 0.901 . . . . 61.34 109.368 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 48.7 mt -139.69 136.1 39.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.267 1.427 . . . . 64.53 108.0 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -137.77 143.57 41.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.247 -1.39 . . . . 64.3 107.247 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.84 165.37 27.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.287 1.035 . . . . 52.21 108.539 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.05 135.19 25.87 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 124.098 0.856 . . . . 74.52 113.054 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -104.88 -42.74 5.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.208 1.803 . . . . 70.04 109.211 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -66.32 158.78 76.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.906 -1.146 . . . . 73.33 107.906 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.55 -31.65 40.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.221 1.281 . . . . 64.33 110.947 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -70.99 -23.7 62.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.747 0.703 . . . . 61.23 112.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -89.94 -0.97 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.621 0.768 . . . . 32.14 111.79 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -67.84 120.48 14.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.291 -2.115 . . . . 74.5 105.291 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.11 2.34 36.04 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.116 0.865 . . . . 42.44 112.875 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 65.8 p -129.55 151.34 50.27 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.769 1.285 . . . . 70.34 108.058 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.55 171.13 16.26 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.001 -1.062 . . . . 74.3 110.74 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -138.38 151.87 47.9 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.947 0.899 . . . . 71.13 110.393 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.49 152.62 35.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.153 -2.166 . . . . 63.22 105.153 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 404' ' ' LEU . 23.5 t -127.73 129.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.172 -1.788 . . . . 72.14 106.172 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.23 161.99 13.42 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.848 -1.538 . . . . 72.14 106.848 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.08 -43.85 41.64 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.722 -0.611 . . . . 72.42 111.083 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -123.02 164.13 19.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.78 1.232 . . . . 53.44 109.74 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.0 tt -83.33 -10.82 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 114.564 1.32 . . . . 74.55 114.564 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -83.55 -53.7 5.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.619 -1.252 . . . . 75.4 107.619 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.8 -40.56 88.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.746 0.654 . . . . 74.21 110.294 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.34 79.01 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.544 0.738 . . . . 61.11 111.082 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.57 -46.15 76.96 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 119.124 -0.465 . . . . 64.23 110.253 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -55.51 -44.57 76.75 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.731 0.645 . . . . 75.44 110.123 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.71 -50.01 54.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.481 0.712 . . . . 71.2 110.051 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.8 t -50.88 -54.16 26.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.624 1.17 . . . . 74.2 110.937 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -63.3 -33.8 76.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.268 0.84 . . . . 63.21 113.268 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -80.91 -23.29 39.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 118.607 0.639 . . . . 75.1 111.911 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.26 -23.6 22.28 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.167 0.508 . . . . 63.32 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -61.67 114.13 3.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.193 1.397 . . . . 42.0 108.677 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 10.63 75.01 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.394 -1.226 . . . . 74.52 114.578 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.6 119.11 9.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.573 1.187 . . . . 73.33 108.571 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.26 109.31 17.69 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.497 1.519 . . . . 75.43 110.431 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 10.6 m -141.23 151.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.702 1.201 . . . . 75.13 109.585 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 76.8 m 44.68 43.75 6.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.892 1.277 . . . . 73.03 110.661 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.53 35.49 11.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.138 2.575 . . . . 74.34 112.371 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -144.72 -179.99 6.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.311 2.245 . . . . 75.43 108.09 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -128.41 157.23 41.62 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.85 1.26 . . . . 64.41 108.909 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -120.15 119.3 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.195 -0.668 . . . . 73.21 109.195 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.14 122.73 38.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 126.847 2.059 . . . . 73.2 106.294 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.39 129.41 61.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.398 -1.704 . . . . 71.42 106.398 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.36 153.68 51.76 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.99 -1.115 . . . . 72.42 107.99 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -84.1 156.93 21.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 71.32 108.314 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.95 140.16 43.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 104.202 -2.518 . . . . 74.11 104.202 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.673 -1.232 . . . . 72.22 107.673 178.852 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . 0.435 ' CD2' HH22 ' B' ' 49' ' ' ARG . 29.4 tp . . . . . 0 C--O 1.224 -0.266 0 CA-C-O 118.779 -0.629 . . . . 63.34 109.712 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.18 -41.01 82.95 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.273 0.629 . . . . 72.35 110.291 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.87 -9.34 58.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.796 1.238 . . . . 64.24 112.871 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 79.9 mtp -76.21 -12.21 60.05 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.962 -1.086 . . . . 64.44 110.062 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -114.61 158.85 39.15 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.774 1.629 . . . . 75.41 112.601 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.37 170.93 17.19 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.978 1.785 . . . . 42.31 109.721 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -87.45 163.37 16.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.94 -1.027 . . . . 63.32 111.035 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.69 18.26 35.75 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.155 1.359 . . . . 65.03 112.415 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.26 157.05 39.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.15 1.38 . . . . 70.3 107.564 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -137.94 147.19 44.08 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.602 -0.518 . . . . 61.54 109.602 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.19 150.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.478 0.581 . . . . 54.22 109.664 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.08 86.21 57.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.23 -1.396 . . . . 70.32 107.23 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.49 159.55 27.23 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.951 2.434 . . . . 74.0 113.03 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.63 168.94 21.24 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.837 2.358 . . . . 65.14 110.803 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo . . . . . 0 C--N 1.348 0.517 0 C-N-CA 124.499 3.466 . . . . 74.41 115.348 -179.467 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 C--O 1.237 0.425 0 N-CA-C 106.645 -1.613 . . . . 75.13 106.645 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -121.96 -172.88 2.53 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.668 1.587 . . . . 52.11 109.449 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.37 -17.24 14.87 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.088 -1.008 . . . . 61.01 112.532 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.27 114.43 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.912 -1.514 . . . . 74.41 106.912 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 74.4 mt -102.97 170.83 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.251 1.02 . . . . 71.43 109.032 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -140.68 142.22 34.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.991 2.116 . . . . 74.03 106.509 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 mm -128.24 148.25 32.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 119.19 0.904 . . . . 74.42 108.711 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -133.42 162.31 32.2 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.264 1.825 . . . . 74.31 107.682 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.78 21.47 9.15 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.07 2.148 . . . . 71.15 112.292 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -61.03 155.25 55.9 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.396 1.078 . . . . 54.11 111.338 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.42 138.23 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.525 2.816 . . . . 71.11 111.05 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.47 -23.46 65.5 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.9 0.88 . . . . 72.51 112.635 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 113.58 14.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.024 -1.843 . . . . 62.25 106.024 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.5 129.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.195 -1.039 . . . . 73.3 108.195 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 12.5 p -83.23 169.15 16.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.385 -0.598 . . . . 64.5 109.385 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.78 84.47 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.663 -0.684 . . . . 44.32 109.47 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -47.98 -47.05 33.2 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.14 1.376 . . . . 73.21 112.571 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.87 -52.68 63.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.154 0.982 . . . . 74.34 109.701 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 75.4 mmm -59.38 -48.28 82.23 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.982 0.513 . . . . 44.13 110.812 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.22 -29.02 70.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.036 -0.983 . . . . 73.0 109.767 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.73 -62.28 1.45 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.726 1.148 . . . . 62.13 108.346 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 60.1 mt -45.44 -58.3 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.576 1.95 . . . . 70.3 111.339 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -78.04 -38.17 45.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.863 1.061 . . . . 63.54 113.863 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.04 -37.39 85.45 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.866 -0.894 . . . . 42.32 110.866 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -57.34 -31.48 65.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.463 0.631 . . . . 74.21 110.89 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -78.26 -55.35 5.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.599 -0.889 . . . . 73.3 108.599 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.81 -166.74 33.75 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.496 -0.752 . . . . 51.41 112.619 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.19 156.17 26.16 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.476 2.784 . . . . 72.31 114.453 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.83 102.84 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.175 -2.528 . . . . 73.52 104.175 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -75.77 -54.66 6.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.348 -0.982 . . . . 74.21 108.348 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -151.9 154.43 36.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.225 0.61 . . . . 70.41 109.613 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 80.1 mt -145.85 135.32 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.848 -1.538 . . . . 72.01 106.848 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.435 HH22 ' CD2' ' A' ' 404' ' ' LEU . 13.6 mtm-85 -133.48 120.5 20.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.375 -2.084 . . . . 71.41 105.375 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.49 136.51 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 126.149 1.78 . . . . 61.32 110.404 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.35 134.67 45.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.114 -1.595 . . . . 51.03 109.114 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -118.79 -23.23 7.06 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.502 1.521 . . . . 71.12 112.824 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 64.1 p -70.84 158.61 87.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 71.53 106.904 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.09 -10.89 22.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.02 1.813 . . . . 63.05 112.618 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -97.07 -45.51 6.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.661 1.584 . . . . 64.22 109.51 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.4 p -76.51 -19.11 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.245 0.93 . . . . 73.23 113.022 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -52.89 139.27 27.73 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 107.428 -1.323 . . . . 65.31 107.428 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.85 -6.24 56.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.743 -1.032 . . . . 62.24 111.385 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -132.86 159.67 39.17 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 119.281 1.541 . . . . 63.23 111.115 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.36 164.8 32.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.726 1.611 . . . . 64.54 108.468 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.77 125.48 32.06 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.86 -1.534 . . . . 64.12 106.86 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.63 146.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.141 -1.8 . . . . 73.21 106.141 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.692 -2.336 . . . . 73.4 104.692 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 22.0 m-85 -97.56 144.59 27.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.937 . . . . 74.45 108.471 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.15 -30.65 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 75.14 110.162 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -121.3 126.49 49.65 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.47 1.108 . . . . 74.41 109.487 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.73 -34.97 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.139 0.427 . . . . 73.03 111.621 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -61.45 -46.17 91.22 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.303 0.641 . . . . 73.11 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -67.6 -30.07 69.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.578 0.626 . . . . 73.12 110.139 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -62.44 -49.3 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.807 -1.183 . . . . 63.0 107.807 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -60.29 -43.75 95.98 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 109.026 -0.731 . . . . 61.41 109.026 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.03 -58.03 9.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.008 0.923 . . . . 75.41 110.814 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.41 -33.49 71.3 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.264 1.026 . . . . 64.54 110.279 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.8 t -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.62 1.1 . . . . 63.11 109.289 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -48.32 45.84 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.947 -1.095 . . . . 70.3 111.711 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -65.13 -17.55 64.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.084 1.142 . . . . 75.4 114.084 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 tp -107.39 -17.54 14.1 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.988 1.267 . . . . 65.01 113.101 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -65.11 105.47 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.912 -0.493 . . . . 65.31 110.368 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.08 16.72 46.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.215 -1.325 . . . . 54.4 114.808 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.96 111.17 4.81 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.412 1.606 . . . . 74.52 109.028 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.88 120.08 19.94 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.004 0.921 . . . . 72.42 110.039 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -149.72 149.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.802 -1.555 . . . . 65.34 106.802 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 15.9 m 51.84 32.52 9.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.683 1.193 . . . . 74.53 112.711 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.54 30.63 17.57 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.761 1.624 . . . . 72.42 111.46 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -135.43 167.32 21.28 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 127.735 2.414 . . . . 62.41 108.076 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -115.27 124.17 50.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.148 0.979 . . . . 74.31 110.908 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -77.97 156.21 30.34 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.31 -1.367 . . . . 72.44 107.31 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.27 140.23 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.474 -1.676 . . . . 71.53 106.474 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.27 153.88 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.649 1.58 . . . . 64.12 107.308 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -157.06 165.88 34.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.466 1.506 . . . . 63.23 108.646 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -102.83 164.84 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.73 2.812 . . . . 75.33 110.76 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -114.79 160.76 19.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.206 -1.405 . . . . 75.04 107.206 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 115.985 -1.959 . . . . 74.02 111.38 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 11.8 tp . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 111.742 0.275 . . . . 75.1 111.742 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.35 -44.37 62.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.869 1.268 . . . . 74.15 111.832 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.07 -22.55 62.1 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.623 0.369 . . . . 61.24 110.718 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.5 mtp -70.59 -38.59 74.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.629 -0.7 . . . . 65.14 109.517 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -72.18 155.54 91.52 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 119.352 0.978 . . . . 71.11 112.084 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.471 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 71.8 Cg_endo -72.84 167.4 27.35 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.185 2.59 . . . . 61.11 111.372 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -79.45 153.32 29.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.309 1.444 . . . . 75.02 111.4 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.76 24.23 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.797 -1.001 . . . . 73.15 114.88 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.471 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 13.1 m-85 -124.54 158.01 33.97 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.528 1.664 . . . . 74.4 111.901 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -127.28 133.95 50.1 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.457 1.503 . . . . 70.02 107.784 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.09 150.72 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.229 -1.397 . . . . 72.25 107.229 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.8 tp -125.07 78.02 66.71 Favored Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 108.667 -0.864 . . . . 63.13 108.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -56.76 162.79 8.11 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.076 2.517 . . . . 71.43 111.315 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 159.73 51.11 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.102 1.868 . . . . 73.24 110.914 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 N--CA 1.452 -0.943 0 C-N-CA 122.671 2.247 . . . . 74.31 112.288 179.809 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 107.114 -1.439 . . . . 72.02 107.114 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.04 148.87 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.173 -1.788 . . . . 62.34 106.173 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.73 83.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 39.9 mt -68.56 116.08 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 125.934 1.694 . . . . 61.31 111.636 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 25.4 mt -104.2 149.15 25.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.111 -1.07 . . . . 75.41 108.111 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -123.7 137.56 54.68 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.511 -2.403 . . . . 63.14 104.511 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.427 ' HB ' HD11 ' B' ' 26' ' ' LEU . 6.3 mm -125.41 151.2 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.583 -1.636 . . . . 74.43 106.583 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -136.27 164.28 28.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.549 1.94 . . . . 73.51 108.461 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.53 13.56 8.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.546 1.938 . . . . 71.15 111.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' B' ' 23' ' ' ILE . 67.6 mt -66.06 155.99 85.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.94 1.296 . . . . 70.43 112.715 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.59 153.3 72.58 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.11 2.54 . . . . 72.03 111.192 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -86.19 -19.81 29.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 74.34 110.496 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -130.39 115.59 17.09 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.797 1.639 . . . . 73.22 107.05 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 157.05 5.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.845 -1.168 . . . . 71.41 107.845 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 15.5 p -101.89 164.49 11.69 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.215 1.406 . . . . 44.02 110.363 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.4 84.27 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.504 -1.665 . . . . 65.0 106.504 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.46 -37.13 77.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.629 2.372 . . . . 63.24 111.16 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.61 -47.87 16.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.204 -0.935 . . . . 62.41 109.645 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.8 mmm -58.33 -42.86 87.75 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.336 0.516 . . . . 74.0 110.859 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -73.55 -34.95 65.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.932 -0.556 . . . . 64.54 111.444 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.25 -58.08 5.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.994 0.815 . . . . 75.45 111.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mt -52.16 -62.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.461 1.504 . . . . 62.41 110.734 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -64.96 -22.84 67.07 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 119.019 -0.515 . . . . 65.11 111.406 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -29.11 68.09 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 125.834 1.683 . . . . 62.41 111.171 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -61.44 -24.26 66.41 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.369 1.584 . . . . 75.51 110.185 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -88.94 -46.89 8.54 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.671 0.788 . . . . 73.54 110.386 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.17 -171.51 43.94 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 119.499 1.045 . . . . 72.22 114.835 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.47 116.57 3.71 Favored 'Trans proline' 0 C--N 1.347 0.477 1 C-N-CA 125.711 4.274 . . . . 72.15 113.985 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.1 mt -83.46 125.79 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.558 1.143 . . . . 73.12 109.731 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.36 -60.41 2.04 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.422 -1.325 . . . . 73.15 107.422 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -156.57 149.43 23.86 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.203 0.911 . . . . 74.1 109.497 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 29.5 mt -129.53 144.2 38.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.943 2.097 . . . . 74.13 108.48 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -141.96 154.79 45.31 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.335 -1.728 . . . . 71.54 106.335 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.01 165.7 19.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 71.43 109.354 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 145.78 49.39 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.532 -1.027 . . . . 43.4 110.532 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -105.18 -52.69 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.738 -1.208 . . . . 74.15 107.738 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 70.2 p -69.89 156.99 90.82 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 124.204 1.002 . . . . 74.42 109.825 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.81 -39.21 64.31 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.613 1.542 . . . . 62.02 109.796 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.64 -7.2 24.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.502 1.121 . . . . 75.33 113.398 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 8.3 p -102.25 -4.43 25.72 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.571 1.078 . . . . 64.13 109.651 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -69.86 150.04 47.23 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.156 -1.59 . . . . 71.24 108.32 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.18 -7.52 64.36 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.16 -1.356 . . . . 65.13 113.73 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.4 p -140.51 162.75 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.212 2.006 . . . . 44.21 107.346 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.424 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -165.66 173.63 10.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 61.3 109.98 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.63 144.72 50.82 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.801 0.841 . . . . 71.52 109.694 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 86.4 t -133.5 141.1 45.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.408 1.083 . . . . 74.14 108.626 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.92 130.64 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 106.454 -1.684 . . . . 65.25 106.454 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 45.0 m-85 -104.09 166.35 10.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.869 2.068 . . . . 72.45 107.49 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.31 -69.54 0.3 Allowed 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.366 -0.834 . . . . 71.25 111.866 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.67 151.11 21.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.517 1.053 . . . . 73.25 110.642 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.5 tt -61.75 -33.86 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.483 0.713 . . . . 73.21 111.781 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -69.03 -47.67 64.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.103 -0.703 . . . . 71.44 109.103 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.04 -46.09 85.92 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -57.43 -54.85 42.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.161 1.385 . . . . 72.21 111.432 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -52.08 -36.83 51.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.706 1.202 . . . . 71.51 113.172 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -69.27 -36.3 76.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.896 0.771 . . . . 71.55 110.35 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.44 -32.06 71.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.108 0.867 . . . . 72.54 110.642 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 61.3 m -55.84 -41.57 74.49 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.075 0.55 . . . . 75.11 110.516 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -84.67 -35.98 22.23 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.547 0.739 . . . . 73.23 111.54 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -15.82 63.1 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.277 -0.889 . . . . 63.4 112.524 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.7 tp -104.84 -16.15 14.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.053 0.842 . . . . 41.22 112.206 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -72.2 134.67 45.79 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.446 -1.409 . . . . 72.22 110.085 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.32 10.1 84.38 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.777 1.18 . . . . 64.1 113.193 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -72.34 120.74 18.37 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.874 1.27 . . . . 71.43 110.078 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -87.79 120.07 28.75 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.19 1.796 . . . . 75.04 107.466 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.96 135.94 42.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.367 -0.975 . . . . 75.44 108.367 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.3 m 46.58 47.14 14.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.422 1.489 . . . . 71.51 112.194 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 18.0 m120 54.72 30.74 14.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.511 1.524 . . . . 63.02 112.786 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -136.2 -179.87 5.93 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.325 2.65 . . . . 74.53 106.48 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -139.59 133.84 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.326 -1.731 . . . . 60.05 106.326 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.89 172.79 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.352 -0.981 . . . . 71.53 108.352 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.59 140.13 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.28 -2.489 . . . . 65.43 104.28 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.81 142.72 41.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.807 1.243 . . . . 72.5 108.676 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -153.29 150.33 28.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.162 0.985 . . . . 71.32 109.665 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -85.55 163.49 18.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.098 1.359 . . . . 71.32 110.562 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -77.9 167.17 21.92 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.547 -0.538 . . . . 71.42 109.547 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.248 1.023 0 N-CA-C 105.422 -2.066 . . . . 61.35 105.422 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.2 tp . . . . . 0 C--O 1.223 -0.338 0 N-CA-C 106.971 -1.492 . . . . 72.35 106.971 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -65.45 -44.32 87.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.298 0.954 . . . . 71.41 110.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.84 60.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.502 1.121 . . . . 42.13 113.485 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.9 mtp -79.39 -6.6 57.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.062 1.345 . . . . 73.13 113.068 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -107.58 159.25 30.99 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 114.55 1.315 . . . . 72.02 114.55 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.66 158.94 54.87 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.215 3.276 . . . . 54.31 112.538 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -75.28 147.78 39.94 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.497 1.519 . . . . 75.11 109.165 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.35 17.41 62.52 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.529 -0.732 . . . . 51.44 114.656 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -124.35 102.97 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 105.325 -2.102 . . . . 73.02 105.325 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -83.78 155.39 23.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.508 1.123 . . . . 65.24 110.684 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.1 t -70.05 144.38 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.003 0.921 . . . . 62.23 110.193 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 50.7 tp -126.38 79.55 70.38 Favored Pre-proline 0 N--CA 1.452 -0.339 0 N-CA-C 107.346 -1.353 . . . . 71.44 107.346 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.18 163.81 37.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.124 1.883 . . . . 75.2 110.023 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.11 161.45 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.556 2.171 . . . . 73.01 109.774 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.451 -0.982 0 C-N-CA 121.43 1.42 . . . . 54.35 109.375 179.517 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.9 t . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 107.817 -1.179 . . . . 74.13 107.817 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -133.69 -176.97 4.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.4 1.88 . . . . 72.01 108.924 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.77 -43.86 5.45 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.649 -1.282 . . . . 75.23 111.607 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.5 mt -73.68 144.03 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.394 -1.335 . . . . 75.13 107.394 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 88.0 mt -124.18 157.2 35.28 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.737 1.615 . . . . 54.41 108.565 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -124.31 133.52 53.44 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.392 2.277 . . . . 71.32 106.837 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -120.29 146.95 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.601 1.16 . . . . 75.14 108.283 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -135.59 163.02 31.07 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.157 1.383 . . . . 74.0 109.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 65.08 14.69 9.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.952 2.101 . . . . 70.3 113.851 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.54 153.13 91.07 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 120.796 -1.19 . . . . 73.15 109.588 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.47 140.11 56.34 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.762 2.308 . . . . 74.53 110.532 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.58 -30.1 71.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.913 1.079 . . . . 75.03 113.913 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -130.26 117.91 20.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.888 -1.523 . . . . 72.25 106.888 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 tt -165.88 140.89 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.958 2.503 . . . . 72.23 104.366 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 18.0 p -75.12 174.4 9.47 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.027 0.831 . . . . 64.22 109.944 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.06 76.21 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 107.126 -1.435 . . . . 52.05 107.126 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -47.84 -54.3 12.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 128.326 2.65 . . . . 71.22 112.739 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -62.21 -49.51 75.48 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.36 0.527 . . . . 75.12 110.099 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 72.3 mmm -56.26 -49.44 74.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 119.213 -0.422 . . . . 75.2 111.088 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . 0.407 ' CZ ' HD12 ' B' ' 48' ' ' ILE . 14.8 m-85 -61.51 -43.96 97.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.559 -1.21 . . . . 73.25 110.009 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -58.59 7.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.105 -1.072 . . . . 43.25 108.105 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 64.2 mt -47.61 -67.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.854 2.062 . . . . 64.45 112.345 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -68.34 -26.93 65.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.281 0.845 . . . . 74.21 113.281 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 -20.65 66.44 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 124.874 1.226 . . . . 64.34 112.983 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -26.75 68.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.387 1.593 . . . . 75.41 110.486 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -85.88 -10.16 55.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.784 0.661 . . . . 74.04 112.784 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.96 -171.59 22.37 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.355 0.98 . . . . 40.33 111.54 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.75 153.14 73.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.776 2.984 . . . . 70.3 111.36 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mt -118.21 138.25 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.286 -1.005 . . . . 71.21 108.286 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -51.9 9.78 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.17 1.388 . . . . 70.12 111.485 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -161.9 157.58 24.08 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.76 0.824 . . . . 74.34 109.473 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . 0.407 HD12 ' CZ ' ' B' ' 36' ' ' TYR . 21.4 mt -145.78 142.36 21.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.993 1.317 . . . . 73.33 108.268 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -145.45 150.76 37.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.763 -1.569 . . . . 72.42 106.763 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.16 147.27 30.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.468 0.707 . . . . 65.44 109.656 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.28 135.6 31.77 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.328 -1.909 . . . . 75.41 108.328 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.95 -21.36 5.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.876 1.065 . . . . 62.22 113.876 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.7 p -69.69 159.8 82.35 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 104.56 -2.385 . . . . 72.14 104.56 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.02 -45.36 36.56 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.505 1.47 . . . . 75.52 111.241 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.07 -5.8 29.3 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.826 1.417 . . . . 73.54 114.826 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -116.45 -18.07 10.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.293 1.406 . . . . 64.22 112.799 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -52.55 126.96 21.21 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.822 0.849 . . . . 75.44 109.686 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.05 48.33 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.459 -1.19 . . . . 70.13 112.653 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 61.6 p -127.56 146.81 50.4 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.03 1.915 . . . . 70.21 107.535 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -156.23 174.26 15.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.614 0.366 . . . . 41.21 111.229 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.14 155.46 48.13 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.396 1.078 . . . . 74.52 109.17 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -138.63 139.83 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 104.412 -2.44 . . . . 73.1 104.412 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.39 123.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.56 -2.015 . . . . 53.35 105.56 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -97.91 166.15 11.59 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.827 -1.546 . . . . 71.42 106.827 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -71.28 -47.6 55.9 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.754 -0.591 . . . . 72.44 109.774 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.86 154.6 38.06 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.911 0.778 . . . . 73.15 110.737 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.93 -37.5 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 113.736 1.013 . . . . 72.0 113.736 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -57.95 -48.23 80.58 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.161 -0.923 . . . . 75.03 111.528 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.14 -40.87 95.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 123.935 0.772 . . . . 72.24 109.349 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -54.71 42.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.156 -0.313 . . . . 54.21 110.156 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -69.76 -30.18 67.7 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.523 -0.751 . . . . 64.34 111.894 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.67 -53.97 51.79 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.109 -1.071 . . . . 72.33 108.109 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.03 93.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.417 1.087 . . . . 63.5 110.611 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 13.3 t -46.56 -69.16 0.14 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.823 1.249 . . . . 73.44 113.018 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.39 -27.77 67.37 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.074 1.138 . . . . 71.21 114.074 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -33.71 72.49 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.775 0.716 . . . . 73.13 109.607 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -90.01 -24.91 21.09 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.987 1.315 . . . . 71.33 112.992 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -57.34 111.26 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.481 1.512 . . . . 42.53 110.675 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.11 9.85 57.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.324 1.916 . . . . 74.02 114.43 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -61.74 130.03 43.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.543 1.671 . . . . 73.13 110.363 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -89.84 100.92 13.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.417 2.287 . . . . 64.13 110.653 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.84 133.51 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.402 1.081 . . . . 72.22 110.621 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m 42.79 49.41 5.03 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.827 1.651 . . . . 50.43 112.121 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 32.1 t30 58.94 33.25 22.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.603 2.361 . . . . 64.33 112.878 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -140.16 158.33 44.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.985 -1.072 . . . . 72.12 108.26 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -118.07 118.14 31.09 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.822 -1.547 . . . . 75.13 106.822 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.6 mt -73.63 174.05 8.87 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.692 -1.225 . . . . 65.15 107.692 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.02 137.4 52.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.094 -2.558 . . . . 71.33 104.094 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 t -126.83 121.67 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.743 -1.947 . . . . 74.41 105.743 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 34.6 tp -136.15 153.21 51.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.573 -0.899 . . . . 63.44 108.573 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -74.75 163.11 28.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.694 0.798 . . . . 73.12 108.949 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -104.49 154.58 19.72 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.957 -1.868 . . . . 60.53 105.957 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 C--O 1.246 0.871 0 C-N-CA 124.387 1.075 . . . . 74.1 110.652 -178.587 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 21.8 tp . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 110.302 -0.258 . . . . 53.01 110.302 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.93 -36.87 80.87 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.965 -0.459 . . . . 64.44 111.042 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.5 -37.62 36.27 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.378 1.071 . . . . 33.22 110.851 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.2 mtp -66.41 -12.51 57.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.519 1.128 . . . . 74.43 111.846 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -99.25 157.28 34.32 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 124.095 0.958 . . . . 63.1 110.107 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -89.41 172.5 4.09 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.199 2.599 . . . . 64.21 109.017 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.63 159.34 33.2 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.606 -0.684 . . . . 54.24 110.906 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.2 20.97 58.04 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 117.825 -1.541 . . . . 75.22 115.451 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -125.49 140.09 53.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.985 1.893 . . . . 74.03 110.631 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -122.26 151.28 41.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.572 1.949 . . . . 62.24 109.104 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.86 151.38 6.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 122.563 1.173 . . . . 64.43 110.604 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.0 tp -126.48 87.47 56.3 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 103.398 -2.815 . . . . 74.11 103.398 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -64.01 168.9 11.35 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.222 2.615 . . . . 71.32 111.226 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.74 163.3 35.83 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.37 1.38 . . . . 64.12 108.661 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo . . . . . 0 C--O 1.24 0.579 0 C-N-CA 123.604 2.869 . . . . 73.33 113.745 179.462 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.568 HG11 ' HG2' ' B' ' 71' ' ' LYS . 35.2 t . . . . . 0 C--O 1.236 0.365 0 N-CA-C 107.511 -1.292 . . . . 75.14 107.511 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -61.92 152.52 31.79 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.743 1.217 . . . . 73.24 110.43 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 -59.11 -61.48 2.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.418 -0.801 . . . . 72.13 112.903 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.79 134.41 26.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.005 -0.739 . . . . 74.51 109.005 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.35 157.52 26.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.947 2.099 . . . . 63.25 109.175 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -124.93 135.7 53.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.493 1.917 . . . . 72.32 108.397 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mm -118.12 143.07 29.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 126.193 1.797 . . . . 74.12 108.767 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -133.6 162.59 31.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.324 . . . . 73.44 107.571 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 21.5 t30 65.58 30.23 10.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.422 2.689 . . . . 72.33 111.666 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 50.8 mt -70.06 147.67 95.78 Favored Pre-proline 0 C--O 1.236 0.348 0 O-C-N 121.736 -0.603 . . . . 72.14 111.196 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.99 152.49 68.16 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.826 2.351 . . . . 74.04 110.579 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -83.95 -11.03 57.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.496 0.718 . . . . 72.31 112.107 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.86 113.85 17.12 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.36 -2.089 . . . . 75.54 105.36 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -163.2 167.62 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.785 -1.561 . . . . 73.35 106.785 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -133.98 175.71 9.23 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.203 1.801 . . . . 74.11 111.607 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.02 -35.87 80.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.881 -0.785 . . . . 61.24 108.881 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.43 -50.63 71.1 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.771 -0.455 . . . . 74.23 109.771 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -63.72 -55.07 26.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.582 1.153 . . . . 71.04 111.374 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.8 mmm -57.28 -27.67 62.33 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 113.749 1.018 . . . . 70.53 113.749 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -93.85 -20.62 19.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.909 0.777 . . . . 65.0 111.208 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.9 -52.19 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.219 0.918 . . . . 54.12 110.957 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.99 -52.75 40.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.786 1.634 . . . . 61.22 110.858 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.93 -30.47 39.96 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 118.146 -0.93 . . . . 61.11 113.13 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -31.58 78.55 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.871 -0.892 . . . . 64.2 110.871 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -60.4 -15.35 25.38 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.203 1.401 . . . . 71.45 113.023 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.01 -16.76 14.21 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.315 1.046 . . . . 74.32 113.616 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.1 174.72 29.18 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.055 1.312 . . . . 74.53 110.902 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.48 145.4 64.64 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 124.297 3.331 . . . . 63.21 110.946 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 24.4 mt -99.78 124.68 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.547 1.139 . . . . 55.11 111.231 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -83.19 -56.34 3.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.56 -1.274 . . . . 74.02 107.56 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -157.72 152.85 25.72 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.426 1.012 . . . . 64.3 112.456 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mt -134.46 118.29 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.963 2.105 . . . . 70.02 107.627 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -127.21 120.34 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.119 -2.178 . . . . 73.23 105.119 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.41 159.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.235 2.214 . . . . 73.22 111.095 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.88 146.69 38.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.107 -1.597 . . . . 40.24 109.107 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -112.73 -45.61 3.2 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.471 1.108 . . . . 73.1 111.61 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 15.6 p -74.42 162.14 75.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.941 1.696 . . . . 63.33 111.858 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.88 9.29 2.03 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.626 2.884 . . . . 60.44 112.319 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.64 1.51 11.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.889 1.276 . . . . 71.13 111.521 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 35.6 p -116.75 -1.2 12.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.801 2.04 . . . . 74.02 109.461 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -63.77 145.9 54.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.806 2.042 . . . . 71.13 112.194 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.52 6.16 70.05 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.851 -0.971 . . . . 74.15 112.873 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 21.1 p -141.1 150.35 42.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.041 1.42 . . . . 64.22 110.613 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.92 171.32 14.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.444 1.498 . . . . 74.41 109.107 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -118.11 159.98 22.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.245 1.018 . . . . 71.13 109.428 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.36 139.11 47.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.278 -1.379 . . . . 74.22 107.278 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 t -127.71 123.74 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.757 -1.942 . . . . 73.24 105.757 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.3 165.78 11.52 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 105.13 -2.174 . . . . 63.44 105.13 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -73.32 -35.0 65.99 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.291 -0.881 . . . . 74.24 112.052 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.2 162.52 22.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.946 0.794 . . . . 75.55 112.54 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 tt -67.84 -43.49 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.051 0.94 . . . . 65.21 109.596 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.98 -41.81 99.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.754 1.222 . . . . 74.44 111.474 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.49 -44.92 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.511 -0.922 . . . . 54.22 108.511 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.42 85.79 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.129 0.572 . . . . 62.44 109.524 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.568 ' HG2' HG11 ' B' ' 17' ' ' VAL . 41.2 mtpt -59.24 -48.87 79.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.375 1.07 . . . . 72.42 111.111 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.79 -40.01 94.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.326 0.967 . . . . 52.32 110.827 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.62 66.83 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.638 -0.696 . . . . 65.1 111.486 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.56 -64.37 0.97 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 117.85 -1.071 . . . . 73.34 109.319 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.34 -33.67 74.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.125 1.329 . . . . 70.33 112.969 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -64.47 -31.07 72.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.043 0.383 . . . . 74.33 110.262 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.4 tp -102.47 -26.23 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.882 1.438 . . . . 73.23 114.882 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -61.8 106.31 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.364 1.865 . . . . 75.52 110.34 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.54 10.74 63.19 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.55 -1.139 . . . . 51.44 113.19 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.22 121.26 10.93 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.934 1.367 . . . . 71.45 109.894 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.83 112.19 15.74 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.08 1.752 . . . . 64.31 107.815 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.97 148.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.348 0.659 . . . . 74.23 110.589 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 87.6 m 34.0 54.95 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.294 2.638 . . . . 65.25 114.588 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 52.33 31.26 9.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.859 2.064 . . . . 43.42 112.452 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -140.23 -170.71 3.03 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 128.781 2.833 . . . . 43.44 107.864 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -148.64 153.0 37.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.87 2.068 . . . . 64.34 105.741 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.1 172.84 6.6 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.421 -0.955 . . . . 73.44 108.421 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.21 150.66 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.068 -1.456 . . . . 75.12 107.068 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.1 136.17 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.476 1.91 . . . . 54.41 107.626 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.3 tp -146.61 151.61 37.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.209 1.803 . . . . 71.03 107.824 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . 0.46 ' CZ ' HG13 ' B' ' 17' ' ' VAL . 7.0 m-85 -94.6 155.82 16.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.029 0.931 . . . . 73.32 111.288 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -80.5 175.55 10.56 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.212 0.605 . . . . 75.0 112.52 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 125.931 1.692 . . . . 75.51 109.985 -179.094 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 61.8 tp . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 118.543 -0.741 . . . . 53.32 110.273 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -66.52 -32.51 73.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.822 1.192 . . . . 53.35 110.018 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.84 56.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.331 1.052 . . . . 75.42 111.917 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 67.3 mtp -88.17 -12.26 44.45 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.293 1.437 . . . . 74.55 113.245 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -114.61 160.81 31.75 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 125.707 1.603 . . . . 54.54 111.59 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.25 167.42 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.232 1.954 . . . . 71.11 110.151 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.87 169.95 15.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.403 0.681 . . . . 71.41 110.306 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 80.51 22.42 62.37 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.034 -1.041 . . . . 72.21 113.277 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -124.58 156.86 36.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.851 -1.166 . . . . 74.43 107.851 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.0 149.47 47.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.032 0.933 . . . . 42.45 110.09 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.63 151.12 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.076 -0.712 . . . . 73.43 109.076 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.419 HD22 HG11 ' B' ' 50' ' ' VAL . 34.2 tp -131.09 82.98 61.93 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 107.978 -1.119 . . . . 70.32 107.978 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.45 164.18 7.49 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.872 3.048 . . . . 71.11 112.236 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.46 162.38 20.92 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.053 2.502 . . . . 72.53 112.648 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo . . . . . 0 N--CA 1.458 -0.606 0 C-N-CA 122.879 2.386 . . . . 73.31 110.485 179.464 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 t . . . . . 0 C--O 1.233 0.2 0 N-CA-C 106.307 -1.738 . . . . 65.53 106.307 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -134.46 158.84 42.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.494 -1.298 . . . . 64.13 107.494 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -65.42 -23.37 66.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 117.811 -1.09 . . . . 61.13 113.084 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 66.9 mt -89.53 126.11 42.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.441 -2.059 . . . . 75.43 105.441 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 95.0 mt -120.47 163.27 18.19 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.498 1.519 . . . . 64.42 109.229 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -129.29 136.49 50.12 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.211 1.804 . . . . 75.11 108.295 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mm -129.41 149.86 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.108 0.963 . . . . 73.35 108.5 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.469 ' HE ' HG11 ' B' ' 88' ' ' VAL . 56.1 mtm180 -139.49 163.87 31.39 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.813 1.645 . . . . 74.43 108.088 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 71.27 19.34 5.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.935 1.694 . . . . 72.05 111.222 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.86 155.4 89.86 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.119 0.968 . . . . 73.01 111.511 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.51 147.37 70.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.325 2.017 . . . . 71.43 107.31 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -82.8 -17.59 43.56 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.732 -0.605 . . . . 75.22 112.333 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -124.72 91.61 3.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.171 0.989 . . . . 75.34 110.572 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -146.69 139.15 19.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.191 -1.04 . . . . 70.1 108.191 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 1.2 p -89.26 164.7 14.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.368 1.067 . . . . 71.35 109.595 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.46 -23.43 65.86 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.594 -0.521 . . . . 74.35 109.594 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.5 -57.61 11.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.521 2.728 . . . . 63.44 110.215 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -72.26 -35.11 68.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.81 0.844 . . . . 73.1 109.933 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.6 mmm -63.43 -48.94 75.7 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.957 -0.757 . . . . 71.25 108.957 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.19 -29.83 70.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.385 -0.817 . . . . 75.44 110.387 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.75 -65.17 0.72 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.471 -0.937 . . . . 74.54 108.471 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.77 -60.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 126.128 1.771 . . . . 74.33 111.92 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -68.64 -17.16 64.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.106 -0.473 . . . . 72.54 112.047 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.96 -27.45 34.2 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.264 1.411 . . . . 41.21 113.068 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -52.59 -40.67 62.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.591 1.696 . . . . 64.11 109.507 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -77.0 -11.77 59.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 116.795 2.146 . . . . 75.15 116.795 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.97 20.53 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.362 1.437 . . . . 75.23 111.49 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.56 147.26 90.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.219 2.613 . . . . 63.23 111.666 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.9 131.7 50.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.55 1.54 . . . . 63.32 109.545 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.77 -58.08 3.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.375 -1.343 . . . . 54.41 107.375 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -162.85 160.86 25.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 0.667 . . . . 64.23 110.594 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mt -142.29 145.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.298 1.839 . . . . 75.44 108.548 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -140.59 144.44 35.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 104.377 -2.453 . . . . 64.02 104.377 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . 0.419 HG11 HD22 ' A' ' 415' ' ' LEU . 17.3 m -129.35 162.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.315 1.046 . . . . 62.41 111.563 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.55 146.0 39.73 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.003 -0.839 . . . . 43.34 111.003 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -124.36 -0.63 8.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.652 1.581 . . . . 70.14 112.589 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -127.02 164.06 37.68 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.378 1.871 . . . . 73.05 109.814 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 -25.64 80.31 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.732 2.288 . . . . 60.1 113.956 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -93.39 1.58 56.84 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.73 1.15 . . . . 73.13 111.542 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.6 p -117.11 -28.78 6.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.283 1.033 . . . . 71.51 111.568 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 139.52 58.48 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.056 -1.028 . . . . 72.3 108.438 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.63 -23.51 35.86 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.302 1.43 . . . . 54.31 113.345 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.3 p -119.69 157.52 28.35 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 107.651 -1.24 . . . . 74.0 107.651 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.13 175.26 10.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.348 -0.845 . . . . 64.2 111.025 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -134.1 141.54 47.18 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.705 -1.22 . . . . 73.51 107.705 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 88.6 t -125.73 149.54 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.578 -1.638 . . . . 70.34 106.578 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t -127.73 132.6 68.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.48 -0.933 . . . . 74.1 108.48 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -101.09 164.02 12.01 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.667 -1.605 . . . . 74.5 106.667 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.7 -33.01 20.17 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.8 -1.187 . . . . 75.31 110.087 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -123.57 138.37 54.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.636 0.774 . . . . 74.23 109.868 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 tt -60.1 -30.55 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.594 -1.262 . . . . 73.13 107.594 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -60.46 -22.99 64.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.324 1.05 . . . . 74.23 111.647 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.23 -43.95 10.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.359 0.981 . . . . 70.31 108.441 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.21 74.67 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.226 -0.657 . . . . 70.23 109.226 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.35 -54.43 47.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.208 1.403 . . . . 72.23 109.817 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -64.88 -51.91 59.44 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.12 0.568 . . . . 73.33 110.955 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.39 -29.5 61.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.716 0.635 . . . . 54.31 112.716 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -64.37 0.98 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.061 -1.088 . . . . 75.22 108.061 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.55 -32.73 73.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.755 -0.64 . . . . 74.03 111.953 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -78.77 -16.4 57.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.612 0.967 . . . . 62.53 113.612 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 24.3 tp -110.68 -19.01 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.282 1.401 . . . . 73.2 112.331 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 83.9 p -58.26 118.05 5.08 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.061 1.345 . . . . 71.44 112.479 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.76 82.62 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.885 -1.508 . . . . 72.03 113.616 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.3 122.93 13.69 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.632 1.716 . . . . 72.14 108.728 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -96.72 115.73 27.93 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 126.079 1.752 . . . . 71.25 110.134 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 m -144.5 159.01 14.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.199 1.4 . . . . 74.21 107.535 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 69.1 m 43.85 41.56 3.89 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.206 1.402 . . . . 55.21 112.472 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 63.1 t30 56.75 21.77 6.27 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.632 2.373 . . . . 71.31 113.659 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -132.59 -179.3 5.37 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.874 2.07 . . . . 75.14 108.385 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -122.61 147.61 46.22 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.647 -1.612 . . . . 71.52 106.647 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 33.7 mt -96.31 156.39 16.36 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.343 -0.984 . . . . 71.35 108.343 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . 0.469 HG11 ' HE ' ' B' ' 24' ' ' ARG . 70.9 t -110.41 128.55 66.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.955 -2.609 . . . . 63.01 103.955 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 94.4 t -124.7 111.89 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.05 -1.833 . . . . 63.45 106.05 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -136.5 164.35 28.37 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.292 1.037 . . . . 44.31 110.963 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -89.27 163.11 15.51 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.17 1.388 . . . . 72.03 111.364 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -101.24 169.1 9.13 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.567 -2.012 . . . . 74.05 105.567 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.46 -0.941 . . . . 55.1 108.46 -179.734 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 34.0 tp . . . . . 0 N--CA 1.458 -0.053 0 CA-C-O 119.444 -0.313 . . . . 53.44 111.135 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.5 -9.47 58.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.814 0.733 . . . . 75.32 112.239 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -123.22 -6.94 8.26 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.11 1.764 . . . . 74.33 112.504 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 57.7 mtp -73.73 -24.72 59.94 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.338 -1.476 . . . . 61.44 114.682 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -83.37 153.37 65.57 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 118.814 0.734 . . . . 74.22 111.546 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.74 172.14 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.477 3.451 . . . . 63.31 112.505 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -81.99 157.6 24.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.662 1.985 . . . . 73.41 110.388 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.38 19.08 53.89 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.052 0.834 . . . . 61.25 112.577 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -124.06 158.18 32.79 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.513 1.125 . . . . 74.35 111.338 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -129.21 145.64 51.29 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.909 1.684 . . . . 73.23 107.015 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.1 t -74.25 151.07 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.605 -0.887 . . . . 75.0 108.605 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.5 tp -124.19 85.51 54.98 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 105.062 -2.199 . . . . 73.31 105.062 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.23 167.9 10.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.432 2.755 . . . . 73.31 112.252 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.19 164.28 36.29 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.353 2.035 . . . . 54.11 110.107 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo . . . . . 0 N--CA 1.458 -0.608 0 C-N-CA 123.925 3.083 . . . . 71.02 112.801 179.214 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 107.404 -1.332 . . . . 64.44 107.404 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -140.45 168.02 20.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.875 1.27 . . . . 55.15 110.273 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -82.57 -9.0 59.59 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.476 -1.39 . . . . 60.34 111.617 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 30.6 mt -106.18 141.26 21.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.321 -1.363 . . . . 65.01 107.321 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -116.24 151.59 35.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.603 1.561 . . . . 51.02 108.039 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -121.32 122.27 39.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.01 1.724 . . . . 53.13 106.696 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -114.07 147.95 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.12 1.768 . . . . 71.14 109.426 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -142.69 163.79 31.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.004 1.722 . . . . 64.44 111.362 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t30 74.56 18.19 2.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.18 2.592 . . . . 70.31 111.691 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 mt -70.03 153.37 95.42 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 124.452 1.101 . . . . 73.21 110.737 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.08 159.57 47.38 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.319 2.679 . . . . 73.11 110.757 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.27 -11.01 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.108 -0.37 . . . . 72.44 111.183 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -127.39 104.47 7.94 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.326 -2.102 . . . . 70.44 105.326 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 tt -158.58 155.08 4.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.193 1.397 . . . . 61.11 108.596 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -105.28 169.81 8.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.304 1.442 . . . . 73.53 111.106 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.11 84.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.05 -1.093 . . . . 73.55 108.05 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.1 -45.8 91.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.45 1.5 . . . . 61.54 111.675 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.74 -37.8 85.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.262 0.625 . . . . 54.11 110.628 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.9 mmm -73.81 -53.31 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.809 1.243 . . . . 65.42 111.736 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -59.79 -30.07 68.65 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 118.386 -0.816 . . . . 73.42 111.323 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.52 -61.32 2.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.991 0.814 . . . . 73.04 109.417 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 -65.4 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 125.781 1.633 . . . . 73.52 112.625 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -63.32 -34.45 77.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.596 0.961 . . . . 74.24 113.596 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.53 -24.22 77.08 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.088 0.858 . . . . 61.43 112.028 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -64.01 -14.67 55.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.022 0.911 . . . . 64.52 113.077 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -105.08 -4.48 21.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.566 1.546 . . . . 75.54 111.771 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.71 173.38 13.16 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.426 1.012 . . . . 71.21 111.637 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.53 128.85 21.03 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.544 2.829 . . . . 62.03 112.04 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.76 135.7 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.57 1.548 . . . . 62.42 108.179 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -81.25 -62.69 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 106.559 -1.645 . . . . 75.22 106.559 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -151.87 160.98 43.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.557 0.617 . . . . 73.21 111.886 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.96 134.55 48.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 126.923 2.089 . . . . 63.13 107.019 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -130.2 128.11 41.04 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.585 -2.006 . . . . 72.42 105.585 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 m -108.76 147.33 13.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.791 1.236 . . . . 52.15 109.009 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.35 135.24 14.97 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.471 -1.052 . . . . 72.02 110.471 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.96 -15.05 9.35 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.232 1.197 . . . . 63.32 114.232 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 21.6 p -77.71 160.21 75.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.411 -1.7 . . . . 74.45 106.411 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.54 -20.43 49.54 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.282 1.988 . . . . 73.21 114.021 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.74 -21.24 20.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.982 0.913 . . . . 64.4 113.064 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 80.4 p -101.58 -12.33 18.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.891 0.768 . . . . 72.02 112.374 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 -64.02 116.5 5.94 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.066 -1.457 . . . . 73.13 107.066 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.93 16.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.7 -1.056 . . . . 51.42 112.753 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -128.5 159.34 35.78 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 118.518 1.159 . . . . 65.41 108.26 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.98 170.38 20.69 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.291 -0.881 . . . . 71.32 110.503 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -122.31 142.57 50.35 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.716 -1.216 . . . . 73.12 107.716 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.06 137.63 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 126.174 1.79 . . . . 74.41 106.775 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -129.03 128.35 67.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 118.422 -0.799 . . . . 63.15 109.893 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -97.45 166.15 11.66 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.609 1.164 . . . . 73.33 107.878 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -74.92 -55.3 5.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.923 0.889 . . . . 75.34 108.72 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.98 121.44 32.08 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 114.274 1.213 . . . . 62.04 114.274 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.4 tt -66.08 -19.41 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.681 -0.489 . . . . 74.41 109.681 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.9 -60.83 2.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.322 1.049 . . . . 73.34 108.387 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.08 -36.69 70.88 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.785 0.834 . . . . 71.03 111.738 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -29.69 62.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.247 0.476 . . . . 74.22 112.014 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -80.05 -46.11 17.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.946 -1.096 . . . . 72.04 108.404 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -57.22 -32.2 66.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.268 0.556 . . . . 72.2 110.592 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.25 -43.95 18.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.269 1.428 . . . . 64.14 111.769 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 11.5 p -55.83 -42.36 75.6 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.198 0.908 . . . . 71.4 110.906 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.64 -18.17 62.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.401 0.519 . . . . 63.41 112.401 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -95.53 -17.88 21.07 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.678 0.791 . . . . 71.15 112.037 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 12.0 tp -101.52 -3.5 28.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.701 0.682 . . . . 74.23 112.534 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.7 p -68.08 134.9 51.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.652 1.215 . . . . 73.02 111.505 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.38 62.44 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.219 -0.926 . . . . 60.13 113.013 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -68.49 141.33 55.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.109 1.455 . . . . 73.31 110.876 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -90.45 127.66 36.28 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.821 1.248 . . . . 74.22 109.286 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.01 125.39 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 127.779 2.432 . . . . 54.14 109.034 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 72.5 m 50.78 41.98 27.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.779 1.232 . . . . 73.42 110.738 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 20.2 m120 61.19 14.64 5.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.476 1.91 . . . . 62.42 113.469 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -122.06 169.77 10.51 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.626 1.971 . . . . 74.02 107.461 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -107.22 -177.0 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.085 -1.079 . . . . 72.44 108.085 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.62 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.555 2.342 . . . . 54.43 106.072 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -133.25 110.52 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.627 -1.619 . . . . 44.33 106.627 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.88 144.59 9.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.007 -1.479 . . . . 75.43 107.007 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 tp -154.27 154.7 33.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.089 1.356 . . . . 43.31 107.342 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -81.24 164.28 22.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.841 1.656 . . . . 64.02 110.482 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -101.06 157.79 16.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.874 0.47 . . . . 73.25 110.229 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 36.0 m120 . . . . . 0 C--O 1.256 1.41 0 CA-C-O 115.945 -1.978 . . . . 62.3 110.229 -179.39 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 12.3 tp . . . . . 0 CA--C 1.529 0.161 0 N-CA-C 110.489 -0.189 . . . . 72.01 110.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -79.69 -51.51 9.14 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.907 -0.775 . . . . 74.02 108.907 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.19 89.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.511 1.924 . . . . 61.41 113.291 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.0 mtp -57.94 -36.87 73.12 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.307 1.043 . . . . 73.05 113.377 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -68.47 149.92 97.86 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.374 0.988 . . . . 74.11 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.44 160.47 47.68 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.162 1.908 . . . . 64.4 111.064 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -71.06 160.87 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.72 -1.127 . . . . 71.21 109.525 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.72 17.46 63.65 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 121.651 -0.655 . . . . 62.01 113.296 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -124.47 156.96 36.36 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.487 1.515 . . . . 75.11 108.009 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -136.68 144.58 44.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.733 1.213 . . . . 63.14 109.549 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.8 t -70.91 151.18 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.566 -0.901 . . . . 53.1 108.566 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 17.8 tp -120.72 83.44 35.75 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.699 1.6 . . . . 64.23 108.378 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.28 162.26 17.68 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.2 2.6 . . . . 53.44 112.909 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.65 168.39 22.84 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.109 3.206 . . . . 75.42 111.094 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 CA--C 1.539 0.76 0 C-N-CA 122.434 2.089 . . . . 75.45 109.855 177.662 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.2 t . . . . . 0 C--O 1.236 0.367 0 N-CA-C 108.501 -0.926 . . . . 31.35 108.501 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -128.65 171.37 12.24 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.183 1.393 . . . . 74.42 109.663 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -30.04 70.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.951 0.723 . . . . 71.12 112.951 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.93 135.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.625 1.57 . . . . 74.23 109.519 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 98.4 mt -126.47 158.71 35.34 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.005 1.722 . . . . 52.23 110.973 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -128.26 108.49 10.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.59 1.556 . . . . 63.23 110.635 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.84 144.71 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 127.19 2.196 . . . . 74.3 107.73 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' B' ' 59' ' ' THR . 58.0 mtm180 -144.56 164.19 31.65 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.97 2.508 . . . . 73.22 110.98 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 52.1 t30 72.43 11.26 5.74 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.139 1.376 . . . . 62.11 111.544 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.55 154.58 79.19 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 124.851 1.261 . . . . 73.12 111.231 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.63 150.75 74.96 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.245 1.963 . . . . 73.14 112.652 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -83.37 -15.39 50.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.504 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -130.06 109.34 10.77 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.524 1.53 . . . . 70.24 107.506 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 15.9 tt -162.57 171.18 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 128.386 2.675 . . . . 64.15 105.466 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -126.18 165.87 18.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.585 1.154 . . . . 72.14 109.976 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.35 74.91 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.543 -0.91 . . . . 23.2 108.543 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.43 -54.61 45.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.831 1.652 . . . . 71.43 109.513 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.5 -36.46 84.27 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.187 1.395 . . . . 51.12 111.363 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 66.2 mmm -64.69 -58.2 6.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.473 -0.936 . . . . 70.42 108.473 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -58.8 -35.76 73.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.635 0.774 . . . . 75.01 110.915 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -59.81 -26.3 65.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 75.13 111.744 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.06 -69.74 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.01 0.924 . . . . 73.05 108.986 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -55.31 -38.09 68.22 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.921 1.452 . . . . 75.3 114.921 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -33.66 85.93 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.302 0.953 . . . . 73.14 112.942 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -65.87 -29.14 69.55 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.109 -1.23 . . . . 64.41 110.221 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -79.89 -22.27 43.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.762 0.825 . . . . 73.23 110.263 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.68 168.93 19.44 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.875 1.702 . . . . 62.44 109.48 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -63.22 159.92 37.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.108 2.539 . . . . 60.22 113.505 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -113.29 143.9 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.686 1.995 . . . . 71.43 110.536 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.34 -56.18 2.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 125.216 1.406 . . . . 71.53 108.043 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -153.72 155.09 35.29 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.359 -1.348 . . . . 75.22 107.359 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -136.82 135.38 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 104.491 -2.411 . . . . 65.43 104.491 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -133.2 123.98 26.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.314 -2.106 . . . . 73.44 105.314 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.8 m -110.04 151.26 12.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.593 -1.262 . . . . 73.23 107.593 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.69 30.79 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.446 -1.062 . . . . 72.14 110.446 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.78 -38.86 3.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.463 -0.78 . . . . 61.34 111.22 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 30.0 p -69.38 161.6 72.43 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.388 -0.597 . . . . 65.42 109.388 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.2 -2.58 8.33 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.141 1.894 . . . . 70.01 112.255 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -105.84 -9.72 17.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.487 1.915 . . . . 70.11 111.868 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -116.62 -12.05 10.97 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.87 1.268 . . . . 71.44 110.723 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -57.58 142.09 45.8 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.55 -1.344 . . . . 64.53 108.341 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.16 -5.68 83.56 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 118.676 -1.069 . . . . 52.14 114.633 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . 0.422 HG22 ' HG2' ' B' ' 24' ' ' ARG . 36.1 p -124.52 153.85 41.45 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.399 1.6 . . . . 71.04 109.144 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.69 166.2 33.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.876 0.846 . . . . 72.54 109.525 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.94 141.98 51.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.532 -2.025 . . . . 72.35 105.532 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.84 142.56 42.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.591 -2.003 . . . . 74.44 105.591 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.78 134.33 65.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.222 -1.77 . . . . 74.42 106.222 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 9.8 m-85 -98.03 166.84 11.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.881 1.672 . . . . 64.42 111.472 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.8 -73.64 0.46 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.94 -1.504 . . . . 75.31 106.94 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -81.77 134.96 35.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.116 0.96 . . . . 71.41 109.332 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.46 HG22 ' H ' ' B' ' 67' ' ' ILE . 1.0 OUTLIER -58.65 -34.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 125.318 1.447 . . . . 62.21 108.443 177.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.33 -30.01 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.152 0.581 . . . . 72.41 110.874 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -71.43 -47.39 56.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.526 -0.916 . . . . 73.21 108.526 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -55.45 -42.94 74.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.768 0.827 . . . . 75.32 111.94 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -57.28 -61.9 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.38 1.072 . . . . 70.33 109.487 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -52.95 -53.09 54.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.769 0.827 . . . . 62.12 111.812 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.78 -38.67 86.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 114.428 1.27 . . . . 71.33 114.428 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 37.3 t -58.26 -49.81 75.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 118.437 0.562 . . . . 62.12 110.693 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -62.9 -52.77 61.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.795 -0.446 . . . . 73.24 109.795 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -58.36 -26.22 62.9 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.891 0.7 . . . . 74.34 112.891 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.9 tp -96.77 -6.75 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.432 0.901 . . . . 74.04 113.432 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -62.19 121.86 14.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.299 -1.501 . . . . 73.31 109.999 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.71 18.52 70.32 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.35 -1.25 . . . . 52.31 112.777 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -55.06 120.11 6.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.08 1.44 . . . . 71.45 110.32 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -72.88 115.99 12.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.69 2.396 . . . . 73.03 110.749 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.12 144.47 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.156 1.382 . . . . 73.2 108.83 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.0 m 39.73 52.18 2.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 73.31 112.992 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.36 23.54 9.03 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.089 1.356 . . . . 72.33 113.69 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -136.85 -176.6 4.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.591 2.356 . . . . 73.54 107.517 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.47 137.4 38.67 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.956 1.703 . . . . 74.32 107.071 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.39 148.94 24.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.335 0.588 . . . . 74.11 110.446 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.87 156.72 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.117 1.767 . . . . 62.33 107.186 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 93.2 t -142.33 123.12 11.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.714 -2.328 . . . . 64.44 104.714 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 42.4 tp -151.48 146.09 25.66 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.776 0.83 . . . . 74.01 109.754 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -80.37 156.63 26.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.158 -0.682 . . . . 75.0 109.158 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -75.71 175.39 8.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.373 -0.973 . . . . 73.2 108.373 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 124.302 1.041 . . . . 73.24 112.329 -178.472 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.3 tp . . . . . 0 C--O 1.225 -0.192 0 N-CA-C 107.244 -1.391 . . . . 64.04 107.244 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.58 -49.11 73.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.765 0.257 . . . . 65.34 110.816 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.51 -24.89 61.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.53 1.532 . . . . 30.04 113.777 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 62.4 mtp -86.59 -17.59 33.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.335 -0.853 . . . . 63.34 111.416 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -90.42 146.79 35.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 119.017 0.826 . . . . 53.02 111.844 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.84 163.85 23.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.292 2.661 . . . . 61.24 111.045 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -76.86 173.47 11.67 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.465 -0.939 . . . . 63.13 108.465 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 78.62 18.89 74.72 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 121.372 -0.83 . . . . 51.52 111.731 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.8 117.17 19.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.523 1.529 . . . . 74.32 108.901 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.42 148.0 22.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.45 1.1 . . . . 72.11 108.119 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.71 151.96 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.819 -1.175 . . . . 63.12 110.948 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 22.9 tp -120.67 77.9 29.18 Favored Pre-proline 0 C--O 1.237 0.401 0 N-CA-C 107.17 -1.419 . . . . 54.52 107.17 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.78 166.54 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.729 2.286 . . . . 73.41 111.467 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.17 174.92 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.882 1 C-N-CA 125.698 4.265 . . . . 53.42 115.063 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo . . . . . 0 N--CA 1.457 -0.666 0 C-N-CA 122.732 2.288 . . . . 65.43 110.993 179.667 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 41.4 t . . . . . 0 C--O 1.238 0.463 0 N-CA-C 107.87 -1.159 . . . . 73.33 107.87 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -98.03 175.25 6.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.635 1.174 . . . . 71.33 109.71 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.69 -34.31 72.72 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.686 -1.259 . . . . 72.52 114.215 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.12 138.05 21.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.512 1.125 . . . . 72.41 109.793 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.36 146.81 49.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.787 -1.19 . . . . 72.41 107.787 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -99.55 138.79 36.15 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.894 -1.891 . . . . 74.22 105.894 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.8 mm -117.03 134.86 59.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 126.155 1.782 . . . . 60.44 106.365 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -127.83 162.5 26.51 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.909 0.884 . . . . 61.3 110.485 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.57 38.35 12.45 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.656 1.983 . . . . 53.15 111.557 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 67.3 mt -76.56 153.76 83.62 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 108.488 -0.93 . . . . 62.33 108.488 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.96 163.94 35.71 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.632 2.221 . . . . 74.42 109.844 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -94.06 -13.03 27.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.994 0.518 . . . . 73.2 112.017 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -126.23 99.7 5.99 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.215 1.406 . . . . 74.43 107.943 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.1 143.43 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.565 -1.272 . . . . 51.44 107.565 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -98.45 178.13 5.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.98 0.912 . . . . 64.3 110.441 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.42 80.95 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.194 -0.457 . . . . 70.12 110.15 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -52.83 -60.54 3.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 127.73 2.412 . . . . 64.24 110.027 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.53 -47.55 81.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.426 1.49 . . . . 71.53 110.88 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.7 mmm -59.25 -39.09 81.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.088 -0.383 . . . . 75.21 110.865 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -76.37 -30.36 57.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.722 -0.656 . . . . 72.01 110.319 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.23 -27.13 65.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.67 1.188 . . . . 74.13 110.16 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 58.7 mt -76.26 -68.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.38 1.072 . . . . 74.2 109.16 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.32 -23.86 65.68 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.892 1.442 . . . . 73.14 114.892 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.92 -13.85 69.89 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 115.584 0.994 . . . . 64.12 115.584 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.51 -28.78 63.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.096 1.448 . . . . 72.51 110.592 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.82 -34.27 22.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.505 -0.76 . . . . 73.1 112.351 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.2 -166.55 39.67 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 120.204 1.365 . . . . 50.51 111.915 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.28 162.57 41.85 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.084 3.189 . . . . 62.45 112.858 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 59.5 mt -118.38 130.47 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.965 0.906 . . . . 61.31 109.247 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -88.44 -59.7 2.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.131 -1.063 . . . . 75.41 108.131 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -155.61 155.12 32.71 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.66 0.267 . . . . 74.31 110.851 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.05 127.79 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 104.984 -2.228 . . . . 73.12 104.984 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -128.31 120.82 27.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 102.842 -3.021 . . . . 74.21 102.842 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.65 144.65 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.736 0.814 . . . . 54.15 111.359 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.64 115.58 6.0 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 106.076 -2.81 . . . . 70.5 106.076 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -103.55 -10.89 18.12 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.194 0.998 . . . . 52.3 113.46 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.9 p -95.16 158.36 34.93 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.375 0.989 . . . . 71.13 108.461 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.59 -15.73 38.53 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.77 2.313 . . . . 73.11 113.045 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -97.29 -10.7 25.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.514 1.125 . . . . 74.24 112.286 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 39.9 p -116.96 -19.23 9.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.731 1.212 . . . . 61.33 112.21 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -53.26 150.32 6.32 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.434 1.494 . . . . 74.41 110.317 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.51 3.51 88.84 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.069 -1.406 . . . . 73.13 112.703 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 59.1 p -143.77 153.36 42.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.753 1.776 . . . . 64.33 109.979 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.35 172.82 12.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.751 2.021 . . . . 75.14 108.359 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -127.78 156.02 43.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.889 -1.522 . . . . 64.35 106.889 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.22 142.97 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.872 -1.159 . . . . 74.3 107.872 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.04 133.33 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.621 1.169 . . . . 73.03 108.369 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.99 154.12 17.91 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.374 -1.713 . . . . 71.23 106.374 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -72.69 -20.09 61.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 119.546 -0.862 . . . . 74.24 110.931 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.83 117.87 30.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.579 1.552 . . . . 52.43 109.681 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.76 -27.48 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 125.175 1.39 . . . . 62.4 111.966 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -73.36 -41.61 63.21 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.344 -1.472 . . . . 74.11 107.569 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -37.31 87.09 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.569 -0.901 . . . . 71.21 108.569 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.4 78.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.63 -0.7 . . . . 63.0 109.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -29.54 70.44 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.288 -0.863 . . . . 75.2 110.612 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.87 -53.31 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.129 1.331 . . . . 75.53 108.568 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.41 -14.15 17.36 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.086 1.143 . . . . 74.12 114.086 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 91.6 m -64.23 -66.62 0.52 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.448 1.022 . . . . 71.42 109.735 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.3 -34.56 76.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 119.13 -0.462 . . . . 74.22 110.168 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -64.83 -21.61 66.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.161 -0.923 . . . . 75.13 112.858 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 tp -106.54 -23.71 12.4 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.083 1.311 . . . . 74.35 111.324 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 12.5 m -69.79 110.1 4.76 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.005 -1.06 . . . . 72.01 108.352 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.44 10.54 53.58 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.649 1.595 . . . . 74.04 112.277 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -72.72 106.38 4.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.457 1.628 . . . . 71.23 107.627 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.93 124.93 27.11 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.349 -0.982 . . . . 63.4 108.349 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 m -141.31 144.37 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 118.983 0.811 . . . . 72.25 110.302 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 m 45.78 38.97 4.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.155 1.382 . . . . 53.04 113.384 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 64.79 20.91 12.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.558 1.143 . . . . 75.21 111.871 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.3 mmm-85 -135.6 -178.17 5.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.145 2.178 . . . . 73.34 108.257 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -133.07 155.31 49.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.867 1.267 . . . . 74.25 109.571 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -109.63 150.16 28.65 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.033 1.333 . . . . 74.44 107.514 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.18 112.76 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.335 -1.728 . . . . 74.31 106.335 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.56 141.73 14.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.072 -2.196 . . . . 74.35 105.072 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.57 142.51 45.33 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.269 -1.382 . . . . 63.43 107.269 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.11 114.0 21.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.457 -0.942 . . . . 74.21 108.457 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -74.05 148.22 42.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.192 -2.522 . . . . 73.03 104.192 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.06 1.744 . . . . 72.24 109.088 -178.868 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 52.0 tp . . . . . 0 CA--C 1.534 0.344 0 CA-C-O 118.427 -0.796 . . . . 74.1 111.29 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.26 -38.24 88.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.069 0.849 . . . . 64.14 110.202 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.46 68.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.631 0.773 . . . . 52.03 110.964 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.4 mtp -65.42 -41.56 93.45 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 118.908 -0.568 . . . . 72.52 110.261 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -65.1 155.71 83.23 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 112.983 0.734 . . . . 73.1 112.983 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.73 159.86 34.79 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.077 1.851 . . . . 52.44 109.33 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.48 161.97 25.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.363 -1.289 . . . . 73.21 110.631 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.79 17.89 60.84 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.76 -0.587 . . . . 44.25 113.693 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -125.16 157.68 35.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.298 1.439 . . . . 64.41 108.896 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -127.07 143.82 51.18 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.445 1.498 . . . . 63.11 109.305 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 63.1 t -71.08 141.06 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.675 -0.861 . . . . 61.13 108.675 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 28.7 tp -117.17 84.05 16.49 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.096 1.358 . . . . 71.01 107.547 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.12 166.04 24.47 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.185 1.924 . . . . 74.42 110.041 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.21 171.84 2.12 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.615 2.877 . . . . 64.34 113.413 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 CA--C 1.536 0.622 0 C-N-CA 123.621 2.881 . . . . 63.42 110.369 178.252 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.447 -0.575 . . . . 71.14 109.447 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -140.58 159.21 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.263 -1.754 . . . . 72.44 106.263 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -56.24 -32.11 64.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.597 1.959 . . . . 73.34 111.917 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 53.4 mt -75.13 123.67 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 71.22 107.306 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 mt -120.15 126.53 50.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.733 2.013 . . . . 74.15 108.204 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.11 134.36 39.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.225 1.41 . . . . 74.42 108.917 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.2 mm -124.16 154.86 31.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.871 0.868 . . . . 75.31 109.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -135.01 163.52 29.69 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.833 2.053 . . . . 75.1 108.992 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 66.7 15.32 10.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.766 1.626 . . . . 53.12 113.545 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.01 152.17 92.82 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 107.571 -1.27 . . . . 74.02 107.571 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.23 160.06 46.83 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.588 1.525 . . . . 51.12 110.807 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -78.32 -20.95 50.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.893 0.877 . . . . 71.23 112.499 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.76 120.89 24.45 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.075 1.35 . . . . 73.32 107.553 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 tt -158.48 163.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.872 1.269 . . . . 75.13 108.201 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -117.43 168.23 10.55 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.916 1.286 . . . . 63.23 111.046 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.92 76.76 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.621 -0.704 . . . . 64.24 109.762 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -53.62 -51.33 63.42 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.531 1.133 . . . . 61.32 109.273 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.52 -39.62 94.12 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.335 0.654 . . . . 72.53 111.608 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.1 -45.04 82.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.859 -0.591 . . . . 53.52 110.101 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -71.52 -27.41 63.18 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.844 0.747 . . . . 74.21 109.585 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.59 -35.33 77.21 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.626 -1.296 . . . . 74.25 109.291 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.37 -72.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.76 1.224 . . . . 65.13 111.822 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.11 -34.51 73.6 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.14 0.976 . . . . 64.12 110.701 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.43 -6.69 88.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.972 -0.349 . . . . 63.03 112.269 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -64.21 -48.18 76.88 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.235 1.517 . . . . 54.15 108.531 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -62.32 -40.07 95.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.769 1.628 . . . . 65.05 112.342 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.58 37.73 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.07 0.843 . . . . 74.21 111.525 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.46 165.15 25.94 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.1 2.534 . . . . 74.45 111.434 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 mt -126.47 137.26 58.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.582 -1.266 . . . . 74.41 107.582 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -76.89 -56.18 4.82 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.409 -0.807 . . . . 71.41 110.273 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -163.28 153.39 15.72 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.189 -1.041 . . . . 65.24 108.189 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 49.7 mt -131.59 147.63 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.628 1.171 . . . . 74.11 108.537 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -142.91 141.83 31.58 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.772 -1.566 . . . . 73.51 106.772 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.14 155.88 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.848 0.859 . . . . 71.5 109.735 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.47 145.81 49.66 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.796 -1.321 . . . . 51.45 109.796 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.33 1.32 8.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.758 1.223 . . . . 74.25 112.535 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' B' ' 54' ' ' PRO . 60.6 p -124.71 162.35 43.41 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.433 1.493 . . . . 75.41 109.33 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' B' ' 53' ' ' THR . 50.7 Cg_endo -64.02 2.63 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.483 3.455 . . . . 74.12 114.258 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -116.74 -19.4 9.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.05 1.34 . . . . 53.13 111.883 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 42.5 p -104.96 -19.69 13.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.015 0.926 . . . . 71.31 109.384 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -64.15 138.19 58.33 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.038 -1.664 . . . . 75.04 107.02 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -20.22 44.35 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.32 0.962 . . . . 74.41 111.207 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 37.4 p -120.07 158.95 25.77 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 106.964 -1.495 . . . . 60.24 106.964 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.8 175.09 11.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.784 -1.198 . . . . 62.21 109.413 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -135.04 141.44 46.14 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.293 -1.003 . . . . 73.11 108.293 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.8 147.56 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.55 -2.018 . . . . 70.45 105.55 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 t -127.06 140.09 50.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.838 -1.541 . . . . 74.25 106.838 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -109.77 166.38 10.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.595 1.558 . . . . 70.34 110.469 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.97 -55.11 7.01 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.151 0.98 . . . . 70.35 110.551 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -112.32 177.56 4.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.361 1.065 . . . . 73.05 108.644 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -94.74 -24.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.067 -1.021 . . . . 52.2 110.178 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.57 -54.83 22.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.317 -0.864 . . . . 62.45 111.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -67.05 -35.69 80.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.149 0.979 . . . . 53.15 110.218 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.57 -49.33 77.08 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.956 -0.757 . . . . 74.51 108.956 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -61.45 -45.09 95.75 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.526 0.73 . . . . 62.43 109.676 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -55.93 -52.27 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.608 -0.516 . . . . 72.44 109.608 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.81 73.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.491 -0.766 . . . . 61.13 112.599 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.42 -49.58 77.02 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.57 1.077 . . . . 65.52 109.785 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -71.73 -44.62 63.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.18 -0.914 . . . . 61.22 111.297 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -60.33 -30.16 69.34 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.784 0.72 . . . . 72.51 112.854 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 23.0 tp -90.85 -29.12 17.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.262 0.483 . . . . 72.2 112.18 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 90.2 p -64.58 118.65 9.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.584 -0.895 . . . . 64.13 108.584 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.84 63.73 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.739 -1.034 . . . . 63.52 113.094 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -77.32 110.23 11.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.713 1.756 . . . . 72.02 106.359 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.94 121.92 15.77 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.098 1.359 . . . . 70.32 111.025 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.0 137.74 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.339 -0.985 . . . . 73.23 108.339 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 35.1 m 38.77 38.84 0.3 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.375 1.87 . . . . 73.44 113.596 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.13 42.54 25.54 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.322 1.449 . . . . 73.23 111.137 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -143.35 171.22 14.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.164 2.586 . . . . 74.54 107.633 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -133.19 137.08 46.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.975 1.31 . . . . 70.14 109.187 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -98.08 115.59 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.634 2.374 . . . . 70.51 110.151 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 97.8 t -84.34 129.61 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.148 -1.797 . . . . 65.14 106.148 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 84.3 t -111.26 137.06 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.738 2.015 . . . . 74.13 106.376 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -154.48 143.81 21.3 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.819 1.247 . . . . 75.45 109.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -74.36 155.75 37.81 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.527 -0.733 . . . . 74.35 110.941 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -78.23 170.2 17.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 106.905 -1.517 . . . . 64.13 106.905 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 123.985 0.914 . . . . 73.54 109.364 179.365 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 51.9 tp . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.237 -1.023 . . . . 73.24 108.237 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.47 -33.47 75.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.446 0.698 . . . . 70.44 110.79 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.98 -2.99 33.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.333 1.053 . . . . 73.42 112.288 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.6 mtp -100.07 7.21 44.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.723 1.209 . . . . 64.12 111.906 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -110.82 148.77 39.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 73.5 110.107 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.04 166.46 29.56 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.152 3.235 . . . . 65.31 113.581 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.16 159.38 22.05 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.49 1.516 . . . . 72.12 110.512 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.35 17.4 39.8 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.243 1.878 . . . . 40.3 113.729 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.75 157.81 43.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.354 2.262 . . . . 74.0 106.267 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.8 144.61 49.61 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.785 0.834 . . . . 72.11 109.122 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.427 HG22 ' HD2' ' B' ' 49' ' ' ARG . 34.9 t -70.03 143.99 14.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.997 -1.112 . . . . 70.02 107.997 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' B' ' 32' ' ' ALA . 47.1 tp -135.53 80.79 43.96 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.101 -1.444 . . . . 73.2 107.101 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.08 171.08 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.376 3.384 . . . . 72.04 112.814 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.17 162.21 3.06 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.105 3.203 . . . . 64.14 112.847 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo . . . . . 0 C--N 1.348 0.533 0 C-N-CA 123.575 2.85 . . . . 74.43 112.984 179.721 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.413 HG11 ' HD3' ' B' ' 71' ' ' LYS . 20.4 t . . . . . 0 CA--C 1.536 0.438 0 N-CA-C 108.454 -0.943 . . . . 70.4 108.454 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -137.53 155.03 49.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.733 1.613 . . . . 74.51 106.95 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -26.19 68.56 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.745 -0.597 . . . . 73.15 112.093 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.92 115.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.597 -1.26 . . . . 63.41 107.597 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 59.6 mt -109.03 159.31 16.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.53 1.132 . . . . 72.3 109.291 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -127.88 135.39 49.95 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.59 2.356 . . . . 62.1 106.635 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mm -120.95 153.19 24.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.27 1.828 . . . . 71.14 110.191 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -142.71 163.96 31.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.639 1.976 . . . . 64.03 111.549 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 63.58 24.87 14.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.954 2.502 . . . . 75.42 114.708 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 71.9 mt -75.44 156.77 85.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.305 -0.872 . . . . 72.22 111.685 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.56 138.81 46.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 N-CA-C 106.521 -2.146 . . . . 74.23 106.521 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -71.13 -10.89 60.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.308 1.043 . . . . 73.42 112.269 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -126.47 108.8 11.52 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.195 1.798 . . . . 72.22 107.289 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -156.98 137.43 4.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.758 -0.83 . . . . 74.4 108.758 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -86.45 163.73 17.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.573 1.149 . . . . 63.02 110.481 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . 0.574 ' HB2' HD11 ' A' ' 415' ' ' LEU . . . -62.16 -32.55 73.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 43.42 110.021 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.48 -32.58 74.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.622 1.169 . . . . 62.31 110.915 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.53 -45.76 43.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.552 -1.277 . . . . 73.22 107.552 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.4 mmm -55.44 -53.38 56.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.521 0.728 . . . . 64.52 110.168 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -71.66 -10.36 59.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.372 0.879 . . . . 74.51 113.372 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.43 -60.27 1.99 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.018 -1.104 . . . . 72.22 108.018 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.99 -54.81 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.324 1.85 . . . . 61.21 109.874 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -78.56 -16.47 57.4 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.601 0.593 . . . . 71.52 112.601 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.01 -27.2 74.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.266 0.936 . . . . 73.33 112.735 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -14.17 11.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.707 1.253 . . . . 70.04 113.157 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -107.72 -5.13 17.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.705 1.202 . . . . 64.41 113.831 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.93 -174.1 21.27 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.864 1.211 . . . . 74.15 112.874 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.2 138.99 40.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.986 3.124 . . . . 42.4 111.525 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 39.0 mt -101.4 122.3 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.756 1.622 . . . . 75.41 109.725 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -69.61 -47.99 61.58 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.529 -0.732 . . . . 71.14 112.404 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -165.48 159.87 17.28 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.457 1.026 . . . . 64.42 110.635 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 mt -144.32 135.83 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.78 2.032 . . . . 64.33 109.654 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.427 ' HD2' HG22 ' A' ' 414' ' ' VAL . 0.5 OUTLIER -136.16 126.24 26.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 102.847 -3.019 . . . . 75.5 102.847 178.125 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 m -112.64 142.28 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.115 0.566 . . . . 74.34 110.581 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.1 46.89 Favored Glycine 0 C--O 1.241 0.591 0 C-N-CA 124.339 0.971 . . . . 72.11 111.282 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -118.39 -30.46 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.765 0.783 . . . . 43.22 111.806 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -74.14 158.08 86.02 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.695 -1.224 . . . . 73.51 107.695 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.31 -27.44 63.6 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.814 1.676 . . . . 64.51 110.099 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -17.61 63.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.824 1.25 . . . . 64.1 111.667 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 69.3 p -107.47 0.38 22.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.518 1.127 . . . . 72.44 111.928 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -56.14 127.95 33.14 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 120.148 -1.595 . . . . 71.45 108.793 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.17 89.31 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.847 -1.53 . . . . 71.03 114.348 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -121.18 152.44 38.79 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 120.343 2.071 . . . . 50.33 109.336 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.28 174.99 12.08 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.401 1.08 . . . . 62.22 109.274 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -132.25 134.63 45.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.004 -1.48 . . . . 71.31 107.004 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.2 142.62 43.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.634 -1.247 . . . . 74.33 107.634 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 t -122.53 147.25 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.42 -1.326 . . . . 71.34 107.42 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -120.91 166.38 13.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.763 1.625 . . . . 71.22 107.828 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.76 -68.6 0.36 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 113.039 0.755 . . . . 73.31 113.039 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -106.25 148.19 28.24 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.247 1.023 . . . . 65.21 110.862 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.67 -31.85 45.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.275 -0.875 . . . . 74.24 109.301 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -64.48 -30.7 71.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.924 1.29 . . . . 60.35 112.37 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.14 -60.46 2.27 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.235 -1.394 . . . . 61.43 107.235 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.34 67.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 62.3 113.898 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.413 ' HD3' HG11 ' B' ' 17' ' ' VAL . 0.3 OUTLIER -56.25 -60.25 3.78 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.256 0.934 . . . . 73.33 110.039 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -73.41 -39.61 64.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.999 -0.68 . . . . 62.11 110.314 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.76 -33.73 64.58 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.441 -0.79 . . . . 71.43 112.692 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.26 -52.99 62.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.27 -1.011 . . . . 61.22 108.27 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.83 -38.99 93.14 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.0 0.52 . . . . 73.12 110.81 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -18.5 60.57 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 117.492 -1.242 . . . . 73.54 112.22 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.82 -32.86 11.49 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.368 1.44 . . . . 63.04 111.716 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -63.26 152.27 38.16 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.916 -1.513 . . . . 41.14 106.916 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.49 9.57 44.5 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 119.166 -0.797 . . . . 65.41 113.624 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -74.06 125.23 27.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.132 -1.803 . . . . 65.15 106.132 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -80.86 116.67 20.96 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.738 1.615 . . . . 72.24 110.49 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.45 141.9 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 123.473 0.709 . . . . 71.31 109.829 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 62.9 m 24.47 58.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.115 2.566 . . . . 63.14 115.666 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 m120 56.18 27.51 11.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.369 1.468 . . . . 73.14 113.963 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -131.87 167.91 18.76 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.203 2.601 . . . . 72.31 109.353 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -138.74 104.26 5.05 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.749 -1.575 . . . . 74.53 106.749 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -69.31 161.06 30.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.066 1.347 . . . . 61.25 110.023 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -133.17 122.65 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.354 1.061 . . . . 64.14 108.618 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 t -98.35 136.22 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.434 1.093 . . . . 73.33 109.268 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -148.86 153.72 38.46 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.435 1.094 . . . . 73.21 109.343 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.93 147.1 23.92 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.27 1.028 . . . . 74.52 110.407 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -76.59 121.47 23.24 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 105.819 -1.919 . . . . 70.1 105.819 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.2 -0.905 . . . . 72.24 109.112 179.639 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 119.185 -0.436 . . . . 62.0 110.184 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.15 -45.58 92.58 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 123.343 0.657 . . . . 74.25 109.75 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.23 79.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.424 0.69 . . . . 71.34 111.904 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 85.2 mtp -71.73 -7.48 48.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.169 0.988 . . . . 71.12 111.1 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -107.46 143.26 26.85 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.219 0.918 . . . . 74.13 109.069 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 36.3 Cg_endo -71.93 164.35 35.94 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.323 2.682 . . . . 74.03 114.035 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -70.02 161.14 30.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.836 2.054 . . . . 70.22 110.278 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 75.62 17.69 80.03 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.132 -0.98 . . . . 74.04 115.273 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . 0.479 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 67.1 m-85 -125.1 156.96 37.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 105.639 -1.985 . . . . 70.13 105.639 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -137.44 154.42 49.94 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.128 -0.693 . . . . 74.25 109.128 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.03 142.15 16.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.405 1.082 . . . . 73.45 110.625 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.45 83.42 66.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 106.171 -1.789 . . . . 71.23 106.171 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -67.96 171.97 11.55 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.34 2.026 . . . . 51.32 110.643 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.03 163.66 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.424 2.083 . . . . 33.04 110.834 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo . . . . . 0 CA--C 1.541 0.83 0 C-N-CA 122.399 2.066 . . . . 61.44 108.9 177.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t . . . . . 0 C--O 1.238 0.488 0 N-CA-C 109.368 -0.604 . . . . 72.43 109.368 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -126.17 143.33 51.17 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.002 2.121 . . . . 43.53 108.693 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -60.34 -28.5 68.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.564 1.546 . . . . 64.31 111.149 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.4 mt -88.86 147.73 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.161 2.184 . . . . 75.32 108.513 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.51 155.34 39.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.445 1.498 . . . . 73.34 109.612 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -130.63 105.06 7.57 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.324 2.249 . . . . 73.44 107.215 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -83.88 149.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 126.527 1.931 . . . . 73.42 110.645 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -140.49 162.65 34.83 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.63 1.172 . . . . 53.23 109.379 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 68.32 24.97 7.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.248 2.219 . . . . 62.42 113.173 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -67.38 153.47 94.76 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 121.221 -0.924 . . . . 74.01 110.033 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.68 158.21 50.95 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.456 2.771 . . . . 72.32 109.965 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -73.1 -14.07 61.32 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.522 -0.736 . . . . 64.41 112.128 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -130.2 129.18 43.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.562 -1.273 . . . . 75.43 107.562 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -166.79 160.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.383 2.273 . . . . 74.33 106.048 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -122.13 177.21 5.43 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.651 1.18 . . . . 60.24 110.129 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.69 88.63 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.179 -0.674 . . . . 45.21 109.179 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.3 -46.39 86.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.409 1.483 . . . . 72.23 110.482 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.23 -41.33 99.09 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.896 0.771 . . . . 72.45 110.646 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.4 mmm -63.77 -55.95 19.25 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.711 -0.478 . . . . 75.14 109.711 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.52 -25.06 68.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.288 -0.863 . . . . 72.22 111.038 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.36 -57.82 4.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.406 1.003 . . . . 75.13 109.857 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.4 mt -60.27 -58.33 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 125.55 1.54 . . . . 74.31 110.434 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -65.16 -22.64 66.94 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.793 0.664 . . . . 73.44 112.793 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.68 79.87 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 118.481 0.582 . . . . 64.11 113.927 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -69.24 -9.09 51.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.06 0.93 . . . . 52.14 111.306 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -104.72 -7.31 19.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.374 1.07 . . . . 73.32 111.14 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.12 -174.29 21.23 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.137 1.827 . . . . 70.01 111.396 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.99 169.25 9.29 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.091 2.528 . . . . 64.24 109.764 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.58 145.06 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 O-C-N 120.887 -1.133 . . . . 53.32 109.286 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -78.71 -63.44 1.41 Allowed 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.392 -1.336 . . . . 70.34 107.392 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -160.14 165.93 30.73 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.129 0.972 . . . . 74.21 109.257 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.38 146.44 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.479 1.512 . . . . 74.24 107.484 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -137.22 126.98 25.48 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 104.319 -2.474 . . . . 44.42 104.319 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.04 164.53 17.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 123.377 0.671 . . . . 75.21 109.471 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.45 146.19 44.08 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.174 -1.171 . . . . 71.15 110.174 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -124.46 -58.99 1.49 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.951 -1.129 . . . . 54.12 107.951 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.37 161.05 61.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.305 0.642 . . . . 74.13 109.285 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.58 -9.34 23.94 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.786 2.324 . . . . 75.01 115.121 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.21 -11.51 16.51 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.347 0.976 . . . . 64.53 112.584 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -99.39 -11.42 21.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.596 0.635 . . . . 73.51 111.318 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -69.06 152.84 44.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.457 -0.942 . . . . 74.44 108.457 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.22 -20.23 50.84 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.684 1.135 . . . . 73.4 112.241 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 50.4 p -133.32 165.45 24.8 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.852 -1.536 . . . . 63.45 106.852 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.07 175.57 10.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.741 -1.225 . . . . 73.51 111.545 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.17 146.44 50.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.855 0.752 . . . . 73.11 111.575 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -131.94 145.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.2 1.4 . . . . 62.54 107.803 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.39 136.57 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.436 -1.691 . . . . 73.51 106.436 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.98 166.32 13.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.634 -1.617 . . . . 71.22 106.634 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -78.34 -68.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.478 0.711 . . . . 64.43 110.059 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.84 144.16 30.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 74.12 112.969 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.42 -33.83 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.918 0.887 . . . . 74.3 109.933 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -67.17 -45.97 75.37 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.064 0.946 . . . . 75.24 110.621 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -57.74 -46.6 84.25 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.754 0.822 . . . . 71.21 109.71 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.36 83.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.392 -0.337 . . . . 64.34 111.054 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -67.37 -53.63 27.67 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.206 0.602 . . . . 62.14 110.929 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -59.77 -42.64 93.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.905 -0.569 . . . . 60.52 109.789 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.86 92.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.373 -0.602 . . . . 71.23 109.373 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 t -51.98 -53.34 42.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.771 0.828 . . . . 74.15 110.683 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -73.77 -14.53 61.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.849 1.055 . . . . 64.23 113.849 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -95.19 -21.36 18.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.626 1.103 . . . . 74.35 110.002 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 35.8 tp -99.78 -7.46 25.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.308 1.843 . . . . 65.05 111.468 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 32.4 p -57.96 117.01 3.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.978 1.311 . . . . 62.2 111.442 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.64 10.6 71.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.231 -1.316 . . . . 73.45 114.654 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -51.55 121.94 7.22 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.72 1.208 . . . . 75.43 112.875 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -83.57 118.1 23.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.8 2.04 . . . . 72.12 110.655 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.9 155.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.216 2.606 . . . . 72.42 105.642 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 m 49.67 21.74 0.69 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.388 1.475 . . . . 62.12 112.992 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 38.7 t30 59.24 55.55 4.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.166 2.186 . . . . 74.13 108.572 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -142.81 -167.75 2.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 128.152 2.581 . . . . 72.14 107.572 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -145.11 111.99 5.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.496 -2.409 . . . . 73.52 104.496 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.0 mt -77.32 172.77 12.78 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.919 -1.113 . . . . 54.42 108.96 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.81 146.94 31.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.427 -1.323 . . . . 74.22 107.427 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.92 115.61 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.217 1.407 . . . . 74.24 107.383 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.29 120.59 25.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.063 1.345 . . . . 74.21 107.715 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -55.68 145.27 24.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.645 0.657 . . . . 74.14 111.408 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.95 175.53 10.46 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.407 -0.59 . . . . 72.44 109.407 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--O 1.245 0.848 0 C-N-CA 125.643 1.577 . . . . 52.14 107.073 178.661 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 118.536 -0.745 . . . . 74.51 110.744 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -67.17 -46.86 72.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.022 0.828 . . . . 64.13 109.189 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.52 -6.89 5.71 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.106 1.15 . . . . 72.21 114.106 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 95.8 mtp -100.51 -0.03 38.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.889 1.276 . . . . 72.22 110.123 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.25 155.94 43.79 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.327 1.451 . . . . 65.13 111.542 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.29 163.27 36.79 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.235 2.623 . . . . 41.53 111.243 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.13 164.87 19.37 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.735 0.814 . . . . 74.44 110.291 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 76.58 21.66 74.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.506 -1.163 . . . . 64.43 114.587 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -124.21 158.35 32.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.641 1.721 . . . . 74.53 108.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -135.46 153.28 51.81 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.659 1.184 . . . . 73.14 109.074 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.38 146.7 11.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 123.521 0.728 . . . . 63.43 109.416 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 37.8 tp -132.92 82.55 54.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.21 -1.404 . . . . 63.14 107.21 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.72 165.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.06 2.507 . . . . 73.23 111.656 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -69.45 160.23 50.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.045 1.83 . . . . 71.23 111.229 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo . . . . . 0 N--CA 1.459 -0.539 0 C-N-CA 125.226 3.951 . . . . 73.42 114.488 -179.072 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t . . . . . 0 C--O 1.244 0.78 0 N-CA-C 105.859 -1.904 . . . . 74.44 105.859 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' B' ' 92' ' ' TYR . 0.0 OUTLIER -145.07 161.21 40.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.375 1.47 . . . . 74.13 108.16 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -80.79 -7.55 59.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.331 2.252 . . . . 74.41 116.032 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -103.29 121.59 54.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 120.488 1.494 . . . . 64.45 107.549 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 71.2 mt -110.19 142.39 41.8 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.282 1.033 . . . . 72.42 108.781 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.46 125.01 53.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.77 -2.307 . . . . 73.45 104.77 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.41 153.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.256 1.422 . . . . 73.25 108.408 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.437 ' HG2' HG22 ' B' ' 59' ' ' THR . 65.1 mtt180 -145.92 163.44 35.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.363 1.865 . . . . 74.15 108.744 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 70.17 21.28 6.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.088 1.755 . . . . 64.11 112.752 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.0 mt -78.17 156.05 79.35 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 121.022 -1.049 . . . . 63.11 110.883 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.03 164.25 36.41 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.971 1.781 . . . . 72.14 111.354 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -93.66 -16.85 23.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 74.32 111.646 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -120.57 99.03 6.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 74.24 106.066 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.5 tt -163.32 174.11 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.988 2.115 . . . . 74.1 106.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -136.47 -170.05 2.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.03 1.332 . . . . 61.11 110.438 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.75 -40.75 65.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.678 -0.49 . . . . 64.22 109.678 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -49.04 -58.36 5.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.095 2.158 . . . . 63.0 110.926 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.42 -42.74 99.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.859 0.299 . . . . 62.34 110.913 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 92.7 mmm -67.57 -23.05 65.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 117.86 -1.067 . . . . 53.32 113.047 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -90.88 -38.17 13.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.744 1.156 . . . . 74.44 108.562 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.44 -52.09 36.51 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.96 1.304 . . . . 73.33 111.601 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.68 -61.47 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.626 0.771 . . . . 72.12 109.41 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -64.17 -19.97 65.68 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.778 0.288 . . . . 74.21 111.778 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.34 -16.62 75.54 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 125.025 1.298 . . . . 54.11 112.143 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -57.25 -32.98 67.11 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.329 1.064 . . . . 64.21 109.759 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -74.71 -60.44 2.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.194 0.998 . . . . 74.33 109.345 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.27 37.41 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.926 -1.27 . . . . 73.54 109.926 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.35 162.72 22.73 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.544 2.163 . . . . 73.34 109.978 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mt -126.51 138.52 54.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.537 -0.912 . . . . 72.14 108.537 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -68.53 -64.21 0.91 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.893 -0.78 . . . . 73.03 108.893 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -159.01 164.21 35.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.234 1.014 . . . . 74.12 108.94 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 95.3 mt -137.66 150.94 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.471 1.908 . . . . 65.21 107.796 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -146.17 148.28 32.38 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.657 1.983 . . . . 74.04 106.318 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.11 166.88 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.374 1.07 . . . . 74.2 110.707 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.37 146.22 40.4 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.168 -1.173 . . . . 71.45 110.168 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -122.92 -16.68 7.0 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.741 1.216 . . . . 71.31 112.157 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 18.8 p -95.0 159.02 33.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.443 -1.688 . . . . 33.24 106.443 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.32 -34.35 93.67 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.758 1.639 . . . . 64.21 111.696 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -72.42 -21.14 61.3 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.314 1.227 . . . . 73.31 114.314 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 34.6 p -92.62 -0.13 57.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.895 0.878 . . . . 74.32 111.25 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.77 140.74 57.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.357 -1.349 . . . . 64.15 107.357 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.83 -10.82 61.39 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.503 -1.72 . . . . 64.32 114.129 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . 0.437 HG22 ' HG2' ' B' ' 24' ' ' ARG . 73.3 p -113.32 149.41 34.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.275 2.037 . . . . 64.43 109.329 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.8 175.67 12.84 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.902 -1.124 . . . . 75.35 109.569 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -136.27 150.04 48.75 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 122.86 0.464 . . . . 74.13 110.1 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -133.23 146.99 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.722 1.609 . . . . 62.11 106.96 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.9 t -127.43 140.66 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.544 -2.021 . . . . 71.03 105.544 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.95 163.63 24.08 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.873 1.269 . . . . 73.03 109.052 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -97.68 -53.5 3.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.952 1.301 . . . . 73.35 109.722 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.74 115.09 15.07 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.893 -1.151 . . . . 70.24 107.893 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 tt -71.52 -21.45 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.938 -1.134 . . . . 72.14 107.938 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.34 -50.31 47.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.826 1.65 . . . . 74.43 109.421 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.54 -42.37 91.99 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.479 -0.934 . . . . 70.43 108.479 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.66 -45.88 92.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.319 0.648 . . . . 74.34 110.671 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -57.5 -47.09 82.85 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.915 0.78 . . . . 74.52 111.267 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -66.19 -55.09 18.02 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.915 -0.772 . . . . 75.31 108.915 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -38.63 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.688 1.595 . . . . 74.13 113.933 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.08 -41.33 78.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.463 1.105 . . . . 30.55 110.234 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.51 -35.93 17.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.178 -0.305 . . . . 73.21 110.178 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.24 -31.71 69.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 74.25 111.213 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.57 -9.63 21.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.313 1.445 . . . . 74.24 112.785 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 31.3 t -73.92 108.47 6.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.889 -1.152 . . . . 63.03 107.889 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.12 12.41 60.16 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.589 -1.117 . . . . 22.43 112.815 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -68.01 121.66 16.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.618 1.209 . . . . 55.02 108.111 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -76.12 115.46 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.259 1.024 . . . . 61.34 110.391 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 m -140.38 137.78 36.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.766 1.226 . . . . 63.31 109.414 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.6 m 42.39 46.86 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.407 1.883 . . . . 71.51 113.426 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 66.56 10.06 7.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.139 2.176 . . . . 31.2 113.361 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -117.36 -179.37 3.7 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.621 2.368 . . . . 72.35 108.248 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -140.43 117.79 11.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.228 -1.027 . . . . 75.22 108.228 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.34 162.21 29.11 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.482 0.658 . . . . 53.23 110.52 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 94.4 t -128.97 159.41 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.475 1.91 . . . . 74.04 107.015 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 t -143.41 128.0 14.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.241 -1.392 . . . . 65.32 107.241 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.83 144.56 37.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.378 1.071 . . . . 75.21 109.782 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -68.87 163.43 24.34 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 75.12 109.588 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . 0.524 ' H ' ' ND2' ' B' ' 18' ' ' ASN . 23.3 t80 -87.81 147.15 25.28 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.312 -1.366 . . . . 74.44 107.312 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.254 1.321 0 N-CA-C 106.272 -1.751 . . . . 75.21 106.272 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 40.0 tp . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 110.292 -0.262 . . . . 75.35 110.292 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.82 -30.13 67.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.777 1.631 . . . . 64.22 111.872 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.8 34.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.584 1.154 . . . . 64.24 111.693 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 94.4 mtp -85.5 -20.18 30.08 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.146 -0.972 . . . . 73.01 110.098 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.1 158.55 39.2 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 124.167 0.987 . . . . 74.31 111.388 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.98 160.31 30.39 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.14 1.894 . . . . 41.4 110.192 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.38 158.95 24.47 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.072 0.939 . . . . 72.24 109.811 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.16 51.63 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.77 0.7 . . . . 55.03 112.36 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.05 156.27 38.46 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.518 1.527 . . . . 73.24 107.008 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -132.07 147.71 52.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.833 0.453 . . . . 74.43 111.007 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.531 1.132 . . . . 62.54 108.331 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.24 85.94 42.5 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 106.743 -1.577 . . . . 72.12 106.743 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.28 168.39 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.056 3.171 . . . . 65.53 112.33 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.91 168.25 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.355 2.703 . . . . 54.24 111.944 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 N--CA 1.453 -0.911 0 C-N-CA 123.076 2.517 . . . . 61.54 110.817 179.11 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.429 HG13 ' CE1' ' B' ' 91' ' ' TYR . 94.6 t . . . . . 0 C--O 1.239 0.516 0 N-CA-C 105.031 -2.211 . . . . 73.24 105.031 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.19 160.05 32.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.256 1.023 . . . . 71.45 108.79 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -63.67 -24.3 67.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.859 1.663 . . . . 63.42 112.958 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.3 137.66 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.04 -1.467 . . . . 75.53 107.04 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 69.2 mt -127.79 157.23 40.97 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.838 2.055 . . . . 64.41 109.593 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -126.02 149.29 48.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.465 1.506 . . . . 65.2 107.12 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mm -136.68 154.72 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.825 -1.546 . . . . 73.51 106.825 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -135.13 163.77 29.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.479 1.512 . . . . 74.45 108.465 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 70.81 15.19 6.92 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.13 1.772 . . . . 73.21 111.068 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' B' ' 60' ' ' ALA . 45.0 mt -69.14 151.2 97.2 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 121.058 -1.026 . . . . 70.4 110.938 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.69 140.68 92.18 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.546 2.83 . . . . 72.21 112.412 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -75.63 -27.01 58.25 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.619 -0.675 . . . . 73.35 111.232 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.03 88.72 2.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.203 1.401 . . . . 72.12 107.877 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -134.7 154.58 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.773 -0.825 . . . . 54.24 108.773 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 43.6 p -114.88 176.17 5.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.833 2.053 . . . . 71.03 108.314 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.81 -38.36 90.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.706 -0.621 . . . . 73.41 111.315 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -49.38 -58.07 5.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.886 1.274 . . . . 73.01 113.582 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.95 -35.2 79.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.595 0.634 . . . . 64.23 111.511 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.9 mmm -68.17 -52.91 29.23 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.369 -0.832 . . . . 55.04 110.132 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -66.8 -25.92 66.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.953 -1.022 . . . . 72.32 111.824 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.63 -59.62 2.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.235 1.379 . . . . 73.14 109.938 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.67 -62.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.407 1.883 . . . . 72.2 111.486 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -63.36 -35.52 80.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.237 -0.585 . . . . 55.14 110.428 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.6 -29.7 67.37 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 123.726 0.679 . . . . 60.23 112.212 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -17.46 56.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.187 0.995 . . . . 73.34 111.566 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.66 -36.93 8.97 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.503 1.121 . . . . 44.02 111.768 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.54 -174.01 45.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 65.42 110.68 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.56 171.41 13.15 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.718 2.278 . . . . 71.32 112.052 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.0 mt -127.81 131.49 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.781 1.232 . . . . 75.12 108.288 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.38 -57.51 3.22 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.154 -1.054 . . . . 63.34 108.154 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -157.12 153.29 27.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.646 0.778 . . . . 71.43 109.944 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 42.1 mt -134.64 137.81 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.874 1.67 . . . . 74.42 107.185 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -137.8 129.19 27.91 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.951 -2.24 . . . . 75.15 104.951 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 18.7 m -110.9 154.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.217 1.407 . . . . 72.32 110.952 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.35 117.85 8.76 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.334 -1.506 . . . . 65.03 109.334 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -100.79 -38.14 8.4 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.135 0.974 . . . . 75.01 112.086 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -64.22 157.67 69.14 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.51 -0.922 . . . . 52.31 108.51 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.02 -14.67 46.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.486 1.457 . . . . 74.23 112.783 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -98.66 -11.09 22.38 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.389 -0.815 . . . . 63.34 112.355 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.1 p -103.02 -23.65 13.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.891 1.223 . . . . 72.12 112.187 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -51.11 131.07 27.23 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.051 -1.463 . . . . 75.04 107.051 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.45 -13.04 15.87 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.381 1.467 . . . . 70.14 110.902 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.1 p -134.01 166.68 22.17 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 118.595 1.197 . . . . 75.5 110.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -164.25 169.29 17.78 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.306 1.443 . . . . 65.41 107.807 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -119.84 147.72 44.34 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 74.34 108.489 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.55 140.35 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.515 -2.032 . . . . 70.33 105.515 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.1 130.79 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 102.481 -3.155 . . . . 63.04 102.481 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -99.49 161.28 13.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.051 -0.722 . . . . 74.11 109.051 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -76.37 -31.85 58.26 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.052 -0.659 . . . . 74.23 110.472 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -123.55 165.92 16.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.204 1.402 . . . . 63.0 110.682 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -76.37 -46.81 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 121.435 -0.79 . . . . 73.21 110.806 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -59.64 -38.31 81.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.986 0.914 . . . . 75.5 110.84 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -62.06 -42.13 98.87 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.946 -0.761 . . . . 74.01 108.946 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.33 -51.43 68.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.576 0.751 . . . . 75.41 109.753 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -55.82 -52.33 64.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.932 0.893 . . . . 75.24 110.825 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.84 -49.45 76.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.129 -0.693 . . . . 62.34 109.129 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.05 89.14 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 118.104 -0.95 . . . . 74.13 111.906 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 67.7 m -60.51 -53.82 52.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.575 1.08 . . . . 45.25 109.588 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.21 -42.99 99.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.167 -0.444 . . . . 70.5 112.026 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -69.26 -24.22 63.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.417 -0.802 . . . . 72.53 111.231 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.1 tp -98.27 -13.11 20.95 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.406 1.457 . . . . 65.41 113.262 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 127.2 31.87 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.718 -1.216 . . . . 51.52 107.718 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.49 75.74 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.274 -1.292 . . . . 54.42 113.031 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -68.54 111.99 5.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.382 1.591 . . . . 74.21 108.187 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -85.33 115.14 22.91 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.376 2.27 . . . . 75.2 110.445 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.9 144.55 20.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.074 -1.084 . . . . 53.23 108.074 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.7 m 40.48 49.81 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.026 1.73 . . . . 72.45 112.745 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 m120 63.0 18.54 10.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.48 2.312 . . . . 75.05 115.626 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -137.75 167.24 22.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 120.028 1.285 . . . . 72.21 109.988 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -112.28 127.15 55.9 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.288 1.035 . . . . 75.4 109.925 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.82 106.18 6.23 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.039 -1.097 . . . . 65.03 108.039 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.72 136.69 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.552 -0.907 . . . . 74.51 108.552 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.63 132.63 56.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.746 2.018 . . . . 72.5 108.866 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -154.65 130.25 9.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.494 1.043 . . . . 71.41 110.034 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . 0.429 ' CE1' HG13 ' B' ' 17' ' ' VAL . 70.0 m-85 -69.34 158.74 34.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.759 -0.588 . . . . 75.41 110.224 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -79.08 160.95 26.86 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 107.661 -1.237 . . . . 73.32 107.661 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 116.823 -1.561 . . . . 74.31 107.265 179.069 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 15.5 tp . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 110.415 -0.217 . . . . 74.43 110.415 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.23 -62.52 1.44 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.355 -1.35 . . . . 72.42 107.355 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -64.21 -1.68 1.73 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.083 2.153 . . . . 61.44 115.722 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 70.4 mtp -95.51 -10.08 30.69 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.849 -1.157 . . . . 75.35 111.501 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -106.01 148.3 36.31 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 118.808 0.731 . . . . 73.53 111.251 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.67 158.98 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.149 1.899 . . . . 61.53 107.719 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -73.86 165.45 25.1 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.708 0.766 . . . . 74.22 111.609 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.83 17.92 36.52 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.653 1.597 . . . . 54.12 111.228 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.58 139.52 53.52 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.758 1.223 . . . . 75.34 109.72 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.202 1.401 . . . . 74.21 109.424 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.62 151.09 9.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.518 1.151 . . . . 72.43 109.095 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 33.5 tp -116.51 76.02 7.03 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.358 1.463 . . . . 71.42 111.44 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.66 163.92 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.011 1.807 . . . . 71.22 108.773 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.8 166.37 30.16 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.226 1.95 . . . . 55.41 110.988 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo . . . . . 0 N--CA 1.455 -0.755 0 C-N-CA 122.617 2.211 . . . . 54.14 111.116 178.508 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.542 HG11 ' HD3' ' B' ' 71' ' ' LYS . 75.1 t . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 105.889 -1.893 . . . . 72.42 105.889 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -67.18 141.93 57.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.971 -1.122 . . . . 75.11 107.971 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . 0.46 ' H ' ' HD3' ' B' ' 19' ' ' ARG 0.283 0.0 OUTLIER -57.8 -7.33 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 118.151 2.648 . . . . 52.32 118.151 -178.714 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.453 HG13 ' HE ' ' B' ' 19' ' ' ARG . 65.5 mt -101.87 128.11 54.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 105.602 -1.999 . . . . 61.25 105.602 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 mt -100.76 142.19 32.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.466 -1.309 . . . . 72.14 107.466 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.44 128.56 55.24 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.605 -2.368 . . . . 54.41 104.605 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 mm -118.74 136.53 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.968 -1.494 . . . . 75.44 106.968 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -125.93 163.68 22.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.597 1.559 . . . . 74.34 107.735 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 71.24 20.18 5.15 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.634 1.574 . . . . 54.24 112.078 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.13 153.82 93.85 Favored Pre-proline 0 C--O 1.237 0.445 0 O-C-N 121.4 -0.813 . . . . 62.41 110.593 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.89 159.23 52.64 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.74 2.96 . . . . 74.33 110.077 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -89.74 -19.11 25.16 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.112 0.565 . . . . 73.23 111.351 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' B' ' 29' ' ' LYS . 7.8 mmpt? -130.08 101.04 5.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.9 1.68 . . . . 62.32 108.348 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.51 155.67 6.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 127.431 2.293 . . . . 63.44 105.472 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -105.1 174.17 5.99 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.273 -0.892 . . . . 72.21 109.671 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.28 72.78 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.352 -0.981 . . . . 64.32 108.352 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -54.67 -35.46 63.57 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.404 1.482 . . . . 54.24 112.474 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -70.34 -42.75 71.45 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.911 1.232 . . . . 63.45 108.229 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.6 mmm -64.75 -45.07 87.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.605 -0.887 . . . . 72.13 108.605 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.83 -27.48 69.2 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 117.98 -1.01 . . . . 72.43 111.644 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.18 -65.26 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.233 0.924 . . . . 71.45 110.148 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mt -57.55 -53.37 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.673 1.189 . . . . 74.21 111.818 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -74.72 -17.01 60.72 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.697 -0.627 . . . . 64.22 111.647 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.4 -12.91 66.53 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 124.0 0.81 . . . . 44.32 113.096 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -58.09 -29.91 65.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.16 1.48 . . . . 65.52 110.495 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.63 -5.42 59.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.034 2.134 . . . . 50.12 114.525 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.65 -171.87 23.58 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 119.808 1.186 . . . . 22.12 111.702 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.29 163.77 28.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.38 2.054 . . . . 60.1 109.247 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mt -129.43 123.22 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.981 -1.075 . . . . 70.52 108.532 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -65.11 -67.07 0.47 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.454 -0.943 . . . . 64.41 108.454 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -156.89 160.64 39.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.932 0.787 . . . . 71.32 112.062 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -140.11 140.95 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.062 2.145 . . . . 73.31 106.258 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -132.59 120.06 21.31 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 103.272 -2.862 . . . . 63.01 103.272 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.98 146.12 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 119.26 0.936 . . . . 75.22 111.435 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.09 141.31 41.22 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.768 -2.133 . . . . 63.05 107.768 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 -9.94 4.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.195 0.998 . . . . 72.33 113.017 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 44.9 p -97.51 161.57 25.46 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.762 1.225 . . . . 75.22 108.478 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.33 5.76 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.85 3.033 . . . . 74.3 113.635 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -120.58 -9.74 9.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.148 1.379 . . . . 74.15 111.408 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -117.36 -25.58 6.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.569 1.148 . . . . 74.31 113.147 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -50.6 143.47 9.34 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.917 0.887 . . . . 73.44 112.134 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.0 85.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.096 -0.836 . . . . 61.24 111.273 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -138.05 150.27 46.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.941 1.37 . . . . 70.13 108.71 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.12 168.35 19.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.177 1.391 . . . . 75.24 107.82 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -120.85 155.53 33.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.367 -1.716 . . . . 63.43 106.367 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 t -125.52 124.47 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.31 -2.107 . . . . 61.43 105.31 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -110.55 123.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.026 -2.212 . . . . 64.51 105.026 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -98.09 166.46 11.41 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.377 -1.712 . . . . 72.13 106.377 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.78 -42.59 94.95 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.491 -1.381 . . . . 74.41 110.366 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.78 175.32 5.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.605 1.562 . . . . 74.44 111.146 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.2 tt -81.69 -38.19 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.333 1.453 . . . . 60.31 108.621 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -60.44 -37.16 80.07 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.197 0.453 . . . . 72.41 111.661 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.14 -42.79 96.64 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 119.377 -0.344 . . . . 75.43 111.003 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.79 -50.19 63.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.445 -0.946 . . . . 63.45 108.445 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.542 ' HD3' HG11 ' B' ' 17' ' ' VAL . 7.2 mmtp -48.87 -54.88 13.48 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.614 1.566 . . . . 73.24 110.23 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -59.63 -60.18 4.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.043 0.937 . . . . 71.32 110.273 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.65 -29.1 51.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.052 1.131 . . . . 73.41 114.052 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.6 t -60.46 -38.25 83.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.447 0.699 . . . . 55.41 111.917 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -88.51 -28.6 20.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.596 0.635 . . . . 72.21 110.954 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -67.58 -31.13 70.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.226 0.466 . . . . 75.11 111.449 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.67 -3.43 20.61 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.256 1.576 . . . . 64.34 115.256 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 25.7 p -60.08 124.56 20.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.343 1.429 . . . . 75.53 109.677 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.05 13.99 73.22 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.231 -1.316 . . . . 75.31 114.334 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.48 119.53 5.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.884 1.842 . . . . 73.02 110.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -78.08 129.76 35.6 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.911 -1.144 . . . . 73.44 107.911 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -144.08 140.18 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 125.835 1.654 . . . . 75.13 106.789 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m 37.43 49.28 0.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 73.43 112.749 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 35.57 15.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.242 1.417 . . . . 41.22 113.947 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.61 -177.22 4.63 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.847 3.259 . . . . 72.35 104.657 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -139.23 137.14 35.7 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.865 -1.147 . . . . 61.32 109.456 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.75 158.22 21.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.414 -1.328 . . . . 73.02 107.414 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.79 131.77 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.683 -2.71 . . . . 75.13 103.683 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 t -115.33 135.35 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.035 1.334 . . . . 61.13 107.859 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.46 150.67 36.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.745 0.818 . . . . 51.32 110.608 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . 0.482 ' CD1' HG13 ' B' ' 17' ' ' VAL . 6.7 m-85 -78.52 160.97 27.38 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.392 -0.818 . . . . 75.31 111.546 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.28 176.58 6.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.152 0.981 . . . . 75.11 110.156 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 112.624 0.601 . . . . 52.4 112.624 -179.772 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 108.533 -0.914 . . . . 74.31 108.533 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.93 -10.46 57.34 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.295 1.038 . . . . 70.02 112.289 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -97.55 -36.15 10.4 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.028 1.331 . . . . 55.54 109.481 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.28 -13.58 61.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 73.42 112.608 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.67 157.78 42.04 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.911 1.232 . . . . 73.52 112.003 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.09 166.29 28.14 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.803 2.336 . . . . 74.12 111.241 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -84.69 174.99 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.557 1.143 . . . . 72.43 108.889 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 82.32 19.02 65.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.762 -1.021 . . . . 51.12 112.826 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -125.49 155.71 40.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.382 1.591 . . . . 74.32 106.908 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -130.35 133.69 46.61 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.117 -0.99 . . . . 74.32 108.656 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' B' ' 49' ' ' ARG . 48.3 t -69.08 151.31 10.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.617 -1.253 . . . . 71.04 107.617 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.6 tp -125.73 85.72 58.61 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 125.637 1.575 . . . . 71.23 108.662 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -66.21 178.78 2.28 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.913 2.409 . . . . 72.43 109.566 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.44 170.99 1.04 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.704 2.936 . . . . 71.33 113.386 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo . . . . . 0 C--N 1.349 0.558 0 C-N-CA 125.06 3.84 . . . . 73.42 114.899 -179.831 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.601 HG13 ' CE1' ' B' ' 91' ' ' TYR . 88.1 t . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 108.763 -0.829 . . . . 52.41 108.763 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -138.48 159.85 41.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.993 1.717 . . . . 65.21 108.73 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -72.63 -24.42 61.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.057 1.343 . . . . 72.41 109.505 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -89.54 129.65 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.296 1.438 . . . . 53.04 107.475 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.54 153.53 36.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.876 1.27 . . . . 75.01 107.882 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -119.31 111.6 18.39 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.963 -2.606 . . . . 72.44 103.963 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -96.59 145.67 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.661 -1.977 . . . . 65.42 105.661 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -136.88 163.2 31.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.038 1.335 . . . . 75.12 109.19 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.8 t30 63.12 33.68 14.3 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.062 2.145 . . . . 64.21 111.066 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 55.0 mt -73.79 158.72 85.71 Favored Pre-proline 0 C--O 1.237 0.417 0 O-C-N 121.497 -0.752 . . . . 74.14 109.013 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.16 156.38 65.99 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.886 1.724 . . . . 72.15 109.498 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.23 -25.69 58.33 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.536 -0.727 . . . . 70.44 112.002 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -129.75 128.09 41.73 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.261 -1.385 . . . . 74.43 107.261 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tt -157.51 169.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.553 -1.277 . . . . 63.32 107.553 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 16.9 p -126.49 169.1 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.532 1.933 . . . . 62.14 108.982 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.82 90.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.393 -0.966 . . . . 72.42 108.393 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.45 -55.31 30.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.018 1.327 . . . . 45.21 111.852 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.24 -40.41 85.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.069 0.395 . . . . 73.32 111.438 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.35 -44.01 72.48 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 73.53 111.587 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.14 -23.18 60.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.972 0.909 . . . . 73.33 111.026 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.63 -59.32 2.77 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.273 1.029 . . . . 73.55 108.51 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.17 -67.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.811 1.645 . . . . 74.25 111.027 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -66.99 -32.41 73.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.643 0.608 . . . . 73.35 112.643 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.84 -32.34 81.48 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 120.468 1.485 . . . . 64.41 112.567 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -75.58 -21.34 57.92 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.335 -1.097 . . . . 70.41 110.236 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.36 -30.97 30.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.347 1.059 . . . . 74.21 110.734 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.97 -175.29 44.71 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.116 0.871 . . . . 75.2 111.668 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.06 165.72 25.42 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.911 2.407 . . . . 73.44 110.673 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -132.52 113.68 21.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 123.662 0.785 . . . . 74.25 109.637 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -81.52 -49.09 11.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.526 -1.287 . . . . 74.32 107.526 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -168.9 162.24 11.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.442 1.497 . . . . 74.54 108.496 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.2 mt -144.78 140.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.43 2.292 . . . . 64.43 106.016 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 414' ' ' VAL . 0.1 OUTLIER -148.53 121.88 9.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.055 -1.831 . . . . 75.12 106.055 176.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.12 167.07 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.63 0.772 . . . . 60.25 109.629 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.38 137.14 42.6 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.669 -0.973 . . . . 54.41 110.669 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -107.34 -49.66 3.22 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.606 1.962 . . . . 62.3 110.661 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -70.57 158.21 88.35 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.109 -0.7 . . . . 61.24 109.109 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.51 14.83 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.549 3.499 . . . . 70.55 115.36 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.01 -47.13 2.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.817 2.047 . . . . 73.14 109.419 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 51.2 p -72.84 -29.45 63.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.972 0.909 . . . . 43.25 109.856 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -50.37 124.77 11.17 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.162 0.985 . . . . 74.42 110.249 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.81 -13.07 17.59 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.746 1.165 . . . . 72.35 110.56 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -128.02 166.07 19.09 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.897 1.348 . . . . 64.25 108.761 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.26 168.14 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.154 -0.966 . . . . 74.25 111.066 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -120.54 124.04 44.37 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.977 -1.12 . . . . 75.44 107.977 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.78 142.25 24.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.507 -2.405 . . . . 64.04 104.507 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.74 122.9 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.718 -1.586 . . . . 73.11 106.718 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.56 165.97 11.73 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.47 1.108 . . . . 74.34 108.467 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.14 -59.36 2.12 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.347 0.659 . . . . 75.23 109.744 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.06 117.6 29.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 126.087 1.755 . . . . 73.44 107.303 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.54 -35.62 60.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 119.39 -0.338 . . . . 70.11 110.815 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -60.37 -50.4 73.76 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.916 0.886 . . . . 73.43 110.073 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.33 -32.17 73.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.551 -0.537 . . . . 74.5 109.551 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.23 92.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.835 -0.802 . . . . 72.22 108.835 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.49 ' HG2' HG11 ' B' ' 17' ' ' VAL . 13.7 mtmt -60.1 -46.56 89.2 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.17 -1.048 . . . . 55.13 108.17 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.99 -52.85 63.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.831 0.707 . . . . 74.04 110.031 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.02 79.74 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.655 -0.688 . . . . 63.01 111.705 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.13 -51.32 68.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.989 0.813 . . . . 75.05 108.995 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -65.71 -37.91 87.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.439 0.563 . . . . 74.41 111.814 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.18 -31.53 72.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.251 0.221 . . . . 75.32 110.424 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.6 tp -91.1 -24.23 20.07 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.844 0.683 . . . . 74.3 112.844 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 3.0 m -68.25 106.4 2.44 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.955 0.902 . . . . 72.25 109.931 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.51 9.45 56.6 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.751 1.643 . . . . 71.14 113.042 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -72.18 141.36 49.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.171 -1.418 . . . . 72.45 107.171 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -110.9 135.02 52.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.758 1.623 . . . . 60.25 110.848 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -157.16 150.16 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 127.499 2.32 . . . . 75.32 107.351 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 53.0 m 44.61 50.25 8.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.614 1.166 . . . . 75.54 113.7 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 44.5 t30 55.5 18.83 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.759 1.624 . . . . 74.34 113.235 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 61.2 mtt85 -134.97 173.82 11.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.739 2.016 . . . . 73.34 110.585 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -130.57 133.34 46.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 105.751 -1.944 . . . . 74.35 105.751 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.21 172.09 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.07 -1.085 . . . . 44.31 108.07 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 5.2 t -134.11 126.7 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 103.757 -2.683 . . . . 72.03 103.757 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.3 t -114.55 137.81 46.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.488 -1.671 . . . . 73.3 106.488 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 46.4 tp -146.81 155.94 42.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.619 1.567 . . . . 74.41 107.159 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . 0.601 ' CE1' HG13 ' B' ' 17' ' ' VAL . 52.8 m-85 -87.74 163.22 16.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.246 -0.65 . . . . 61.25 109.246 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.86 170.01 15.45 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.577 -0.897 . . . . 62.44 108.577 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 . . . . . 0 C--O 1.246 0.909 0 O-C-N 120.909 -1.119 . . . . 75.4 109.342 179.817 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 119.191 -0.433 . . . . 63.12 109.896 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.02 -37.76 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.3 0.64 . . . . 75.52 109.393 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.68 -29.22 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.177 0.991 . . . . 54.13 110.924 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 35.0 mtm -88.95 -1.63 58.2 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.198 0.999 . . . . 73.51 111.672 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -108.47 148.48 37.75 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 119.151 0.887 . . . . 73.31 112.978 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.95 149.74 59.83 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.634 2.223 . . . . 74.13 109.931 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.65 166.22 23.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.158 0.983 . . . . 75.32 111.661 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.48 17.61 56.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.753 1.168 . . . . 72.23 113.024 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -124.42 158.11 33.56 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.254 1.822 . . . . 72.44 108.462 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -127.88 151.65 48.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.553 -0.906 . . . . 73.31 108.553 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 13.9 t -69.98 150.96 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.212 -1.403 . . . . 62.4 107.212 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.0 tp -128.95 75.73 79.95 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.579 -0.897 . . . . 73.34 108.579 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.08 161.32 44.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.942 2.428 . . . . 73.44 110.736 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.69 159.13 54.96 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.974 2.449 . . . . 51.43 112.563 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 C-N-CA 123.661 2.908 . . . . 72.31 111.312 179.879 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.412 HG11 ' HG2' ' B' ' 71' ' ' LYS . 3.9 t . . . . . 0 CA--C 1.539 0.549 0 N-CA-C 105.346 -2.094 . . . . 75.42 105.346 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -144.06 -179.02 6.23 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.11 -0.994 . . . . 72.13 110.005 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -88.24 -30.91 19.33 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.282 -0.886 . . . . 74.31 109.568 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 mt -82.45 132.93 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.389 -1.338 . . . . 74.33 107.389 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.33 151.84 42.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.121 2.168 . . . . 64.54 107.376 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -110.65 131.82 54.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.221 -1.77 . . . . 74.55 106.221 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.59 138.34 48.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.289 -1.375 . . . . 74.23 107.289 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -138.35 163.59 31.46 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.277 1.431 . . . . 73.11 109.572 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 67.31 31.21 6.65 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.329 1.852 . . . . 43.34 109.991 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 49.4 mt -70.34 156.41 91.92 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 124.468 1.107 . . . . 63.12 111.715 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.96 152.62 51.94 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.814 3.009 . . . . 70.2 109.961 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -80.28 -25.11 39.61 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.539 -0.726 . . . . 74.54 112.431 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -129.01 114.78 16.84 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.45 1.5 . . . . 62.03 106.956 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.28 168.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 127.068 2.147 . . . . 61.44 106.409 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -136.89 169.54 17.59 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.465 1.106 . . . . 52.13 108.605 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.78 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.041 0.536 . . . . 72.23 111.139 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.29 -25.41 64.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.62 1.568 . . . . 62.12 113.043 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -94.46 -35.88 12.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.213 1.005 . . . . 63.13 109.426 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.5 mmm -64.92 -53.2 50.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.501 1.12 . . . . 54.12 109.82 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -67.52 -16.89 64.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.606 -0.712 . . . . 65.41 111.938 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.26 -67.03 0.54 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.859 -1.163 . . . . 64.04 107.859 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.99 -62.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 C-N-CA 126.484 1.914 . . . . 72.32 111.353 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -62.34 -21.5 65.35 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.467 0.914 . . . . 73.12 113.467 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.46 66.24 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.122 0.868 . . . . 51.41 112.386 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.56 -31.46 72.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.218 -1.401 . . . . 64.45 107.218 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.95 -61.76 1.89 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.32 1.048 . . . . 75.15 109.708 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.84 178.11 45.86 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.719 1.145 . . . . 63.42 115.085 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 121.86 9.15 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.367 3.378 . . . . 75.34 109.927 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 mt -86.38 151.07 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.483 -0.932 . . . . 74.12 108.483 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -87.5 -62.86 1.4 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 107.168 -1.419 . . . . 72.03 107.168 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.53 161.27 41.73 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.122 0.969 . . . . 73.21 109.849 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -140.02 142.37 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.741 1.616 . . . . 74.43 107.482 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 -141.67 131.39 24.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.197 -2.89 . . . . 60.31 103.197 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.94 157.4 30.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.478 0.711 . . . . 62.43 111.3 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.05 146.99 44.88 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.821 1.201 . . . . 65.24 111.048 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.09 -49.53 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.46 1.104 . . . . 70.52 108.886 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -66.4 159.76 70.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.691 -0.855 . . . . 72.52 108.691 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.13 -12.21 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.719 1.612 . . . . 62.42 110.594 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.73 -9.88 45.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.015 2.526 . . . . 65.14 111.865 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 33.4 p -116.75 -33.42 4.82 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.039 0.936 . . . . 62.15 109.153 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -54.33 117.2 3.09 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.936 1.694 . . . . 74.01 108.049 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.31 -8.38 9.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.592 2.044 . . . . 73.41 109.75 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 71.8 p -139.77 158.89 43.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.567 1.147 . . . . 61.1 109.953 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.27 172.45 13.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 75.23 107.939 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -128.36 144.55 51.15 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.007 -1.849 . . . . 75.02 106.007 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.41 141.17 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.399 -2.075 . . . . 44.01 105.399 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -123.62 130.46 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.891 -1.892 . . . . 54.22 105.891 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -96.86 160.8 14.16 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 105.48 -2.044 . . . . 63.42 105.48 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.81 -46.27 89.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.1 0.407 . . . . 72.15 112.1 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -120.88 176.16 5.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.566 1.947 . . . . 75.43 110.526 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -90.59 -11.58 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.776 1.23 . . . . 72.23 113.653 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -83.24 -52.82 6.24 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.6 -1.313 . . . . 72.22 110.1 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -30.75 68.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.114 0.966 . . . . 73.4 110.846 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.68 88.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.014 0.526 . . . . 71.44 110.842 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . 0.412 ' HG2' HG11 ' B' ' 17' ' ' VAL . 22.7 mttp -71.86 -39.12 69.9 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.535 -0.728 . . . . 70.05 109.809 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -54.77 -53.45 54.95 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 107.703 -1.221 . . . . 71.05 107.703 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.52 96.51 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.883 0.873 . . . . 71.13 111.937 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 50.9 t -50.91 -58.6 5.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.852 0.861 . . . . 74.54 111.395 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.95 -37.16 83.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 119.3 -0.381 . . . . 71.31 111.528 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.47 -26.82 68.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.021 0.528 . . . . 71.24 112.114 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 30.3 tp -103.78 -14.38 16.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.693 1.197 . . . . 73.43 113.987 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 9.4 t -59.06 116.29 3.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.112 -0.992 . . . . 55.13 110.031 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.45 20.22 69.49 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.96 -1.467 . . . . 62.0 114.262 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -52.13 133.03 33.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.052 1.426 . . . . 75.51 109.988 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -84.98 97.14 9.63 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.643 1.577 . . . . 73.2 111.149 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.86 146.71 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.09 1.756 . . . . 62.53 107.369 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 32.6 m 46.36 31.68 1.34 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 54.14 113.297 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.07 23.71 11.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.52 1.528 . . . . 55.12 112.003 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -116.54 179.19 4.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.41 2.684 . . . . 74.53 108.03 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -137.82 121.69 17.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 71.11 106.707 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.73 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.537 -0.912 . . . . 73.42 108.537 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.96 107.07 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 105.167 -2.16 . . . . 44.43 105.167 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.18 132.86 39.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.237 1.015 . . . . 72.33 109.197 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.6 tp -143.85 157.25 44.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.867 1.267 . . . . 72.43 109.182 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -86.28 157.73 19.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.064 0.946 . . . . 53.04 108.891 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -81.95 161.52 23.03 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.76 . . . . 75.12 109.756 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 38.4 t30 . . . . . 0 C--O 1.243 0.752 0 C-N-CA 126.265 1.826 . . . . 72.21 108.698 -179.245 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 13.5 tp . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 119.36 -0.352 . . . . 62.32 110.936 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -61.95 -45.2 94.73 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.296 1.838 . . . . 74.13 108.743 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.754 1.222 . . . . 71.22 110.747 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 47.2 mtp -78.18 -20.71 51.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 75.21 111.55 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.2 155.34 42.85 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.08 0.952 . . . . 64.33 110.322 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.99 168.53 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.542 2.162 . . . . 54.31 110.523 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.33 169.68 5.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.955 2.102 . . . . 71.54 112.468 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 66.04 20.9 69.33 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.731 -1.038 . . . . 65.02 113.955 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -122.95 157.09 33.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.674 1.737 . . . . 73.15 109.533 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -135.99 146.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.759 -1.109 . . . . 72.23 108.657 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . 0.409 HG13 HE21 ' B' ' 47' ' ' GLN . 98.0 t -70.28 151.06 9.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 105.779 -1.934 . . . . 54.53 105.779 178.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.59 90.62 31.58 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.231 -2.877 . . . . 65.22 103.231 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.9 163.4 7.52 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.681 2.254 . . . . 74.51 112.622 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.65 155.63 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.97 1.78 . . . . 74.23 109.284 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 C-N-CA 121.792 1.661 . . . . 54.3 112.581 -179.241 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 106.381 -1.711 . . . . 72.44 106.381 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -137.13 159.36 42.14 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.808 1.243 . . . . 63.31 109.24 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -55.92 -34.24 65.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.318 1.447 . . . . 62.22 113.514 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.5 136.13 24.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.155 -1.424 . . . . 64.22 107.155 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.5 mt -128.56 156.58 43.1 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.708 2.003 . . . . 75.13 107.912 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -124.94 126.13 45.01 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.297 1.839 . . . . 64.33 107.315 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -115.92 146.17 20.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.117 -1.438 . . . . 74.25 107.117 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -126.99 163.52 23.51 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.143 1.777 . . . . 75.24 107.529 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 66.11 28.96 10.12 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.313 1.445 . . . . 74.3 112.193 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' B' ' 60' ' ' ALA . 78.2 mt -77.56 150.4 79.3 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 121.109 -0.994 . . . . 75.12 112.009 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.3 148.55 88.57 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.725 2.95 . . . . 71.5 109.647 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -84.97 -21.78 29.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 74.14 112.066 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -124.87 94.96 4.34 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.523 -1.288 . . . . 74.02 107.523 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 tt -147.53 170.42 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.525 2.33 . . . . 74.5 106.333 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 61.3 p -131.26 170.17 14.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.013 1.279 . . . . 75.13 110.761 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.55 74.45 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.614 -0.513 . . . . 71.22 109.614 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.74 -36.75 72.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.371 1.868 . . . . 64.52 110.323 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.86 -42.68 13.04 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.496 -0.752 . . . . 62.12 110.397 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 97.8 mmm -58.9 -35.27 72.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.667 -0.683 . . . . 73.05 111.362 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.59 -12.42 48.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.678 0.791 . . . . 62.42 111.535 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.69 -61.81 1.63 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.57 1.532 . . . . 72.51 108.606 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.0 mt -48.6 -57.82 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.514 1.126 . . . . 42.1 109.705 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -73.81 -23.91 59.73 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.443 0.535 . . . . 71.11 112.443 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.96 -23.41 74.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.165 0.888 . . . . 44.24 111.747 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -73.04 -2.77 22.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 1.227 . . . . 43.3 109.762 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -107.68 -11.58 15.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.78 -1.105 . . . . 75.21 111.863 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.32 26.6 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.512 1.051 . . . . 51.25 112.761 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.0 151.74 83.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.316 3.344 . . . . 75.44 110.818 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 54.0 mt -121.77 130.26 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 107.908 -1.145 . . . . 75.45 107.908 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -74.17 -63.42 1.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.478 -0.934 . . . . 75.42 108.478 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . 0.409 HE21 HG13 ' A' ' 414' ' ' VAL . 10.9 tt0 -158.16 165.62 34.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.476 0.71 . . . . 71.43 109.188 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 59.3 mt -140.84 145.98 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.912 1.685 . . . . 75.42 107.468 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -136.26 154.4 50.91 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.333 -2.099 . . . . 75.52 105.333 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.57 153.01 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 123.919 0.887 . . . . 35.02 109.009 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.73 136.27 19.61 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.174 -1.971 . . . . 71.52 108.174 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -115.69 -23.48 8.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.665 -0.494 . . . . 73.41 109.665 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.7 p -80.28 156.82 73.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.684 0.794 . . . . 64.22 110.276 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.2 -14.04 34.24 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.059 2.506 . . . . 64.21 114.065 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -97.52 -1.11 44.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.354 0.979 . . . . 72.45 112.999 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 81.4 p -116.86 -13.04 10.7 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.409 1.004 . . . . 52.34 113.159 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -50.84 116.47 1.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.08 1.352 . . . . 73.34 109.803 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 -20.79 9.03 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.674 1.131 . . . . 54.54 112.33 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -124.11 128.17 48.89 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.348 1.059 . . . . 73.33 109.797 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.427 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -140.34 175.76 9.33 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.512 1.125 . . . . 65.24 111.56 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -128.76 147.1 50.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.189 0.595 . . . . 75.24 110.269 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.59 148.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 126.667 1.987 . . . . 63.1 105.894 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 15.9 t -127.61 124.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.806 -1.924 . . . . 73.21 105.806 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -98.65 163.04 12.81 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.531 -1.285 . . . . 62.42 107.531 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -89.18 -61.71 1.64 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.759 -0.83 . . . . 72.21 108.759 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.18 138.82 32.78 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.033 -1.042 . . . . 73.13 110.986 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt -71.43 -43.47 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.203 -0.935 . . . . 74.04 110.7 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.159 0.89 . . . . 75.5 111.334 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.93 -48.05 22.77 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.316 1.446 . . . . 51.13 108.038 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.85 79.75 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.03 0.932 . . . . 51.31 108.832 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -65.03 -36.96 86.03 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.945 1.298 . . . . 64.05 111.321 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -63.59 -55.85 20.48 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 107.782 -1.192 . . . . 60.13 107.782 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.4 73.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.958 0.903 . . . . 25.51 111.09 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.96 -57.07 11.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.211 -1.403 . . . . 74.13 107.211 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.87 -42.12 98.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 119.253 -0.403 . . . . 71.41 111.11 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.263 -0.875 . . . . 72.41 112.592 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.46 -28.12 13.08 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.723 1.601 . . . . 73.31 111.293 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 20.6 t -66.23 107.92 2.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.517 1.527 . . . . 65.43 107.64 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.24 10.09 54.76 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.204 1.383 . . . . 75.45 113.57 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -74.7 122.12 22.76 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.362 1.581 . . . . 71.41 108.004 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -85.07 132.65 34.29 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.773 -1.195 . . . . 34.3 107.773 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -146.19 135.69 17.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.964 -1.495 . . . . 51.43 106.964 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.6 m 46.2 42.38 9.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.65 1.58 . . . . 73.24 113.268 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.64 3.93 4.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.804 2.842 . . . . 54.45 114.256 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.88 161.81 15.98 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.196 -1.565 . . . . 75.22 109.917 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -110.52 117.71 34.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.542 -0.911 . . . . 74.21 108.542 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.64 154.6 39.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.667 -0.864 . . . . 73.11 108.667 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.0 127.52 67.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.031 -1.47 . . . . 65.35 107.031 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -115.77 137.77 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 71.35 108.183 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -144.59 137.1 26.5 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.859 0.864 . . . . 54.34 110.272 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -66.87 153.66 42.91 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.043 0.937 . . . . 73.11 108.95 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -76.37 163.69 26.74 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.498 -0.752 . . . . 75.35 112.99 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 C--O 1.249 1.076 0 C-N-CA 127.284 2.234 . . . . 73.4 105.596 179.389 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 25.9 tp . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 107.033 -1.469 . . . . 75.31 107.033 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -60.73 -41.89 96.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.85 -0.796 . . . . 74.01 108.85 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.88 45.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.92 0.888 . . . . 51.32 112.493 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.1 mtp -84.94 -1.25 56.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.446 1.098 . . . . 72.22 111.486 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -112.4 158.16 38.02 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 119.817 1.19 . . . . 75.03 111.711 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.96 175.61 10.19 Favored 'Trans proline' 0 C--O 1.239 0.567 0 C-N-CA 123.619 2.879 . . . . 74.34 112.204 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.56 166.15 21.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.358 -0.837 . . . . 71.2 110.33 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.01 78.96 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 121.388 -0.82 . . . . 71.13 113.531 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -123.38 157.57 33.06 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.711 -1.464 . . . . 75.35 107.902 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.77 137.09 43.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.203 -1.777 . . . . 71.04 106.203 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.7 t -70.31 149.67 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.004 -0.739 . . . . 63.23 109.004 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 35.9 tp -125.52 77.63 68.86 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.777 -1.194 . . . . 64.32 107.777 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.4 169.27 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.838 2.358 . . . . 71.24 111.701 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.18 161.46 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.424 3.416 . . . . 52.35 114.387 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo . . . . . 0 N--CA 1.46 -0.465 0 C-N-CA 124.669 3.579 . . . . 55.33 115.837 179.809 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t . . . . . 0 C--O 1.235 0.315 0 N-CA-C 105.083 -2.191 . . . . 72.32 105.083 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -130.75 166.55 20.54 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.717 1.207 . . . . 72.42 109.738 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.21 -41.78 73.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.521 -0.752 . . . . 74.11 112.966 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.14 133.96 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.146 -1.057 . . . . 63.23 108.146 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 36.9 mt -123.47 156.58 35.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.175 1.39 . . . . 73.41 109.397 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -111.71 137.53 49.49 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.554 2.342 . . . . 73.54 107.554 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.8 mm -123.18 144.65 32.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.919 2.088 . . . . 53.33 107.189 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.4 ' HG2' HG22 ' B' ' 59' ' ' THR . 74.8 mtp85 -144.83 163.03 35.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.426 1.09 . . . . 53.43 110.75 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 72.04 25.47 3.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.805 2.442 . . . . 74.55 111.278 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -73.91 157.22 87.44 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.998 1.319 . . . . 65.0 112.7 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.71 160.28 44.1 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.651 2.901 . . . . 63.31 112.263 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -93.73 -10.96 32.53 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.752 1.621 . . . . 75.31 110.936 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mmmp? -128.69 95.32 4.08 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 106.883 -1.525 . . . . 73.14 106.883 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -155.16 160.71 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 124.206 0.941 . . . . 61.4 108.526 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 8.4 p -138.08 175.73 9.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.171 1.388 . . . . 73.43 109.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.97 70.74 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.285 0.634 . . . . 35.23 111.981 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -56.93 -46.22 82.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.134 0.974 . . . . 73.33 111.96 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -78.29 -40.54 36.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.549 0.74 . . . . 72.34 109.721 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.2 mmm -61.05 -46.23 91.54 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 120.984 -1.072 . . . . 70.42 110.261 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -71.68 -23.27 61.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.374 -0.822 . . . . 71.11 109.938 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.64 -46.6 75.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.761 1.164 . . . . 54.34 108.063 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mt -67.79 -69.49 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.04 1.336 . . . . 73.21 110.902 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' PHE . . . . . 0.429 ' CE1' HG21 ' B' ' 62' ' ' VAL . 86.7 m-85 -60.32 -26.22 66.38 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.886 1.809 . . . . 71.25 115.886 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.54 -23.6 73.71 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.341 0.973 . . . . 54.33 111.946 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -65.83 -15.19 62.67 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.306 -1.114 . . . . 74.33 111.037 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -107.33 -4.48 18.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.936 1.458 . . . . 73.02 114.936 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.92 -173.7 21.45 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.753 1.16 . . . . 63.23 114.053 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.27 117.89 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 125.264 3.976 . . . . 53.25 113.791 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 71.5 mt -77.27 103.07 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 127.195 2.198 . . . . 74.21 108.682 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -66.46 -61.79 1.81 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.854 -1.154 . . . . 74.54 110.637 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -160.78 142.85 12.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.892 0.769 . . . . 73.03 111.603 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 16.7 mt -126.89 140.32 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.502 1.121 . . . . 74.24 109.539 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -137.37 122.47 19.13 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.767 -2.679 . . . . 65.32 103.767 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -111.17 145.99 16.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.501 1.12 . . . . 72.44 108.732 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.84 125.36 16.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.089 -2.405 . . . . 64.42 107.089 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -100.37 -20.57 15.76 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.521 1.16 . . . . 65.0 113.954 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -73.75 157.14 87.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.998 -1.853 . . . . 73.44 105.998 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.24 -20.29 70.39 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.106 1.871 . . . . 53.11 111.843 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.8 -44.43 16.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.282 1.433 . . . . 74.22 109.774 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 77.4 p -74.62 -0.94 19.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.254 -0.904 . . . . 61.12 112.176 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -64.61 163.44 13.71 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.887 -1.133 . . . . 73.44 109.363 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 -9.36 6.07 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.547 -1.141 . . . . 32.44 112.567 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' THR . . . . . 0.4 HG22 ' HG2' ' B' ' 24' ' ' ARG . 44.3 p -128.77 144.63 51.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.469 1.634 . . . . 65.22 110.312 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.72 175.37 12.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.224 1.01 . . . . 64.21 110.027 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -127.62 156.16 42.73 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.324 0.649 . . . . 51.31 110.531 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' B' ' 39' ' ' PHE . 62.1 t -142.55 144.95 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.537 -1.282 . . . . 70.1 107.537 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.48 149.16 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.077 -1.453 . . . . 75.42 107.077 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -116.24 160.2 20.78 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.403 -1.436 . . . . 75.32 108.78 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -65.7 -40.99 92.85 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.396 -0.594 . . . . 52.45 109.396 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -122.35 142.52 50.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.195 -1.039 . . . . 73.11 108.195 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.45 -24.51 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.681 -0.637 . . . . 73.43 110.845 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.66 -25.42 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.415 1.086 . . . . 73.55 110.581 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -74.9 -53.08 9.68 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 105.338 -2.097 . . . . 70.45 105.338 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.85 -35.71 33.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.241 1.016 . . . . 72.21 111.943 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -57.14 -69.14 0.17 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.07 1.348 . . . . 74.1 111.659 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -37.55 81.6 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.511 -0.743 . . . . 64.22 111.671 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.34 80.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.543 -0.741 . . . . 65.1 111.838 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.71 -61.67 2.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.053 -0.721 . . . . 73.31 109.053 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.51 -31.79 70.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.603 0.964 . . . . 74.31 113.603 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -73.88 -26.77 60.73 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.446 0.566 . . . . 72.32 111.1 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.21 -16.53 18.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.119 0.968 . . . . 74.45 112.669 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -63.11 108.06 1.16 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.141 1.777 . . . . 72.52 108.238 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.5 83.1 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.209 -1.329 . . . . 65.32 113.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.02 141.53 45.36 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 119.112 1.456 . . . . 73.15 111.006 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -94.96 113.61 25.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 115.231 1.567 . . . . 74.0 115.231 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 m -133.21 141.77 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 71.13 105.401 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 74.8 m 42.92 36.71 0.92 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.84 1.656 . . . . 54.32 113.607 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 65.26 21.56 12.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.299 1.84 . . . . 60.04 112.668 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.54 -179.54 3.74 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.779 2.432 . . . . 75.12 108.442 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -138.03 114.11 10.05 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.873 -1.899 . . . . 70.24 105.873 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -69.02 168.76 13.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.297 0.639 . . . . 71.44 110.97 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.02 107.85 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.855 1.262 . . . . 71.11 107.73 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.74 135.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.19 -1.411 . . . . 71.32 107.19 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -151.98 141.96 22.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.253 1.021 . . . . 74.03 108.803 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -73.17 154.75 40.17 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.943 0.792 . . . . 74.25 110.215 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.09 148.16 38.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.964 -1.495 . . . . 74.41 106.964 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 126.977 2.111 . . . . 74.31 106.417 178.771 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.87 0 N-CA-C 106.797 -2.521 . . . . 73.52 106.797 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.53 133.59 21.59 Favored Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 107.204 -1.406 . . . . 73.33 107.204 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.04 72.24 6.62 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.794 2.329 . . . . 52.55 108.356 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -55.64 134.5 51.21 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.125 -1.065 . . . . 75.22 108.125 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.26 -179.58 6.48 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.418 0.687 . . . . 74.13 111.614 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -147.74 -179.57 6.98 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.795 1.638 . . . . 72.51 109.468 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -136.52 168.54 19.28 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 125.756 1.622 . . . . 72.32 108.582 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -132.77 152.18 51.83 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.785 0.834 . . . . 41.44 109.836 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -125.24 -165.57 1.42 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.061 1.344 . . . . 74.43 109.286 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -139.5 179.05 6.78 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 126.09 1.756 . . . . 75.42 106.445 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 78.8 m95 -139.52 154.8 47.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.033 -1.84 . . . . 74.42 106.033 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -85.27 -166.12 1.41 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.221 1.809 . . . . 74.13 109.875 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -65.11 162.94 15.89 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 121.369 -0.832 . . . . 73.42 110.295 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -71.02 161.63 30.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.073 -0.967 . . . . 71.11 109.163 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 41.6 pt -71.18 173.81 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.721 1.208 . . . . 55.01 110.763 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.12 159.36 31.13 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.991 0.9 . . . . 64.41 111.127 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -155.8 176.12 13.04 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 125.911 1.685 . . . . 54.05 107.945 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 31.5 mtp85 -125.12 85.67 2.44 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.741 -0.599 . . . . 74.11 110.911 -178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -51.32 144.87 9.07 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.066 1.346 . . . . 73.22 109.411 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -56.54 160.45 5.39 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 124.918 1.287 . . . . 75.13 111.565 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.97 -174.58 1.79 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.123 1.882 . . . . 74.44 108.903 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 30.6 mt -73.34 70.62 1.21 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.144 -0.972 . . . . 74.52 109.69 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 75.5 m -81.87 175.48 10.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.048 1.339 . . . . 75.55 109.484 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.0 -40.7 73.73 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.489 1.116 . . . . 73.23 111.852 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -58.88 -26.03 63.89 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 113.491 0.922 . . . . 73.14 113.491 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -68.83 -20.86 64.31 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.741 1.155 . . . . 54.31 110.882 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 18.1 tp -63.98 -34.08 77.18 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.24 -0.652 . . . . 63.21 109.24 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.94 -41.88 90.76 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 123.833 0.853 . . . . 75.24 109.669 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.48 -25.53 61.46 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.086 1.354 . . . . 42.34 111.48 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.0 mtp -88.95 -17.41 29.56 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.893 0.877 . . . . 64.11 112.64 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -83.11 145.51 49.38 Favored Pre-proline 0 N--CA 1.455 -0.212 0 CA-C-N 119.32 0.963 . . . . 71.34 110.212 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -67.28 157.49 61.51 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.423 2.082 . . . . 74.33 112.197 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -73.99 134.99 43.12 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.218 -1.356 . . . . 72.34 108.984 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.6 24.37 18.45 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-O 118.845 -0.975 . . . . 63.33 113.549 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -124.17 108.87 12.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.965 -1.495 . . . . 74.14 106.965 -179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 15.3 tptm -83.96 150.5 25.62 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 114.909 -1.041 . . . . 74.41 108.332 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 15.3 t -69.65 151.56 9.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 109.226 -0.657 . . . . 74.31 109.226 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 25.9 tp -120.76 78.88 30.94 Favored Pre-proline 0 CA--C 1.532 0.259 0 C-N-CA 123.999 0.92 . . . . 65.43 109.278 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.97 160.01 50.69 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 N-CA-C 108.346 -1.444 . . . . 61.14 108.346 178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -67.15 157.5 61.43 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.141 1.894 . . . . 75.34 110.955 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -67.23 149.78 81.58 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.066 1.844 . . . . 72.41 109.755 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -67.77 139.9 56.65 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 122.99 0.516 . . . . 64.54 109.731 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 73.57 14.04 79.86 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 118.911 -0.939 . . . . 74.13 113.396 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -69.39 122.89 19.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 119.395 1.597 . . . . 74.44 108.389 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 91.9 t -135.43 89.49 22.53 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 106.988 -1.486 . . . . 74.33 106.988 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -80.43 -168.53 0.64 Allowed 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.065 2.51 . . . . 64.12 109.512 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.8 pp . . . . . 0 C--O 1.251 1.154 0 C-N-CA 126.522 1.929 . . . . 64.51 106.225 177.953 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.409 0 N-CA-C 109.386 -1.486 . . . . 73.43 109.386 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -146.26 91.87 2.11 Favored 'General case' 0 C--N 1.333 -0.109 0 N-CA-C 105.404 -2.073 . . . . 73.34 105.404 178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.06 -170.05 2.89 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.28 1.432 . . . . 52.35 110.055 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -129.11 108.28 10.24 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.52 1.128 . . . . 71.32 108.284 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 49.8 pt -132.84 144.94 35.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 106.667 -1.605 . . . . 73.24 106.667 178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -69.31 171.93 7.82 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.342 -0.614 . . . . 75.35 109.342 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.7 tp 52.84 65.66 5.72 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 106.513 -1.662 . . . . 71.11 106.513 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -68.29 151.14 76.66 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.554 2.169 . . . . 74.41 113.78 -177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -71.46 -13.2 30.23 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 123.647 2.898 . . . . 75.14 112.853 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -77.82 -6.32 53.74 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.161 -0.962 . . . . 53.14 111.722 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.446 HG11 ' HG2' ' B' ' 71' ' ' LYS . 59.7 t -108.36 150.51 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 125.405 1.482 . . . . 74.51 107.803 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -134.2 176.87 8.2 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.573 2.349 . . . . 54.13 108.022 -179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -77.54 -9.87 59.17 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.803 -0.56 . . . . 60.25 110.188 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -92.03 115.89 31.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 C-N-CA 126.397 1.879 . . . . 64.12 107.641 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 43.7 mt -114.51 127.02 55.59 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.473 1.509 . . . . 64.33 109.456 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -92.62 135.42 34.1 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.172 -1.418 . . . . 71.14 107.172 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 mm -122.93 136.91 58.18 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 125.562 1.545 . . . . 73.44 107.968 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 mtp85 -123.42 162.06 23.55 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 124.786 1.234 . . . . 73.33 107.803 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 42.8 t30 70.05 25.51 4.77 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 127.655 2.382 . . . . 63.14 113.776 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 87.4 mt -69.27 150.81 97.17 Favored Pre-proline 0 C--O 1.233 0.196 0 N-CA-C 108.215 -1.031 . . . . 60.33 108.215 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -64.66 151.6 85.03 Favored 'Trans proline' 0 N--CA 1.456 -0.732 0 C-N-CA 121.728 1.619 . . . . 54.21 110.204 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -73.89 -25.46 60.04 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.704 -0.623 . . . . 62.41 110.364 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.78 109.56 17.27 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 108.259 -1.015 . . . . 74.13 108.259 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 tt -159.09 152.44 6.01 Favored 'Isoleucine or valine' 0 C--O 1.24 0.579 0 N-CA-C 107.636 -1.246 . . . . 55.23 107.636 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 46.5 p -113.34 172.74 6.77 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.807 1.243 . . . . 72.45 110.33 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.9 -32.08 73.11 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.169 -1.048 . . . . 52.12 108.169 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -52.17 -49.61 63.44 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 126.722 2.009 . . . . 74.12 110.658 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -70.74 -49.93 41.56 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.26 1.024 . . . . 62.33 109.647 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 98.1 mmm -56.25 -43.35 78.62 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.694 -0.629 . . . . 64.35 112.186 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -67.82 -29.44 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.34 0.973 . . . . 75.54 110.789 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -76.56 -35.94 57.91 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.389 0.995 . . . . 71.44 110.585 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.1 mt -74.26 -58.84 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 C-N-CA 125.522 1.529 . . . . 60.21 110.84 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.462 ' CE2' HG21 ' B' ' 62' ' ' VAL . 78.9 m-85 -74.09 -23.62 59.36 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 121.074 -1.016 . . . . 71.42 112.353 -178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.91 -7.59 88.38 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.602 0.637 . . . . 52.11 112.638 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -63.06 -26.31 68.78 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.573 1.149 . . . . 63.42 111.745 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -94.58 -21.12 19.04 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.175 0.99 . . . . 75.42 112.802 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.71 -159.62 29.68 Favored Glycine 0 CA--C 1.53 1.014 0 CA-C-N 119.622 1.101 . . . . 51.14 110.387 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -71.92 151.25 56.38 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.381 2.054 . . . . 73.43 109.236 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 mt -112.73 137.3 46.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 106.277 -1.749 . . . . 75.54 106.277 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.59 -66.02 0.79 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.109 -1.071 . . . . 74.35 108.109 179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -161.49 153.8 19.96 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 118.724 0.693 . . . . 71.13 111.41 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 74.6 mt -136.0 150.75 28.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-O 123.223 1.487 . . . . 74.34 109.6 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.3 mtt180 -136.22 163.84 29.46 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 104.09 -2.559 . . . . 74.32 104.09 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -144.18 149.33 17.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 120.664 1.575 . . . . 74.22 108.4 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.2 139.1 48.38 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.85 -1.7 . . . . 72.14 108.85 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.67 -9.67 6.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.936 0.894 . . . . 75.52 112.332 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.94 159.73 32.53 Favored Pre-proline 0 CA--C 1.537 0.451 0 C-N-CA 126.52 1.928 . . . . 64.24 106.335 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.17 -29.57 89.38 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.95 1.767 . . . . 65.32 112.575 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -91.49 2.31 56.52 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.35 1.06 . . . . 74.12 112.786 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 49.5 p -116.42 -31.58 5.53 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 120.702 1.592 . . . . 75.24 112.452 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 28.4 mtp-105 -54.52 136.04 45.22 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.264 1.026 . . . . 62.22 108.538 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.42 -5.57 44.79 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.078 0.847 . . . . 54.13 112.367 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 58.6 p -142.82 158.38 43.69 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-N 119.044 1.422 . . . . 64.32 108.849 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.21 160.59 21.4 Favored 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 123.446 0.698 . . . . 51.22 110.549 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -117.06 132.93 56.57 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 127.063 2.145 . . . . 63.14 106.874 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.462 HG21 ' CE2' ' B' ' 39' ' ' PHE . 89.3 t -111.82 150.5 14.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 C-N-CA 125.302 1.441 . . . . 51.14 107.825 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.8 t -124.01 125.67 71.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 107.212 -1.403 . . . . 72.43 107.212 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -97.8 161.77 13.59 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 107.543 -1.28 . . . . 63.21 107.543 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -74.27 -31.24 62.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.167 -0.924 . . . . 73.15 111.765 -178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.63 172.45 8.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.763 1.225 . . . . 63.14 109.468 179.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.9 tt -95.61 -29.16 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 107.986 -1.116 . . . . 61.21 107.986 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -62.44 -62.6 1.64 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 125.713 1.605 . . . . 75.34 109.721 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -60.31 -35.05 74.7 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 124.402 1.081 . . . . 51.45 111.293 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.48 -55.24 33.32 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.609 -0.886 . . . . 72.42 108.609 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.446 ' HG2' HG11 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -62.06 -35.26 78.09 Favored 'General case' 0 C--N 1.342 0.275 0 CA-C-O 117.891 -1.052 . . . . 60.41 111.364 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -59.67 -53.46 57.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.984 0.811 . . . . 60.24 109.902 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.51 -29.74 65.14 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 118.831 -0.604 . . . . 64.24 112.432 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.0 t -50.8 -48.77 59.52 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.314 1.046 . . . . 62.13 110.091 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.01 -59.97 3.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.621 0.769 . . . . 62.33 109.373 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -57.93 -15.54 9.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 115.922 1.823 . . . . 72.33 115.922 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 tp -99.67 -1.96 36.64 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.011 1.278 . . . . 52.41 111.153 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.1 p -75.47 132.59 40.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.257 -1.386 . . . . 71.33 107.257 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 74.29 10.28 81.7 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.048 -0.862 . . . . 63.12 113.114 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -66.45 133.91 51.39 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 118.961 1.381 . . . . 61.33 107.294 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.28 126.77 53.69 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 124.641 1.177 . . . . 64.33 109.119 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 5.4 m -136.83 141.72 39.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 126.115 1.766 . . . . 74.13 107.036 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 88.9 m 49.46 29.61 2.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.328 1.051 . . . . 60.14 111.887 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 15.7 m120 71.27 23.31 4.06 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.284 2.233 . . . . 72.31 113.279 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -132.14 141.74 49.23 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 125.223 1.409 . . . . 74.13 108.726 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -88.47 151.1 22.77 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 123.501 0.72 . . . . 73.12 109.164 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 91.5 mt -106.44 167.67 9.68 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.878 -0.786 . . . . 73.43 108.878 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 79.4 t -132.73 137.75 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.538 -1.282 . . . . 64.53 107.538 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 36.6 t -118.9 139.89 44.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 125.328 1.451 . . . . 64.53 109.094 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 52.0 tp -146.42 165.43 29.38 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.154 1.782 . . . . 71.13 108.369 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.44 164.09 11.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.261 1.425 . . . . 74.44 112.486 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -83.32 115.14 21.86 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.772 1.229 . . . . 74.33 108.683 179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 63.4 t30 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.201 -0.904 . . . . 75.53 110.852 -178.9 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.314 0 N-CA-C 108.818 -1.713 . . . . 71.1 108.818 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 15.2 t -134.88 110.71 11.05 Favored Pre-proline 0 CA--C 1.533 0.305 0 N-CA-C 105.607 -1.997 . . . . 71.35 105.607 179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -78.13 166.08 25.15 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 121.954 1.769 . . . . 74.12 109.381 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -155.37 146.52 22.64 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.036 -1.838 . . . . 74.24 106.036 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -145.85 47.19 1.26 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 128.089 2.556 . . . . 65.2 107.216 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -58.52 102.52 0.11 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 125.795 1.638 . . . . 71.25 109.719 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -112.34 100.11 8.54 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.898 1.279 . . . . 72.14 107.865 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -132.9 147.78 52.29 Favored 'General case' 0 C--O 1.232 0.148 0 N-CA-C 107.68 -1.23 . . . . 74.32 107.68 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 39.9 p90 -127.34 -178.24 4.38 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 125.324 1.45 . . . . 71.4 109.842 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 5.2 ptp85 -164.26 171.4 14.96 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.884 2.074 . . . . 71.13 106.846 178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 29.3 t-105 -170.7 120.09 0.55 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.386 -2.079 . . . . 73.24 105.386 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -109.65 154.13 23.26 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.965 -0.754 . . . . 73.44 108.965 -179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -149.65 138.88 21.33 Favored 'General case' 0 CA--C 1.519 -0.236 0 O-C-N 120.918 -1.114 . . . . 65.2 109.467 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -116.24 148.07 40.83 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 105.108 -2.182 . . . . 70.52 105.108 177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -162.04 120.17 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.742 -1.947 . . . . 73.02 105.742 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -147.16 93.41 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.603 -0.888 . . . . 43.52 108.603 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -71.17 163.77 26.96 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 109.066 -0.716 . . . . 75.41 109.066 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -110.79 120.58 42.86 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.62 -1.622 . . . . 73.23 106.62 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -116.78 72.01 0.81 Allowed 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.254 -1.758 . . . . 73.25 106.254 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -142.08 157.06 64.59 Favored Pre-proline 0 C--O 1.234 0.269 0 C-N-CA 124.482 1.113 . . . . 71.24 110.304 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -73.9 178.46 6.81 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.986 2.457 . . . . 55.11 108.591 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 69.2 mt -95.78 146.19 24.74 Favored 'General case' 0 C--O 1.233 0.19 0 O-C-N 121.293 -0.879 . . . . 71.4 108.819 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 66.3 m -126.26 177.74 6.24 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 125.763 1.625 . . . . 74.41 108.38 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.26 -30.39 69.41 Favored 'General case' 0 N--CA 1.465 0.288 0 O-C-N 120.906 -1.122 . . . . 71.31 111.356 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -65.17 -30.96 71.92 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.256 0.48 . . . . 65.42 110.153 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -68.31 -30.62 69.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.936 -0.764 . . . . 73.34 108.936 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . 0.401 HD21 HG21 ' B' ' 63' ' ' VAL . 60.8 tp -70.9 -42.17 70.32 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -60.93 -44.11 97.67 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.949 -0.76 . . . . 75.14 108.949 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -68.36 -40.02 81.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.433 1.493 . . . . 63.2 111.6 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 90.3 mtp -74.47 -21.59 59.51 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.366 1.066 . . . . 74.13 112.527 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -76.71 152.65 83.1 Favored Pre-proline 0 CA--C 1.537 0.476 0 CA-C-N 120.076 1.307 . . . . 62.24 109.265 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.499 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 86.8 Cg_endo -72.1 177.1 7.56 Favored 'Trans proline' 0 CA--C 1.536 0.588 0 C-N-CA 124.833 3.688 . . . . 65.14 112.521 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -95.01 143.58 26.37 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.111 0.964 . . . . 75.32 112.724 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 93.52 29.53 9.99 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.587 1.089 . . . . 73.51 113.658 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.499 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 49.6 m-85 -125.98 157.12 38.65 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.049 1.34 . . . . 75.13 109.671 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.79 142.4 50.4 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 107.377 -1.342 . . . . 74.24 107.377 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 9.6 t -69.61 151.79 9.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 108.415 -0.957 . . . . 52.11 108.415 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.4 tp -120.88 85.8 40.52 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.655 -0.653 . . . . 71.03 109.312 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -61.56 159.68 31.17 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.947 2.431 . . . . 62.44 111.051 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.17 166.47 26.76 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 124.385 3.39 . . . . 75.02 113.384 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.02 172.75 14.05 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.573 2.182 . . . . 75.42 109.238 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -104.21 100.07 9.8 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.549 1.139 . . . . 70.33 109.047 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 139.79 -12.83 3.15 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.883 1.23 . . . . 32.21 111.939 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -51.15 141.57 14.16 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.466 1.507 . . . . 73.43 111.842 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 73.4 t -116.75 96.49 48.68 Favored Pre-proline 0 CA--C 1.539 0.538 0 C-N-CA 127.125 2.17 . . . . 53.21 106.076 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -78.16 170.31 18.88 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.872 2.382 . . . . 64.24 111.497 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--O 1.255 1.382 0 N-CA-C 106.105 -1.813 . . . . 64.14 106.105 178.358 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.538 0 N-CA-C 111.118 -0.793 . . . . 32.13 111.118 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 13.5 ttt-85 -124.47 110.02 13.99 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.53 -2.026 . . . . 71.14 105.53 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.86 172.11 14.21 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.924 0.89 . . . . 40.33 112.897 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -165.43 156.59 14.17 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 129.603 3.161 . . . . 73.4 105.518 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 4.5 mp -92.65 107.96 19.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 104.419 -2.437 . . . . 74.41 104.419 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 65.3 mtp85 -142.69 163.47 32.73 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.801 -1.185 . . . . 54.55 107.801 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 mt -68.77 157.41 88.74 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 123.991 0.917 . . . . 74.42 108.879 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.77 163.93 35.3 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.77 2.314 . . . . 74.33 110.264 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.04 -45.16 29.65 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.177 1.918 . . . . 61.53 110.149 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.34 170.08 19.33 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 123.84 0.856 . . . . 70.45 109.987 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 t -143.91 152.45 16.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 106.982 -1.488 . . . . 63.25 106.982 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -131.82 159.15 39.37 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.532 1.533 . . . . 64.25 108.667 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 48.6 mtm-85 -82.87 -25.24 32.73 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.706 0.802 . . . . 74.41 110.662 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 80.3 mt -83.4 135.21 25.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 103.019 -2.956 . . . . 74.5 103.019 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.2 mt -121.7 165.81 15.24 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.679 1.591 . . . . 73.25 108.518 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -129.04 130.25 46.34 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.951 2.1 . . . . 63.24 109.123 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -113.22 151.27 15.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 C-N-CA 127.302 2.241 . . . . 71.32 107.849 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -146.57 159.93 42.8 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 121.661 -0.65 . . . . 62.21 110.945 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 53.6 t30 64.97 19.03 11.75 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 127.204 2.202 . . . . 54.1 113.975 178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 27.4 mt -58.92 152.77 47.69 Favored Pre-proline 0 C--O 1.236 0.372 0 C-N-CA 123.04 0.536 . . . . 75.04 112.239 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.92 144.53 96.64 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.303 2.669 . . . . 73.01 110.34 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -77.78 -14.27 59.64 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.299 -0.876 . . . . 74.51 111.59 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 ttpp -123.49 105.5 9.83 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.443 -1.688 . . . . 62.32 106.443 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.9 tt -156.59 164.35 1.22 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.458 0 C-N-CA 125.915 1.686 . . . . 71.21 106.744 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.27 169.03 17.49 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.593 1.557 . . . . 55.53 109.336 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.22 -31.64 70.36 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 118.923 -0.561 . . . . 52.11 110.316 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -55.59 -39.79 71.18 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.388 1.475 . . . . 73.22 111.825 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -83.79 -47.79 10.76 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.646 1.178 . . . . 75.52 110.413 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.3 mmm -53.45 -47.98 69.22 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 122.609 0.364 . . . . 75.02 110.82 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -69.21 -34.96 75.68 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.281 -0.866 . . . . 64.14 111.672 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -60.28 -56.65 18.95 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 118.81 0.732 . . . . 74.04 109.328 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 48.8 mt -54.48 -63.49 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 126.751 2.02 . . . . 72.33 111.234 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -63.52 -24.34 67.77 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.204 0.911 . . . . 74.1 112.854 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.5 79.96 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-O 118.797 -1.001 . . . . 53.24 112.258 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.409 ' HA ' ' HE2' ' B' ' 41' ' ' LYS . 7.3 mmpt? -60.3 -19.34 54.74 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.53 1.665 . . . . 52.53 113.215 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -107.52 -31.25 8.2 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 117.404 -1.284 . . . . 72.44 113.861 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 174.0 -152.4 14.83 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 119.716 1.144 . . . . 73.31 112.774 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.18 162.48 28.56 Favored 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 124.163 3.242 . . . . 73.22 111.84 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 63.2 mt -125.99 132.58 70.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 107.141 -1.429 . . . . 33.44 107.141 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -58.05 2.67 Favored 'General case' 0 C--O 1.226 -0.135 0 N-CA-C 107.973 -1.121 . . . . 72.3 107.973 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -156.22 160.11 39.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.952 0.901 . . . . 61.34 109.368 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 48.7 mt -139.69 136.1 39.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 125.267 1.427 . . . . 64.53 108.0 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 65.4 mtt180 -137.77 143.57 41.18 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 107.247 -1.39 . . . . 64.3 107.247 178.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -127.84 165.37 27.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 124.287 1.035 . . . . 52.21 108.539 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.05 135.19 25.87 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 124.098 0.856 . . . . 74.52 113.054 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -104.88 -42.74 5.27 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 126.208 1.803 . . . . 70.04 109.211 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.0 p -66.32 158.78 76.23 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 107.906 -1.146 . . . . 73.33 107.906 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.55 -31.65 40.9 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.221 1.281 . . . . 64.33 110.947 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -70.99 -23.7 62.25 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.747 0.703 . . . . 61.23 112.46 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -89.94 -0.97 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.621 0.768 . . . . 32.14 111.79 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 23.4 mmt180 -67.84 120.48 14.21 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 105.291 -2.115 . . . . 74.5 105.291 178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.11 2.34 36.04 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.116 0.865 . . . . 42.44 112.875 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 65.8 p -129.55 151.34 50.27 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 118.769 1.285 . . . . 70.34 108.058 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -163.55 171.13 16.26 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.001 -1.062 . . . . 74.3 110.74 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -138.38 151.87 47.9 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.947 0.899 . . . . 71.13 110.393 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.49 152.62 35.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 105.153 -2.166 . . . . 63.22 105.153 177.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 404' ' ' LEU . 23.5 t -127.73 129.91 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 106.172 -1.788 . . . . 72.14 106.172 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -98.23 161.99 13.42 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 106.848 -1.538 . . . . 72.14 106.848 178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -76.08 -43.85 41.64 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.722 -0.611 . . . . 72.42 111.083 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -123.02 164.13 19.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 124.78 1.232 . . . . 53.44 109.74 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.0 tt -83.33 -10.82 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 114.564 1.32 . . . . 74.55 114.564 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -83.55 -53.7 5.49 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.619 -1.252 . . . . 75.4 107.619 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -59.8 -40.56 88.73 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.746 0.654 . . . . 74.21 110.294 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.07 -46.34 79.01 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.544 0.738 . . . . 61.11 111.082 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -66.57 -46.15 76.96 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 119.124 -0.465 . . . . 64.23 110.253 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -55.51 -44.57 76.75 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 123.731 0.645 . . . . 75.44 110.123 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.71 -50.01 54.26 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.481 0.712 . . . . 71.2 110.051 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.8 t -50.88 -54.16 26.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.624 1.17 . . . . 74.2 110.937 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -63.3 -33.8 76.31 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 113.268 0.84 . . . . 63.21 113.268 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -80.91 -23.29 39.03 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 118.607 0.639 . . . . 75.1 111.911 178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.26 -23.6 22.28 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.167 0.508 . . . . 63.32 110.87 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 23.0 t -61.67 114.13 3.12 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 125.193 1.397 . . . . 42.0 108.677 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.96 10.63 75.01 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.394 -1.226 . . . . 74.52 114.578 179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -63.6 119.11 9.21 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.573 1.187 . . . . 73.33 108.571 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.26 109.31 17.69 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 125.497 1.519 . . . . 75.43 110.431 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 10.6 m -141.23 151.96 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 124.702 1.201 . . . . 75.13 109.585 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 76.8 m 44.68 43.75 6.92 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.892 1.277 . . . . 73.03 110.661 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 m120 50.53 35.49 11.46 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 128.138 2.575 . . . . 74.34 112.371 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 13.6 mmt85 -144.72 -179.99 6.94 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.311 2.245 . . . . 75.43 108.09 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -128.41 157.23 41.62 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.85 1.26 . . . . 64.41 108.909 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.5 mt -120.15 119.3 32.87 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.195 -0.668 . . . . 73.21 109.195 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 61.9 t -84.14 122.73 38.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 126.847 2.059 . . . . 73.2 106.294 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 t -107.39 129.41 61.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 106.398 -1.704 . . . . 71.42 106.398 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 45.1 tp -134.36 153.68 51.76 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.99 -1.115 . . . . 72.42 107.99 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -84.1 156.93 21.92 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 71.32 108.314 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 35.6 t80 -74.95 140.16 43.51 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 104.202 -2.518 . . . . 74.11 104.202 176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.673 -1.232 . . . . 72.22 107.673 178.852 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.823 0 N-CA-C 110.088 -1.205 . . . . 40.42 110.088 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . 0.252 10.0 t -131.81 69.58 81.08 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 123.858 0.863 . . . . 61.32 108.678 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.28 161.37 44.65 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.583 2.189 . . . . 62.33 109.771 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -144.21 -178.91 6.19 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 129.001 2.921 . . . . 73.15 107.968 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -116.49 77.45 1.11 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.894 -2.261 . . . . 64.52 104.894 179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -59.84 145.82 44.18 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 122.521 0.329 . . . . 61.44 110.281 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -74.65 117.46 16.51 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 105.392 -2.077 . . . . 71.34 105.392 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -136.22 99.29 4.08 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.763 0.825 . . . . 71.35 112.332 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -67.47 177.37 1.96 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.013 1.325 . . . . 74.43 110.776 178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 41.2 mtt-85 -140.86 158.47 43.9 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 124.575 1.15 . . . . 75.54 109.606 178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -108.06 166.35 10.79 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 126.643 1.977 . . . . 63.41 108.955 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -77.43 168.02 20.7 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.005 0.922 . . . . 64.14 110.99 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -172.06 172.2 4.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.052 1.341 . . . . 64.32 108.135 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.11 104.88 15.41 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 101.94 -3.356 . . . . 60.31 101.94 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 6.3 tp 179.9 176.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 129.87 3.268 . . . . 73.43 105.241 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -139.97 128.05 22.31 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.77 -1.937 . . . . 54.32 105.77 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -61.17 159.74 11.5 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.954 0.724 . . . . 72.03 112.954 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.16 1.8 7.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 126.224 1.81 . . . . 75.14 111.475 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -64.06 -26.19 68.44 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 114.676 1.361 . . . . 62.33 114.676 -179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 118.87 154.7 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.909 1 C-N-CA 136.117 5.767 . . . . 74.43 106.322 -178.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -66.99 91.14 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 123.807 3.005 . . . . 73.1 108.574 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 86.2 mt -152.47 147.48 26.29 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.952 2.101 . . . . 75.42 107.917 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 24.8 t -153.67 164.55 38.1 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 123.877 0.871 . . . . 74.43 109.154 178.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.58 -22.22 66.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.957 0.903 . . . . 74.54 112.629 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -72.01 -22.4 61.42 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.296 -0.878 . . . . 62.23 110.167 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -85.24 -30.21 24.01 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.768 -0.826 . . . . 74.21 108.768 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . 0.435 ' CD2' HH22 ' B' ' 49' ' ' ARG . 29.4 tp -56.62 -39.64 73.96 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 123.677 0.791 . . . . 63.34 109.712 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -58.18 -41.01 82.95 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.273 0.629 . . . . 72.35 110.291 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.87 -9.34 58.52 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.796 1.238 . . . . 64.24 112.871 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 79.9 mtp -76.21 -12.21 60.05 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 120.962 -1.086 . . . . 64.44 110.062 178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -114.61 158.85 39.15 Favored Pre-proline 0 N--CA 1.451 -0.396 0 C-N-CA 125.774 1.629 . . . . 75.41 112.601 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.37 170.93 17.19 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.978 1.785 . . . . 42.31 109.721 177.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -87.45 163.37 16.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.94 -1.027 . . . . 63.32 111.035 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.69 18.26 35.75 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.155 1.359 . . . . 65.03 112.415 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -126.26 157.05 39.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 125.15 1.38 . . . . 70.3 107.564 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 37.8 tptt -137.94 147.19 44.08 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 109.602 -0.518 . . . . 61.54 109.602 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 66.3 t -70.19 150.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 118.478 0.581 . . . . 54.22 109.664 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.7 tp -125.08 86.21 57.04 Favored Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 107.23 -1.396 . . . . 70.32 107.23 178.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_exo -60.49 159.55 27.23 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.951 2.434 . . . . 74.0 113.03 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.63 168.94 21.24 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 122.837 2.358 . . . . 65.14 110.803 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.66 159.11 3.65 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 124.499 3.466 . . . . 74.41 115.348 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -93.24 82.36 4.52 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.055 1.342 . . . . 42.41 108.007 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 113.88 37.74 1.24 Allowed Glycine 0 CA--C 1.531 1.039 0 CA-C-O 118.269 -1.295 . . . . 65.23 114.103 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -65.27 1.32 1.1 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.703 1.752 . . . . 70.42 115.245 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 2.5 t 64.96 73.11 0.44 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 128.642 2.777 . . . . 73.5 111.938 179.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -79.18 0.05 10.34 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.909 3.073 . . . . 62.32 111.775 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 51.3 mt . . . . . 0 C--O 1.25 1.131 0 C-N-CA 126.453 1.901 . . . . 75.05 108.031 -178.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.938 0 N-CA-C 110.733 -0.947 . . . . 71.15 110.733 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -54.09 127.14 25.41 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 107.76 -1.2 . . . . 75.34 107.76 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.71 150.8 26.52 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.06 -0.719 . . . . 64.24 109.06 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -150.32 157.98 43.65 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.369 0.668 . . . . 63.13 110.459 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 15.4 tt -154.07 151.64 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 127.223 2.209 . . . . 62.52 105.186 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -156.89 176.04 13.28 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 107.303 -1.369 . . . . 71.02 107.303 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -100.46 150.15 36.7 Favored Pre-proline 0 C--O 1.239 0.51 0 N-CA-C 107.633 -1.247 . . . . 53.31 107.633 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -67.26 165.22 27.52 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.51 2.14 . . . . 54.54 109.681 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.31 -38.64 33.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.452 2.101 . . . . 75.03 112.552 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 21.5 pt-20 -154.39 164.14 39.09 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.846 1.658 . . . . 72.22 108.36 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 t -152.97 146.37 14.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 126.765 2.026 . . . . 75.13 106.645 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -121.96 -172.88 2.53 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 125.668 1.587 . . . . 52.11 109.449 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -104.37 -17.24 14.87 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 121.088 -1.008 . . . . 61.01 112.532 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 97.7 mt -94.27 114.43 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 106.912 -1.514 . . . . 74.41 106.912 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 74.4 mt -102.97 170.83 7.74 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.251 1.02 . . . . 71.43 109.032 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -140.68 142.22 34.93 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.991 2.116 . . . . 74.03 106.509 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.1 mm -128.24 148.25 32.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 119.19 0.904 . . . . 74.42 108.711 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -133.42 162.31 32.2 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 126.264 1.825 . . . . 74.31 107.682 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 67.78 21.47 9.15 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 127.07 2.148 . . . . 71.15 112.292 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 69.2 mt -61.03 155.25 55.9 Favored Pre-proline 0 CA--C 1.535 0.397 0 C-N-CA 124.396 1.078 . . . . 54.11 111.338 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.42 138.23 45.57 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.525 2.816 . . . . 71.11 111.05 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.47 -23.46 65.5 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.9 0.88 . . . . 72.51 112.635 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.05 113.58 14.72 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 106.024 -1.843 . . . . 62.25 106.024 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 tt -159.5 129.19 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.195 -1.039 . . . . 73.3 108.195 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 12.5 p -83.23 169.15 16.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.385 -0.598 . . . . 64.5 109.385 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.26 -47.78 84.47 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-O 118.663 -0.684 . . . . 44.32 109.47 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -47.98 -47.05 33.2 Favored 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 125.14 1.376 . . . . 73.21 112.571 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -61.87 -52.68 63.11 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.154 0.982 . . . . 74.34 109.701 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 75.4 mmm -59.38 -48.28 82.23 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.982 0.513 . . . . 44.13 110.812 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -64.22 -29.02 70.14 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 118.036 -0.983 . . . . 73.0 109.767 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -68.73 -62.28 1.45 Allowed 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.726 1.148 . . . . 62.13 108.346 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 60.1 mt -45.44 -58.3 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.576 1.95 . . . . 70.3 111.339 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -78.04 -38.17 45.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 113.863 1.061 . . . . 63.54 113.863 -177.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.04 -37.39 85.45 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.866 -0.894 . . . . 42.32 110.866 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -57.34 -31.48 65.77 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 117.463 0.631 . . . . 74.21 110.89 179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -78.26 -55.35 5.32 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.599 -0.889 . . . . 73.3 108.599 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.81 -166.74 33.75 Favored Glycine 0 CA--C 1.525 0.688 0 O-C-N 121.496 -0.752 . . . . 51.41 112.619 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.19 156.17 26.16 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.476 2.784 . . . . 72.31 114.453 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 93.7 mt -126.83 102.84 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.175 -2.528 . . . . 73.52 104.175 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 29.5 tpt85 -75.77 -54.66 6.6 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 108.348 -0.982 . . . . 74.21 108.348 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -151.9 154.43 36.1 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.225 0.61 . . . . 70.41 109.613 -178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 80.1 mt -145.85 135.32 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 106.848 -1.538 . . . . 72.01 106.848 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.435 HH22 ' CD2' ' A' ' 404' ' ' LEU . 13.6 mtm-85 -133.48 120.5 20.93 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 105.375 -2.084 . . . . 71.41 105.375 177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.8 m -100.49 136.51 31.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 126.149 1.78 . . . . 61.32 110.404 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.35 134.67 45.25 Favored Glycine 0 C--N 1.336 0.545 0 N-CA-C 109.114 -1.595 . . . . 51.03 109.114 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -118.79 -23.23 7.06 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.502 1.521 . . . . 71.12 112.824 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 64.1 p -70.84 158.61 87.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 106.904 -1.517 . . . . 71.53 106.904 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.09 -10.89 22.41 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 122.02 1.813 . . . . 63.05 112.618 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -97.07 -45.51 6.54 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.661 1.584 . . . . 64.22 109.51 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.4 p -76.51 -19.11 58.31 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 119.245 0.93 . . . . 73.23 113.022 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -52.89 139.27 27.73 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 107.428 -1.323 . . . . 65.31 107.428 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.85 -6.24 56.89 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 118.743 -1.032 . . . . 62.24 111.385 -178.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.3 p -132.86 159.67 39.17 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 119.281 1.541 . . . . 63.23 111.115 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.36 164.8 32.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.726 1.611 . . . . 64.54 108.468 179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.77 125.48 32.06 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.86 -1.534 . . . . 64.12 106.86 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.6 t -108.63 146.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.141 -1.8 . . . . 73.21 106.141 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 14.1 t -126.59 130.74 71.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 104.692 -2.336 . . . . 73.4 104.692 179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.47 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 22.0 m-85 -97.56 144.59 27.09 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.471 -0.937 . . . . 74.45 108.471 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.15 -30.65 66.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 75.14 110.162 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -121.3 126.49 49.65 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.47 1.108 . . . . 74.41 109.487 -178.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.9 tt -57.73 -34.97 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 118.139 0.427 . . . . 73.03 111.621 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -61.45 -46.17 91.22 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.303 0.641 . . . . 73.11 110.548 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -67.6 -30.07 69.56 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 118.578 0.626 . . . . 73.12 110.139 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -62.44 -49.3 76.01 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.807 -1.183 . . . . 63.0 107.807 178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -60.29 -43.75 95.98 Favored 'General case' 0 C--N 1.342 0.247 0 N-CA-C 109.026 -0.731 . . . . 61.41 109.026 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.03 -58.03 9.63 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.008 0.923 . . . . 75.41 110.814 -179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.41 -33.49 71.3 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.264 1.026 . . . . 64.54 110.279 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 9.8 t -58.14 -48.24 80.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 119.62 1.1 . . . . 63.11 109.289 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -48.32 45.84 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 120.947 -1.095 . . . . 70.3 111.711 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 15.8 m170 -65.13 -17.55 64.57 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 114.084 1.142 . . . . 75.4 114.084 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.5 tp -107.39 -17.54 14.1 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.988 1.267 . . . . 65.01 113.101 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 77.4 p -65.11 105.47 1.08 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.912 -0.493 . . . . 65.31 110.368 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 93.08 16.72 46.3 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 118.215 -1.325 . . . . 54.4 114.808 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.96 111.17 4.81 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.412 1.606 . . . . 74.52 109.028 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -74.88 120.08 19.94 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.004 0.921 . . . . 72.42 110.039 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -149.72 149.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 106.802 -1.555 . . . . 65.34 106.802 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 15.9 m 51.84 32.52 9.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.683 1.193 . . . . 74.53 112.711 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 54.5 t30 56.54 30.63 17.57 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.761 1.624 . . . . 72.42 111.46 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -135.43 167.32 21.28 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 127.735 2.414 . . . . 62.41 108.076 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 42.9 p90 -115.27 124.17 50.66 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.148 0.979 . . . . 74.31 110.908 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 25.6 mt -77.97 156.21 30.34 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 107.31 -1.367 . . . . 72.44 107.31 178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 96.8 t -133.27 140.23 47.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 106.474 -1.676 . . . . 71.53 106.474 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.27 153.88 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.649 1.58 . . . . 64.12 107.308 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -157.06 165.88 34.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.466 1.506 . . . . 63.23 108.646 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.3 m-30 -102.83 164.84 11.39 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.73 2.812 . . . . 75.33 110.76 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -114.79 160.76 19.05 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.206 -1.405 . . . . 75.04 107.206 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 115.985 -1.959 . . . . 74.02 111.38 -179.835 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.147 0 N-CA-C 105.248 -3.141 . . . . 74.3 105.248 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 1.1 p -68.3 166.83 21.62 Favored Pre-proline 0 CA--C 1.546 0.794 0 N-CA-C 106.582 -1.636 . . . . 74.3 106.582 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -67.41 161.96 40.97 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 N-CA-C 108.146 -1.521 . . . . 71.44 108.146 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.77 139.58 48.98 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.282 -1.377 . . . . 43.02 107.282 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -159.1 134.26 8.33 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 106.172 -1.788 . . . . 72.13 106.172 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.0 pp -159.37 172.52 17.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.511 1.524 . . . . 74.52 108.802 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -151.35 173.39 14.57 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 126.771 2.029 . . . . 74.34 108.278 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -77.55 -177.76 4.92 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.328 1.051 . . . . 75.13 108.711 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 10.9 m-90 -67.55 -39.3 84.96 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 121.417 -0.802 . . . . 72.12 110.777 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 75.1 mtt85 -153.97 149.32 27.13 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.389 1.476 . . . . 72.13 109.321 179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -86.74 165.61 15.92 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.426 -1.324 . . . . 74.31 107.426 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -65.11 141.86 58.56 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.715 0.806 . . . . 65.21 109.319 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -166.92 108.87 0.68 Allowed 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.407 -1.331 . . . . 75.12 107.407 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -91.88 167.3 12.23 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.304 1.042 . . . . 72.03 109.792 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 16.0 tt -60.97 156.47 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.32 1.048 . . . . 64.21 112.115 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -80.87 150.44 29.09 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.495 -0.928 . . . . 73.33 108.495 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -79.8 137.05 36.87 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 105.874 -1.898 . . . . 73.3 105.874 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -104.22 127.49 51.85 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 106.212 -1.774 . . . . 64.51 106.212 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -67.49 -45.65 75.25 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.825 0.45 . . . . 73.32 110.659 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.63 152.21 87.26 Favored Pre-proline 0 CA--C 1.53 0.197 0 CA-C-O 118.49 -0.767 . . . . 61.32 109.26 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.24 108.94 1.25 Allowed 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.958 2.439 . . . . 55.13 107.829 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 67.0 mt -145.53 57.94 1.25 Allowed 'General case' 0 C--O 1.239 0.505 0 C-N-CA 126.245 1.818 . . . . 74.53 107.714 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 14.5 m -67.43 168.2 11.25 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.162 -0.681 . . . . 42.42 109.162 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -57.27 -33.75 67.93 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.012 0.745 . . . . 53.32 113.012 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -74.89 -25.87 59.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 113.631 0.975 . . . . 72.01 113.631 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -60.68 -28.37 68.55 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 119.565 1.075 . . . . 72.33 111.293 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 11.8 tp -53.99 -37.64 64.21 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.811 2.045 . . . . 75.1 111.742 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -72.35 -44.37 62.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.869 1.268 . . . . 74.15 111.832 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -71.07 -22.55 62.1 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.623 0.369 . . . . 61.24 110.718 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 83.5 mtp -70.59 -38.59 74.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 118.629 -0.7 . . . . 65.14 109.517 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -72.18 155.54 91.52 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 119.352 0.978 . . . . 71.11 112.084 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.471 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 71.8 Cg_endo -72.84 167.4 27.35 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.185 2.59 . . . . 61.11 111.372 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -79.45 153.32 29.74 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.309 1.444 . . . . 75.02 111.4 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.4 27.76 24.23 Favored Glycine 0 CA--C 1.533 1.186 0 CA-C-O 118.797 -1.001 . . . . 73.15 114.88 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.471 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 13.1 m-85 -124.54 158.01 33.97 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.528 1.664 . . . . 74.4 111.901 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -127.28 133.95 50.1 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.457 1.503 . . . . 70.02 107.784 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 36.7 t -70.09 150.72 9.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 N-CA-C 107.229 -1.397 . . . . 72.25 107.229 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.8 tp -125.07 78.02 66.71 Favored Pre-proline 0 CA--C 1.53 0.201 0 N-CA-C 108.667 -0.864 . . . . 63.13 108.667 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -56.76 162.79 8.11 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.076 2.517 . . . . 71.43 111.315 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.47 159.73 51.11 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.102 1.868 . . . . 73.24 110.914 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.91 170.43 11.56 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.671 2.247 . . . . 74.31 112.288 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -66.34 92.98 0.2 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 125.535 1.534 . . . . 64.21 113.114 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 93.11 34.71 6.63 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 118.524 -1.153 . . . . 74.43 115.37 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -65.87 130.21 42.48 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 119.667 1.734 . . . . 74.31 113.283 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 48.6 t -140.03 93.32 9.33 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 104.612 -2.366 . . . . 71.14 104.612 178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.13 -12.71 23.5 Favored 'Trans proline' 0 CA--C 1.533 0.431 0 C-N-CA 122.495 2.13 . . . . 63.44 114.355 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 15.1 mm . . . . . 0 C--O 1.252 1.191 0 N-CA-C 107.097 -1.446 . . . . 73.15 107.097 -179.45 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 N-CA-C 110.36 -1.096 . . . . 52.02 110.36 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -141.82 162.34 35.72 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.467 1.134 . . . . 65.43 109.052 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.36 165.26 20.09 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.281 1.033 . . . . 61.15 110.072 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -84.79 91.3 7.95 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.207 -1.034 . . . . 43.11 108.207 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 83.1 mt -75.65 116.29 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.152 0 N-CA-C 104.331 -2.47 . . . . 65.25 104.331 178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -69.08 -61.58 1.73 Allowed 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 118.638 -0.696 . . . . 74.11 110.886 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -120.81 154.37 57.45 Favored Pre-proline 0 C--O 1.233 0.206 0 C-N-CA 123.274 0.629 . . . . 60.54 109.695 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -62.65 162.15 25.8 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.221 2.614 . . . . 62.4 111.062 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.69 -43.12 13.64 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.191 2.594 . . . . 72.12 112.599 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -155.07 155.83 34.79 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.991 -1.485 . . . . 74.44 106.991 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 85.2 t -148.14 102.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.114 -1.439 . . . . 72.02 107.114 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -67.04 148.87 51.38 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 106.173 -1.788 . . . . 62.34 106.173 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.5 -40.73 83.63 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.452 -0.944 . . . . 74.11 108.452 178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 39.9 mt -68.56 116.08 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 125.934 1.694 . . . . 61.31 111.636 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 25.4 mt -104.2 149.15 25.53 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.111 -1.07 . . . . 75.41 108.111 178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -123.7 137.56 54.68 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 104.511 -2.403 . . . . 63.14 104.511 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.427 ' HB ' HD11 ' B' ' 26' ' ' LEU . 6.3 mm -125.41 151.2 31.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 106.583 -1.636 . . . . 74.43 106.583 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 47.1 mtp180 -136.27 164.28 28.45 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.549 1.94 . . . . 73.51 108.461 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 69.53 13.56 8.3 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.546 1.938 . . . . 71.15 111.7 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.427 HD11 ' HB ' ' B' ' 23' ' ' ILE . 67.6 mt -66.06 155.99 85.62 Favored Pre-proline 0 C--O 1.237 0.422 0 C-N-CA 124.94 1.296 . . . . 70.43 112.715 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.59 153.3 72.58 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 123.11 2.54 . . . . 72.03 111.192 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -86.19 -19.81 29.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.235 -0.893 . . . . 74.34 110.496 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 12.0 ttmm -130.39 115.59 17.09 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 125.797 1.639 . . . . 73.22 107.05 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 tt -151.44 157.05 5.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.845 -1.168 . . . . 71.41 107.845 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 15.5 p -101.89 164.49 11.69 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.215 1.406 . . . . 44.02 110.363 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.95 -36.4 84.27 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.504 -1.665 . . . . 65.0 106.504 176.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -59.46 -37.13 77.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 127.629 2.372 . . . . 63.24 111.16 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.61 -47.87 16.26 Favored 'General case' 0 CA--C 1.521 -0.152 0 O-C-N 121.204 -0.935 . . . . 62.41 109.645 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.8 mmm -58.33 -42.86 87.75 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.336 0.516 . . . . 74.0 110.859 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -73.55 -34.95 65.43 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 118.932 -0.556 . . . . 64.54 111.444 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -67.25 -58.08 5.49 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 118.994 0.815 . . . . 75.45 111.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 44.8 mt -52.16 -62.27 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.461 1.504 . . . . 62.41 110.734 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -64.96 -22.84 67.07 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 119.019 -0.515 . . . . 65.11 111.406 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.65 -29.11 68.09 Favored Glycine 0 C--N 1.337 0.614 0 C-N-CA 125.834 1.683 . . . . 62.41 111.171 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -61.44 -24.26 66.41 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.369 1.584 . . . . 75.51 110.185 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -88.94 -46.89 8.54 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 123.671 0.788 . . . . 73.54 110.386 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 178.17 -171.51 43.94 Favored Glycine 0 CA--C 1.532 1.151 0 CA-C-N 119.499 1.045 . . . . 72.22 114.835 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -63.47 116.57 3.71 Favored 'Trans proline' 0 C--N 1.347 0.477 1 C-N-CA 125.711 4.274 . . . . 72.15 113.985 -178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.1 mt -83.46 125.79 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.558 1.143 . . . . 73.12 109.731 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.9 tpt180 -85.36 -60.41 2.04 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.422 -1.325 . . . . 73.15 107.422 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -156.57 149.43 23.86 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 119.203 0.911 . . . . 74.1 109.497 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 29.5 mt -129.53 144.2 38.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 126.943 2.097 . . . . 74.13 108.48 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -141.96 154.79 45.31 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 106.335 -1.728 . . . . 71.54 106.335 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -141.01 165.7 19.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 124.123 0.969 . . . . 71.43 109.354 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.21 145.78 49.39 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.532 -1.027 . . . . 43.4 110.532 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -105.18 -52.69 2.79 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 107.738 -1.208 . . . . 74.15 107.738 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 70.2 p -69.89 156.99 90.82 Favored Pre-proline 0 C--O 1.24 0.603 0 C-N-CA 124.204 1.002 . . . . 74.42 109.825 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.81 -39.21 64.31 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 121.613 1.542 . . . . 62.02 109.796 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -67.64 -7.2 24.7 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.502 1.121 . . . . 75.33 113.398 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 8.3 p -102.25 -4.43 25.72 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 119.571 1.078 . . . . 64.13 109.651 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 49.2 mtt180 -69.86 150.04 47.23 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 120.156 -1.59 . . . . 71.24 108.32 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.18 -7.52 64.36 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.16 -1.356 . . . . 65.13 113.73 179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 32.4 p -140.51 162.75 34.61 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 120.212 2.006 . . . . 44.21 107.346 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.424 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -165.66 173.63 10.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.798 0.839 . . . . 61.3 109.98 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -126.63 144.72 50.82 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 123.801 0.841 . . . . 71.52 109.694 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 86.4 t -133.5 141.1 45.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 124.408 1.083 . . . . 74.14 108.626 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.92 130.64 69.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 106.454 -1.684 . . . . 65.25 106.454 179.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 45.0 m-85 -104.09 166.35 10.47 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.869 2.068 . . . . 72.45 107.49 178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -66.31 -69.54 0.3 Allowed 'General case' 0 CA--C 1.532 0.25 0 O-C-N 121.366 -0.834 . . . . 71.25 111.866 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -98.67 151.11 21.07 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 119.517 1.053 . . . . 73.25 110.642 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.5 tt -61.75 -33.86 59.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 123.483 0.713 . . . . 73.21 111.781 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -69.03 -47.67 64.86 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.103 -0.703 . . . . 71.44 109.103 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -58.04 -46.09 85.92 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.483 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -57.43 -54.85 42.17 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 125.161 1.385 . . . . 72.21 111.432 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -52.08 -36.83 51.98 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.706 1.202 . . . . 71.51 113.172 -179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -69.27 -36.3 76.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 118.896 0.771 . . . . 71.55 110.35 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.44 -32.06 71.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 119.108 0.867 . . . . 72.54 110.642 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 61.3 m -55.84 -41.57 74.49 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 123.075 0.55 . . . . 75.11 110.516 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -84.67 -35.98 22.23 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 123.547 0.739 . . . . 73.23 111.54 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.96 -15.82 63.1 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.277 -0.889 . . . . 63.4 112.524 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.7 tp -104.84 -16.15 14.98 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.053 0.842 . . . . 41.22 112.206 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 35.0 p -72.2 134.67 45.79 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.446 -1.409 . . . . 72.22 110.085 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 75.32 10.1 84.38 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.777 1.18 . . . . 64.1 113.193 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -72.34 120.74 18.37 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 124.874 1.27 . . . . 71.43 110.078 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 35.0 t-20 -87.79 120.07 28.75 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.19 1.796 . . . . 75.04 107.466 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.1 m -138.96 135.94 42.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 108.367 -0.975 . . . . 75.44 108.367 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.3 m 46.58 47.14 14.61 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.422 1.489 . . . . 71.51 112.194 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 18.0 m120 54.72 30.74 14.04 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.511 1.524 . . . . 63.02 112.786 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -136.2 -179.87 5.93 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 128.325 2.65 . . . . 74.53 106.48 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -139.59 133.84 31.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 106.326 -1.731 . . . . 60.05 106.326 179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -80.89 172.79 13.31 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.352 -0.981 . . . . 71.53 108.352 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.59 140.13 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 104.28 -2.489 . . . . 65.43 104.28 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 60.7 t -125.81 142.72 41.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 124.807 1.243 . . . . 72.5 108.676 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 47.7 tp -153.29 150.33 28.83 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.162 0.985 . . . . 71.32 109.665 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -85.55 163.49 18.35 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 125.098 1.359 . . . . 71.32 110.562 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -77.9 167.17 21.92 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 109.547 -0.538 . . . . 71.42 109.547 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 C--O 1.248 1.023 0 N-CA-C 105.422 -2.066 . . . . 61.35 105.422 179.843 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.989 0 N-CA-C 108.662 -1.775 . . . . 52.01 108.662 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 5.6 t -146.98 120.9 5.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 102.477 -3.157 . . . . 71.21 102.477 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -74.3 166.23 29.98 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.756 1.638 . . . . 72.54 110.843 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.45 170.9 14.82 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 128.031 2.532 . . . . 73.53 109.028 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -149.39 147.56 28.43 Favored 'General case' 0 C--O 1.231 0.131 0 N-CA-C 107.055 -1.461 . . . . 63.21 107.055 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 93.4 mt -139.33 107.41 5.73 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 108.021 -1.103 . . . . 73.34 108.021 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -76.89 148.1 36.64 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.565 -0.902 . . . . 74.1 108.565 178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -147.99 113.17 5.53 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.62 -0.881 . . . . 73.41 108.62 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 99.3 m95 -68.93 122.88 19.56 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.33 -0.989 . . . . 71.35 108.33 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 7.6 tpt85 -62.35 -54.25 43.24 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 118.567 -0.73 . . . . 71.4 111.073 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 41.9 t-105 -156.05 162.12 40.34 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.355 -1.35 . . . . 75.2 107.355 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' A' ' 390' ' ' ARG . 6.3 tt0 -126.69 -158.69 0.88 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 127.577 2.351 . . . . 72.0 107.263 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . 0.4 ' H ' ' HG2' ' A' ' 389' ' ' GLU . 0.0 OUTLIER -144.39 121.38 11.38 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 101.806 -3.405 . . . . 65.23 101.806 178.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -126.1 168.28 14.22 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 119.883 1.219 . . . . 71.54 110.147 -178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.05 142.29 41.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 123.832 0.853 . . . . 43.34 109.224 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -146.07 82.97 1.62 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 104.328 -2.471 . . . . 60.15 104.328 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 30.9 tp10 -128.46 69.95 1.37 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.514 1.526 . . . . 75.04 108.081 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.6 172.99 7.68 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.874 2.469 . . . . 74.4 108.849 -178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -64.57 109.28 1.93 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.439 0.637 . . . . 72.33 109.785 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -89.36 142.23 29.58 Favored Pre-proline 0 C--N 1.323 -0.558 0 C-N-CA 126.241 1.816 . . . . 63.04 107.927 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -71.98 142.1 38.0 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 N-CA-C 107.868 -1.628 . . . . 74.34 107.868 178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 53.6 mt -64.57 135.33 55.88 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.08 0.552 . . . . 74.14 110.582 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.5 t -158.68 -170.99 3.25 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.537 1.935 . . . . 72.35 107.212 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.38 -18.02 63.04 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.202 -0.936 . . . . 53.43 112.0 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -62.65 -44.26 96.72 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.787 1.235 . . . . 72.04 108.545 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -63.41 -20.91 65.96 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.204 1.001 . . . . 72.22 111.157 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.2 tp -82.64 -38.51 23.42 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 106.971 -1.492 . . . . 72.35 106.971 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -65.45 -44.32 87.59 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.298 0.954 . . . . 71.41 110.908 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.73 -23.84 60.47 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.502 1.121 . . . . 42.13 113.485 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.9 mtp -79.39 -6.6 57.17 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.062 1.345 . . . . 73.13 113.068 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -107.58 159.25 30.99 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 114.55 1.315 . . . . 72.02 114.55 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.66 158.94 54.87 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.215 3.276 . . . . 54.31 112.538 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -75.28 147.78 39.94 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.497 1.519 . . . . 75.11 109.165 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.35 17.41 62.52 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.529 -0.732 . . . . 51.44 114.656 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -124.35 102.97 7.94 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 105.325 -2.102 . . . . 73.02 105.325 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 25.6 mtpt -83.78 155.39 23.05 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 124.508 1.123 . . . . 65.24 110.684 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 7.1 t -70.05 144.38 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 124.003 0.921 . . . . 62.23 110.193 -178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 50.7 tp -126.38 79.55 70.38 Favored Pre-proline 0 N--CA 1.452 -0.339 0 N-CA-C 107.346 -1.353 . . . . 71.44 107.346 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.18 163.81 37.05 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.124 1.883 . . . . 75.2 110.023 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.11 161.45 42.73 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.556 2.171 . . . . 73.01 109.774 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.48 145.64 77.43 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 121.43 1.42 . . . . 54.35 109.375 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -54.1 -44.02 70.9 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.144 -0.48 . . . . 73.42 110.714 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -74.02 11.42 6.24 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-O 117.184 -1.898 . . . . 62.31 115.906 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -66.48 161.36 23.01 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 121.161 2.48 . . . . 74.42 109.582 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 22.7 t -131.18 79.1 71.41 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 107.118 -1.438 . . . . 72.23 107.118 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.05 114.29 3.86 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 N-CA-C 106.019 -2.339 . . . . 72.22 106.019 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 36.2 mm . . . . . 0 C--O 1.25 1.084 0 C-N-CA 127.847 2.459 . . . . 73.42 106.34 -178.301 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.938 0 N-CA-C 110.508 -1.037 . . . . 75.45 110.508 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -145.7 131.5 19.05 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 103.193 -2.892 . . . . 72.25 103.193 178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.0 67.46 4.7 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.881 0.764 . . . . 72.43 109.501 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -118.64 165.62 13.74 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.935 1.294 . . . . 73.24 109.436 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 85.3 mt -119.25 137.82 51.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 105.516 -2.031 . . . . 43.23 105.516 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.39 163.64 35.85 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.733 1.213 . . . . 73.34 108.69 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.46 159.59 84.38 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 109.006 -0.739 . . . . 61.24 109.006 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.83 171.42 17.44 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 123.961 3.107 . . . . 73.55 111.386 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -61.7 -31.94 86.42 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.643 2.228 . . . . 70.11 113.231 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -156.04 167.61 29.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.198 1.399 . . . . 71.1 108.608 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 31.9 t -141.39 165.8 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 125.662 1.585 . . . . 74.13 107.817 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -133.69 -176.97 4.34 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.4 1.88 . . . . 72.01 108.924 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.77 -43.86 5.45 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 120.649 -1.282 . . . . 75.23 111.607 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 83.5 mt -73.68 144.03 13.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.394 -1.335 . . . . 75.13 107.394 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 88.0 mt -124.18 157.2 35.28 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.737 1.615 . . . . 54.41 108.565 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -124.31 133.52 53.44 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 127.392 2.277 . . . . 71.32 106.837 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -120.29 146.95 24.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 C-N-CA 124.601 1.16 . . . . 75.14 108.283 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 53.0 mtp180 -135.59 163.02 31.07 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.157 1.383 . . . . 74.0 109.639 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 65.08 14.69 9.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.952 2.101 . . . . 70.3 113.851 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.54 153.13 91.07 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 120.796 -1.19 . . . . 73.15 109.588 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -66.47 140.11 56.34 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.762 2.308 . . . . 74.53 110.532 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -62.58 -30.1 71.08 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 113.913 1.079 . . . . 75.03 113.913 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -130.26 117.91 20.55 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 106.888 -1.523 . . . . 72.25 106.888 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 tt -165.88 140.89 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.56 0 C-N-CA 127.958 2.503 . . . . 72.23 104.366 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 18.0 p -75.12 174.4 9.47 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 119.027 0.831 . . . . 64.22 109.944 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -69.89 -38.06 76.21 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 107.126 -1.435 . . . . 52.05 107.126 177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -47.84 -54.3 12.91 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 128.326 2.65 . . . . 71.22 112.739 -179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -62.21 -49.51 75.48 Favored 'General case' 0 C--O 1.226 -0.148 0 CA-C-N 118.36 0.527 . . . . 75.12 110.099 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 72.3 mmm -56.26 -49.44 74.17 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 119.213 -0.422 . . . . 75.2 111.088 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . 0.407 ' CZ ' HD12 ' B' ' 48' ' ' ILE . 14.8 m-85 -61.51 -43.96 97.92 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 117.559 -1.21 . . . . 73.25 110.009 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -58.59 7.22 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 108.105 -1.072 . . . . 43.25 108.105 178.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 64.2 mt -47.61 -67.18 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.854 2.062 . . . . 64.45 112.345 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -68.34 -26.93 65.85 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 113.281 0.845 . . . . 74.21 113.281 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -64.72 -20.65 66.44 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 124.874 1.226 . . . . 64.34 112.983 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.65 -26.75 68.2 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 119.387 1.593 . . . . 75.41 110.486 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -85.88 -10.16 55.77 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.784 0.661 . . . . 74.04 112.784 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.96 -171.59 22.37 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 119.355 0.98 . . . . 40.33 111.54 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.75 153.14 73.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.776 2.984 . . . . 70.3 111.36 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mt -118.21 138.25 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.286 -1.005 . . . . 71.21 108.286 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.77 -51.9 9.78 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 125.17 1.388 . . . . 70.12 111.485 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -161.9 157.58 24.08 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.76 0.824 . . . . 74.34 109.473 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . 0.407 HD12 ' CZ ' ' B' ' 36' ' ' TYR . 21.4 mt -145.78 142.36 21.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 C-N-CA 124.993 1.317 . . . . 73.33 108.268 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -145.45 150.76 37.09 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.763 -1.569 . . . . 72.42 106.763 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 32.2 m -134.16 147.27 30.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.468 0.707 . . . . 65.44 109.656 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -67.28 135.6 31.77 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 108.328 -1.909 . . . . 75.41 108.328 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -122.95 -21.36 5.53 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.876 1.065 . . . . 62.22 113.876 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 4.7 p -69.69 159.8 82.35 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 104.56 -2.385 . . . . 72.14 104.56 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -57.02 -45.36 36.56 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 121.505 1.47 . . . . 75.52 111.241 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.07 -5.8 29.3 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 114.826 1.417 . . . . 73.54 114.826 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 72.7 p -116.45 -18.07 10.51 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.293 1.406 . . . . 64.22 112.799 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 77.1 mtt180 -52.55 126.96 21.21 Favored 'General case' 0 C--O 1.231 0.085 0 C-N-CA 123.822 0.849 . . . . 75.44 109.686 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.99 4.05 48.33 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-O 118.459 -1.19 . . . . 70.13 112.653 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 61.6 p -127.56 146.81 50.4 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 120.03 1.915 . . . . 70.21 107.535 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -156.23 174.26 15.65 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.614 0.366 . . . . 41.21 111.229 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.14 155.46 48.13 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.396 1.078 . . . . 74.52 109.17 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.9 t -138.63 139.83 40.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 104.412 -2.44 . . . . 73.1 104.412 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.5 t -127.39 123.34 61.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 105.56 -2.015 . . . . 53.35 105.56 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -97.91 166.15 11.59 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.827 -1.546 . . . . 71.42 106.827 178.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -71.28 -47.6 55.9 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.754 -0.591 . . . . 72.44 109.774 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -122.86 154.6 38.06 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 118.911 0.778 . . . . 73.15 110.737 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.0 tt -57.93 -37.5 61.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 113.736 1.013 . . . . 72.0 113.736 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -57.95 -48.23 80.58 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 118.161 -0.923 . . . . 75.03 111.528 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.14 -40.87 95.03 Favored 'General case' 0 CA--C 1.52 -0.185 0 O-C-N 123.935 0.772 . . . . 72.24 109.349 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.63 -54.71 42.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.156 -0.313 . . . . 54.21 110.156 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 23.5 pttp -69.76 -30.18 67.7 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 118.523 -0.751 . . . . 64.34 111.894 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -59.67 -53.97 51.79 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 108.109 -1.071 . . . . 72.33 108.109 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.03 93.83 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.417 1.087 . . . . 63.5 110.611 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 13.3 t -46.56 -69.16 0.14 Allowed 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.823 1.249 . . . . 73.44 113.018 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -67.39 -27.77 67.37 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 114.074 1.138 . . . . 71.21 114.074 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.94 -33.71 72.49 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 118.775 0.716 . . . . 73.13 109.607 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.6 tp -90.01 -24.91 21.09 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.987 1.315 . . . . 71.33 112.992 -178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 6.0 t -57.34 111.26 1.03 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.481 1.512 . . . . 42.53 110.675 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 95.11 9.85 57.84 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 126.324 1.916 . . . . 74.02 114.43 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -61.74 130.03 43.86 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.543 1.671 . . . . 73.13 110.363 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -89.84 100.92 13.64 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.417 2.287 . . . . 64.13 110.653 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.84 133.51 69.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 124.402 1.081 . . . . 72.22 110.621 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 46.2 m 42.79 49.41 5.03 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.827 1.651 . . . . 50.43 112.121 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 32.1 t30 58.94 33.25 22.92 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 127.603 2.361 . . . . 64.33 112.878 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 77.4 mtt180 -140.16 158.33 44.21 Favored 'General case' 0 CA--C 1.51 -0.591 0 O-C-N 120.985 -1.072 . . . . 72.12 108.26 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -118.07 118.14 31.09 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 106.822 -1.547 . . . . 75.13 106.822 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 37.6 mt -73.63 174.05 8.87 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.692 -1.225 . . . . 65.15 107.692 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 18.0 t -134.02 137.4 52.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 104.094 -2.558 . . . . 71.33 104.094 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 9.9 t -126.83 121.67 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 105.743 -1.947 . . . . 74.41 105.743 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 34.6 tp -136.15 153.21 51.34 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.573 -0.899 . . . . 63.44 108.573 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 15.3 m-30 -74.75 163.11 28.05 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.694 0.798 . . . . 73.12 108.949 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -104.49 154.58 19.72 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 105.957 -1.868 . . . . 60.53 105.957 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 29.2 m120 . . . . . 0 C--O 1.246 0.871 0 C-N-CA 124.387 1.075 . . . . 74.1 110.652 -178.587 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.208 0 CA-C-O 116.217 -2.435 . . . . 63.41 107.07 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 20.7 p 23.97 80.11 0.2 Allowed Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 126.979 2.112 . . . . 75.53 114.594 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.89 168.26 23.55 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.567 1.511 . . . . 74.25 109.792 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -130.67 157.44 42.77 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 125.908 1.683 . . . . 74.21 106.876 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -136.73 86.02 2.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.444 -1.317 . . . . 74.35 107.444 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 95.5 mt -66.59 160.83 24.48 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.457 -0.942 . . . . 74.52 108.457 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.37 169.06 18.28 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.311 0.645 . . . . 53.33 110.051 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -154.97 171.83 19.08 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.571 1.549 . . . . 72.01 107.285 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -122.85 130.66 53.15 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.18 -1.415 . . . . 64.22 107.18 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -76.48 149.42 36.78 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.634 -0.876 . . . . 52.2 108.634 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 72.0 t-105 -155.03 158.69 39.5 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.187 -1.412 . . . . 74.54 107.187 178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -76.89 172.09 13.7 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.594 0.711 . . . . 74.02 112.028 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 54.1 mtt-85 -153.89 171.81 18.38 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 126.736 2.014 . . . . 72.23 107.492 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.38 131.48 39.16 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 104.438 -2.43 . . . . 71.25 104.438 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 10.4 tp -148.82 159.98 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 108.65 -0.87 . . . . 64.53 108.65 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -126.16 47.79 2.21 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 125.264 1.426 . . . . 71.4 109.62 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -56.67 118.45 4.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.086 0.955 . . . . 74.34 109.914 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 15.1 mtt-85 -75.77 104.3 6.25 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 124.639 1.175 . . . . 74.02 108.341 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -111.05 178.29 4.39 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 123.291 0.636 . . . . 64.53 111.891 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -68.03 154.28 94.05 Favored Pre-proline 0 CA--C 1.53 0.194 0 C-N-CA 123.965 0.906 . . . . 72.3 111.095 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -80.04 -12.93 12.99 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 122.817 2.344 . . . . 62.25 112.68 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 91.8 mt -127.8 115.74 19.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 101.417 -3.549 . . . . 32.13 101.417 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 63.5 p -136.05 -175.05 3.85 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.958 0.885 . . . . 73.2 110.071 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -40.46 97.2 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 126.871 2.069 . . . . 70.2 108.127 178.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -67.26 -29.67 69.35 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.848 0.459 . . . . 65.34 110.607 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -75.32 -37.44 60.76 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.471 -0.566 . . . . 54.42 109.471 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.01 -30.98 69.51 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.429 0.559 . . . . 53.01 110.302 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -67.93 -36.87 80.87 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.965 -0.459 . . . . 64.44 111.042 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -79.5 -37.62 36.27 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.378 1.071 . . . . 33.22 110.851 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 87.2 mtp -66.41 -12.51 57.42 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.519 1.128 . . . . 74.43 111.846 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -99.25 157.28 34.32 Favored Pre-proline 0 C--O 1.238 0.465 0 C-N-CA 124.095 0.958 . . . . 63.1 110.107 179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -89.41 172.5 4.09 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 123.199 2.599 . . . . 64.21 109.017 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -73.63 159.34 33.2 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 121.606 -0.684 . . . . 54.24 110.906 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.2 20.97 58.04 Favored Glycine 0 CA--C 1.527 0.795 0 CA-C-O 117.825 -1.541 . . . . 75.22 115.451 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -125.49 140.09 53.07 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.985 1.893 . . . . 74.03 110.631 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.8 tptp -122.26 151.28 41.24 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.572 1.949 . . . . 62.24 109.104 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 90.7 t -74.86 151.38 6.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-O 122.563 1.173 . . . . 64.43 110.604 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 34.0 tp -126.48 87.47 56.3 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 103.398 -2.815 . . . . 74.11 103.398 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -64.01 168.9 11.35 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.222 2.615 . . . . 71.32 111.226 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -67.74 163.3 35.83 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 121.37 1.38 . . . . 64.12 108.661 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_exo -48.58 152.94 3.71 Favored 'Trans proline' 0 C--O 1.24 0.579 0 C-N-CA 123.604 2.869 . . . . 73.33 113.745 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -57.9 133.11 55.17 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.397 0.679 . . . . 63.34 112.634 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 55.26 25.14 39.3 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 118.453 -1.193 . . . . 53.11 113.06 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -64.55 101.63 0.47 Allowed 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 118.731 1.265 . . . . 74.33 108.104 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 79.8 t -135.92 82.79 36.27 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 105.139 -2.171 . . . . 74.43 105.139 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -75.93 -176.4 3.0 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 123.046 2.498 . . . . 72.44 110.031 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.4 tt . . . . . 0 C--O 1.253 1.237 0 N-CA-C 104.78 -2.304 . . . . 74.11 104.78 178.836 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.721 0 N-CA-C 109.441 -1.464 . . . . 53.14 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -145.1 112.19 6.01 Favored 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 106.795 -1.557 . . . . 65.31 106.795 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -156.48 136.33 12.59 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.515 1.526 . . . . 61.31 107.4 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -154.71 130.71 10.2 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.45 1.1 . . . . 53.05 108.896 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . 0.618 ' H ' HD12 ' B' ' 11' ' ' ILE . 1.9 mp -68.61 -25.37 30.66 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 125.858 1.663 . . . . 42.43 113.096 -178.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.99 158.49 18.62 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.348 -0.845 . . . . 63.31 110.622 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.84 155.55 38.09 Favored Pre-proline 0 C--O 1.241 0.643 0 C-N-CA 124.176 0.99 . . . . 52.43 108.595 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -68.49 165.43 29.16 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.725 1.616 . . . . 73.13 111.103 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -71.92 2.68 4.54 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.506 3.47 . . . . 64.22 114.313 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -148.87 120.08 7.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 125.961 1.704 . . . . 54.0 107.287 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.568 HG11 ' HG2' ' B' ' 71' ' ' LYS . 35.2 t -145.14 91.92 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.365 0 N-CA-C 107.511 -1.292 . . . . 75.14 107.511 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.1 t30 -61.92 152.52 31.79 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.743 1.217 . . . . 73.24 110.43 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 -59.11 -61.48 2.6 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 118.418 -0.801 . . . . 72.13 112.903 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 77.5 mt -60.79 134.41 26.17 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 109.005 -0.739 . . . . 74.51 109.005 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 46.4 mt -117.35 157.52 26.0 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 126.947 2.099 . . . . 63.25 109.175 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -124.93 135.7 53.08 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.493 1.917 . . . . 72.32 108.397 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mm -118.12 143.07 29.87 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 126.193 1.797 . . . . 74.12 108.767 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -133.6 162.59 31.51 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.011 1.324 . . . . 73.44 107.571 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 21.5 t30 65.58 30.23 10.65 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.422 2.689 . . . . 72.33 111.666 -178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 50.8 mt -70.06 147.67 95.78 Favored Pre-proline 0 C--O 1.236 0.348 0 O-C-N 121.736 -0.603 . . . . 72.14 111.196 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.99 152.49 68.16 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.826 2.351 . . . . 74.04 110.579 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -83.95 -11.03 57.47 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.496 0.718 . . . . 72.31 112.107 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -126.86 113.85 17.12 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 105.36 -2.089 . . . . 75.54 105.36 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -163.2 167.62 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 106.785 -1.561 . . . . 73.35 106.785 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 7.4 p -133.98 175.71 9.23 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.203 1.801 . . . . 74.11 111.607 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.02 -35.87 80.85 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.881 -0.785 . . . . 61.24 108.881 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.43 -50.63 71.1 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.771 -0.455 . . . . 74.23 109.771 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -63.72 -55.07 26.08 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.582 1.153 . . . . 71.04 111.374 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.8 mmm -57.28 -27.67 62.33 Favored 'General case' 0 N--CA 1.462 0.126 0 N-CA-C 113.749 1.018 . . . . 70.53 113.749 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -93.85 -20.62 19.89 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.909 0.777 . . . . 65.0 111.208 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.9 -52.19 7.73 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 119.219 0.918 . . . . 54.12 110.957 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.99 -52.75 40.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 125.786 1.634 . . . . 61.22 110.858 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -79.93 -30.47 39.96 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 118.146 -0.93 . . . . 61.11 113.13 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -31.58 78.55 Favored Glycine 0 C--N 1.339 0.744 0 N-CA-C 110.871 -0.892 . . . . 64.2 110.871 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -60.4 -15.35 25.38 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.203 1.401 . . . . 71.45 113.023 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.01 -16.76 14.21 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.315 1.046 . . . . 74.32 113.616 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 159.1 174.72 29.18 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.055 1.312 . . . . 74.53 110.902 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -68.48 145.4 64.64 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 124.297 3.331 . . . . 63.21 110.946 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 24.4 mt -99.78 124.68 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 124.547 1.139 . . . . 55.11 111.231 -178.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -83.19 -56.34 3.83 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.56 -1.274 . . . . 74.02 107.56 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -157.72 152.85 25.72 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 119.426 1.012 . . . . 64.3 112.456 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 31.2 mt -134.46 118.29 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.963 2.105 . . . . 70.02 107.627 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 60.1 mtp180 -127.21 120.34 28.52 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 105.119 -2.178 . . . . 73.23 105.119 178.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.7 m -99.41 159.05 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 127.235 2.214 . . . . 73.22 111.095 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -72.88 146.69 38.67 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 109.107 -1.597 . . . . 40.24 109.107 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -112.73 -45.61 3.2 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.471 1.108 . . . . 73.1 111.61 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 15.6 p -74.42 162.14 75.05 Favored Pre-proline 0 CA--C 1.541 0.614 0 C-N-CA 125.941 1.696 . . . . 63.33 111.858 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -74.88 9.29 2.03 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.626 2.884 . . . . 60.44 112.319 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.64 1.51 11.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.889 1.276 . . . . 71.13 111.521 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 35.6 p -116.75 -1.2 12.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.801 2.04 . . . . 74.02 109.461 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -63.77 145.9 54.9 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 126.806 2.042 . . . . 71.13 112.194 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.52 6.16 70.05 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.851 -0.971 . . . . 74.15 112.873 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 21.1 p -141.1 150.35 42.76 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 119.041 1.42 . . . . 64.22 110.613 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.92 171.32 14.21 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.444 1.498 . . . . 74.41 109.107 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -118.11 159.98 22.33 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 124.245 1.018 . . . . 71.13 109.428 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 90.9 t -135.36 139.11 47.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.278 -1.379 . . . . 74.22 107.278 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 t -127.71 123.74 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.757 -1.942 . . . . 73.24 105.757 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -99.3 165.78 11.52 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 105.13 -2.174 . . . . 63.44 105.13 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.9 mt-10 -73.32 -35.0 65.99 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.291 -0.881 . . . . 74.24 112.052 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -123.2 162.52 22.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.946 0.794 . . . . 75.55 112.54 -179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 17.3 tt -67.84 -43.49 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 124.051 0.94 . . . . 65.21 109.596 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -62.98 -41.81 99.66 Favored 'General case' 0 C--N 1.332 -0.155 0 C-N-CA 124.754 1.222 . . . . 74.44 111.474 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.49 -44.92 89.46 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.511 -0.922 . . . . 54.22 108.511 -179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.45 -47.42 85.79 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.129 0.572 . . . . 62.44 109.524 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.568 ' HG2' HG11 ' B' ' 17' ' ' VAL . 41.2 mtpt -59.24 -48.87 79.99 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 124.375 1.07 . . . . 72.42 111.111 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.79 -40.01 94.54 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.326 0.967 . . . . 52.32 110.827 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.96 -24.62 66.83 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 118.638 -0.696 . . . . 65.1 111.486 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 36.8 t -59.56 -64.37 0.97 Allowed 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 117.85 -1.071 . . . . 73.34 109.319 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.34 -33.67 74.0 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 120.125 1.329 . . . . 70.33 112.969 -178.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -64.47 -31.07 72.13 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.043 0.383 . . . . 74.33 110.262 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 28.4 tp -102.47 -26.23 13.33 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 114.882 1.438 . . . . 73.23 114.882 -178.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 8.5 t -61.8 106.31 0.67 Allowed 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.364 1.865 . . . . 75.52 110.34 -178.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.54 10.74 63.19 Favored Glycine 0 C--N 1.339 0.72 0 CA-C-O 118.55 -1.139 . . . . 51.44 113.19 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -59.22 121.26 10.93 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 118.934 1.367 . . . . 71.45 109.894 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -78.83 112.19 15.74 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.08 1.752 . . . . 64.31 107.815 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.97 148.27 18.05 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 123.348 0.659 . . . . 74.23 110.589 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 87.6 m 34.0 54.95 0.58 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 128.294 2.638 . . . . 65.25 114.588 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 52.33 31.26 9.18 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 126.859 2.064 . . . . 43.42 112.452 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 58.4 mtt180 -140.23 -170.71 3.03 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 128.781 2.833 . . . . 43.44 107.864 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -148.64 153.0 37.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.87 2.068 . . . . 64.34 105.741 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 72.6 mt -107.1 172.84 6.6 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.421 -0.955 . . . . 73.44 108.421 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 46.7 t -133.21 150.66 32.77 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 107.068 -1.456 . . . . 75.12 107.068 178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 90.4 t -130.1 136.17 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 126.476 1.91 . . . . 54.41 107.626 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.3 tp -146.61 151.61 37.56 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.209 1.803 . . . . 71.03 107.824 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . 0.46 ' CZ ' HG13 ' B' ' 17' ' ' VAL . 7.0 m-85 -94.6 155.82 16.71 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.029 0.931 . . . . 73.32 111.288 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -80.5 175.55 10.56 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 123.212 0.605 . . . . 75.0 112.52 -178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 . . . . . 0 C--O 1.247 0.965 0 C-N-CA 125.931 1.692 . . . . 75.51 109.985 -179.094 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.819 0 N-CA-C 110.133 -1.187 . . . . 73.33 110.133 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 8.8 t -154.16 47.29 0.34 Allowed Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 123.881 0.872 . . . . 75.31 111.435 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -66.32 166.88 19.97 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.61 2.207 . . . . 54.2 112.239 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -83.02 134.96 35.02 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.916 -1.142 . . . . 73.14 107.916 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -120.08 151.2 39.38 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 106.96 -1.496 . . . . 63.42 106.96 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 10.5 mp -59.59 130.63 47.79 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 106.916 -1.513 . . . . 73.32 106.916 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -67.6 79.86 0.18 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.831 1.253 . . . . 61.04 109.599 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -157.92 88.21 0.96 Allowed 'General case' 0 C--O 1.243 0.728 0 C-N-CA 126.589 1.955 . . . . 75.31 107.828 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -82.22 173.54 12.0 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 109.059 -0.719 . . . . 53.41 109.059 178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -88.31 161.73 16.98 Favored 'General case' 0 C--N 1.331 -0.21 0 O-C-N 121.639 -0.663 . . . . 63.24 111.252 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 52.64 48.34 22.73 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.393 1.477 . . . . 72.13 110.427 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -65.52 153.92 40.08 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 123.778 0.831 . . . . 75.44 110.431 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -80.82 148.81 29.82 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 109.748 -0.464 . . . . 65.52 109.748 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 45.59 36.65 2.68 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.578 2.351 . . . . 75.14 113.028 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 5.1 tp -61.39 131.53 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 C-N-CA 126.014 1.726 . . . . 70.25 108.611 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -78.34 169.93 17.46 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.544 1.538 . . . . 72.3 111.965 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -72.37 109.05 5.81 Favored 'General case' 0 C--O 1.237 0.397 0 O-C-N 120.861 -1.149 . . . . 72.02 108.477 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -111.24 132.56 54.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.38 1.072 . . . . 74.23 109.701 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -55.7 124.86 18.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.01 -1.478 . . . . 74.32 107.01 178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -129.31 151.57 78.05 Favored Pre-proline 0 N--CA 1.47 0.562 0 C-N-CA 123.997 0.919 . . . . 73.31 111.432 -178.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -74.13 177.18 8.57 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.344 2.696 . . . . 73.41 110.546 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.51 145.76 32.21 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 123.323 0.649 . . . . 52.43 109.529 179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.3 t -81.15 -176.67 6.08 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 123.096 1.426 . . . . 61.24 109.706 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -70.86 -19.72 62.61 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 126.955 2.102 . . . . 71.01 109.963 177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -81.45 -56.2 4.19 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.618 1.967 . . . . 73.11 111.332 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -57.84 -24.93 59.75 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.915 0.779 . . . . 74.41 111.798 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 61.8 tp -67.51 -27.57 67.1 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 125.088 1.355 . . . . 53.32 110.273 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -66.52 -32.51 73.91 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 119.822 1.192 . . . . 53.35 110.018 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -67.83 -10.84 56.32 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.331 1.052 . . . . 75.42 111.917 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 67.3 mtp -88.17 -12.26 44.45 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.293 1.437 . . . . 74.55 113.245 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -114.61 160.81 31.75 Favored Pre-proline 0 N--CA 1.465 0.3 0 C-N-CA 125.707 1.603 . . . . 54.54 111.59 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -74.25 167.42 27.21 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.232 1.954 . . . . 71.11 110.151 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -72.87 169.95 15.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.403 0.681 . . . . 71.41 110.306 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 80.51 22.42 62.37 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.034 -1.041 . . . . 72.21 113.277 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -124.58 156.86 36.72 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.851 -1.166 . . . . 74.43 107.851 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -137.0 149.47 47.52 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.032 0.933 . . . . 42.45 110.09 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 11.6 t -70.63 151.12 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.076 -0.712 . . . . 73.43 109.076 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.419 HD22 HG11 ' B' ' 50' ' ' VAL . 34.2 tp -131.09 82.98 61.93 Favored Pre-proline 0 C--O 1.238 0.487 0 N-CA-C 107.978 -1.119 . . . . 70.32 107.978 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.45 164.18 7.49 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 123.872 3.048 . . . . 71.11 112.236 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.46 162.38 20.92 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.053 2.502 . . . . 72.53 112.648 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -71.06 170.56 17.83 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.879 2.386 . . . . 73.31 110.485 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -66.49 151.48 47.14 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 121.898 -0.501 . . . . 60.12 109.77 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 55.29 21.32 25.78 Favored Glycine 0 C--N 1.339 0.712 0 N-CA-C 116.566 1.386 . . . . 54.01 116.566 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -72.43 102.43 3.19 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 118.463 1.132 . . . . 65.52 110.043 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 12.1 t -134.99 70.08 70.45 Favored Pre-proline 0 CA--C 1.545 0.774 0 N-CA-C 104.572 -2.381 . . . . 70.2 104.572 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.97 170.43 16.83 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.735 2.957 . . . . 70.41 112.898 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 17.2 tt . . . . . 0 C--O 1.251 1.143 0 C-N-CA 125.412 1.485 . . . . 72.05 110.646 -179.122 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.748 0 N-CA-C 110.549 -1.02 . . . . 43.1 110.549 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -84.47 117.69 23.82 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 107.531 -1.285 . . . . 71.13 107.531 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -126.8 159.64 33.23 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.572 1.949 . . . . 42.32 107.505 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 49.4 m-20 -145.31 85.53 1.73 Allowed 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 105.378 -2.082 . . . . 71.14 105.378 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 19.6 tt -137.0 139.92 43.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 N-CA-C 107.924 -1.139 . . . . 52.32 107.924 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -60.47 163.4 5.31 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.38 -0.97 . . . . 55.51 108.38 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 76.33 85.7 0.09 OUTLIER Pre-proline 0 C--O 1.236 0.374 0 C-N-CA 127.256 2.222 . . . . 34.33 105.072 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -71.53 161.37 45.63 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.272 2.648 . . . . 74.23 111.113 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.94 -37.13 9.14 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.346 2.031 . . . . 62.34 111.72 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -166.1 155.16 11.44 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.482 1.913 . . . . 71.24 106.639 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 t -151.19 128.41 2.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 106.307 -1.738 . . . . 65.53 106.307 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -134.46 158.84 42.87 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.494 -1.298 . . . . 64.13 107.494 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -65.42 -23.37 66.93 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 117.811 -1.09 . . . . 61.13 113.084 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 66.9 mt -89.53 126.11 42.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 105.441 -2.059 . . . . 75.43 105.441 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 95.0 mt -120.47 163.27 18.19 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.498 1.519 . . . . 64.42 109.229 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -129.29 136.49 50.12 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 126.211 1.804 . . . . 75.11 108.295 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mm -129.41 149.86 34.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.108 0.963 . . . . 73.35 108.5 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.469 ' HE ' HG11 ' B' ' 88' ' ' VAL . 56.1 mtm180 -139.49 163.87 31.39 Favored 'General case' 0 CA--C 1.513 -0.464 0 C-N-CA 125.813 1.645 . . . . 74.43 108.088 178.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 71.27 19.34 5.41 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.935 1.694 . . . . 72.05 111.222 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 52.1 mt -66.86 155.4 89.86 Favored Pre-proline 0 C--O 1.24 0.586 0 C-N-CA 124.119 0.968 . . . . 73.01 111.511 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.51 147.37 70.65 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.325 2.017 . . . . 71.43 107.31 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -82.8 -17.59 43.56 Favored 'General case' 0 C--N 1.331 -0.22 0 O-C-N 121.732 -0.605 . . . . 75.22 112.333 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -124.72 91.61 3.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.171 0.989 . . . . 75.34 110.572 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -146.69 139.15 19.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 108.191 -1.04 . . . . 70.1 108.191 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 1.2 p -89.26 164.7 14.83 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.368 1.067 . . . . 71.35 109.595 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.46 -23.43 65.86 Favored 'General case' 0 C--O 1.219 -0.506 0 N-CA-C 109.594 -0.521 . . . . 74.35 109.594 178.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -57.5 -57.61 11.9 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.521 2.728 . . . . 63.44 110.215 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -72.26 -35.11 68.69 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.81 0.844 . . . . 73.1 109.933 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.6 mmm -63.43 -48.94 75.7 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 108.957 -0.757 . . . . 71.25 108.957 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -65.19 -29.83 70.69 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 118.385 -0.817 . . . . 75.44 110.387 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.75 -65.17 0.72 Allowed 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 108.471 -0.937 . . . . 74.54 108.471 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 63.1 mt -50.77 -60.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.151 0 C-N-CA 126.128 1.771 . . . . 74.33 111.92 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -68.64 -17.16 64.05 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 119.106 -0.473 . . . . 72.54 112.047 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.96 -27.45 34.2 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 125.264 1.411 . . . . 41.21 113.068 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 10.3 mmpt? -52.59 -40.67 62.88 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.591 1.696 . . . . 64.11 109.507 179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -77.0 -11.77 59.85 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 116.795 2.146 . . . . 75.15 116.795 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.97 20.53 Favored Glycine 0 CA--C 1.534 1.256 0 CA-C-N 120.362 1.437 . . . . 75.23 111.49 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -64.56 147.26 90.21 Favored 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.219 2.613 . . . . 63.23 111.666 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 72.8 mt -102.9 131.7 50.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.55 1.54 . . . . 63.32 109.545 -179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -78.77 -58.08 3.43 Favored 'General case' 0 CA--C 1.519 -0.221 0 N-CA-C 107.375 -1.343 . . . . 54.41 107.375 178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -162.85 160.86 25.58 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.667 0.667 . . . . 64.23 110.594 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 37.7 mt -142.29 145.8 23.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 C-N-CA 126.298 1.839 . . . . 75.44 108.548 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 47.7 mtt180 -140.59 144.44 35.82 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 104.377 -2.453 . . . . 64.02 104.377 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . 0.419 HG11 HD22 ' A' ' 415' ' ' LEU . 17.3 m -129.35 162.48 36.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 C-N-CA 124.315 1.046 . . . . 62.41 111.563 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.55 146.0 39.73 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.003 -0.839 . . . . 43.34 111.003 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -124.36 -0.63 8.2 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.652 1.581 . . . . 70.14 112.589 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -127.02 164.06 37.68 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 126.378 1.871 . . . . 73.05 109.814 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.06 -25.64 80.31 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.732 2.288 . . . . 60.1 113.956 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -93.39 1.58 56.84 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.73 1.15 . . . . 73.13 111.542 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.6 p -117.11 -28.78 6.12 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.283 1.033 . . . . 71.51 111.568 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.19 139.52 58.48 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.056 -1.028 . . . . 72.3 108.438 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.63 -23.51 35.86 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 125.302 1.43 . . . . 54.31 113.345 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 60.3 p -119.69 157.52 28.35 Favored 'General case' 0 C--O 1.241 0.605 0 N-CA-C 107.651 -1.24 . . . . 74.0 107.651 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.13 175.26 10.36 Favored 'General case' 0 CA--C 1.518 -0.278 0 O-C-N 121.348 -0.845 . . . . 64.2 111.025 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -134.1 141.54 47.18 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 107.705 -1.22 . . . . 73.51 107.705 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 88.6 t -125.73 149.54 30.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 106.578 -1.638 . . . . 70.34 106.578 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 17.4 t -127.73 132.6 68.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 N-CA-C 108.48 -0.933 . . . . 74.1 108.48 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -101.09 164.02 12.01 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 106.667 -1.605 . . . . 74.5 106.667 177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -86.7 -33.01 20.17 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.8 -1.187 . . . . 75.31 110.087 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -123.57 138.37 54.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.636 0.774 . . . . 74.23 109.868 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 tt -60.1 -30.55 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.594 -1.262 . . . . 73.13 107.594 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -60.46 -22.99 64.1 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.324 1.05 . . . . 74.23 111.647 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -89.23 -43.95 10.62 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 119.359 0.981 . . . . 70.31 108.441 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.65 -38.21 74.67 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 109.226 -0.657 . . . . 70.23 109.226 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 3.5 mmmm -58.35 -54.43 47.07 Favored 'General case' 0 C--O 1.231 0.118 0 C-N-CA 125.208 1.403 . . . . 72.23 109.817 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -64.88 -51.91 59.44 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 123.12 0.568 . . . . 73.33 110.955 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.39 -29.5 61.58 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.716 0.635 . . . . 54.31 112.716 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -64.37 0.98 Allowed 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 108.061 -1.088 . . . . 75.22 108.061 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.55 -32.73 73.74 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 118.755 -0.64 . . . . 74.03 111.953 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -78.77 -16.4 57.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.612 0.967 . . . . 62.53 113.612 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 24.3 tp -110.68 -19.01 13.02 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.282 1.401 . . . . 73.2 112.331 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 83.9 p -58.26 118.05 5.08 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.061 1.345 . . . . 71.44 112.479 -179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.83 10.76 82.62 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-O 117.885 -1.508 . . . . 72.03 113.616 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.3 122.93 13.69 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 119.632 1.716 . . . . 72.14 108.728 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -96.72 115.73 27.93 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 126.079 1.752 . . . . 71.25 110.134 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.6 m -144.5 159.01 14.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.199 1.4 . . . . 74.21 107.535 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 69.1 m 43.85 41.56 3.89 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.206 1.402 . . . . 55.21 112.472 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 63.1 t30 56.75 21.77 6.27 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 127.632 2.373 . . . . 71.31 113.659 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -132.59 -179.3 5.37 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 126.874 2.07 . . . . 75.14 108.385 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -122.61 147.61 46.22 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 106.647 -1.612 . . . . 71.52 106.647 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 33.7 mt -96.31 156.39 16.36 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.343 -0.984 . . . . 71.35 108.343 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . 0.469 HG11 ' HE ' ' B' ' 24' ' ' ARG . 70.9 t -110.41 128.55 66.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 103.955 -2.609 . . . . 63.01 103.955 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 94.4 t -124.7 111.89 29.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 106.05 -1.833 . . . . 63.45 106.05 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 28.8 tp -136.5 164.35 28.37 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.292 1.037 . . . . 44.31 110.963 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -89.27 163.11 15.51 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 125.17 1.388 . . . . 72.03 111.364 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -101.24 169.1 9.13 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 105.567 -2.012 . . . . 74.05 105.567 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 C--O 1.249 1.041 0 N-CA-C 108.46 -0.941 . . . . 55.1 108.46 -179.734 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.851 0 CA-C-O 118.976 -0.902 . . . . 51.12 111.267 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 91.0 m -138.7 96.91 9.3 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 107.261 -1.385 . . . . 62.21 107.261 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.79 163.34 35.85 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.15 1.9 . . . . 72.14 109.349 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -146.51 82.02 1.58 Allowed 'General case' 0 C--O 1.235 0.296 0 N-CA-C 105.211 -2.144 . . . . 74.32 105.211 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -142.75 158.97 43.11 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 124.906 1.282 . . . . 73.24 108.952 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 29.4 mt -51.82 156.71 1.37 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.248 2.219 . . . . 54.43 112.527 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -131.55 162.74 29.6 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 113.574 0.953 . . . . 62.12 113.574 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -122.29 160.41 25.37 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 126.081 1.752 . . . . 72.42 112.104 -179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -140.48 161.44 37.71 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 126.147 1.779 . . . . 73.5 108.308 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.04 130.51 31.48 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 119.067 0.849 . . . . 71.13 109.744 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -161.42 176.13 11.46 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 127.92 2.488 . . . . 74.32 105.642 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -68.95 158.0 35.55 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 121.344 -0.847 . . . . 73.13 111.642 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 87.6 mtm-85 -127.74 43.46 3.12 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.031 1.332 . . . . 73.25 108.625 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -58.43 155.47 11.94 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.255 0.622 . . . . 73.03 110.263 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 17.9 pt -55.69 145.0 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 122.058 0.932 . . . . 65.32 112.811 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 31.4 p30 -157.48 -175.02 5.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 128.171 2.588 . . . . 72.01 106.655 179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 53.8 mm-40 -137.46 79.67 1.76 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 103.543 -2.762 . . . . 72.12 103.543 178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -154.31 164.53 38.45 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 123.856 0.863 . . . . 74.11 108.863 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -70.13 123.44 21.62 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.049 -1.834 . . . . 72.14 106.049 177.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 28.5 mtt-85 -146.26 162.6 34.16 Favored Pre-proline 0 C--N 1.33 -0.277 0 C-N-CA 124.667 1.187 . . . . 64.42 110.259 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.06 147.51 54.69 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.35 1.367 . . . . 64.12 109.768 178.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 63.1 mt -69.62 134.29 48.58 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 106.337 -1.727 . . . . 65.32 106.337 178.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 16.7 m -92.35 -177.04 4.51 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.427 1.108 . . . . 35.23 111.888 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -73.31 -46.16 51.16 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.945 2.098 . . . . 62.55 110.21 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -63.65 -29.92 71.09 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 119.875 1.216 . . . . 63.13 111.834 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -64.46 -35.8 82.11 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.287 -0.634 . . . . 61.42 109.287 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 34.0 tp -59.82 -27.23 66.42 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.862 -0.524 . . . . 53.44 111.135 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -72.5 -9.47 58.59 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.814 0.733 . . . . 75.32 112.239 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -123.22 -6.94 8.26 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.11 1.764 . . . . 74.33 112.504 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 57.7 mtp -73.73 -24.72 59.94 Favored 'General case' 0 N--CA 1.467 0.383 0 O-C-N 120.338 -1.476 . . . . 61.44 114.682 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -83.37 153.37 65.57 Favored Pre-proline 0 C--O 1.241 0.634 0 CA-C-N 118.814 0.734 . . . . 74.22 111.546 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.74 172.14 14.18 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 124.477 3.451 . . . . 63.31 112.505 178.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -81.99 157.6 24.17 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.662 1.985 . . . . 73.41 110.388 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.38 19.08 53.89 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 124.052 0.834 . . . . 61.25 112.577 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -124.06 158.18 32.79 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 124.513 1.125 . . . . 74.35 111.338 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -129.21 145.64 51.29 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.909 1.684 . . . . 73.23 107.015 -179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 19.1 t -74.25 151.07 7.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.605 -0.887 . . . . 75.0 108.605 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 42.5 tp -124.19 85.51 54.98 Favored Pre-proline 0 CA--C 1.533 0.324 0 N-CA-C 105.062 -2.199 . . . . 73.31 105.062 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -62.23 167.9 10.22 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.432 2.755 . . . . 73.31 112.252 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.19 164.28 36.29 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.353 2.035 . . . . 54.11 110.107 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.49 149.81 29.39 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.925 3.083 . . . . 71.02 112.801 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -67.99 143.3 55.65 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.041 0.448 . . . . 75.22 110.84 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 69.93 -3.63 9.45 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 125.067 1.318 . . . . 52.52 114.365 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 37.8 t80 -61.72 156.55 19.94 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 119.575 1.688 . . . . 75.31 110.649 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 15.5 t -125.49 79.37 67.21 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 123.694 0.798 . . . . 64.43 109.195 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -77.1 171.19 18.32 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.629 2.219 . . . . 64.44 110.08 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 C--O 1.242 0.677 0 C-N-CA 125.563 1.545 . . . . 51.1 108.312 179.62 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.725 0 N-CA-C 110.906 -0.878 . . . . 75.22 110.906 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -62.43 111.07 1.87 Allowed 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.234 1.013 . . . . 71.13 108.712 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.01 163.28 33.23 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 127.197 2.199 . . . . 61.21 107.594 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -117.52 73.76 0.9 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 122.136 0.97 . . . . 62.23 110.694 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 13.9 pt -70.82 153.73 8.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 C-N-CA 125.184 1.394 . . . . 75.11 108.722 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -86.23 -17.9 33.56 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 120.713 -1.242 . . . . 74.12 111.299 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -152.22 156.92 34.04 Favored Pre-proline 0 CA--C 1.533 0.319 0 C-N-CA 127.139 2.176 . . . . 64.14 107.816 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -60.77 169.14 6.03 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.766 2.977 . . . . 71.5 111.876 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -64.98 -41.76 16.33 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.86 2.373 . . . . 74.24 113.738 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -163.92 153.59 14.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.399 1.88 . . . . 61.12 107.607 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 t -150.67 161.01 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 126.023 1.729 . . . . 64.44 107.404 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -140.45 168.02 20.78 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.875 1.27 . . . . 55.15 110.273 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 11.8 ttp-105 -82.57 -9.0 59.59 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.476 -1.39 . . . . 60.34 111.617 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 30.6 mt -106.18 141.26 21.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.321 -1.363 . . . . 65.01 107.321 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.4 mt -116.24 151.59 35.48 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.603 1.561 . . . . 51.02 108.039 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -121.32 122.27 39.51 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 126.01 1.724 . . . . 53.13 106.696 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -114.07 147.95 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.12 1.768 . . . . 71.14 109.426 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 64.7 mtp180 -142.69 163.79 31.85 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.004 1.722 . . . . 64.44 111.362 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t30 74.56 18.19 2.89 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.18 2.592 . . . . 70.31 111.691 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 62.4 mt -70.03 153.37 95.42 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 124.452 1.101 . . . . 73.21 110.737 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -73.08 159.57 47.38 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 123.319 2.679 . . . . 73.11 110.757 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -92.27 -11.01 36.39 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 122.108 -0.37 . . . . 72.44 111.183 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.7 ttpt -127.39 104.47 7.94 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 105.326 -2.102 . . . . 70.44 105.326 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 tt -158.58 155.08 4.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 125.193 1.397 . . . . 61.11 108.596 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -105.28 169.81 8.24 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.304 1.442 . . . . 73.53 111.106 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.24 -38.11 84.66 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 108.05 -1.093 . . . . 73.55 108.05 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -60.1 -45.8 91.72 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.45 1.5 . . . . 61.54 111.675 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -61.74 -37.8 85.6 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.262 0.625 . . . . 54.11 110.628 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.9 mmm -73.81 -53.31 10.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.809 1.243 . . . . 65.42 111.736 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -59.79 -30.07 68.65 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 118.386 -0.816 . . . . 73.42 111.323 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.52 -61.32 2.71 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.991 0.814 . . . . 73.04 109.417 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 21.6 mt -55.94 -65.4 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 125.781 1.633 . . . . 73.52 112.625 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -63.32 -34.45 77.73 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 113.596 0.961 . . . . 74.24 113.596 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.53 -24.22 77.08 Favored Glycine 0 CA--C 1.522 0.518 0 CA-C-N 119.088 0.858 . . . . 61.43 112.028 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -64.01 -14.67 55.89 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.022 0.911 . . . . 64.52 113.077 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -105.08 -4.48 21.87 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.566 1.546 . . . . 75.54 111.771 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.71 173.38 13.16 Favored Glycine 0 CA--C 1.531 1.041 0 CA-C-N 119.426 1.012 . . . . 71.21 111.637 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -65.53 128.85 21.03 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.544 2.829 . . . . 62.03 112.04 -179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 74.6 mt -90.76 135.7 25.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 C-N-CA 125.57 1.548 . . . . 62.42 108.179 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -81.25 -62.69 1.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 N-CA-C 106.559 -1.645 . . . . 75.22 106.559 177.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -151.87 160.98 43.36 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.557 0.617 . . . . 73.21 111.886 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 24.9 mt -136.96 134.55 48.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 126.923 2.089 . . . . 63.13 107.019 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -130.2 128.11 41.04 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 105.585 -2.006 . . . . 72.42 105.585 178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 m -108.76 147.33 13.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 124.791 1.236 . . . . 52.15 109.009 -179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.35 135.24 14.97 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 110.471 -1.052 . . . . 72.02 110.471 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.96 -15.05 9.35 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.232 1.197 . . . . 63.32 114.232 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 21.6 p -77.71 160.21 75.0 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 106.411 -1.7 . . . . 74.45 106.411 177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.54 -20.43 49.54 Favored 'Trans proline' 0 CA--C 1.535 0.565 0 C-N-CA 122.282 1.988 . . . . 73.21 114.021 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -92.74 -21.24 20.07 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.982 0.913 . . . . 64.4 113.064 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 80.4 p -101.58 -12.33 18.55 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.891 0.768 . . . . 72.02 112.374 -178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 -64.02 116.5 5.94 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.066 -1.457 . . . . 73.13 107.066 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.93 16.9 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-O 118.7 -1.056 . . . . 51.42 112.753 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 74.4 p -128.5 159.34 35.78 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 118.518 1.159 . . . . 65.41 108.26 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.98 170.38 20.69 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.291 -0.881 . . . . 71.32 110.503 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -122.31 142.57 50.35 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.716 -1.216 . . . . 73.12 107.716 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -132.06 137.63 54.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 C-N-CA 126.174 1.79 . . . . 74.41 106.775 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 35.0 t -129.03 128.35 67.08 Favored 'Isoleucine or valine' 0 C--O 1.231 0.094 0 CA-C-O 118.422 -0.799 . . . . 63.15 109.893 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -97.45 166.15 11.66 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 124.609 1.164 . . . . 73.33 107.878 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -74.92 -55.3 5.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.923 0.889 . . . . 75.34 108.72 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.98 121.44 32.08 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 114.274 1.213 . . . . 62.04 114.274 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.4 tt -66.08 -19.41 25.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 109.681 -0.489 . . . . 74.41 109.681 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -74.9 -60.83 2.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.322 1.049 . . . . 73.34 108.387 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -57.08 -36.69 70.88 Favored 'General case' 0 CA--C 1.521 -0.169 0 C-N-CA 123.785 0.834 . . . . 71.03 111.738 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.57 -29.69 62.33 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 118.247 0.476 . . . . 74.22 112.014 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 33.4 mttp -80.05 -46.11 17.13 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 120.946 -1.096 . . . . 72.04 108.404 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -57.22 -32.2 66.26 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.268 0.556 . . . . 72.2 110.592 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.25 -43.95 18.45 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.269 1.428 . . . . 64.14 111.769 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 11.5 p -55.83 -42.36 75.6 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 119.198 0.908 . . . . 71.4 110.906 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -71.64 -18.17 62.21 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 112.401 0.519 . . . . 63.41 112.401 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -95.53 -17.88 21.07 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.678 0.791 . . . . 71.15 112.037 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 12.0 tp -101.52 -3.5 28.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 118.701 0.682 . . . . 74.23 112.534 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 94.7 p -68.08 134.9 51.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 122.652 1.215 . . . . 73.02 111.505 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 61.98 22.38 62.44 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 121.219 -0.926 . . . . 60.13 113.013 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -68.49 141.33 55.62 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.109 1.455 . . . . 73.31 110.876 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -90.45 127.66 36.28 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.821 1.248 . . . . 74.22 109.286 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.01 125.39 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 127.779 2.432 . . . . 54.14 109.034 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 72.5 m 50.78 41.98 27.05 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.779 1.232 . . . . 73.42 110.738 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 20.2 m120 61.19 14.64 5.69 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.476 1.91 . . . . 62.42 113.469 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 17.4 mmm180 -122.06 169.77 10.51 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.626 1.971 . . . . 74.02 107.461 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -107.22 -177.0 3.23 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.085 -1.079 . . . . 72.44 108.085 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 41.2 mt -142.62 165.26 27.87 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 127.555 2.342 . . . . 54.43 106.072 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 60.7 t -133.25 110.52 15.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 N-CA-C 106.627 -1.619 . . . . 44.33 106.627 178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.88 144.59 9.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 N-CA-C 107.007 -1.479 . . . . 75.43 107.007 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 9.4 tp -154.27 154.7 33.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.089 1.356 . . . . 43.31 107.342 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -81.24 164.28 22.39 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.841 1.656 . . . . 64.02 110.482 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -101.06 157.79 16.5 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 122.874 0.47 . . . . 73.25 110.229 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 36.0 m120 . . . . . 0 C--O 1.256 1.41 0 CA-C-O 115.945 -1.978 . . . . 62.3 110.229 -179.39 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.138 0 N-CA-C 108.783 -1.727 . . . . 70.22 108.783 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 7.3 p -107.38 93.95 10.67 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 105.648 -1.982 . . . . 51.2 105.648 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.54 172.51 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.115 1.877 . . . . 72.4 111.465 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -79.88 -168.3 1.56 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.252 2.221 . . . . 75.2 108.337 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -129.4 -82.46 0.56 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 107.747 -1.205 . . . . 63.51 107.747 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 29.8 tp -157.57 164.55 37.18 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.544 -1.28 . . . . 75.32 107.544 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.62 164.12 31.31 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.792 1.237 . . . . 74.35 108.913 179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -153.6 146.95 24.82 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.933 1.293 . . . . 63.34 107.586 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 73.5 t90 -153.3 130.26 11.02 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 105.733 -1.951 . . . . 74.31 105.733 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -159.92 139.27 11.07 Favored 'General case' 0 CA--C 1.521 -0.167 0 N-CA-C 107.493 -1.299 . . . . 75.43 107.493 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 74.6 m95 -149.44 151.67 34.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.791 1.636 . . . . 72.11 106.833 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -145.97 -168.85 3.1 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.488 1.115 . . . . 74.43 108.516 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -160.96 -164.23 1.16 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 119.607 1.094 . . . . 73.52 110.093 -179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -133.01 -177.07 4.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.739 2.416 . . . . 75.24 104.981 177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 4.3 tp -141.66 123.7 13.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 120.596 -1.315 . . . . 71.21 108.017 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -160.29 157.66 28.45 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 126.281 1.833 . . . . 73.42 107.246 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -176.22 169.81 2.71 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 126.735 2.014 . . . . 73.51 108.0 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -153.83 161.19 42.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 126.268 1.827 . . . . 61.43 107.249 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 397' ' ' ARG . 7.7 p-10 -101.1 -73.57 0.64 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.034 -1.099 . . . . 73.22 108.034 178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . 0.41 ' H ' ' CG ' ' A' ' 396' ' ' ASN . 24.2 mmt85 65.46 151.86 0.12 Allowed Pre-proline 0 N--CA 1.466 0.34 0 C-N-CA 130.181 3.392 . . . . 63.44 115.544 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -71.91 113.41 3.66 Favored 'Trans proline' 0 C--N 1.351 0.691 0 N-CA-C 105.018 -2.724 . . . . 70.5 105.018 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 31.7 mt -128.72 -169.43 2.08 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 123.761 0.824 . . . . 75.41 110.974 -177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 12.1 m -142.45 -78.71 0.24 Allowed 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 125.568 1.547 . . . . 63.13 109.532 -179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.37 -33.11 67.0 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.638 -0.664 . . . . 74.33 110.533 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -75.68 -39.0 58.25 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.599 0.36 . . . . 73.44 110.85 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -64.64 -30.07 71.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 119.057 0.844 . . . . 55.11 110.112 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 12.3 tp -62.58 -25.54 68.13 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.607 1.163 . . . . 72.01 110.489 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -79.69 -51.51 9.14 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.907 -0.775 . . . . 74.02 108.907 179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.19 89.2 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 126.511 1.924 . . . . 61.41 113.291 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.0 mtp -57.94 -36.87 73.12 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.307 1.043 . . . . 73.05 113.377 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -68.47 149.92 97.86 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 119.374 0.988 . . . . 74.11 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.44 160.47 47.68 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.162 1.908 . . . . 64.4 111.064 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -71.06 160.87 32.11 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.72 -1.127 . . . . 71.21 109.525 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.72 17.46 63.65 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 121.651 -0.655 . . . . 62.01 113.296 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -124.47 156.96 36.36 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.487 1.515 . . . . 75.11 108.009 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -136.68 144.58 44.03 Favored 'General case' 0 CA--C 1.519 -0.248 0 C-N-CA 124.733 1.213 . . . . 63.14 109.549 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 93.8 t -70.91 151.18 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 N-CA-C 108.566 -0.901 . . . . 53.1 108.566 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 17.8 tp -120.72 83.44 35.75 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 125.699 1.6 . . . . 64.23 108.378 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.28 162.26 17.68 Favored 'Trans proline' 0 CA--C 1.543 0.962 0 C-N-CA 123.2 2.6 . . . . 53.44 112.909 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.65 168.39 22.84 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 124.109 3.206 . . . . 75.42 111.094 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -69.18 164.1 35.26 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 122.434 2.089 . . . . 75.45 109.855 177.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -88.22 160.42 17.71 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.451 -0.78 . . . . 73.42 110.057 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 59.5 1.83 1.36 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.795 1.664 . . . . 62.4 116.169 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -59.39 149.16 30.01 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.823 2.049 . . . . 73.34 112.997 -178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 35.1 t -134.06 89.47 28.78 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 124.472 1.109 . . . . 73.41 108.961 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -83.97 178.92 5.03 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.924 3.083 . . . . 63.43 109.698 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 12.4 tt . . . . . 0 C--O 1.252 1.194 0 C-N-CA 124.991 1.316 . . . . 73.32 108.63 179.14 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.527 0 N-CA-C 109.939 -1.264 . . . . 54.43 109.939 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -154.72 173.06 16.93 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 117.882 0.841 . . . . 71.03 110.148 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.51 151.72 39.54 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.202 1.801 . . . . 74.24 106.143 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -141.83 117.37 10.29 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 127.408 2.283 . . . . 74.33 105.16 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.44 164.35 28.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 123.972 0.909 . . . . 71.14 111.035 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 22.1 mtm180 -74.09 168.33 19.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.824 -1.08 . . . . 60.45 109.122 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 36.9 mt 53.61 48.87 5.37 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.622 1.169 . . . . 74.1 112.672 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -72.66 166.64 29.32 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.654 2.236 . . . . 70.54 110.442 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.95 -50.26 0.17 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.086 2.524 . . . . 54.23 111.895 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -68.01 84.6 0.23 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 128.39 2.676 . . . . 62.21 112.901 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 91.2 t -149.29 137.91 14.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 108.501 -0.926 . . . . 31.35 108.501 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -128.65 171.37 12.24 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.183 1.393 . . . . 74.42 109.663 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.89 -30.04 70.57 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.951 0.723 . . . . 71.12 112.951 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 48.2 mt -83.93 135.0 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 125.625 1.57 . . . . 74.23 109.519 -178.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 98.4 mt -126.47 158.71 35.34 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.005 1.722 . . . . 52.23 110.973 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -128.26 108.49 10.64 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.59 1.556 . . . . 63.23 110.635 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -99.84 144.71 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 C-N-CA 127.19 2.196 . . . . 74.3 107.73 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' B' ' 59' ' ' THR . 58.0 mtm180 -144.56 164.19 31.65 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.97 2.508 . . . . 73.22 110.98 -178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 52.1 t30 72.43 11.26 5.74 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.139 1.376 . . . . 62.11 111.544 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.55 154.58 79.19 Favored Pre-proline 0 C--O 1.237 0.433 0 C-N-CA 124.851 1.261 . . . . 73.12 111.231 -179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.63 150.75 74.96 Favored 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.245 1.963 . . . . 73.14 112.652 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -83.37 -15.39 50.07 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.216 -0.447 . . . . 74.1 110.504 178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -130.06 109.34 10.77 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 125.524 1.53 . . . . 70.24 107.506 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 15.9 tt -162.57 171.18 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 128.386 2.675 . . . . 64.15 105.466 179.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 21.4 p -126.18 165.87 18.1 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 124.585 1.154 . . . . 72.14 109.976 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.7 -33.35 74.91 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 108.543 -0.91 . . . . 23.2 108.543 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -58.43 -54.61 45.07 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.831 1.652 . . . . 71.43 109.513 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.5 -36.46 84.27 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 125.187 1.395 . . . . 51.12 111.363 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 66.2 mmm -64.69 -58.2 6.93 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 108.473 -0.936 . . . . 70.42 108.473 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -58.8 -35.76 73.36 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.635 0.774 . . . . 75.01 110.915 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -59.81 -26.3 65.66 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.814 1.246 . . . . 75.13 111.744 179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 73.5 mt -94.06 -69.74 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.01 0.924 . . . . 73.05 108.986 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -55.31 -38.09 68.22 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 114.921 1.452 . . . . 75.3 114.921 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.72 -33.66 85.93 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 124.302 0.953 . . . . 73.14 112.942 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 7.8 mmmm -65.87 -29.14 69.55 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 121.109 -1.23 . . . . 64.41 110.221 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -79.89 -22.27 43.03 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.762 0.825 . . . . 73.23 110.263 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 155.68 168.93 19.44 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.875 1.702 . . . . 62.44 109.48 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -63.22 159.92 37.14 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.108 2.539 . . . . 60.22 113.505 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mt -113.29 143.9 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.686 1.995 . . . . 71.43 110.536 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.34 -56.18 2.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 125.216 1.406 . . . . 71.53 108.043 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -153.72 155.09 35.29 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 107.359 -1.348 . . . . 75.22 107.359 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 28.6 mt -136.82 135.38 48.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 104.491 -2.411 . . . . 65.43 104.491 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtp85 -133.2 123.98 26.59 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 105.314 -2.106 . . . . 73.44 105.314 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.8 m -110.04 151.26 12.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.593 -1.262 . . . . 73.23 107.593 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -77.4 145.69 30.79 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.446 -1.062 . . . . 72.14 110.446 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.78 -38.86 3.85 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 118.463 -0.78 . . . . 61.34 111.22 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 30.0 p -69.38 161.6 72.43 Favored Pre-proline 0 CA--C 1.54 0.568 0 N-CA-C 109.388 -0.597 . . . . 65.42 109.388 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.2 -2.58 8.33 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.141 1.894 . . . . 70.01 112.255 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -105.84 -9.72 17.05 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.487 1.915 . . . . 70.11 111.868 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 57.4 p -116.62 -12.05 10.97 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.87 1.268 . . . . 71.44 110.723 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -57.58 142.09 45.8 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.55 -1.344 . . . . 64.53 108.341 178.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.16 -5.68 83.56 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-O 118.676 -1.069 . . . . 52.14 114.633 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . 0.422 HG22 ' HG2' ' B' ' 24' ' ' ARG . 36.1 p -124.52 153.85 41.45 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 119.399 1.6 . . . . 71.04 109.144 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -153.69 166.2 33.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.876 0.846 . . . . 72.54 109.525 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -123.94 141.98 51.55 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 105.532 -2.025 . . . . 72.35 105.532 178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 91.7 t -132.84 142.56 42.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 105.591 -2.003 . . . . 74.44 105.591 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 46.2 t -127.78 134.33 65.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.222 -1.77 . . . . 74.42 106.222 178.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' B' ' 70' ' ' ALA . 9.8 m-85 -98.03 166.84 11.24 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.881 1.672 . . . . 64.42 111.472 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -86.8 -73.64 0.46 Allowed 'General case' 0 CA--C 1.509 -0.607 0 N-CA-C 106.94 -1.504 . . . . 75.31 106.94 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -81.77 134.96 35.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.116 0.96 . . . . 71.41 109.332 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.46 HG22 ' H ' ' B' ' 67' ' ' ILE . 1.0 OUTLIER -58.65 -34.16 50.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 C-N-CA 125.318 1.447 . . . . 62.21 108.443 177.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -70.33 -30.01 66.87 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.152 0.581 . . . . 72.41 110.874 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -71.43 -47.39 56.19 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 108.526 -0.916 . . . . 73.21 108.526 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' B' ' 64' ' ' TYR . . . -55.45 -42.94 74.93 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 123.768 0.827 . . . . 75.32 111.94 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -57.28 -61.9 2.15 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.38 1.072 . . . . 70.33 109.487 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 48.3 m-80 -52.95 -53.09 54.75 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 123.769 0.827 . . . . 62.12 111.812 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.78 -38.67 86.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 114.428 1.27 . . . . 71.33 114.428 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 37.3 t -58.26 -49.81 75.82 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 118.437 0.562 . . . . 62.12 110.693 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -62.9 -52.77 61.78 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.795 -0.446 . . . . 73.24 109.795 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 t-160 -58.36 -26.22 62.9 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.891 0.7 . . . . 74.34 112.891 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.9 tp -96.77 -6.75 35.46 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.432 0.901 . . . . 74.04 113.432 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -62.19 121.86 14.16 Favored 'General case' 0 C--O 1.233 0.236 0 O-C-N 120.299 -1.501 . . . . 73.31 109.999 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 67.71 18.52 70.32 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.35 -1.25 . . . . 52.31 112.777 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -55.06 120.11 6.46 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 119.08 1.44 . . . . 71.45 110.32 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -72.88 115.99 12.84 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 127.69 2.396 . . . . 73.03 110.749 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.12 144.47 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 C-N-CA 125.156 1.382 . . . . 73.2 108.83 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.0 m 39.73 52.18 2.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.378 1.871 . . . . 73.31 112.992 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 66.1 t30 57.36 23.54 9.03 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.089 1.356 . . . . 72.33 113.69 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 32.2 mmt180 -136.85 -176.6 4.42 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 127.591 2.356 . . . . 73.54 107.517 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -137.47 137.4 38.67 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 125.956 1.703 . . . . 74.32 107.071 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -87.39 148.94 24.78 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 121.335 0.588 . . . . 74.11 110.446 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.87 156.72 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 C-N-CA 126.117 1.767 . . . . 62.33 107.186 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 93.2 t -142.33 123.12 11.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 104.714 -2.328 . . . . 64.44 104.714 178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 42.4 tp -151.48 146.09 25.66 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 123.776 0.83 . . . . 74.01 109.754 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -80.37 156.63 26.61 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 109.158 -0.682 . . . . 75.0 109.158 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -75.71 175.39 8.7 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.373 -0.973 . . . . 73.2 108.373 179.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 124.302 1.041 . . . . 73.24 112.329 -178.472 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.244 0 N-CA-C 108.846 -1.702 . . . . 64.24 108.846 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.0 t -141.99 129.52 11.55 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 106.05 -1.833 . . . . 64.04 106.05 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -83.54 -179.19 4.06 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.665 2.243 . . . . 73.45 108.941 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -138.89 161.36 37.47 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.264 1.826 . . . . 74.44 106.116 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -134.41 97.28 3.78 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.868 -1.16 . . . . 54.53 107.868 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.32 144.26 57.1 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.236 -0.653 . . . . 74.31 109.236 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -74.95 80.07 2.16 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.952 -0.758 . . . . 55.12 108.952 179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -78.21 57.38 1.84 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.662 1.185 . . . . 70.43 110.121 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -123.02 167.89 13.05 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.295 1.838 . . . . 73.52 109.527 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -168.22 179.27 4.59 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 128.568 2.747 . . . . 70.2 106.597 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -134.64 -170.61 2.59 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 118.294 0.497 . . . . 61.55 110.04 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -117.2 -175.86 2.88 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.653 1.181 . . . . 64.52 111.041 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 18.2 mtm105 -140.34 76.9 1.58 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.59 1.156 . . . . 53.34 108.888 -178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.75 147.65 51.49 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.633 0.651 . . . . 70.43 110.246 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 29.0 pt -141.48 143.06 28.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 124.971 1.308 . . . . 73.33 109.78 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -158.87 179.14 9.35 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.395 1.078 . . . . 45.55 111.094 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.91 179.91 2.09 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.5 0.72 . . . . 61.12 110.307 179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -135.71 137.15 41.44 Favored 'General case' 0 CA--C 1.516 -0.338 0 O-C-N 121.21 -0.931 . . . . 63.3 110.697 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.71 0.43 13.87 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 126.277 1.831 . . . . 72.34 110.204 178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -100.94 146.93 32.98 Favored Pre-proline 0 C--O 1.236 0.375 0 C-N-CA 124.686 1.194 . . . . 71.42 111.107 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.1 159.91 51.49 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 123.692 2.928 . . . . 64.41 109.2 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 59.8 mt -62.53 116.73 5.38 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.756 -0.59 . . . . 71.03 110.173 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 16.0 m -111.04 -149.28 0.44 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 127.089 2.156 . . . . 54.44 107.565 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.04 -33.6 17.09 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.152 -0.968 . . . . 73.31 112.622 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -58.95 -40.07 83.58 Favored 'General case' 0 CA--C 1.522 -0.123 0 C-N-CA 123.82 0.848 . . . . 73.22 110.723 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -64.77 -30.91 71.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 123.209 0.603 . . . . 62.14 110.26 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 39.3 tp -72.88 -47.49 45.48 Favored 'General case' 0 C--O 1.225 -0.192 0 N-CA-C 107.244 -1.391 . . . . 64.04 107.244 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.58 -49.11 73.6 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.765 0.257 . . . . 65.34 110.816 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -58.51 -24.89 61.67 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.53 1.532 . . . . 30.04 113.777 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 62.4 mtp -86.59 -17.59 33.57 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.335 -0.853 . . . . 63.34 111.416 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -90.42 146.79 35.21 Favored Pre-proline 0 CA--C 1.532 0.265 0 CA-C-N 119.017 0.826 . . . . 53.02 111.844 -177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.84 163.85 23.23 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.292 2.661 . . . . 61.24 111.045 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -76.86 173.47 11.67 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 108.465 -0.939 . . . . 63.13 108.465 178.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 78.62 18.89 74.72 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 121.372 -0.83 . . . . 51.52 111.731 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -129.8 117.17 19.81 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.523 1.529 . . . . 74.32 108.901 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.42 148.0 22.93 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.45 1.1 . . . . 72.11 108.119 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 12.2 t -69.71 151.96 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 120.819 -1.175 . . . . 63.12 110.948 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 22.9 tp -120.67 77.9 29.18 Favored Pre-proline 0 C--O 1.237 0.401 0 N-CA-C 107.17 -1.419 . . . . 54.52 107.17 178.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.78 166.54 13.65 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.729 2.286 . . . . 73.41 111.467 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.17 174.92 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.882 1 C-N-CA 125.698 4.265 . . . . 53.42 115.063 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.79 149.87 66.26 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.732 2.288 . . . . 65.43 110.993 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -82.86 70.3 9.83 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 106.409 -1.7 . . . . 73.43 106.409 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 136.44 60.57 0.06 OUTLIER Glycine 0 CA--C 1.524 0.636 0 C-N-CA 125.519 1.533 . . . . 34.12 111.052 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -93.82 9.58 36.65 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 117.775 0.787 . . . . 72.34 113.007 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 2.5 t 60.53 63.88 2.67 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 126.415 1.886 . . . . 72.31 110.766 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -69.62 125.1 11.81 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.307 2.671 . . . . 71.54 111.592 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--O 1.25 1.116 0 N-CA-C 105.371 -2.085 . . . . 72.22 105.371 177.422 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.705 0 N-CA-C 111.49 -0.644 . . . . 72.1 111.49 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -134.84 116.06 14.36 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 107.12 -1.437 . . . . 74.23 107.12 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.7 120.08 8.82 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.699 -1.593 . . . . 34.32 106.699 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -124.46 164.1 20.44 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 125.02 1.328 . . . . 75.22 108.022 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 pt -126.1 11.63 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 N-CA-C 113.918 1.081 . . . . 61.44 113.918 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -135.0 121.34 20.32 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 107.396 -1.335 . . . . 74.2 107.396 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 mp -54.95 155.75 7.84 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 123.591 0.757 . . . . 71.52 110.915 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.25 162.33 20.39 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.045 2.497 . . . . 61.31 114.491 -178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.03 -27.52 57.72 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.172 2.581 . . . . 75.43 113.123 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -58.22 -20.6 42.95 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.94 2.096 . . . . 53.2 113.427 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 41.4 t -74.79 104.15 3.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 C-N-CA 124.908 1.283 . . . . 73.33 107.87 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -98.03 175.25 6.18 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.635 1.174 . . . . 71.33 109.71 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.69 -34.31 72.72 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.686 -1.259 . . . . 72.52 114.215 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 33.6 mt -95.12 138.05 21.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 124.512 1.125 . . . . 72.41 109.793 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.36 146.81 49.9 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.787 -1.19 . . . . 72.41 107.787 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -99.55 138.79 36.15 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 105.894 -1.891 . . . . 74.22 105.894 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 14.8 mm -117.03 134.86 59.26 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 C-N-CA 126.155 1.782 . . . . 60.44 106.365 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 81.0 mtp180 -127.83 162.5 26.51 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 123.909 0.884 . . . . 61.3 110.485 -178.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 56.1 t30 62.57 38.35 12.45 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 126.656 1.983 . . . . 53.15 111.557 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 67.3 mt -76.56 153.76 83.62 Favored Pre-proline 0 C--O 1.239 0.523 0 N-CA-C 108.488 -0.93 . . . . 62.33 108.488 178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.96 163.94 35.71 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.632 2.221 . . . . 74.42 109.844 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -94.06 -13.03 27.31 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.994 0.518 . . . . 73.2 112.017 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -126.23 99.7 5.99 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.215 1.406 . . . . 74.43 107.943 179.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 18.9 tt -162.1 143.43 3.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 N-CA-C 107.565 -1.272 . . . . 51.44 107.565 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 40.4 p -98.45 178.13 5.13 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.98 0.912 . . . . 64.3 110.441 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.31 -35.42 80.95 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.194 -0.457 . . . . 70.12 110.15 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -52.83 -60.54 3.14 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 127.73 2.412 . . . . 64.24 110.027 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -57.53 -47.55 81.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.426 1.49 . . . . 71.53 110.88 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.7 mmm -59.25 -39.09 81.72 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.088 -0.383 . . . . 75.21 110.865 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -76.37 -30.36 57.52 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 118.722 -0.656 . . . . 72.01 110.319 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -69.23 -27.13 65.19 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.67 1.188 . . . . 74.13 110.16 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 58.7 mt -76.26 -68.25 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.38 1.072 . . . . 74.2 109.16 179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -67.32 -23.86 65.68 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 114.892 1.442 . . . . 73.14 114.892 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.92 -13.85 69.89 Favored Glycine 0 C--N 1.337 0.609 0 N-CA-C 115.584 0.994 . . . . 64.12 115.584 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -72.51 -28.78 63.08 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 119.096 1.448 . . . . 72.51 110.592 179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -84.82 -34.27 22.74 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 118.505 -0.76 . . . . 73.1 112.351 -179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 171.2 -166.55 39.67 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 120.204 1.365 . . . . 50.51 111.915 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.28 162.57 41.85 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 124.084 3.189 . . . . 62.45 112.858 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 59.5 mt -118.38 130.47 73.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 C-N-CA 123.965 0.906 . . . . 61.31 109.247 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 22.6 tpt180 -88.44 -59.7 2.16 Favored 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 108.131 -1.063 . . . . 75.41 108.131 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -155.61 155.12 32.71 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 120.66 0.267 . . . . 74.31 110.851 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.5 mt -145.05 127.79 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 104.984 -2.228 . . . . 73.12 104.984 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -128.31 120.82 27.84 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 102.842 -3.021 . . . . 74.21 102.842 178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 16.1 m -99.65 144.65 11.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 123.736 0.814 . . . . 54.15 111.359 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.64 115.58 6.0 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 106.076 -2.81 . . . . 70.5 106.076 178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -103.55 -10.89 18.12 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.194 0.998 . . . . 52.3 113.46 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 17.9 p -95.16 158.36 34.93 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-N 119.375 0.989 . . . . 71.13 108.461 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.59 -15.73 38.53 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.77 2.313 . . . . 73.11 113.045 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -97.29 -10.7 25.2 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.514 1.125 . . . . 74.24 112.286 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 39.9 p -116.96 -19.23 9.89 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.731 1.212 . . . . 61.33 112.21 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -53.26 150.32 6.32 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 125.434 1.494 . . . . 74.41 110.317 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.51 3.51 88.84 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.069 -1.406 . . . . 73.13 112.703 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 59.1 p -143.77 153.36 42.33 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.753 1.776 . . . . 64.33 109.979 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.35 172.82 12.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.751 2.021 . . . . 75.14 108.359 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -127.78 156.02 43.14 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.889 -1.522 . . . . 64.35 106.889 178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 96.6 t -134.22 142.97 39.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 107.872 -1.159 . . . . 74.3 107.872 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 t -129.04 133.33 66.16 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 124.621 1.169 . . . . 73.03 108.369 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.99 154.12 17.91 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 106.374 -1.713 . . . . 71.23 106.374 177.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -72.69 -20.09 61.3 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 119.546 -0.862 . . . . 74.24 110.931 179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -118.83 117.87 30.03 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.579 1.552 . . . . 52.43 109.681 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 12.7 tt -61.76 -27.48 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 C-N-CA 125.175 1.39 . . . . 62.4 111.966 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -73.36 -41.61 63.21 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 120.344 -1.472 . . . . 74.11 107.569 177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.1 -37.31 87.09 Favored 'General case' 0 N--CA 1.462 0.159 0 N-CA-C 108.569 -0.901 . . . . 71.21 108.569 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -57.02 -48.4 78.58 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 118.63 -0.7 . . . . 63.0 109.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.19 -29.54 70.44 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 118.288 -0.863 . . . . 75.2 110.612 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.87 -53.31 21.94 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 120.129 1.331 . . . . 75.53 108.568 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.41 -14.15 17.36 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 114.086 1.143 . . . . 74.12 114.086 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 91.6 m -64.23 -66.62 0.52 Allowed 'General case' 0 C--O 1.231 0.119 0 CA-C-N 119.448 1.022 . . . . 71.42 109.735 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -68.3 -34.56 76.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 119.13 -0.462 . . . . 74.22 110.168 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -64.83 -21.61 66.83 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 118.161 -0.923 . . . . 75.13 112.858 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 29.8 tp -106.54 -23.71 12.4 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.083 1.311 . . . . 74.35 111.324 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 12.5 m -69.79 110.1 4.76 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 121.005 -1.06 . . . . 72.01 108.352 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.44 10.54 53.58 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 125.649 1.595 . . . . 74.04 112.277 -178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -72.72 106.38 4.69 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 119.457 1.628 . . . . 71.23 107.627 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.93 124.93 27.11 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.349 -0.982 . . . . 63.4 108.349 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 16.8 m -141.31 144.37 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.161 0 CA-C-N 118.983 0.811 . . . . 72.25 110.302 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 13.5 m 45.78 38.97 4.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.155 1.382 . . . . 53.04 113.384 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 64.79 20.91 12.26 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.558 1.143 . . . . 75.21 111.871 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.3 mmm-85 -135.6 -178.17 5.0 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 127.145 2.178 . . . . 73.34 108.257 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -133.07 155.31 49.46 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.867 1.267 . . . . 74.25 109.571 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 49.7 mt -109.63 150.16 28.65 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.033 1.333 . . . . 74.44 107.514 178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 48.6 t -119.18 112.76 38.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.404 0 N-CA-C 106.335 -1.728 . . . . 74.31 106.335 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 44.8 t -91.56 141.73 14.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 105.072 -2.196 . . . . 74.35 105.072 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.57 142.51 45.33 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 107.269 -1.382 . . . . 63.43 107.269 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 29.0 m-85 -84.11 114.0 21.45 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.457 -0.942 . . . . 74.21 108.457 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -74.05 148.22 42.14 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 104.192 -2.522 . . . . 73.03 104.192 178.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 . . . . . 0 C--O 1.248 1.022 0 C-N-CA 126.06 1.744 . . . . 72.24 109.088 -178.868 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.171 0 N-CA-C 108.669 -1.772 . . . . 72.11 108.669 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.8 t -140.07 139.67 21.91 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 105.572 -2.01 . . . . 65.34 105.572 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -81.61 -179.26 4.76 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.51 2.14 . . . . 72.24 109.233 178.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.27 173.24 11.82 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 127.656 2.382 . . . . 54.32 106.699 178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -145.39 161.0 40.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.196 0.998 . . . . 72.22 108.415 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.1 pp -134.31 167.39 20.8 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 124.636 1.175 . . . . 75.21 109.709 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -159.58 178.54 9.76 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.92 1.688 . . . . 73.14 108.179 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -149.27 166.65 28.28 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.238 1.415 . . . . 74.22 108.096 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 24.8 p90 -139.76 169.74 17.17 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.593 1.157 . . . . 74.22 109.476 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 23.2 ttt-85 -154.39 144.25 21.73 Favored 'General case' 0 C--N 1.335 -0.055 0 C-N-CA 124.788 1.235 . . . . 71.41 107.716 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 18.3 m-90 -76.59 116.42 17.26 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 106.1 -1.815 . . . . 65.52 106.1 177.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.27 166.01 23.74 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.22 -0.659 . . . . 72.23 109.22 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.53 104.96 5.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 125.367 1.467 . . . . 73.12 107.182 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -113.66 171.27 7.68 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.16 1.384 . . . . 74.2 107.915 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 81.2 mt -131.99 136.09 57.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.558 -2.016 . . . . 73.21 105.558 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -157.27 120.48 4.06 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.289 -1.375 . . . . 74.34 107.289 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -62.57 171.34 2.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 124.591 1.156 . . . . 74.23 109.919 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -128.23 -38.22 1.8 Allowed 'General case' 0 CA--C 1.515 -0.39 0 O-C-N 121.748 -0.595 . . . . 73.33 110.115 178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 56.78 12.1 1.07 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.139 1.375 . . . . 71.21 111.826 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -66.0 158.8 74.41 Favored Pre-proline 0 N--CA 1.455 -0.197 0 C-N-CA 128.649 2.78 . . . . 61.05 113.026 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -75.4 148.98 34.49 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.239 1.96 . . . . 74.33 109.207 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 27.7 mt -63.09 119.46 9.55 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 123.982 0.913 . . . . 64.53 108.94 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 3.9 t -100.34 164.33 11.98 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 123.367 1.556 . . . . 63.33 111.183 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -73.53 -30.33 63.02 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 127.755 2.422 . . . . 74.24 111.128 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -69.13 -29.74 67.85 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 118.825 -0.607 . . . . 75.32 111.601 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -67.14 -34.26 77.2 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.684 -0.858 . . . . 65.31 108.684 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 52.0 tp -63.47 -40.17 96.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.437 1.095 . . . . 74.1 111.29 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.26 -38.24 88.53 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 119.069 0.849 . . . . 64.14 110.202 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -72.55 -35.46 68.01 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.631 0.773 . . . . 52.03 110.964 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 64.4 mtp -65.42 -41.56 93.45 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 118.908 -0.568 . . . . 72.52 110.261 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -65.1 155.71 83.23 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 112.983 0.734 . . . . 73.1 112.983 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.73 159.86 34.79 Favored 'Trans proline' 0 N--CA 1.444 -1.401 0 C-N-CA 122.077 1.851 . . . . 52.44 109.33 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -79.48 161.97 25.73 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.363 -1.289 . . . . 73.21 110.631 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 85.79 17.89 60.84 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.76 -0.587 . . . . 44.25 113.693 179.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -125.16 157.68 35.81 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 125.298 1.439 . . . . 64.41 108.896 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -127.07 143.82 51.18 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.445 1.498 . . . . 63.11 109.305 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 63.1 t -71.08 141.06 17.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.675 -0.861 . . . . 61.13 108.675 179.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 28.7 tp -117.17 84.05 16.49 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 125.096 1.358 . . . . 71.01 107.547 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.12 166.04 24.47 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.185 1.924 . . . . 74.42 110.041 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -59.21 171.84 2.12 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.615 2.877 . . . . 64.34 113.413 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.48 118.94 5.42 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 123.621 2.881 . . . . 63.42 110.369 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -64.05 150.71 44.79 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.816 -0.552 . . . . 44.14 110.499 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 71.54 0.56 39.95 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 117.615 -1.659 . . . . 61.42 115.366 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -61.05 143.26 55.72 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.513 1.656 . . . . 75.15 110.277 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 95.6 t -137.24 80.14 35.1 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 107.727 -1.212 . . . . 71.41 107.727 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -72.05 137.86 29.88 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.528 2.152 . . . . 72.44 110.199 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 25.5 mt . . . . . 0 C--O 1.249 1.062 0 N-CA-C 106.785 -1.561 . . . . 74.21 106.785 179.139 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.978 0 N-CA-C 109.917 -1.273 . . . . 41.11 109.917 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -65.14 102.14 0.61 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 106.638 -1.616 . . . . 71.2 106.638 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -153.21 175.1 13.43 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.898 1.279 . . . . 71.03 109.658 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -65.21 127.81 33.23 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.771 0.828 . . . . 64.23 110.122 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 8.1 tt -136.79 116.85 16.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 123.835 0.854 . . . . 51.02 110.125 -179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -121.16 172.0 8.29 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.595 1.958 . . . . 40.22 106.973 178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 19.6 tp 48.22 65.64 6.77 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.684 1.194 . . . . 65.1 110.155 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -71.07 158.44 55.13 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.751 1.634 . . . . 62.34 112.061 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -68.68 -15.69 41.32 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.487 2.792 . . . . 75.2 113.415 -179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -67.71 -16.52 64.18 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.03 0.932 . . . . 73.03 111.914 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 t -88.38 133.91 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 123.432 0.693 . . . . 71.14 109.447 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -140.58 159.21 42.69 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.263 -1.754 . . . . 72.44 106.263 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -56.24 -32.11 64.17 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 126.597 1.959 . . . . 73.34 111.917 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 53.4 mt -75.13 123.67 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 107.306 -1.368 . . . . 71.22 107.306 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 62.3 mt -120.15 126.53 50.93 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.733 2.013 . . . . 74.15 108.204 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -96.11 134.36 39.26 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 125.225 1.41 . . . . 74.42 108.917 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.2 mm -124.16 154.86 31.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 123.871 0.868 . . . . 75.31 109.16 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 60.7 mtp85 -135.01 163.52 29.69 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.833 2.053 . . . . 75.1 108.992 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 32.7 m-20 66.7 15.32 10.1 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.766 1.626 . . . . 53.12 113.545 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.01 152.17 92.82 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 107.571 -1.27 . . . . 74.02 107.571 178.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.23 160.06 46.83 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.588 1.525 . . . . 51.12 110.807 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -78.32 -20.95 50.38 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.893 0.877 . . . . 71.23 112.499 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.76 120.89 24.45 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.075 1.35 . . . . 73.32 107.553 179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 7.0 tt -158.48 163.88 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.872 1.269 . . . . 75.13 108.201 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 17.0 p -117.43 168.23 10.55 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.916 1.286 . . . . 63.23 111.046 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.92 76.76 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-O 118.621 -0.704 . . . . 64.24 109.762 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -53.62 -51.33 63.42 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 124.531 1.133 . . . . 61.32 109.273 179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -62.52 -39.62 94.12 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.335 0.654 . . . . 72.53 111.608 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 94.4 mmm -66.1 -45.04 82.56 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 118.859 -0.591 . . . . 53.52 110.101 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -71.52 -27.41 63.18 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.844 0.747 . . . . 74.21 109.585 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -68.59 -35.33 77.21 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 120.626 -1.296 . . . . 74.25 109.291 178.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.6 mt -93.37 -72.79 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 124.76 1.224 . . . . 65.13 111.822 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -60.11 -34.51 73.6 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.14 0.976 . . . . 64.12 110.701 -178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.43 -6.69 88.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.972 -0.349 . . . . 63.03 112.269 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -64.21 -48.18 76.88 Favored 'General case' 0 C--N 1.342 0.259 0 CA-C-N 119.235 1.517 . . . . 54.15 108.531 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -62.32 -40.07 95.1 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.769 1.628 . . . . 65.05 112.342 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 173.33 -165.58 37.73 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.07 0.843 . . . . 74.21 111.525 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -66.46 165.15 25.94 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.1 2.534 . . . . 74.45 111.434 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.1 mt -126.47 137.26 58.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 107.582 -1.266 . . . . 74.41 107.582 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 -76.89 -56.18 4.82 Favored 'General case' 0 C--N 1.333 -0.124 0 O-C-N 121.409 -0.807 . . . . 71.41 110.273 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -163.28 153.39 15.72 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 108.189 -1.041 . . . . 65.24 108.189 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 49.7 mt -131.59 147.63 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.628 1.171 . . . . 74.11 108.537 179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -142.91 141.83 31.58 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 106.772 -1.566 . . . . 73.51 106.772 178.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -130.14 155.88 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 123.848 0.859 . . . . 71.5 109.735 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.47 145.81 49.66 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 109.796 -1.321 . . . . 51.45 109.796 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -124.33 1.32 8.4 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.758 1.223 . . . . 74.25 112.535 -179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' B' ' 54' ' ' PRO . 60.6 p -124.71 162.35 43.41 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.433 1.493 . . . . 75.41 109.33 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' B' ' 53' ' ' THR . 50.7 Cg_endo -64.02 2.63 1.0 Allowed 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.483 3.455 . . . . 74.12 114.258 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -116.74 -19.4 9.94 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.05 1.34 . . . . 53.13 111.883 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 42.5 p -104.96 -19.69 13.77 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.015 0.926 . . . . 71.31 109.384 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 5.5 ptp180 -64.15 138.19 58.33 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 120.038 -1.664 . . . . 75.04 107.02 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.88 -20.22 44.35 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.32 0.962 . . . . 74.41 111.207 -178.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 37.4 p -120.07 158.95 25.77 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 106.964 -1.495 . . . . 60.24 106.964 178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.8 175.09 11.62 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 120.784 -1.198 . . . . 62.21 109.413 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -135.04 141.44 46.14 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.293 -1.003 . . . . 73.11 108.293 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 95.2 t -127.8 147.56 32.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 105.55 -2.018 . . . . 70.45 105.55 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.3 t -127.06 140.09 50.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 106.838 -1.541 . . . . 74.25 106.838 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -109.77 166.38 10.96 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 125.595 1.558 . . . . 70.34 110.469 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -72.97 -55.11 7.01 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.151 0.98 . . . . 70.35 110.551 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -112.32 177.56 4.6 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 124.361 1.065 . . . . 73.05 108.644 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -94.74 -24.52 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 O-C-N 121.067 -1.021 . . . . 52.2 110.178 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -65.57 -54.83 22.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.317 -0.864 . . . . 62.45 111.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -67.05 -35.69 80.43 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 124.149 0.979 . . . . 53.15 110.218 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.57 -49.33 77.08 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 108.956 -0.757 . . . . 74.51 108.956 178.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -61.45 -45.09 95.75 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.526 0.73 . . . . 62.43 109.676 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -55.93 -52.27 64.73 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 109.608 -0.516 . . . . 72.44 109.608 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.22 -31.81 73.16 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 118.491 -0.766 . . . . 61.13 112.599 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.42 -49.58 77.02 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.57 1.077 . . . . 65.52 109.785 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -71.73 -44.62 63.82 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 118.18 -0.914 . . . . 61.22 111.297 -178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 36.6 m170 -60.33 -30.16 69.34 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 118.784 0.72 . . . . 72.51 112.854 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 23.0 tp -90.85 -29.12 17.72 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 118.262 0.483 . . . . 72.2 112.18 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 90.2 p -64.58 118.65 9.15 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.584 -0.895 . . . . 64.13 108.584 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 90.8 9.84 63.73 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 118.739 -1.034 . . . . 63.52 113.094 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -77.32 110.23 11.88 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 119.713 1.756 . . . . 72.02 106.359 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -64.94 121.92 15.77 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.098 1.359 . . . . 70.32 111.025 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -140.0 137.74 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 108.339 -0.985 . . . . 73.23 108.339 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 35.1 m 38.77 38.84 0.3 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.375 1.87 . . . . 73.44 113.596 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 57.13 42.54 25.54 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.322 1.449 . . . . 73.23 111.137 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -143.35 171.22 14.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 128.164 2.586 . . . . 74.54 107.633 179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -133.19 137.08 46.04 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.975 1.31 . . . . 70.14 109.187 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 24.1 mt -98.08 115.59 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.634 2.374 . . . . 70.51 110.151 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 97.8 t -84.34 129.61 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 106.148 -1.797 . . . . 65.14 106.148 178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 84.3 t -111.26 137.06 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 126.738 2.015 . . . . 74.13 106.376 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.1 tp -154.48 143.81 21.3 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.819 1.247 . . . . 75.45 109.232 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -74.36 155.75 37.81 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 121.527 -0.733 . . . . 74.35 110.941 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -78.23 170.2 17.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 106.905 -1.517 . . . . 64.13 106.905 176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 6.6 p30 . . . . . 0 C--O 1.252 1.205 0 C-N-CA 123.985 0.914 . . . . 73.54 109.364 179.365 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.912 0 N-CA-C 107.188 -2.365 . . . . 63.13 107.188 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.3 m -135.74 109.76 10.15 Favored Pre-proline 0 N--CA 1.451 -0.415 0 N-CA-C 104.558 -2.386 . . . . 71.14 104.558 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -73.1 168.34 24.99 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 121.851 1.701 . . . . 75.14 110.145 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.39 -164.33 1.37 Allowed 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 127.481 2.313 . . . . 65.34 108.828 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -133.8 113.24 12.07 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 103.857 -2.646 . . . . 75.21 103.857 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.6 157.8 25.91 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.744 0.818 . . . . 74.43 109.736 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -146.09 153.89 41.21 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.298 1.039 . . . . 70.31 109.549 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -86.21 148.6 25.58 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.468 0.707 . . . . 74.43 109.703 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 70.2 p-90 -129.02 -14.08 4.46 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.948 0.899 . . . . 74.42 112.681 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -83.17 67.96 9.39 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 107.578 -1.267 . . . . 74.22 107.578 178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -79.88 -61.52 1.97 Allowed 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 108.096 -1.076 . . . . 73.14 108.096 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -65.82 134.44 53.09 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.315 -0.624 . . . . 74.32 109.315 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 40.0 ttp85 -171.24 77.85 0.07 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.032 2.133 . . . . 54.34 107.658 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.65 128.21 35.01 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 104.838 -2.282 . . . . 74.14 104.838 177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 42.8 pt -138.6 165.53 24.52 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 118.982 0.81 . . . . 74.4 110.658 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -134.36 164.6 27.06 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 126.327 1.851 . . . . 74.55 107.512 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -71.2 -73.81 0.17 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.601 -1.259 . . . . 54.22 107.601 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 5.8 ttt-85 -171.08 91.97 0.15 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.961 0.904 . . . . 72.32 108.897 179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -128.11 125.69 39.68 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.924 1.238 . . . . 74.34 110.203 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 4.1 ptt-85 -169.4 159.2 7.35 Favored Pre-proline 0 C--O 1.239 0.532 0 C-N-CA 126.562 1.945 . . . . 74.34 108.506 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -70.48 -177.33 2.06 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.545 2.163 . . . . 64.04 109.233 177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 76.0 mt -144.67 144.43 31.24 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 123.99 0.916 . . . . 74.11 108.573 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' A' ' 403' ' ' GLU . 18.7 t -111.91 169.51 8.79 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.76 1.224 . . . . 62.14 109.006 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.54 -30.05 68.75 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.306 -0.627 . . . . 64.11 109.306 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -79.58 -35.16 40.13 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.135 1.374 . . . . 73.51 110.249 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . 0.403 ' HB2' ' H ' ' A' ' 400' ' ' SER . 29.7 mt-10 -63.7 -24.07 67.63 Favored 'General case' 0 N--CA 1.458 -0.063 0 C-N-CA 123.068 0.547 . . . . 61.03 111.414 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 51.9 tp -58.84 -43.14 90.63 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.237 -1.023 . . . . 73.24 108.237 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.47 -33.47 75.76 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.446 0.698 . . . . 70.44 110.79 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -75.98 -2.99 33.17 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.333 1.053 . . . . 73.42 112.288 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.6 mtp -100.07 7.21 44.83 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.723 1.209 . . . . 64.12 111.906 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -110.82 148.77 39.27 Favored Pre-proline 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 73.5 110.107 179.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.04 166.46 29.56 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.152 3.235 . . . . 65.31 113.581 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -83.16 159.38 22.05 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.49 1.516 . . . . 72.12 110.512 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.35 17.4 39.8 Favored Glycine 0 N--CA 1.468 0.774 0 C-N-CA 126.243 1.878 . . . . 40.3 113.729 -178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -132.75 157.81 43.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 127.354 2.262 . . . . 74.0 106.267 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.8 144.61 49.61 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 123.785 0.834 . . . . 72.11 109.122 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.427 HG22 ' HD2' ' B' ' 49' ' ' ARG . 34.9 t -70.03 143.99 14.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 107.997 -1.112 . . . . 70.02 107.997 -179.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . 0.574 HD11 ' HB2' ' B' ' 32' ' ' ALA . 47.1 tp -135.53 80.79 43.96 Favored Pre-proline 0 CA--C 1.537 0.461 0 N-CA-C 107.101 -1.444 . . . . 73.2 107.101 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.08 171.08 3.28 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 124.376 3.384 . . . . 72.04 112.814 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.17 162.21 3.06 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 124.105 3.203 . . . . 64.14 112.847 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -46.3 133.95 15.66 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 123.575 2.85 . . . . 74.43 112.984 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -64.59 -36.84 85.53 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.32 -0.993 . . . . 72.11 108.32 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -87.01 24.38 9.15 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.382 1.944 . . . . 64.03 112.958 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -69.33 134.56 49.24 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 118.558 1.179 . . . . 72.55 108.932 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.76 95.74 22.2 Favored Pre-proline 0 CA--C 1.539 0.525 0 N-CA-C 106.735 -1.58 . . . . 64.33 106.735 179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.53 81.6 2.47 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 123.654 2.903 . . . . 55.25 111.556 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 66.6 mt . . . . . 0 C--O 1.247 0.962 0 N-CA-C 104.754 -2.313 . . . . 65.35 104.754 178.248 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 110.047 -1.221 . . . . 74.42 110.047 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 77.9 mtp180 -109.77 -51.95 2.82 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.934 1.293 . . . . 64.22 107.736 178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.57 123.29 16.94 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.097 -1.446 . . . . 74.32 107.097 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -149.68 136.35 19.34 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 118.908 0.777 . . . . 74.01 109.713 -179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.17 139.14 52.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 C-N-CA 124.55 1.14 . . . . 75.23 108.244 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.55 26.99 2.09 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.201 2.2 . . . . 73.32 108.835 179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.75 64.78 15.73 Favored Pre-proline 0 C--O 1.239 0.544 0 O-C-N 121.009 -1.057 . . . . 52.13 109.72 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -70.07 167.46 24.79 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.304 2.669 . . . . 74.03 112.363 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.4 -18.99 25.76 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.639 2.226 . . . . 74.43 112.918 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -66.94 -15.23 63.55 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.302 1.041 . . . . 64.45 112.476 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.413 HG11 ' HD3' ' B' ' 71' ' ' LYS . 20.4 t -77.99 122.74 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 119.673 1.124 . . . . 70.4 108.454 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -137.53 155.03 49.71 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.733 1.613 . . . . 74.51 106.95 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -62.72 -26.19 68.56 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.745 -0.597 . . . . 73.15 112.093 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 62.4 mt -81.92 115.12 23.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.597 -1.26 . . . . 63.41 107.597 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 59.6 mt -109.03 159.31 16.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.53 1.132 . . . . 72.3 109.291 179.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -127.88 135.39 49.95 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 127.59 2.356 . . . . 62.1 106.635 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.0 mm -120.95 153.19 24.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 126.27 1.828 . . . . 71.14 110.191 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -142.71 163.96 31.41 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.639 1.976 . . . . 64.03 111.549 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 63.58 24.87 14.17 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 127.954 2.502 . . . . 75.42 114.708 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 71.9 mt -75.44 156.77 85.13 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.305 -0.872 . . . . 72.22 111.685 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -67.56 138.81 46.89 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 N-CA-C 106.521 -2.146 . . . . 74.23 106.521 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -71.13 -10.89 60.51 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.308 1.043 . . . . 73.42 112.269 -179.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -126.47 108.8 11.52 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.195 1.798 . . . . 72.22 107.289 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 16.2 tt -156.98 137.43 4.43 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 N-CA-C 108.758 -0.83 . . . . 74.4 108.758 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 2.5 p -86.45 163.73 17.39 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.573 1.149 . . . . 63.02 110.481 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.574 ' HB2' HD11 ' A' ' 415' ' ' LEU . . . -62.16 -32.55 73.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.853 0.861 . . . . 43.42 110.021 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -66.48 -32.58 74.03 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.622 1.169 . . . . 62.31 110.915 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -74.53 -45.76 43.6 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.552 -1.277 . . . . 73.22 107.552 178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.4 mmm -55.44 -53.38 56.97 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.521 0.728 . . . . 64.52 110.168 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -71.66 -10.36 59.66 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.372 0.879 . . . . 74.51 113.372 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -89.43 -60.27 1.99 Allowed 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 108.018 -1.104 . . . . 72.22 108.018 178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.8 mt -48.99 -54.81 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 126.324 1.85 . . . . 61.21 109.874 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -78.56 -16.47 57.4 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.601 0.593 . . . . 71.52 112.601 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.01 -27.2 74.12 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.266 0.936 . . . . 73.33 112.735 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.49 -14.17 11.69 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.707 1.253 . . . . 70.04 113.157 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -107.72 -5.13 17.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.705 1.202 . . . . 64.41 113.831 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.93 -174.1 21.27 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-N 119.864 1.211 . . . . 74.15 112.874 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.2 138.99 40.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.986 3.124 . . . . 42.4 111.525 -179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 39.0 mt -101.4 122.3 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 125.756 1.622 . . . . 75.41 109.725 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -69.61 -47.99 61.58 Favored 'General case' 0 C--O 1.233 0.224 0 O-C-N 121.529 -0.732 . . . . 71.14 112.404 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -165.48 159.87 17.28 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 119.457 1.026 . . . . 64.42 110.635 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 mt -144.32 135.83 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 126.78 2.032 . . . . 64.33 109.654 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.427 ' HD2' HG22 ' A' ' 414' ' ' VAL . 0.5 OUTLIER -136.16 126.24 26.17 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 102.847 -3.019 . . . . 75.5 102.847 178.125 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 4.2 m -112.64 142.28 25.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 C-N-CA 123.115 0.566 . . . . 74.34 110.581 -178.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -58.71 141.1 46.89 Favored Glycine 0 C--O 1.241 0.591 0 C-N-CA 124.339 0.971 . . . . 72.11 111.282 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -118.39 -30.46 5.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 117.765 0.783 . . . . 43.22 111.806 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 22.0 p -74.14 158.08 86.02 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 107.695 -1.224 . . . . 73.51 107.695 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -64.31 -27.44 63.6 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 121.814 1.676 . . . . 64.51 110.099 178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -17.61 63.22 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 124.824 1.25 . . . . 64.1 111.667 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 69.3 p -107.47 0.38 22.77 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.518 1.127 . . . . 72.44 111.928 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 15.5 mmt180 -56.14 127.95 33.14 Favored 'General case' 0 N--CA 1.464 0.25 0 O-C-N 120.148 -1.595 . . . . 71.45 108.793 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.43 -0.17 89.31 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-O 117.847 -1.53 . . . . 71.03 114.348 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 28.8 p -121.18 152.44 38.79 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 120.343 2.071 . . . . 50.33 109.336 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.28 174.99 12.08 Favored 'General case' 0 C--N 1.333 -0.136 0 C-N-CA 124.401 1.08 . . . . 62.22 109.274 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -132.25 134.63 45.54 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.004 -1.48 . . . . 71.31 107.004 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 63.1 t -130.2 142.62 43.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 N-CA-C 107.634 -1.247 . . . . 74.33 107.634 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 31.3 t -122.53 147.25 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 107.42 -1.326 . . . . 71.34 107.42 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -120.91 166.38 13.88 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 125.763 1.625 . . . . 71.22 107.828 178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.76 -68.6 0.36 Allowed 'General case' 0 C--O 1.241 0.63 0 N-CA-C 113.039 0.755 . . . . 73.31 113.039 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -106.25 148.19 28.24 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-O 122.247 1.023 . . . . 65.21 110.862 -178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -58.67 -31.85 45.08 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.387 0 CA-C-N 115.275 -0.875 . . . . 74.24 109.301 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -64.48 -30.7 71.73 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.924 1.29 . . . . 60.35 112.37 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -70.14 -60.46 2.27 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 107.235 -1.394 . . . . 61.43 107.235 -179.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.06 -25.34 67.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.767 1.227 . . . . 62.3 113.898 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.413 ' HD3' HG11 ' B' ' 17' ' ' VAL . 0.3 OUTLIER -56.25 -60.25 3.78 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 119.256 0.934 . . . . 73.33 110.039 -179.37 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -73.41 -39.61 64.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 119.999 -0.68 . . . . 62.11 110.314 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.76 -33.73 64.58 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 118.441 -0.79 . . . . 71.43 112.692 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.8 t -61.26 -52.99 62.44 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.27 -1.011 . . . . 61.22 108.27 179.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 57.4 m-20 -63.83 -38.99 93.14 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.0 0.52 . . . . 73.12 110.81 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.56 -18.5 60.57 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 117.492 -1.242 . . . . 73.54 112.22 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 27.9 tp -97.82 -32.86 11.49 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 120.368 1.44 . . . . 63.04 111.716 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 30.4 m -63.26 152.27 38.16 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 106.916 -1.513 . . . . 41.14 106.916 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 65.49 9.57 44.5 Favored Glycine 0 CA--C 1.538 1.517 0 CA-C-O 119.166 -0.797 . . . . 65.41 113.624 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -74.06 125.23 27.83 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.132 -1.803 . . . . 65.15 106.132 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -80.86 116.67 20.96 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 125.738 1.615 . . . . 72.24 110.49 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 6.7 m -141.45 141.9 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 123.473 0.709 . . . . 71.31 109.829 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 62.9 m 24.47 58.58 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 128.115 2.566 . . . . 63.14 115.666 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 12.7 m120 56.18 27.51 11.73 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.369 1.468 . . . . 73.14 113.963 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 88.1 mtt-85 -131.87 167.91 18.76 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 128.203 2.601 . . . . 72.31 109.353 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -138.74 104.26 5.05 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 106.749 -1.575 . . . . 74.53 106.749 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 9.5 mt -69.31 161.06 30.07 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.066 1.347 . . . . 61.25 110.023 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.9 t -133.17 122.65 45.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 124.354 1.061 . . . . 64.14 108.618 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 16.1 t -98.35 136.22 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 124.434 1.093 . . . . 73.33 109.268 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 55.7 tp -148.86 153.72 38.46 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.435 1.094 . . . . 73.21 109.343 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.93 147.1 23.92 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 124.27 1.028 . . . . 74.52 110.407 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -76.59 121.47 23.24 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 105.819 -1.919 . . . . 70.1 105.819 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.2 -0.905 . . . . 72.24 109.112 179.639 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.999 0 N-CA-C 108.324 -1.91 . . . . 53.34 108.324 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 5.9 m -88.95 114.38 59.86 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 117.574 -1.203 . . . . 75.22 108.096 -179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -80.32 -178.44 4.48 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.529 2.152 . . . . 72.41 109.308 178.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -140.92 135.34 31.16 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 103.133 -2.914 . . . . 73.02 103.133 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -147.62 61.08 1.15 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.443 1.497 . . . . 74.43 109.424 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 65.8 tp -43.58 116.5 0.96 Allowed 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 126.826 2.05 . . . . 75.23 111.994 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -151.32 162.98 39.94 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 125.332 1.453 . . . . 74.22 108.362 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -156.34 171.34 20.4 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.997 0.919 . . . . 75.22 109.641 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 6.2 m95 -127.79 163.39 24.47 Favored 'General case' 0 C--O 1.231 0.121 0 C-N-CA 125.524 1.53 . . . . 71.44 107.972 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.42 114.87 26.96 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 117.535 -1.221 . . . . 75.34 110.097 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -75.74 116.28 16.28 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 100.721 -3.807 . . . . 74.1 100.721 175.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.47 -154.97 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.362 1.465 . . . . 70.32 112.183 -177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -137.9 148.05 44.97 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 125.758 1.623 . . . . 72.11 107.288 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -74.15 144.09 45.01 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.89 -1.152 . . . . 73.3 107.89 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 11.3 mt -131.67 134.64 60.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 106.612 -1.625 . . . . 53.51 106.612 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.52 172.44 12.97 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.026 1.73 . . . . 63.34 111.717 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.94 163.95 29.08 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 107.2 -1.407 . . . . 73.33 107.2 177.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -123.22 85.66 2.46 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.514 -1.662 . . . . 64.04 106.514 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -131.76 131.52 43.05 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 123.658 0.783 . . . . 62.14 109.831 -179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -99.61 162.19 22.0 Favored Pre-proline 0 C--O 1.238 0.473 0 C-N-CA 123.873 0.869 . . . . 75.03 109.91 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.75 155.73 67.7 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 N-CA-C 106.342 -2.215 . . . . 53.53 106.342 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 15.8 mt -109.92 -70.95 0.78 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 105.654 -1.98 . . . . 65.33 105.654 -179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 29.4 t -105.97 -168.7 1.47 Allowed 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 103.91 -2.626 . . . . 51.25 103.91 177.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -79.95 -11.71 59.77 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.53 -1.356 . . . . 71.43 109.539 178.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -66.71 -59.34 3.66 Favored 'General case' 0 C--O 1.23 0.066 0 C-N-CA 126.925 2.09 . . . . 75.1 109.817 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -64.7 -39.04 92.98 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 107.763 -1.199 . . . . 44.02 107.763 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.06 -45.81 91.61 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 119.185 -0.436 . . . . 62.0 110.184 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.15 -45.58 92.58 Favored 'General case' 0 C--O 1.227 -0.093 0 C-N-CA 123.343 0.657 . . . . 74.25 109.75 179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.21 -35.23 79.63 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.424 0.69 . . . . 71.34 111.904 179.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 85.2 mtp -71.73 -7.48 48.32 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.169 0.988 . . . . 71.12 111.1 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -107.46 143.26 26.85 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.219 0.918 . . . . 74.13 109.069 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.479 ' HG2' ' CE1' ' A' ' 412' ' ' TYR . 36.3 Cg_endo -71.93 164.35 35.94 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 123.323 2.682 . . . . 74.03 114.035 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -70.02 161.14 30.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.836 2.054 . . . . 70.22 110.278 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 75.62 17.69 80.03 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 121.132 -0.98 . . . . 74.04 115.273 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . 0.479 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 67.1 m-85 -125.1 156.96 37.46 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 105.639 -1.985 . . . . 70.13 105.639 178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -137.44 154.42 49.94 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.128 -0.693 . . . . 74.25 109.128 -178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 2.6 t -70.03 142.15 16.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 C-N-CA 124.405 1.082 . . . . 73.45 110.625 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.3 tp -127.45 83.42 66.08 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 106.171 -1.789 . . . . 71.23 106.171 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -67.96 171.97 11.55 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.34 2.026 . . . . 51.32 110.643 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.03 163.66 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.424 2.083 . . . . 33.04 110.834 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -73.75 176.02 9.96 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.399 2.066 . . . . 61.44 108.9 177.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -93.47 174.66 7.08 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 107.271 -1.381 . . . . 73.3 107.271 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 59.77 29.9 68.24 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-O 119.3 -0.722 . . . . 62.25 112.449 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -101.93 158.27 16.26 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 107.048 -1.464 . . . . 70.21 107.048 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 40.1 t -116.45 80.57 10.23 Favored Pre-proline 0 C--O 1.233 0.218 0 O-C-N 121.712 -0.618 . . . . 73.12 110.002 -178.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.09 173.78 8.91 Favored 'Trans proline' 0 N--CA 1.453 -0.909 0 N-CA-C 107.7 -1.692 . . . . 41.43 107.7 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 26.9 mt . . . . . 0 C--O 1.253 1.239 0 N-CA-C 102.894 -3.002 . . . . 74.32 102.894 179.39 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.512 0 N-CA-C 110.28 -1.128 . . . . 75.44 110.28 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.1 ptp180 -137.97 172.32 13.1 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 126.098 1.759 . . . . 72.14 109.241 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.97 -175.04 3.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 124.729 1.212 . . . . 54.15 109.162 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -132.62 151.53 51.92 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 125.964 1.706 . . . . 70.23 107.391 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 3.3 mp -137.87 158.22 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.535 1.934 . . . . 75.31 106.706 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -92.87 -65.59 0.99 Allowed 'General case' 0 N--CA 1.461 0.087 0 O-C-N 121.16 -0.963 . . . . 72.12 108.587 179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.09 152.75 79.66 Favored Pre-proline 0 N--CA 1.451 -0.378 0 C-N-CA 124.446 1.098 . . . . 73.23 109.705 -178.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -67.37 161.46 43.09 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.122 3.215 . . . . 72.53 110.569 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.82 -48.3 1.01 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.75 2.3 . . . . 54.13 112.301 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -141.81 147.32 37.07 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 126.28 1.832 . . . . 63.31 108.436 -179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 74.1 t -148.31 151.18 13.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 C-N-CA 124.541 1.137 . . . . 72.43 109.368 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -126.17 143.33 51.17 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 127.002 2.121 . . . . 43.53 108.693 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -60.34 -28.5 68.21 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.564 1.546 . . . . 64.31 111.149 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.4 mt -88.86 147.73 5.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 127.161 2.184 . . . . 75.32 108.513 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 89.3 mt -124.51 155.34 39.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.445 1.498 . . . . 73.34 109.612 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -130.63 105.06 7.57 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 127.324 2.249 . . . . 73.44 107.215 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mm -83.88 149.3 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 126.527 1.931 . . . . 73.42 110.645 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 -140.49 162.65 34.83 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.63 1.172 . . . . 53.23 109.379 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 68.32 24.97 7.19 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.248 2.219 . . . . 62.42 113.173 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 77.3 mt -67.38 153.47 94.76 Favored Pre-proline 0 C--O 1.24 0.556 0 O-C-N 121.221 -0.924 . . . . 74.01 110.033 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.68 158.21 50.95 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 123.456 2.771 . . . . 72.32 109.965 179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 21.7 m-30 -73.1 -14.07 61.32 Favored 'General case' 0 CA--C 1.534 0.355 0 O-C-N 121.522 -0.736 . . . . 64.41 112.128 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -130.2 129.18 43.07 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 107.562 -1.273 . . . . 75.43 107.562 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -166.79 160.76 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 C-N-CA 127.383 2.273 . . . . 74.33 106.048 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 72.6 p -122.13 177.21 5.43 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.651 1.18 . . . . 60.24 110.129 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.16 -42.69 88.63 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.179 -0.674 . . . . 45.21 109.179 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -58.3 -46.39 86.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.409 1.483 . . . . 72.23 110.482 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.23 -41.33 99.09 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.896 0.771 . . . . 72.45 110.646 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 88.4 mmm -63.77 -55.95 19.25 Favored 'General case' 0 C--N 1.338 0.071 0 N-CA-C 109.711 -0.478 . . . . 75.14 109.711 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -63.52 -25.06 68.08 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 118.288 -0.863 . . . . 72.22 111.038 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -69.36 -57.82 4.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 119.406 1.003 . . . . 75.13 109.857 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.4 mt -60.27 -58.33 7.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 125.55 1.54 . . . . 74.31 110.434 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -65.16 -22.64 66.94 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 112.793 0.664 . . . . 73.44 112.793 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.68 79.87 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 118.481 0.582 . . . . 64.11 113.927 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 71.6 mttt -69.24 -9.09 51.42 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 118.06 0.93 . . . . 52.14 111.306 179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -104.72 -7.31 19.63 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.374 1.07 . . . . 73.32 111.14 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.12 -174.29 21.23 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 126.137 1.827 . . . . 70.01 111.396 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -62.99 169.25 9.29 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 123.091 2.528 . . . . 64.24 109.764 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 80.6 mt -130.58 145.06 36.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 O-C-N 120.887 -1.133 . . . . 53.32 109.286 -178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -78.71 -63.44 1.41 Allowed 'General case' 0 C--O 1.225 -0.201 0 N-CA-C 107.392 -1.336 . . . . 70.34 107.392 178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -160.14 165.93 30.73 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.129 0.972 . . . . 74.21 109.257 -178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 21.6 mt -138.38 146.44 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.479 1.512 . . . . 74.24 107.484 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 71.5 mtt180 -137.22 126.98 25.48 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 104.319 -2.474 . . . . 44.42 104.319 178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 26.2 m -121.04 164.53 17.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 C-N-CA 123.377 0.671 . . . . 75.21 109.471 -179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -59.45 146.19 44.08 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.174 -1.171 . . . . 71.15 110.174 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -124.46 -58.99 1.49 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.951 -1.129 . . . . 54.12 107.951 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -66.37 161.05 61.6 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 123.305 0.642 . . . . 74.13 109.285 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -66.58 -9.34 23.94 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.786 2.324 . . . . 75.01 115.121 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -105.21 -11.51 16.51 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.347 0.976 . . . . 64.53 112.584 -179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 22.4 p -99.39 -11.42 21.18 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.596 0.635 . . . . 73.51 111.318 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -69.06 152.84 44.71 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 108.457 -0.942 . . . . 74.44 108.457 178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.22 -20.23 50.84 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.684 1.135 . . . . 73.4 112.241 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 50.4 p -133.32 165.45 24.8 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.852 -1.536 . . . . 63.45 106.852 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.07 175.57 10.13 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 120.741 -1.225 . . . . 73.51 111.545 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.17 146.44 50.4 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 118.855 0.752 . . . . 73.11 111.575 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -131.94 145.94 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 125.2 1.4 . . . . 62.54 107.803 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.1 t -127.39 136.57 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.436 -1.691 . . . . 73.51 106.436 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.98 166.32 13.01 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 106.634 -1.617 . . . . 71.22 106.634 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -78.34 -68.29 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.478 0.711 . . . . 64.43 110.059 179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -82.84 144.16 30.29 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 121.771 0.796 . . . . 74.12 112.969 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.2 tt -64.42 -33.83 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 123.918 0.887 . . . . 74.3 109.933 179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -67.17 -45.97 75.37 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 124.064 0.946 . . . . 75.24 110.621 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -57.74 -46.6 84.25 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.754 0.822 . . . . 71.21 109.71 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.36 83.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.392 -0.337 . . . . 64.34 111.054 179.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 17.3 mtpt -67.37 -53.63 27.67 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.206 0.602 . . . . 62.14 110.929 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -59.77 -42.64 93.75 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 118.905 -0.569 . . . . 60.52 109.789 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.65 -45.86 92.23 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.373 -0.602 . . . . 71.23 109.373 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 29.5 t -51.98 -53.34 42.67 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.771 0.828 . . . . 74.15 110.683 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -73.77 -14.53 61.13 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 113.849 1.055 . . . . 64.23 113.849 -178.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 9.9 m170 -95.19 -21.36 18.53 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.626 1.103 . . . . 74.35 110.002 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 35.8 tp -99.78 -7.46 25.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.308 1.843 . . . . 65.05 111.468 -179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 32.4 p -57.96 117.01 3.86 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.978 1.311 . . . . 62.2 111.442 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.64 10.6 71.65 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 118.231 -1.316 . . . . 73.45 114.654 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -51.55 121.94 7.22 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.72 1.208 . . . . 75.43 112.875 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -83.57 118.1 23.58 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 126.8 2.04 . . . . 72.12 110.655 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.9 155.13 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.216 2.606 . . . . 72.42 105.642 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 30.2 m 49.67 21.74 0.69 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.388 1.475 . . . . 62.12 112.992 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 38.7 t30 59.24 55.55 4.26 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.166 2.186 . . . . 74.13 108.572 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 85.9 mtt-85 -142.81 -167.75 2.6 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 128.152 2.581 . . . . 72.14 107.572 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -145.11 111.99 5.91 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 104.496 -2.409 . . . . 73.52 104.496 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 54.0 mt -77.32 172.77 12.78 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.919 -1.113 . . . . 54.42 108.96 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.81 146.94 31.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.427 -1.323 . . . . 74.22 107.427 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 5.0 t -129.92 115.61 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 125.217 1.407 . . . . 74.24 107.383 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.0 tp -129.29 120.59 25.93 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.063 1.345 . . . . 74.21 107.715 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -55.68 145.27 24.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 118.645 0.657 . . . . 74.14 111.408 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -78.95 175.53 10.46 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.407 -0.59 . . . . 72.44 109.407 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 . . . . . 0 C--O 1.245 0.848 0 C-N-CA 125.643 1.577 . . . . 52.14 107.073 178.661 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.548 0 N-CA-C 109.596 -1.402 . . . . 62.05 109.596 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 29.7 m 62.71 81.53 0.23 Allowed Pre-proline 0 CA--C 1.537 0.474 0 C-N-CA 125.146 1.378 . . . . 75.4 111.788 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -69.81 113.34 3.35 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.962 2.441 . . . . 75.02 106.785 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -61.17 125.65 24.5 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 119.682 1.128 . . . . 62.11 110.771 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -114.33 121.15 42.77 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 106.98 -1.489 . . . . 75.34 106.98 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 6.2 mp -123.26 76.88 1.43 Allowed 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.789 1.235 . . . . 72.34 108.904 -178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 42.5 tp60 -72.87 -55.81 6.1 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.485 0.714 . . . . 72.43 109.765 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -162.17 170.9 18.29 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.944 1.297 . . . . 53.53 109.483 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -143.38 166.61 24.28 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 126.074 1.75 . . . . 70.14 109.152 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 11.5 tpp180 -140.27 158.33 44.2 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 123.535 0.734 . . . . 61.04 110.417 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 31.4 p90 -155.98 153.49 29.62 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.51 1.124 . . . . 72.13 110.471 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -169.57 171.59 7.48 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.694 2.397 . . . . 73.01 107.644 177.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -142.53 166.59 24.25 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.209 1.404 . . . . 75.22 109.622 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -124.6 -160.74 0.96 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.677 1.591 . . . . 75.12 108.713 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 60.6 mt -107.13 151.11 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 127.079 2.152 . . . . 40.14 106.17 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -112.88 87.8 2.67 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 123.22 0.608 . . . . 72.43 110.44 -179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -154.15 161.56 41.78 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 123.929 0.891 . . . . 61.35 109.006 178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -117.42 99.56 7.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 106.829 -1.545 . . . . 63.02 106.829 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 12.1 p-10 -157.85 131.48 7.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 118.163 0.438 . . . . 43.32 110.168 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 59.47 167.13 0.08 OUTLIER Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.139 1.775 . . . . 72.02 113.031 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -76.83 121.96 6.12 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 N-CA-C 106.269 -2.243 . . . . 61.5 106.269 178.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 18.5 mt -119.48 -179.18 3.79 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 107.564 -1.272 . . . . 75.25 107.564 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 16.5 m -127.85 -92.46 0.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.423 -0.584 . . . . 72.42 109.423 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -65.53 -24.56 67.14 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 126.104 1.761 . . . . 74.41 112.046 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -79.1 -39.88 32.55 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.807 -0.812 . . . . 74.33 108.807 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -64.37 -27.36 68.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.641 0.776 . . . . 62.34 109.783 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 56.7 tp -63.21 -37.89 89.02 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.048 0.939 . . . . 74.51 110.744 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -67.17 -46.86 72.74 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.022 0.828 . . . . 64.13 109.189 179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -63.52 -6.89 5.71 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 114.106 1.15 . . . . 72.21 114.106 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 95.8 mtp -100.51 -0.03 38.64 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.889 1.276 . . . . 72.22 110.123 178.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.25 155.94 43.79 Favored Pre-proline 0 CA--C 1.536 0.404 0 C-N-CA 125.327 1.451 . . . . 65.13 111.542 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.29 163.27 36.79 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.235 2.623 . . . . 41.53 111.243 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -68.13 164.87 19.37 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.735 0.814 . . . . 74.44 110.291 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 76.58 21.66 74.39 Favored Glycine 0 CA--C 1.525 0.708 0 CA-C-O 118.506 -1.163 . . . . 64.43 114.587 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -124.21 158.35 32.64 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 119.641 1.721 . . . . 74.53 108.155 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -135.46 153.28 51.81 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.659 1.184 . . . . 73.14 109.074 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 6.5 t -70.38 146.7 11.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 123.521 0.728 . . . . 63.43 109.416 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 37.8 tp -132.92 82.55 54.89 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 107.21 -1.404 . . . . 63.14 107.21 178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.72 165.9 29.36 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.06 2.507 . . . . 73.23 111.656 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -69.45 160.23 50.57 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.045 1.83 . . . . 71.23 111.229 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -76.44 177.46 8.78 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 125.226 3.951 . . . . 73.42 114.488 -179.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -87.31 164.41 16.29 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.915 -1.142 . . . . 72.45 107.915 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 39.29 64.57 0.95 Allowed Glycine 0 CA--C 1.528 0.897 0 C-N-CA 126.236 1.874 . . . . 73.21 113.89 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -133.25 164.8 26.28 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.852 1.261 . . . . 62.35 108.822 179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 70.8 t -134.04 102.63 12.06 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 106.597 -1.631 . . . . 71.11 106.597 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.17 -18.16 18.58 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.24 2.627 . . . . 63.21 114.009 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.3 tp . . . . . 0 C--O 1.25 1.094 0 N-CA-C 106.352 -1.721 . . . . 75.13 106.352 179.46 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.559 0 N-CA-C 108.71 -1.756 . . . . 53.03 108.71 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 29.1 ptt-85 -144.39 176.93 9.0 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 119.659 1.73 . . . . 73.34 111.171 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.07 154.82 42.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.443 1.097 . . . . 61.44 109.839 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -83.07 128.76 34.77 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 126.143 1.777 . . . . 52.13 108.604 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 36.1 pt -105.93 172.32 1.74 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 108.796 -0.816 . . . . 74.31 108.796 178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 22.2 ttt85 -155.18 159.55 40.21 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 108.687 -0.857 . . . . 64.01 108.687 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.3 mm? 24.17 72.72 0.32 Allowed Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 128.794 2.838 . . . . 74.04 114.528 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.05 162.82 40.8 Favored 'Trans proline' 0 CA--C 1.545 1.073 0 C-N-CA 121.943 1.762 . . . . 53.3 108.718 178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.53 -34.57 7.21 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 121.816 1.678 . . . . 64.32 112.431 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -141.37 162.7 34.85 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.662 1.185 . . . . 73.42 109.727 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 t -155.96 158.09 3.6 Favored 'Isoleucine or valine' 0 C--O 1.244 0.78 0 C-N-CA 127.096 2.158 . . . . 74.44 105.859 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' B' ' 92' ' ' TYR . 0.0 OUTLIER -145.07 161.21 40.01 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.375 1.47 . . . . 74.13 108.16 177.688 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 43.7 mtm180 -80.79 -7.55 59.43 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.331 2.252 . . . . 74.41 116.032 -178.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.3 mt -103.29 121.59 54.77 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 120.488 1.494 . . . . 64.45 107.549 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 71.2 mt -110.19 142.39 41.8 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.282 1.033 . . . . 72.42 108.781 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -111.46 125.01 53.44 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 104.77 -2.307 . . . . 73.45 104.77 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 mm -111.41 153.86 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 125.256 1.422 . . . . 73.25 108.408 -178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.437 ' HG2' HG22 ' B' ' 59' ' ' THR . 65.1 mtt180 -145.92 163.44 35.1 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 126.363 1.865 . . . . 74.15 108.744 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 70.17 21.28 6.01 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.088 1.755 . . . . 64.11 112.752 179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 58.0 mt -78.17 156.05 79.35 Favored Pre-proline 0 C--O 1.235 0.328 0 O-C-N 121.022 -1.049 . . . . 63.11 110.883 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -71.03 164.25 36.41 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 121.971 1.781 . . . . 72.14 111.354 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -93.66 -16.85 23.88 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 74.32 111.646 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -120.57 99.03 6.31 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 126.305 1.842 . . . . 74.24 106.066 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.5 tt -163.32 174.11 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 126.988 2.115 . . . . 74.1 106.777 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 48.0 p -136.47 -170.05 2.59 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.03 1.332 . . . . 61.11 110.438 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.75 -40.75 65.79 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.678 -0.49 . . . . 64.22 109.678 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -49.04 -58.36 5.04 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 127.095 2.158 . . . . 63.0 110.926 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.42 -42.74 99.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 117.859 0.299 . . . . 62.34 110.913 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 92.7 mmm -67.57 -23.05 65.37 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 117.86 -1.067 . . . . 53.32 113.047 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -90.88 -38.17 13.09 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 119.744 1.156 . . . . 74.44 108.562 178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -68.44 -52.09 36.51 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 124.96 1.304 . . . . 73.33 111.601 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 56.4 mt -59.68 -61.47 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.626 0.771 . . . . 72.12 109.41 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -64.17 -19.97 65.68 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 111.778 0.288 . . . . 74.21 111.778 -179.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.34 -16.62 75.54 Favored Glycine 0 C--N 1.338 0.663 0 C-N-CA 125.025 1.298 . . . . 54.11 112.143 179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -57.25 -32.98 67.11 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.329 1.064 . . . . 64.21 109.759 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -74.71 -60.44 2.28 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.194 0.998 . . . . 74.33 109.345 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -176.07 -169.27 37.41 Favored Glycine 0 CA--C 1.531 1.084 0 N-CA-C 109.926 -1.27 . . . . 73.54 109.926 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -62.35 162.72 22.73 Favored 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 122.544 2.163 . . . . 73.34 109.978 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 47.3 mt -126.51 138.52 54.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.537 -0.912 . . . . 72.14 108.537 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -68.53 -64.21 0.91 Allowed 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.893 -0.78 . . . . 73.03 108.893 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 4.2 tp60 -159.01 164.21 35.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.234 1.014 . . . . 74.12 108.94 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 95.3 mt -137.66 150.94 25.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 126.471 1.908 . . . . 65.21 107.796 179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -146.17 148.28 32.38 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 126.657 1.983 . . . . 74.04 106.318 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 19.6 m -132.11 166.88 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.374 1.07 . . . . 74.2 110.707 -178.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -71.37 146.22 40.4 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.168 -1.173 . . . . 71.45 110.168 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -122.92 -16.68 7.0 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.741 1.216 . . . . 71.31 112.157 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 18.8 p -95.0 159.02 33.97 Favored Pre-proline 0 CA--C 1.535 0.397 0 N-CA-C 106.443 -1.688 . . . . 33.24 106.443 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.32 -34.35 93.67 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 121.758 1.639 . . . . 64.21 111.696 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -72.42 -21.14 61.3 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 114.314 1.227 . . . . 73.31 114.314 -179.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 34.6 p -92.62 -0.13 57.35 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.895 0.878 . . . . 74.32 111.25 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -60.77 140.74 57.48 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 107.357 -1.349 . . . . 64.15 107.357 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.83 -10.82 61.39 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-O 117.503 -1.72 . . . . 64.32 114.129 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . 0.437 HG22 ' HG2' ' B' ' 24' ' ' ARG . 73.3 p -113.32 149.41 34.0 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 120.275 2.037 . . . . 64.43 109.329 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.8 175.67 12.84 Favored 'General case' 0 C--O 1.232 0.164 0 O-C-N 120.902 -1.124 . . . . 75.35 109.569 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -136.27 150.04 48.75 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 122.86 0.464 . . . . 74.13 110.1 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -133.23 146.99 31.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 C-N-CA 125.722 1.609 . . . . 62.11 106.96 179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 23.9 t -127.43 140.66 48.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 105.544 -2.021 . . . . 71.03 105.544 178.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.95 163.63 24.08 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 124.873 1.269 . . . . 73.03 109.052 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 -97.68 -53.5 3.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.952 1.301 . . . . 73.35 109.722 178.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -75.74 115.09 15.07 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.893 -1.151 . . . . 70.24 107.893 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 16.7 tt -71.52 -21.45 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 N-CA-C 107.938 -1.134 . . . . 72.14 107.938 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -69.34 -50.31 47.59 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 125.826 1.65 . . . . 74.43 109.421 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -65.54 -42.37 91.99 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.479 -0.934 . . . . 70.43 108.479 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.66 -45.88 92.44 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.319 0.648 . . . . 74.34 110.671 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -57.5 -47.09 82.85 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 118.915 0.78 . . . . 74.52 111.267 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -66.19 -55.09 18.02 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.915 -0.772 . . . . 75.31 108.915 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -53.5 -38.63 63.88 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.688 1.595 . . . . 74.13 113.933 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 52.3 t -57.08 -41.33 78.63 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.463 1.105 . . . . 30.55 110.234 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -87.51 -35.93 17.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 110.178 -0.305 . . . . 73.21 110.178 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -59.24 -31.71 69.31 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.108 1.363 . . . . 74.25 111.213 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.4 tp -100.57 -9.63 21.8 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.313 1.445 . . . . 74.24 112.785 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 31.3 t -73.92 108.47 6.76 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 107.889 -1.152 . . . . 63.03 107.889 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.12 12.41 60.16 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 118.589 -1.117 . . . . 22.43 112.815 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -68.01 121.66 16.57 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 118.618 1.209 . . . . 55.02 108.111 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -76.12 115.46 15.86 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.259 1.024 . . . . 61.34 110.391 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 14.0 m -140.38 137.78 36.73 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 C-N-CA 124.766 1.226 . . . . 63.31 109.414 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 61.6 m 42.39 46.86 4.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.407 1.883 . . . . 71.51 113.426 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 66.56 10.06 7.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.139 2.176 . . . . 31.2 113.361 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -117.36 -179.37 3.7 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.621 2.368 . . . . 72.35 108.248 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -140.43 117.79 11.4 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.228 -1.027 . . . . 75.22 108.228 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.34 162.21 29.11 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.482 0.658 . . . . 53.23 110.52 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 94.4 t -128.97 159.41 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 126.475 1.91 . . . . 74.04 107.015 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.9 t -143.41 128.0 14.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 107.241 -1.392 . . . . 65.32 107.241 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.83 144.56 37.36 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 124.378 1.071 . . . . 75.21 109.782 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 9.0 m-30 -68.87 163.43 24.34 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.588 0.755 . . . . 75.12 109.588 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . 0.524 ' H ' ' ND2' ' B' ' 18' ' ' ASN . 23.3 t80 -87.81 147.15 25.28 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 107.312 -1.366 . . . . 74.44 107.312 178.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 m120 . . . . . 0 C--O 1.254 1.321 0 N-CA-C 106.272 -1.751 . . . . 75.21 106.272 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.912 0 N-CA-C 106.036 -2.826 . . . . 50.11 106.036 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.69 163.99 43.59 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 107.682 -1.229 . . . . 73.24 107.682 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.56 -21.69 25.46 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 121.665 1.577 . . . . 70.35 110.485 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -123.75 172.59 8.73 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.859 2.064 . . . . 71.3 108.647 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -103.71 -4.79 23.26 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.622 1.169 . . . . 71.32 110.206 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 10.1 tt -62.33 132.09 51.46 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.504 1.522 . . . . 72.33 108.246 179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -156.18 161.88 40.26 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.986 0.914 . . . . 54.32 109.167 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -123.55 -4.24 8.26 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.386 1.074 . . . . 52.21 112.43 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -93.66 -177.27 4.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.308 1.043 . . . . 72.11 108.591 179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -149.78 -166.93 2.68 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 124.973 1.309 . . . . 71.45 107.725 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 30.1 t-105 -135.77 174.45 10.59 Favored 'General case' 0 C--O 1.245 0.836 0 N-CA-C 106.854 -1.536 . . . . 75.52 106.854 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -176.72 0.08 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 129.041 2.937 . . . . 45.33 112.791 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -140.24 172.17 13.12 Favored 'General case' 0 C--O 1.234 0.237 0 O-C-N 120.978 -1.077 . . . . 73.21 113.581 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -73.64 178.82 4.48 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 113.621 -1.627 . . . . 63.24 107.856 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 61.0 mt -105.3 142.74 17.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 122.477 1.132 . . . . 60.11 110.658 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -74.24 127.81 33.93 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 128.381 2.672 . . . . 75.42 110.442 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -117.17 151.23 37.31 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 122.087 0.946 . . . . 73.01 109.703 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 9.8 tpp180 -64.55 108.47 1.68 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.523 1.529 . . . . 75.54 109.834 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -80.42 65.13 5.46 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 106.333 -1.729 . . . . 71.24 106.333 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -140.23 151.99 65.96 Favored Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 125.471 1.508 . . . . 75.44 110.464 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.68 119.05 6.04 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.191 1.928 . . . . 74.42 109.307 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 95.2 mt -71.48 -73.66 0.17 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.217 -1.401 . . . . 61.32 107.217 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 6.2 t -157.09 -177.85 6.93 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.465 1.506 . . . . 70.03 107.513 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.14 -29.93 68.96 Favored 'General case' 0 C--O 1.224 -0.28 0 C-N-CA 123.588 0.755 . . . . 74.15 111.789 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -62.55 -23.7 67.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.519 1.128 . . . . 73.2 112.469 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -92.19 -46.67 7.62 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 106.898 -1.519 . . . . 71.44 106.898 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 40.0 tp -57.45 -39.73 76.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.741 0.816 . . . . 75.35 110.292 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -58.82 -30.13 67.41 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.777 1.631 . . . . 64.22 111.872 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -88.48 -15.8 34.39 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.584 1.154 . . . . 64.24 111.693 179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 94.4 mtp -85.5 -20.18 30.08 Favored 'General case' 0 C--O 1.233 0.235 0 O-C-N 121.146 -0.972 . . . . 73.01 110.098 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -92.1 158.55 39.2 Favored Pre-proline 0 N--CA 1.451 -0.399 0 C-N-CA 124.167 0.987 . . . . 74.31 111.388 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.98 160.31 30.39 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.14 1.894 . . . . 41.4 110.192 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -81.38 158.95 24.47 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 122.072 0.939 . . . . 72.24 109.811 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.16 51.63 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 123.77 0.7 . . . . 55.03 112.36 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -125.05 156.27 38.46 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 125.518 1.527 . . . . 73.24 107.008 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -132.07 147.71 52.45 Favored 'General case' 0 CA--C 1.518 -0.26 0 C-N-CA 122.833 0.453 . . . . 74.43 111.007 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 4.3 t -70.33 139.75 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.531 1.132 . . . . 62.54 108.331 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 59.8 tp -121.24 85.94 42.5 Favored Pre-proline 0 C--O 1.236 0.362 0 N-CA-C 106.743 -1.577 . . . . 72.12 106.743 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.28 168.39 2.82 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.056 3.171 . . . . 65.53 112.33 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.91 168.25 19.28 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.355 2.703 . . . . 54.24 111.944 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.2 146.91 37.26 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.076 2.517 . . . . 61.54 110.817 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -56.66 -3.32 0.1 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 127.472 2.309 . . . . 63.35 116.249 -178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -165.83 67.53 0.2 Allowed Glycine 0 CA--C 1.517 0.193 0 N-CA-C 106.839 -2.504 . . . . 51.23 106.839 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -84.42 113.83 21.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.338 0.655 . . . . 74.11 110.27 -179.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.96 76.8 63.92 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 105.467 -2.049 . . . . 65.1 105.467 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.46 157.21 40.96 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.172 1.915 . . . . 52.41 109.842 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.253 1.262 0 N-CA-C 103.899 -2.63 . . . . 74.52 103.899 177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 111.312 -0.715 . . . . 73.24 111.312 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -130.43 166.15 21.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.744 1.618 . . . . 74.2 107.755 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . 42.05 75.91 0.08 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.742 1.617 . . . . 74.32 111.309 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -129.03 114.6 16.6 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 124.294 1.038 . . . . 73.41 109.177 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 22.5 pt -124.25 16.36 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.195 0.998 . . . . 71.25 112.286 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -46.33 148.41 0.93 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.116 0.966 . . . . 75.21 111.319 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 47.02 69.16 2.86 Favored Pre-proline 0 C--O 1.238 0.456 0 C-N-CA 125.448 1.499 . . . . 72.41 109.571 -179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -65.15 165.28 22.37 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.505 2.137 . . . . 74.53 109.983 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.07 -27.25 65.52 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.133 1.889 . . . . 73.01 112.633 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -158.61 169.48 24.31 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.513 1.125 . . . . 75.51 108.859 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.429 HG13 ' CE1' ' B' ' 91' ' ' TYR . 94.6 t -152.47 140.32 13.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 105.031 -2.211 . . . . 73.24 105.031 177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -127.19 160.05 32.44 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.256 1.023 . . . . 71.45 108.79 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 65.7 mtm180 -63.67 -24.3 67.73 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.859 1.663 . . . . 63.42 112.958 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 44.6 mt -98.3 137.66 25.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 107.04 -1.467 . . . . 75.53 107.04 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 69.2 mt -127.79 157.23 40.97 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 126.838 2.055 . . . . 64.41 109.593 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -126.02 149.29 48.94 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.465 1.506 . . . . 65.2 107.12 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mm -136.68 154.72 32.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.825 -1.546 . . . . 73.51 106.825 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 84.7 mtt-85 -135.13 163.77 29.17 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 125.479 1.512 . . . . 74.45 108.465 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.5 m-20 70.81 15.19 6.92 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.13 1.772 . . . . 73.21 111.068 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.428 ' CD1' ' HB3' ' B' ' 60' ' ' ALA . 45.0 mt -69.14 151.2 97.2 Favored Pre-proline 0 C--O 1.237 0.441 0 O-C-N 121.058 -1.026 . . . . 70.4 110.938 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.69 140.68 92.18 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.546 2.83 . . . . 72.21 112.412 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -75.63 -27.01 58.25 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.619 -0.675 . . . . 73.35 111.232 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.03 88.72 2.97 Favored 'General case' 0 CA--C 1.515 -0.376 0 C-N-CA 125.203 1.401 . . . . 72.12 107.877 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tt -134.7 154.58 37.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.773 -0.825 . . . . 54.24 108.773 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 43.6 p -114.88 176.17 5.17 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.833 2.053 . . . . 71.03 108.314 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.81 -38.36 90.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 O-C-N 121.706 -0.621 . . . . 73.41 111.315 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -49.38 -58.07 5.77 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 124.886 1.274 . . . . 73.01 113.582 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -63.95 -35.2 79.89 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.595 0.634 . . . . 64.23 111.511 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.9 mmm -68.17 -52.91 29.23 Favored 'General case' 0 C--O 1.232 0.133 0 O-C-N 121.369 -0.832 . . . . 55.04 110.132 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -66.8 -25.92 66.7 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 117.953 -1.022 . . . . 72.32 111.824 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -69.63 -59.62 2.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 120.235 1.379 . . . . 73.14 109.938 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.2 mt -60.67 -62.31 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.407 1.883 . . . . 72.2 111.486 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -63.36 -35.52 80.66 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 120.237 -0.585 . . . . 55.14 110.428 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.6 -29.7 67.37 Favored Glycine 0 C--N 1.34 0.785 0 C-N-CA 123.726 0.679 . . . . 60.23 112.212 179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -17.46 56.11 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.187 0.995 . . . . 73.34 111.566 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.66 -36.93 8.97 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 124.503 1.121 . . . . 44.02 111.768 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 172.54 -174.01 45.52 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 124.7 1.143 . . . . 65.42 110.68 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -68.56 171.41 13.15 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.718 2.278 . . . . 71.32 112.052 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 83.0 mt -127.81 131.49 69.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 124.781 1.232 . . . . 75.12 108.288 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.38 -57.51 3.22 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 108.154 -1.054 . . . . 63.34 108.154 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -157.12 153.29 27.53 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 123.646 0.778 . . . . 71.43 109.944 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 42.1 mt -134.64 137.81 50.54 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 125.874 1.67 . . . . 74.42 107.185 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -137.8 129.19 27.91 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 104.951 -2.24 . . . . 75.15 104.951 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 18.7 m -110.9 154.05 12.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 125.217 1.407 . . . . 72.32 110.952 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -68.35 117.85 8.76 Favored Glycine 0 C--N 1.339 0.709 0 N-CA-C 109.334 -1.506 . . . . 65.03 109.334 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -100.79 -38.14 8.4 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 124.135 0.974 . . . . 75.01 112.086 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -64.22 157.67 69.14 Favored Pre-proline 0 C--O 1.239 0.538 0 N-CA-C 108.51 -0.922 . . . . 52.31 108.51 178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.02 -14.67 46.56 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.486 1.457 . . . . 74.23 112.783 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -98.66 -11.09 22.38 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.389 -0.815 . . . . 63.34 112.355 179.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 65.1 p -103.02 -23.65 13.68 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 119.891 1.223 . . . . 72.12 112.187 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -51.11 131.07 27.23 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 107.051 -1.463 . . . . 75.04 107.051 178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.45 -13.04 15.87 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 125.381 1.467 . . . . 70.14 110.902 -177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.1 p -134.01 166.68 22.17 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 118.595 1.197 . . . . 75.5 110.014 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -164.25 169.29 17.78 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 125.306 1.443 . . . . 65.41 107.807 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -119.84 147.72 44.34 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.489 -0.93 . . . . 74.34 108.489 179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 38.7 t -128.55 140.35 49.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.515 -2.032 . . . . 70.33 105.515 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 38.2 t -127.1 130.79 71.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 102.481 -3.155 . . . . 63.04 102.481 178.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -99.49 161.28 13.71 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.051 -0.722 . . . . 74.11 109.051 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -76.37 -31.85 58.26 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 120.052 -0.659 . . . . 74.23 110.472 179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -123.55 165.92 16.32 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.204 1.402 . . . . 63.0 110.682 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 5.7 tt -76.37 -46.81 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 121.435 -0.79 . . . . 73.21 110.806 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -59.64 -38.31 81.02 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 123.986 0.914 . . . . 75.5 110.84 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -62.06 -42.13 98.87 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 108.946 -0.761 . . . . 74.01 108.946 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.33 -51.43 68.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.576 0.751 . . . . 75.41 109.753 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -55.82 -52.33 64.4 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.932 0.893 . . . . 75.24 110.825 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -57.84 -49.45 76.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.129 -0.693 . . . . 62.34 109.129 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.34 -39.05 89.14 Favored 'General case' 0 C--N 1.338 0.103 0 CA-C-O 118.104 -0.95 . . . . 74.13 111.906 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 67.7 m -60.51 -53.82 52.93 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 119.575 1.08 . . . . 45.25 109.588 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -63.21 -42.99 99.38 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 119.167 -0.444 . . . . 70.5 112.026 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -69.26 -24.22 63.95 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 118.417 -0.802 . . . . 72.53 111.231 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.1 tp -98.27 -13.11 20.95 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 120.406 1.457 . . . . 65.41 113.262 -178.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.62 127.2 31.87 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.718 -1.216 . . . . 51.52 107.718 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 85.19 11.49 75.74 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-O 118.274 -1.292 . . . . 54.42 113.031 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -68.54 111.99 5.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 119.382 1.591 . . . . 74.21 108.187 179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 15.8 t30 -85.33 115.14 22.91 Favored 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 127.376 2.27 . . . . 75.2 110.445 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 12.4 m -145.9 144.55 20.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 108.074 -1.084 . . . . 53.23 108.074 178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 12.7 m 40.48 49.81 2.69 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.026 1.73 . . . . 72.45 112.745 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 8.6 m120 63.0 18.54 10.99 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.48 2.312 . . . . 75.05 115.626 178.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 14.2 mmt180 -137.75 167.24 22.12 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 120.028 1.285 . . . . 72.21 109.988 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -112.28 127.15 55.9 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.288 1.035 . . . . 75.4 109.925 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 62.7 mt -74.82 106.18 6.23 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.039 -1.097 . . . . 65.03 108.039 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 t -72.72 136.69 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 N-CA-C 108.552 -0.907 . . . . 74.51 108.552 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 79.7 t -108.63 132.63 56.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 C-N-CA 126.746 2.018 . . . . 72.5 108.866 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 41.5 tp -154.65 130.25 9.92 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.494 1.043 . . . . 71.41 110.034 178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . 0.429 ' CE1' HG13 ' B' ' 17' ' ' VAL . 70.0 m-85 -69.34 158.74 34.46 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 121.759 -0.588 . . . . 75.41 110.224 179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -79.08 160.95 26.86 Favored 'General case' 0 C--O 1.244 0.804 0 N-CA-C 107.661 -1.237 . . . . 73.32 107.661 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 116.823 -1.561 . . . . 74.31 107.265 179.069 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.22 0 N-CA-C 108.358 -1.897 . . . . 73.22 108.358 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 9.5 t -128.5 128.19 23.59 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 105.684 -1.969 . . . . 70.55 105.684 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -83.32 -170.25 0.86 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.863 2.375 . . . . 55.21 108.492 178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -125.12 174.69 7.88 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.512 1.925 . . . . 74.21 106.504 177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -156.69 54.36 0.53 Allowed 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.592 -0.521 . . . . 75.35 109.592 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.42 165.6 20.5 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.478 0.656 . . . . 75.31 109.354 178.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -152.93 169.08 23.73 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.162 0.985 . . . . 74.51 109.014 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -152.18 161.38 42.71 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.093 1.357 . . . . 53.33 107.695 179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 1.9 m-90 -125.44 172.88 9.29 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.845 0.858 . . . . 73.32 109.887 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -122.52 179.96 4.41 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.074 1.749 . . . . 74.21 108.728 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 60.4 t90 -147.84 160.49 42.7 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.927 1.691 . . . . 74.32 107.305 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.89 169.59 21.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.091 2.156 . . . . 71.14 107.167 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 21.1 ptt-85 -143.18 158.14 43.88 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.968 0.907 . . . . 65.51 108.747 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -75.46 148.35 39.14 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 123.368 0.418 . . . . 75.23 111.559 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 49.6 mm -82.76 123.44 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 106.553 -1.647 . . . . 72.11 106.553 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -77.16 175.99 9.14 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.493 1.117 . . . . 74.22 109.411 178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -122.21 165.98 15.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.384 1.088 . . . . 72.23 112.746 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -156.12 165.07 37.49 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 128.844 2.857 . . . . 65.31 106.896 179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -71.44 138.28 48.94 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.027 -1.101 . . . . 64.31 108.027 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -151.42 158.6 34.31 Favored Pre-proline 0 C--O 1.24 0.563 0 C-N-CA 127.405 2.282 . . . . 63.33 107.657 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.91 167.0 28.47 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.897 1.732 . . . . 73.2 109.758 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 87.7 mt -100.78 134.64 43.45 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.005 -1.109 . . . . 75.31 108.005 179.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 69.8 m -133.2 -174.24 3.43 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 129.3 3.04 . . . . 73.31 107.509 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.25 -15.93 63.48 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.289 -0.882 . . . . 74.14 109.69 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -68.86 -44.07 74.1 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 126.716 2.006 . . . . 73.42 110.071 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 28.0 mp0 -71.6 -41.4 69.0 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 108.118 -1.068 . . . . 73.43 108.118 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 15.5 tp -61.1 -24.59 66.35 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 124.204 0.94 . . . . 74.43 110.415 179.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -73.23 -62.52 1.44 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 107.355 -1.35 . . . . 72.42 107.355 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -64.21 -1.68 1.73 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.083 2.153 . . . . 61.44 115.722 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 70.4 mtp -95.51 -10.08 30.69 Favored 'General case' 0 N--CA 1.466 0.342 0 O-C-N 120.849 -1.157 . . . . 75.35 111.501 178.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -106.01 148.3 36.31 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-N 118.808 0.731 . . . . 73.53 111.251 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.67 158.98 54.23 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.149 1.899 . . . . 61.53 107.719 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -73.86 165.45 25.1 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-O 121.708 0.766 . . . . 74.22 111.609 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 94.83 17.92 36.52 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.653 1.597 . . . . 54.12 111.228 -178.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -125.58 139.52 53.52 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.758 1.223 . . . . 75.34 109.72 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 44.0 tttm -115.14 142.3 46.84 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.202 1.401 . . . . 74.21 109.424 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 85.6 t -69.62 151.09 9.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 CA-C-O 122.518 1.151 . . . . 72.43 109.095 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 33.5 tp -116.51 76.02 7.03 Favored Pre-proline 0 N--CA 1.45 -0.47 0 C-N-CA 125.358 1.463 . . . . 71.42 111.44 -178.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.66 163.92 37.37 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.011 1.807 . . . . 71.22 108.773 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -72.8 166.37 30.16 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 122.226 1.95 . . . . 55.41 110.988 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.59 144.59 24.97 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 122.617 2.211 . . . . 54.14 111.116 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -52.2 -33.07 39.34 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 113.052 0.76 . . . . 75.01 113.052 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . -116.76 35.94 3.97 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-O 118.343 -1.254 . . . . 41.43 112.269 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -63.98 154.33 34.44 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 120.087 1.943 . . . . 72.44 110.836 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 11.2 t -138.63 93.7 10.82 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 124.386 1.074 . . . . 64.43 110.245 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.01 -166.66 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.284 2.656 . . . . 73.21 110.129 178.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 13.7 tt . . . . . 0 C--O 1.245 0.822 0 N-CA-C 106.096 -1.816 . . . . 74.31 106.096 177.93 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.7 0 N-CA-C 108.198 -1.961 . . . . 33.41 108.198 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.52 84.05 2.08 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.281 -1.377 . . . . 70.22 107.281 178.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.22 58.9 3.18 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.01 0.924 . . . . 73.23 108.794 179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -67.07 169.07 9.0 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 121.651 -0.655 . . . . 73.04 109.698 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 13.5 pt -123.12 32.76 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.187 0.995 . . . . 71.12 113.542 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -77.97 68.9 4.11 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.238 -1.539 . . . . 61.13 109.925 179.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 3.9 mm? 56.8 83.66 0.22 Allowed Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 127.596 2.358 . . . . 75.21 110.198 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.38 170.33 9.64 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.043 2.495 . . . . 61.33 112.88 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.8 -33.59 52.94 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.0 1.8 . . . . 44.52 111.127 178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -67.8 8.92 0.32 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.98 2.512 . . . . 55.22 115.85 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.542 HG11 ' HD3' ' B' ' 71' ' ' LYS . 75.1 t -72.21 83.74 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 105.889 -1.893 . . . . 72.42 105.889 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -67.18 141.93 57.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.971 -1.122 . . . . 75.11 107.971 -179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . 0.46 ' H ' ' HD3' ' B' ' 19' ' ' ARG 0.283 0.0 OUTLIER -57.8 -7.33 0.69 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 118.151 2.648 . . . . 52.32 118.151 -178.714 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.453 HG13 ' HE ' ' B' ' 19' ' ' ARG . 65.5 mt -101.87 128.11 54.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 105.602 -1.999 . . . . 61.25 105.602 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 58.9 mt -100.76 142.19 32.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 107.466 -1.309 . . . . 72.14 107.466 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -109.44 128.56 55.24 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 104.605 -2.368 . . . . 54.41 104.605 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 mm -118.74 136.53 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 106.968 -1.494 . . . . 75.44 106.968 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -125.93 163.68 22.45 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.597 1.559 . . . . 74.34 107.735 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 59.6 m-20 71.24 20.18 5.15 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 125.634 1.574 . . . . 54.24 112.078 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 96.8 mt -67.13 153.82 93.85 Favored Pre-proline 0 C--O 1.237 0.445 0 O-C-N 121.4 -0.813 . . . . 62.41 110.593 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -66.89 159.23 52.64 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.74 2.96 . . . . 74.33 110.077 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -89.74 -19.11 25.16 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.112 0.565 . . . . 73.23 111.351 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.493 ' HA ' ' HE2' ' B' ' 29' ' ' LYS . 7.8 mmpt? -130.08 101.04 5.64 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 125.9 1.68 . . . . 62.32 108.348 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.6 tt -152.51 155.67 6.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 127.431 2.293 . . . . 63.44 105.472 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 35.4 p -105.1 174.17 5.99 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 121.273 -0.892 . . . . 72.21 109.671 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.62 -48.28 72.78 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 108.352 -0.981 . . . . 64.32 108.352 178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -54.67 -35.46 63.57 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.404 1.482 . . . . 54.24 112.474 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -70.34 -42.75 71.45 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 119.911 1.232 . . . . 63.45 108.229 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 85.6 mmm -64.75 -45.07 87.98 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.605 -0.887 . . . . 72.13 108.605 178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -63.83 -27.48 69.2 Favored 'General case' 0 C--O 1.227 -0.124 0 CA-C-O 117.98 -1.01 . . . . 72.43 111.644 179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -75.18 -65.26 0.9 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 119.233 0.924 . . . . 71.45 110.148 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mt -57.55 -53.37 45.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 C-N-CA 124.673 1.189 . . . . 74.21 111.818 -177.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -74.72 -17.01 60.72 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 121.697 -0.627 . . . . 64.22 111.647 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.4 -12.91 66.53 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 124.0 0.81 . . . . 44.32 113.096 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -58.09 -29.91 65.83 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.16 1.48 . . . . 65.52 110.495 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -83.63 -5.42 59.17 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.034 2.134 . . . . 50.12 114.525 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.65 -171.87 23.58 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 119.808 1.186 . . . . 22.12 111.702 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.29 163.77 28.1 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.38 2.054 . . . . 60.1 109.247 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 18.5 mt -129.43 123.22 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 O-C-N 120.981 -1.075 . . . . 70.52 108.532 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -65.11 -67.07 0.47 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.454 -0.943 . . . . 64.41 108.454 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -156.89 160.64 39.33 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.932 0.787 . . . . 71.32 112.062 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 84.5 mt -140.11 140.95 34.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.062 2.145 . . . . 73.31 106.258 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 18.9 ttt180 -132.59 120.06 21.31 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 103.272 -2.862 . . . . 63.01 103.272 178.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 14.9 m -99.98 146.12 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 119.26 0.936 . . . . 75.22 111.435 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -66.09 141.31 41.22 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 107.768 -2.133 . . . . 63.05 107.768 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -128.86 -9.94 4.92 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.195 0.998 . . . . 72.33 113.017 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 44.9 p -97.51 161.57 25.46 Favored Pre-proline 0 CA--C 1.538 0.486 0 C-N-CA 124.762 1.225 . . . . 75.22 108.478 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.33 5.76 0.83 Allowed 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.85 3.033 . . . . 74.3 113.635 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -120.58 -9.74 9.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.148 1.379 . . . . 74.15 111.408 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -117.36 -25.58 6.99 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.569 1.148 . . . . 74.31 113.147 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 14.9 mtp180 -50.6 143.47 9.34 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.917 0.887 . . . . 73.44 112.134 -178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.0 85.77 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.096 -0.836 . . . . 61.24 111.273 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 30.2 p -138.05 150.27 46.77 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 118.941 1.37 . . . . 70.13 108.71 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.12 168.35 19.14 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.177 1.391 . . . . 75.24 107.82 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -120.85 155.53 33.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.367 -1.716 . . . . 63.43 106.367 178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 31.0 t -125.52 124.47 66.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 105.31 -2.107 . . . . 61.43 105.31 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 20.9 t -110.55 123.78 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 105.026 -2.212 . . . . 64.51 105.026 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -98.09 166.46 11.41 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 106.377 -1.712 . . . . 72.13 106.377 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -64.78 -42.59 94.95 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 120.491 -1.381 . . . . 74.41 110.366 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -117.78 175.32 5.71 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.605 1.562 . . . . 74.44 111.146 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 8.2 tt -81.69 -38.19 15.86 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 125.333 1.453 . . . . 60.31 108.621 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -60.44 -37.16 80.07 Favored 'General case' 0 C--N 1.34 0.187 0 CA-C-N 118.197 0.453 . . . . 72.41 111.661 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -64.14 -42.79 96.64 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 119.377 -0.344 . . . . 75.43 111.003 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.79 -50.19 63.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.445 -0.946 . . . . 63.45 108.445 178.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.542 ' HD3' HG11 ' B' ' 17' ' ' VAL . 7.2 mmtp -48.87 -54.88 13.48 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 125.614 1.566 . . . . 73.24 110.23 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -59.63 -60.18 4.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.043 0.937 . . . . 71.32 110.273 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.65 -29.1 51.4 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 114.052 1.131 . . . . 73.41 114.052 -179.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 7.6 t -60.46 -38.25 83.6 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.447 0.699 . . . . 55.41 111.917 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -88.51 -28.6 20.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 118.596 0.635 . . . . 72.21 110.954 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -67.58 -31.13 70.98 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 118.226 0.466 . . . . 75.11 111.449 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 13.1 tp -106.67 -3.43 20.61 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 115.256 1.576 . . . . 64.34 115.256 -177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 25.7 p -60.08 124.56 20.61 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 120.343 1.429 . . . . 75.53 109.677 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.05 13.99 73.22 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.231 -1.316 . . . . 75.31 114.334 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -54.48 119.53 5.37 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.884 1.842 . . . . 73.02 110.076 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -78.08 129.76 35.6 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.911 -1.144 . . . . 73.44 107.911 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 22.2 m -144.08 140.18 24.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 125.835 1.654 . . . . 75.13 106.789 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.7 m 37.43 49.28 0.95 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.12 1.368 . . . . 73.43 112.749 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 30.6 m120 51.72 35.57 15.45 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.242 1.417 . . . . 41.22 113.947 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -136.61 -177.22 4.63 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 129.847 3.259 . . . . 72.35 104.657 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -139.23 137.14 35.7 Favored 'General case' 0 CA--C 1.518 -0.268 0 O-C-N 120.865 -1.147 . . . . 61.32 109.456 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 68.9 mt -83.75 158.22 21.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.414 -1.328 . . . . 73.02 107.414 178.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 92.9 t -130.79 131.77 64.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 103.683 -2.71 . . . . 75.13 103.683 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 13.3 t -115.33 135.35 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 125.035 1.334 . . . . 61.13 107.859 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 60.8 tp -145.46 150.67 36.92 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.745 0.818 . . . . 51.32 110.608 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . 0.482 ' CD1' HG13 ' B' ' 17' ' ' VAL . 6.7 m-85 -78.52 160.97 27.38 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.392 -0.818 . . . . 75.31 111.546 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -91.28 176.58 6.52 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.152 0.981 . . . . 75.11 110.156 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 p30 . . . . . 0 C--O 1.253 1.25 0 N-CA-C 112.624 0.601 . . . . 52.4 112.624 -179.772 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.252 0 CA-C-O 116.585 -2.231 . . . . 51.21 107.845 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 21.9 p 32.95 69.95 0.82 Allowed Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 125.784 1.634 . . . . 73.4 113.84 178.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -65.97 160.85 42.32 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 121.92 1.747 . . . . 72.22 111.143 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.27 62.83 0.51 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.563 1.945 . . . . 53.1 112.462 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -80.66 64.88 5.6 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.682 -1.229 . . . . 73.43 107.682 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.8 pp -132.16 -177.74 4.59 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 127.386 2.274 . . . . 62.53 108.563 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -153.38 178.53 9.69 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 124.299 1.039 . . . . 44.34 109.161 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -147.56 167.13 25.31 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.309 0.644 . . . . 55.35 111.657 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 16.9 p90 -135.52 163.59 29.74 Favored 'General case' 0 C--O 1.24 0.565 0 C-N-CA 127.813 2.445 . . . . 74.33 109.115 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -78.61 170.61 16.37 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 107.202 -1.407 . . . . 75.11 107.202 177.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -128.0 153.18 47.04 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.295 -0.878 . . . . 73.41 108.78 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -137.84 101.14 4.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.023 -1.473 . . . . 73.11 107.023 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -105.41 122.65 46.41 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 125.803 1.641 . . . . 73.12 106.863 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -73.22 126.82 30.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 105.593 -2.002 . . . . 55.22 105.593 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 48.6 mm -108.21 104.65 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 123.048 1.404 . . . . 63.42 108.67 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -82.7 -7.88 59.63 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 126.506 1.922 . . . . 61.23 110.369 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -73.18 167.17 21.71 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.737 1.215 . . . . 73.44 113.946 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -123.06 93.59 4.0 Favored 'General case' 0 CA--C 1.519 -0.233 0 C-N-CA 126.279 1.832 . . . . 64.04 108.131 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 54.3 p30 -108.11 13.95 25.53 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.075 0.95 . . . . 60.32 112.894 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 5.1 ptt-85 -142.77 158.87 58.76 Favored Pre-proline 0 N--CA 1.466 0.339 0 C-N-CA 125.743 1.617 . . . . 72.2 109.39 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.62 9.9 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.657 2.904 . . . . 72.3 114.993 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 36.7 mt -141.67 146.37 36.04 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 124.756 1.222 . . . . 62.32 108.115 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 4.5 m -129.21 173.62 10.32 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.804 2.442 . . . . 75.42 109.651 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -61.56 -26.65 68.09 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.762 1.625 . . . . 52.01 115.121 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.04 -45.15 59.17 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.595 -1.316 . . . . 53.42 110.029 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -64.58 -21.35 66.68 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 121.527 -0.733 . . . . 73.14 109.821 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.8 tp -60.34 -40.05 89.31 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 108.533 -0.914 . . . . 74.31 108.533 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.93 -10.46 57.34 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.295 1.038 . . . . 70.02 112.289 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -97.55 -36.15 10.4 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.028 1.331 . . . . 55.54 109.481 178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 89.7 mtp -71.28 -13.58 61.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.912 0.885 . . . . 73.42 112.608 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -114.67 157.78 42.04 Favored Pre-proline 0 C--O 1.237 0.434 0 CA-C-N 119.911 1.232 . . . . 73.52 112.003 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -76.09 166.29 28.14 Favored 'Trans proline' 0 C--O 1.239 0.574 0 C-N-CA 122.803 2.336 . . . . 74.12 111.241 178.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -84.69 174.99 9.49 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.557 1.143 . . . . 72.43 108.889 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 82.32 19.02 65.34 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-O 118.762 -1.021 . . . . 51.12 112.826 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -125.49 155.71 40.11 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 119.382 1.591 . . . . 74.32 106.908 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -130.35 133.69 46.61 Favored 'General case' 0 C--O 1.236 0.371 0 O-C-N 121.117 -0.99 . . . . 74.32 108.656 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' B' ' 49' ' ' ARG . 48.3 t -69.08 151.31 10.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 107.617 -1.253 . . . . 71.04 107.617 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 48.6 tp -125.73 85.72 58.61 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 125.637 1.575 . . . . 71.23 108.662 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -66.21 178.78 2.28 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.913 2.409 . . . . 72.43 109.566 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.44 170.99 1.04 Allowed 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.704 2.936 . . . . 71.33 113.386 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.17 163.21 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 125.06 3.84 . . . . 73.42 114.899 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -73.95 -0.17 15.36 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 115.258 1.577 . . . . 52.2 115.258 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 162.9 60.12 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.441 -1.864 . . . . 64.44 108.441 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.64 159.21 2.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 123.752 0.821 . . . . 70.02 111.923 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 66.8 t -123.87 78.02 57.66 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 107.054 -1.462 . . . . 63.3 107.054 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -70.57 162.22 43.27 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.097 1.865 . . . . 73.4 109.357 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 6.2 tt . . . . . 0 C--O 1.251 1.144 0 N-CA-C 103.645 -2.724 . . . . 75.3 103.645 178.291 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 110.481 -1.048 . . . . 64.44 110.481 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -74.73 66.79 1.51 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.701 1.201 . . . . 71.13 109.255 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -131.52 98.88 4.63 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.082 0.953 . . . . 71.14 109.236 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -67.42 157.07 35.03 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.188 -1.042 . . . . 60.3 108.188 178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 6.6 pt -126.88 174.55 10.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 123.49 0.716 . . . . 60.44 110.921 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.15 17.77 2.61 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 126.4 1.88 . . . . 73.32 109.936 178.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 38.0 mt -128.53 62.44 59.91 Favored Pre-proline 0 C--O 1.236 0.384 0 C-N-CA 124.613 1.165 . . . . 63.23 108.418 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.15 168.93 17.82 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.774 2.316 . . . . 61.45 108.478 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.48 -43.51 17.37 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.298 1.332 . . . . 54.05 111.508 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -154.13 163.46 40.07 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.26 1.424 . . . . 74.01 109.28 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.601 HG13 ' CE1' ' B' ' 91' ' ' TYR . 88.1 t -146.1 157.63 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 124.8 1.24 . . . . 52.41 108.763 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -138.48 159.85 41.04 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.993 1.717 . . . . 65.21 108.73 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -72.63 -24.42 61.06 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.057 1.343 . . . . 72.41 109.505 177.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 69.9 mt -89.54 129.65 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 C-N-CA 125.296 1.438 . . . . 53.04 107.475 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 mt -120.54 153.53 36.6 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.876 1.27 . . . . 75.01 107.882 178.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -119.31 111.6 18.39 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.963 -2.606 . . . . 72.44 103.963 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -96.59 145.67 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 105.661 -1.977 . . . . 65.42 105.661 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 39.6 mtp180 -136.88 163.2 31.24 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 125.038 1.335 . . . . 75.12 109.19 -178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 41.8 t30 63.12 33.68 14.3 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.062 2.145 . . . . 64.21 111.066 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 55.0 mt -73.79 158.72 85.71 Favored Pre-proline 0 C--O 1.237 0.417 0 O-C-N 121.497 -0.752 . . . . 74.14 109.013 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.16 156.38 65.99 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.886 1.724 . . . . 72.15 109.498 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -75.23 -25.69 58.33 Favored 'General case' 0 C--O 1.231 0.122 0 O-C-N 121.536 -0.727 . . . . 70.44 112.002 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -129.75 128.09 41.73 Favored 'General case' 0 CA--C 1.512 -0.496 0 N-CA-C 107.261 -1.385 . . . . 74.43 107.261 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 8.7 tt -157.51 169.83 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.553 -1.277 . . . . 63.32 107.553 178.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 16.9 p -126.49 169.1 13.37 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.532 1.933 . . . . 62.14 108.982 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.0 -38.82 90.08 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.393 -0.966 . . . . 72.42 108.393 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -54.45 -55.31 30.21 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.018 1.327 . . . . 45.21 111.852 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -59.24 -40.41 85.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.069 0.395 . . . . 73.32 111.438 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.35 -44.01 72.48 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 73.53 111.587 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -73.14 -23.18 60.44 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.972 0.909 . . . . 73.33 111.026 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -73.63 -59.32 2.77 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 124.273 1.029 . . . . 73.55 108.51 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.17 -67.45 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 125.811 1.645 . . . . 74.25 111.027 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -66.99 -32.41 73.63 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.643 0.608 . . . . 73.35 112.643 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.84 -32.34 81.48 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 120.468 1.485 . . . . 64.41 112.567 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -75.58 -21.34 57.92 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.335 -1.097 . . . . 70.41 110.236 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -82.36 -30.97 30.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.347 1.059 . . . . 74.21 110.734 179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 170.97 -175.29 44.71 Favored Glycine 0 CA--C 1.527 0.833 0 CA-C-N 119.116 0.871 . . . . 75.2 111.668 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.06 165.72 25.42 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.911 2.407 . . . . 73.44 110.673 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 95.1 mt -132.52 113.68 21.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 C-N-CA 123.662 0.785 . . . . 74.25 109.637 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -81.52 -49.09 11.0 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 107.526 -1.287 . . . . 74.32 107.526 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -168.9 162.24 11.19 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 125.442 1.497 . . . . 74.54 108.496 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.2 mt -144.78 140.52 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 127.43 2.292 . . . . 64.43 106.016 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 414' ' ' VAL . 0.1 OUTLIER -148.53 121.88 9.03 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 106.055 -1.831 . . . . 75.12 106.055 176.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 3.2 m -103.12 167.07 2.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 123.63 0.772 . . . . 60.25 109.629 -179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.38 137.14 42.6 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.669 -0.973 . . . . 54.41 110.669 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -107.34 -49.66 3.22 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 126.606 1.962 . . . . 62.3 110.661 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -70.57 158.21 88.35 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.109 -0.7 . . . . 61.24 109.109 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.51 14.83 0.18 Allowed 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.549 3.499 . . . . 70.55 115.36 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -120.01 -47.13 2.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 126.817 2.047 . . . . 73.14 109.419 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 51.2 p -72.84 -29.45 63.22 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.972 0.909 . . . . 43.25 109.856 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 -50.37 124.77 11.17 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 124.162 0.985 . . . . 74.42 110.249 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.81 -13.07 17.59 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.746 1.165 . . . . 72.35 110.56 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 42.7 p -128.02 166.07 19.09 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 118.897 1.348 . . . . 64.25 108.761 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -162.26 168.14 22.81 Favored 'General case' 0 CA--C 1.52 -0.19 0 O-C-N 121.154 -0.966 . . . . 74.25 111.066 -179.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -120.54 124.04 44.37 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 107.977 -1.12 . . . . 75.44 107.977 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.0 t -111.78 142.25 24.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.507 -2.405 . . . . 64.04 104.507 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 44.8 t -125.74 122.9 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 106.718 -1.586 . . . . 73.11 106.718 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -97.56 165.97 11.73 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.47 1.108 . . . . 74.34 108.467 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.14 -59.36 2.12 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 123.347 0.659 . . . . 75.23 109.744 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -92.06 117.6 29.99 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 126.087 1.755 . . . . 73.44 107.303 179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 tt -59.54 -35.62 60.19 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 CA-C-O 119.39 -0.338 . . . . 70.11 110.815 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -60.37 -50.4 73.76 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.916 0.886 . . . . 73.43 110.073 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -65.33 -32.17 73.68 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 109.551 -0.537 . . . . 74.5 109.551 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.16 -39.23 92.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 108.835 -0.802 . . . . 72.22 108.835 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.49 ' HG2' HG11 ' B' ' 17' ' ' VAL . 13.7 mtmt -60.1 -46.56 89.2 Favored 'General case' 0 C--N 1.342 0.282 0 N-CA-C 108.17 -1.048 . . . . 55.13 108.17 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -59.99 -52.85 63.63 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 123.831 0.707 . . . . 74.04 110.031 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.02 79.74 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 118.655 -0.688 . . . . 63.01 111.705 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 42.5 t -62.13 -51.32 68.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.989 0.813 . . . . 75.05 108.995 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -65.71 -37.91 87.75 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 118.439 0.563 . . . . 74.41 111.814 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -67.18 -31.53 72.0 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 122.251 0.221 . . . . 75.32 110.424 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 15.6 tp -91.1 -24.23 20.07 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.844 0.683 . . . . 74.3 112.844 -178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 3.0 m -68.25 106.4 2.44 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.955 0.902 . . . . 72.25 109.931 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 96.51 9.45 56.6 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.751 1.643 . . . . 71.14 113.042 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -72.18 141.36 49.05 Favored 'General case' 0 C--O 1.242 0.694 0 N-CA-C 107.171 -1.418 . . . . 72.45 107.171 177.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -110.9 135.02 52.06 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.758 1.623 . . . . 60.25 110.848 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.6 m -157.16 150.16 9.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 127.499 2.32 . . . . 75.32 107.351 178.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 53.0 m 44.61 50.25 8.41 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.614 1.166 . . . . 75.54 113.7 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 44.5 t30 55.5 18.83 2.86 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.759 1.624 . . . . 74.34 113.235 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 61.2 mtt85 -134.97 173.82 11.29 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.739 2.016 . . . . 73.34 110.585 -178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 50.5 p90 -130.57 133.34 46.12 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 105.751 -1.944 . . . . 74.35 105.751 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 83.1 mt -78.21 172.09 14.08 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.07 -1.085 . . . . 44.31 108.07 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 5.2 t -134.11 126.7 50.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 103.757 -2.683 . . . . 72.03 103.757 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 11.3 t -114.55 137.81 46.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 N-CA-C 106.488 -1.671 . . . . 73.3 106.488 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 46.4 tp -146.81 155.94 42.74 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 125.619 1.567 . . . . 74.41 107.159 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . 0.601 ' CE1' HG13 ' B' ' 17' ' ' VAL . 52.8 m-85 -87.74 163.22 16.62 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 109.246 -0.65 . . . . 61.25 109.246 179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -82.86 170.01 15.45 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.577 -0.897 . . . . 62.44 108.577 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 . . . . . 0 C--O 1.246 0.909 0 O-C-N 120.909 -1.119 . . . . 75.4 109.342 179.817 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.282 0 N-CA-C 111.368 -0.693 . . . . 70.11 111.368 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . 0.272 3.5 t -148.64 -161.27 0.04 OUTLIER Pre-proline 0 CA--C 1.558 1.27 1 C-N-CA 132.564 4.346 . . . . 73.14 102.458 179.14 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -71.92 86.86 0.88 Allowed 'Trans proline' 0 CA--C 1.546 1.08 0 CA-C-N 124.963 2.808 . . . . 74.14 108.057 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.89 -5.88 3.28 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 126.426 1.89 . . . . 64.35 112.179 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -150.08 158.21 43.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 128.151 2.58 . . . . 73.32 106.412 178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 97.4 mt -123.13 128.42 50.06 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 108.528 -0.916 . . . . 74.23 108.528 -179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 70.1 mm-40 -109.21 41.54 1.61 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.175 1.39 . . . . 72.11 109.125 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -74.3 161.82 29.51 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.353 -0.842 . . . . 63.52 109.571 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -124.8 169.85 11.61 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.927 0.891 . . . . 72.24 110.443 -179.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -142.71 157.92 44.17 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.017 1.727 . . . . 72.4 107.739 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -148.29 60.91 1.1 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.534 0.734 . . . . 74.33 112.006 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -69.61 170.95 9.75 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.154 -0.966 . . . . 72.23 108.959 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -154.22 123.0 6.27 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.119 1.368 . . . . 74.3 107.515 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.74 126.09 2.12 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.267 1.427 . . . . 71.34 107.255 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 8.2 tp -156.69 141.59 8.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 106.345 -1.724 . . . . 73.13 106.345 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -155.96 141.39 17.67 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.985 -1.117 . . . . 64.2 107.985 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -145.92 167.3 23.63 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.991 0.916 . . . . 54.41 109.89 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -105.89 166.9 10.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 123.399 0.68 . . . . 71.5 109.634 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -67.23 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 127.956 2.502 . . . . 73.55 114.103 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -64.46 154.07 85.0 Favored Pre-proline 0 C--O 1.238 0.477 0 C-N-CA 125.251 1.42 . . . . 73.23 109.374 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -67.96 162.53 39.43 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 107.052 -1.941 . . . . 61.04 107.052 177.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 53.1 mt -61.06 108.71 0.92 Allowed 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.438 0.695 . . . . 65.25 111.081 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 1.2 m -63.81 160.93 16.3 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.453 1.101 . . . . 73.31 108.646 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -73.28 -12.01 60.7 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.755 -1.215 . . . . 75.24 110.993 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -79.97 -46.47 16.62 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.527 1.531 . . . . 73.34 107.07 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -62.83 -19.22 63.86 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.498 1.519 . . . . 74.01 111.028 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 17.3 tp -72.95 -35.46 66.98 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.057 0.943 . . . . 63.12 109.896 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -72.02 -37.76 69.7 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.3 0.64 . . . . 75.52 109.393 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -61.68 -29.22 69.94 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.177 0.991 . . . . 54.13 110.924 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 35.0 mtm -88.95 -1.63 58.2 Favored 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 124.198 0.999 . . . . 73.51 111.672 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -108.47 148.48 37.75 Favored Pre-proline 0 C--O 1.233 0.188 0 CA-C-N 119.151 0.887 . . . . 73.31 112.978 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.95 149.74 59.83 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.634 2.223 . . . . 74.13 109.931 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -73.65 166.22 23.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.158 0.983 . . . . 75.32 111.661 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 88.48 17.61 56.7 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.753 1.168 . . . . 72.23 113.024 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -124.42 158.11 33.56 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.254 1.822 . . . . 72.44 108.462 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -127.88 151.65 48.8 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 108.553 -0.906 . . . . 73.31 108.553 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 13.9 t -69.98 150.96 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 N-CA-C 107.212 -1.403 . . . . 62.4 107.212 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 29.0 tp -128.95 75.73 79.95 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 108.579 -0.897 . . . . 73.34 108.579 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -68.08 161.32 44.85 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.942 2.428 . . . . 73.44 110.736 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.69 159.13 54.96 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.974 2.449 . . . . 51.43 112.563 -178.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -61.31 125.6 17.31 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.661 2.908 . . . . 72.31 111.312 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -65.97 147.87 52.68 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.779 -0.823 . . . . 75.32 108.779 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 67.36 1.02 12.67 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 124.569 1.081 . . . . 61.34 114.051 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -63.19 142.02 58.54 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 120.45 2.125 . . . . 65.44 109.25 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 89.7 t -135.3 89.29 23.48 Favored Pre-proline 0 CA--C 1.531 0.239 0 C-N-CA 124.019 0.928 . . . . 54.12 109.56 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -72.1 147.23 48.16 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 N-CA-C 107.844 -1.637 . . . . 72.35 107.844 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--O 1.251 1.17 0 C-N-CA 127.745 2.418 . . . . 74.23 104.509 179.528 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.546 -0.622 . . . . 74.0 111.546 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.71 36.79 1.63 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.811 2.045 . . . . 74.24 111.126 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -133.68 158.39 43.37 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.613 -1.304 . . . . 73.31 109.702 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -138.86 168.32 20.09 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.291 1.836 . . . . 71.42 108.527 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 5.7 tp -145.71 153.74 13.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 105.241 -2.133 . . . . 72.34 105.241 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 8.9 mmm180 -143.4 162.66 35.17 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.55 1.14 . . . . 74.52 108.363 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 tm? 39.93 71.2 1.25 Allowed Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 126.623 1.969 . . . . 73.31 110.125 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.05 161.26 40.65 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 N-CA-C 108.299 -1.462 . . . . 62.44 108.299 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -64.47 -22.22 65.64 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.945 1.763 . . . . 61.43 112.205 -178.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -163.74 164.87 23.63 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 125.123 1.369 . . . . 71.1 109.702 -178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.412 HG11 ' HG2' ' B' ' 71' ' ' LYS . 3.9 t -151.6 158.5 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 N-CA-C 105.346 -2.094 . . . . 75.42 105.346 177.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -144.06 -179.02 6.23 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.11 -0.994 . . . . 72.13 110.005 -179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -88.24 -30.91 19.33 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.282 -0.886 . . . . 74.31 109.568 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 43.0 mt -82.45 132.93 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 N-CA-C 107.389 -1.338 . . . . 74.33 107.389 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.33 151.84 42.06 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.121 2.168 . . . . 64.54 107.376 179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -110.65 131.82 54.72 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 106.221 -1.77 . . . . 74.55 106.221 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -117.59 138.34 48.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 107.289 -1.375 . . . . 74.23 107.289 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -138.35 163.59 31.46 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 125.277 1.431 . . . . 73.11 109.572 -178.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 67.31 31.21 6.65 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.329 1.852 . . . . 43.34 109.991 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 49.4 mt -70.34 156.41 91.92 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 124.468 1.107 . . . . 63.12 111.715 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.96 152.62 51.94 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 123.814 3.009 . . . . 70.2 109.961 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -80.28 -25.11 39.61 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.539 -0.726 . . . . 74.54 112.431 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 2.3 mppt? -129.01 114.78 16.84 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.45 1.5 . . . . 62.03 106.956 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 tt -162.28 168.78 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.646 0 C-N-CA 127.068 2.147 . . . . 61.44 106.409 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 39.8 p -136.89 169.54 17.59 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.465 1.106 . . . . 52.13 108.605 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -55.21 -34.78 64.21 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.041 0.536 . . . . 72.23 111.139 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.29 -25.41 64.09 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.62 1.568 . . . . 62.12 113.043 -179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -94.46 -35.88 12.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.213 1.005 . . . . 63.13 109.426 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 96.5 mmm -64.92 -53.2 50.14 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.501 1.12 . . . . 54.12 109.82 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -67.52 -16.89 64.44 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 118.606 -0.712 . . . . 65.41 111.938 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -71.26 -67.03 0.54 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 107.859 -1.163 . . . . 64.04 107.859 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 77.4 mt -53.99 -62.03 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.335 -0.063 0 C-N-CA 126.484 1.914 . . . . 72.32 111.353 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -62.34 -21.5 65.35 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.467 0.914 . . . . 73.12 113.467 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.71 -21.46 66.24 Favored Glycine 0 C--N 1.34 0.773 0 C-N-CA 124.122 0.868 . . . . 51.41 112.386 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -63.56 -31.46 72.63 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.218 -1.401 . . . . 64.45 107.218 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -77.95 -61.76 1.89 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 124.32 1.048 . . . . 75.15 109.708 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.84 178.11 45.86 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 119.719 1.145 . . . . 63.42 115.085 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.77 121.86 9.15 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 124.367 3.378 . . . . 75.34 109.927 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 16.4 mt -86.38 151.07 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.483 -0.932 . . . . 74.12 108.483 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -87.5 -62.86 1.4 Allowed 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 107.168 -1.419 . . . . 72.03 107.168 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -154.53 161.27 41.73 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.122 0.969 . . . . 73.21 109.849 -179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 97.5 mt -140.02 142.37 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 125.741 1.616 . . . . 74.43 107.482 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 54.9 mtt85 -141.67 131.39 24.18 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 103.197 -2.89 . . . . 60.31 103.197 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 22.3 m -123.94 157.4 30.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 123.478 0.711 . . . . 62.43 111.3 -177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.05 146.99 44.88 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.821 1.201 . . . . 65.24 111.048 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.09 -49.53 1.83 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.46 1.104 . . . . 70.52 108.886 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 77.1 p -66.4 159.76 70.55 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 108.691 -0.855 . . . . 72.52 108.691 178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.13 -12.21 35.16 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 121.719 1.612 . . . . 62.42 110.594 178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -90.73 -9.88 45.07 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.015 2.526 . . . . 65.14 111.865 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 33.4 p -116.75 -33.42 4.82 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.039 0.936 . . . . 62.15 109.153 178.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 17.3 mtt-85 -54.33 117.2 3.09 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 125.936 1.694 . . . . 74.01 108.049 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.31 -8.38 9.0 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 126.592 2.044 . . . . 73.41 109.75 -178.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 71.8 p -139.77 158.89 43.35 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 124.567 1.147 . . . . 61.1 109.953 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -164.27 172.45 13.55 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 124.815 1.246 . . . . 75.23 107.939 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -128.36 144.55 51.15 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.007 -1.849 . . . . 75.02 106.007 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 98.0 t -125.41 141.17 46.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.399 -2.075 . . . . 44.01 105.399 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 13.7 t -123.62 130.46 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 105.891 -1.892 . . . . 54.22 105.891 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -96.86 160.8 14.16 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 105.48 -2.044 . . . . 63.42 105.48 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -59.81 -46.27 89.75 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 112.1 0.407 . . . . 72.15 112.1 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -120.88 176.16 5.68 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.566 1.947 . . . . 75.43 110.526 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 14.2 tt -90.59 -11.58 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.776 1.23 . . . . 72.23 113.653 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -83.24 -52.82 6.24 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 120.6 -1.313 . . . . 72.22 110.1 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.61 -30.75 68.91 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.114 0.966 . . . . 73.4 110.846 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.68 88.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.014 0.526 . . . . 71.44 110.842 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.412 ' HG2' HG11 ' B' ' 17' ' ' VAL . 22.7 mttp -71.86 -39.12 69.9 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 121.535 -0.728 . . . . 70.05 109.809 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -54.77 -53.45 54.95 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 107.703 -1.221 . . . . 71.05 107.703 179.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.03 -40.52 96.51 Favored 'General case' 0 C--O 1.225 -0.188 0 C-N-CA 123.883 0.873 . . . . 71.13 111.937 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 50.9 t -50.91 -58.6 5.61 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 123.852 0.861 . . . . 74.54 111.395 -179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -66.95 -37.16 83.77 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 119.3 -0.381 . . . . 71.31 111.528 -179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.47 -26.82 68.11 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.021 0.528 . . . . 71.24 112.114 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 30.3 tp -103.78 -14.38 16.08 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.693 1.197 . . . . 73.43 113.987 -179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 9.4 t -59.06 116.29 3.73 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.112 -0.992 . . . . 55.13 110.031 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 66.45 20.22 69.49 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 117.96 -1.467 . . . . 62.0 114.262 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -52.13 133.03 33.75 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 119.052 1.426 . . . . 75.51 109.988 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -84.98 97.14 9.63 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.643 1.577 . . . . 73.2 111.149 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 2.4 m -138.86 146.71 25.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 126.09 1.756 . . . . 62.53 107.369 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 32.6 m 46.36 31.68 1.34 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.1 1.36 . . . . 54.14 113.297 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 10.6 m120 59.07 23.71 11.92 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.52 1.528 . . . . 55.12 112.003 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -116.54 179.19 4.07 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 128.41 2.684 . . . . 74.53 108.03 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -137.82 121.69 17.67 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.707 -1.59 . . . . 71.11 106.707 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 27.3 mt -74.73 168.17 20.37 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.537 -0.912 . . . . 73.42 108.537 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 6.6 t -132.96 107.07 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 105.167 -2.16 . . . . 44.43 105.167 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 58.9 t -96.18 132.86 39.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 124.237 1.015 . . . . 72.33 109.197 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 59.6 tp -143.85 157.25 44.49 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.867 1.267 . . . . 72.43 109.182 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -86.28 157.73 19.85 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.064 0.946 . . . . 53.04 108.891 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -81.95 161.52 23.03 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.76 . . . . 75.12 109.756 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 38.4 t30 . . . . . 0 C--O 1.243 0.752 0 C-N-CA 126.265 1.826 . . . . 72.21 108.698 -179.245 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.121 0 N-CA-C 109.135 -1.586 . . . . 74.34 109.135 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 5.2 t -147.9 150.51 36.04 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 105.59 -2.004 . . . . 75.42 105.59 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.21 107.97 1.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.772 2.315 . . . . 74.03 109.434 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 60.8 tt0 -85.84 89.29 7.73 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.401 -1.333 . . . . 71.33 107.401 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -80.68 107.46 13.51 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 106.717 -1.586 . . . . 71.13 106.717 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 87.1 mt -68.04 95.25 0.54 Allowed 'General case' 0 C--O 1.233 0.2 0 C-N-CA 124.956 1.302 . . . . 75.41 109.918 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -128.95 134.26 48.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 105.152 -2.166 . . . . 53.3 105.152 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . 53.65 28.09 7.59 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.099 0.56 . . . . 35.35 111.49 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 52.4 p-90 -71.99 -23.92 61.49 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.962 1.305 . . . . 74.45 110.592 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -66.1 156.62 33.37 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.809 -1.182 . . . . 72.44 107.809 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 10.0 m0 -130.24 -89.11 0.48 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 106.709 -1.589 . . . . 73.24 106.709 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -75.92 -165.97 0.52 Allowed 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 126.61 1.964 . . . . 74.51 110.484 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.64 156.63 41.72 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.243 1.017 . . . . 74.51 108.378 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.24 54.85 1.74 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.241 1.417 . . . . 60.44 108.502 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 2.4 pp -114.17 148.69 16.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 C-N-CA 124.724 1.21 . . . . 64.24 109.081 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 53.31 21.63 2.4 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 126.373 1.869 . . . . 73.52 113.544 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -75.71 47.46 0.41 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.641 2.377 . . . . 70.13 111.004 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 74.8 mtt85 -74.04 1.97 9.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.507 1.523 . . . . 74.44 110.961 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 22.1 p-10 -65.17 -34.89 79.45 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.907 1.283 . . . . 72.02 111.177 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 45.0 mmm-85 -68.56 151.13 97.41 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 107.201 -1.407 . . . . 74.43 107.201 178.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -68.8 -11.36 31.67 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 122.585 2.19 . . . . 73.44 112.013 179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 50.3 mt -55.8 136.86 50.9 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 126.713 2.005 . . . . 75.02 107.097 178.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 70.0 p -151.23 -172.31 4.18 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 124.008 0.923 . . . . 64.53 108.52 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -67.33 -30.61 70.48 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.248 -1.39 . . . . 74.21 107.248 177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.92 -48.9 42.19 Favored 'General case' 0 C--N 1.343 0.314 0 C-N-CA 125.09 1.356 . . . . 74.31 108.852 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -60.27 -33.11 71.86 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 119.254 -0.978 . . . . 73.35 109.091 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 13.5 tp -73.91 -40.29 63.25 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.728 0.811 . . . . 62.32 110.936 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -61.95 -45.2 94.73 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.296 1.838 . . . . 74.13 108.743 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.13 77.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.754 1.222 . . . . 71.22 110.747 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 47.2 mtp -78.18 -20.71 51.37 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.065 0.946 . . . . 75.21 111.55 179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -92.2 155.34 42.85 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 124.08 0.952 . . . . 64.33 110.322 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -77.99 168.53 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.542 2.162 . . . . 54.31 110.523 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.33 169.68 5.55 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.955 2.102 . . . . 71.54 112.468 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 66.04 20.9 69.33 Favored Glycine 0 CA--C 1.528 0.854 0 CA-C-O 118.731 -1.038 . . . . 65.02 113.955 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -122.95 157.09 33.38 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 119.674 1.737 . . . . 73.15 109.533 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -135.99 146.78 47.56 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.759 -1.109 . . . . 72.23 108.657 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . 0.409 HG13 HE21 ' B' ' 47' ' ' GLN . 98.0 t -70.28 151.06 9.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 105.779 -1.934 . . . . 54.53 105.779 178.269 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 41.9 tp -116.59 90.62 31.58 Favored Pre-proline 0 N--CA 1.453 -0.302 0 N-CA-C 103.231 -2.877 . . . . 65.22 103.231 178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.9 163.4 7.52 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.681 2.254 . . . . 74.51 112.622 -179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.65 155.63 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 121.97 1.78 . . . . 74.23 109.284 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -60.65 151.45 76.0 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.792 1.661 . . . . 54.3 112.581 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -69.65 150.35 47.12 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.898 -1.149 . . . . 33.03 107.898 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 63.31 23.44 66.44 Favored Glycine 0 CA--C 1.528 0.881 0 CA-C-O 118.244 -1.309 . . . . 74.41 114.036 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -75.17 120.81 21.17 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 119.587 1.693 . . . . 61.34 111.297 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 11.8 t -130.49 83.49 62.17 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 125.971 1.708 . . . . 70.34 107.06 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -63.89 173.38 4.84 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.22 2.613 . . . . 75.43 113.639 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 13.5 tt . . . . . 0 C--O 1.253 1.281 0 C-N-CA 125.816 1.647 . . . . 54.33 109.199 -179.281 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.686 0 N-CA-C 111.27 -0.732 . . . . 23.33 111.27 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -83.65 89.58 7.15 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 105.564 -2.013 . . . . 64.13 105.564 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -176.4 167.8 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.963 2.105 . . . . 71.44 107.71 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -109.15 169.61 8.58 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.663 -0.866 . . . . 74.34 108.663 178.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 47.4 pt -138.87 143.14 32.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 107.143 -1.429 . . . . 65.01 107.143 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -69.95 170.65 10.82 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 122.873 0.469 . . . . 74.2 109.982 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 12.4 tp 50.37 70.35 2.08 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 125.271 1.428 . . . . 64.23 109.093 -178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -62.84 166.31 14.27 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.148 1.899 . . . . 60.14 111.487 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -60.96 -47.58 12.46 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.978 1.786 . . . . 73.5 109.352 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -156.9 170.0 23.5 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.359 1.864 . . . . 75.13 108.889 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 65.5 t -152.9 137.97 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 106.381 -1.711 . . . . 72.44 106.381 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -137.13 159.36 42.14 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.808 1.243 . . . . 63.31 109.24 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 73.8 mtm180 -55.92 -34.24 65.43 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.318 1.447 . . . . 62.22 113.514 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 56.6 mt -79.5 136.13 24.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.155 -1.424 . . . . 64.22 107.155 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 80.5 mt -128.56 156.58 43.1 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 126.708 2.003 . . . . 75.13 107.912 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -124.94 126.13 45.01 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.297 1.839 . . . . 64.33 107.315 -179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -115.92 146.17 20.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.117 -1.438 . . . . 74.25 107.117 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -126.99 163.52 23.51 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 126.143 1.777 . . . . 75.24 107.529 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 66.11 28.96 10.12 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.313 1.445 . . . . 74.3 112.193 178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' B' ' 60' ' ' ALA . 78.2 mt -77.56 150.4 79.3 Favored Pre-proline 0 C--O 1.239 0.514 0 O-C-N 121.109 -0.994 . . . . 75.12 112.009 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.3 148.55 88.57 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.725 2.95 . . . . 71.5 109.647 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -84.97 -21.78 29.4 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.95 0.5 . . . . 74.14 112.066 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -124.87 94.96 4.34 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 107.523 -1.288 . . . . 74.02 107.523 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 12.8 tt -147.53 170.42 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 127.525 2.33 . . . . 74.5 106.333 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 61.3 p -131.26 170.17 14.96 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 120.013 1.279 . . . . 75.13 110.761 -178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.65 -34.55 74.45 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.614 -0.513 . . . . 71.22 109.614 178.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -57.74 -36.75 72.49 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.371 1.868 . . . . 64.52 110.323 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -86.86 -42.68 13.04 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.496 -0.752 . . . . 62.12 110.397 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 97.8 mmm -58.9 -35.27 72.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 118.667 -0.683 . . . . 73.05 111.362 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -86.59 -12.42 48.66 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.678 0.791 . . . . 62.42 111.535 178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.69 -61.81 1.63 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 120.57 1.532 . . . . 72.51 108.606 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 93.0 mt -48.6 -57.82 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 C-N-CA 124.514 1.126 . . . . 42.1 109.705 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -73.81 -23.91 59.73 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.443 0.535 . . . . 71.11 112.443 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.96 -23.41 74.74 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 124.165 0.888 . . . . 44.24 111.747 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 5.4 mtmp? -73.04 -2.77 22.55 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.653 1.227 . . . . 43.3 109.762 178.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -107.68 -11.58 15.4 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 117.78 -1.105 . . . . 75.21 111.863 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.17 -175.32 26.6 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 119.512 1.051 . . . . 51.25 112.761 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.0 151.74 83.16 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.316 3.344 . . . . 75.44 110.818 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 54.0 mt -121.77 130.26 74.75 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 107.908 -1.145 . . . . 75.45 107.908 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 10.0 ttt85 -74.17 -63.42 1.23 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.478 -0.934 . . . . 75.42 108.478 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . 0.409 HE21 HG13 ' A' ' 414' ' ' VAL . 10.9 tt0 -158.16 165.62 34.47 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.476 0.71 . . . . 71.43 109.188 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 59.3 mt -140.84 145.98 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.912 1.685 . . . . 75.42 107.468 179.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -136.26 154.4 50.91 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.333 -2.099 . . . . 75.52 105.333 177.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 10.5 m -135.57 153.01 32.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 123.919 0.887 . . . . 35.02 109.009 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -75.73 136.27 19.61 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 108.174 -1.971 . . . . 71.52 108.174 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -115.69 -23.48 8.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.665 -0.494 . . . . 73.41 109.665 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.7 p -80.28 156.82 73.69 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 123.684 0.794 . . . . 64.22 110.276 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -70.2 -14.04 34.24 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.059 2.506 . . . . 64.21 114.065 -178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -97.52 -1.11 44.74 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.354 0.979 . . . . 72.45 112.999 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 81.4 p -116.86 -13.04 10.7 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.409 1.004 . . . . 52.34 113.159 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -50.84 116.47 1.98 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.08 1.352 . . . . 73.34 109.803 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.12 -20.79 9.03 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 124.674 1.131 . . . . 54.54 112.33 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . . . . . . . . . 40.8 p -124.11 128.17 48.89 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.348 1.059 . . . . 73.33 109.797 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.427 ' HB3' ' CD1' ' B' ' 26' ' ' LEU . . . -140.34 175.76 9.33 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.512 1.125 . . . . 65.24 111.56 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -128.76 147.1 50.75 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.189 0.595 . . . . 75.24 110.269 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 59.9 t -127.59 148.93 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 C-N-CA 126.667 1.987 . . . . 63.1 105.894 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 15.9 t -127.61 124.27 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 105.806 -1.924 . . . . 73.21 105.806 178.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -98.65 163.04 12.81 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 107.531 -1.285 . . . . 62.42 107.531 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -89.18 -61.71 1.64 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 108.759 -0.83 . . . . 72.21 108.759 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.18 138.82 32.78 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 121.033 -1.042 . . . . 73.13 110.986 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 3.9 tt -71.43 -43.47 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 O-C-N 121.203 -0.935 . . . . 74.04 110.7 179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -63.63 -28.03 69.64 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 119.159 0.89 . . . . 75.5 111.334 179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -75.93 -48.05 22.77 Favored 'General case' 0 C--N 1.334 -0.107 0 C-N-CA 125.316 1.446 . . . . 51.13 108.038 178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.22 -45.85 79.75 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.03 0.932 . . . . 51.31 108.832 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -65.03 -36.96 86.03 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.945 1.298 . . . . 64.05 111.321 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -63.59 -55.85 20.48 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 107.782 -1.192 . . . . 60.13 107.782 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.88 -32.4 73.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.958 0.903 . . . . 25.51 111.09 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 49.5 t -62.96 -57.07 11.99 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.211 -1.403 . . . . 74.13 107.211 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.87 -42.12 98.68 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 119.253 -0.403 . . . . 71.41 111.11 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -70.04 -20.12 63.26 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 118.263 -0.875 . . . . 72.41 112.592 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 33.2 tp -100.46 -28.12 13.08 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 120.723 1.601 . . . . 73.31 111.293 179.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 20.6 t -66.23 107.92 2.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 125.517 1.527 . . . . 65.43 107.64 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 97.24 10.09 54.76 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 125.204 1.383 . . . . 75.45 113.57 -178.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -74.7 122.12 22.76 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.362 1.581 . . . . 71.41 108.004 178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -85.07 132.65 34.29 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.773 -1.195 . . . . 34.3 107.773 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -146.19 135.69 17.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.964 -1.495 . . . . 51.43 106.964 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 34.6 m 46.2 42.38 9.97 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.65 1.58 . . . . 73.24 113.268 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 70.64 3.93 4.76 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.804 2.842 . . . . 54.45 114.256 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? -111.88 161.81 15.98 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 120.196 -1.565 . . . . 75.22 109.917 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -110.52 117.71 34.29 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.542 -0.911 . . . . 74.21 108.542 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.64 154.6 39.65 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.667 -0.864 . . . . 73.11 108.667 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 39.2 t -128.0 127.52 67.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 107.031 -1.47 . . . . 65.35 107.031 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -115.77 137.77 48.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 126.28 1.832 . . . . 71.35 108.183 -179.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 57.1 tp -144.59 137.1 26.5 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.859 0.864 . . . . 54.34 110.272 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -66.87 153.66 42.91 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 124.043 0.937 . . . . 73.11 108.95 179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -76.37 163.69 26.74 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.498 -0.752 . . . . 75.35 112.99 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 1.4 t30 . . . . . 0 C--O 1.249 1.076 0 C-N-CA 127.284 2.234 . . . . 73.4 105.596 179.389 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.745 0 N-CA-C 111.034 -0.826 . . . . 64.3 111.034 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' THR . . . . . . . . . . . . . 6.0 t -131.96 154.27 81.66 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 126.943 2.097 . . . . 74.24 106.075 179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.25 123.99 11.94 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 CA-C-N 121.447 1.553 . . . . 53.11 108.646 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -153.0 159.7 42.93 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.384 1.074 . . . . 74.44 108.217 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -139.39 162.03 36.02 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.176 1.79 . . . . 72.3 106.905 178.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -103.06 156.31 17.77 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 109.598 -0.519 . . . . 65.43 109.598 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -156.5 176.28 12.92 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 128.565 2.746 . . . . 71.52 106.46 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ALA . . . . . . . . . . . . . . . -147.11 118.96 8.09 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 125.936 1.695 . . . . 73.45 107.658 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -70.27 167.69 17.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.122 0.569 . . . . 73.21 110.791 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ARG . . . . . . . . . . . . . 12.6 ptm180 -120.6 145.69 47.12 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.714 1.205 . . . . 72.53 109.033 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' TRP . . . . . . . . . . . . . 50.2 p-90 -138.61 139.76 38.69 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 107.931 -1.137 . . . . 73.03 107.931 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -153.84 125.75 7.77 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 103.848 -2.649 . . . . 74.4 103.848 -179.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ARG . . . . . . . . . . . . . 14.9 mmm-85 -147.36 88.43 1.71 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.173 0.897 . . . . 70.21 109.678 -178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -93.89 179.51 5.32 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 109.294 -0.632 . . . . 64.22 109.294 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 64.8 mt -115.01 107.79 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 106.434 -1.691 . . . . 71.11 106.434 -178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -145.32 179.24 7.52 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 126.524 1.93 . . . . 71.53 106.32 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLU . . . . . . . . . . . . . 26.2 pt-20 -149.61 125.04 10.25 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 105.466 -2.05 . . . . 73.44 105.466 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -140.31 168.9 18.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 124.951 1.301 . . . . 71.1 109.888 -179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -85.84 25.96 1.04 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.136 1.775 . . . . 63.45 110.382 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -65.58 149.06 97.73 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 124.043 0.937 . . . . 61.2 109.733 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.78 167.49 26.19 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.831 2.354 . . . . 64.34 112.4 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' LEU . . . . . . . . . . . . . 58.5 mt -37.61 118.1 0.62 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 127.59 2.356 . . . . 63.21 112.041 179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' SER . . . . . . . . . . . . . 25.1 m -138.11 -166.61 2.0 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.799 2.04 . . . . 53.55 108.426 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.96 -23.68 65.98 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 121.446 -0.784 . . . . 71.41 111.179 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -61.82 -48.1 82.14 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 107.613 -1.254 . . . . 73.23 107.613 178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -68.38 -17.03 64.14 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.458 1.103 . . . . 74.3 110.624 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' LEU . . . . . . . . . . . . . 25.9 tp -86.64 -38.91 16.6 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 107.033 -1.469 . . . . 75.31 107.033 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -60.73 -41.89 96.23 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 108.85 -0.796 . . . . 74.01 108.85 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' ALA . . . . . . . . . . . . . . . -60.29 -17.88 45.46 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.92 0.888 . . . . 51.32 112.493 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' MET . . . . . . . . . . . . . 93.1 mtp -84.94 -1.25 56.46 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.446 1.098 . . . . 72.22 111.486 179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -112.4 158.16 38.02 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 119.817 1.19 . . . . 75.03 111.711 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -72.96 175.61 10.19 Favored 'Trans proline' 0 C--O 1.239 0.567 0 C-N-CA 123.619 2.879 . . . . 74.34 112.204 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.56 166.15 21.42 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.358 -0.837 . . . . 71.2 110.33 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLY . . . . . . . . . . . . . . . 69.41 37.01 78.96 Favored Glycine 0 N--CA 1.45 -0.414 0 O-C-N 121.388 -0.82 . . . . 71.13 113.531 178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -123.38 157.57 33.06 Favored 'General case' 0 C--O 1.234 0.283 0 O-C-N 120.711 -1.464 . . . . 75.35 107.902 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.77 137.09 43.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 106.203 -1.777 . . . . 71.04 106.203 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' VAL . . . . . . . . . . . . . 34.7 t -70.31 149.67 10.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 N-CA-C 109.004 -0.739 . . . . 63.23 109.004 -179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' LEU . . . . . . . . . . . . . 35.9 tp -125.52 77.63 68.86 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 107.777 -1.194 . . . . 64.32 107.777 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.4 169.27 9.85 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.838 2.358 . . . . 71.24 111.701 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -51.18 161.46 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.424 3.416 . . . . 52.35 114.387 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -52.4 155.63 9.44 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 124.669 3.579 . . . . 55.33 115.837 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' ALA . . . . . . . . . . . . . . . -80.81 155.93 26.4 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 106.736 -1.579 . . . . 63.51 106.736 177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' GLY . . . . . . . . . . . . . . . 67.33 13.34 62.47 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.979 -0.901 . . . . 63.13 114.477 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -78.94 156.21 28.64 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 119.326 1.563 . . . . 73.34 109.485 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' VAL . . . . . . . . . . . . . 4.3 t -125.63 67.32 58.37 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 123.971 0.908 . . . . 71.41 109.759 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -75.99 -1.56 11.57 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 123.393 2.728 . . . . 65.41 114.571 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' ILE . . . . . . . . . . . . . 29.3 mm . . . . . 0 C--O 1.253 1.272 0 CA-C-N 120.316 1.416 . . . . 74.01 107.979 -179.433 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.688 0 N-CA-C 109.936 -1.265 . . . . 54.12 109.936 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.68 124.22 23.04 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 106.343 -1.725 . . . . 74.21 106.343 178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -59.76 126.63 28.34 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.316 0.507 . . . . 74.22 110.142 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -107.56 -3.52 19.26 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.3 1.84 . . . . 75.21 113.201 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ILE . . . . . . . . . . . . . 33.8 pt -95.84 171.65 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.432 0 C-N-CA 126.586 1.954 . . . . 60.11 110.92 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -92.89 -36.38 12.84 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 121.484 -0.76 . . . . 74.3 112.226 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 4.7 mp -100.14 172.91 4.13 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 125.047 1.339 . . . . 55.34 113.952 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.25 172.41 16.07 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.87 3.047 . . . . 73.03 109.41 178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.78 -63.77 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.86 2.374 . . . . 63.43 111.657 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -149.61 142.97 25.24 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 127.811 2.444 . . . . 74.22 106.109 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 59.2 t -142.4 135.92 27.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.083 -2.191 . . . . 72.32 105.083 178.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -130.75 166.55 20.54 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 124.717 1.207 . . . . 72.42 109.738 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ARG . . . . . . . . . . . . . 45.8 mtp180 -70.21 -41.78 73.17 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 118.521 -0.752 . . . . 74.11 112.966 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 57.7 mt -89.14 133.96 29.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 108.146 -1.057 . . . . 63.23 108.146 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' LEU . . . . . . . . . . . . . 36.9 mt -123.47 156.58 35.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 125.175 1.39 . . . . 73.41 109.397 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -111.71 137.53 49.49 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 127.554 2.342 . . . . 73.54 107.554 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 23.8 mm -123.18 144.65 32.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 126.919 2.088 . . . . 53.33 107.189 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.4 ' HG2' HG22 ' B' ' 59' ' ' THR . 74.8 mtp85 -144.83 163.03 35.32 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.426 1.09 . . . . 53.43 110.75 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 72.04 25.47 3.01 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 127.805 2.442 . . . . 74.55 111.278 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -73.91 157.22 87.44 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.998 1.319 . . . . 65.0 112.7 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.71 160.28 44.1 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 123.651 2.901 . . . . 63.31 112.263 179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -93.73 -10.96 32.53 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.752 1.621 . . . . 75.31 110.936 178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 mmmp? -128.69 95.32 4.08 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 106.883 -1.525 . . . . 73.14 106.883 -179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . . . . . . . . . 17.5 tt -155.16 160.71 2.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 124.206 0.941 . . . . 61.4 108.526 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' THR . . . . . . . . . . . . . 8.4 p -138.08 175.73 9.32 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.171 1.388 . . . . 73.43 109.078 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.89 -36.97 70.74 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.285 0.634 . . . . 35.23 111.981 -179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 24.4 mp0 -56.93 -46.22 82.2 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.134 0.974 . . . . 73.33 111.96 -179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -78.29 -40.54 36.57 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.549 0.74 . . . . 72.34 109.721 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' MET . . . . . . . . . . . . . 79.2 mmm -61.05 -46.23 91.54 Favored 'General case' 0 CA--C 1.529 0.171 0 O-C-N 120.984 -1.072 . . . . 70.42 110.261 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -71.68 -23.27 61.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 118.374 -0.822 . . . . 71.11 109.938 -179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -66.64 -46.6 75.26 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 119.761 1.164 . . . . 54.34 108.063 177.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 51.3 mt -67.79 -69.49 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.04 1.336 . . . . 73.21 110.902 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' PHE . . . . . 0.429 ' CE1' HG21 ' B' ' 62' ' ' VAL . 86.7 m-85 -60.32 -26.22 66.38 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 115.886 1.809 . . . . 71.25 115.886 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.54 -23.6 73.71 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-N 119.341 0.973 . . . . 54.33 111.946 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -65.83 -15.19 62.67 Favored 'General case' 0 C--O 1.236 0.348 0 O-C-N 121.306 -1.114 . . . . 74.33 111.037 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -107.33 -4.48 18.58 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 114.936 1.458 . . . . 73.02 114.936 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.92 -173.7 21.45 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-N 119.753 1.16 . . . . 63.23 114.053 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.27 117.89 5.16 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 125.264 3.976 . . . . 53.25 113.791 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 71.5 mt -77.27 103.07 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 127.195 2.198 . . . . 74.21 108.682 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -66.46 -61.79 1.81 Allowed 'General case' 0 N--CA 1.471 0.61 0 O-C-N 120.854 -1.154 . . . . 74.54 110.637 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -160.78 142.85 12.48 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 118.892 0.769 . . . . 73.03 111.603 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' ILE . . . . . . . . . . . . . 16.7 mt -126.89 140.32 49.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 C-N-CA 124.502 1.121 . . . . 74.24 109.539 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -137.37 122.47 19.13 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 103.767 -2.679 . . . . 65.32 103.767 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' VAL . . . . . . . . . . . . . 33.5 m -111.17 145.99 16.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 124.501 1.12 . . . . 72.44 108.732 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . -69.84 125.36 16.13 Favored Glycine 0 CA--C 1.523 0.572 0 N-CA-C 107.089 -2.405 . . . . 64.42 107.089 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -100.37 -20.57 15.76 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 118.521 1.16 . . . . 65.0 113.954 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 1.2 p -73.75 157.14 87.8 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 105.998 -1.853 . . . . 73.44 105.998 177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.24 -20.29 70.39 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.106 1.871 . . . . 53.11 111.843 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.8 -44.43 16.97 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.282 1.433 . . . . 74.22 109.774 179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 77.4 p -74.62 -0.94 19.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.254 -0.904 . . . . 61.12 112.176 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -64.61 163.44 13.71 Favored 'General case' 0 C--N 1.341 0.213 0 O-C-N 120.887 -1.133 . . . . 73.44 109.363 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 72.54 -9.36 6.07 Favored Glycine 0 CA--C 1.529 0.927 0 CA-C-O 118.547 -1.141 . . . . 32.44 112.567 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' THR . . . . . 0.4 HG22 ' HG2' ' B' ' 24' ' ' ARG . 44.3 p -128.77 144.63 51.21 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.469 1.634 . . . . 65.22 110.312 -178.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.72 175.37 12.69 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.224 1.01 . . . . 64.21 110.027 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -127.62 156.16 42.73 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.324 0.649 . . . . 51.31 110.531 179.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.429 HG21 ' CE1' ' B' ' 39' ' ' PHE . 62.1 t -142.55 144.95 23.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 107.537 -1.282 . . . . 70.1 107.537 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 t -127.48 149.16 32.27 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.077 -1.453 . . . . 75.42 107.077 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -116.24 160.2 20.78 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 120.403 -1.436 . . . . 75.32 108.78 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -65.7 -40.99 92.85 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.396 -0.594 . . . . 52.45 109.396 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -122.35 142.52 50.42 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.195 -1.039 . . . . 73.11 108.195 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.45 -24.51 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 O-C-N 121.681 -0.637 . . . . 73.43 110.845 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -64.66 -25.42 67.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.415 1.086 . . . . 73.55 110.581 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -74.9 -53.08 9.68 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 105.338 -2.097 . . . . 70.45 105.338 178.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ALA . . . . . . . . . . . . . . . -50.85 -35.71 33.94 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.241 1.016 . . . . 72.21 111.943 179.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -57.14 -69.14 0.17 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.07 1.348 . . . . 74.1 111.659 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -67.99 -37.55 81.6 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 121.511 -0.743 . . . . 64.22 111.671 -178.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.53 -37.34 80.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 118.543 -0.741 . . . . 65.1 111.838 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.71 -61.67 2.16 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.053 -0.721 . . . . 73.31 109.053 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -60.51 -31.79 70.84 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 113.603 0.964 . . . . 74.31 113.603 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' HIS . . . . . . . . . . . . . 19.0 t-160 -73.88 -26.77 60.73 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.446 0.566 . . . . 72.32 111.1 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.21 -16.53 18.52 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.119 0.968 . . . . 74.45 112.669 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 10.7 t -63.11 108.06 1.16 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 126.141 1.777 . . . . 72.52 108.238 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.73 10.5 83.1 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 118.209 -1.329 . . . . 65.32 113.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -57.02 141.53 45.36 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 119.112 1.456 . . . . 73.15 111.006 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -94.96 113.61 25.34 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 115.231 1.567 . . . . 74.0 115.231 -178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' VAL . . . . . . . . . . . . . 11.9 m -133.21 141.77 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 105.401 -2.074 . . . . 71.13 105.401 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' CYS . . . . . . . . . . . . . 74.8 m 42.92 36.71 0.92 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.84 1.656 . . . . 54.32 113.607 -178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 65.26 21.56 12.04 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.299 1.84 . . . . 60.04 112.668 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.54 -179.54 3.74 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.779 2.432 . . . . 75.12 108.442 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -138.03 114.11 10.05 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 105.873 -1.899 . . . . 70.24 105.873 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 50.6 mt -69.02 168.76 13.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.297 0.639 . . . . 71.44 110.97 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 12.2 t -132.02 107.85 13.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 124.855 1.262 . . . . 71.11 107.73 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 54.9 t -92.74 135.91 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 107.19 -1.411 . . . . 71.32 107.19 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' LEU . . . . . . . . . . . . . 31.7 tp -151.98 141.96 22.12 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.253 1.021 . . . . 74.03 108.803 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -73.17 154.75 40.17 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 118.943 0.792 . . . . 74.25 110.215 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -76.09 148.16 38.1 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 106.964 -1.495 . . . . 74.41 106.964 177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' ASN . . . . . . . . . . . . . 2.5 p30 . . . . . 0 C--O 1.248 1.016 0 C-N-CA 126.977 2.111 . . . . 74.31 106.417 178.771 . . . . . . . . 0 0 . 1 stop_ save_